Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AC048338.2 ENSG00000284934 "Novel protein" 12 122207662-122227534 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "adrenal gland: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 19.5" "Low region specificity" "Detected in many" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" 0.0 3.0 0.1 0.3 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.4 1.7 19.5 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.4 0.6 0.4 0.1 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093525.2 ENSG00000260272 "Novel protein" 16 2496032-2520218 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 3.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 44.1;Club cells: 17.3;granulocytes: 17.7;Macrophages: 7.7;Respiratory ciliated cells: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;RPMI-8226: 1.1;SCLC-21H: 1.0;SH-SY5Y: 1.3" HPA044712 Uncertain NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 11: Alveolar cells - Smell perception" "HPA044712: AB_10795619" "unprognostic (4.12e-1)" "unprognostic (9.64e-2)" "unprognostic (4.36e-3)" "unprognostic (1.13e-1)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (3.34e-2)" "unprognostic (2.34e-1)" "unprognostic (1.37e-1)" "unprognostic (9.77e-3)" "unprognostic (9.13e-2)" "unprognostic (9.83e-2)" "unprognostic (5.98e-3)" 0.4 0.2 0.0 0.0 0.0 0.7 0.4 0.0 0.4 0.3 0.0 0.3 0.0 0.2 0.0 0.1 0.3 0.0 0.3 0.0 0.0 3.0 0.2 0.7 0.0 0.1 0.0 0.1 0.4 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.0 0.0 0.2 0.3 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.1 0.1 0.3 0.4 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.7 0.1 0.3 0.0 0.0 0.3 0.1 0.0 1.1 0.1 0.0 1.0 1.3 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 22.4 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 ACTL6B "ACTL6, BAF53B" ENSG00000077080 "Actin like 6B" O94805 7 100643097-100656448 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 20.7;pituitary gland: 15.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.0;Excitatory neurons: 22.1;Horizontal cells: 6.7;Inhibitory neurons: 19.0" "Group enriched" "Detected in some" 11 "glioma: 3.9;pancreatic cancer: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 76 "SCLC-21H: 28.5;SH-SY5Y: 28.7" "Low region specificity" "Detected in all" HPA045126 Uncertain Approved "Nucleoli rim,Mitotic chromosome" Yes NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli rim, Mitotic chromosome" "HPA045126: AB_10961265" "unprognostic (3.31e-2)" "unprognostic (6.89e-2)" "unprognostic (4.59e-3)" "unprognostic (4.15e-2)" "unprognostic (1.27e-3)" "unprognostic (4.81e-3)" "unprognostic (6.00e-2)" "unprognostic (8.26e-3)" "unprognostic (1.29e-1)" "unprognostic (4.72e-3)" "unprognostic (1.28e-1)" "unprognostic (3.01e-4)" "unprognostic (1.64e-1)" "unprognostic (6.84e-2)" "unprognostic (2.01e-2)" 0.0 1.8 13.8 0.0 14.5 0.0 0.0 9.4 20.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.9 8.5 0.0 0.0 0.0 0.0 4.4 1.8 0.0 0.8 0.1 15.3 0.0 4.3 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.5 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 28.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 14.5 9.4 20.7 14.9 8.5 4.4 1.8 4.3 1.7 3.9 11.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.6 8.0 0.0 0.1 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 22.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.7 19.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.0 0.0 1.2 0.0 3.5 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 ADAMTS19 ENSG00000145808 "ADAM metallopeptidase with thrombospondin type 1 motif 19" 5 129460281-129738683 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 3.3;cervix: 10.2;endometrium 1: 9.8;placenta: 3.7;smooth muscle: 5.9" "Group enriched" "Detected in some" 4 "Excitatory neurons: 82.6;Inhibitory neurons: 79.7;Oligodendrocytes: 31.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7;testis cancer: 1.2" "Region enhanced" "Detected in some" "basal ganglia: 3.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MCF7: 15.9;SH-SY5Y: 34.8" "Region enriched" "Detected in single" 5 "olfactory bulb: 2.6" "Low region specificity" "Detected in many" "HPA056171, HPA058438" Uncertain Approved Vesicles,Midbody "Secreted to extracellular matrix" Yes NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Midbody" "HPA056171: AB_2683054, HPA058438: AB_2683718" "unprognostic (1.14e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.10e-3)" "unprognostic (1.09e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-2)" "unprognostic (4.17e-2)" "unprognostic (5.99e-3)" "unprognostic (5.17e-1)" "unprognostic (1.14e-1)" "unprognostic (5.88e-2)" "unprognostic (3.06e-2)" 0.0 0.6 1.0 0.0 3.3 0.0 0.0 0.0 1.5 10.2 0.1 0.2 0.1 9.8 0.0 0.2 0.2 0.0 0.2 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 0.0 3.7 0.0 0.1 0.3 0.5 0.3 0.0 0.5 0.0 0.1 5.9 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 15.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 34.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.3 0.0 1.5 0.8 0.2 0.0 0.5 0.0 0.0 0.3 0.6 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 1.4 0.0 0.0 1.8 0.0 15.6 0.0 0.3 0.0 0.0 1.5 0.5 8.9 0.2 0.0 0.0 82.6 0.2 0.7 1.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 79.7 0.1 0.0 0.0 0.3 0.7 0.0 0.1 0.0 1.0 0.0 1.1 0.0 12.5 31.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.4 0.1 0.1 0.0 5.2 0.1 0.1 0.3 0.0 ADAMTS9 KIAA1312 ENSG00000163638 "ADAM metallopeptidase with thrombospondin type 1 motif 9" Q9P2N4 3 64515654-64688000 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 41.2" "Cell type enhanced" "Detected in many" "Adipocytes: 166.3;Astrocytes: 84.2;Basal prostatic cells: 87.2;Endometrial stromal cells: 179.1;Endothelial cells: 221.0;Prostatic glandular cells: 115.7;Smooth muscle cells: 94.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 23.6;RPTEC TERT1: 27.1;SH-SY5Y: 128.3;SuSa: 40.5;WM-115: 28.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028567, HPA028577, HPA028601" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" No NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "Endoplasmic reticulum" "HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694" "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (4.83e-2)" "unprognostic (3.08e-1)" "unprognostic (1.37e-2)" "unprognostic (7.80e-3)" "unprognostic (5.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "unprognostic (7.67e-2)" "unprognostic (3.16e-3)" "unprognostic (1.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-3)" "unprognostic (5.00e-3)" 41.2 4.8 4.0 12.2 5.0 0.1 19.0 5.5 5.3 16.2 7.9 8.1 1.2 13.2 1.1 5.3 10.2 7.8 15.6 4.4 5.6 9.5 2.7 13.6 1.9 10.8 8.1 7.3 9.8 6.3 2.2 31.7 8.5 7.9 2.7 1.4 3.2 3.7 7.4 2.6 3.7 12.1 8.0 4.1 4.7 0.8 8.1 1.0 7.3 7.3 1.1 22.5 9.0 6.4 0.0 1.2 13.9 0.0 0.6 0.1 1.3 0.2 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.3 0.4 0.0 1.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.9 0.0 8.8 2.6 0.0 0.0 0.5 0.0 23.6 0.0 0.5 0.0 0.3 0.1 0.0 0.0 7.5 1.1 0.0 0.0 2.4 0.1 27.1 0.3 0.1 128.3 0.0 0.0 0.0 40.5 0.0 0.7 5.4 0.8 0.4 0.0 0.8 0.0 0.0 0.0 0.5 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 5.0 5.5 5.3 4.4 5.6 10.8 8.1 8.5 8.0 8.1 6.4 166.3 3.2 4.8 84.2 0.0 17.5 87.2 0.0 4.6 0.0 6.9 15.9 6.6 2.8 2.6 38.6 2.1 1.0 0.2 1.1 0.0 69.7 0.9 13.2 179.1 221.0 1.2 0.0 4.2 3.3 0.6 31.4 1.5 33.8 0.0 8.4 27.1 0.3 7.5 0.0 14.3 1.1 0.0 0.3 20.1 0.4 2.5 2.7 26.6 21.5 0.0 0.2 0.0 26.7 0.6 45.5 1.0 2.2 0.0 115.7 0.0 10.8 0.1 0.1 0.0 20.7 94.8 0.3 0.7 1.3 13.5 1.6 3.2 12.1 0.9 36.7 ADAMTSL2 KIAA0605 ENSG00000197859 "ADAMTS like 2" Q86TH1 9 133532164-133575519 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 73.2;liver: 35.8" "Cell type enhanced" "Detected in some" "Distal tubular cells: 5.9;Endothelial cells: 5.7;Fibroblasts: 8.5;Microglial cells: 12.2;Sertoli cells: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 7.4;RPMI-8226: 10.1;SH-SY5Y: 30.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045634, HPA053812" Approved Approved Vesicles "Secreted in other tissues" NA NA 170000000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA045634: AB_2679399, HPA053812: AB_2682271" "unprognostic (5.10e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.35e-2)" "unprognostic (1.07e-1)" "unprognostic (5.50e-2)" "unprognostic (6.78e-3)" "unprognostic (1.31e-2)" "unprognostic (5.49e-2)" "unprognostic (1.35e-1)" "prognostic favorable (6.70e-4)" "unprognostic (5.17e-2)" "unprognostic (7.37e-2)" "unprognostic (1.56e-1)" "unprognostic (3.40e-1)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" 3.7 28.5 6.8 1.0 7.3 0.1 1.5 12.0 10.1 2.3 1.4 2.7 1.4 3.1 3.1 1.8 3.1 2.5 73.2 5.8 7.9 25.9 35.8 23.2 3.4 19.3 11.1 4.9 7.1 1.2 15.9 1.5 20.8 8.4 0.3 0.3 3.4 2.2 4.3 0.8 3.2 0.9 8.5 6.4 2.3 3.1 9.3 0.6 12.1 0.5 0.6 5.3 1.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.6 0.5 0.0 1.1 0.7 10.1 0.0 0.0 1.4 30.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 7.3 12.0 10.1 5.8 7.9 19.3 11.1 20.8 8.5 9.3 7.6 1.4 0.0 0.5 4.9 0.1 0.1 0.1 0.0 0.0 4.2 0.0 0.1 2.3 0.0 0.0 1.8 0.0 0.1 0.0 1.4 5.9 0.2 0.1 0.1 0.1 5.7 5.3 0.0 5.0 0.0 0.1 8.5 0.0 0.0 0.0 0.1 4.6 0.9 0.3 0.0 3.8 0.4 0.0 0.3 0.8 1.1 4.7 0.6 0.0 12.2 0.0 0.4 0.0 2.5 4.0 0.2 0.5 3.0 0.0 0.2 0.0 0.7 0.0 0.2 6.6 1.1 1.6 0.1 0.8 0.4 0.3 0.0 0.6 0.7 1.1 0.2 ADCYAP1R1 "PAC1, PAC1R, PACAPR" ENSG00000078549 "ADCYAP receptor type I" P41586 7 31052308-31111479 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 148.0" "Group enriched" "Detected in some" 4 "Astrocytes: 57.1;Inhibitory neurons: 45.7" "Cancer enriched" "Detected in some" 11 "glioma: 45.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.7;NTERA-2: 4.8;SCLC-21H: 4.1;SH-SY5Y: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030739, HPA049877" Enhanced Enhanced Vesicles NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" Vesicles "HPA030739: AB_2732461, HPA049877: AB_2680928" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.16e-2)" "prognostic favorable (5.78e-4)" "unprognostic (2.17e-1)" "unprognostic (8.36e-2)" "unprognostic (4.93e-2)" "unprognostic (5.75e-2)" "unprognostic (3.50e-2)" "unprognostic (3.88e-1)" "unprognostic (1.58e-1)" "unprognostic (6.67e-3)" "unprognostic (6.43e-4)" "unprognostic (1.09e-3)" "unprognostic (9.55e-2)" "unprognostic (3.85e-2)" "unprognostic (2.75e-4)" 7.4 11.4 91.8 2.3 79.8 0.0 4.0 53.4 57.6 13.1 3.5 7.1 0.8 5.3 1.5 2.9 29.5 1.3 3.8 69.7 106.5 0.1 0.2 0.8 0.1 96.0 102.7 1.8 1.6 1.6 9.8 0.0 88.9 1.8 1.3 2.7 2.2 3.2 1.3 1.1 2.2 3.7 67.9 0.5 3.5 1.6 148.0 0.8 2.1 8.0 0.8 1.8 4.3 43.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 7.4 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.6 0.8 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.8 79.8 53.4 57.6 69.7 106.5 96.0 102.7 88.9 67.9 148.0 43.7 4.2 0.0 0.0 57.1 0.0 0.5 0.0 0.0 0.0 1.7 0.2 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.2 0.7 0.0 0.0 10.8 0.0 0.0 4.6 0.0 6.3 0.0 1.2 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.7 0.9 11.5 0.0 1.8 2.8 0.0 0.0 0.0 11.6 1.5 0.0 0.0 5.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 5.8 0.3 1.5 0.0 0.3 0.0 0.2 0.1 0.0 0.1 ADGRB3 "BAI3, KIAA0550" ENSG00000135298 "Adhesion G protein-coupled receptor B3" O60242 6 68635282-69389506 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.6;pituitary gland: 23.7" "Group enriched" "Detected in some" 10 "Astrocytes: 1795.3;Excitatory neurons: 3843.1;Inhibitory neurons: 2738.1;Oligodendrocyte precursor cells: 2036.3;Oligodendrocytes: 1210.5" "Cancer enriched" "Detected in single" 10 "glioma: 3.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 8.8;SH-SY5Y: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 8600 "Cluster 6: Brain - Smell perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (2.69e-1)" "unprognostic (3.72e-3)" "unprognostic (3.27e-2)" "unprognostic (1.04e-1)" "unprognostic (2.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (5.08e-5)" "unprognostic (4.93e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-3)" "unprognostic (2.43e-1)" "unprognostic (1.01e-1)" "unprognostic (8.16e-3)" 0.8 3.9 21.1 0.8 25.5 0.0 0.6 49.6 29.7 1.3 0.0 4.3 0.4 2.2 0.9 0.7 0.9 0.9 1.9 31.1 12.1 1.0 0.5 1.7 0.0 0.0 0.6 1.6 0.3 0.1 23.7 0.1 1.1 1.0 1.3 7.1 1.2 1.4 0.3 0.4 1.4 3.3 0.0 0.6 1.3 1.9 18.2 0.1 0.8 1.4 0.0 2.6 1.4 19.1 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.0 0.0 1.2 1.0 0.0 0.0 8.8 19.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 21.1 25.5 49.6 29.7 31.1 12.1 0.0 0.6 1.1 0.0 18.2 19.1 3.1 0.0 0.0 1795.3 0.3 0.0 0.1 0.0 0.0 47.3 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.2 4.8 0.6 0.0 0.0 3843.1 0.0 0.0 2.1 0.0 0.0 0.0 0.8 3.6 0.0 0.0 0.0 2738.1 0.0 0.0 0.6 0.0 3.1 5.0 1.3 0.0 216.4 1.0 0.8 0.0 2036.3 1210.5 0.1 0.0 8.6 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.6 7.4 11.8 3.2 0.2 0.0 0.0 0.0 0.5 0.0 0.1 AKT3 "PKBG, PRKBG, RAC-gamma" ENSG00000117020 "AKT serine/threonine kinase 3" Q9Y243 1 243488233-243851079 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.9" "Group enriched" "Detected in many" 6 "Astrocytes: 457.4;Excitatory neurons: 756.1;Inhibitory neurons: 514.5;Microglial cells: 414.1;Oligodendrocyte precursor cells: 633.3;Oligodendrocytes: 475.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013090, HPA026441" Approved Supported Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "CAB013090: AB_2533692, HPA026441: AB_1844711" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (2.40e-2)" "unprognostic (8.45e-2)" "unprognostic (1.89e-1)" "unprognostic (1.75e-1)" "unprognostic (1.96e-1)" "unprognostic (3.77e-1)" "unprognostic (2.32e-1)" "unprognostic (2.28e-1)" "unprognostic (5.47e-3)" "unprognostic (1.37e-1)" "unprognostic (6.71e-2)" "unprognostic (3.64e-3)" "unprognostic (1.29e-1)" "unprognostic (8.14e-2)" "prognostic unfavorable (9.27e-4)" 19.3 9.7 13.4 6.0 17.0 3.8 15.5 59.9 36.6 20.0 0.0 24.5 2.6 22.7 8.6 5.9 20.3 8.2 11.8 22.8 5.6 11.2 4.7 15.3 5.9 1.2 3.9 26.4 4.5 7.4 13.9 13.1 7.4 15.8 4.9 17.0 5.1 15.6 5.9 6.3 11.8 15.7 0.8 8.1 10.2 9.7 20.3 7.0 14.4 11.5 4.6 18.8 14.8 31.1 30.8 7.2 31.0 0.4 16.9 20.6 13.9 20.8 22.5 11.8 12.9 1.1 13.9 0.5 3.0 28.9 12.1 1.2 16.3 8.5 18.9 9.0 15.3 1.0 1.0 0.3 11.7 0.6 6.5 11.3 0.3 15.5 16.9 30.3 30.2 7.2 0.5 1.1 9.0 0.9 7.6 3.3 14.4 0.3 5.1 4.2 19.7 0.6 4.8 4.1 31.4 41.9 1.3 0.5 40.1 19.1 1.9 21.5 25.6 22.7 17.7 1.1 19.5 4.6 4.6 7.1 19.4 5.2 25.3 1.3 0.8 0.1 0.6 0.1 1.1 0.6 0.6 0.6 0.3 0.8 0.6 0.7 0.7 1.4 0.3 0.5 0.1 0.3 13.4 17.0 59.9 36.6 22.8 5.6 1.2 3.9 7.4 0.8 20.3 31.1 65.4 3.2 2.2 457.4 22.2 2.4 15.0 1.3 17.1 43.6 6.1 5.1 5.4 4.3 2.7 27.6 33.3 11.0 24.4 0.0 0.0 11.6 82.8 1.7 35.5 43.7 0.0 5.0 756.1 1.7 8.0 27.9 2.6 1.1 5.1 29.7 48.2 0.6 2.9 42.1 514.5 0.0 2.0 10.5 12.5 72.8 27.4 9.5 7.2 414.1 8.6 20.1 19.6 633.3 475.9 0.7 0.0 35.3 14.4 27.0 0.0 6.9 0.3 35.0 19.7 40.1 35.6 15.0 14.6 1.7 1.7 12.4 27.8 8.3 0.0 12.2 AL133500.1 ENSG00000285547 "Novel protein" X 72301691-72572843 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "epididymis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.2;SH-SY5Y: 1.4" "HPA048560, HPA049051" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm Cytosol "HPA048560: AB_2680442, HPA049051: AB_2680612" 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.5 0.4 0.4 0.1 0.2 0.0 0.0 0.6 0.6 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.2 0.0 0.1 0.1 0.5 1.2 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.1 0.6 0.0 0.1 0.2 0.4 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AL590132.1 ENSG00000284299 "Novel protein" 1 210858125-211134146 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.3" NA NA "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 36: Stromal cells - Cell proliferation" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALK CD246 ENSG00000171094 "ALK receptor tyrosine kinase" Q9UM73 2 29192774-29921586 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 10.9" "Group enriched" "Detected in some" 5 "Inhibitory neurons: 274.2;Oligodendrocyte precursor cells: 433.8" "Group enriched" "Detected in some" 5 "glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 31.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010694 Approved Supported "Plasma membrane" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "HPA010694: AB_1078133" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.56e-7)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (9.07e-3)" "unprognostic (6.29e-3)" "unprognostic (1.18e-1)" "unprognostic (1.01e-1)" "unprognostic (2.67e-4)" "unprognostic (3.70e-2)" "unprognostic (2.06e-2)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (3.61e-2)" 0.3 0.6 2.2 0.2 2.4 0.0 0.1 0.7 2.8 0.1 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.5 3.9 0.0 0.0 0.1 0.0 4.4 6.8 0.0 0.0 0.0 1.3 0.0 10.9 0.0 0.2 0.7 0.1 0.1 0.0 0.1 0.3 0.1 2.9 0.0 0.1 1.2 2.7 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 4.3 0.0 0.0 0.1 0.4 31.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.4 0.7 2.8 1.5 3.9 4.4 6.8 10.9 2.9 2.7 2.1 0.0 0.0 0.0 66.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 0.5 0.1 0.2 0.0 0.0 12.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 274.2 0.0 0.0 0.0 0.0 41.2 0.0 0.5 0.0 7.5 0.0 0.6 0.0 433.8 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ANKRD13B FLJ25555 ENSG00000198720 "Ankyrin repeat domain 13B" Q86YJ7 17 29589769-29614761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 27.4;Endometrial stromal cells: 24.2;Excitatory neurons: 19.4;Horizontal cells: 16.8;Late spermatids: 44.7;Oligodendrocytes: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 52.0;SH-SY5Y: 57.6;SK-BR-3: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051886, HPA063748" Uncertain Supported Vesicles NA NA "Cluster 43: Testis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 36: Stromal cells - Cell proliferation" Vesicles "HPA051886: AB_2681652, HPA063748: AB_2685112" "unprognostic (1.61e-1)" "unprognostic (2.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (3.10e-4)" "unprognostic (1.84e-1)" "unprognostic (1.84e-1)" "unprognostic (1.03e-2)" "prognostic favorable (7.58e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (5.92e-6)" "unprognostic (9.93e-2)" "unprognostic (1.18e-1)" "unprognostic (3.94e-2)" "unprognostic (5.36e-3)" 12.0 3.7 12.5 1.7 14.3 0.7 7.5 11.9 15.9 16.3 0.0 10.2 0.8 13.6 0.8 6.5 12.0 3.7 10.3 13.9 6.2 2.8 1.2 5.5 1.6 13.4 9.4 15.1 3.7 1.6 14.6 0.9 10.4 7.7 0.6 2.0 4.3 1.8 9.6 7.5 4.5 2.9 7.2 2.6 4.9 18.9 10.8 0.9 5.8 1.3 0.3 10.0 11.6 22.9 6.6 11.5 13.3 35.4 8.2 8.0 5.1 2.0 1.2 1.4 2.7 6.1 1.4 7.4 6.4 2.8 4.9 24.3 7.2 7.8 0.2 14.8 23.5 2.3 22.3 5.3 3.5 2.4 4.6 7.9 10.2 2.2 5.8 6.4 10.1 12.8 6.0 6.1 1.9 5.9 16.0 7.5 11.4 6.8 9.7 33.4 9.5 23.4 3.0 2.2 52.0 57.6 3.9 48.0 4.3 1.2 7.4 4.4 6.7 7.4 7.2 5.2 7.2 11.4 15.7 9.2 5.2 12.1 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.3 11.9 15.9 13.9 6.2 13.4 9.4 10.4 7.2 10.8 22.9 2.6 0.0 0.0 6.8 0.1 1.7 1.0 0.7 3.4 4.5 1.8 2.7 2.3 0.0 0.4 0.0 2.1 0.1 0.6 0.6 1.9 1.6 27.4 0.9 24.2 2.4 3.0 1.7 19.4 0.6 0.2 5.5 2.6 1.0 0.0 3.8 1.4 0.6 0.1 16.8 14.6 0.8 0.0 0.3 1.6 44.7 14.6 0.3 0.0 0.0 0.0 1.8 0.0 11.1 17.8 0.5 0.0 7.5 0.5 3.2 0.1 0.2 0.0 5.2 0.0 2.4 2.5 6.0 4.7 2.6 1.7 0.1 0.7 1.0 1.1 1.5 ANKRD45 "CT117, FLJ45235" ENSG00000183831 "Ankyrin repeat domain 45" Q5TZF3 1 173608336-173669851 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 6.7;choroid plexus: 14.3;fallopian tube: 12.7;parathyroid gland: 9.3;testis: 11.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5;Early spermatids: 48.8;Endometrial ciliated cells: 23.7;Late spermatids: 16.8;Respiratory ciliated cells: 31.8;Spermatocytes: 54.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.5;BJ hTERT+: 2.0;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;GAMG: 1.9;HBF TERT88: 1.9;SH-SY5Y: 5.7" "HPA031655, HPA031656, HPA031657" Enhanced Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Plasma membrane, Centrosome" "HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196" "unprognostic (1.93e-1)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-1)" "unprognostic (3.57e-2)" "unprognostic (2.69e-3)" "unprognostic (4.15e-2)" "unprognostic (6.93e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (4.49e-2)" "unprognostic (8.80e-3)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (1.61e-1)" 0.2 0.6 2.8 0.0 5.4 0.2 0.1 1.9 2.5 1.3 14.3 0.2 0.0 1.6 0.7 0.0 12.7 0.3 0.4 4.3 2.8 1.3 0.0 1.2 0.0 5.2 6.7 0.7 0.3 9.3 1.8 0.0 3.9 0.8 0.1 2.6 0.0 0.3 0.2 0.0 0.0 1.1 3.3 0.4 0.1 11.0 3.8 0.2 0.5 0.0 0.0 0.1 0.1 4.0 0.0 0.0 5.5 0.0 0.0 0.3 0.1 0.0 2.0 1.7 2.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 5.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.2 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.8 5.4 1.9 2.5 4.3 2.8 5.2 6.7 3.9 3.3 3.8 4.0 0.2 0.0 1.7 12.4 0.0 0.3 0.3 1.1 0.0 0.7 0.1 0.4 0.9 0.0 1.5 5.5 37.5 0.2 0.0 0.3 1.9 0.6 48.8 23.7 1.3 1.3 0.0 0.0 4.6 0.5 0.3 0.4 0.0 0.6 0.0 1.1 3.3 0.0 0.1 0.0 4.1 0.0 6.1 0.0 0.0 16.8 1.8 0.2 0.0 2.8 0.0 3.3 0.0 0.5 3.2 0.1 0.0 0.4 0.0 0.2 0.0 0.4 31.8 1.7 0.0 0.1 0.8 54.9 7.9 0.0 0.0 0.1 0.0 5.5 0.4 0.1 AP3B2 NAPTB ENSG00000103723 "Adaptor related protein complex 3 subunit beta 2" Q13367 15 82659281-82710112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.7;pituitary gland: 18.8;retina: 33.0" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 27.1;Excitatory neurons: 61.7;Inhibitory neurons: 56.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 22.8;Rod photoreceptor cells: 58.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.5;NTERA-2: 9.5;RT4: 17.3;SCLC-21H: 29.0;SH-SY5Y: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039467, HPA039818" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039467: AB_10795143, HPA039818: AB_10795299" "unprognostic (3.17e-1)" "unprognostic (9.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.48e-6)" "unprognostic (8.44e-2)" "unprognostic (7.62e-2)" "unprognostic (5.82e-2)" "unprognostic (2.32e-1)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (3.57e-3)" "unprognostic (1.12e-1)" "unprognostic (8.66e-2)" "unprognostic (4.95e-2)" "unprognostic (3.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.43e-2)" 0.7 4.5 15.3 0.9 18.6 1.1 1.4 15.5 20.7 0.9 0.0 1.1 0.7 1.1 2.3 0.7 0.9 0.4 0.2 19.6 5.5 0.6 0.2 0.3 0.5 15.6 5.4 1.2 2.1 12.7 18.8 0.6 13.2 1.4 0.6 33.0 0.9 1.4 0.3 0.9 0.9 1.3 1.1 0.7 1.1 6.2 4.7 1.0 2.1 0.4 1.3 0.8 0.6 11.3 0.2 0.4 9.5 3.2 1.6 0.2 5.7 0.5 0.0 0.8 0.2 0.4 0.4 0.8 4.9 0.2 1.8 0.9 1.0 0.0 0.2 3.2 0.7 0.3 0.4 0.2 0.3 0.4 1.8 1.0 1.1 0.1 0.7 0.1 0.0 2.8 1.0 0.7 0.1 2.5 0.3 0.5 9.5 0.1 0.1 0.3 0.0 0.2 0.0 17.3 29.0 17.5 3.2 1.4 2.4 1.0 0.2 1.9 0.2 0.3 0.9 0.4 1.3 1.6 8.8 0.7 2.2 0.5 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.3 0.2 0.9 0.1 0.1 0.4 0.0 0.1 15.3 18.6 15.5 20.7 19.6 5.5 15.6 5.4 13.2 1.1 4.7 11.3 0.1 0.0 1.1 20.9 0.1 0.4 2.1 0.6 1.2 18.4 1.5 2.3 0.8 0.0 0.1 0.0 27.1 0.1 0.2 0.1 0.0 0.2 8.0 0.2 0.6 0.1 13.9 0.0 61.7 0.4 0.1 1.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 13.5 56.9 0.5 6.1 0.0 0.6 5.4 0.9 0.1 0.0 4.7 0.0 4.1 0.0 44.7 22.8 0.0 0.1 0.4 1.2 0.7 0.0 0.4 0.0 58.6 0.0 1.3 0.7 9.8 3.1 0.7 0.1 0.0 0.1 0.2 0.0 0.6 APBA2 "D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L" ENSG00000034053 "Amyloid beta precursor protein binding family A member 2" Q99767 15 28884483-29118315 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.7;lymphoid tissue: 10.7" "Cell type enhanced" "Detected in many" "Astrocytes: 53.2;Excitatory neurons: 142.7;Horizontal cells: 89.2;Inhibitory neurons: 106.1;NK-cells: 63.8;Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 74.1" "Cancer enhanced" "Detected in many" "glioma: 17.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 5.4;naive CD8 T-cell: 5.6" "Lineage enriched" "Detected in many" 4 "T-cells: 5.6" "Cell line enhanced" "Detected in some" "HEL: 8.4;SH-SY5Y: 20.0;U-937: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037065, HPA058796, HPA070376" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "CAB037065: AB_477178, HPA058796: , HPA070376: " "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.42e-1)" "unprognostic (5.96e-2)" "unprognostic (1.41e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-1)" "unprognostic (8.19e-2)" "unprognostic (4.71e-2)" "unprognostic (9.25e-2)" "unprognostic (4.21e-5)" "unprognostic (1.98e-2)" "unprognostic (4.74e-2)" "unprognostic (7.63e-3)" "unprognostic (4.28e-1)" 1.0 1.6 4.3 0.7 4.4 0.7 0.9 8.7 8.4 2.9 0.0 1.3 0.4 1.2 0.4 1.7 1.6 0.3 0.4 8.0 2.5 0.9 0.9 3.3 0.6 3.3 2.4 1.1 5.9 0.0 7.6 0.1 2.4 2.5 0.2 1.1 0.4 0.1 0.1 1.0 4.9 0.0 2.2 10.7 1.4 5.7 3.0 1.4 2.7 0.0 0.7 1.3 1.5 4.9 0.0 1.6 0.7 3.7 0.0 0.0 0.0 0.9 1.4 0.1 0.5 0.0 0.0 0.0 3.5 0.0 2.3 0.0 0.5 0.0 0.0 0.0 3.1 8.4 0.0 0.1 3.1 0.0 0.2 0.4 2.5 0.4 0.0 0.4 4.4 1.8 5.0 0.2 0.0 0.5 0.2 2.4 1.1 0.0 3.3 0.0 0.4 0.2 0.0 0.0 5.4 20.0 0.0 0.0 0.2 0.1 0.0 1.0 4.4 0.0 4.4 0.0 0.9 0.0 0.1 0.0 0.1 14.9 1.7 0.0 0.0 0.0 0.9 0.0 0.2 0.0 1.5 3.3 0.0 0.0 5.4 5.6 0.1 1.3 0.0 0.0 0.0 2.0 4.3 4.4 8.7 8.4 8.0 2.5 3.3 2.4 2.4 2.2 3.0 4.9 0.5 0.0 0.6 53.2 1.8 0.4 0.2 0.0 0.0 21.5 1.9 2.3 1.4 0.0 0.1 0.0 0.0 0.1 36.5 0.1 1.9 1.8 18.9 2.9 6.4 1.2 0.0 2.1 142.7 5.8 0.2 2.2 0.0 2.1 0.0 1.9 3.6 0.5 1.2 89.2 106.1 0.3 0.0 1.6 0.4 10.4 1.8 0.8 3.6 33.7 1.9 1.3 63.8 97.0 74.1 3.3 0.0 3.8 12.3 0.1 0.0 0.3 0.2 4.5 0.0 0.4 2.1 1.6 14.5 0.4 0.3 0.1 30.7 10.6 0.0 0.1 APC2 APCL ENSG00000115266 "APC regulator of WNT signaling pathway 2" O95996 19 1446302-1473244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 64.5" "Cell type enhanced" "Detected in some" "Astrocytes: 142.4;Bipolar cells: 50.4;Excitatory neurons: 26.8;Horizontal cells: 45.4;Inhibitory neurons: 27.5;Muller glia cells: 29.4;Oligodendrocyte precursor cells: 28.1" "Cancer enriched" "Detected in some" 27 "glioma: 17.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.8;SCLC-21H: 9.3;SH-SY5Y: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078002 Supported "Cytokinetic bridge,Midbody,Cytosol" Yes No "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Cytokinetic bridge, Midbody" Cytosol "HPA078002: AB_2686874" "unprognostic (1.78e-3)" "unprognostic (1.65e-1)" "unprognostic (2.88e-5)" "unprognostic (3.64e-2)" "unprognostic (3.59e-1)" "unprognostic (1.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-2)" "unprognostic (3.45e-2)" "unprognostic (9.49e-3)" "unprognostic (7.39e-2)" "unprognostic (3.70e-2)" "unprognostic (4.99e-2)" "unprognostic (1.98e-3)" 0.1 2.4 41.5 0.0 27.3 0.0 0.0 41.4 42.4 0.1 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.3 37.1 20.8 0.0 0.0 0.0 0.0 64.5 42.3 0.0 0.3 0.0 6.2 0.0 54.9 0.1 0.0 2.7 0.2 0.0 0.2 0.1 0.4 0.1 38.3 0.0 0.3 1.0 54.6 0.0 0.1 0.0 0.0 0.1 0.2 49.0 0.2 0.6 7.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.1 0.0 0.5 0.2 0.1 0.0 0.0 1.0 0.1 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.6 0.0 0.0 9.3 31.7 1.1 0.0 0.5 0.1 0.1 0.0 0.0 0.4 0.6 0.1 0.1 1.7 0.5 0.2 0.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.5 27.3 41.4 42.4 37.1 20.8 64.5 42.3 54.9 38.3 54.6 49.0 0.3 0.0 0.0 142.4 0.3 0.0 0.2 0.2 1.2 50.4 0.4 0.4 3.4 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.5 0.5 0.5 0.0 0.0 26.8 0.0 0.1 0.3 0.0 0.6 0.0 0.2 0.0 0.0 0.1 45.4 27.5 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 3.7 0.0 29.4 2.1 28.1 17.8 0.0 0.0 0.7 0.0 0.1 0.2 0.2 0.0 11.1 0.0 0.6 0.4 0.4 0.7 2.4 0.0 0.0 0.3 0.2 0.1 0.2 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058346-131089885 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 22 "adrenal gland: 105.4;brain: 144.3;pituitary gland: 176.9" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Breast glandular cells: 2.7;Oligodendrocyte precursor cells: 1.0;Skeletal myocytes: 1.5" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 161 "SH-SY5Y: 176.9" "Region enhanced" "Detected in many" "hypothalamus: 89.4" "Low region specificity" "Detected in many" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Yes NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 0.2 105.4 20.1 0.0 3.7 0.0 1.4 0.8 3.2 1.6 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 13.5 132.5 0.0 0.0 0.0 0.0 35.0 46.1 0.0 0.0 0.0 176.9 0.1 144.3 0.2 0.1 0.0 0.2 0.0 6.6 0.1 0.0 0.0 4.7 0.0 0.1 0.8 52.1 0.4 0.1 1.1 0.0 0.0 0.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 176.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 3.7 0.8 3.2 13.5 132.5 35.0 46.1 144.3 4.7 52.1 10.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ARL16 ENSG00000214087 "ADP ribosylation factor like GTPase 16" 17 81681187-81683797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043711 Uncertain NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 39: Non-specific - Basic cellular processes" "HPA043711: AB_10964639" "unprognostic (1.73e-2)" "unprognostic (1.92e-2)" "unprognostic (3.20e-1)" "unprognostic (5.73e-3)" "unprognostic (5.73e-2)" "unprognostic (1.24e-1)" "unprognostic (6.60e-3)" "unprognostic (1.05e-1)" "unprognostic (1.26e-2)" "unprognostic (3.23e-1)" "unprognostic (1.17e-2)" "unprognostic (5.80e-2)" "unprognostic (5.77e-2)" "unprognostic (2.44e-1)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (1.11e-1)" 27.1 23.6 23.2 7.5 24.9 13.2 26.7 23.3 27.2 28.7 20.9 27.7 8.4 25.3 17.9 22.0 23.2 13.4 23.2 25.5 22.4 39.4 20.1 18.3 13.5 22.0 22.2 27.2 22.0 18.2 18.9 17.8 21.9 25.7 8.3 13.8 21.0 14.2 23.6 24.6 16.9 11.1 23.5 19.1 21.9 25.3 22.7 16.2 22.6 18.9 10.8 26.6 24.7 24.1 23.2 36.0 39.6 46.4 18.7 24.3 22.6 46.3 43.3 55.0 42.5 42.9 23.7 22.4 28.5 43.1 39.7 21.3 32.6 33.9 32.6 19.9 58.0 24.9 29.5 20.0 52.7 54.8 18.9 29.5 19.1 42.0 40.8 39.8 35.2 28.6 19.7 19.2 36.3 21.5 52.0 57.5 32.4 27.7 43.4 57.7 37.6 15.2 40.2 30.1 71.5 72.5 30.5 18.5 48.5 33.0 24.9 49.2 40.2 74.9 38.5 40.4 56.1 28.0 12.8 43.7 44.7 29.5 42.3 41.8 27.0 27.6 21.1 25.3 25.8 43.2 19.9 19.5 23.4 52.4 31.9 24.2 15.1 41.9 21.3 32.1 20.3 22.5 23.2 24.9 23.3 27.2 25.5 22.4 22.0 22.2 21.9 23.5 22.7 24.1 39.1 25.6 30.9 6.2 32.7 37.7 28.7 64.2 36.5 37.1 47.9 61.1 20.1 38.6 48.4 44.1 31.3 64.6 41.8 49.2 60.7 48.4 10.4 44.0 31.1 35.4 36.1 21.5 13.4 44.5 47.5 38.5 60.1 35.1 21.5 44.2 29.3 21.2 35.0 21.9 10.6 37.5 42.7 20.0 34.9 8.8 40.7 26.1 33.8 7.5 41.1 43.3 43.3 14.1 11.3 43.9 39.7 44.0 29.4 38.8 60.7 86.1 40.9 38.9 52.6 22.4 41.7 66.5 50.3 34.7 34.7 38.6 33.8 54.7 45.4 31.4 ARL5B ARL8 ENSG00000165997 "ADP ribosylation factor like GTPase 5B" Q96KC2 10 18659431-18681639 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 314.7;Langerhans cells: 304.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027002 Approved NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" "HPA027002: AB_10601685" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (4.04e-2)" "unprognostic (4.32e-2)" "unprognostic (1.77e-2)" "unprognostic (7.86e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "unprognostic (8.34e-2)" "unprognostic (6.54e-2)" "unprognostic (1.83e-1)" "unprognostic (7.54e-2)" "unprognostic (2.62e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (1.07e-1)" 11.1 20.8 3.2 7.8 3.5 19.6 6.5 6.0 5.6 8.1 4.5 7.5 9.3 9.3 3.7 8.5 4.7 14.1 6.8 3.6 4.0 5.7 29.8 9.7 7.1 3.4 3.9 7.9 9.0 6.1 6.8 13.1 3.6 6.3 8.4 5.7 7.2 3.6 4.3 6.6 10.0 6.7 4.0 5.6 6.4 5.7 3.9 13.5 8.2 6.2 7.1 12.6 5.9 4.3 14.8 8.1 36.5 14.2 10.4 11.9 22.1 12.5 6.0 11.8 19.9 26.7 12.4 18.3 5.0 6.5 7.6 14.2 25.5 9.1 15.0 5.9 19.5 18.4 9.5 38.2 26.7 8.8 10.3 11.9 12.4 11.3 12.3 11.5 18.7 13.8 23.7 19.0 9.4 7.0 21.1 6.4 25.2 15.4 3.5 26.1 23.8 12.0 10.5 12.7 4.7 30.4 9.6 10.0 17.9 27.9 5.9 10.1 12.7 6.7 20.5 12.9 10.6 10.1 13.8 24.9 6.7 7.3 6.2 1.2 0.7 0.5 0.5 0.8 0.7 0.5 0.5 0.6 0.9 0.5 0.8 0.6 0.9 1.0 0.5 0.5 0.7 0.5 3.2 3.5 6.0 5.6 3.6 4.0 3.4 3.9 3.6 4.0 3.9 4.3 70.1 38.5 26.0 10.4 36.1 152.3 76.0 42.9 122.9 9.9 84.3 50.4 16.7 21.5 36.9 9.2 6.2 26.7 53.5 96.8 5.9 25.9 74.5 117.1 52.1 54.5 65.4 16.4 12.4 15.8 39.1 44.9 72.9 314.7 101.1 26.6 15.7 44.8 13.4 10.1 12.1 65.2 14.2 25.3 304.3 15.8 6.8 94.1 58.7 12.2 8.0 9.1 7.2 19.1 14.7 20.8 81.6 5.7 49.0 63.8 58.5 8.1 34.5 7.4 6.6 41.9 50.8 27.8 15.5 134.6 167.1 43.2 47.1 21.5 43.5 153.1 ASCL1 "ASH1, bHLHa46, HASH1" ENSG00000139352 "Achaete-scute family bHLH transcription factor 1" P50553 12 102957674-102960513 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.0;choroid plexus: 13.7;liver: 11.1;pituitary gland: 30.1" "Group enriched" "Detected in some" 5 "Astrocytes: 17.0;Enteroendocrine cells: 36.4;Oligodendrocyte precursor cells: 42.7" "Group enriched" "Detected in many" 6 "glioma: 21.4;lung cancer: 11.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "SCLC-21H: 53.7;SH-SY5Y: 29.0" "Low region specificity" "Detected in all" "HPA029217, HPA076307" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm Cytosol "HPA029217: AB_10669595, HPA076307: " "unprognostic (7.92e-2)" "unprognostic (4.37e-3)" "unprognostic (4.55e-2)" "unprognostic (5.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.22e-2)" "unprognostic (1.56e-1)" "unprognostic (2.09e-1)" "unprognostic (4.84e-2)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (7.10e-6)" "unprognostic (3.40e-1)" "unprognostic (2.17e-1)" "unprognostic (3.76e-1)" "unprognostic (5.52e-2)" 0.0 1.1 18.7 0.0 18.3 0.0 0.0 18.9 23.0 0.5 13.7 0.1 0.0 0.2 0.0 0.0 0.8 0.0 0.0 18.2 16.8 0.0 11.1 0.5 0.5 20.1 18.1 0.4 0.2 0.0 30.1 0.0 18.5 0.3 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 1.2 0.1 18.7 5.5 0.1 0.0 0.0 0.0 0.3 19.4 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.7 29.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 18.3 18.9 23.0 18.2 16.8 20.1 18.1 18.5 19.9 18.7 19.4 0.1 0.0 0.0 17.0 0.3 0.0 0.3 0.0 0.0 4.3 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.0 36.4 0.0 1.7 0.0 0.0 0.2 4.6 0.1 0.0 0.0 0.0 1.8 0.1 5.0 4.1 0.0 6.1 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 2.4 0.0 42.7 0.3 0.2 0.0 0.4 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.5 0.2 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.4 ASTN2 KIAA0634 ENSG00000148219 "Astrotactin 2" O75129 9 116423112-117415070 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.2" "Cell type enhanced" "Detected in many" "Astrocytes: 354.6;Excitatory neurons: 370.0;Inhibitory neurons: 1011.0;Late spermatids: 228.2;Oligodendrocyte precursor cells: 900.3;Oligodendrocytes: 225.9" "Cancer enhanced" "Detected in all" "prostate cancer: 15.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027035 Uncertain Approved Nucleoplasm,Cytosol No No "Cluster 15: NK-cells - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol Nucleoplasm "HPA027035: AB_1845122" "unprognostic (3.25e-2)" "unprognostic (2.70e-2)" "unprognostic (7.41e-3)" "unprognostic (5.42e-3)" "unprognostic (1.89e-1)" "unprognostic (2.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.80e-1)" "unprognostic (3.40e-2)" "unprognostic (2.93e-1)" "prognostic favorable (6.66e-16)" "unprognostic (3.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" 3.3 9.8 26.1 2.7 26.3 3.6 4.3 39.0 36.0 5.3 9.0 5.2 3.4 3.2 3.9 2.2 8.0 2.5 22.5 27.0 25.8 5.5 4.1 2.2 2.4 29.3 36.2 2.8 6.7 3.1 11.6 1.8 28.7 25.2 3.2 13.4 5.8 11.3 7.3 2.4 4.1 2.8 21.4 2.4 5.6 17.6 35.0 6.0 1.8 5.6 1.8 3.2 3.5 39.2 3.7 12.0 4.3 7.1 7.6 7.0 15.4 5.7 2.3 2.5 2.8 8.1 4.4 8.8 6.1 3.8 9.3 1.3 11.5 0.6 3.1 4.8 2.9 3.1 5.8 17.0 3.0 1.8 6.2 9.5 1.1 7.8 0.7 5.4 1.8 10.5 3.9 5.9 7.9 3.8 4.1 1.4 13.2 10.6 6.4 4.9 27.5 2.5 8.0 12.3 6.3 37.9 6.8 2.0 4.8 14.5 15.5 1.3 3.5 5.9 9.1 5.6 4.9 9.0 5.0 8.3 10.5 2.0 25.8 2.5 0.4 0.5 2.8 0.3 3.6 1.5 3.1 2.4 0.2 1.6 3.0 2.5 1.9 5.9 0.6 0.9 8.8 1.0 26.1 26.3 39.0 36.0 27.0 25.8 29.3 36.2 28.7 21.4 35.0 39.2 0.6 6.4 8.9 354.6 1.1 1.3 3.2 0.4 1.2 4.9 4.2 4.8 22.7 2.8 5.0 1.8 10.4 0.4 1.0 0.4 3.9 0.8 122.5 4.7 5.5 1.3 12.6 0.4 370.0 1.1 0.4 4.9 4.1 0.7 6.3 37.0 0.7 2.9 3.2 10.1 1011.0 1.0 0.0 0.0 1.6 228.2 2.8 1.0 0.0 36.5 0.2 3.0 0.0 900.3 225.9 0.5 2.1 5.7 3.6 11.7 5.7 6.9 11.7 5.1 0.0 1.9 2.0 7.7 13.2 0.3 0.6 0.3 3.8 1.9 1.8 2.2 ATCAY BNIP-H ENSG00000167654 "ATCAY kinesin light chain interacting caytaxin" Q86WG3 19 3879864-3928082 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Neurogenesis, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 46.6;pituitary gland: 25.6;retina: 17.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 128.5;Excitatory neurons: 67.0;Horizontal cells: 47.1;Inhibitory neurons: 82.2;Oligodendrocyte precursor cells: 94.0" "Cancer enriched" "Detected in some" 8 "glioma: 15.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 7.3;SCLC-21H: 13.2;SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017755 Enhanced NA NA "Cluster 11: Basophils - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "HPA017755: AB_2669655" "unprognostic (7.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.63e-2)" "unprognostic (1.91e-1)" "unprognostic (7.11e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" "unprognostic (3.05e-2)" "unprognostic (4.89e-2)" "unprognostic (9.83e-4)" "unprognostic (7.22e-2)" "unprognostic (8.78e-3)" "unprognostic (1.78e-1)" "unprognostic (1.36e-1)" "unprognostic (1.24e-2)" "unprognostic (2.67e-1)" 0.1 6.9 32.1 0.6 34.6 0.3 0.0 0.5 46.6 0.9 0.0 1.1 0.5 0.1 0.1 0.2 0.0 0.2 0.1 29.8 36.1 0.1 0.0 0.1 0.2 17.8 13.8 0.1 0.3 0.0 25.6 0.1 16.7 1.8 0.3 17.6 0.1 3.2 1.2 0.3 0.6 0.2 3.3 0.1 0.4 0.2 17.3 0.0 0.1 0.0 0.0 0.1 0.6 24.6 0.5 0.1 2.7 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.6 0.5 0.2 0.0 1.5 0.4 0.2 0.0 0.0 0.2 0.2 0.8 1.1 0.2 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.5 0.1 0.2 0.2 0.4 7.3 0.1 0.1 0.2 0.4 0.2 0.1 0.2 13.2 9.3 0.2 0.2 0.1 1.2 0.2 0.2 0.5 0.3 0.6 0.4 0.7 0.3 0.3 0.2 0.3 1.3 0.2 0.6 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.6 0.3 0.1 0.1 0.1 0.1 32.1 34.6 0.5 46.6 29.8 36.1 17.8 13.8 16.7 3.3 17.3 24.6 0.2 0.0 3.4 3.3 0.6 0.6 0.8 0.0 0.0 128.5 0.2 0.1 1.9 2.8 0.0 0.0 22.9 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.9 0.7 0.0 0.0 67.0 0.0 0.2 1.1 0.0 0.8 7.0 0.1 0.7 0.1 0.1 47.1 82.2 0.2 0.0 0.6 2.6 0.0 0.0 0.5 3.6 5.6 0.1 5.4 2.1 94.0 3.9 0.0 0.0 0.4 0.0 0.5 0.0 0.1 0.0 18.7 0.0 1.9 0.7 0.7 1.7 0.0 0.4 0.0 0.6 0.0 0.1 0.4 AZIN1 "OAZI, OAZIN, ODC1L" ENSG00000155096 "Antizyme inhibitor 1" O14977 8 102826308-102893864 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 261.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027948 Approved Approved Vesicles NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 41: Macrophages - Immune response" Vesicles "HPA027948: AB_10602391" "unprognostic (1.16e-2)" "unprognostic (4.81e-3)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (8.55e-2)" "unprognostic (3.41e-2)" "unprognostic (7.19e-2)" "unprognostic (1.51e-2)" "unprognostic (2.10e-1)" "unprognostic (2.24e-1)" "unprognostic (2.07e-3)" "unprognostic (4.33e-3)" "unprognostic (1.25e-2)" "unprognostic (1.08e-1)" "unprognostic (2.83e-1)" "unprognostic (3.08e-2)" "unprognostic (1.68e-1)" 61.7 48.1 45.7 48.1 50.3 141.1 57.8 44.8 51.2 55.3 43.5 49.1 66.6 44.4 30.3 52.7 64.0 43.6 51.5 51.9 50.5 39.4 78.0 40.1 58.1 48.1 48.2 38.7 136.6 38.3 31.6 82.8 48.1 52.5 53.6 57.8 47.7 49.5 41.9 32.7 80.8 44.5 53.8 35.9 52.2 35.7 46.7 58.6 67.5 30.9 60.6 62.3 27.3 60.0 320.4 81.7 129.0 92.6 122.7 83.3 77.6 145.4 168.5 103.5 106.8 87.1 217.5 148.0 111.0 121.9 64.3 119.5 113.8 114.5 165.8 244.7 57.4 147.4 30.1 72.3 156.0 81.0 120.7 58.9 136.1 72.5 182.4 92.2 72.8 86.0 112.6 124.0 165.2 92.6 201.8 59.3 144.9 239.3 123.0 87.3 136.5 84.2 108.2 146.7 208.2 327.3 49.1 100.0 144.3 209.9 131.7 84.7 85.9 83.2 83.9 135.7 118.6 122.3 104.2 207.4 98.3 120.1 117.0 73.3 57.7 68.0 31.2 64.1 36.7 43.7 40.8 29.9 55.9 27.5 33.1 32.1 68.5 40.1 64.5 44.3 50.0 65.7 45.7 50.3 44.8 51.2 51.9 50.5 48.1 48.2 48.1 53.8 46.7 60.0 56.3 60.9 27.7 30.0 59.6 93.8 121.1 52.8 93.4 31.5 64.0 39.8 46.3 28.6 52.8 42.3 37.5 148.7 54.0 48.4 52.8 39.6 62.6 95.1 37.9 34.9 84.9 62.7 35.9 50.5 55.0 55.5 59.1 85.4 68.5 31.9 33.5 65.0 54.7 23.5 31.9 77.3 63.1 72.8 127.2 107.9 49.7 86.0 64.0 23.4 53.0 50.4 32.0 30.2 23.7 66.6 44.0 32.4 97.6 106.7 114.6 52.6 167.6 42.3 19.7 36.0 57.1 34.5 30.7 90.8 82.3 261.9 71.6 26.2 66.0 117.0 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369499-382117 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3;ovary: 27.8" "Cell type enhanced" "Detected in many" "Astrocytes: 133.2;Bipolar cells: 23.8;Excitatory neurons: 31.2;Horizontal cells: 33.7;Inhibitory neurons: 32.3;Muller glia cells: 45.6;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 32.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 35.4;NTERA-2: 32.0;SCLC-21H: 39.5;SH-SY5Y: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043276, HPA053126" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA No "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Cytosol" Vesicles "HPA043276: , HPA053126: AB_2682049" "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 0.9 0.6 23.1 0.9 17.2 0.0 3.3 5.1 33.3 17.2 0.0 5.9 0.6 14.1 0.6 2.3 11.9 0.5 1.6 23.8 12.9 1.0 0.3 0.5 0.3 19.3 20.7 27.8 1.1 2.6 17.9 0.0 14.9 6.3 0.2 5.3 2.0 1.2 0.0 2.1 2.9 1.0 8.4 0.3 2.1 1.5 15.1 0.3 0.5 0.0 0.3 1.8 6.3 13.4 0.0 4.8 35.4 20.4 0.0 0.1 8.4 6.5 1.7 2.9 0.8 3.7 0.0 0.0 4.8 0.7 5.6 1.4 4.8 8.5 0.8 0.0 12.3 0.0 13.4 11.4 0.4 0.0 8.7 0.6 5.0 0.2 3.8 12.7 0.4 1.9 11.5 0.0 0.0 10.8 0.4 0.0 32.0 0.6 14.0 0.0 0.0 4.9 0.4 0.0 39.5 47.6 2.4 1.7 0.5 3.7 14.0 0.0 9.0 2.0 11.1 3.5 0.4 0.1 1.7 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 17.2 5.1 33.3 23.8 12.9 19.3 20.7 14.9 8.4 15.1 13.4 0.1 0.0 0.0 133.2 0.2 0.8 1.5 1.4 0.6 23.8 6.5 8.9 12.5 0.0 0.1 1.8 4.2 0.1 0.3 0.1 0.0 1.3 0.0 0.6 7.1 0.6 1.8 0.0 31.2 0.0 0.0 2.4 0.0 1.1 0.0 6.9 0.0 0.0 0.2 33.7 32.3 0.1 2.0 0.0 0.0 0.0 3.1 0.1 3.6 2.8 0.2 45.6 0.0 28.1 32.5 0.2 0.0 1.2 0.0 2.6 0.0 0.0 0.1 8.6 0.0 0.0 3.3 0.1 0.2 0.1 0.3 0.3 0.1 0.6 0.5 0.4 BEGAIN KIAA1446 ENSG00000183092 "Brain enriched guanylate kinase associated" Q9BUH8 14 100537147-100587413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;pancreas: 23.8;pituitary gland: 19.6" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 143.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Group enriched" "Detected in some" 7 "HeLa: 56.6;SH-SY5Y: 129.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002899 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Golgi apparatus, Cytosol" "HPA002899: AB_1078277" "unprognostic (2.98e-4)" "unprognostic (2.75e-3)" "unprognostic (2.66e-2)" "unprognostic (2.66e-4)" "unprognostic (2.77e-3)" "unprognostic (1.93e-2)" "unprognostic (5.16e-2)" "unprognostic (6.35e-2)" "unprognostic (3.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.15e-2)" "unprognostic (5.47e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (3.11e-1)" "unprognostic (2.75e-1)" "unprognostic (2.60e-1)" 1.9 3.2 15.3 0.4 14.9 4.0 1.7 16.4 27.2 3.4 0.0 1.2 2.6 2.4 0.8 1.0 6.0 1.2 2.6 22.0 5.1 1.0 0.7 1.4 0.5 6.4 1.5 4.8 23.8 4.6 19.6 1.6 6.6 4.1 0.2 2.1 1.5 1.3 0.7 1.2 2.7 0.8 1.0 5.8 1.2 2.8 3.2 1.0 1.0 0.1 0.5 1.5 1.3 11.9 0.8 3.3 1.8 11.1 0.0 0.0 0.3 0.3 0.0 0.5 0.1 0.0 1.1 0.3 0.5 0.5 2.5 0.4 0.5 0.0 0.0 0.0 1.1 5.1 56.6 0.0 0.1 0.2 0.3 0.3 0.2 0.9 1.2 0.0 0.1 0.7 0.6 0.1 0.0 4.4 0.4 1.6 1.3 0.3 1.9 0.1 0.3 7.0 0.0 0.2 2.9 129.7 3.0 0.1 3.0 0.0 0.9 13.7 0.0 0.4 3.8 0.1 0.0 0.0 0.0 0.2 9.2 2.5 0.3 0.8 0.1 3.4 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.4 0.0 0.1 15.3 14.9 16.4 27.2 22.0 5.1 6.4 1.5 6.6 1.0 3.2 11.9 0.8 0.0 0.6 18.6 0.3 2.4 1.8 0.3 0.0 3.7 0.5 1.1 2.3 0.0 0.7 0.0 0.0 0.1 0.2 0.3 0.0 1.4 0.4 0.1 0.1 0.6 0.0 0.0 18.4 8.0 0.2 1.5 0.0 0.1 9.5 0.1 1.4 0.0 0.3 143.0 10.9 0.0 0.0 0.0 0.8 0.8 1.8 0.3 1.8 4.7 1.1 0.8 0.0 15.6 0.8 2.9 1.1 6.8 0.3 1.6 2.7 0.1 0.1 2.3 0.0 1.7 0.7 0.9 1.5 0.3 2.0 0.1 0.3 0.4 0.4 0.4 BMPR1B "ALK6, CDw293" ENSG00000138696 "Bone morphogenetic protein receptor type 1B" O00238 4 94757955-95158448 "CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Chondrogenesis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.1;cervix: 24.7;prostate: 22.4" "Cell type enriched" "Detected in many" 7 "Astrocytes: 480.6" "Cancer enhanced" "Detected in many" "breast cancer: 32.4;prostate cancer: 24.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 22.0;MCF7: 11.1;SH-SY5Y: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "unprognostic (2.25e-1)" "unprognostic (1.80e-2)" "unprognostic (1.40e-3)" "prognostic favorable (2.84e-4)" "unprognostic (1.57e-1)" "unprognostic (4.22e-2)" "unprognostic (1.92e-1)" "unprognostic (2.86e-2)" "unprognostic (2.95e-2)" "unprognostic (1.01e-1)" "unprognostic (3.97e-2)" "unprognostic (3.93e-1)" "unprognostic (1.62e-3)" "unprognostic (7.89e-4)" "unprognostic (6.22e-2)" "unprognostic (3.81e-3)" "unprognostic (2.63e-2)" 0.7 4.6 13.4 0.3 15.4 0.1 1.0 13.5 15.0 24.7 2.1 0.9 0.1 4.4 2.4 0.2 12.5 2.6 0.8 12.5 16.0 7.8 0.8 1.7 0.0 19.3 20.1 6.2 1.1 0.1 1.9 0.7 17.5 22.4 0.2 8.1 1.0 14.2 3.0 0.8 0.1 0.6 15.3 0.9 2.4 3.7 15.6 6.4 0.5 1.1 0.0 0.2 0.5 12.1 0.0 22.0 5.6 0.0 2.3 4.8 0.2 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.2 1.0 0.0 1.3 3.6 8.4 0.1 0.0 4.9 0.0 1.4 0.0 0.6 0.5 0.1 2.7 9.0 2.8 6.2 0.4 0.1 0.0 0.0 0.0 7.1 11.1 0.6 0.1 2.1 0.1 3.2 0.2 3.4 0.1 4.3 0.1 0.2 18.8 0.3 3.2 3.2 0.8 1.7 0.0 0.0 4.0 3.8 0.2 4.3 0.0 0.0 0.0 1.5 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 13.4 15.4 13.5 15.0 12.5 16.0 19.3 20.1 17.5 15.3 15.6 12.1 0.0 6.4 0.0 480.6 0.0 2.7 1.3 13.1 1.2 0.4 3.8 1.0 3.4 2.8 33.4 60.7 0.0 0.0 0.0 0.0 1.9 3.0 1.4 28.5 1.4 1.1 18.4 0.0 51.0 0.4 0.3 1.5 0.0 20.8 0.0 38.6 2.9 0.0 0.1 0.0 2.5 0.0 8.2 0.0 1.2 1.4 3.1 0.4 28.4 22.5 0.0 38.5 0.0 10.1 2.8 0.7 0.0 3.8 0.0 28.5 0.0 0.2 15.7 1.6 0.0 1.7 2.9 1.2 10.6 0.4 2.3 0.0 0.5 4.4 0.0 1.6 BSN ZNF231 ENSG00000164061 "Bassoon presynaptic cytomatrix protein" Q9UPA5 3 49554477-49671549 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 33.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 76.6;Horizontal cells: 25.2;Inhibitory neurons: 50.1;Oligodendrocyte precursor cells: 22.6" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Region enhanced" "Detected in many" "cerebral cortex: 33.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 2.0;SCLC-21H: 4.4;SH-SY5Y: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034757 Enhanced NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA034757: AB_10671233" "unprognostic (8.57e-2)" "unprognostic (3.45e-1)" "unprognostic (7.31e-2)" "unprognostic (3.50e-4)" "unprognostic (7.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (5.46e-3)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (6.21e-5)" "unprognostic (2.50e-3)" "unprognostic (5.38e-5)" "unprognostic (9.33e-2)" "unprognostic (3.03e-1)" "unprognostic (2.30e-1)" "unprognostic (7.34e-2)" 0.1 1.4 8.2 0.1 17.6 0.0 0.1 0.1 33.6 0.2 0.0 0.2 0.1 0.3 3.0 0.0 0.1 0.0 0.2 17.2 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.3 0.6 0.3 5.3 0.1 0.0 0.2 0.0 3.4 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.3 3.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 4.9 0.1 0.2 1.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 1.2 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.4 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.7 2.0 0.2 0.0 0.4 0.2 0.1 0.8 0.1 0.5 0.0 0.1 0.2 0.0 0.2 4.4 2.7 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 17.6 0.1 33.6 17.2 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 9.4 0.0 0.0 0.1 0.0 0.0 15.0 0.2 0.5 2.5 0.0 0.0 0.0 6.2 0.1 0.0 0.1 0.0 0.0 7.8 0.4 0.3 0.5 0.0 0.0 76.6 0.5 0.1 0.3 0.0 0.3 0.0 0.6 0.7 0.4 0.1 25.2 50.1 0.1 0.0 0.3 0.0 11.7 1.2 0.1 1.8 9.4 0.0 3.9 2.1 22.6 6.3 0.1 0.0 0.4 0.0 0.1 0.1 0.3 0.0 8.8 0.0 1.0 1.3 6.7 8.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 C11orf96 AG2 ENSG00000187479 "Chromosome 11 open reading frame 96" Q7Z7L8 11 43925342-43943878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 750.2;ovary: 721.3" "Cell type enhanced" "Detected in many" "Adipocytes: 796.5;Endometrial stromal cells: 906.3;Fibroblasts: 801.3;Granulosa cells: 982.4;Peritubular cells: 474.3;Smooth muscle cells: 1942.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 9 "SH-SY5Y: 197.7" "Low region specificity" "Detected in all" HPA038843 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" No NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA038843: AB_10673296" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.28e-2)" "unprognostic (8.15e-3)" "unprognostic (5.49e-2)" "unprognostic (3.42e-3)" "unprognostic (8.11e-3)" "unprognostic (1.15e-2)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (2.34e-5)" "unprognostic (2.65e-2)" "unprognostic (2.07e-1)" "unprognostic (1.18e-2)" "unprognostic (3.19e-2)" 478.3 199.0 28.7 39.2 24.3 4.9 203.5 26.1 34.2 305.0 18.4 151.0 19.7 283.4 8.7 44.8 750.2 61.1 269.3 24.8 44.4 226.8 179.2 377.9 6.8 93.8 42.4 721.3 60.7 3.2 126.5 15.4 38.5 157.3 8.4 1.3 22.2 14.3 110.8 97.2 130.3 28.4 35.1 54.4 240.2 67.8 44.5 5.0 119.4 10.3 0.7 176.3 148.1 21.0 0.0 0.0 0.0 0.0 4.0 2.0 1.1 0.3 1.3 0.0 0.1 0.1 0.0 0.0 0.5 0.5 2.1 0.1 0.4 0.0 0.0 0.0 2.9 6.2 0.1 0.0 0.8 0.5 0.6 0.3 0.1 1.4 0.0 0.0 1.2 2.1 2.3 0.0 0.0 0.0 2.4 2.7 1.7 0.0 0.9 10.3 0.7 4.7 0.0 0.0 2.2 197.7 0.0 0.0 19.4 5.5 0.0 2.3 2.7 9.2 3.8 2.3 0.2 22.5 0.2 3.2 7.1 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 24.3 26.1 34.2 24.8 44.4 93.8 42.4 38.5 35.1 44.5 21.0 796.5 6.4 139.9 0.0 1.9 92.9 15.2 1.6 5.2 15.4 8.2 13.7 6.0 0.0 1.9 0.0 2.1 1.5 13.7 0.3 0.0 4.5 4.3 34.1 906.3 260.3 0.0 2.7 0.0 0.6 4.4 801.3 4.1 183.3 13.9 982.4 172.7 6.4 3.8 1.7 0.0 0.2 0.0 8.4 171.8 13.9 215.6 27.1 174.3 0.0 0.1 2.7 0.0 0.0 0.0 1.9 0.0 474.3 9.4 73.6 0.0 0.0 0.9 9.3 302.4 173.2 1942.9 2.1 1.5 6.5 88.5 3.1 14.2 243.9 0.1 50.5 C1GALT1C1L ENSG00000223658 "C1GALT1 specific chaperone 1 like" P0DN25 2 43675151-43676429 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 7.0;Muller glia cells: 5.1;Spermatocytes: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 13.1;U-2 OS: 8.2" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (2.18e-1)" "unprognostic (3.71e-2)" "unprognostic (2.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.32e-1)" "unprognostic (5.71e-3)" "unprognostic (2.19e-3)" "unprognostic (4.91e-2)" "unprognostic (2.78e-2)" "unprognostic (2.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.67e-1)" "unprognostic (7.73e-2)" "unprognostic (3.81e-3)" "unprognostic (8.88e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-2)" 1.7 1.8 0.7 0.4 1.0 0.0 2.0 1.0 1.1 2.1 0.8 2.3 0.3 4.0 6.0 0.3 1.1 0.6 2.3 0.7 0.9 1.8 0.1 0.3 0.2 0.9 1.0 1.1 1.0 2.0 0.7 0.9 0.9 1.5 0.7 3.9 1.2 2.4 0.5 0.5 0.5 3.2 0.9 0.3 0.5 5.8 0.9 0.2 1.2 0.8 0.3 1.0 0.7 1.0 0.0 0.3 0.0 0.0 2.4 1.2 0.1 0.2 0.4 0.8 1.0 0.5 3.8 0.0 3.7 0.3 3.3 0.3 0.0 0.2 2.0 0.0 2.9 1.7 1.1 0.8 0.8 0.0 0.0 1.6 0.6 2.5 0.1 1.3 2.6 0.0 2.0 0.0 0.2 4.0 0.0 3.7 0.0 0.0 0.0 0.0 1.4 0.0 3.2 0.8 0.1 13.1 0.0 0.2 2.7 0.3 0.9 2.7 0.0 3.3 8.2 0.2 0.8 0.0 2.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 1.0 1.1 0.7 0.9 0.9 1.0 0.9 0.9 0.9 1.0 0.9 0.0 0.5 0.0 0.0 0.0 0.5 0.0 1.8 1.0 0.5 1.0 0.5 2.8 0.6 0.0 0.0 0.3 0.1 0.0 0.0 1.3 2.8 1.0 7.0 0.5 0.0 0.0 0.0 0.6 0.3 2.4 0.0 0.3 0.0 1.6 0.7 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.1 0.1 0.2 1.5 3.7 0.0 1.9 2.1 18.8 2.4 0.2 0.0 0.1 0.0 2.2 0.3 0.1 C2orf81 "hCG40743, LOC388963" ENSG00000284308 "Chromosome 2 open reading frame 81" A6NN90 2 74414176-74421591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.3" "Cell type enhanced" "Detected in many" "Early spermatids: 45.6;Late spermatids: 31.4;Respiratory ciliated cells: 25.7;Spermatocytes: 20.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 13.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 15.1;RPMI-8226: 14.5;SCLC-21H: 17.8;SH-SY5Y: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049564, HPA054835" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nucleoli fibrillar center" "HPA049564: , HPA054835: AB_2682620" 2.1 1.5 3.4 1.7 3.9 0.5 2.6 3.7 4.7 5.7 10.0 3.1 1.1 4.9 0.8 1.1 17.7 2.4 2.0 4.4 4.2 5.1 0.7 3.8 2.6 6.1 6.3 4.0 2.2 5.5 17.6 0.6 3.7 5.0 0.4 3.0 2.1 2.5 0.7 1.6 2.5 0.9 4.6 3.7 2.1 27.3 3.6 2.2 3.7 0.5 0.8 3.1 2.5 3.5 4.4 8.0 2.4 8.6 2.6 2.2 0.8 0.6 2.6 0.7 0.8 0.2 4.9 10.5 1.8 1.3 2.1 1.6 0.2 2.1 0.8 5.9 0.4 1.1 0.5 0.0 1.3 2.1 2.1 1.3 5.2 1.0 1.0 3.0 0.1 5.6 0.2 1.6 1.3 15.1 2.7 5.5 4.6 2.4 1.7 1.4 0.8 14.5 3.2 1.9 17.8 19.3 2.4 3.9 1.3 0.3 3.7 1.9 0.0 0.9 3.8 2.7 2.2 3.7 7.4 3.4 5.2 2.0 1.8 0.1 1.9 0.0 0.6 2.0 0.3 6.6 0.7 0.8 6.3 5.8 3.3 1.6 0.1 3.0 1.5 13.3 0.7 1.3 3.4 3.9 3.7 4.7 4.4 4.2 6.1 6.3 3.7 4.6 3.6 3.5 1.7 0.0 2.4 0.0 0.8 0.6 1.0 2.9 1.8 0.9 1.9 4.7 1.4 4.3 3.6 3.7 0.0 0.0 2.9 0.7 5.9 3.2 45.6 11.7 1.9 2.1 7.2 0.0 1.1 2.2 0.0 4.1 0.5 3.1 0.0 1.1 4.2 0.0 0.0 3.3 0.9 1.7 4.1 1.9 3.4 31.4 3.4 1.1 3.6 1.0 6.1 6.1 1.0 1.0 0.2 2.6 0.3 7.5 0.2 0.7 0.4 5.9 25.7 3.9 6.6 2.4 3.9 20.1 1.5 0.1 0.9 0.0 0.6 1.2 1.2 0.3 CACFD1 "C9orf7, D9S2135, flower" ENSG00000160325 "Calcium channel flower domain containing 1" Q9UGQ2 9 133459965-133470848 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 75.5;Gastric mucus-secreting cells: 67.2;Hepatocytes: 47.9;Paneth cells: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.8" "Group enriched" "Detected in many" 4 "B-cells: 2.0;granulocytes: 3.8" "Cell line enhanced" "Detected in many" "T-47d: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015280 Approved Nucleoplasm NA NA "Cluster 10: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA015280: AB_1845833" "unprognostic (3.15e-2)" "unprognostic (4.25e-1)" "unprognostic (1.96e-3)" "unprognostic (4.48e-1)" "unprognostic (2.77e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-2)" "unprognostic (5.49e-2)" "unprognostic (3.97e-1)" "unprognostic (3.17e-1)" "unprognostic (1.67e-3)" "unprognostic (3.91e-2)" "prognostic favorable (2.83e-8)" "unprognostic (5.10e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (3.99e-3)" 5.1 11.3 6.4 1.9 6.2 2.4 7.0 8.2 6.9 9.5 6.9 19.9 5.8 9.9 5.3 9.9 9.3 4.5 11.2 5.8 6.0 28.2 58.6 12.8 1.5 7.5 6.1 10.7 18.9 7.9 19.0 1.2 6.0 13.3 2.8 2.1 15.8 4.0 9.0 5.4 14.9 2.4 5.9 7.3 28.4 23.9 6.5 0.9 17.4 1.8 1.7 11.8 6.9 7.8 0.4 2.1 4.3 2.7 0.8 0.1 2.5 2.0 2.9 1.5 0.3 5.7 4.8 0.2 4.2 2.0 2.6 1.2 2.2 1.6 0.0 1.1 1.4 0.6 4.8 2.5 2.5 0.0 0.6 0.0 3.2 1.3 1.0 4.8 1.8 1.1 0.8 1.8 2.4 3.7 0.3 0.7 3.4 3.3 1.5 1.4 0.6 9.3 2.9 1.7 4.9 9.1 2.5 5.6 0.9 2.6 9.5 1.6 0.4 3.5 2.2 0.6 0.1 3.4 4.8 2.4 1.1 0.3 1.1 3.8 0.5 1.6 0.2 0.0 0.0 2.0 0.1 0.4 0.4 0.7 0.1 0.5 0.0 0.6 0.2 0.2 0.2 0.1 6.4 6.2 8.2 6.9 5.8 6.0 7.5 6.1 6.0 5.9 6.5 7.8 1.7 19.2 19.6 3.3 5.5 2.8 5.5 5.0 3.4 4.6 13.0 8.9 9.8 21.5 8.8 20.2 12.5 1.9 1.0 75.5 3.9 22.0 13.4 9.8 5.4 3.8 29.2 0.0 5.8 33.1 3.3 4.0 67.2 15.1 4.5 5.9 5.3 47.9 3.6 3.3 4.8 43.1 10.2 5.6 2.2 8.1 8.1 2.1 5.4 1.9 5.9 6.7 2.1 4.5 4.7 26.2 53.2 7.5 3.9 7.0 31.7 16.5 5.2 9.8 0.0 3.4 4.4 13.7 14.7 2.9 1.6 2.9 1.9 2.9 24.5 6.2 CACNA2D2 KIAA0558 ENSG00000007402 "Calcium voltage-gated channel auxiliary subunit alpha2delta 2" Q9NY47 3 50362613-50504244 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 49.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Alveolar cells type 2: 182.3;Inhibitory neurons: 36.0" "Cancer enhanced" "Detected in many" "testis cancer: 20.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 192.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034771, HPA071829" Enhanced Approved Vesicles NA NA 9700000 "Cluster 35: T-regs - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 11: Alveolar cells - Smell perception" Vesicles "HPA034771: AB_10603555, HPA071829: AB_2686454" "unprognostic (2.06e-1)" "unprognostic (2.37e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (7.62e-5)" "unprognostic (6.59e-2)" "unprognostic (6.37e-2)" "unprognostic (6.91e-2)" "unprognostic (6.57e-3)" "unprognostic (4.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.21e-4)" "unprognostic (2.71e-2)" "unprognostic (1.57e-4)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (3.55e-1)" "unprognostic (4.22e-2)" 1.0 0.6 4.7 1.3 5.2 1.2 1.2 9.9 6.9 1.4 0.3 1.6 1.2 1.6 0.9 0.6 1.1 0.7 8.4 0.7 13.9 2.3 0.3 49.1 1.2 8.3 8.4 2.1 4.3 2.5 7.1 1.8 14.0 3.0 1.9 8.6 1.3 1.1 1.8 2.6 1.6 1.2 4.8 1.4 4.1 6.5 11.4 1.0 2.2 1.5 0.5 0.5 0.7 2.1 0.0 0.1 3.0 6.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.0 0.6 0.2 24.8 0.0 0.1 0.1 1.8 0.2 0.2 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.4 0.0 1.1 0.1 0.2 7.9 0.2 0.5 0.2 0.0 0.7 0.0 0.0 18.6 192.7 0.6 0.4 0.0 5.5 1.5 0.0 0.0 0.1 1.8 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.9 0.7 0.9 0.7 0.0 0.5 1.2 0.7 0.0 0.9 0.0 0.1 1.2 0.4 4.7 5.2 9.9 6.9 0.7 13.9 8.3 8.4 14.0 4.8 11.4 2.1 0.4 76.9 182.3 4.2 0.4 1.5 0.4 0.0 1.8 21.5 2.5 1.7 4.6 0.0 2.5 1.8 20.9 0.0 6.8 0.8 0.0 0.2 0.7 0.1 0.4 0.6 1.2 2.7 7.8 0.0 0.0 1.5 3.1 0.2 20.3 0.3 0.4 0.0 0.1 0.0 36.0 11.0 0.0 0.0 0.4 4.0 0.3 0.4 0.0 1.9 0.1 4.3 15.5 6.0 0.9 0.4 0.3 1.9 2.9 0.7 0.2 0.7 2.2 9.8 13.1 2.4 2.4 2.6 11.2 0.2 0.6 0.3 2.9 3.4 0.6 0.3 CACNG2 "MGC138502, MGC138504, stargazin" ENSG00000166862 "Calcium voltage-gated channel auxiliary subunit gamma 2" Q9Y698 22 36560857-36703752 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 20.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 87.5;Horizontal cells: 26.9;Inhibitory neurons: 119.7;Oligodendrocyte precursor cells: 43.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 6: Brain - Smell perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (7.54e-2)" "unprognostic (3.06e-1)" "unprognostic (8.80e-3)" "unprognostic (2.34e-2)" "unprognostic (3.07e-2)" 0.0 0.7 5.7 0.0 7.1 0.0 0.0 13.8 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 6.0 0.0 0.0 0.0 0.0 5.9 3.8 0.0 0.0 0.0 1.2 0.0 6.5 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 7.1 13.8 20.7 6.0 6.0 5.9 3.8 6.5 2.6 6.2 11.0 0.0 0.0 0.0 3.9 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 0.4 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 119.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.5 0.0 0.2 0.0 43.7 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964707-67033398 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 35.1;prostate: 11.7" "Cell type enriched" "Detected in some" 6 "Oligodendrocyte precursor cells: 145.3" "Group enriched" "Detected in many" 5 "breast cancer: 30.3;glioma: 35.8;ovarian cancer: 14.8;prostate cancer: 10.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 6 "SH-SY5Y: 387.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 118.1" "HPA005803, HPA065370" Enhanced Approved Vesicles NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Vesicles "HPA005803: AB_2667439, HPA065370: AB_2685480" "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.5 0.8 26.5 0.1 35.1 0.0 5.3 6.9 26.8 0.4 4.2 0.8 0.2 0.5 0.1 0.2 4.2 0.4 0.2 14.5 17.9 0.2 0.0 5.7 0.0 11.7 16.7 0.1 0.4 1.2 0.3 0.7 15.0 11.7 0.1 0.7 1.7 1.3 0.1 0.5 0.1 1.1 14.3 0.0 1.5 0.2 29.6 0.0 0.1 0.0 0.0 0.4 0.7 9.5 6.4 4.1 15.6 0.0 0.0 0.0 4.4 0.0 0.0 1.4 0.0 4.6 0.2 0.0 0.2 0.0 41.2 64.1 0.1 0.0 0.0 0.0 0.3 0.0 1.8 3.7 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 34.5 0.1 0.3 15.7 7.3 0.0 0.0 0.4 8.7 0.0 11.1 15.8 387.4 3.6 10.4 0.0 38.1 38.5 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 35.1 6.9 26.8 14.5 17.9 11.7 16.7 15.0 14.3 29.6 9.5 0.0 3.2 1.3 0.0 0.0 0.0 1.1 0.3 0.0 0.2 6.4 3.4 1.3 0.0 1.4 0.0 0.0 0.3 0.1 0.6 0.0 0.1 2.6 1.0 0.2 0.1 7.7 0.0 1.8 0.2 0.2 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.7 0.0 3.4 0.0 145.3 0.3 0.7 0.2 0.0 0.0 2.6 0.0 0.0 1.9 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.7 CASD1 "C7orf12, FLJ21213, FLJ21879" ENSG00000127995 "CAS1 domain containing 1" Q96PB1 7 94509219-94557019 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 93.7;Inhibitory neurons: 108.5;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 170.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044404 Uncertain Approved Nucleoplasm Yes No "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA044404: AB_10964353" "unprognostic (4.02e-2)" "unprognostic (4.16e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (7.04e-2)" "unprognostic (7.90e-2)" "unprognostic (3.66e-2)" "unprognostic (2.18e-2)" "unprognostic (9.83e-2)" "unprognostic (4.74e-2)" "unprognostic (4.95e-3)" "unprognostic (2.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (1.93e-1)" "unprognostic (7.07e-2)" "unprognostic (2.59e-3)" 11.1 25.3 11.4 9.6 14.0 6.0 15.7 11.1 12.9 11.3 4.8 16.5 6.5 14.1 14.6 6.3 11.0 10.0 17.1 14.9 17.4 12.4 9.0 11.3 12.5 8.8 10.7 16.4 9.8 13.8 8.7 12.3 12.9 13.9 19.3 22.1 20.3 9.4 14.1 3.8 6.1 11.0 11.3 10.6 7.3 13.1 14.6 11.2 16.0 19.6 10.8 9.1 4.3 14.0 5.5 10.4 34.7 12.9 10.4 12.3 5.9 7.2 12.8 7.9 10.2 6.5 13.2 13.9 18.5 9.8 14.1 3.0 8.8 2.5 15.4 22.2 7.1 12.3 8.5 11.9 8.8 20.5 0.0 11.4 9.2 7.2 10.3 15.4 12.6 16.0 6.7 29.3 19.6 8.0 28.5 11.6 17.7 7.7 8.2 19.3 28.0 10.8 15.9 14.9 13.1 44.5 11.4 20.7 7.4 24.9 5.4 12.8 6.7 19.6 15.5 16.2 10.6 28.0 28.1 28.5 10.7 4.7 12.9 0.0 0.2 0.0 0.6 0.2 1.6 0.6 0.9 0.8 0.4 0.5 0.9 0.7 0.0 0.6 0.2 0.3 0.6 0.2 11.4 14.0 11.1 12.9 14.9 17.4 8.8 10.7 12.9 11.3 14.6 14.0 26.2 28.9 26.3 76.0 15.4 4.6 5.8 5.8 4.0 56.4 14.4 12.8 21.1 17.2 12.8 20.2 18.8 14.2 14.6 29.7 3.9 5.1 3.4 18.0 13.1 16.4 7.2 4.6 93.7 5.6 5.7 14.6 5.1 9.9 10.2 23.7 16.1 13.3 8.8 67.3 108.5 30.2 2.0 9.8 5.5 7.0 11.5 10.8 24.9 61.8 7.1 23.3 10.3 122.6 170.3 6.8 11.8 9.8 9.2 10.0 0.6 10.8 18.1 31.4 19.7 41.2 12.2 9.6 12.8 4.7 4.5 16.8 12.2 25.8 19.5 4.5 CBFA2T2 "MTGR1, ZMYND3" ENSG00000078699 "CBFA2/RUNX1 partner transcriptional co-repressor 2" O43439 20 33490075-33650036 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 128.3;Excitatory neurons: 114.7;Inhibitory neurons: 116.6;Oligodendrocytes: 166.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 45.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060523, HPA072433" Supported Approved "Nuclear speckles" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 6: Brain - Smell perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nuclear speckles" "HPA060523: AB_2684305, HPA072433: AB_2686520" "unprognostic (6.51e-3)" "unprognostic (3.29e-1)" "unprognostic (2.16e-2)" "unprognostic (1.91e-3)" "unprognostic (1.21e-1)" "unprognostic (8.37e-3)" "unprognostic (2.85e-3)" "unprognostic (3.90e-2)" "unprognostic (3.08e-1)" "unprognostic (3.89e-2)" "prognostic favorable (6.93e-6)" "unprognostic (7.83e-2)" "unprognostic (1.39e-3)" "unprognostic (9.40e-2)" "unprognostic (1.21e-1)" "unprognostic (2.24e-2)" "unprognostic (3.12e-2)" 6.4 4.8 11.3 5.8 11.6 5.5 6.6 9.0 13.8 11.8 4.9 11.9 7.5 7.5 5.0 9.2 8.4 4.1 7.6 13.1 11.7 7.5 7.5 8.5 6.6 10.5 9.7 11.6 7.0 9.1 9.7 4.5 11.5 16.8 9.1 15.4 8.2 5.8 9.6 12.1 10.6 5.9 7.5 8.9 8.8 11.1 11.8 8.9 10.7 5.7 6.3 9.5 10.6 17.7 6.8 6.5 9.3 6.8 9.2 7.0 9.5 4.1 4.9 5.5 4.6 13.8 6.3 7.9 8.4 5.7 12.3 9.0 5.4 6.8 4.8 3.3 4.1 10.9 6.5 8.3 5.8 4.5 9.0 5.9 8.9 5.7 7.9 6.8 4.9 8.1 6.2 5.1 4.8 6.1 9.6 7.6 3.2 8.3 7.1 7.5 10.3 8.3 6.3 9.7 30.1 45.1 20.7 8.0 6.7 9.4 7.5 6.9 5.3 13.1 5.9 8.9 5.0 9.3 11.0 4.5 6.7 4.1 4.2 4.2 1.1 1.2 2.1 1.0 1.9 2.7 2.2 2.7 0.5 2.7 1.3 1.8 2.2 1.2 0.7 1.5 1.9 0.7 11.3 11.6 9.0 13.8 13.1 11.7 10.5 9.7 11.5 7.5 11.8 17.7 9.9 12.8 21.7 128.3 17.8 19.1 12.9 9.3 26.2 29.9 15.9 11.3 11.4 7.2 11.1 12.9 45.9 12.8 12.7 17.1 1.9 8.5 12.0 14.4 11.6 11.8 90.4 11.6 114.7 6.4 11.4 14.1 19.4 17.1 1.3 16.3 11.4 8.1 9.4 13.5 116.6 50.1 14.2 11.0 13.7 14.9 14.0 8.4 17.8 59.0 12.1 10.9 17.5 74.4 166.9 9.4 15.6 12.8 19.1 21.8 14.4 5.4 11.4 38.5 13.1 12.5 11.9 24.1 18.1 20.4 15.3 8.9 19.5 7.5 18.9 15.2 CBLN2 ENSG00000141668 "Cerebellin 2 precursor" Q8IUK8 18 72536680-72638521 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 32.5" "Cell type enriched" "Detected in some" 13 "Excitatory neurons: 508.3" "Cancer enriched" "Detected in single" 7 "breast cancer: 3.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 54.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in brain" NA NA 1400000 "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (2.03e-2)" "unprognostic (3.52e-1)" "unprognostic (1.13e-3)" "unprognostic (9.09e-5)" "unprognostic (7.10e-2)" "unprognostic (6.27e-3)" "unprognostic (7.39e-2)" "unprognostic (2.17e-1)" "unprognostic (1.37e-4)" "unprognostic (5.01e-4)" "unprognostic (8.15e-2)" "unprognostic (6.07e-4)" "unprognostic (7.19e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (4.93e-2)" 0.4 0.2 7.9 0.3 17.3 0.0 0.1 0.0 32.5 0.3 0.0 1.8 1.5 0.0 0.0 0.0 0.1 0.0 0.1 3.3 0.2 2.5 0.4 0.0 0.0 5.9 4.5 0.1 0.0 0.0 0.2 0.0 8.7 0.9 1.5 5.1 0.0 5.1 0.0 0.8 2.5 0.8 0.0 0.0 0.1 0.2 13.8 0.0 0.0 0.0 0.7 0.1 0.0 12.8 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 54.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 17.3 0.0 32.5 3.3 0.2 5.9 4.5 8.7 0.0 13.8 12.8 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.3 37.8 0.0 508.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.3 0.6 0.6 0.0 0.0 10.3 0.0 0.5 0.0 9.5 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.3 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CBLN4 "CBLNL1, dJ885A10.1" ENSG00000054803 "Cerebellin 4 precursor" Q9NTU7 20 55997357-56005519 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 17.8;brain: 19.3;epididymis: 8.8" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 8.9;Excitatory neurons: 26.9;Inhibitory neurons: 31.6;Peritubular cells: 38.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 50 "SH-SY5Y: 9.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074497 Supported "Secreted in brain" NA NA 10000000 "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA074497: " "unprognostic (3.61e-1)" "unprognostic (8.43e-3)" "unprognostic (2.43e-1)" "unprognostic (1.61e-2)" "unprognostic (1.99e-1)" "unprognostic (4.00e-1)" "unprognostic (3.25e-1)" "unprognostic (2.11e-1)" "unprognostic (1.42e-1)" "unprognostic (3.88e-1)" "unprognostic (9.63e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-3)" "unprognostic (3.22e-4)" "unprognostic (7.50e-2)" "unprognostic (3.58e-2)" "unprognostic (1.79e-3)" 1.6 17.8 14.6 0.1 3.4 0.0 1.4 0.0 9.4 1.9 0.0 0.0 0.0 0.7 8.8 0.1 3.8 0.5 0.0 14.4 5.8 0.6 0.9 0.7 0.0 0.7 19.3 2.0 0.7 0.3 0.1 0.2 2.4 0.1 0.0 0.3 0.1 0.3 0.3 0.0 0.1 0.3 0.0 0.0 0.3 2.0 12.2 0.1 0.9 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 3.4 0.0 9.4 14.4 5.8 0.7 19.3 2.4 0.0 12.2 0.2 0.1 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.2 8.9 0.0 26.9 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.0 1.3 0.1 1.7 31.6 0.0 0.0 0.0 0.0 1.0 2.1 0.2 0.0 1.9 0.0 0.2 0.0 1.0 2.0 0.0 0.0 38.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CCDC188 ENSG00000234409 "Coiled-coil domain containing 188" H7C350 22 20148416-20151055 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 40.2" "Group enriched" "Detected in some" 89 "Early spermatids: 313.0;Late spermatids: 988.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 15 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 15 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "AF22: 4.0;SCLC-21H: 5.5;SH-SY5Y: 7.2;TIME: 3.1;U-2 OS: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA049901 Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 78: Testis - Spermatogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear bodies" Nucleoplasm "HPA049901: AB_2680943" "unprognostic (9.83e-2)" "unprognostic (3.09e-2)" "unprognostic (9.79e-2)" "unprognostic (6.42e-3)" "unprognostic (2.45e-1)" "unprognostic (3.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.02e-1)" "unprognostic (8.43e-2)" "unprognostic (4.08e-3)" "unprognostic (1.67e-5)" "unprognostic (1.16e-1)" "unprognostic (5.37e-5)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-2)" 1.5 0.6 0.4 0.5 0.6 0.5 1.3 0.5 0.6 0.8 0.0 0.5 0.8 0.8 0.0 0.3 1.0 0.3 0.6 1.0 1.3 0.9 0.2 1.0 0.6 0.1 0.0 0.3 0.5 0.0 9.6 0.6 0.0 0.5 0.0 0.2 0.4 0.0 0.6 1.1 0.6 0.2 0.0 1.5 0.5 40.2 1.4 0.0 0.6 0.0 0.0 0.7 0.6 0.0 0.0 0.0 4.0 0.2 0.0 0.5 0.0 1.1 0.5 0.9 0.7 0.0 0.1 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.2 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.1 0.6 0.2 2.6 0.8 0.3 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 5.5 7.2 0.4 0.0 0.4 0.1 0.0 0.1 3.1 1.6 3.0 2.0 0.2 0.5 0.1 0.2 2.7 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.6 0.5 0.6 1.0 1.3 0.1 0.0 0.0 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.0 7.3 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 988.5 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 4.1 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CCDC33 "CT61, FLJ32855" ENSG00000140481 "Coiled-coil domain containing 33" Q8N5R6 15 74202705-74336472 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 23.6;testis: 20.2" "Group enriched" "Detected in some" 9 "Early spermatids: 54.2;Endometrial ciliated cells: 70.1;Late spermatids: 54.6;Respiratory ciliated cells: 56.7" "Group enriched" "Detected in some" 5 "endometrial cancer: 1.4;ovarian cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 4.4;SCLC-21H: 2.4;SH-SY5Y: 2.9" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "midbrain: 7.4" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.11e-2)" "unprognostic (5.53e-2)" "unprognostic (3.57e-1)" "unprognostic (5.13e-3)" "unprognostic (6.37e-3)" "unprognostic (2.16e-1)" "unprognostic (3.16e-3)" "unprognostic (3.68e-2)" "unprognostic (9.87e-2)" "unprognostic (2.05e-2)" "unprognostic (4.46e-1)" "unprognostic (4.18e-2)" "unprognostic (6.12e-2)" "unprognostic (9.37e-2)" 0.0 0.2 0.6 0.0 0.4 0.0 0.0 0.2 0.0 2.0 0.5 0.0 0.0 0.3 0.1 0.0 23.6 0.0 0.1 0.5 0.6 0.0 0.0 2.6 0.0 2.1 3.4 0.1 0.0 0.0 0.4 0.1 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 20.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.4 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.5 0.6 2.1 3.4 1.6 2.3 0.4 0.6 0.2 0.0 1.5 0.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.3 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.3 54.2 70.1 1.5 0.2 0.0 0.0 0.6 0.0 0.0 0.5 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.1 0.0 0.0 54.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.6 0.0 0.4 0.0 0.0 0.0 0.4 56.7 0.0 0.0 0.0 1.1 0.6 0.2 0.0 0.0 1.8 0.1 0.2 0.0 0.1 CCDC40 "CFAP172, CILD15, FAP172, FLJ20753, FLJ32021, KIAA1640" ENSG00000141519 "Coiled-coil domain containing 40" Q4G0X9 17 80036632-80100613 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 31.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 58.5;Respiratory ciliated cells: 92.9;Rod photoreceptor cells: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.1;SH-SY5Y: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022974 Enhanced Approved Microtubules NA NA "Cluster 11: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Microtubules "HPA022974: AB_1848791" "unprognostic (5.89e-3)" "unprognostic (2.30e-1)" "unprognostic (8.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "unprognostic (1.44e-2)" "unprognostic (1.53e-2)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.04e-5)" "unprognostic (7.38e-2)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.86e-1)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" "unprognostic (4.26e-2)" 2.0 2.3 2.3 0.9 2.2 0.3 2.2 1.8 2.3 2.6 31.4 2.3 0.5 3.2 2.5 0.7 14.8 2.1 3.1 2.2 4.1 7.5 1.7 3.2 0.7 7.4 10.8 1.7 2.6 1.8 6.9 0.6 3.7 3.2 0.5 5.7 2.3 1.6 0.8 1.1 1.6 1.0 4.6 1.2 1.8 8.4 4.8 0.3 4.9 0.5 0.5 1.7 1.2 2.2 2.2 7.0 6.2 6.9 0.8 0.9 1.6 2.0 1.4 1.7 1.8 0.7 3.0 0.3 0.9 1.4 2.9 0.6 1.6 1.5 0.4 0.1 1.3 0.1 3.9 3.5 1.4 0.1 2.2 1.6 2.1 2.1 0.2 3.0 0.9 1.3 0.8 0.0 1.4 2.5 0.1 0.4 2.8 3.0 2.3 1.8 3.3 0.0 3.5 1.4 12.1 8.7 3.1 1.5 1.4 3.3 2.8 0.2 1.1 3.8 2.3 2.5 0.4 2.0 0.7 0.3 0.8 0.2 1.9 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.3 2.2 1.8 2.3 2.2 4.1 7.4 10.8 3.7 4.6 4.8 2.2 0.8 12.8 5.2 16.6 0.6 0.6 2.4 2.5 0.6 4.2 2.9 3.0 3.6 0.0 10.0 7.3 14.6 0.4 0.1 0.3 1.9 2.9 13.6 58.5 4.0 1.4 3.0 0.0 10.7 1.5 1.0 2.3 1.5 4.7 0.0 1.8 1.8 1.2 1.4 11.8 11.7 1.7 8.2 4.3 1.4 7.9 1.2 1.5 0.0 10.3 0.3 4.7 0.0 8.0 1.9 0.9 1.1 3.4 0.1 1.5 0.3 2.1 92.9 28.6 0.0 3.3 3.2 16.0 5.3 0.5 0.3 0.3 0.5 2.4 0.7 1.1 CCDC74B DKFZp434E2321 ENSG00000152076 "Coiled-coil domain containing 74B" Q96LY2 2 130139287-130145134 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 55.4" "Cell type enhanced" "Detected in many" "Early spermatids: 322.3;Late spermatids: 129.6;Respiratory ciliated cells: 70.3;Spermatocytes: 142.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.2;SH-SY5Y: 14.8" HPA060727 Uncertain Vesicles NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" Vesicles "HPA060727: " "prognostic favorable (4.46e-4)" "unprognostic (4.75e-3)" "unprognostic (2.67e-1)" "unprognostic (2.76e-3)" "unprognostic (2.81e-1)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (9.43e-2)" "unprognostic (2.99e-1)" "unprognostic (2.10e-1)" "unprognostic (6.43e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (2.43e-2)" "unprognostic (1.48e-4)" "unprognostic (8.31e-3)" "unprognostic (9.94e-3)" 1.5 1.9 3.5 0.3 3.6 0.0 2.4 2.6 4.3 17.0 7.6 1.6 0.2 8.9 0.8 0.4 14.1 1.4 1.5 4.1 5.4 3.8 0.1 2.8 0.3 6.2 7.2 5.0 0.8 11.1 19.7 0.2 5.1 7.1 0.1 0.6 0.6 2.8 0.2 1.0 0.7 1.2 5.7 0.4 1.5 55.4 6.1 0.6 7.0 0.0 0.2 2.4 3.6 3.9 0.0 1.9 2.8 0.1 2.5 5.4 0.6 2.2 1.1 0.3 0.5 0.9 0.7 0.1 3.5 2.0 3.2 1.0 0.2 0.3 0.4 2.0 5.5 0.0 7.0 0.1 0.3 0.1 0.2 1.1 0.0 0.9 0.0 3.4 0.1 1.3 0.1 1.7 0.8 2.1 0.0 0.0 5.7 0.5 5.9 4.6 0.0 3.2 1.7 0.0 10.2 14.8 1.6 0.1 0.2 0.6 5.9 0.7 0.4 1.1 4.8 5.9 0.5 0.1 0.3 0.0 6.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.6 2.6 4.3 4.1 5.4 6.2 7.2 5.1 5.7 6.1 3.9 0.2 3.2 0.5 1.6 0.1 0.5 3.0 6.3 1.2 0.5 6.1 9.5 0.4 1.5 4.3 5.5 0.0 0.2 0.2 0.1 3.9 1.5 322.3 42.8 9.9 0.2 11.4 0.0 1.6 0.2 0.8 3.6 0.0 2.2 0.0 7.8 0.0 0.0 0.3 3.3 1.1 0.1 2.0 0.0 0.2 129.6 10.2 0.6 0.0 1.0 0.0 6.2 0.0 0.5 0.3 0.0 0.1 12.4 0.1 3.9 0.0 1.2 70.3 0.1 0.0 0.9 3.2 142.7 16.4 0.7 1.1 0.1 0.3 28.8 0.1 0.7 CDH20 "Cdh7, CDH7L3" ENSG00000101542 "Cadherin 20" Q9HBT6 18 61333430-61555779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 33.7;retina: 11.0;tongue: 24.1" "Group enriched" "Detected in some" 6 "Astrocytes: 1264.4;Oligodendrocyte precursor cells: 742.4;Oligodendrocytes: 1030.7" "Cancer enriched" "Detected in single" 15 "glioma: 6.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 23 "basophil: 2.3" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "AF22: 1.8;ASC diff: 5.7;HHSteC: 2.6;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015490 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA015490: AB_1845900" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (1.42e-2)" "unprognostic (3.68e-3)" "unprognostic (2.11e-1)" "unprognostic (5.15e-2)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (3.82e-2)" "unprognostic (1.27e-1)" "unprognostic (3.01e-2)" "unprognostic (1.93e-1)" 4.7 0.1 22.1 0.0 29.9 0.0 0.9 24.8 19.9 0.2 2.3 0.0 0.0 0.1 0.6 0.8 0.2 0.0 0.1 20.0 19.8 0.1 0.0 0.0 0.0 27.5 28.7 0.0 0.1 0.0 1.6 0.0 29.1 0.2 0.0 11.0 0.4 0.0 4.7 0.5 0.2 0.0 21.5 0.1 0.1 0.4 23.1 0.0 0.3 24.1 0.0 0.3 0.0 33.7 0.0 0.0 1.8 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 22.1 29.9 24.8 19.9 20.0 19.8 27.5 28.7 29.1 21.5 23.1 33.7 0.2 0.0 0.0 1264.4 0.1 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 2.6 0.1 0.2 0.2 0.0 0.0 146.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 98.7 0.1 0.0 0.3 0.0 2.7 0.0 0.1 0.0 41.2 0.0 11.1 0.0 742.4 1030.7 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 1.1 0.0 1.0 0.2 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CDK5 PSSALRE ENSG00000164885 "Cyclin dependent kinase 5" Q00535 7 151053815-151057897 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Lissencephaly, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008909, HPA064535" Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB008909: , HPA064535: AB_2685280" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (4.22e-2)" "unprognostic (1.43e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-1)" "unprognostic (5.67e-3)" "unprognostic (1.05e-2)" "unprognostic (1.22e-1)" "unprognostic (5.78e-3)" "unprognostic (6.25e-3)" "unprognostic (3.35e-1)" "unprognostic (4.47e-2)" "unprognostic (1.46e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" 6.3 16.8 50.2 9.4 53.2 11.2 8.6 44.9 65.8 8.6 40.0 9.3 10.9 6.7 24.9 10.2 8.2 9.5 9.8 57.5 50.9 13.5 12.5 8.3 9.8 48.6 45.3 4.5 9.5 22.8 14.7 8.6 48.4 8.8 9.9 11.3 9.6 10.2 8.5 9.5 8.6 10.4 43.2 9.4 7.9 4.9 50.1 14.2 10.0 7.2 11.6 8.8 6.0 50.9 31.9 40.8 37.3 59.7 48.8 36.1 17.8 24.4 41.7 47.9 40.3 31.2 31.0 34.7 71.3 31.8 63.5 23.5 67.8 40.6 22.6 24.9 43.3 38.2 32.4 30.7 31.6 29.0 64.4 37.9 28.7 39.0 13.5 62.8 38.8 57.6 36.3 24.0 50.7 68.4 76.4 57.9 39.3 57.2 80.5 38.9 14.8 41.5 46.2 27.9 23.0 97.8 30.9 37.7 43.8 36.0 18.6 25.9 22.7 42.2 10.3 31.2 39.2 52.1 61.4 13.7 66.4 46.5 75.8 18.9 39.4 20.1 13.5 46.2 11.1 13.3 12.8 13.6 44.7 12.8 9.8 11.8 5.7 19.9 36.4 26.9 31.9 23.8 50.2 53.2 44.9 65.8 57.5 50.9 48.6 45.3 48.4 43.2 50.1 50.9 7.6 0.0 6.0 1.6 6.2 3.6 8.2 18.0 6.2 12.1 9.6 10.4 3.1 8.6 14.7 11.0 2.1 26.8 5.4 8.0 39.2 21.4 0.8 14.9 10.9 8.9 9.0 12.2 5.8 18.9 12.3 7.6 9.7 9.3 30.5 23.6 7.9 11.1 41.9 0.0 6.4 8.9 18.3 21.9 6.2 1.3 4.7 16.6 10.6 1.9 19.9 12.6 12.3 1.5 3.7 22.8 15.0 11.3 12.4 4.3 20.2 35.7 14.4 7.1 6.6 4.5 13.1 3.9 11.2 11.4 6.3 9.0 7.3 14.2 9.5 9.0 CDK5R2 "NCK5AI, P39, p39nck5ai" ENSG00000171450 "Cyclin dependent kinase 5 regulatory subunit 2" Q13319 2 218959666-218962155 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 52.2;pituitary gland: 35.2;retina: 26.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 78.8;Cone photoreceptor cells: 20.9;Enteroendocrine cells: 22.8;Excitatory neurons: 17.7;Horizontal cells: 15.2;Rod photoreceptor cells: 50.9" "Cancer enhanced" "Detected in some" "glioma: 3.9;pancreatic cancer: 2.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 18.4;SH-SY5Y: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (1.96e-1)" "unprognostic (6.53e-2)" "unprognostic (3.85e-5)" "unprognostic (1.73e-6)" "unprognostic (3.67e-2)" "unprognostic (2.83e-4)" "unprognostic (1.27e-3)" "unprognostic (7.21e-2)" "unprognostic (1.78e-1)" "unprognostic (6.71e-3)" "unprognostic (3.53e-3)" "unprognostic (2.34e-10)" "unprognostic (1.54e-1)" "unprognostic (1.64e-4)" "unprognostic (6.46e-2)" 0.0 3.9 17.0 0.3 21.5 0.0 0.0 0.0 52.2 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 20.2 17.4 0.0 0.0 0.0 0.0 7.1 3.6 0.0 1.0 0.0 35.2 0.0 10.7 0.0 0.1 26.3 0.0 0.0 0.0 0.0 0.4 0.1 1.4 0.0 0.9 0.8 15.6 0.0 0.0 0.0 0.0 0.0 0.1 20.0 0.4 0.4 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 2.1 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 18.4 13.3 0.7 0.0 0.1 0.4 0.0 0.0 0.0 0.2 1.3 0.0 0.3 0.0 0.0 0.0 0.6 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 21.5 0.0 52.2 20.2 17.4 7.1 3.6 10.7 1.4 15.6 20.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 78.8 0.0 0.0 0.5 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 22.8 0.0 17.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 15.2 11.9 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 8.1 0.0 2.0 2.6 0.2 1.2 0.0 0.0 0.1 0.1 0.0 0.0 50.9 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 CDKL4 ENSG00000205111 "Cyclin dependent kinase like 4" Q5MAI5 2 39175646-39229588 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 2.0;testis: 2.9" "Cell type enhanced" "Detected in some" "Early spermatids: 11.8;Excitatory neurons: 5.4;Late spermatids: 6.8;Respiratory ciliated cells: 5.9;Spermatocytes: 8.7;Spermatogonia: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 2.1;RT4: 1.3;SH-SY5Y: 2.6" "Low region specificity" "Detected in all" HPA067895 Uncertain NA NA "Cluster 35: T-regs - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA067895: AB_2685920" "unprognostic (3.57e-2)" "unprognostic (3.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.98e-2)" "unprognostic (3.29e-1)" "unprognostic (7.46e-3)" "unprognostic (3.26e-2)" "unprognostic (4.26e-1)" "unprognostic (3.82e-2)" "unprognostic (6.13e-3)" "unprognostic (1.77e-2)" "unprognostic (8.43e-2)" "unprognostic (8.45e-4)" "unprognostic (8.59e-2)" "unprognostic (4.95e-1)" "unprognostic (3.08e-1)" "unprognostic (3.26e-2)" 0.1 0.4 0.6 0.0 0.6 0.0 0.1 0.7 0.7 0.1 2.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.7 1.1 0.1 0.0 0.2 0.1 0.5 0.6 0.1 0.1 0.2 0.5 0.4 0.5 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 2.9 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 2.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 1.3 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.6 0.7 0.7 0.7 1.1 0.5 0.6 0.5 0.2 1.0 0.4 0.5 3.2 0.0 0.7 0.0 0.1 0.2 0.3 0.0 0.1 0.6 0.5 0.2 0.0 2.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 11.8 1.2 0.3 0.3 0.0 0.0 5.4 0.2 0.4 0.2 1.1 1.8 0.0 0.2 0.0 0.1 0.2 0.0 3.4 0.0 2.0 0.0 0.0 6.8 0.3 0.2 0.0 1.9 0.0 0.2 0.0 1.5 0.4 0.4 0.1 0.4 0.1 0.4 0.0 0.3 5.9 0.8 0.0 0.5 0.1 8.7 4.3 0.0 0.0 0.0 0.3 0.2 0.0 0.1 CDKN1C "BWCR, BWS, KIP2, P57" ENSG00000129757 "Cyclin dependent kinase inhibitor 1C" P49918 11 2883213-2885775 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 206.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 575.3;Extravillous trophoblasts: 1531.7;Syncytiotrophoblasts: 2241.2;Theca cells: 781.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "intermediate monocyte: 155.1;non-classical monocyte: 376.4" "Lineage enriched" "Detected in many" 14 "monocytes: 376.4" "Cell line enhanced" "Detected in many" "EFO-21: 12.0;HeLa: 12.8;RPMI-8226: 18.7;SH-SY5Y: 33.0;SiHa: 25.2;SK-MEL-30: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002924 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nucleoplasm, Nuclear bodies" Cytosol "HPA002924: AB_1079548" "unprognostic (5.49e-3)" "unprognostic (2.62e-1)" "unprognostic (9.82e-3)" "unprognostic (5.79e-3)" "unprognostic (4.15e-1)" "unprognostic (2.84e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-1)" "unprognostic (3.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.95e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-1)" "unprognostic (3.31e-2)" "unprognostic (8.53e-2)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" 127.4 182.9 8.2 3.3 38.0 1.7 92.5 43.3 18.7 73.7 6.5 48.1 1.4 70.6 0.2 29.9 70.7 0.8 82.6 11.7 18.8 149.5 8.3 34.5 0.2 55.1 33.5 206.4 28.5 0.2 27.8 28.1 45.0 33.1 0.2 0.5 21.7 1.5 60.3 26.6 25.0 0.4 31.8 20.6 54.1 8.6 34.3 0.2 17.0 0.9 0.4 75.0 49.4 95.3 0.1 0.1 1.6 0.0 0.4 0.5 1.8 0.3 0.6 0.3 0.0 3.3 0.4 0.0 12.0 0.2 0.1 0.5 0.3 0.3 0.1 5.6 1.2 0.1 12.8 0.0 3.3 0.0 1.4 2.4 1.6 0.0 0.2 0.1 0.3 0.1 2.7 0.8 0.5 0.1 0.0 6.0 10.6 0.5 4.0 2.2 0.0 18.7 0.7 0.0 3.5 33.0 25.2 0.3 15.2 0.9 0.2 2.8 0.4 0.0 2.2 0.0 0.1 7.3 0.0 0.1 0.0 1.8 6.8 9.1 1.2 0.9 0.4 155.1 1.8 0.0 0.4 0.6 26.9 0.3 1.0 0.3 2.2 0.0 376.4 0.2 0.7 14.7 8.2 38.0 43.3 18.7 11.7 18.8 55.1 33.5 45.0 31.8 34.3 95.3 357.3 3.2 5.8 1.0 11.6 10.7 81.7 4.9 30.7 11.9 81.0 150.5 45.3 61.5 10.8 31.3 6.2 575.3 46.9 20.3 15.6 9.8 176.5 38.8 101.5 100.8 106.5 0.8 0.6 0.6 1531.7 141.0 17.9 56.2 0.0 31.2 74.6 4.0 91.0 8.4 1.2 25.0 12.2 23.5 23.2 276.4 74.3 54.9 35.6 4.7 14.1 68.3 0.0 3.5 65.7 4.3 4.2 44.4 12.9 64.6 4.0 78.5 7.5 27.4 32.9 238.3 71.4 2.1 3.5 17.3 11.8 2241.2 25.1 781.8 15.2 71.8 CDR2L HUMPPA ENSG00000109089 "Cerebellar degeneration related protein 2 like" Q86X02 17 74987632-75005800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 23.2;Glandular and luminal cells: 28.9;Late spermatids: 30.9;Pancreatic endocrine cells: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 61.8;U-138 MG: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022015 Enhanced Approved Cytosol NA NA "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" Cytosol "HPA022015: AB_1846462" "unprognostic (4.60e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-2)" "unprognostic (3.85e-2)" "unprognostic (2.17e-1)" "unprognostic (7.36e-3)" "unprognostic (9.22e-2)" "unprognostic (1.78e-2)" "unprognostic (9.11e-2)" "unprognostic (2.11e-1)" "unprognostic (4.21e-2)" "unprognostic (1.84e-1)" "unprognostic (5.89e-2)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" 9.0 5.9 17.7 2.7 34.2 0.1 8.0 40.8 21.7 10.3 19.4 10.5 22.4 12.7 0.9 6.7 6.8 8.8 19.6 14.9 25.2 16.5 1.5 12.9 0.9 42.2 33.9 3.2 4.3 2.6 6.0 7.0 38.6 7.4 1.4 1.7 8.3 5.1 2.1 4.6 11.5 5.4 28.4 1.8 15.1 7.8 35.5 0.5 4.7 3.2 0.7 9.5 6.9 45.1 15.0 42.1 9.2 19.3 15.8 13.8 4.2 21.3 9.4 12.2 15.5 25.1 13.5 0.0 21.9 37.3 11.0 39.2 11.0 5.2 8.0 0.3 18.6 0.1 26.2 16.3 9.1 1.7 0.7 8.1 8.1 29.0 3.0 8.7 26.5 3.2 6.5 2.1 13.0 13.5 2.0 1.6 12.0 35.3 20.6 6.9 14.0 6.5 32.5 9.3 15.8 53.4 26.8 61.8 2.0 5.5 17.1 2.8 19.0 62.4 13.1 39.7 13.6 2.0 1.3 0.0 17.3 5.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.7 34.2 40.8 21.7 14.9 25.2 42.2 33.9 38.6 28.4 35.5 45.1 9.4 16.0 0.0 0.7 0.0 6.0 2.1 2.3 4.6 3.9 7.3 5.8 4.1 11.5 3.4 5.5 0.0 2.9 0.8 0.3 15.6 12.9 7.5 23.2 12.8 12.5 4.9 0.0 2.6 6.9 0.5 6.8 14.8 28.9 0.0 0.7 7.9 0.4 1.6 0.0 5.3 4.2 2.0 0.6 4.6 30.9 2.8 1.6 1.8 5.6 0.6 0.9 0.0 2.5 16.8 26.0 0.0 2.6 0.4 8.1 19.5 2.7 4.0 2.5 0.0 4.2 6.8 3.1 1.7 2.6 2.4 2.3 0.5 1.6 2.3 14.1 CELF3 "BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4" ENSG00000159409 "CUGBP Elav-like family member 3" Q5SZQ8 1 151700058-151716803 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 70.7;pituitary gland: 109.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 101.4;Cone photoreceptor cells: 39.6;Enteroendocrine cells: 52.8;Excitatory neurons: 21.1;Horizontal cells: 20.2;Inhibitory neurons: 20.4" "Group enriched" "Detected in many" 5 "glioma: 4.4;pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 42.1;SH-SY5Y: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006292 Uncertain Approved Nucleoplasm NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "HPA006292: AB_10602250" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (7.67e-2)" "unprognostic (1.96e-1)" "unprognostic (1.75e-1)" "unprognostic (6.64e-2)" "unprognostic (1.38e-1)" "unprognostic (3.02e-2)" "unprognostic (3.12e-1)" "unprognostic (3.48e-3)" "unprognostic (3.49e-3)" "unprognostic (6.90e-2)" "unprognostic (1.82e-8)" "unprognostic (8.50e-2)" "unprognostic (9.01e-2)" "unprognostic (2.41e-1)" "unprognostic (3.05e-2)" 0.1 11.2 41.9 0.2 41.1 0.3 0.0 22.1 70.7 0.0 0.0 2.1 3.0 0.0 0.0 0.0 0.8 0.0 0.1 48.5 37.5 0.1 0.0 0.1 0.0 8.6 16.4 0.0 6.1 0.0 109.0 0.1 10.9 0.1 0.7 23.6 0.0 0.0 0.0 0.1 2.1 0.2 5.2 0.0 4.9 3.1 28.5 0.0 0.1 0.0 0.0 0.1 0.2 20.5 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 42.1 29.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.9 41.1 22.1 70.7 48.5 37.5 8.6 16.4 10.9 5.2 28.5 20.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 101.4 0.0 0.0 0.9 0.0 0.0 0.0 39.6 0.1 0.0 0.3 0.0 0.0 13.1 0.3 0.0 0.0 52.8 0.0 21.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.2 20.4 1.5 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 6.0 0.7 0.1 0.1 0.0 0.0 0.1 0.0 0.8 0.0 5.5 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 CEP44 KIAA1712 ENSG00000164118 "Centrosomal protein 44" Q9C0F1 4 174283730-174333380 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 58.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 73.9;SH-SY5Y: 142.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041515, HPA041835" Approved NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "HPA041515: AB_10795638, HPA041835: AB_10794637" "unprognostic (2.43e-1)" "unprognostic (1.30e-1)" "unprognostic (1.26e-1)" "unprognostic (4.03e-2)" "unprognostic (8.69e-2)" "unprognostic (6.96e-2)" "unprognostic (1.07e-2)" "unprognostic (6.62e-2)" "unprognostic (1.90e-2)" "unprognostic (1.11e-2)" "unprognostic (7.97e-2)" "unprognostic (2.72e-3)" "unprognostic (5.54e-2)" "unprognostic (2.44e-1)" "unprognostic (2.80e-1)" "unprognostic (1.21e-2)" "unprognostic (1.90e-2)" 6.1 8.7 5.7 7.8 8.2 11.1 9.7 11.5 7.6 7.9 7.4 9.2 7.6 10.5 9.2 8.7 7.6 8.1 8.7 7.8 6.0 5.9 7.8 7.1 10.2 7.5 6.5 10.8 6.3 9.2 8.1 11.5 8.5 8.4 8.6 12.6 7.6 6.1 5.8 13.0 8.6 7.6 6.6 8.8 8.7 13.4 6.6 11.0 9.0 6.2 8.5 7.3 7.3 13.2 12.5 11.4 19.2 9.6 12.1 17.3 10.7 18.7 7.1 12.1 12.5 6.9 27.1 19.0 18.1 4.8 11.5 10.1 20.4 9.3 15.5 30.9 32.2 23.2 33.1 8.0 8.3 17.7 16.6 9.2 14.4 9.9 10.6 12.0 10.6 14.7 30.9 73.9 14.6 4.9 20.7 13.7 10.0 9.4 9.8 15.4 18.2 15.6 10.8 5.0 34.5 142.6 16.1 12.8 14.2 17.6 13.8 12.7 11.5 9.6 10.5 23.1 11.8 18.7 14.0 24.0 18.6 15.7 19.6 5.9 3.1 2.3 3.9 3.7 3.9 5.6 4.1 3.4 3.2 5.6 5.2 4.5 2.3 2.8 4.6 3.0 8.7 2.7 5.7 8.2 11.5 7.6 7.8 6.0 7.5 6.5 8.5 6.6 6.6 13.2 12.6 9.6 16.4 24.5 14.4 9.9 9.0 10.1 14.8 22.8 10.7 8.0 17.1 8.6 11.9 1.8 33.3 6.6 14.2 8.0 5.9 7.8 6.6 25.4 15.8 9.1 7.7 27.4 24.0 8.0 10.3 14.2 10.2 20.0 12.0 19.4 6.1 7.8 6.6 15.2 25.5 7.8 8.2 9.5 6.0 7.9 16.4 12.3 8.8 10.3 7.9 11.1 8.2 39.2 58.4 9.5 4.9 10.1 13.7 7.2 9.2 4.9 31.5 30.3 13.1 21.1 14.6 44.8 15.0 8.8 11.1 6.7 13.0 9.3 8.1 10.1 CFAP77 "C9orf171, FLJ46082" ENSG00000188523 "Cilia and flagella associated protein 77" Q6ZQR2 9 132410043-132573319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 11.5;fallopian tube: 29.7;testis: 19.3" "Cell type enhanced" "Detected in some" "Early spermatids: 127.1;Endometrial ciliated cells: 58.4;Late spermatids: 47.6;Respiratory ciliated cells: 36.5;Spermatocytes: 25.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 5.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021329, HPA024647, HPA061069" Enhanced Approved Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657" "unprognostic (7.28e-4)" "unprognostic (5.68e-2)" "unprognostic (5.25e-2)" "prognostic favorable (7.31e-4)" "unprognostic (1.70e-2)" "unprognostic (1.74e-1)" "unprognostic (3.01e-1)" "unprognostic (2.31e-2)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (1.77e-1)" "unprognostic (2.41e-3)" "unprognostic (2.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (7.95e-2)" 0.0 0.0 1.2 0.0 1.0 0.0 0.0 2.0 0.1 1.2 11.5 0.0 0.0 0.5 0.2 0.0 29.7 0.0 2.4 1.0 1.5 0.1 0.0 2.1 0.0 4.1 6.0 0.0 0.1 0.0 0.6 0.0 3.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 19.3 1.4 0.2 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 2.0 0.1 1.0 1.5 4.1 6.0 3.1 3.3 1.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 58.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.6 0.3 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 36.5 3.8 0.0 0.0 0.0 25.5 3.5 0.0 0.0 0.1 0.1 0.1 0.0 0.1 CFAP91 "AAT-1, AAT1, AAT1alpha, C3orf15, CaM-IP2, MAATS1, SPATA26" ENSG00000183833 "Cilia and flagella associated protein 91" Q7Z4T9 3 119703022-119767102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.1" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;hTERT-RPE1: 1.4;RPTEC TERT1: 2.4;SCLC-21H: 3.5;SH-SY5Y: 2.5;T-47d: 1.8;U-87 MG: 1.9" HPA074084 Supported NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" "HPA074084: " "unprognostic (6.70e-2)" "unprognostic (3.54e-2)" "unprognostic (3.31e-1)" "unprognostic (3.93e-2)" "unprognostic (2.40e-2)" "unprognostic (1.89e-2)" "unprognostic (1.36e-1)" "unprognostic (4.02e-2)" "unprognostic (1.19e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (9.11e-2)" "unprognostic (4.07e-2)" "unprognostic (9.46e-2)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "unprognostic (4.46e-2)" 0.6 2.1 0.8 0.0 1.0 0.0 1.8 0.5 1.0 3.4 5.7 1.4 0.0 4.0 5.0 0.3 14.1 1.2 0.4 1.0 1.7 2.5 0.4 2.1 0.1 2.4 2.1 3.4 4.9 4.0 7.2 0.2 1.8 2.3 0.5 4.1 1.5 4.5 0.1 0.3 0.6 0.8 1.6 2.4 1.7 8.7 1.4 0.4 4.6 0.0 0.3 1.1 1.1 1.0 0.1 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.2 0.2 1.2 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 2.4 0.0 3.5 2.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.5 1.0 1.0 1.7 2.4 2.1 1.8 1.6 1.4 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CHGA ENSG00000100604 "Chromogranin A" P10645 14 92923150-92935285 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "parathyroid gland: 6568.4" "Cell type enriched" "Detected in many" 7 "Enteroendocrine cells: 6553.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 114.8" "Group enriched" "Detected in many" 16 "cerebral cortex: 326.0;white matter: 124.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 151 "SCLC-21H: 489.5;SH-SY5Y: 1339.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000023, HPA017369, CAB040544, CAB055506, CAB058688" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 295000000 100000000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" Vesicles "CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698" "prognostic favorable (7.85e-5)" "unprognostic (4.89e-2)" "unprognostic (5.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.43e-2)" "unprognostic (5.95e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (4.56e-2)" "prognostic favorable (4.07e-4)" "unprognostic (1.85e-1)" "unprognostic (8.81e-13)" "unprognostic (1.07e-2)" "unprognostic (1.77e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (3.99e-4)" 14.5 1248.5 8.6 9.4 11.4 0.2 0.3 0.0 326.0 8.3 0.0 92.0 242.7 0.4 0.3 1.0 1.1 0.2 0.2 4.4 1.7 1.0 0.4 1.6 0.1 14.4 0.0 0.2 102.5 6568.4 446.2 0.0 4.1 12.2 105.2 11.0 0.2 0.3 0.1 0.6 179.9 0.9 0.0 0.1 364.5 77.7 4.3 0.6 24.6 0.0 0.0 1.3 1.2 124.4 0.0 0.5 2.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.8 2.7 0.0 0.0 0.2 0.0 1.4 0.0 0.0 489.5 1339.4 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 4.2 0.3 0.4 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 11.4 0.0 326.0 4.4 1.7 14.4 0.0 4.1 0.0 4.3 124.4 0.1 0.0 0.0 11.1 1.0 0.9 0.4 0.0 0.0 17.3 0.2 0.3 2.9 0.0 0.0 0.0 29.2 0.3 0.0 9.8 0.0 0.1 1.3 6.0 2.3 0.8 6553.1 0.0 59.5 0.4 0.1 4.1 195.7 0.5 0.0 0.5 0.0 0.0 1.5 16.8 37.7 820.4 14.2 0.0 0.0 7.9 39.7 0.1 7.2 15.9 2.0 3.7 0.0 10.6 12.8 46.5 137.8 137.3 0.0 6.6 36.7 0.0 0.0 16.2 0.0 0.0 0.2 4.7 2.2 0.0 0.0 0.3 0.2 0.4 25.9 5.1 CHGB "SCG1, SgI" ENSG00000089199 "Chromogranin B" P05060 20 5911510-5925353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "adrenal gland: 3466.0;pituitary gland: 1425.3" "Cell type enriched" "Detected in many" 5 "Enteroendocrine cells: 1036.1" "Cancer enriched" "Detected in many" 6 "pancreatic cancer: 154.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "SCLC-21H: 355.0;SH-SY5Y: 541.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008759, CAB009403, HPA012602" Enhanced Supported Enhanced Vesicles "Intracellular and membrane" NA NA 6500000 "Cluster 20: T-cells - T-cell receptor" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" Vesicles "CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706" "unprognostic (1.79e-3)" "unprognostic (7.72e-2)" "unprognostic (3.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.68e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (7.96e-3)" "unprognostic (2.86e-1)" "unprognostic (6.18e-3)" "unprognostic (7.93e-2)" "prognostic favorable (9.96e-4)" "unprognostic (8.56e-2)" "unprognostic (8.21e-2)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "unprognostic (2.73e-1)" "unprognostic (1.01e-2)" 27.5 3466.0 17.1 5.3 9.9 0.8 2.1 134.2 90.9 0.6 0.0 7.9 60.2 1.6 4.2 0.6 13.7 0.4 71.9 101.9 92.2 8.3 0.7 2.4 3.1 76.5 100.2 25.8 92.8 6.4 1425.3 0.7 188.4 5.3 14.2 56.9 6.1 3.8 11.0 1.7 31.6 0.9 12.8 0.3 133.3 14.9 19.3 4.0 9.7 0.8 1.4 0.4 2.3 14.2 0.0 7.9 0.9 0.0 0.2 0.2 0.4 0.2 0.0 0.1 0.0 1.9 0.0 0.0 4.3 0.0 4.9 0.1 0.0 0.1 0.1 0.6 0.1 2.6 0.0 1.6 0.1 4.2 0.2 1.5 0.0 0.0 2.1 0.1 0.1 0.2 0.4 0.1 1.0 0.0 0.1 0.9 19.7 1.3 0.0 0.1 0.0 0.4 0.5 0.2 355.0 541.8 0.0 0.5 0.4 2.1 0.3 0.4 0.3 0.1 6.4 0.4 3.3 0.0 0.7 2.7 0.5 3.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 17.1 9.9 134.2 90.9 101.9 92.2 76.5 100.2 188.4 12.8 19.3 14.2 0.0 3.2 2.4 7.5 0.3 4.2 9.9 0.8 0.0 93.3 0.1 0.3 114.4 0.0 0.7 69.9 20.9 0.1 0.0 1.6 1.9 0.5 7.1 0.2 0.7 3.0 1036.1 0.0 31.6 0.4 0.0 18.9 4.1 0.3 0.0 202.8 0.0 0.3 0.1 75.7 28.8 61.9 65.1 0.3 9.5 8.3 0.9 1.6 7.2 9.4 1.1 13.7 1.0 7.5 5.2 22.9 17.7 0.4 0.0 3.3 3.2 0.3 4.4 75.6 13.1 3.0 1.6 76.6 41.8 0.0 3.7 0.3 1.0 3.0 2.2 4.2 CHRM3 ENSG00000133019 "Cholinergic receptor muscarinic 3" P20309 1 239386565-239915452 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;salivary gland: 17.5" "Group enriched" "Detected in many" 28 "Excitatory neurons: 802.9;Inhibitory neurons: 624.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 17.2;SH-SY5Y: 53.5;U-266/70: 21.7;U-266/84: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024106, HPA048036" Approved Supported "Plasma membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "HPA024106: AB_1854211, HPA048036: AB_2680238" "unprognostic (1.63e-1)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (4.11e-3)" "unprognostic (3.48e-3)" "unprognostic (5.81e-2)" "unprognostic (2.30e-3)" "unprognostic (5.18e-2)" "unprognostic (1.71e-1)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" "unprognostic (6.44e-2)" "unprognostic (5.34e-4)" "unprognostic (3.04e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (4.88e-2)" 0.3 0.4 4.6 0.8 7.3 0.2 0.8 0.0 11.8 0.4 0.0 7.0 1.4 1.9 0.4 7.5 0.8 0.7 0.4 7.5 0.0 1.1 0.4 1.1 0.1 0.0 0.0 4.8 10.6 0.5 0.5 0.8 0.0 1.1 2.8 1.7 17.5 3.0 0.0 1.3 1.5 4.1 0.0 0.7 5.0 2.5 4.1 0.1 2.0 0.1 0.1 7.0 0.4 2.9 0.0 0.1 0.4 0.4 0.0 0.0 0.9 0.6 0.1 0.3 0.1 0.0 0.0 0.0 2.1 0.0 0.0 5.8 0.6 3.8 2.7 0.0 3.7 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 1.1 9.1 0.9 1.4 0.0 0.0 4.6 4.6 9.1 0.0 1.1 17.2 0.7 0.8 0.1 53.5 0.0 0.1 0.1 4.0 1.8 0.0 0.3 2.3 0.8 0.1 0.5 21.7 16.3 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 4.6 7.3 0.0 11.8 7.5 0.0 0.0 0.0 0.0 0.0 4.1 2.9 6.1 0.0 3.7 6.2 0.0 0.0 2.1 0.0 0.6 19.0 4.6 3.2 1.2 0.0 0.8 0.0 0.0 3.2 0.3 11.0 1.9 0.4 19.6 0.1 0.1 3.0 3.5 4.6 802.9 17.3 0.7 3.9 11.7 0.2 1.3 7.5 4.2 0.3 0.5 0.0 624.0 6.0 0.0 0.0 0.0 3.9 0.0 0.2 7.2 22.5 0.0 0.3 0.0 8.5 11.2 2.6 25.3 0.4 0.2 2.5 2.2 1.4 1.6 0.6 0.0 0.2 1.1 12.9 3.0 0.2 0.0 0.5 0.1 0.8 15.5 0.2 CHRNA3 ENSG00000080644 "Cholinergic receptor nicotinic alpha 3 subunit" P32297 15 78593052-78621295 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 39.3;lymphoid tissue: 65.8;retina: 53.5" "Cell type enriched" "Detected in some" 19 "Cone photoreceptor cells: 164.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 356.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029430 Enhanced Supported "Nuclear speckles,Plasma membrane" NA NA "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane" "Nuclear speckles" "HPA029430: AB_10603785" "unprognostic (2.28e-1)" "unprognostic (3.45e-1)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.16e-3)" "unprognostic (1.97e-1)" "unprognostic (4.28e-2)" "unprognostic (7.20e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-4)" "unprognostic (2.65e-3)" "unprognostic (2.76e-1)" "unprognostic (1.53e-1)" "unprognostic (4.48e-1)" 0.3 39.3 4.4 5.1 2.0 0.0 0.1 6.3 1.0 1.0 0.3 8.1 1.5 0.5 0.0 0.1 0.0 0.3 0.4 0.7 2.3 0.0 0.0 0.2 0.3 3.1 6.4 0.1 0.2 0.0 1.1 0.1 10.0 0.2 4.0 53.5 0.1 0.0 0.1 0.7 3.0 3.7 0.3 0.1 2.8 1.0 9.2 65.8 0.2 0.0 0.8 0.2 0.7 1.0 0.1 0.3 0.7 0.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 1.5 0.0 8.8 0.0 0.0 0.3 1.4 0.5 0.4 0.1 0.0 0.1 4.0 0.0 0.3 0.0 0.0 0.0 0.0 22.6 0.2 0.0 0.0 0.3 7.1 0.0 1.6 0.1 0.2 0.4 0.3 0.1 0.0 0.4 67.7 356.1 0.3 0.1 0.1 0.5 0.4 0.0 0.0 0.1 1.7 0.1 0.4 0.2 0.7 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 2.0 6.3 1.0 0.7 2.3 3.1 6.4 10.0 0.3 9.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.8 0.0 0.0 0.0 164.7 0.0 0.0 0.2 1.9 0.0 3.7 0.1 1.2 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.7 0.4 3.6 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.1 0.1 0.3 2.1 0.0 0.0 0.0 0.0 2.6 0.1 0.1 CHRNB2 ENSG00000160716 "Cholinergic receptor nicotinic beta 2 subunit" P17787 1 154567778-154580013 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.4;retina: 8.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 12.7;Cone photoreceptor cells: 14.6;Horizontal cells: 42.1;Inhibitory neurons: 7.8;Late spermatids: 11.8;Rod photoreceptor cells: 7.6" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 25.7;SH-SY5Y: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "unprognostic (1.13e-1)" "unprognostic (6.33e-2)" "unprognostic (8.15e-3)" "unprognostic (3.32e-1)" "unprognostic (4.37e-3)" "unprognostic (2.25e-1)" "unprognostic (3.51e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.37e-1)" "unprognostic (1.24e-3)" "unprognostic (1.83e-1)" "unprognostic (4.36e-1)" "unprognostic (2.32e-1)" "unprognostic (1.45e-1)" "unprognostic (5.65e-2)" "unprognostic (1.84e-1)" 0.0 1.0 6.5 0.1 7.5 0.0 0.4 2.2 17.4 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 8.7 5.3 0.0 0.0 0.0 0.0 3.8 5.5 0.0 0.6 0.1 3.6 0.0 3.8 0.0 0.1 8.3 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.3 0.7 11.8 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 25.7 25.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 7.5 2.2 17.4 8.7 5.3 3.8 5.5 3.8 0.3 11.8 6.5 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 12.7 0.1 0.3 1.5 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.2 3.6 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 42.1 7.8 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 1.0 0.0 1.3 0.0 1.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 1.5 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 CHRNB4 ENSG00000117971 "Cholinergic receptor nicotinic beta 4 subunit" P30926 15 78624111-78727754 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.0;retina: 2.7;testis: 5.8" "Group enriched" "Detected in some" 11 "Early spermatids: 44.1;Late spermatids: 54.9" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "SCLC-21H: 30.9;SH-SY5Y: 40.7" "Group enriched" "Detected in some" 5 "olfactory bulb: 5.3;pons and medulla: 1.4;thalamus: 4.2" HPA059484 Approved "Endoplasmic reticulum,Cell Junctions" NA NA "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Endoplasmic reticulum" "Cell Junctions" "HPA059484: " "unprognostic (4.74e-2)" "unprognostic (4.54e-1)" "unprognostic (1.26e-2)" "unprognostic (8.77e-5)" "unprognostic (8.15e-2)" "unprognostic (6.43e-3)" "unprognostic (1.10e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (1.49e-1)" "unprognostic (1.45e-4)" "unprognostic (7.00e-3)" "unprognostic (2.58e-1)" "unprognostic (8.50e-2)" "unprognostic (7.76e-2)" 0.0 2.4 0.2 0.6 0.1 0.3 0.0 0.1 0.2 0.2 0.2 1.1 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.5 0.7 1.8 0.1 0.0 0.2 0.4 0.0 1.4 0.0 0.4 2.7 0.1 0.0 0.3 0.1 0.3 0.4 0.0 0.4 0.3 5.8 0.2 3.0 0.1 0.0 0.4 0.0 0.2 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.6 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.9 40.7 0.2 0.5 0.1 0.3 0.1 0.1 0.0 0.2 0.5 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.5 0.7 1.8 1.4 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 44.1 0.3 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 54.9 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.5 0.1 0.2 0.0 0.4 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.0 0.0 1.6 2.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 CNTN4 BIG-2 ENSG00000144619 "Contactin 4" Q8IWV2 3 2098813-3057959 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 22.6" "Cell type enhanced" "Detected in many" "Early spermatids: 411.7;Excitatory neurons: 960.7;Inhibitory neurons: 1048.5;Oligodendrocyte precursor cells: 248.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 8.3;CACO-2: 9.0;HEK 293: 5.5;SH-SY5Y: 16.5;WM-115: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 170000000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.64e-1)" "unprognostic (7.17e-3)" "unprognostic (9.85e-2)" "unprognostic (5.75e-2)" "unprognostic (9.94e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-1)" "unprognostic (1.08e-1)" "unprognostic (2.21e-1)" "unprognostic (2.60e-2)" "unprognostic (7.38e-3)" "unprognostic (2.41e-2)" "prognostic favorable (1.00e-4)" "unprognostic (1.22e-2)" "unprognostic (2.88e-2)" "unprognostic (2.10e-1)" "unprognostic (2.13e-1)" 3.4 0.5 2.2 1.1 6.4 0.0 2.5 13.5 12.3 8.7 0.0 4.6 1.8 8.3 1.9 3.1 4.2 5.1 2.5 1.8 2.7 4.2 2.9 2.4 1.1 0.5 5.4 1.0 1.6 22.6 1.9 7.9 1.2 4.3 3.3 19.8 0.9 5.6 0.7 0.7 4.1 4.5 4.2 1.0 3.6 13.4 7.7 2.2 10.3 4.0 2.6 3.6 1.7 4.0 0.0 0.0 1.1 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 16.5 0.0 0.0 0.1 1.2 0.1 0.2 0.0 0.0 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 6.4 13.5 12.3 1.8 2.7 0.5 5.4 1.2 4.2 7.7 4.0 0.4 9.6 3.6 26.8 0.1 0.8 1.3 0.0 1.8 96.5 2.0 1.8 1.4 7.2 5.6 0.0 0.0 0.1 0.0 1.8 0.0 4.4 411.7 0.3 9.1 1.9 7.8 0.0 960.7 0.0 0.1 18.1 0.0 0.3 0.0 6.9 0.7 0.4 0.3 101.0 1048.5 2.0 0.0 0.3 0.7 156.3 5.0 0.4 1.8 31.9 0.0 27.5 0.0 248.3 14.7 0.0 1.6 5.3 0.4 0.4 3.7 3.7 0.0 5.9 6.6 0.5 8.3 4.5 4.9 0.9 0.0 0.3 0.1 0.1 3.5 0.2 CNTN6 NB-3 ENSG00000134115 "Contactin 6" Q9UQ52 3 1092658-1404217 "Predicted membrane proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.0;thyroid gland: 9.7" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 35.3;Excitatory neurons: 127.6;Inhibitory neurons: 75.9;Oligodendrocyte precursor cells: 52.8" "Group enriched" "Detected in some" 15 "renal cancer: 2.7;thyroid cancer: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;SH-SY5Y: 2.3;SuSa: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016645 Uncertain NA NA 4700000 "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA016645: AB_1847149" "unprognostic (1.09e-1)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-1)" "unprognostic (1.05e-4)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (3.80e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.26e-3)" "unprognostic (5.45e-2)" "unprognostic (5.23e-2)" "unprognostic (1.15e-1)" "unprognostic (4.46e-2)" 0.0 3.2 1.3 0.0 2.4 0.0 0.1 11.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 1.4 0.1 0.0 3.2 0.0 2.2 2.2 0.0 0.0 0.0 0.3 2.0 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 3.7 0.0 9.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.4 11.0 2.3 1.1 1.4 2.2 2.2 2.7 1.9 3.7 1.3 0.0 35.3 3.6 15.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.5 0.0 3.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.0 127.6 0.0 0.2 3.3 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 75.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.5 0.0 0.0 0.0 52.8 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 1.1 0.0 0.0 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein family member 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 7.9" "Group enriched" "Detected in some" 49 "Excitatory neurons: 554.6;Inhibitory neurons: 906.4;Oligodendrocyte precursor cells: 760.0" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;SH-SY5Y: 2.6" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: AB_2686083, HPA069356: AB_2686127" "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.0 0.5 2.4 0.0 0.6 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 4.3 5.1 0.1 0.0 0.0 0.0 6.8 6.3 0.0 0.1 0.0 0.0 0.0 7.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 7.9 4.3 5.1 6.8 6.3 7.3 0.0 7.2 0.8 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.1 0.0 0.0 554.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 906.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 9.4 0.0 1.0 0.0 760.0 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 COLEC11 "CL-K1, MGC3279" ENSG00000118004 "Collectin subfamily member 11" Q9BWP8 2 3594832-3644644 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 54.2;liver: 143.1" "Cell type enhanced" "Detected in many" "Fibroblasts: 37.4;Hepatic stellate cells: 89.3;Peritubular cells: 52.3;Proximal tubular cells: 127.1;Sertoli cells: 72.3" "Cancer enhanced" "Detected in many" "liver cancer: 13.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HHSteC: 135.7;SH-SY5Y: 111.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA035241 Uncertain "Secreted to blood" NA NA 130000000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 85: Liver - Metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA035241: AB_10600701" "unprognostic (3.35e-1)" "unprognostic (4.73e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" "unprognostic (1.53e-2)" "unprognostic (1.40e-2)" "unprognostic (7.95e-3)" "unprognostic (5.85e-3)" "unprognostic (6.96e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-1)" "unprognostic (6.96e-2)" "unprognostic (2.26e-1)" "unprognostic (9.27e-3)" "unprognostic (7.54e-2)" "unprognostic (1.46e-1)" "unprognostic (1.60e-1)" 13.8 40.6 1.0 0.9 1.0 1.9 3.3 4.8 1.9 1.8 6.9 2.8 3.5 1.2 0.4 1.6 4.4 54.2 46.6 1.4 0.9 24.8 143.1 2.4 1.9 1.3 0.5 46.4 13.8 1.2 5.8 2.4 1.3 3.3 0.6 0.5 0.6 1.1 0.6 1.4 3.8 1.1 0.4 3.8 3.1 7.4 1.1 4.0 17.0 0.8 0.2 7.1 1.0 1.3 0.2 1.4 0.7 2.5 0.0 0.0 11.7 0.7 0.0 0.3 0.2 0.7 0.2 0.3 4.0 0.1 0.4 0.4 0.1 0.4 0.3 0.2 0.8 0.6 1.4 5.0 135.7 0.2 1.0 1.6 0.1 0.2 0.0 0.4 0.1 0.8 11.1 0.8 0.0 0.1 0.0 0.8 0.6 0.2 0.9 0.0 0.0 0.5 0.0 0.3 2.1 111.7 1.6 1.1 0.8 0.3 0.5 1.0 0.0 0.0 0.7 0.6 0.5 3.2 26.2 1.5 0.3 1.3 0.6 0.7 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.4 0.2 0.9 0.3 0.1 0.2 0.1 0.0 1.0 1.0 4.8 1.9 1.4 0.9 1.3 0.5 1.3 0.4 1.1 1.3 7.3 0.0 0.0 0.7 0.6 1.0 0.0 0.0 2.8 0.5 0.1 0.3 1.2 0.0 0.0 0.0 0.0 1.6 0.0 0.1 17.6 0.0 0.3 1.1 22.0 4.2 0.0 0.0 2.2 0.0 1.4 37.4 0.0 0.6 0.0 1.3 89.3 7.9 2.5 0.0 0.9 0.1 0.0 1.9 0.3 0.5 7.5 0.8 3.6 1.0 0.0 1.4 0.0 0.5 0.2 0.1 0.0 52.3 0.0 0.2 0.0 127.1 0.0 0.1 72.3 0.3 18.0 1.3 11.6 0.6 0.9 1.2 0.7 27.0 0.0 0.1 CORO6 FLJ14871 ENSG00000167549 "Coronin 6" Q6QEF8 17 29614756-29622907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 600.0;tongue: 252.6" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 38.1;Excitatory neurons: 64.1;Extravillous trophoblasts: 32.7;Horizontal cells: 30.3;Inhibitory neurons: 73.8;Skeletal myocytes: 25.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in many" "REH: 16.5;RH-30: 17.8;SH-SY5Y: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021556 Approved "Golgi apparatus" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" "Golgi apparatus" "HPA021556: " "unprognostic (7.12e-3)" "unprognostic (2.68e-2)" "unprognostic (2.60e-4)" "unprognostic (9.25e-4)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (1.11e-2)" "unprognostic (1.62e-1)" "unprognostic (3.00e-4)" "unprognostic (6.70e-2)" "unprognostic (6.61e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.61e-7)" "unprognostic (8.48e-2)" "unprognostic (4.09e-1)" "unprognostic (1.92e-1)" "unprognostic (1.13e-2)" 11.2 3.2 7.6 1.2 7.8 0.5 10.3 1.1 23.0 6.8 0.0 23.2 1.3 14.4 1.9 15.3 15.8 4.1 70.6 5.9 5.3 1.9 0.7 9.7 0.7 11.9 2.5 4.7 1.5 16.0 4.3 27.9 10.8 14.6 2.2 2.0 16.0 4.4 600.0 6.2 11.7 11.9 2.2 1.4 8.9 1.9 6.4 1.8 99.4 252.6 0.8 21.7 8.5 12.6 10.2 4.4 3.8 0.0 5.9 3.2 6.0 3.3 1.2 2.1 0.8 0.3 0.0 0.1 0.8 5.3 0.3 10.5 2.9 0.6 1.0 0.2 4.9 0.0 9.8 1.3 9.4 0.0 0.6 11.5 0.9 1.1 0.0 5.4 2.2 0.0 0.7 0.2 7.1 0.0 6.8 0.3 1.2 0.0 0.2 16.5 17.8 0.4 0.5 0.0 0.1 21.9 0.9 3.0 0.0 2.8 0.0 1.4 0.6 1.4 0.0 1.7 1.4 8.3 4.7 1.2 3.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 7.8 1.1 23.0 5.9 5.3 11.9 2.5 10.8 2.2 6.4 12.6 1.1 0.0 0.0 4.6 0.4 1.5 2.5 0.6 1.8 3.5 0.8 1.9 38.1 0.0 0.6 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.2 0.1 2.4 1.8 0.0 0.0 64.1 0.0 32.7 7.7 0.5 0.2 0.0 1.0 2.2 0.1 1.3 30.3 73.8 0.0 2.0 1.2 0.8 0.6 7.2 0.7 0.0 7.5 0.0 0.2 2.1 5.0 6.6 0.0 0.0 4.1 0.7 1.0 0.0 0.3 0.2 1.5 6.6 25.6 6.0 2.4 3.9 0.2 0.4 2.5 1.3 1.1 0.0 0.2 COX4I2 "COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2" ENSG00000131055 "Cytochrome c oxidase subunit 4I2" Q96KJ9 20 31637912-31645006 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 49.1;placenta: 115.4" "Group enriched" "Detected in some" 5 "Sertoli cells: 414.2;Smooth muscle cells: 191.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "SH-SY5Y: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "unprognostic (2.64e-1)" "unprognostic (2.09e-2)" "unprognostic (2.76e-3)" "unprognostic (2.18e-2)" "unprognostic (4.51e-2)" "prognostic favorable (6.04e-5)" "unprognostic (5.60e-2)" "unprognostic (1.13e-1)" "unprognostic (2.51e-1)" "unprognostic (7.45e-2)" "unprognostic (1.04e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (9.78e-4)" "unprognostic (1.11e-1)" "unprognostic (3.30e-3)" "unprognostic (1.43e-1)" "unprognostic (5.59e-2)" 19.1 1.1 6.7 1.7 6.7 0.0 15.9 6.5 9.1 4.8 6.1 4.7 1.9 7.5 3.9 5.4 4.9 10.6 39.7 6.5 6.7 10.9 1.1 49.1 4.7 6.8 7.0 2.9 2.3 9.3 2.2 115.4 7.0 10.1 2.7 1.1 3.6 4.7 8.7 4.9 5.8 7.1 6.6 1.7 4.2 1.5 7.0 1.8 14.7 19.4 3.0 7.7 6.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 6.7 6.5 9.1 6.5 6.7 6.8 7.0 7.0 6.6 7.0 6.6 55.0 0.0 0.0 0.0 0.5 6.4 0.3 0.0 2.2 0.4 0.9 1.9 2.7 0.0 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.2 0.1 0.7 23.5 0.0 0.0 0.0 0.0 0.3 9.5 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 7.5 0.7 3.7 0.5 8.8 2.8 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.7 414.2 4.6 191.6 0.1 1.0 0.8 6.7 2.5 1.0 1.0 0.0 0.3 CPT1C "CATL1, CPT1P, CPTIC, FLJ23809" ENSG00000169169 "Carnitine palmitoyltransferase 1C" Q8TCG5 19 49690898-49713731 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;pituitary gland: 28.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 43.4;Excitatory neurons: 34.0;Horizontal cells: 32.0;Inhibitory neurons: 28.1;Late spermatids: 29.7;Oligodendrocyte precursor cells: 21.1" "Cancer enriched" "Detected in many" 5 "glioma: 9.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 40.2;AN3-CA: 33.2;SCLC-21H: 27.4;SH-SY5Y: 70.1;U-87 MG: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014529, HPA063621" Approved Approved Centrosome NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Centrosome "HPA014529: AB_1847206, HPA063621: AB_2732706" "unprognostic (1.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.73e-1)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "prognostic favorable (1.84e-4)" "unprognostic (4.36e-1)" "unprognostic (1.92e-10)" "unprognostic (9.44e-4)" "unprognostic (3.35e-2)" "unprognostic (3.91e-1)" "unprognostic (4.72e-3)" 3.4 5.3 14.0 1.6 14.8 0.0 2.1 8.5 19.1 6.5 18.8 2.6 1.3 8.1 2.3 1.0 4.9 4.4 3.8 19.2 15.6 1.7 0.8 2.1 1.3 10.1 9.2 5.1 1.4 1.4 28.4 0.7 10.3 3.4 0.6 12.4 1.0 2.5 0.7 1.0 1.8 4.6 4.9 4.9 1.5 3.5 12.9 0.2 2.4 0.2 0.6 2.7 3.7 14.4 0.0 0.0 40.2 33.2 14.0 11.0 0.0 12.6 25.2 16.2 22.4 0.7 0.0 0.8 0.0 12.7 2.0 3.0 0.0 0.0 8.5 0.6 0.1 0.0 0.1 0.0 22.7 0.0 0.0 12.7 0.0 13.3 0.1 4.3 22.2 0.1 0.1 0.0 0.9 0.7 0.2 0.0 1.8 2.7 8.8 0.0 0.0 0.0 0.9 0.0 27.4 70.1 0.1 0.1 0.0 0.6 0.1 0.1 18.3 1.0 0.2 7.7 6.7 0.2 3.2 0.4 29.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 14.8 8.5 19.1 19.2 15.6 10.1 9.2 10.3 4.9 12.9 14.4 3.8 0.0 0.0 7.5 0.4 2.2 3.1 0.5 3.4 43.4 0.9 1.3 1.4 1.5 0.0 0.0 16.7 1.1 0.3 0.1 0.0 0.0 8.9 0.5 14.1 7.4 0.0 0.0 34.0 0.0 4.4 6.0 0.0 1.2 0.0 1.9 5.0 0.1 0.3 32.0 28.1 0.1 0.0 0.9 1.2 29.7 3.4 0.8 0.0 7.5 0.0 18.3 0.0 21.1 14.9 0.3 0.0 13.2 1.4 2.1 0.0 0.0 0.0 19.1 0.0 5.8 6.3 3.1 7.0 1.0 1.8 1.1 0.7 4.4 0.2 1.6 CRACD "CRAD, KIAA1211" ENSG00000109265 "Capping protein inhibiting regulator of actin dynamics" Q6ZU35 4 56049073-56328625 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;intestine: 19.7;testis: 29.6" "Cell type enriched" "Detected in single" 11 "Cardiomyocytes: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.7;SH-SY5Y: 56.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043249, HPA048148" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 59000 "Cluster 45: Intestine - Brush border" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "Golgi apparatus" "HPA043249: AB_2678388, HPA048148: AB_2680286" "unprognostic (1.65e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-3)" "unprognostic (1.31e-1)" "unprognostic (6.04e-1)" "unprognostic (6.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" "unprognostic (8.05e-6)" "unprognostic (1.02e-1)" "unprognostic (6.54e-2)" "unprognostic (2.79e-2)" "unprognostic (2.93e-1)" 0.5 2.3 6.6 3.1 9.6 3.9 0.3 8.7 5.6 1.6 0.0 9.5 13.8 3.5 4.2 0.5 2.9 11.3 0.8 5.7 12.8 0.7 0.6 1.0 2.2 18.8 13.3 1.2 1.8 6.3 0.9 0.6 19.1 1.7 8.1 4.1 1.0 3.5 0.0 0.5 19.7 4.4 8.7 2.5 2.7 29.6 11.9 0.6 0.1 0.2 1.9 1.3 1.2 6.2 0.0 2.9 11.2 0.9 0.3 0.0 4.1 0.1 0.4 0.5 1.2 3.4 0.4 10.2 0.3 0.0 9.1 0.0 9.6 0.2 0.3 0.9 5.6 5.7 5.1 0.5 1.6 4.8 0.8 0.4 0.2 0.0 0.1 3.6 5.3 9.1 0.0 9.8 0.1 1.4 7.1 0.4 6.0 8.7 7.2 6.8 6.1 0.2 0.1 2.6 26.7 56.7 1.0 0.3 6.9 9.4 2.4 0.5 2.1 0.3 2.8 0.7 2.6 9.7 6.9 0.1 2.8 0.2 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 9.6 8.7 5.6 5.7 12.8 18.8 13.3 19.1 8.7 11.9 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CRIPT HSPC139 ENSG00000119878 "CXXC repeat containing interactor of PDZ3 domain" Q9P021 2 46616416-46630176 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046080, HPA056765" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Nucleoplasm, Nucleoli fibrillar center" "HPA046080: AB_2679529, HPA056765: AB_2683230" "unprognostic (3.38e-2)" "unprognostic (4.08e-1)" "unprognostic (1.67e-1)" "unprognostic (7.51e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.10e-1)" "unprognostic (6.07e-2)" "unprognostic (1.54e-2)" "unprognostic (3.38e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.43e-1)" "unprognostic (1.12e-2)" "unprognostic (4.42e-2)" 7.0 7.7 4.7 2.2 4.6 6.0 6.6 7.6 6.0 5.9 5.3 7.2 3.0 5.9 5.5 6.3 5.5 1.8 11.9 4.8 4.1 7.2 6.1 4.3 3.3 5.5 4.3 7.2 5.4 2.7 6.0 2.1 5.0 5.6 2.8 10.7 7.0 1.9 12.3 6.1 5.6 2.2 3.6 4.7 6.3 5.8 4.6 2.4 4.7 2.8 3.1 6.3 6.3 7.8 3.8 2.5 2.3 2.4 2.7 2.9 3.4 2.7 1.8 1.7 1.7 2.9 2.7 2.9 5.7 2.9 2.4 2.6 2.3 2.4 3.3 4.4 2.6 3.6 3.4 3.8 3.1 2.8 2.2 3.3 2.9 2.4 1.7 3.2 2.7 1.6 3.7 3.4 2.1 2.4 1.9 3.5 3.0 3.6 2.5 1.7 4.6 4.4 3.2 2.7 4.2 6.7 3.1 2.4 3.2 2.3 2.0 2.1 3.5 2.7 2.6 2.7 3.0 3.7 3.1 2.8 4.1 3.1 2.3 6.3 2.6 3.8 2.9 2.3 2.6 3.6 3.0 2.6 2.1 3.5 3.0 2.9 5.8 3.0 2.4 3.2 3.6 1.9 4.7 4.6 7.6 6.0 4.8 4.1 5.5 4.3 5.0 3.6 4.6 7.8 28.6 19.2 13.7 19.2 34.5 43.1 65.5 71.3 28.5 28.9 56.5 54.4 60.4 45.8 51.8 31.3 25.0 56.7 48.4 38.5 68.4 64.5 41.8 46.4 33.7 29.5 65.1 91.8 22.5 39.8 81.4 35.1 20.4 37.7 28.5 28.3 38.6 57.5 48.1 16.8 25.7 39.9 42.7 38.9 30.2 15.9 36.4 29.3 30.2 20.6 48.7 40.4 51.5 44.2 31.2 67.6 58.4 25.6 46.2 58.6 81.0 102.6 48.7 51.2 19.7 26.0 48.0 56.0 49.6 39.1 53.0 95.6 35.8 26.2 32.6 74.9 CSRNP3 "FAM130A2, FLJ32093, PPP1R73, TAIP-2" ENSG00000178662 "Cysteine and serine rich nuclear protein 3" Q8WYN3 2 165469647-165689407 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 358.3;Inhibitory neurons: 315.3;Oligodendrocyte precursor cells: 344.8;Oligodendrocytes: 95.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.8;PC-3: 2.4;SCLC-21H: 7.1;SH-SY5Y: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017905 Approved Uncertain "Nucleoplasm,Nucleoli rim" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoli rim" Nucleoplasm "HPA017905: AB_1857757" "unprognostic (2.85e-1)" "unprognostic (1.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.61e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-2)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (1.01e-1)" "unprognostic (1.82e-3)" "unprognostic (7.41e-2)" "unprognostic (5.36e-2)" "unprognostic (3.17e-1)" "unprognostic (1.08e-2)" 0.9 2.3 9.4 0.4 9.3 0.0 3.2 0.0 14.4 2.3 7.0 0.8 0.7 2.7 0.8 0.7 0.9 0.9 1.4 10.6 10.5 1.5 0.6 0.4 0.2 0.0 0.7 3.4 3.7 1.1 3.4 0.2 0.0 1.5 0.9 6.4 2.2 2.1 0.1 0.7 0.6 2.5 0.0 0.8 0.7 0.6 8.6 0.5 2.3 0.7 0.2 0.6 1.0 6.5 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.4 0.0 0.3 0.1 0.5 0.0 0.2 0.0 0.7 0.4 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.0 0.6 0.5 0.0 7.1 5.8 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.2 0.0 0.3 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.3 0.0 14.4 10.6 10.5 0.0 0.7 0.0 0.0 8.6 6.5 2.5 3.2 5.1 81.6 0.2 5.2 4.0 2.3 6.8 55.7 16.2 13.5 8.7 5.7 1.6 11.0 70.9 0.3 0.0 0.7 3.9 2.7 2.9 2.3 9.6 3.6 7.7 0.0 358.3 2.3 0.1 8.2 2.0 2.3 0.0 47.9 1.4 3.6 2.6 11.8 315.3 4.7 4.1 0.3 1.6 1.7 7.5 0.4 7.2 7.5 0.0 19.6 0.0 344.8 95.4 0.9 1.9 8.2 0.0 0.6 1.7 7.2 0.5 20.4 6.6 4.4 23.0 0.6 1.6 6.3 4.5 0.3 0.2 13.2 2.6 2.0 CTNNA2 "CAP-R, CT114" ENSG00000066032 "Catenin alpha 2" P26232 2 79185231-80648861 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Differentiation" "Developmental protein" "Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 99.0;epididymis: 67.0;retina: 80.4" "Cell type enhanced" "Detected in some" "Astrocytes: 3673.8;Early spermatids: 560.8;Excitatory neurons: 1358.5;Inhibitory neurons: 1056.9;Oligodendrocyte precursor cells: 1304.4" "Group enriched" "Detected in some" 7 "endometrial cancer: 3.9;glioma: 11.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 96 "basophil: 55.3" "Lineage enriched" "Detected in single" 553 "granulocytes: 55.3" "Cell line enhanced" "Detected in some" "AF22: 7.1;Karpas-707: 8.2;NTERA-2: 6.7;SCLC-21H: 3.8;SH-SY5Y: 10.7" "Low region specificity" "Detected in all" CAB037175 Enhanced NA NA "Cluster 38: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "CAB037175: AB_476883" "unprognostic (9.15e-2)" "unprognostic (2.26e-2)" "unprognostic (2.66e-1)" "unprognostic (1.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.23e-1)" "unprognostic (3.31e-2)" "unprognostic (4.04e-1)" "unprognostic (3.17e-2)" "unprognostic (5.62e-2)" "unprognostic (7.96e-3)" "unprognostic (8.76e-2)" "unprognostic (2.27e-4)" "unprognostic (7.80e-2)" "unprognostic (8.44e-4)" "unprognostic (1.73e-4)" "unprognostic (2.83e-1)" 0.1 4.7 74.1 0.5 82.5 0.1 0.0 51.8 99.0 0.4 28.5 1.9 0.3 3.3 67.0 0.2 1.9 0.2 0.2 78.8 59.3 0.1 0.1 0.0 0.0 47.0 71.2 0.1 0.8 0.0 7.1 0.0 50.8 1.0 0.9 80.4 0.2 0.7 0.2 0.1 0.7 0.5 36.6 0.0 1.1 17.4 78.9 0.0 0.0 0.0 0.0 0.1 0.4 62.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 6.7 0.3 0.0 0.0 0.0 0.0 0.7 0.0 3.8 10.7 0.0 0.0 0.5 1.0 0.0 0.6 0.0 0.4 0.7 0.2 0.0 2.3 0.0 0.0 2.7 0.0 2.0 55.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 74.1 82.5 51.8 99.0 78.8 59.3 47.0 71.2 50.8 36.6 78.9 62.0 0.0 0.0 0.0 3673.8 0.0 0.0 0.0 0.0 0.0 17.2 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 560.8 12.9 7.0 0.5 0.0 0.0 1358.5 0.0 0.0 0.1 0.0 34.3 0.0 4.7 0.0 0.0 0.0 5.0 1056.9 0.0 0.0 0.0 0.0 144.4 2.5 0.5 0.0 187.4 0.0 112.1 0.0 1304.4 230.7 0.3 0.0 3.0 0.0 0.0 0.0 0.2 0.0 5.0 0.0 0.0 0.2 10.3 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.1 CUX2 "CDP2, CUTL2, KIAA0293" ENSG00000111249 "Cut like homeobox 2" O14529 12 111034165-111350554 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 20.6;choroid plexus: 25.7;liver: 20.4;prostate: 11.4" "Cell type enhanced" "Detected in some" "dendritic cells: 28.1;Excitatory neurons: 175.4;Hepatocytes: 50.9;Horizontal cells: 26.9;Inhibitory neurons: 72.5" "Group enriched" "Detected in some" 4 "liver cancer: 5.2;prostate cancer: 11.2" "Region enhanced" "Detected in many" "cerebral cortex: 20.6" "Immune cell enriched" "Detected in single" 70 "plasmacytoid DC: 6.9" "Lineage enriched" "Detected in single" 70 "dendritic cells: 6.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 6.6;HDLM-2: 2.9;hTERT-HME1: 3.5;SCLC-21H: 6.5;SH-SY5Y: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (3.87e-2)" "unprognostic (6.98e-3)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.78e-2)" "unprognostic (1.22e-2)" "unprognostic (9.44e-2)" "unprognostic (2.33e-1)" "unprognostic (3.30e-2)" "unprognostic (7.83e-5)" "unprognostic (2.67e-1)" "unprognostic (3.54e-3)" "unprognostic (4.31e-2)" "unprognostic (9.03e-2)" "unprognostic (4.64e-2)" "unprognostic (1.90e-2)" 0.0 0.0 2.3 0.2 1.4 0.2 1.8 0.0 20.6 0.8 25.7 0.3 0.1 0.1 0.3 0.1 0.0 0.0 0.0 3.5 0.0 0.2 20.4 0.0 0.5 0.0 1.5 0.0 0.1 0.0 2.1 0.0 0.0 11.4 0.0 2.3 0.0 2.9 0.1 0.2 0.2 0.0 0.0 0.2 1.5 0.5 5.2 0.2 4.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 6.6 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 6.5 14.0 0.0 0.0 0.0 0.4 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 2.3 1.4 0.0 20.6 3.5 0.0 0.0 1.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 7.2 0.5 0.0 3.5 0.7 0.0 6.4 2.6 3.0 1.0 2.8 0.1 0.0 0.0 0.0 28.1 0.1 0.0 0.0 1.2 3.7 0.1 0.1 0.0 2.7 175.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 50.9 0.7 26.9 72.5 0.0 0.0 0.6 0.0 0.6 0.0 0.5 0.0 1.9 0.0 0.1 0.0 20.1 1.8 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.9 0.0 0.3 0.1 0.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.6 CYB561 "CYB561A1, FRRS2" ENSG00000008283 "Cytochrome b561" P49447 17 63432304-63446354 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Transport" Translocase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 74.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "pons: 124.7" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 432.2;SK-BR-3: 209.2;T-47d: 168.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014753 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" "HPA014753: AB_1847364" "prognostic unfavorable (8.89e-5)" "unprognostic (2.90e-1)" "unprognostic (4.01e-1)" "prognostic favorable (2.95e-5)" "unprognostic (1.81e-3)" "unprognostic (3.82e-1)" "unprognostic (1.37e-2)" "unprognostic (8.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.91e-2)" "unprognostic (8.97e-2)" "unprognostic (6.38e-2)" "unprognostic (8.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.89e-1)" 14.8 125.6 22.2 12.3 24.4 4.1 32.8 6.8 23.1 45.0 70.6 26.4 36.6 12.3 57.2 51.9 55.8 17.3 16.2 20.4 33.2 24.5 21.0 30.9 8.3 17.2 23.2 9.4 118.0 76.1 74.1 16.2 124.7 63.3 21.1 9.8 85.0 37.8 6.0 37.3 31.9 9.2 9.8 8.7 48.1 6.0 28.0 3.5 40.8 4.6 12.8 16.4 27.4 17.9 99.3 31.9 2.6 20.5 11.5 52.7 43.3 10.3 12.0 12.3 4.9 29.2 96.9 0.2 23.0 75.5 3.3 83.1 20.3 8.0 4.8 26.1 8.7 12.7 20.4 2.0 21.7 1.3 4.3 8.6 84.1 11.2 1.5 17.9 23.9 0.1 41.2 17.7 4.0 140.3 0.5 4.9 20.9 80.5 49.9 0.3 0.2 31.0 40.0 49.8 73.7 432.2 26.0 209.2 10.4 7.3 168.6 6.2 3.6 25.9 29.4 60.6 3.1 0.4 0.4 0.1 22.6 5.1 14.0 0.3 2.0 0.2 19.2 5.7 24.6 0.6 14.4 13.2 2.1 0.6 1.3 4.2 5.2 20.3 7.7 0.1 0.0 5.8 22.2 24.4 6.8 23.1 20.4 33.2 17.2 23.2 124.7 9.8 28.0 17.9 14.6 28.9 37.8 3.6 3.5 16.4 23.7 16.0 26.2 6.1 37.4 24.6 12.8 20.0 36.7 23.9 0.0 25.1 7.0 22.2 3.9 41.1 6.9 74.5 12.5 18.3 21.6 3.4 14.1 50.5 29.2 15.0 30.1 53.9 15.9 7.3 11.4 11.1 4.7 0.0 10.7 31.7 18.3 7.0 9.8 6.2 3.7 4.1 3.6 9.4 6.0 5.2 2.1 0.5 0.6 30.8 11.4 3.4 15.3 41.6 32.1 11.9 68.5 26.8 6.6 5.1 7.6 6.9 7.2 34.2 27.8 24.8 11.4 0.4 26.2 22.6 CYGB "HGB, STAP" ENSG00000161544 Cytoglobin Q8WWM9 17 76527356-76551175 "Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 104.4" "Cell type enhanced" "Detected in many" "Adipocytes: 94.3;Fibroblasts: 87.6;Leydig cells: 95.7;Melanocytes: 78.2;Sertoli cells: 92.1;Smooth muscle cells: 95.6" "Cancer enhanced" "Detected in all" "melanoma: 34.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 79.6;Hep G2: 61.7;HHSteC: 120.7;HSkMC: 95.4;SH-SY5Y: 129.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017757, HPA061642" Approved Approved Supported "Nuclear speckles,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Nuclear speckles" Cytosol "HPA017757: AB_1847410, HPA061642: AB_2684573" "unprognostic (6.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.97e-2)" "prognostic favorable (2.55e-5)" "prognostic unfavorable (1.85e-4)" "unprognostic (3.36e-2)" "unprognostic (3.31e-3)" "unprognostic (2.01e-1)" "unprognostic (7.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.08e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (3.34e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (7.76e-2)" 79.6 20.8 10.1 12.0 10.7 1.7 55.1 20.6 13.6 27.7 14.1 27.1 21.1 19.6 4.6 12.8 20.4 13.2 104.4 9.5 15.8 12.4 19.0 27.8 7.2 17.5 26.0 13.8 12.8 11.7 10.9 8.9 26.8 29.9 9.3 77.6 14.2 11.0 19.3 19.5 26.6 5.9 10.1 12.2 22.9 5.3 14.3 5.3 50.1 9.6 2.6 50.7 25.6 9.8 0.2 1.1 1.8 0.4 79.6 23.1 26.1 0.7 2.0 0.3 0.9 0.0 0.3 0.2 24.1 2.4 0.3 0.7 0.1 33.7 0.1 0.1 0.2 0.4 0.4 61.7 120.7 0.0 0.0 95.4 7.2 2.5 2.5 0.4 0.3 0.8 0.3 0.1 1.2 0.8 0.2 0.4 0.3 0.0 1.4 0.5 0.3 0.2 0.4 0.1 0.6 129.8 0.1 0.0 2.7 5.9 0.2 0.6 0.2 3.1 1.6 0.3 0.0 1.2 0.3 0.3 0.2 0.3 9.9 0.0 0.1 0.1 0.2 0.1 0.1 1.6 0.1 0.0 0.1 2.2 0.2 0.5 0.9 1.0 0.0 0.0 0.2 0.2 10.1 10.7 20.6 13.6 9.5 15.8 17.5 26.0 26.8 10.1 14.3 9.8 94.3 3.2 2.0 2.0 3.5 10.8 1.3 17.3 3.4 38.5 1.4 5.7 6.1 0.0 6.7 0.0 0.0 1.4 1.9 0.1 0.0 0.8 0.7 2.9 4.2 23.1 0.0 0.0 2.4 0.2 0.6 87.6 1.5 0.7 0.0 0.2 2.2 1.2 0.4 8.4 12.3 0.0 0.0 0.0 13.3 2.5 95.7 2.6 78.2 3.7 0.0 22.1 0.0 1.0 1.0 0.1 0.0 23.3 0.6 0.8 0.0 0.2 21.1 12.9 92.1 21.8 95.6 1.6 1.4 0.7 6.7 2.9 2.6 9.2 0.0 1.0 DACH1 DACH ENSG00000276644 "Dachshund family transcription factor 1" Q9UI36 13 71437966-71867204 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 88.5;Excitatory neurons: 77.0;Horizontal cells: 87.5;Late spermatids: 103.7;Microglial cells: 143.4;Muller glia cells: 143.8;Spermatocytes: 58.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 4.2;eosinophil: 8.4;NK-cell: 4.2;plasmacytoid DC: 6.4" "Group enriched" "Detected in many" 33 "dendritic cells: 6.4;granulocytes: 8.4;NK-cells: 4.2" "Cell line enhanced" "Detected in some" "AF22: 14.2;HAP1: 22.5;HEK 293: 16.8;HL-60: 37.9;NB-4: 16.7;SCLC-21H: 36.9;SH-SY5Y: 29.5;THP-1: 26.9" "Region enriched" "Detected in all" 5 "basal ganglia: 38.8" "Region enriched" "Detected in all" 5 "basal ganglia: 34.2" "HPA012672, HPA012938, HPA073222" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Nuclear speckles" "HPA012672: AB_1847466, HPA012938: , HPA073222: " "unprognostic (3.16e-1)" "unprognostic (5.26e-2)" "unprognostic (1.41e-2)" "unprognostic (2.36e-1)" "unprognostic (4.21e-2)" "unprognostic (5.63e-2)" "unprognostic (2.22e-2)" "unprognostic (8.08e-3)" "unprognostic (2.12e-2)" "unprognostic (2.50e-1)" "unprognostic (3.04e-3)" "unprognostic (4.37e-1)" "unprognostic (2.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.19e-1)" "unprognostic (1.24e-1)" "unprognostic (5.17e-2)" 4.4 11.1 2.3 1.2 14.0 6.0 4.0 1.6 2.9 9.7 0.3 3.1 5.2 3.8 1.3 0.9 2.8 7.2 2.2 1.0 4.6 8.9 2.0 5.9 0.5 7.0 9.3 0.5 1.9 6.6 3.5 6.9 5.9 7.0 3.3 16.7 2.0 2.3 1.9 1.8 6.7 2.0 2.6 5.4 1.9 6.3 4.3 3.5 0.2 1.2 0.4 2.0 2.7 2.4 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 22.5 0.0 0.0 0.0 16.8 0.2 0.0 0.0 0.4 37.9 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.9 16.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 36.9 29.5 0.0 0.0 0.0 0.1 0.9 26.9 0.0 0.4 0.3 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.2 4.2 0.1 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 4.2 0.0 6.4 0.0 0.1 2.3 14.0 1.6 2.9 1.0 4.6 7.0 9.3 5.9 2.6 4.3 2.4 36.4 0.0 0.6 15.7 0.5 1.7 3.6 0.0 0.0 15.4 19.4 9.3 2.1 1.5 0.0 7.3 4.2 0.0 12.5 0.9 5.9 1.0 88.5 5.0 4.7 34.2 34.1 2.5 77.0 0.0 0.0 4.6 1.1 3.2 5.1 0.3 2.9 0.0 0.2 87.5 28.2 21.4 0.0 1.2 1.2 103.7 3.4 2.5 0.0 143.4 1.1 143.8 0.0 6.6 3.9 0.6 0.3 1.9 0.0 5.8 3.5 6.9 0.7 6.9 13.1 1.5 4.3 58.8 10.2 0.2 1.3 0.0 1.0 1.3 12.6 2.7 DACT3 "DAPPER3, MGC15476, RRR1" ENSG00000197380 "Dishevelled binding antagonist of beta catenin 3" Q96B18 19 46647551-46661182 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 23.9;Oligodendrocytes: 27.2;Smooth muscle cells: 22.9" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 10.5;SH-SY5Y: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043053 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles Nucleoplasm "HPA043053: AB_10794769" "unprognostic (2.35e-1)" "unprognostic (3.08e-1)" "unprognostic (5.30e-3)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.66e-1)" "unprognostic (2.03e-2)" "unprognostic (3.27e-2)" "unprognostic (2.03e-4)" "unprognostic (1.70e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (7.97e-8)" "unprognostic (1.59e-2)" "unprognostic (4.03e-2)" "unprognostic (3.54e-3)" "prognostic unfavorable (6.66e-4)" 9.1 3.3 42.1 5.9 42.0 1.4 5.4 41.1 54.4 34.7 3.6 53.9 3.9 48.2 14.3 7.4 37.4 7.2 27.5 48.6 33.4 5.9 2.6 14.0 1.1 45.4 40.1 17.0 1.1 1.9 4.1 1.7 39.9 19.7 6.7 5.8 1.7 24.6 2.2 4.1 13.0 31.6 34.7 6.8 18.0 18.7 46.3 0.5 4.8 2.9 0.9 39.0 15.9 58.0 0.2 0.2 5.6 5.3 1.9 1.5 0.5 3.1 5.2 1.0 1.5 0.2 0.3 0.5 2.0 10.5 1.0 0.3 3.6 0.1 1.0 0.3 1.9 1.2 0.8 0.2 2.7 0.1 2.1 4.9 0.1 1.3 0.1 0.6 0.4 0.7 1.8 1.8 0.9 0.4 0.2 1.4 2.2 0.0 0.8 4.6 1.3 0.3 0.2 0.3 2.1 24.6 0.4 0.2 0.4 5.7 0.4 0.5 0.4 2.6 3.2 2.6 0.5 1.6 0.5 0.8 0.5 0.8 1.9 2.6 0.3 0.3 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.5 0.2 0.2 1.6 0.7 0.2 0.3 0.2 0.1 42.1 42.0 41.1 54.4 48.6 33.4 45.4 40.1 39.9 34.7 46.3 58.0 1.9 6.4 5.5 13.7 0.2 2.3 1.5 0.0 0.0 16.5 1.0 2.4 17.8 1.5 0.7 0.0 2.1 5.4 0.5 0.3 0.0 0.0 23.9 0.4 9.3 3.1 1.8 0.0 9.2 0.0 2.6 7.4 0.0 0.8 6.3 0.5 1.8 0.2 1.1 1.7 16.7 0.2 2.0 1.6 9.2 8.6 7.8 1.4 3.6 7.5 1.2 9.2 2.1 15.1 27.2 0.1 1.2 14.7 0.1 1.0 0.2 0.3 0.2 6.3 6.6 2.3 22.9 2.3 2.5 0.4 3.3 9.9 1.0 4.3 0.2 1.0 DAND5 "CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3" ENSG00000179284 "DAN domain BMP antagonist family member 5" Q8N907 19 12965159-12974760 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "heart muscle: 8.5" "Cell type enriched" "Detected in some" 7 "Cardiomyocytes: 17.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 19.8" "Not detected" "Not detected" "HPA043493, HPA049472" Uncertain Approved Mitochondria "Secreted in other tissues" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria "HPA043493: AB_2732505, HPA049472: AB_2680781" "unprognostic (1.18e-2)" "unprognostic (4.63e-2)" "unprognostic (7.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.82e-2)" "unprognostic (8.71e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-1)" "unprognostic (5.95e-3)" "unprognostic (7.27e-3)" "unprognostic (8.17e-2)" "unprognostic (2.15e-1)" "unprognostic (2.48e-10)" "unprognostic (4.43e-1)" "unprognostic (2.48e-2)" "unprognostic (6.77e-2)" "unprognostic (1.37e-1)" 0.1 0.9 0.4 0.1 0.4 0.7 0.3 0.9 0.4 0.1 1.6 2.0 0.2 0.1 0.2 0.1 0.1 0.3 8.5 0.4 0.3 0.1 0.0 0.1 0.1 0.5 0.2 0.1 0.2 0.8 0.1 0.0 0.7 0.1 0.3 0.7 0.4 0.0 0.1 0.3 0.3 0.3 0.2 0.0 0.3 0.3 0.5 0.1 0.2 0.2 0.0 0.1 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.4 0.0 0.8 0.3 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.2 0.0 0.7 0.4 1.2 0.0 0.4 0.3 0.1 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.0 1.0 19.8 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.1 1.2 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.4 1.5 0.4 0.1 0.4 0.0 0.1 0.4 0.4 0.9 0.4 0.4 0.3 0.5 0.2 0.7 0.2 0.5 0.8 0.5 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.7 1.3 17.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.5 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.3 0.3 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.6 0.0 2.1 0.5 0.1 0.2 0.3 0.3 0.0 0.1 0.1 0.5 0.1 DBH DBM ENSG00000123454 "Dopamine beta-hydroxylase" P09172 9 133636363-133659329 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Monooxygenase, Oxidoreductase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 272.7;brain: 236.6" "Cell type enriched" "Detected in some" 6 "Hepatic stellate cells: 10.0" "Cancer enhanced" "Detected in some" "liver cancer: 1.7" "Region enriched" "Detected in many" 8 "pons: 236.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 346 "SH-SY5Y: 1826.4" "Region enriched" "Detected in some" 6 "pons and medulla: 22.1" "Region enriched" "Detected in single" 26 "pons: 18.5" "HPA002130, HPA005960, HPA070789" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA 1600000000 "Cluster 32: T-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" Vesicles "Endoplasmic reticulum" "HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312" "unprognostic (1.93e-3)" "unprognostic (7.52e-3)" "unprognostic (8.53e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-3)" "unprognostic (3.38e-3)" "unprognostic (3.39e-3)" "unprognostic (3.97e-2)" "unprognostic (1.71e-1)" "unprognostic (8.99e-2)" "unprognostic (5.80e-2)" "unprognostic (7.69e-2)" "unprognostic (2.81e-7)" "unprognostic (9.31e-2)" "unprognostic (6.77e-2)" "unprognostic (1.49e-2)" "unprognostic (5.06e-3)" 2.8 272.7 0.1 1.0 0.2 0.2 0.1 0.0 0.8 0.4 0.0 0.1 0.4 0.3 0.2 0.1 0.3 0.3 0.5 0.3 0.2 1.3 36.1 0.8 2.3 9.8 29.4 0.4 4.3 0.0 1.4 1.4 236.6 0.4 0.0 0.1 0.6 0.2 0.1 0.2 0.6 0.0 0.0 0.9 0.4 0.2 0.6 0.2 0.4 0.0 0.0 0.4 1.1 1.0 0.0 0.0 0.1 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 3.2 0.9 0.1 0.0 0.0 0.3 5.2 4.7 0.0 0.0 2.1 1826.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 0.3 0.2 9.8 29.4 236.6 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 DDC AADC ENSG00000132437 "Dopa decarboxylase" P20711 7 50458436-50565405 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Decarboxylase, Lyase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 165.8;kidney: 314.9;retina: 175.6" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 410.3;Proximal enterocytes: 391.5;Proximal tubular cells: 429.5;Rod photoreceptor cells: 498.9" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.5;liver cancer: 13.4;pancreatic cancer: 6.4;renal cancer: 18.7;stomach cancer: 9.9" "Group enriched" "Detected in many" 9 "midbrain: 86.3;pons: 29.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "CACO-2: 54.5;Hep G2: 49.3;OE19: 83.6;SCLC-21H: 130.9;SH-SY5Y: 135.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "midbrain: 74.5;pons: 29.4" HPA017742 Enhanced Approved "Actin filaments" NA NA 120000 "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Actin filaments" "HPA017742: AB_1847832" "unprognostic (1.04e-1)" "unprognostic (3.68e-2)" "unprognostic (2.57e-2)" "unprognostic (3.49e-5)" "unprognostic (1.17e-1)" "unprognostic (1.03e-1)" "unprognostic (1.28e-1)" "unprognostic (5.15e-2)" "unprognostic (4.69e-2)" "unprognostic (5.44e-2)" "unprognostic (9.36e-3)" "unprognostic (5.24e-2)" "unprognostic (1.76e-3)" "unprognostic (1.60e-1)" "unprognostic (3.55e-1)" "unprognostic (7.65e-2)" "unprognostic (1.16e-1)" 0.5 48.9 0.1 2.3 0.7 0.0 1.0 0.0 0.6 0.0 0.2 36.5 154.8 0.0 9.1 0.1 0.0 0.1 0.0 0.2 2.2 314.9 54.6 2.0 0.1 6.1 86.3 0.8 15.8 0.0 0.0 0.0 29.4 0.6 37.5 175.6 0.0 0.0 0.0 0.1 165.8 1.7 0.0 0.1 18.1 1.5 1.9 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 54.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.3 0.0 0.0 11.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 83.6 0.0 0.0 0.0 0.7 1.3 0.0 130.9 135.9 0.0 4.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.2 2.2 6.1 86.3 29.4 0.0 1.9 0.2 0.0 0.0 12.2 0.0 2.5 0.0 0.0 0.0 0.0 89.3 0.1 0.1 0.4 2.8 0.6 3.7 41.7 0.0 0.0 34.4 25.4 0.1 6.6 0.1 0.0 1.8 410.3 0.0 0.3 0.9 0.1 0.1 0.0 0.4 0.0 0.0 1.1 67.2 0.1 3.3 0.4 67.8 0.0 1.3 0.0 5.4 0.0 2.5 0.0 0.0 0.0 45.1 0.0 0.0 0.1 0.2 31.8 0.0 0.0 0.3 391.5 429.5 0.0 498.9 0.0 0.0 0.0 4.0 0.4 0.0 0.0 0.1 1.3 0.1 88.7 0.2 DHRS12 "FLJ13639, SDR40C1" ENSG00000102796 "Dehydrogenase/reductase 12" A0PJE2 13 51767993-51804162 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "pancreas: 66.8" "Cell type enhanced" "Detected in many" "Late spermatids: 69.1;Proximal tubular cells: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB034238, HPA057028, HPA058315" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Golgi apparatus, Vesicles" "CAB034238: AB_2091845, HPA057028: AB_2683314, HPA058315: AB_2683678" "prognostic favorable (1.41e-4)" "unprognostic (1.98e-2)" "unprognostic (2.98e-1)" "unprognostic (7.57e-2)" "unprognostic (2.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.47e-3)" "unprognostic (1.70e-1)" "unprognostic (3.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.21e-2)" "unprognostic (3.98e-1)" "prognostic favorable (2.22e-16)" "unprognostic (2.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.03e-2)" "unprognostic (3.44e-1)" 22.7 10.6 7.8 2.9 7.3 4.5 20.5 8.9 7.8 13.9 6.5 14.0 5.5 13.1 5.0 10.3 14.5 6.1 14.3 7.3 6.7 24.6 28.9 11.7 5.3 7.2 6.6 18.4 66.8 6.6 18.7 3.6 7.0 15.4 3.7 5.9 15.0 5.9 16.0 14.1 12.5 4.0 7.6 15.7 15.0 8.2 7.0 2.3 18.8 4.1 3.5 13.2 11.2 8.3 1.1 2.5 3.8 5.6 1.2 2.6 4.4 1.6 4.1 1.8 1.3 4.5 8.6 4.2 1.2 2.5 2.5 2.0 0.0 0.3 0.3 4.2 3.4 0.6 1.1 3.2 6.6 0.4 0.7 2.7 3.9 0.6 2.4 4.5 5.2 4.0 2.0 3.0 1.3 5.5 1.0 3.5 6.1 4.2 0.6 0.5 0.8 5.8 5.6 3.2 3.4 6.9 2.9 2.5 7.1 5.0 2.8 2.8 3.7 1.3 1.5 0.1 1.7 1.4 1.8 1.9 2.3 1.4 3.7 6.6 16.6 0.5 14.0 14.2 24.1 13.7 19.7 16.9 9.0 13.4 16.4 12.9 31.4 3.8 16.5 10.6 19.8 13.5 7.8 7.3 8.9 7.8 7.3 6.7 7.2 6.6 7.0 7.6 7.0 8.3 14.1 12.8 14.8 11.1 11.4 11.3 12.1 22.2 10.8 11.9 23.5 22.9 15.7 18.6 13.3 16.5 8.4 24.9 8.0 7.8 52.8 12.5 26.1 5.6 7.7 10.1 10.3 2.1 4.9 16.7 17.5 17.1 7.1 6.4 12.0 6.8 8.6 30.7 17.1 3.3 5.4 12.4 22.4 11.2 11.6 69.1 11.1 10.1 14.2 3.7 10.5 32.4 8.2 24.6 12.9 12.6 21.9 9.8 4.8 12.2 25.5 83.5 19.5 18.5 0.0 14.2 11.4 1.4 8.2 10.5 14.9 23.8 13.7 13.4 11.0 12.2 DHX40 "ARG147, DDX40, FLJ22060, PAD" ENSG00000108406 "DEAH-box helicase 40" Q8IX18 17 59565558-59608345 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 103.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044350 Uncertain Approved Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA044350: AB_10960560" "unprognostic (1.58e-2)" "unprognostic (3.10e-1)" "prognostic favorable (4.05e-5)" "unprognostic (4.09e-2)" "unprognostic (5.23e-2)" "unprognostic (2.84e-1)" "unprognostic (4.57e-3)" "unprognostic (7.53e-3)" "unprognostic (2.86e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (3.08e-1)" "unprognostic (9.48e-3)" "unprognostic (2.22e-1)" "unprognostic (1.25e-2)" "unprognostic (1.11e-1)" "unprognostic (3.10e-1)" 17.9 22.0 14.9 12.9 15.7 26.5 26.9 16.9 16.6 22.1 25.1 15.4 14.6 25.7 21.1 17.4 27.3 17.1 18.2 14.3 17.7 32.9 14.9 18.7 16.3 15.1 16.9 32.3 21.1 57.7 21.7 19.7 16.0 21.3 17.1 21.5 17.0 21.6 17.4 21.2 13.9 20.8 15.5 15.5 16.7 29.8 15.1 25.0 30.6 22.3 18.4 19.2 13.5 20.9 28.7 51.7 64.0 42.5 39.4 39.5 36.0 25.3 48.2 37.9 42.8 20.5 28.0 37.7 69.3 37.2 40.0 20.9 46.5 36.2 58.6 29.9 68.8 34.3 35.1 23.4 30.7 42.3 15.3 31.2 33.1 32.3 31.4 62.3 42.0 36.2 29.3 33.9 26.5 53.5 51.8 26.4 24.8 36.0 37.8 48.8 45.1 42.3 39.0 22.9 45.5 113.5 45.7 18.4 48.6 31.3 58.4 24.8 34.5 45.8 56.3 16.6 25.2 41.2 47.5 23.9 53.5 28.9 32.0 9.2 6.8 11.6 7.9 6.6 10.3 4.7 5.6 5.6 7.1 4.9 5.5 6.6 19.4 4.5 4.9 3.7 6.2 7.5 14.9 15.7 16.9 16.6 14.3 17.7 15.1 16.9 16.0 15.5 15.1 20.9 27.3 9.6 20.9 10.1 19.7 19.4 10.4 16.7 26.2 12.6 31.9 26.7 24.3 28.6 25.3 47.8 18.8 8.8 35.5 14.2 11.7 18.4 43.0 68.8 37.8 22.4 18.5 29.8 10.9 16.9 9.3 21.1 20.9 41.8 3.8 41.8 27.5 25.0 9.2 50.5 14.3 19.0 8.2 21.6 14.7 16.7 25.1 18.8 19.6 3.7 14.8 21.7 14.4 7.1 14.6 13.2 11.9 26.7 18.0 13.4 12.6 46.2 57.7 14.6 32.9 17.4 22.8 103.9 51.4 15.3 22.0 12.6 19.1 36.5 17.8 10.9 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479155-11537551 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 9.8;pituitary gland: 3.5;retina: 4.6;testis: 6.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.9;NTERA-2: 2.1;SCLC-21H: 2.0;SH-SY5Y: 6.8;SiHa: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA054579: AB_2682529" "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.0 0.3 7.1 0.1 9.4 0.0 0.0 4.1 9.8 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 8.6 6.9 0.1 0.0 0.1 0.1 3.3 5.7 0.1 0.5 0.0 3.5 0.0 4.6 0.5 0.0 4.6 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.3 0.1 6.3 7.8 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 4.9 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.5 0.0 1.3 0.0 0.1 2.0 6.8 1.6 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 9.4 4.1 9.8 8.6 6.9 3.3 5.7 4.6 3.7 7.8 3.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DKK2 ENSG00000155011 "Dickkopf WNT signaling pathway inhibitor 2" Q9UBU2 4 106921802-107283806 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 15.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 7.6;Fibroblasts: 18.7;Hofbauer cells: 16.8;Inhibitory neurons: 32.5;Langerhans cells: 11.8;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 22.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebral cortex: 1.5;midbrain: 5.0;pons: 6.3;thalamus: 5.7" "CAB009727, HPA052611" Uncertain Supported "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "CAB009727: AB_2091492, HPA052611: AB_2732576" "unprognostic (3.14e-3)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (3.21e-2)" "unprognostic (9.75e-2)" "unprognostic (3.68e-1)" "unprognostic (1.04e-3)" "unprognostic (2.47e-2)" "unprognostic (5.11e-1)" "unprognostic (5.21e-2)" "unprognostic (3.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (6.86e-2)" "unprognostic (3.22e-1)" "unprognostic (4.58e-2)" 1.4 0.8 0.4 0.4 1.4 0.0 3.0 0.0 1.5 15.2 1.2 1.7 0.0 1.0 0.4 1.2 0.5 0.7 2.2 0.7 0.6 0.2 0.2 5.3 0.7 0.9 4.5 4.4 0.2 0.6 1.5 2.8 0.3 2.3 0.5 0.4 1.3 1.7 1.9 4.7 0.3 0.6 0.2 1.3 0.1 0.1 2.3 1.0 0.9 1.2 3.0 0.2 0.8 0.8 0.0 0.0 3.6 0.0 0.6 0.3 0.0 0.1 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 1.5 0.7 0.6 0.9 4.5 0.3 0.2 2.3 0.8 2.6 0.0 0.0 0.3 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.1 5.4 0.0 0.0 5.2 0.0 0.2 18.7 0.0 0.1 0.0 0.0 3.3 0.0 16.8 0.0 32.5 0.0 0.0 0.3 11.8 0.0 4.1 0.3 7.2 2.8 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 7.4 0.0 0.8 2.0 0.0 0.0 DNMT3A ENSG00000119772 "DNA methyltransferase 3 alpha" Q9Y6K1 2 25227855-25342590 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 127.2;Horizontal cells: 95.9;Rod photoreceptor cells: 143.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 59.6;REH: 59.5;SH-SY5Y: 71.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009469, HPA026588" Approved Supported Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "CAB009469: AB_2093990, HPA026588: AB_1847812" "unprognostic (2.38e-1)" "unprognostic (2.94e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (8.38e-2)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-1)" "prognostic favorable (1.18e-4)" "unprognostic (2.35e-2)" "prognostic unfavorable (2.49e-4)" "unprognostic (1.43e-1)" "unprognostic (1.87e-1)" "unprognostic (1.14e-1)" "unprognostic (2.70e-2)" 5.6 9.0 8.9 9.8 12.6 8.7 6.2 9.3 10.7 9.1 2.4 11.3 6.7 9.3 8.7 6.0 7.5 6.3 5.9 8.8 7.9 11.3 5.3 7.3 11.1 9.0 7.6 13.0 8.3 4.2 11.5 15.7 8.6 7.2 6.6 15.4 6.2 5.9 21.0 4.9 8.9 7.1 5.2 13.4 8.5 5.2 9.4 20.6 6.9 10.2 9.0 7.3 6.2 11.3 1.6 8.1 34.6 8.3 3.8 2.7 45.2 1.9 2.2 4.7 3.8 21.1 13.2 0.0 4.7 4.7 3.5 2.2 3.8 5.2 2.8 5.7 4.3 14.7 12.8 25.4 8.8 2.9 7.6 8.2 2.6 6.0 2.2 9.1 19.5 34.0 18.0 2.9 3.5 20.6 33.7 36.5 59.6 14.3 4.2 59.5 32.5 3.8 2.9 3.4 18.6 71.5 2.7 19.6 6.2 29.5 2.1 16.2 6.8 5.4 4.7 1.0 2.5 5.6 5.1 19.6 2.2 8.4 5.5 2.8 1.0 2.1 2.7 1.7 4.0 1.3 1.7 2.4 1.3 1.6 4.6 3.9 2.5 5.5 2.7 2.3 1.9 1.2 8.9 12.6 9.3 10.7 8.8 7.9 9.0 7.6 8.6 5.2 9.4 11.3 18.5 6.4 13.1 28.1 11.0 5.2 10.2 6.6 5.7 73.3 12.1 9.8 15.8 5.7 9.9 20.2 127.2 40.6 15.3 6.3 5.9 16.9 1.6 13.3 19.1 20.5 13.1 15.8 49.4 9.8 10.7 16.4 9.7 10.7 37.4 37.3 11.0 6.4 23.2 95.9 43.2 11.4 2.0 14.2 3.9 1.9 19.3 13.7 7.2 38.4 7.4 20.6 13.4 36.7 63.4 9.3 9.4 15.4 9.8 12.4 6.2 6.6 7.3 143.5 19.7 15.1 14.3 2.8 14.6 8.1 2.6 32.2 19.6 26.1 12.1 10.2 DOC2B DOC2BL ENSG00000272636 "Double C2 domain beta" Q14184 17 142789-181650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.5;retina: 24.6" "Group enriched" "Detected in many" 5 "Adipocytes: 49.4;Cone photoreceptor cells: 175.2;Muller glia cells: 146.7;Rod photoreceptor cells: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 37.2" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 56.1" HPA043168 Uncertain NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "HPA043168: AB_2678349" "prognostic favorable (3.45e-4)" "unprognostic (2.28e-3)" "unprognostic (3.17e-1)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "prognostic favorable (8.68e-4)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.78e-3)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (2.27e-3)" "unprognostic (2.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.27e-3)" "unprognostic (4.87e-3)" 15.9 4.5 11.6 3.0 12.7 6.2 13.9 18.6 21.1 3.7 1.3 4.0 0.0 4.0 0.0 14.4 5.8 0.0 5.3 22.5 6.5 8.7 0.7 3.4 1.3 8.7 11.7 1.1 10.0 0.2 6.7 1.4 10.8 3.6 1.1 24.6 2.1 0.6 2.7 4.4 4.5 1.5 12.6 3.3 3.4 0.3 12.2 0.8 3.0 0.1 2.5 4.4 5.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 12.7 18.6 21.1 22.5 6.5 8.7 11.7 10.8 12.6 12.2 0.9 49.4 0.0 2.3 0.3 0.2 0.0 0.8 0.0 2.2 10.1 1.5 1.3 2.0 0.0 0.0 9.2 175.2 0.0 0.0 0.2 0.0 0.2 1.1 0.7 4.6 22.8 0.0 0.0 3.8 4.2 0.0 2.3 9.2 0.8 0.0 0.1 18.5 0.2 0.1 1.7 2.3 0.0 0.0 0.3 0.0 2.5 0.0 0.5 0.0 1.0 0.6 146.7 0.0 1.5 0.1 4.3 0.0 0.0 0.0 0.9 0.0 0.5 1.5 100.7 0.0 2.3 0.8 0.2 0.1 1.8 0.0 0.3 0.1 0.8 0.2 3.6 DOK4 FLJ10488 ENSG00000125170 "Docking protein 4" Q8TEW6 16 57471922-57487327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 127.9;Paneth cells: 99.9;Proximal enterocytes: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 94.2;CACO-2: 107.8;SH-SY5Y: 239.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008348, HPA055849" Supported Approved Cytosol NA No "Cluster 1: Neutrophils - Mixed function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA008348: , HPA055849: AB_2682942" "unprognostic (3.44e-2)" "unprognostic (2.04e-2)" "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (3.66e-1)" "unprognostic (9.71e-2)" "unprognostic (5.35e-2)" "unprognostic (1.39e-1)" "unprognostic (1.13e-2)" "unprognostic (3.00e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-1)" "unprognostic (2.58e-3)" "unprognostic (4.30e-2)" "unprognostic (2.21e-1)" "unprognostic (4.42e-3)" "unprognostic (1.18e-3)" 10.5 9.2 12.0 9.6 12.2 1.8 8.8 12.2 12.7 20.7 9.0 43.9 46.1 16.9 12.1 32.8 15.2 17.5 14.8 11.1 11.8 42.0 33.7 23.3 4.3 8.3 11.0 19.8 17.6 12.0 19.8 10.9 13.0 18.3 31.3 4.1 12.6 25.8 3.0 43.2 49.9 12.2 7.5 10.5 37.3 7.0 10.8 3.8 10.7 3.9 7.4 16.7 21.6 9.4 10.3 94.2 15.0 26.8 20.6 22.6 16.7 17.7 23.5 12.4 3.8 107.8 53.1 1.1 75.4 37.2 7.3 21.0 9.2 4.9 5.3 2.7 6.9 22.3 28.2 63.2 29.3 0.3 2.3 15.8 14.2 16.4 1.8 27.6 19.0 3.8 7.3 4.3 14.9 9.9 1.1 4.1 9.6 46.1 4.0 8.9 7.8 1.2 64.8 3.9 73.6 239.9 14.5 6.3 4.5 66.0 5.6 4.2 20.5 2.1 15.1 6.1 0.8 2.9 4.1 0.8 6.7 4.7 9.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 12.0 12.2 12.2 12.7 11.1 11.8 8.3 11.0 13.0 7.5 10.8 9.4 8.3 12.8 14.0 0.7 1.4 7.9 7.2 3.6 5.2 15.5 3.7 5.0 2.4 30.0 3.3 14.7 0.0 0.9 1.8 127.9 5.9 15.0 1.2 2.1 5.3 11.3 3.6 1.3 5.0 23.7 7.6 7.9 36.2 2.9 0.0 19.6 6.8 20.4 0.9 8.4 7.1 30.3 2.0 0.8 1.6 2.0 13.4 1.0 3.6 1.0 0.7 2.2 0.0 2.0 0.4 30.8 99.9 12.0 1.4 7.1 96.6 46.9 2.5 0.8 6.6 1.1 6.9 0.2 4.1 11.6 18.0 0.5 2.5 4.8 34.1 6.1 DPYSL3 "CRMP4, DRP-3, ULIP" ENSG00000113657 "Dihydropyrimidinase like 3" Q14195 5 147390808-147510068 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 101.5;Cone photoreceptor cells: 331.5;Granulosa cells: 261.9;Peritubular cells: 205.7;Rod photoreceptor cells: 125.0" "Cancer enhanced" "Detected in all" "glioma: 109.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 685.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010948 Approved Approved Cytosol NA NA 740000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA010948: AB_1847245" "unprognostic (3.92e-2)" "unprognostic (1.90e-1)" "unprognostic (5.00e-3)" "unprognostic (1.39e-1)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (5.99e-2)" "unprognostic (6.92e-2)" "unprognostic (4.72e-2)" "unprognostic (2.08e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.87e-9)" "unprognostic (1.14e-2)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.23e-4)" 58.4 18.6 63.4 54.4 68.6 0.8 37.5 60.3 55.8 66.1 30.4 142.1 18.4 119.9 73.9 69.0 63.4 65.1 59.2 57.0 116.0 7.7 4.4 45.2 18.1 123.7 94.2 88.0 5.5 2.7 12.7 19.8 81.8 104.6 37.6 163.8 24.5 162.0 68.7 23.8 43.3 217.6 115.2 26.4 40.9 19.9 95.2 7.1 22.4 36.0 27.0 118.0 50.6 105.1 0.5 36.1 63.9 0.1 2.3 63.3 1.6 34.1 163.0 71.4 94.4 114.5 3.1 0.0 9.6 100.1 37.4 3.7 13.1 1.4 79.1 16.3 29.2 0.1 30.0 0.2 63.1 0.3 0.2 12.2 0.6 153.8 60.3 178.7 206.9 0.0 0.0 1.3 41.1 0.3 0.2 0.6 135.9 0.2 53.7 0.2 135.1 0.5 63.0 14.2 47.1 685.4 0.3 0.3 10.8 87.9 0.5 1.0 91.1 51.6 38.5 127.0 127.3 113.9 21.7 0.2 47.5 1.4 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 68.6 60.3 55.8 57.0 116.0 123.7 94.2 81.8 115.2 95.2 105.1 59.9 0.0 2.8 101.5 0.0 9.4 3.4 1.5 2.2 14.2 8.1 6.6 7.8 1.5 4.0 0.0 331.5 0.1 0.0 0.2 0.0 9.1 16.8 0.3 4.6 62.6 6.6 0.0 11.3 8.4 0.3 79.8 3.1 1.2 1.3 261.9 57.8 0.4 1.6 5.0 12.9 0.2 24.4 1.2 11.9 19.2 42.9 3.1 19.6 5.6 0.0 28.3 0.0 83.9 0.7 13.7 0.0 205.7 0.3 10.1 0.0 0.1 2.8 125.0 0.0 23.6 40.9 1.8 3.2 3.7 8.2 0.4 1.5 49.6 0.3 4.5 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364066-49396089 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "adrenal gland: 5.4;brain: 10.4" "Cell type enhanced" "Detected in some" "Langerhans cells: 1.2;Melanocytes: 1.8" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 12 "medulla oblongata: 10.1;pons: 10.4;spinal cord: 8.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "RH-30: 11.6;SH-SY5Y: 46.2;U-2197: 17.7" "Region enriched" "Detected in single" 6 "pons and medulla: 3.9" "Group enriched" "Detected in some" 10 "cerebral cortex: 4.0;hippocampal formation: 1.6;medulla oblongata: 2.4;spinal cord: 3.7" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.1 5.4 0.0 0.2 0.1 0.1 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 10.1 0.7 0.0 0.0 0.0 0.2 0.0 10.4 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 8.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 17.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 0.3 10.1 0.7 10.4 8.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.8 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 70.7" "Cancer enriched" "Detected in all" 4 "glioma: 54.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 5 "NK-cells: 1.0;T-cells: 2.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 84.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Cluster 20: T-cells - T-cell receptor" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: AB_2684097" "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favorable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 36.6 58.2 117.1 15.8 120.2 7.2 36.4 117.5 138.2 97.6 115.0 117.4 11.5 95.5 50.7 24.2 92.0 24.5 67.6 124.5 111.4 63.8 12.3 37.2 21.2 107.8 112.1 124.3 41.9 39.4 145.1 28.1 108.6 82.1 16.8 80.8 31.4 48.2 21.0 21.1 46.2 48.5 105.3 46.0 51.0 29.0 112.6 23.6 75.9 16.6 15.5 65.0 60.7 119.0 8.8 22.7 65.9 0.1 0.0 0.1 0.4 13.8 35.4 29.7 30.0 11.8 36.5 12.3 20.5 30.0 0.3 14.2 0.0 1.7 20.9 31.1 4.1 7.1 39.4 12.5 49.4 0.0 0.1 24.5 16.7 22.8 0.3 84.4 33.6 0.1 0.0 40.9 23.1 19.2 38.4 0.3 52.1 7.2 2.0 0.0 55.1 0.7 2.8 22.7 47.7 75.5 10.9 3.1 7.0 15.8 38.4 18.9 0.1 38.6 15.3 17.9 20.2 66.2 53.6 0.2 24.8 0.1 20.6 0.0 0.0 0.0 2.5 0.0 0.6 0.1 0.9 1.2 0.1 0.1 0.8 1.6 0.0 1.0 0.0 0.3 2.2 1.2 117.1 120.2 117.5 138.2 124.5 111.4 107.8 112.1 108.6 105.3 112.6 119.0 4.9 16.0 15.6 25.8 2.9 6.2 10.0 8.7 21.1 47.8 12.2 19.9 11.0 11.5 10.5 12.9 50.1 0.5 10.6 0.5 13.7 8.2 0.9 17.8 17.4 8.5 15.6 4.4 29.9 1.9 0.3 15.1 6.1 5.5 5.7 17.2 15.0 0.6 0.6 70.7 29.3 0.9 10.2 2.0 2.1 2.8 34.2 1.6 3.6 8.4 0.8 27.4 36.0 25.1 19.0 2.6 0.0 31.6 5.8 7.1 0.0 4.6 30.9 42.0 46.0 11.5 37.5 4.6 5.7 2.8 2.8 1.2 10.4 16.8 0.7 3.5 EBF4 "COE4, KIAA1442, O/E-4, RP5-860F19.3" ENSG00000088881 "EBF family member 4" Q9BQW3 20 2692874-2760108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 18.9;Cholangiocytes: 21.5;Endometrial stromal cells: 18.6;Oligodendrocyte precursor cells: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 7.9;HEK 293: 8.4;SH-SY5Y: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "unprognostic (9.95e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.59e-4)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (9.57e-2)" "unprognostic (1.00e-1)" "unprognostic (1.60e-1)" "unprognostic (7.79e-3)" "unprognostic (3.82e-1)" "prognostic favorable (2.47e-5)" "unprognostic (2.68e-2)" "unprognostic (5.58e-3)" "unprognostic (1.87e-3)" "unprognostic (2.91e-1)" "unprognostic (1.17e-2)" "unprognostic (2.87e-3)" 2.6 3.5 12.1 2.7 13.5 0.3 2.7 9.1 15.0 5.0 3.0 3.2 2.8 19.0 2.2 4.1 6.7 5.7 2.9 12.9 11.1 2.6 1.1 3.6 2.3 13.4 11.4 13.7 3.8 14.4 2.9 5.7 9.9 12.4 1.9 3.3 5.6 11.1 1.1 2.8 3.8 12.1 10.6 2.2 3.9 1.2 13.1 0.6 18.0 1.5 1.8 3.0 2.0 17.4 0.0 0.7 4.4 4.4 0.1 1.1 0.9 1.2 3.2 2.2 1.1 0.6 0.4 0.0 2.5 0.5 7.9 0.2 1.5 0.2 1.3 6.2 8.4 0.0 0.0 0.2 2.8 0.0 0.0 0.1 1.0 1.0 0.0 0.8 0.3 1.9 0.0 0.0 0.0 0.4 0.1 6.9 0.6 0.0 0.2 6.4 1.2 0.5 0.0 2.7 3.3 21.2 1.2 0.1 1.9 4.2 2.4 0.3 1.7 0.3 1.0 0.2 3.8 1.4 0.2 1.5 0.0 0.9 3.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.1 13.5 9.1 15.0 12.9 11.1 13.4 11.4 9.9 10.6 13.1 17.4 4.1 0.0 1.1 18.9 0.3 3.4 15.6 3.0 6.8 7.7 18.1 11.0 2.2 21.5 5.5 1.8 0.0 0.2 5.1 0.2 0.0 2.0 0.4 1.2 18.6 3.2 0.0 0.0 3.1 0.4 0.1 5.1 1.1 1.1 0.0 1.9 6.4 5.7 0.3 5.0 12.2 0.2 4.1 0.8 1.4 0.8 3.4 0.3 1.8 10.3 0.0 5.5 2.1 52.3 17.9 0.3 1.7 7.2 0.4 11.3 0.0 0.2 4.9 2.3 6.6 3.3 5.1 0.6 1.4 0.6 1.0 0.3 0.7 0.1 0.4 9.3 EDNRA "ET-A, ETA-R, hET-AR" ENSG00000151617 "Endothelin receptor type A" P25101 4 147480917-147544954 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 113.9" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 117.1;Leydig cells: 43.8;Peritubular cells: 68.1;Sertoli cells: 52.6;Smooth muscle cells: 108.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 9.4;ASC TERT1: 18.2;HHSteC: 9.3;LHCN-M2: 22.7;SH-SY5Y: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013774, CAB018957" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane, Cytosol" "CAB018957: AB_2039838, HPA013774: AB_1847994" "unprognostic (3.08e-2)" "unprognostic (6.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-2)" "unprognostic (7.20e-2)" "unprognostic (2.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.34e-3)" "unprognostic (2.88e-1)" "prognostic unfavorable (1.50e-7)" "prognostic unfavorable (3.93e-4)" "unprognostic (6.20e-3)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" 14.0 5.5 2.1 3.3 2.8 0.0 8.3 2.7 4.2 57.0 2.1 3.2 3.4 44.7 23.3 4.4 18.4 12.7 26.0 2.2 2.2 4.2 3.1 22.7 3.8 2.9 3.1 37.5 1.1 3.4 2.8 12.1 2.9 30.7 3.4 0.3 6.4 113.9 4.0 4.6 2.9 45.1 2.5 8.4 5.4 6.2 2.9 4.9 6.8 5.5 2.6 11.8 24.0 3.0 0.0 1.2 5.2 0.0 9.4 18.2 0.0 2.9 3.8 0.4 0.1 0.2 0.0 0.0 0.0 0.9 0.6 0.0 0.4 0.7 0.2 0.0 1.9 0.0 2.8 0.0 9.3 0.0 0.0 6.9 0.6 0.5 0.0 3.4 0.0 0.0 0.0 1.4 22.7 0.3 0.0 0.1 1.5 0.0 1.1 0.0 0.9 0.1 1.3 1.0 0.0 16.3 0.0 0.0 0.0 3.4 0.0 0.0 0.0 3.6 0.7 0.0 0.0 1.3 0.4 0.0 7.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.8 2.7 4.2 2.2 2.2 2.9 3.1 2.9 2.5 2.9 3.0 7.7 3.2 5.3 1.0 0.0 3.1 0.8 1.7 27.3 0.1 0.8 5.2 24.9 0.0 4.5 0.0 0.0 0.2 0.1 0.0 0.0 0.1 2.9 3.4 117.1 8.0 0.0 0.0 5.3 0.0 0.1 15.9 0.0 2.7 0.0 14.3 0.0 0.0 0.6 0.0 22.5 0.0 0.0 0.0 3.9 3.5 43.8 0.8 3.6 9.4 0.0 0.1 0.0 2.0 1.0 0.2 0.0 68.1 0.0 1.4 0.0 0.5 0.0 0.5 52.6 0.6 108.6 0.7 0.7 7.1 2.7 0.1 0.9 0.3 0.0 0.4 EFS "CASS3, EFS1, EFS2, HEFS, SIN" ENSG00000100842 "Embryonal Fyn-associated substrate" O43281 14 23356403-23365752 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 48.9;Squamous epithelial cells: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 73.2;AN3-CA: 39.5;BEWO: 57.7;SH-SY5Y: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001581, HPA001790" Approved Uncertain Nucleoplasm,Cytosol No NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm Cytosol "HPA001581: AB_2666367, HPA001790: " "unprognostic (9.58e-3)" "unprognostic (1.10e-2)" "unprognostic (3.68e-2)" "unprognostic (1.78e-1)" "unprognostic (6.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-1)" "unprognostic (3.85e-2)" "unprognostic (7.36e-2)" "unprognostic (2.15e-1)" "unprognostic (2.75e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.09e-5)" "unprognostic (3.44e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" 19.3 12.6 39.7 5.5 59.6 0.0 22.7 51.7 45.6 47.3 28.0 24.4 3.1 29.2 9.9 44.1 28.6 8.7 15.0 35.6 39.3 10.0 1.8 12.1 3.6 63.0 57.6 41.9 2.2 22.2 8.4 10.4 54.8 36.8 3.3 10.6 26.2 22.5 3.6 59.0 9.6 12.5 44.8 7.6 11.9 5.4 49.9 3.2 17.5 5.1 4.8 25.3 42.9 76.0 4.7 0.0 73.2 39.5 17.1 20.0 57.7 5.3 11.3 2.0 0.9 0.0 0.0 0.0 0.0 30.3 0.3 27.5 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 11.6 18.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.1 0.0 0.0 0.0 22.6 0.1 0.0 24.1 7.8 66.5 15.1 2.6 0.0 8.7 17.6 0.0 0.0 7.6 0.0 19.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 59.6 51.7 45.6 35.6 39.3 63.0 57.6 54.8 44.8 49.9 76.0 2.0 0.0 6.7 17.0 0.0 11.6 11.6 5.6 9.6 5.0 20.3 16.3 0.7 0.0 4.1 0.0 6.2 9.3 0.2 0.0 1.9 0.1 0.9 0.6 18.9 1.8 0.0 0.0 0.2 0.0 14.7 15.7 0.0 0.7 0.0 4.4 1.8 0.0 1.6 0.0 0.3 0.0 0.0 0.0 3.7 0.8 20.2 0.4 7.2 1.9 0.0 9.0 0.0 22.1 48.9 0.0 0.0 13.9 0.1 7.6 0.0 0.3 1.1 9.3 6.6 12.6 8.9 2.2 0.5 22.7 13.4 18.1 0.5 0.3 0.0 7.0 ELAVL3 "DKFZp547J036, HUC, HUCL, MGC20653, PLE21" ENSG00000196361 "ELAV like RNA binding protein 3" Q14576 19 11451326-11481046 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 106.4" "Cell type enhanced" "Detected in some" "Astrocytes: 36.9;Bipolar cells: 26.9;Excitatory neurons: 78.1;Inhibitory neurons: 91.0;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 120.1" "Cancer enriched" "Detected in some" 10 "glioma: 11.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 80.9;SH-SY5Y: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013066 Enhanced NA NA "Cluster 37: B-cells - Transcription" "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "CAB013066: AB_221448" "unprognostic (1.47e-2)" "unprognostic (2.29e-2)" "unprognostic (1.70e-1)" "unprognostic (7.78e-3)" "unprognostic (8.76e-2)" "unprognostic (2.95e-3)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (1.86e-2)" "unprognostic (2.15e-3)" "unprognostic (2.26e-2)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (9.60e-3)" 0.0 1.2 46.8 0.5 62.8 0.0 0.0 89.7 69.3 0.0 0.0 0.6 0.1 0.1 0.5 0.1 0.0 0.0 0.7 54.1 47.8 0.8 0.1 0.1 0.0 60.0 54.8 0.1 0.1 0.1 5.5 0.0 64.9 0.4 0.2 6.0 0.0 0.2 3.2 0.0 0.2 0.2 50.9 0.1 0.2 0.9 55.6 0.0 0.0 0.1 0.0 0.0 0.1 106.4 0.0 0.2 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 80.9 46.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 62.8 89.7 69.3 54.1 47.8 60.0 54.8 64.9 50.9 55.6 106.4 1.0 0.0 0.0 36.9 0.0 0.6 0.4 0.0 0.6 26.9 1.3 3.3 12.4 0.0 0.0 0.0 4.2 0.2 0.1 0.2 0.0 0.0 3.5 0.2 0.5 1.8 0.0 0.0 78.1 0.0 0.1 0.6 0.0 0.6 0.0 0.1 0.0 0.0 0.1 5.0 91.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 4.7 0.0 3.0 1.0 36.2 120.1 0.1 0.0 0.0 0.0 0.5 0.2 0.2 0.0 7.4 0.0 1.7 2.2 2.9 4.2 1.1 0.1 0.0 0.1 0.5 0.2 0.3 ELAVL4 "HUD, PNEM" ENSG00000162374 "ELAV like RNA binding protein 4" P26378 1 50024029-50203772 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 52.8" "Group enriched" "Detected in some" 4 "Early spermatids: 155.5;Excitatory neurons: 158.7;Inhibitory neurons: 109.7;Late spermatids: 159.4;Oligodendrocyte precursor cells: 75.4" "Cancer enriched" "Detected in some" 4 "glioma: 2.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 5 "monocytes: 1.1" "Cell line enriched" "Detected in some" 17 "SH-SY5Y: 157.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004442, HPA043047" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "CAB004442: AB_627765, HPA043047: AB_2732502" "unprognostic (1.25e-1)" "unprognostic (6.63e-3)" "unprognostic (4.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.28e-2)" "unprognostic (3.83e-4)" "unprognostic (4.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.75e-1)" "unprognostic (3.75e-3)" "unprognostic (7.91e-2)" "unprognostic (2.39e-3)" "unprognostic (7.83e-2)" "unprognostic (2.81e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-2)" 0.1 11.2 13.9 2.4 18.0 0.0 0.2 7.4 52.8 0.0 0.0 2.2 1.4 0.0 0.0 0.2 0.1 0.1 0.2 20.0 18.5 0.1 0.1 0.3 0.2 36.5 14.0 0.0 2.3 0.0 3.4 0.2 31.7 0.1 2.8 3.9 0.2 0.1 0.0 0.4 2.2 1.1 2.0 0.2 1.0 8.5 11.4 0.9 0.0 0.0 0.2 0.1 0.2 17.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.2 157.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 13.9 18.0 7.4 52.8 20.0 18.5 36.5 14.0 31.7 2.0 11.4 17.4 0.1 0.0 0.0 7.2 0.1 0.8 0.0 0.0 0.0 3.9 0.1 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 155.5 0.0 0.0 0.3 32.9 0.0 158.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 109.7 0.1 4.1 4.0 5.0 159.4 1.5 3.1 1.8 22.5 0.0 1.5 0.0 75.4 5.9 0.3 0.0 0.4 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.1 8.9 11.8 0.0 0.9 0.1 0.2 0.0 0.1 0.1 EMILIN1 "DKFZp586M121, gp115" ENSG00000138080 "Elastin microfibril interfacer 1" Q9Y6C2 2 27078615-27086403 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 64.5;Fibroblasts: 111.3;Hepatic stellate cells: 45.0;Leydig cells: 85.1;Peritubular cells: 167.3;Sertoli cells: 72.3;Smooth muscle cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 98.2;BJ hTERT+: 65.0;HHSteC: 99.0;HSkMC: 109.6;SH-SY5Y: 129.4;U-138 MG: 63.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002822 Supported "Secreted to extracellular matrix" NA NA 4300000 "Cluster 49: Eosinophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" "HPA002822: AB_1078738" "unprognostic (3.14e-1)" "unprognostic (2.44e-2)" "unprognostic (3.92e-2)" "unprognostic (3.42e-2)" "unprognostic (3.26e-2)" "unprognostic (1.46e-1)" "unprognostic (3.07e-1)" "unprognostic (2.89e-2)" "unprognostic (4.10e-3)" "unprognostic (3.07e-2)" "unprognostic (1.85e-1)" "unprognostic (7.97e-2)" "prognostic unfavorable (8.13e-9)" "unprognostic (8.96e-3)" "unprognostic (3.77e-2)" "unprognostic (1.20e-2)" "unprognostic (5.70e-3)" 55.5 55.7 6.9 47.0 7.1 1.9 43.6 6.4 7.1 139.8 4.6 223.5 24.9 206.3 7.4 23.3 129.2 35.4 68.9 5.9 7.5 55.5 42.4 100.7 11.7 13.0 7.6 172.4 21.2 1.4 26.9 16.2 9.5 96.4 7.9 0.3 17.5 52.1 10.3 19.1 72.0 50.3 8.3 118.1 87.6 16.9 10.4 2.4 29.7 2.6 2.2 142.9 70.2 8.6 0.9 0.7 5.9 0.9 35.8 49.0 1.1 98.2 65.0 20.7 29.7 0.5 0.8 0.6 0.9 56.6 0.1 0.9 0.2 0.2 3.8 3.1 1.3 1.8 0.5 43.9 99.0 1.5 27.0 109.6 0.1 14.2 0.0 0.2 0.2 1.3 1.0 0.9 4.3 1.1 0.9 28.8 3.2 0.5 0.7 15.6 1.3 1.2 0.0 0.4 1.6 129.4 0.3 0.5 1.1 0.4 0.4 2.5 11.9 63.6 2.0 7.6 0.4 1.7 1.8 1.1 0.7 1.3 17.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 6.9 7.1 6.4 7.1 5.9 7.5 13.0 7.6 9.5 8.3 10.4 8.6 5.2 0.0 0.5 6.5 0.4 3.3 0.2 0.0 0.0 0.6 0.8 7.1 2.9 1.5 0.0 0.0 0.0 1.6 0.6 0.2 0.0 0.4 0.6 1.9 64.5 6.3 0.0 4.0 0.2 0.4 1.5 111.3 0.5 1.3 4.5 0.2 45.0 1.0 6.4 0.0 0.3 0.3 0.0 2.5 5.8 10.0 85.1 4.1 10.6 8.4 0.5 3.6 0.0 0.5 0.3 0.8 0.1 167.3 0.8 0.2 0.5 1.0 0.0 1.1 72.3 35.3 52.4 0.6 0.4 0.4 3.1 2.9 1.3 10.7 0.1 0.1 EML5 "EMAP-2, FAP16, HuEMAP-2" ENSG00000165521 "EMAP like 5" Q05BV3 14 88612431-88792752 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;ovary: 17.4;retina: 9.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 60.5;Excitatory neurons: 79.5;Granulosa cells: 98.7;Inhibitory neurons: 106.8;Oligodendrocyte precursor cells: 98.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 17.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 11.5;SH-SY5Y: 23.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "olfactory bulb: 41.5" "HPA054019, HPA055379" Uncertain NA NA "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "HPA054019: AB_2682345, HPA055379: AB_2682799" "unprognostic (2.28e-1)" "unprognostic (1.80e-1)" "unprognostic (2.49e-1)" "unprognostic (8.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.67e-4)" "unprognostic (3.42e-2)" "unprognostic (4.50e-2)" "unprognostic (1.63e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.36e-1)" "unprognostic (1.11e-4)" "unprognostic (1.21e-2)" "unprognostic (1.05e-1)" "unprognostic (3.82e-1)" "unprognostic (1.53e-3)" 0.4 3.8 3.3 0.7 2.8 0.3 0.8 17.7 2.8 0.7 0.0 1.3 0.2 0.4 0.2 0.8 1.1 0.1 0.2 3.4 2.4 1.4 1.6 0.6 0.2 0.5 5.5 17.4 0.9 2.4 3.9 0.0 1.5 4.4 0.3 9.5 0.8 0.2 0.1 0.5 0.8 0.2 0.3 0.9 0.6 2.7 2.7 0.7 1.6 0.1 0.6 0.8 0.5 1.1 1.3 0.5 0.0 1.0 0.0 0.0 2.6 0.4 0.3 0.2 0.1 0.0 0.9 0.1 0.0 0.0 0.2 3.5 4.1 0.1 0.1 2.2 2.2 1.1 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.5 11.5 0.1 1.2 2.9 0.0 0.2 0.4 1.0 1.4 0.0 0.4 0.1 3.1 3.9 23.8 1.1 1.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.7 4.7 1.0 3.7 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 2.8 17.7 2.8 3.4 2.4 0.5 5.5 1.5 0.3 2.7 1.1 0.2 0.0 5.8 31.3 3.5 0.5 1.0 0.0 0.6 28.2 2.0 0.9 1.5 1.5 1.3 0.0 60.5 0.2 0.7 1.2 0.0 0.9 3.1 2.0 1.2 0.8 10.7 2.1 79.5 0.4 0.1 1.2 3.1 1.9 1.3 98.7 0.0 0.1 0.0 20.2 106.8 0.3 0.0 0.0 0.0 2.9 0.6 0.3 3.6 17.8 0.2 3.6 0.0 98.0 34.5 0.3 1.1 1.2 4.5 5.7 0.0 0.4 4.6 30.1 0.0 1.9 7.4 13.6 8.1 1.5 0.4 0.1 1.7 5.1 0.1 0.6 ESRRG "ERR-gamma, ERRg, NR3B3" ENSG00000196482 "Estrogen related receptor gamma" P62508 1 216503246-217137755 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.6;parathyroid gland: 46.3;retina: 36.1;stomach 1: 35.1" "Group enriched" "Detected in many" 4 "Astrocytes: 330.7;Excitatory neurons: 415.2;Inhibitory neurons: 495.5;Oligodendrocyte precursor cells: 391.6;Oligodendrocytes: 218.7;Syncytiotrophoblasts: 214.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 23.0;SH-SY5Y: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044678 Uncertain Approved Nucleoplasm No NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA044678: AB_10963215" "unprognostic (6.48e-2)" "unprognostic (1.11e-1)" "unprognostic (7.06e-2)" "unprognostic (7.32e-2)" "unprognostic (2.34e-1)" "unprognostic (5.48e-2)" "unprognostic (1.66e-1)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (2.88e-1)" "unprognostic (2.35e-1)" "unprognostic (1.79e-2)" "prognostic favorable (1.13e-11)" "unprognostic (3.04e-1)" "unprognostic (2.55e-1)" "unprognostic (3.65e-4)" "unprognostic (2.05e-1)" 0.4 6.4 1.1 0.2 3.1 0.0 3.6 16.9 12.3 1.5 7.4 0.5 5.3 0.4 0.9 1.6 2.5 0.7 10.6 4.4 2.3 29.0 0.7 0.5 0.2 45.4 4.9 0.7 5.7 46.3 1.5 10.6 49.6 3.1 0.3 36.1 16.0 0.7 5.8 0.8 5.0 0.2 1.6 1.1 35.1 1.1 3.5 0.6 5.9 10.2 0.3 0.7 0.2 6.1 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.2 0.0 0.2 0.0 0.0 23.0 3.4 2.5 8.1 42.4 0.0 0.4 0.0 2.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 3.1 16.9 12.3 4.4 2.3 45.4 4.9 49.6 1.6 3.5 6.1 0.2 0.0 1.8 330.7 0.2 0.3 3.8 0.6 0.6 29.5 9.5 5.2 51.2 10.0 1.8 23.9 58.4 35.4 0.0 0.0 54.8 5.0 5.1 15.9 2.0 1.3 8.3 0.0 415.2 2.4 4.7 3.0 70.3 3.5 0.0 0.5 1.1 0.6 4.8 48.8 495.5 1.7 14.2 0.3 0.4 8.1 0.3 0.5 8.8 36.5 0.0 13.3 0.0 391.6 218.7 0.4 1.3 0.7 0.1 4.9 16.3 29.0 16.0 41.3 0.0 10.3 0.4 1.6 0.3 0.8 0.3 214.9 0.3 1.1 2.6 1.7 EYA1 BOR ENSG00000104313 "EYA transcriptional coactivator and phosphatase 1" Q99502 8 71197433-71592025 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Deafness, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 18.7;parathyroid gland: 23.7" "Cell type enriched" "Detected in some" 11 "Astrocytes: 214.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 27.6;RH-30: 21.3;RPMI-8226: 9.5;SH-SY5Y: 51.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 20.7" HPA028917 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Nuclear bodies" "HPA028917: AB_2672826" "unprognostic (3.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.95e-2)" "unprognostic (9.17e-2)" "unprognostic (2.91e-4)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (1.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-12)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (3.81e-4)" "unprognostic (1.25e-2)" 0.6 0.6 2.8 0.1 7.8 0.0 0.2 0.5 2.1 5.1 18.7 0.1 0.1 0.1 0.1 0.4 2.0 0.3 4.5 1.3 2.5 0.1 0.0 0.4 0.0 2.1 4.9 0.2 0.0 23.7 10.8 0.0 2.3 12.0 0.2 0.4 0.8 4.0 2.8 0.0 0.2 0.2 0.0 0.1 0.8 0.8 4.6 11.7 0.6 2.5 0.1 2.6 4.3 0.6 0.2 0.0 6.4 27.6 0.0 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 1.6 0.0 0.0 4.7 0.0 2.2 0.0 0.0 0.5 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.0 2.0 0.0 1.5 0.0 21.3 9.5 0.0 0.0 2.2 51.4 0.0 0.0 1.6 5.9 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 6.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 7.8 0.5 2.1 1.3 2.5 2.1 4.9 2.3 0.0 4.6 0.6 0.2 0.0 0.0 214.5 0.0 0.1 0.0 6.4 0.6 0.1 0.0 0.1 8.8 0.0 7.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 3.1 0.1 0.2 0.0 0.0 1.3 0.0 0.5 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 13.5 0.0 2.0 0.0 0.0 6.4 0.3 0.0 0.0 11.2 0.0 0.1 0.0 18.6 0.6 0.0 0.0 0.4 0.0 0.1 0.0 0.3 10.5 0.2 0.0 0.2 0.5 0.8 1.0 1.1 0.1 0.5 0.0 1.4 0.0 0.1 FAM155A ENSG00000204442 "Family with sequence similarity 155 member A" B1AL88 13 107163510-107867496 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.7;pituitary gland: 5.4" "Group enriched" "Detected in many" 6 "Astrocytes: 918.7;Excitatory neurons: 3051.8;Inhibitory neurons: 2146.4;Oligodendrocyte precursor cells: 2307.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.3;RPTEC TERT1: 11.4;SCLC-21H: 7.2;SH-SY5Y: 16.6;U-87 MG: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039453 Enhanced NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA039453: AB_10795290" "unprognostic (8.40e-2)" "unprognostic (9.98e-3)" "unprognostic (1.48e-1)" "unprognostic (3.38e-3)" "unprognostic (2.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.26e-1)" "unprognostic (9.06e-2)" "unprognostic (1.02e-5)" "unprognostic (5.56e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-2)" "unprognostic (3.69e-3)" 0.4 1.1 7.5 0.1 8.6 0.0 0.2 5.9 10.7 0.5 1.0 0.2 0.1 0.6 1.7 0.2 0.2 0.4 0.2 9.3 10.5 0.1 0.0 0.4 0.1 6.0 7.1 0.2 0.1 0.0 5.4 0.4 7.1 1.1 0.2 2.0 0.0 1.6 0.0 0.0 0.2 0.4 4.9 0.1 0.2 1.0 8.4 0.0 0.4 0.0 0.3 0.5 0.3 8.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.6 0.0 2.4 0.0 5.3 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 4.5 0.0 0.0 0.2 0.0 11.4 1.9 7.2 16.6 0.0 0.0 0.0 0.2 4.2 0.0 0.2 5.0 2.1 1.7 0.2 0.0 0.0 0.0 10.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 8.6 5.9 10.7 9.3 10.5 6.0 7.1 7.1 4.9 8.4 8.3 2.8 3.2 24.6 918.7 0.0 0.1 0.3 0.0 0.0 19.7 0.9 0.3 0.8 0.0 1.9 3.7 0.0 0.0 0.0 0.0 0.0 1.3 62.3 8.9 39.5 4.4 0.0 0.0 3051.8 0.0 0.1 3.7 0.0 20.7 0.0 0.5 8.2 0.0 0.2 37.0 2146.4 0.0 0.0 0.0 0.4 22.7 1.8 0.2 0.0 306.3 0.0 6.8 0.0 2307.6 37.2 0.5 0.0 1.2 0.0 0.9 0.0 0.1 0.0 1.6 6.6 0.3 1.5 1.1 2.0 0.1 0.0 0.0 0.4 1.0 0.0 0.3 FAM163A "C1orf76, MGC16664, NDSP" ENSG00000143340 "Family with sequence similarity 163 member A" Q96GL9 1 179743163-179816198 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.0;lymphoid tissue: 15.2;pituitary gland: 29.6;testis: 12.6" "Group enriched" "Detected in some" 5 "Early spermatids: 37.7;Late spermatids: 51.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 36 "SH-SY5Y: 112.0" "Low region specificity" "Detected in many" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (8.74e-3)" "unprognostic (3.42e-2)" "unprognostic (1.32e-2)" "unprognostic (3.24e-1)" "unprognostic (2.62e-1)" "unprognostic (1.66e-1)" "unprognostic (5.67e-6)" "unprognostic (5.56e-2)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (3.81e-3)" "unprognostic (9.14e-2)" "unprognostic (7.75e-5)" "unprognostic (1.67e-2)" "unprognostic (2.83e-1)" "unprognostic (1.60e-1)" "unprognostic (4.98e-2)" 0.2 5.8 1.5 1.3 3.1 0.0 0.0 0.1 3.0 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.3 1.1 0.5 0.9 1.3 0.1 0.1 0.0 0.6 17.2 3.8 0.3 0.3 0.0 29.6 0.3 18.0 0.2 0.5 0.7 0.0 0.1 0.1 0.1 1.0 0.3 0.4 0.2 0.9 12.6 9.1 15.2 0.8 0.2 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 112.0 0.1 0.0 0.5 0.1 0.0 1.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.1 0.1 3.0 0.9 1.3 17.2 3.8 18.0 0.4 9.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.7 0.3 0.0 0.1 0.0 0.0 7.8 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 51.9 0.6 0.0 0.0 1.9 0.0 0.0 0.0 1.0 0.3 0.1 0.0 0.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133577081-133609389 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 60.1" "Group enriched" "Detected in some" 6 "Excitatory neurons: 24.8;Inhibitory neurons: 17.8;Late spermatids: 17.3" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Group enriched" "Detected in many" 6 "amygdala: 26.5;basal ganglia: 44.4;cerebral cortex: 60.1;hippocampal formation: 38.2;white matter: 32.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "SH-SY5Y: 50.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067336 Enhanced Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: AB_2685825" "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 10.0 26.5 0.0 44.4 0.0 0.0 0.0 60.1 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.1 0.4 5.2 38.2 0.0 0.8 8.7 0.3 1.7 0.0 0.0 0.4 0.1 0.0 0.5 0.8 7.3 0.2 0.5 0.2 0.3 0.8 0.0 0.0 0.0 0.0 6.0 0.2 0.4 2.4 0.0 0.2 0.2 0.0 0.0 1.1 0.1 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.7 0.2 0.1 0.0 0.0 2.4 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 44.4 0.0 60.1 38.2 0.0 0.0 0.0 7.3 6.0 0.0 32.5 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM172A "C5orf21, DKFZP564D172, Toupee" ENSG00000113391 "Family with sequence similarity 172 member A" Q8WUF8 5 93617725-94111699 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 174.3;Excitatory neurons: 259.9;Inhibitory neurons: 297.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 264.9;Oligodendrocytes: 343.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012299, HPA045505" Approved Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Cytosol "HPA012299: AB_1845724, HPA045505: AB_2679354" "unprognostic (1.12e-2)" "unprognostic (2.17e-1)" "unprognostic (3.10e-2)" "unprognostic (7.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-2)" "unprognostic (1.51e-1)" "unprognostic (1.57e-2)" "unprognostic (2.52e-3)" "unprognostic (1.91e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.38e-1)" "unprognostic (6.56e-2)" "unprognostic (1.72e-2)" "unprognostic (1.03e-2)" 13.6 9.7 10.2 8.1 10.7 7.6 12.9 12.8 11.1 12.7 7.3 8.4 7.5 12.7 10.0 11.6 12.2 9.4 9.3 10.2 11.0 12.3 5.3 9.1 9.2 10.4 9.7 15.0 9.6 12.4 7.1 8.3 10.2 12.4 8.1 14.8 10.9 14.3 3.0 7.7 8.9 11.5 10.6 9.8 8.8 5.6 10.4 9.8 15.5 6.7 9.0 9.4 7.4 11.4 7.5 8.8 20.4 23.1 24.0 29.3 10.7 16.4 12.1 6.7 6.5 6.0 10.1 10.7 11.6 18.7 11.8 6.3 6.3 22.2 15.4 7.4 7.7 14.2 17.0 3.6 10.0 11.5 15.8 25.3 12.2 6.2 11.8 23.7 15.0 10.1 3.0 3.3 27.3 8.3 9.3 8.1 3.1 13.8 7.0 10.3 21.7 10.3 10.1 14.5 17.5 32.1 12.4 5.0 11.6 12.8 12.8 12.9 14.8 15.6 14.1 10.3 18.7 13.4 20.8 11.9 24.0 11.9 29.1 12.4 4.0 5.4 8.2 5.4 8.4 6.7 6.1 6.2 5.3 6.3 6.8 6.9 9.3 9.7 4.1 5.0 6.9 4.8 10.2 10.7 12.8 11.1 10.2 11.0 10.4 9.7 10.2 10.6 10.4 11.4 27.8 54.5 26.4 174.3 40.0 12.2 25.0 26.4 23.3 49.5 31.4 28.2 21.5 22.8 23.4 11.0 31.3 13.0 47.4 14.3 60.7 19.9 47.7 29.2 34.9 25.4 16.9 10.3 259.9 21.2 13.7 32.6 21.9 21.9 25.3 22.7 21.8 14.9 11.3 42.1 297.7 13.9 22.4 21.3 12.1 34.2 38.5 18.0 21.4 227.7 27.9 37.4 58.7 264.9 343.8 20.1 14.7 36.5 17.3 19.7 27.7 35.2 47.5 54.5 13.1 39.5 30.7 22.4 26.1 25.8 10.1 10.9 37.4 30.7 16.4 24.4 FAM221A "C7orf46, DKFZp686F0810, FLJ45875, MGC72075" ENSG00000188732 "Family with sequence similarity 221 member A" A4D161 7 23680130-23703249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 69.2;Respiratory ciliated cells: 51.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 19.3;GAMG: 26.5;MOLT-4: 27.4;SCLC-21H: 23.4;SH-SY5Y: 41.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA019719, HPA026748, HPA026752" Enhanced Approved Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 22: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "HPA019719: AB_1853910, HPA026748: AB_1853911, HPA026752: AB_1853912" "unprognostic (1.28e-1)" "unprognostic (7.28e-3)" "unprognostic (6.03e-3)" "unprognostic (2.54e-1)" "unprognostic (3.33e-2)" "unprognostic (8.04e-2)" "unprognostic (8.51e-3)" "unprognostic (2.18e-3)" "unprognostic (3.10e-2)" "unprognostic (5.69e-2)" "unprognostic (3.75e-1)" "unprognostic (2.42e-2)" "unprognostic (9.30e-3)" "unprognostic (4.26e-2)" "unprognostic (1.11e-2)" "unprognostic (2.40e-1)" "unprognostic (1.81e-2)" 5.5 3.6 14.9 3.2 17.2 1.7 4.3 18.2 24.4 3.5 15.4 6.5 9.9 2.5 3.4 7.2 9.3 3.4 4.1 14.2 15.7 6.4 9.7 4.7 3.8 17.3 16.1 3.8 20.4 2.7 5.3 1.6 18.1 4.8 8.5 4.8 7.5 2.4 2.6 3.9 7.3 1.9 16.7 2.6 11.9 19.7 16.2 7.7 6.0 4.3 4.9 4.9 4.1 23.8 0.0 1.0 11.1 8.9 0.4 0.0 5.4 0.6 0.8 1.4 1.6 11.6 5.5 1.5 19.3 0.3 26.5 2.4 0.0 0.1 2.2 0.0 15.3 3.3 1.1 0.0 3.0 0.0 17.3 0.7 0.7 0.2 0.1 2.4 3.4 11.7 0.0 0.0 0.4 5.5 27.4 0.0 0.0 0.0 5.8 10.8 1.1 0.0 5.8 5.4 23.4 41.3 1.9 0.0 0.0 2.6 5.6 8.0 0.5 0.1 4.2 2.4 1.1 0.1 0.1 0.0 1.1 0.0 2.0 0.0 3.1 4.2 5.1 2.0 10.7 6.6 8.6 6.4 5.4 6.8 9.8 5.5 0.1 7.8 6.0 4.7 12.2 3.3 14.9 17.2 18.2 24.4 14.2 15.7 17.3 16.1 18.1 16.7 16.2 23.8 7.2 16.0 7.2 13.4 7.2 16.2 9.5 10.0 14.8 6.9 17.8 7.7 5.5 20.0 20.0 7.3 2.1 3.5 5.3 8.2 9.8 15.4 8.5 24.7 2.0 6.9 14.9 3.8 13.7 10.6 0.3 12.3 36.7 11.2 5.1 10.2 6.1 16.0 6.7 6.7 16.3 25.7 18.3 4.1 10.8 10.4 4.7 6.1 8.8 12.2 2.1 8.5 2.1 11.6 69.2 11.5 25.2 3.8 7.1 11.7 15.2 12.3 51.6 8.0 19.7 8.5 5.3 45.2 27.6 14.6 18.9 0.8 7.6 4.4 22.5 11.8 FAM222A "C12orf34, FLJ14721" ENSG00000139438 "Family with sequence similarity 222 member A" Q5U5X8 12 109713825-109770495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3;Early spermatids: 29.1;Horizontal cells: 77.4;Oligodendrocytes: 78.5;Rod photoreceptor cells: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 116.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040181, HPA075616" Uncertain Approved "Golgi apparatus,Cell Junctions,Midbody ring" Yes NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus" "Cell Junctions, Midbody ring" "HPA040181: AB_10796448, HPA075616: " "unprognostic (8.59e-3)" "prognostic favorable (1.82e-5)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-2)" "unprognostic (1.03e-1)" "unprognostic (6.66e-2)" "unprognostic (8.17e-2)" "prognostic favorable (4.81e-4)" "unprognostic (1.15e-1)" "unprognostic (4.16e-2)" "prognostic favorable (8.59e-4)" "unprognostic (3.93e-2)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" 0.7 19.0 23.7 0.7 45.2 0.6 1.2 36.7 34.2 0.6 5.6 1.9 4.8 0.3 0.8 2.3 0.4 0.8 8.9 20.0 27.6 10.6 4.0 2.1 0.4 41.2 43.1 13.4 3.9 0.7 22.4 0.1 37.7 1.8 1.0 22.1 3.4 0.5 4.3 3.2 2.2 0.4 29.0 6.2 7.2 23.4 48.4 0.4 0.7 0.6 0.6 0.9 1.8 65.6 2.0 3.1 1.6 3.7 1.0 0.0 1.1 0.6 0.3 1.6 0.2 28.1 0.5 0.3 2.2 0.8 1.7 1.2 1.9 0.1 0.6 16.8 4.0 3.5 0.9 6.5 0.2 2.8 3.6 0.2 0.2 0.3 0.0 0.4 0.1 2.0 1.2 0.6 0.3 11.5 0.7 3.6 3.0 3.3 5.3 2.3 8.0 1.2 3.5 1.5 19.2 116.4 2.5 3.7 8.2 0.5 4.5 3.0 0.2 0.5 3.2 1.3 2.4 2.9 4.0 2.4 0.3 2.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 45.2 36.7 34.2 20.0 27.6 41.2 43.1 37.7 29.0 48.4 65.6 2.1 0.0 0.0 2.3 3.6 2.2 0.9 0.1 3.4 23.4 7.4 6.1 8.1 1.5 0.8 1.8 33.3 0.3 10.4 1.2 7.9 1.7 29.1 1.2 0.5 1.3 7.7 0.0 1.3 0.8 0.2 1.5 1.5 1.8 0.0 0.7 0.7 1.3 0.3 77.4 6.7 5.8 0.0 0.0 2.1 13.4 1.2 1.9 7.2 0.0 0.1 11.2 0.0 9.5 78.5 1.1 0.2 0.4 1.3 1.7 0.9 0.7 0.6 50.3 0.0 2.6 1.5 1.1 5.7 3.3 1.8 0.8 3.7 6.0 1.6 0.4 FBLL1 LOC345630 ENSG00000188573 "Fibrillarin like 1" A6NHQ2 5 168529305-168530634 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 35.4;pituitary gland: 15.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.5;Cone photoreceptor cells: 6.2;Enteroendocrine cells: 6.7;Horizontal cells: 6.7;Inhibitory neurons: 6.6;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 24.2;SH-SY5Y: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049546, HPA077724" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "Nucleoli fibrillar center" Nucleoplasm "HPA049546: AB_2680811, HPA077724: " "unprognostic (2.75e-3)" "unprognostic (2.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (1.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (2.45e-1)" "unprognostic (3.80e-3)" "unprognostic (9.69e-2)" "unprognostic (6.55e-3)" "unprognostic (3.15e-1)" "unprognostic (6.18e-2)" "unprognostic (8.32e-2)" "unprognostic (1.22e-1)" 0.2 3.0 22.0 0.1 21.0 0.0 0.6 12.8 35.4 0.5 4.6 0.9 0.4 0.2 0.0 0.2 0.4 0.2 0.3 20.4 32.2 0.6 0.7 0.1 0.0 22.7 21.0 0.7 0.9 0.4 15.5 0.2 26.1 1.0 0.1 1.4 0.9 0.3 0.1 0.5 0.5 0.2 11.4 0.2 0.5 5.9 23.1 0.0 0.2 0.0 0.0 0.3 0.3 20.1 0.0 0.5 1.8 0.3 0.1 0.0 0.9 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.1 0.1 0.5 0.0 1.3 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 20.2 2.1 0.0 1.2 0.0 0.0 1.5 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 21.0 12.8 35.4 20.4 32.2 22.7 21.0 26.1 11.4 23.1 20.1 0.0 0.0 0.0 2.0 0.0 0.1 0.1 0.0 0.6 8.5 1.4 1.8 1.2 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.4 1.7 0.9 1.4 0.2 6.7 0.0 4.3 0.2 0.1 0.8 0.0 2.4 0.0 1.6 0.0 0.0 0.1 6.7 6.6 0.4 0.0 0.0 0.0 2.3 0.0 0.1 3.6 1.0 0.0 0.7 0.0 3.0 1.1 0.2 0.0 0.0 0.0 0.3 1.0 0.4 0.0 2.8 6.6 0.2 0.4 3.1 0.4 0.2 0.1 0.0 0.1 1.2 0.3 0.0 FBXL16 "C16orf22, Fbl16, MGC33974" ENSG00000127585 "F-box and leucine rich repeat protein 16" Q8N461 16 692498-705808 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 287.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 44.4;Excitatory neurons: 29.2;Horizontal cells: 32.0;Inhibitory neurons: 20.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 155.1;basal ganglia: 287.6;cerebral cortex: 194.9;hippocampal formation: 156.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 18.4;GAMG: 12.3;MCF7: 15.5;SCLC-21H: 30.2;SH-SY5Y: 22.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 240.8;basal ganglia: 720.4;cerebral cortex: 384.6;hippocampal formation: 362.0" "HPA039504, HPA056354" Enhanced NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA039504: AB_10794197, HPA056354: AB_2683105" "unprognostic (5.51e-2)" "unprognostic (3.39e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.58e-2)" "unprognostic (4.79e-3)" "unprognostic (1.83e-1)" "unprognostic (1.19e-2)" "unprognostic (2.19e-1)" "unprognostic (1.75e-1)" "prognostic favorable (7.34e-5)" "unprognostic (1.62e-3)" "prognostic favorable (1.87e-4)" "unprognostic (1.90e-2)" "unprognostic (4.71e-2)" "unprognostic (2.33e-1)" "unprognostic (4.36e-2)" 0.3 4.6 155.1 0.6 287.6 0.1 0.9 0.0 194.9 0.5 0.0 1.5 0.8 0.1 0.0 2.0 0.5 0.0 0.4 156.5 0.0 1.1 0.3 0.4 0.3 0.0 0.0 0.2 2.4 1.2 32.5 0.0 0.0 0.9 0.0 3.3 4.9 0.9 0.3 4.1 1.3 0.0 0.0 0.6 1.4 11.6 8.8 0.3 2.3 0.0 0.2 0.1 1.0 37.6 0.6 0.9 0.3 18.4 0.0 0.2 0.6 0.6 0.1 3.4 0.2 1.8 0.2 0.3 5.0 0.0 12.3 3.4 1.4 2.0 0.2 9.4 0.4 0.0 4.7 0.8 0.0 1.9 0.4 0.0 2.8 0.0 1.6 1.6 0.0 0.7 1.0 4.5 0.0 15.5 0.4 0.0 0.8 0.2 5.8 0.0 0.0 10.8 0.2 0.0 30.2 22.7 3.1 0.5 0.3 0.0 1.7 0.0 0.0 0.1 6.2 0.0 2.4 0.8 5.6 2.4 2.5 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 155.1 287.6 0.0 194.9 156.5 0.0 0.0 0.0 0.0 0.0 8.8 37.6 0.1 0.0 3.7 6.5 0.8 1.0 0.7 1.1 2.2 44.4 3.8 3.7 1.2 0.0 3.9 11.0 2.1 0.6 1.6 0.3 1.9 0.2 1.2 1.6 0.4 0.2 9.6 0.0 29.2 0.0 0.2 0.8 0.0 3.9 0.0 0.0 0.4 0.0 0.1 32.0 20.2 1.0 2.0 0.0 0.3 0.6 0.6 0.1 0.0 6.5 0.1 3.1 0.0 9.0 2.5 0.3 0.1 0.0 0.4 0.7 1.0 0.2 0.1 5.7 0.0 0.1 0.3 5.0 4.6 2.7 1.6 2.5 3.5 0.0 0.4 0.2 FBXO11 "FBX11, UBR6" ENSG00000138081 "F-box protein 11" Q86XK2 2 47789316-47906498 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002690 Supported Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" "HPA002690: AB_1848448" "unprognostic (1.18e-1)" "unprognostic (8.65e-3)" "unprognostic (3.93e-2)" "unprognostic (2.05e-2)" "unprognostic (7.92e-2)" "unprognostic (1.42e-1)" "unprognostic (3.85e-2)" "unprognostic (1.02e-1)" "unprognostic (2.55e-2)" "unprognostic (9.82e-2)" "unprognostic (5.77e-2)" "unprognostic (2.33e-2)" "unprognostic (3.21e-2)" "unprognostic (1.55e-1)" "unprognostic (3.71e-1)" "unprognostic (2.19e-1)" "unprognostic (3.20e-2)" 27.9 19.6 24.5 19.1 25.9 32.2 20.9 32.7 28.7 21.1 21.0 19.7 16.8 33.1 24.8 18.7 22.2 20.9 22.8 26.5 25.6 21.7 26.8 22.5 25.7 22.8 23.1 34.4 19.6 30.2 17.5 23.0 24.0 22.7 20.1 33.3 16.5 20.4 28.3 19.1 17.3 29.7 22.9 24.2 19.1 41.0 25.9 22.5 26.1 28.7 27.7 22.1 16.9 25.2 52.8 26.9 62.9 53.9 42.6 40.2 37.2 36.0 48.6 32.6 31.9 22.9 25.9 32.8 45.4 50.2 40.5 25.6 42.5 37.1 47.9 22.3 21.5 31.6 21.3 36.6 41.0 33.5 32.1 39.3 41.7 28.8 48.2 51.9 42.1 16.6 31.3 33.9 40.4 25.5 31.7 32.8 38.2 34.7 26.2 40.9 58.3 25.5 47.1 42.5 44.1 52.3 34.2 31.5 54.6 46.4 14.7 27.9 46.4 40.2 37.2 27.5 40.0 28.9 16.5 60.9 27.4 30.8 42.1 4.3 1.1 2.1 1.5 1.2 1.6 2.1 1.4 1.7 1.4 1.5 2.6 1.7 2.6 2.2 1.1 2.0 1.6 1.1 24.5 25.9 32.7 28.7 26.5 25.6 22.8 23.1 24.0 22.9 25.9 25.2 40.6 16.0 39.0 100.9 34.1 67.0 44.4 22.0 24.5 45.1 22.3 15.1 11.0 15.7 24.9 18.4 33.3 19.6 37.8 24.7 11.7 17.2 34.4 38.6 40.3 39.4 23.9 17.1 151.4 15.2 16.0 37.0 23.4 48.6 29.1 37.3 33.2 20.0 25.5 55.5 134.8 17.1 24.4 40.1 81.4 40.4 30.1 51.8 35.6 137.7 30.9 30.2 25.7 138.7 143.8 25.8 17.1 39.9 36.3 44.3 17.3 14.6 37.4 42.5 19.7 42.3 34.6 86.6 50.7 24.2 59.0 36.0 35.6 33.4 19.5 65.1 FBXO8 "FBS, FBX8" ENSG00000164117 "F-box protein 8" Q9NRD0 4 174236658-174283667 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002885 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" Nucleoplasm Cytosol "HPA002885: AB_1078835" "unprognostic (8.17e-2)" "unprognostic (6.59e-2)" "unprognostic (2.46e-1)" "unprognostic (3.18e-1)" "unprognostic (4.69e-2)" "unprognostic (2.04e-2)" "unprognostic (7.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-2)" "unprognostic (3.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.25e-1)" "prognostic favorable (1.29e-7)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" 15.7 18.6 13.8 10.5 15.3 10.2 17.8 15.7 17.5 14.3 13.8 18.4 16.3 12.5 19.9 17.0 15.5 15.5 21.2 13.5 16.6 22.9 47.5 14.0 12.9 15.8 14.7 17.0 14.2 21.2 14.2 30.9 16.1 14.7 16.1 17.8 15.2 12.6 6.7 16.1 16.4 16.3 15.1 13.0 15.0 11.2 14.8 15.8 22.2 10.1 12.6 16.0 13.7 17.8 10.0 6.3 12.3 4.3 31.5 33.2 9.8 18.8 19.2 13.3 13.6 5.2 19.9 6.9 19.5 15.7 12.2 6.7 9.2 11.7 13.8 22.5 20.9 7.2 10.4 7.4 23.5 8.5 7.5 19.1 24.5 12.9 13.4 20.5 13.4 8.0 14.9 40.5 18.3 7.9 9.8 8.6 4.4 15.4 7.6 4.9 8.2 12.5 17.8 4.1 13.9 80.8 8.7 16.1 22.4 11.8 11.0 11.0 17.0 9.1 7.3 23.5 11.3 18.5 9.7 6.2 25.2 6.4 13.0 29.4 6.5 14.0 12.1 8.4 15.2 13.2 13.7 12.1 9.0 11.9 12.7 11.6 6.6 10.5 10.0 9.1 16.6 8.4 13.8 15.3 15.7 17.5 13.5 16.6 15.8 14.7 16.1 15.1 14.8 17.8 18.9 3.2 10.0 6.5 15.8 20.6 17.0 26.0 19.4 13.2 16.9 11.4 10.8 15.7 19.5 22.0 6.2 36.6 10.1 20.3 50.9 19.0 20.5 24.9 13.2 15.8 12.1 11.2 10.1 10.9 60.6 32.7 14.8 16.3 2.5 5.3 21.0 58.1 21.2 18.5 13.0 21.5 28.5 19.6 8.2 5.5 17.4 12.2 10.6 11.2 16.3 29.1 9.2 9.0 17.8 12.4 21.4 26.4 9.1 16.8 21.5 44.6 26.2 18.1 13.1 14.9 18.4 34.7 17.6 19.8 31.4 89.6 14.3 10.3 13.7 22.7 FBXW8 "FBW6, FBW8, FBX29, FBXO29" ENSG00000174989 "F-box and WD repeat domain containing 8" Q8N3Y1 12 116910950-117031148 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 53.5;Excitatory neurons: 40.6;Inhibitory neurons: 38.9;Late spermatids: 84.1;Oligodendrocyte precursor cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038850, HPA038851" Supported Supported Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" Cytosol "HPA038850: AB_2676238, HPA038851: AB_10673479" "unprognostic (2.63e-2)" "unprognostic (1.13e-1)" "unprognostic (9.03e-2)" "unprognostic (1.48e-2)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (3.35e-2)" "unprognostic (2.17e-1)" "unprognostic (2.39e-2)" "unprognostic (4.30e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-1)" "unprognostic (6.20e-2)" "unprognostic (6.34e-2)" "unprognostic (2.55e-1)" 5.3 4.9 2.5 4.7 9.5 3.5 5.9 1.5 3.0 5.8 10.1 4.9 3.6 6.5 3.9 5.3 6.3 4.1 4.7 4.1 3.0 4.0 4.0 4.5 5.6 2.9 2.3 8.6 7.1 8.5 8.2 7.6 1.9 4.8 4.9 4.4 6.6 5.2 5.3 5.8 4.3 5.8 1.3 4.1 5.9 4.9 3.7 5.5 9.4 3.4 6.6 5.2 5.0 2.6 8.6 15.5 13.4 10.8 12.1 16.9 8.8 16.0 16.6 11.8 11.4 4.9 5.9 13.0 5.9 21.1 6.3 9.1 10.1 6.3 9.5 20.6 7.3 6.3 7.1 5.0 20.7 8.1 4.7 17.6 5.4 11.0 24.7 16.7 13.2 11.7 8.2 6.0 10.7 22.3 6.4 5.5 15.7 3.9 9.4 10.0 6.1 11.2 9.5 14.6 12.0 33.4 11.5 4.1 7.9 11.3 15.2 7.1 16.7 10.4 4.3 10.8 5.0 19.0 12.6 12.2 14.2 4.9 17.2 0.2 0.8 2.0 1.4 0.8 1.3 2.4 0.8 0.9 1.1 1.9 0.5 0.8 0.0 3.9 1.0 1.1 1.2 0.7 2.5 9.5 1.5 3.0 4.1 3.0 2.9 2.3 1.9 1.3 3.7 2.6 3.2 0.0 6.4 21.9 5.4 1.9 3.0 1.4 5.2 9.1 3.5 4.2 3.1 4.3 5.6 1.8 25.0 9.4 5.5 1.4 1.9 4.2 53.5 4.1 6.6 3.6 9.1 3.8 40.6 4.5 6.5 5.4 8.6 3.6 2.5 11.1 0.7 3.0 4.3 1.7 38.9 4.2 0.0 3.5 0.8 84.1 9.3 2.6 0.0 33.7 2.3 3.1 5.2 38.2 28.3 2.4 3.3 5.3 7.7 5.4 1.0 2.2 4.7 15.2 0.0 7.2 4.2 4.6 6.7 3.5 1.4 6.7 4.5 11.6 3.7 3.2 FERMT2 "KIND2, mig-2, PLEKHC1, UNC112B" ENSG00000073712 "Fermitin family member 2" Q96AC1 14 52857268-52952435 "Predicted intracellular proteins" "Cell adhesion, Cell shape, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040505, HPA072965" Uncertain Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 230000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Focal adhesion sites" "Nucleoplasm, Cytosol" "HPA040505: AB_10673300, HPA072965: " "unprognostic (4.38e-2)" "unprognostic (4.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "unprognostic (4.89e-3)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.58e-1)" "unprognostic (1.99e-1)" "unprognostic (3.87e-2)" "unprognostic (3.96e-3)" "unprognostic (7.69e-2)" "unprognostic (3.14e-1)" "unprognostic (1.73e-3)" 148.4 21.2 28.7 38.8 31.6 0.5 57.6 29.0 37.3 44.7 18.0 104.3 13.1 105.1 26.3 46.8 55.7 65.7 66.9 31.0 27.4 55.4 108.3 47.9 15.3 35.7 29.1 43.6 20.6 18.4 13.1 116.5 33.5 69.1 33.3 29.5 22.6 117.9 48.8 13.4 29.3 155.6 30.6 37.6 46.4 15.5 27.6 6.9 35.9 69.6 6.6 77.7 29.1 38.1 22.8 18.9 101.6 46.8 163.7 133.7 84.6 148.4 95.2 172.3 107.9 34.1 17.6 0.1 49.4 153.1 33.8 9.6 80.1 11.1 128.3 0.2 22.6 31.9 83.1 40.3 209.6 0.4 12.6 129.4 23.5 95.3 125.4 78.5 91.2 16.8 0.6 153.4 131.7 28.0 7.7 0.5 64.3 0.2 51.3 3.9 103.8 0.4 60.9 20.6 6.2 130.5 157.8 35.0 37.7 103.3 30.1 1.1 115.2 134.5 92.4 108.2 56.0 22.6 29.4 0.6 30.9 0.2 33.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 31.6 29.0 37.3 31.0 27.4 35.7 29.1 33.5 30.6 27.6 38.1 152.7 76.9 42.0 116.5 1.0 18.6 150.6 15.5 13.6 39.5 33.8 41.4 65.8 24.3 25.6 40.5 37.5 74.8 2.3 0.2 31.3 48.5 68.2 20.1 141.7 110.4 0.0 2.7 13.7 33.2 178.1 103.9 3.6 40.2 58.3 31.6 110.3 82.3 10.4 15.2 16.1 0.5 4.1 8.9 19.5 27.9 74.9 4.4 46.2 29.0 4.8 52.3 1.0 41.2 92.0 27.6 0.1 174.9 4.5 40.0 0.0 44.7 10.1 56.0 151.2 83.4 174.1 4.1 16.2 2.2 8.1 102.6 7.9 12.3 0.4 37.0 FEV Pet-1 ENSG00000163497 "FEV transcription factor, ETS family member" Q99581 2 218981087-218985184 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "brain: 70.8" "Cell type enriched" "Detected in some" 32 "Enteroendocrine cells: 744.9" "Group enriched" "Detected in some" 10 "pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4" "Group enriched" "Detected in many" 7 "midbrain: 70.8;pons: 20.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HMC-1: 35.5;SH-SY5Y: 43.8" "Region enhanced" "Detected in single" "midbrain: 1.9" "Group enriched" "Detected in some" 5 "midbrain: 4.8;pons: 2.7" HPA067679 Supported Supported "Nuclear speckles" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nuclear speckles" "HPA067679: AB_2685884" "unprognostic (4.58e-1)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "prognostic favorable (4.85e-4)" "unprognostic (2.87e-1)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.15e-1)" 0.1 2.3 0.0 0.0 1.7 0.0 0.0 0.0 0.6 0.0 0.0 1.2 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 6.2 70.8 0.0 1.3 0.0 2.6 0.0 20.1 2.2 1.8 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.1 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.6 0.1 6.2 70.8 20.1 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 744.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.2 6.0 0.0 0.0 3.4 1.2 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.1 FGF14 "FHF4, SCA27" ENSG00000102466 "Fibroblast growth factor 14" Q92915 13 101710804-102402457 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Growth factor" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.4;cervix: 7.3" "Group enriched" "Detected in many" 31 "Excitatory neurons: 1994.2;Inhibitory neurons: 2754.3;Oligodendrocyte precursor cells: 2271.0" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.0;SH-SY5Y: 5.8;U-87 MG: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049828 Approved "Nucleoli fibrillar center" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoli fibrillar center" "HPA049828: AB_2680901" "unprognostic (2.12e-1)" "unprognostic (1.57e-1)" "unprognostic (2.83e-2)" "unprognostic (2.27e-2)" "unprognostic (8.55e-2)" "unprognostic (1.28e-1)" "unprognostic (3.33e-1)" "unprognostic (1.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.22e-2)" "unprognostic (1.22e-1)" "unprognostic (2.45e-1)" "unprognostic (7.80e-3)" "unprognostic (2.20e-3)" "unprognostic (1.65e-1)" "unprognostic (3.86e-2)" "unprognostic (8.48e-2)" 0.5 1.2 3.2 0.0 2.6 0.0 0.3 11.4 5.1 7.3 0.0 0.2 0.1 0.1 0.4 0.5 2.7 0.4 1.5 2.5 7.7 0.1 0.4 1.4 0.0 2.2 1.1 0.1 0.3 0.0 3.3 0.1 2.2 0.1 0.1 1.6 0.3 0.1 0.1 0.4 0.4 0.0 1.6 0.0 0.7 1.0 4.5 0.0 0.2 0.1 0.0 0.2 0.5 2.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.6 11.4 5.1 2.5 7.7 2.2 1.1 2.2 1.6 4.5 2.1 0.5 3.2 1.5 74.4 0.0 0.5 0.5 0.2 2.2 33.2 0.3 1.8 7.4 2.8 8.2 0.0 0.0 0.0 0.3 0.1 0.0 0.3 18.3 4.4 0.4 0.3 19.2 0.0 1994.2 0.0 0.1 9.6 2.0 1.4 0.0 0.1 0.4 2.5 0.1 32.0 2754.3 1.0 6.1 0.0 0.0 35.2 2.5 0.1 1.8 36.5 0.0 5.2 3.1 2271.0 32.3 0.1 0.0 0.0 0.0 0.8 0.0 0.3 53.8 2.7 0.0 1.9 1.9 2.5 5.2 0.3 0.6 0.0 0.2 0.1 0.0 0.1 FLRT1 "MGC21624, SPG68" ENSG00000126500 "Fibronectin leucine rich transmembrane protein 1" 11 64103188-64119173 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 8.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.1;Excitatory neurons: 8.8;Inhibitory neurons: 16.1;Muller glia cells: 6.2;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 13.2" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.0;SCLC-21H: 5.4;SH-SY5Y: 13.5;THP-1: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054589 Uncertain NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA054589: AB_2682533" "unprognostic (5.13e-3)" "unprognostic (1.55e-1)" "unprognostic (1.63e-1)" "unprognostic (8.65e-2)" "unprognostic (2.89e-1)" "unprognostic (9.55e-2)" "unprognostic (2.61e-3)" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (2.98e-1)" "unprognostic (4.64e-3)" "unprognostic (6.02e-2)" "unprognostic (1.79e-1)" "unprognostic (2.62e-2)" "unprognostic (5.62e-2)" "unprognostic (1.29e-3)" "unprognostic (4.37e-2)" 0.3 4.4 7.0 0.3 8.4 0.0 0.4 1.6 6.8 2.9 0.0 3.9 0.5 1.5 0.0 0.8 0.6 0.5 1.2 7.1 3.0 2.5 0.9 0.2 0.0 1.5 4.3 0.5 1.0 0.0 1.2 0.1 0.6 1.2 0.3 1.6 0.7 0.9 0.2 1.0 0.9 0.5 1.6 0.3 1.1 0.3 8.5 0.0 2.2 0.1 0.0 0.7 1.1 7.4 0.4 0.7 2.7 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.4 0.0 1.1 0.6 3.7 0.0 0.0 0.7 0.2 0.0 0.9 0.1 0.0 2.1 0.3 4.0 0.0 0.5 0.1 0.6 1.2 0.1 0.2 0.8 0.2 0.1 0.0 0.3 5.4 13.5 0.3 0.3 0.4 0.0 0.4 11.3 0.1 0.3 1.2 0.0 0.1 0.0 0.0 0.0 0.2 3.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 8.4 1.6 6.8 7.1 3.0 1.5 4.3 0.6 1.6 8.5 7.4 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 8.8 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 6.2 0.0 32.2 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FPGT-TNNI3K ENSG00000259030 "FPGT-TNNI3K readthrough" 1 74198235-74544393 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 8.7" "Cell type enhanced" "Detected in many" "Astrocytes: 13.1;Cardiomyocytes: 10.2;Cone photoreceptor cells: 10.4;Excitatory neurons: 10.3;Inhibitory neurons: 11.2;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 26.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.3;CAPAN-2: 2.2;SiHa: 3.1" HPA072331 Approved Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "HPA072331: " "unprognostic (6.29e-2)" "unprognostic (4.96e-2)" "unprognostic (1.99e-1)" "unprognostic (1.46e-1)" "unprognostic (1.24e-1)" "unprognostic (3.44e-3)" "unprognostic (8.37e-2)" "unprognostic (1.70e-2)" "unprognostic (6.63e-2)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (8.37e-2)" "unprognostic (6.76e-3)" "unprognostic (3.20e-2)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (7.87e-3)" 2.4 1.2 0.8 0.5 1.3 0.4 1.4 2.9 1.9 1.1 0.0 1.8 0.3 1.4 0.8 1.4 1.3 0.8 8.7 1.0 1.2 1.6 0.4 1.4 0.6 1.0 1.0 1.3 0.5 1.0 1.4 0.5 1.4 1.2 0.7 3.4 0.9 1.3 3.5 2.1 0.8 1.5 1.1 1.5 1.0 0.8 0.9 0.2 1.1 1.8 0.6 1.3 1.1 2.4 0.0 0.5 0.3 0.7 0.4 2.3 0.0 1.0 0.5 0.1 0.1 0.5 2.2 0.0 1.5 0.1 0.0 0.0 0.1 1.5 0.2 0.0 0.0 0.8 0.0 0.0 0.3 0.2 0.1 0.9 0.9 0.0 0.1 0.3 0.1 0.1 0.0 0.8 0.5 0.0 0.0 0.1 0.0 0.8 0.4 1.1 1.8 0.0 0.2 0.0 0.5 1.5 3.1 0.1 0.1 0.0 0.0 1.0 0.1 0.3 0.1 0.1 0.4 0.1 0.0 0.9 0.4 0.5 0.4 1.3 1.6 1.4 0.4 1.9 1.2 0.9 1.4 0.8 0.9 0.9 1.8 0.9 1.8 0.4 0.5 0.8 1.6 1.6 0.8 1.3 2.9 1.9 1.0 1.2 1.0 1.0 1.4 1.1 0.9 2.4 0.5 3.2 1.1 13.1 0.9 0.1 0.5 0.2 0.0 4.9 0.6 0.9 10.2 1.5 0.7 0.0 10.4 0.2 0.2 0.5 0.0 0.2 1.4 0.6 0.3 0.9 3.0 0.0 10.3 1.0 0.2 1.3 0.0 0.2 2.5 1.6 1.8 0.5 0.2 5.0 11.2 0.2 0.0 0.9 0.3 0.6 2.8 0.7 1.8 7.5 0.1 1.1 0.0 17.1 26.7 1.3 1.6 0.7 0.3 0.3 0.0 1.4 1.6 2.7 0.0 1.5 1.1 2.1 1.7 0.1 0.1 0.0 0.4 0.8 0.5 0.2 FRMPD1 "FRMD2, KIAA0967" ENSG00000070601 "FERM and PDZ domain containing 1" Q5SYB0 9 37650954-37746904 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 68.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 47.8;Cone photoreceptor cells: 152.2;Inhibitory neurons: 24.3;Rod photoreceptor cells: 79.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 4 "granulocytes: 3.2;NK-cells: 1.3" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042934 Uncertain NA NA "Cluster 11: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA042934: AB_10960422" "unprognostic (6.41e-2)" "unprognostic (6.74e-3)" "unprognostic (1.25e-1)" "unprognostic (1.48e-3)" "unprognostic (4.04e-1)" "unprognostic (7.26e-2)" "unprognostic (1.45e-1)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (2.53e-3)" "unprognostic (2.63e-3)" "unprognostic (3.94e-2)" "unprognostic (1.12e-3)" "unprognostic (7.80e-2)" "unprognostic (4.41e-2)" "unprognostic (2.13e-2)" "unprognostic (5.91e-2)" 0.4 0.5 3.1 0.8 3.8 2.9 0.9 2.9 4.1 0.3 0.4 0.5 0.7 1.0 0.6 1.6 0.8 1.6 0.7 2.6 2.9 0.5 0.5 0.7 1.3 3.1 4.8 0.3 0.9 0.7 0.8 0.4 2.6 0.5 0.5 68.9 4.1 0.5 4.2 6.4 1.1 0.4 2.2 0.4 0.6 9.4 5.5 0.2 1.0 1.2 1.1 0.5 0.1 4.5 0.2 0.3 1.2 0.1 0.0 0.0 1.5 0.5 0.0 0.1 0.1 0.6 0.5 0.3 0.2 0.3 0.5 0.9 0.9 0.5 0.3 0.4 0.3 0.1 0.5 0.3 0.0 0.0 0.2 0.6 0.0 0.5 0.2 0.6 0.0 0.9 0.5 0.2 0.2 0.3 0.1 0.2 0.7 0.1 0.6 0.6 1.0 0.1 0.0 0.9 2.5 1.7 0.0 1.6 0.8 0.4 0.8 0.3 0.0 0.3 0.5 0.5 0.4 0.4 0.7 0.6 0.4 0.3 0.4 3.2 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.2 0.1 0.5 0.3 0.3 1.0 1.3 0.4 0.3 0.2 0.1 3.1 3.8 2.9 4.1 2.6 2.9 3.1 4.8 2.6 2.2 5.5 4.5 0.2 3.2 10.5 11.1 0.3 0.1 0.3 0.0 0.0 47.8 0.5 0.3 1.1 4.3 1.8 0.0 152.2 0.2 0.0 0.4 0.0 0.1 4.8 0.2 0.1 1.4 0.0 0.0 3.7 0.2 0.5 0.8 0.0 0.4 5.1 0.2 0.7 0.8 0.1 1.7 24.3 0.3 0.0 1.3 2.1 1.3 0.9 0.8 0.0 1.0 0.3 9.0 0.0 13.6 6.7 0.1 0.1 0.4 0.1 0.2 0.0 0.0 1.5 79.8 0.0 0.8 0.2 0.4 1.7 0.0 0.4 0.7 1.0 0.1 0.1 0.3 FRRS1L "C9orf4, CG-6" ENSG00000260230 "Ferric chelate reductase 1 like" Q9P0K9 9 109130293-109167249 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.6;ovary: 11.0" "Group enriched" "Detected in many" 4 "Bipolar cells: 59.1;Excitatory neurons: 91.6;Horizontal cells: 97.6;Inhibitory neurons: 81.3;Oligodendrocyte precursor cells: 27.6" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;SH-SY5Y: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071086 Enhanced NA NA "Cluster 17: Basophils - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA071086: AB_2686342" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (2.21e-1)" "unprognostic (9.01e-2)" "unprognostic (3.10e-1)" "unprognostic (8.12e-2)" "unprognostic (1.84e-1)" "unprognostic (9.94e-2)" "unprognostic (1.51e-1)" "unprognostic (9.21e-4)" "unprognostic (7.35e-3)" "unprognostic (7.02e-2)" "unprognostic (5.78e-3)" "unprognostic (5.89e-2)" "unprognostic (2.85e-1)" "unprognostic (5.38e-3)" 0.1 7.8 15.1 0.3 16.6 0.3 0.3 9.2 17.3 1.3 0.0 0.7 0.4 1.5 2.8 1.9 1.4 1.0 1.0 18.6 15.4 0.1 0.1 0.2 0.2 2.5 6.3 11.0 0.6 3.0 7.2 0.0 6.2 3.1 0.3 7.8 0.2 1.7 0.1 0.2 0.5 1.5 6.9 0.2 0.8 0.7 15.4 0.0 0.2 0.1 0.1 0.1 0.2 7.1 0.0 0.2 1.6 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.0 15.1 16.6 9.2 17.3 18.6 15.4 2.5 6.3 6.2 6.9 15.4 7.1 0.1 3.2 0.6 1.3 0.1 0.4 1.5 0.0 0.6 59.1 0.7 0.4 5.0 0.0 0.6 0.0 2.1 0.4 1.5 1.6 0.0 0.0 7.9 3.2 1.6 0.8 1.2 0.0 91.6 0.0 0.2 4.3 0.0 1.8 1.3 16.3 0.4 0.1 0.1 97.6 81.3 0.8 0.0 0.6 1.2 4.6 13.1 0.5 1.8 4.7 0.2 16.6 0.0 27.6 5.9 0.1 0.4 17.0 0.0 1.1 4.1 0.1 0.0 7.0 0.0 1.6 1.5 0.3 1.2 0.0 0.6 0.3 0.3 10.8 1.3 0.8 FSD1 "MGC3213, MIR1" ENSG00000105255 "Fibronectin type III and SPRY domain containing 1" Q9BTV5 19 4304598-4323843 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 16.0;testis: 7.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 12.6;Distal tubular cells: 15.6;Excitatory neurons: 26.6;Horizontal cells: 16.8;Inhibitory neurons: 19.7;NK-cells: 16.5;Spermatogonia: 30.4" "Group enriched" "Detected in many" 6 "glioma: 9.2;testis cancer: 11.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "MAIT T-cell: 3.6;NK-cell: 5.4;plasmacytoid DC: 1.4" "Group enriched" "Detected in many" 35 "dendritic cells: 1.4;NK-cells: 5.4;T-cells: 3.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 55.3;SH-SY5Y: 57.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043141 Supported NA NA "Cluster 15: NK-cells - Transcription" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA043141: AB_10797137" "unprognostic (8.31e-3)" "unprognostic (2.38e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.29e-2)" "unprognostic (9.72e-4)" "unprognostic (1.33e-1)" "unprognostic (9.87e-2)" "unprognostic (1.00e-1)" "unprognostic (3.15e-1)" "unprognostic (8.16e-3)" "unprognostic (1.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.82e-1)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-1)" 0.3 0.7 11.9 0.7 12.7 0.7 0.0 9.3 15.6 0.6 2.5 0.6 1.0 0.5 0.1 0.2 0.1 0.3 0.1 13.9 12.1 0.3 0.4 0.2 1.1 14.7 10.4 0.2 0.1 0.0 2.0 0.8 16.0 0.3 0.1 1.8 0.1 0.1 0.0 0.2 0.9 0.4 7.7 0.9 0.3 7.6 15.5 0.9 0.1 0.0 0.4 0.1 0.3 11.7 0.1 6.7 18.6 9.7 0.1 1.8 7.9 7.9 3.2 25.0 19.3 15.6 0.5 24.3 6.7 5.5 13.1 1.6 17.0 12.8 8.0 15.6 24.9 6.8 5.6 0.5 9.9 0.0 1.6 4.2 0.1 14.6 0.9 10.1 13.5 21.5 1.1 0.0 1.2 18.4 11.2 0.0 23.9 0.1 12.7 0.0 8.8 0.0 0.1 0.6 55.3 57.6 2.1 0.9 1.7 3.0 0.2 0.2 15.3 3.9 17.6 7.3 7.3 13.7 18.4 6.1 9.4 0.0 9.7 0.0 0.0 0.0 0.5 0.0 3.6 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 5.4 0.0 1.4 0.4 0.7 11.9 12.7 9.3 15.6 13.9 12.1 14.7 10.4 16.0 7.7 15.5 11.7 0.2 0.0 1.1 2.0 0.4 0.1 0.7 0.0 0.0 12.6 0.1 0.0 0.5 0.0 0.6 3.7 2.1 3.2 6.1 0.3 15.6 0.1 4.0 0.1 1.1 0.5 2.4 2.7 26.6 0.0 1.3 1.4 0.5 0.2 2.5 3.5 0.7 0.4 0.8 16.8 19.7 0.4 0.0 0.0 0.0 5.3 0.9 0.3 0.0 3.7 0.1 1.7 16.5 8.5 9.5 0.0 0.1 0.4 0.5 0.3 0.0 0.3 0.0 7.1 0.0 0.9 1.6 3.7 30.4 0.0 0.0 2.7 5.6 0.1 0.3 0.4 GAB2 KIAA0571 ENSG00000033327 "GRB2 associated binding protein 2" Q9UQC2 11 78215293-78418348 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 97.9" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 147.9;Microglial cells: 204.2;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 480.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 13.0;neutrophil: 20.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 20.1" "Cell line enhanced" "Detected in many" "SH-SY5Y: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000271, HPA001368, CAB022159" Enhanced Supported "Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" "CAB022159: , HPA000271: AB_1078925, HPA001368: AB_2666287" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (3.56e-3)" "unprognostic (1.99e-3)" "unprognostic (1.04e-2)" "unprognostic (4.69e-2)" "unprognostic (4.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.54e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (1.74e-1)" "prognostic favorable (9.32e-5)" "unprognostic (6.95e-2)" "unprognostic (4.35e-1)" "unprognostic (3.99e-2)" "unprognostic (1.67e-2)" 18.5 8.2 69.5 12.9 80.7 39.9 11.6 56.2 65.3 14.8 31.2 9.4 14.4 19.8 3.1 8.9 13.6 9.3 14.5 54.5 68.4 6.7 4.4 20.0 7.0 79.4 70.9 20.0 6.8 6.8 8.8 15.5 74.0 7.0 11.0 3.5 7.1 7.1 6.4 13.3 10.7 17.3 68.0 13.1 8.2 5.7 72.0 21.3 6.6 6.8 5.8 10.6 10.9 97.9 3.7 3.1 8.8 1.0 12.7 5.4 39.1 5.7 6.8 4.0 3.3 23.8 1.9 1.1 24.8 7.9 1.0 5.9 21.2 0.5 5.2 36.3 2.2 14.6 5.9 4.2 6.3 5.6 2.8 6.1 1.9 15.6 2.4 11.8 23.4 4.2 38.8 1.2 6.7 1.5 2.8 13.8 2.8 8.4 4.4 27.4 8.5 0.5 7.3 13.4 7.6 62.1 1.4 2.9 14.4 12.7 13.2 15.5 19.4 1.8 4.5 15.2 1.4 9.8 1.5 0.6 1.5 8.6 16.8 13.0 3.1 0.9 0.0 1.7 0.0 0.7 0.0 0.0 1.0 0.4 0.0 0.0 20.1 0.0 4.9 2.2 0.2 1.0 69.5 80.7 56.2 65.3 54.5 68.4 79.4 70.9 74.0 68.0 72.0 97.9 6.6 3.2 20.7 57.5 8.7 2.0 0.7 0.5 0.6 4.3 3.6 2.7 10.9 1.5 1.1 0.0 0.0 5.0 4.0 9.2 0.0 2.5 7.0 5.5 9.1 7.6 10.7 4.2 80.7 6.4 16.6 6.9 6.6 10.6 5.7 50.4 5.3 0.8 12.1 16.8 147.9 4.0 4.1 29.5 17.5 5.1 8.1 22.8 7.2 204.2 17.5 0.5 1.0 142.7 480.3 8.2 3.3 10.9 4.2 4.3 10.5 0.8 2.6 2.1 13.1 8.3 5.4 3.7 1.7 1.8 2.8 22.2 3.5 3.5 8.9 2.2 GALNT13 "GalNAc-T13, KIAA1918" ENSG00000144278 "Polypeptide N-acetylgalactosaminyltransferase 13" Q8IUC8 2 153871922-154453979 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.1;retina: 9.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 214.6;Inhibitory neurons: 333.1;Oligodendrocyte precursor cells: 986.7;Oligodendrocytes: 398.2" "Cancer enriched" "Detected in some" 5 "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 43.8;U-251 MG: 12.0;WM-115: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060775 Approved NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA060775: AB_2684358" "unprognostic (1.97e-1)" "unprognostic (3.43e-3)" "unprognostic (2.47e-2)" "unprognostic (1.00e-3)" "unprognostic (4.21e-3)" "unprognostic (7.73e-3)" "unprognostic (6.50e-2)" "unprognostic (8.17e-2)" "unprognostic (3.57e-1)" "unprognostic (9.15e-2)" "unprognostic (3.83e-2)" "unprognostic (3.09e-2)" "unprognostic (5.17e-2)" "unprognostic (2.05e-5)" "unprognostic (8.61e-3)" "unprognostic (1.52e-1)" "unprognostic (2.05e-1)" 2.1 5.0 8.4 0.2 9.9 0.1 1.2 30.1 7.7 1.7 1.0 0.4 0.2 1.8 1.2 0.1 0.4 0.5 0.2 7.6 17.9 0.1 0.0 2.1 0.0 9.3 12.3 0.5 0.3 0.0 1.7 0.4 11.4 2.0 0.3 9.9 4.1 1.4 1.0 0.6 0.3 1.0 9.5 0.0 0.4 0.6 10.8 0.0 0.0 0.0 0.0 0.7 0.2 11.4 0.0 5.2 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.1 5.5 0.0 0.0 0.1 2.8 0.0 5.0 1.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 8.6 0.0 0.1 0.1 0.5 1.0 0.0 0.0 0.2 7.3 0.2 6.9 0.0 0.3 1.0 0.0 0.0 7.5 43.8 0.1 0.1 0.0 0.7 0.0 0.1 0.0 0.1 1.9 0.1 12.0 0.6 0.1 0.0 7.2 0.0 33.5 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.4 9.9 30.1 7.7 7.6 17.9 9.3 12.3 11.4 9.5 10.8 11.4 0.2 25.6 1.1 13.1 0.0 0.1 0.0 0.0 0.0 14.4 0.2 0.3 1.0 0.0 1.3 0.0 52.1 0.1 0.0 0.1 0.0 0.0 1.9 0.4 21.5 0.7 3.5 0.0 214.6 0.2 0.0 2.8 0.0 0.3 0.0 0.1 0.0 0.0 0.1 72.3 333.1 1.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 2.8 0.0 0.9 0.0 986.7 398.2 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.6 0.0 0.2 0.5 0.8 0.6 0.0 0.1 0.0 0.2 4.2 0.9 0.0 GCH1 "DYT14, DYT5, DYT5a, GCH, GTPCH1" ENSG00000131979 "GTP cyclohydrolase 1" P30793 14 54842008-54902826 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" "Allosteric enzyme, Hydrolase" "Disease variant, Dystonia, Parkinsonism, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.4;liver: 36.7" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 212.5;Hepatocytes: 94.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 11.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 12.7" HPA028612 Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" No No "Cluster 51: Monocytes - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Nuclear membrane, Cytosol" "HPA028612: AB_10602135" "unprognostic (3.77e-2)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (2.39e-1)" "unprognostic (9.26e-2)" "unprognostic (1.27e-1)" "unprognostic (7.26e-2)" "unprognostic (1.75e-1)" "unprognostic (3.97e-1)" "prognostic favorable (8.69e-4)" "prognostic favorable (1.41e-4)" "unprognostic (1.23e-1)" "unprognostic (1.96e-2)" "unprognostic (7.22e-3)" "unprognostic (1.76e-2)" "unprognostic (2.23e-1)" "prognostic favorable (6.67e-4)" 2.4 6.0 2.1 8.1 3.0 31.4 1.8 1.1 2.0 0.4 1.5 2.4 9.4 0.4 0.2 3.5 1.2 0.4 1.9 1.9 4.8 4.6 36.7 4.1 7.0 3.5 16.1 0.5 2.6 0.9 1.8 0.3 8.4 1.5 2.4 0.1 1.7 1.0 0.4 2.2 7.5 1.1 2.4 6.9 2.8 1.2 7.8 3.8 0.8 0.2 2.0 3.3 1.4 2.0 4.7 0.6 1.3 7.1 0.0 0.0 23.5 0.0 2.0 2.4 2.9 1.4 1.0 25.0 6.9 0.2 5.8 4.0 4.9 1.5 0.1 10.9 5.2 0.6 0.3 3.1 8.4 0.0 1.9 0.3 0.7 1.2 0.1 0.0 0.7 23.0 2.8 0.0 0.0 5.0 15.1 0.3 0.4 6.5 8.2 9.6 2.8 0.0 2.9 1.6 11.6 50.9 3.3 2.4 1.6 0.4 2.9 1.5 0.3 0.1 4.0 9.9 3.8 10.5 8.4 7.8 3.1 8.4 0.0 0.0 2.6 0.2 2.8 5.3 2.1 0.7 1.0 1.5 2.8 1.9 2.5 1.3 0.3 1.8 11.1 0.1 2.1 1.2 2.1 3.0 1.1 2.0 1.9 4.8 3.5 16.1 8.4 2.4 7.8 2.0 19.2 3.2 4.8 0.7 33.4 74.6 30.9 23.6 17.6 0.0 19.4 13.2 6.5 4.3 13.6 5.5 2.1 1.9 50.9 21.8 7.9 8.7 0.5 16.8 5.8 19.8 212.5 10.1 3.8 9.4 44.3 15.3 43.8 29.3 0.0 0.3 6.8 94.6 6.1 0.0 5.9 22.7 4.1 28.0 33.3 0.6 0.3 55.8 10.6 15.9 29.5 0.7 29.9 0.5 0.8 11.0 13.6 4.9 14.4 20.5 17.1 48.6 6.9 0.4 0.0 12.5 7.5 2.2 6.7 20.8 76.1 4.2 41.8 11.9 12.2 39.0 GDAP1 "CMT2K, CMT4, CMT4A" ENSG00000104381 "Ganglioside induced differentiation associated protein 1" Q8TB36 8 74320613-74518007 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 46.9;Cone photoreceptor cells: 47.9;Excitatory neurons: 75.7;Horizontal cells: 47.1;Inhibitory neurons: 67.3;Oligodendrocyte precursor cells: 67.8;Rod photoreceptor cells: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014266, HPA024334" Enhanced Supported Mitochondria,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Mitochondria Cytosol "HPA014266: AB_1849581, HPA024334: AB_1849583" "unprognostic (3.19e-2)" "unprognostic (1.52e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (3.31e-1)" "unprognostic (4.36e-2)" "unprognostic (1.72e-2)" "prognostic favorable (2.68e-4)" "unprognostic (3.88e-1)" "unprognostic (4.17e-1)" "unprognostic (9.44e-3)" "unprognostic (2.44e-1)" "unprognostic (5.40e-2)" "unprognostic (3.29e-1)" "unprognostic (6.99e-2)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.73e-1)" 2.7 9.6 19.0 3.3 22.5 1.2 4.0 15.2 26.0 2.9 4.9 2.5 2.4 3.9 1.9 4.0 2.8 2.5 2.1 25.3 19.7 4.2 1.5 2.4 3.3 14.5 17.0 6.0 7.4 12.4 20.6 1.2 18.1 4.1 2.4 19.0 2.4 4.1 2.7 1.7 2.3 2.8 12.2 1.9 2.0 4.7 16.7 4.5 6.6 3.1 2.8 3.9 2.6 20.5 3.5 16.8 17.7 4.8 1.2 1.6 1.5 1.8 8.2 8.3 9.5 7.8 5.0 14.8 2.5 1.2 10.6 6.6 12.4 7.0 16.2 19.7 3.6 7.4 8.9 14.0 0.7 7.6 15.8 4.7 2.3 5.3 8.2 0.9 1.1 7.3 3.4 0.3 4.8 5.7 12.6 0.4 20.1 24.5 17.9 8.7 9.2 3.2 2.9 15.3 18.2 38.9 13.1 3.4 9.7 4.9 14.9 2.6 0.0 11.7 6.2 2.9 5.5 9.3 15.7 6.8 7.3 0.3 13.8 0.5 0.9 1.0 0.8 3.1 1.0 1.4 0.8 1.3 0.8 1.3 0.6 0.6 1.8 0.7 5.5 0.2 4.0 0.8 19.0 22.5 15.2 26.0 25.3 19.7 14.5 17.0 18.1 12.2 16.7 20.5 6.4 6.4 5.1 27.1 5.9 1.8 7.4 4.2 6.2 46.9 6.2 6.1 5.9 5.7 3.6 3.7 47.9 0.4 3.9 2.1 9.8 5.2 5.4 15.4 7.0 6.7 20.4 2.1 75.7 5.8 0.3 4.8 3.1 2.8 17.2 2.1 6.4 1.8 4.7 47.1 67.3 1.7 12.2 6.3 2.5 1.3 4.1 4.6 1.8 15.0 2.9 23.5 4.1 67.8 41.9 3.7 1.4 5.7 2.6 2.6 3.6 6.6 4.9 47.7 0.0 8.0 5.5 14.7 13.1 3.7 1.3 0.0 3.1 6.5 1.7 3.8 GFRA3 GFRa-3 ENSG00000146013 "GDNF family receptor alpha 3" O60609 5 138252380-138274621 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.0" "Cell type enhanced" "Detected in some" "Early spermatids: 8.7;Enteroendocrine cells: 53.1;granulocytes: 26.7;Late spermatids: 20.9;Spermatogonia: 8.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.9" "Region enriched" "Detected in single" 8 "cerebellum: 2.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 32.0" "Not detected" "Not detected" HPA020731 Approved Uncertain "Plasma membrane,Cytosol" NA NA 150000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Plasma membrane" Cytosol "HPA020731: AB_1849635" "unprognostic (1.22e-1)" "unprognostic (6.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.47e-3)" "unprognostic (2.77e-3)" "unprognostic (1.27e-1)" "unprognostic (7.65e-3)" "unprognostic (1.44e-1)" "unprognostic (1.33e-2)" "unprognostic (1.90e-5)" "unprognostic (2.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" 1.8 1.6 0.0 2.1 0.2 0.0 1.6 2.5 0.3 7.4 0.0 13.0 2.7 0.5 2.5 2.3 1.2 1.9 5.7 0.1 0.2 0.5 0.5 2.0 0.1 0.1 0.1 1.3 3.7 0.0 2.0 0.0 0.2 4.1 3.8 0.0 3.2 5.9 0.2 3.1 3.3 2.0 0.1 0.0 6.3 4.2 0.1 0.5 0.8 0.4 0.1 5.1 7.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.1 0.0 0.0 2.0 1.2 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 32.0 0.5 0.0 0.3 0.2 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 1.8 0.0 0.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 8.7 0.0 0.0 0.0 53.1 0.0 0.2 0.2 0.2 0.5 0.0 0.0 26.7 0.3 0.0 0.0 0.1 0.0 0.1 0.2 6.1 0.0 0.2 20.9 0.0 0.2 1.8 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 3.8 8.4 0.1 0.0 0.3 0.0 0.1 0.0 0.1 GGTA1 "GGTA, GGTA1P, GLYT2" ENSG00000204136 "Glycoprotein alpha-galactosyltransferase 1 (inactive)" Q4G0N0 9 121444991-121499844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 133.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Endothelial cells: 2.2;granulocytes: 3.8;Macrophages: 2.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "classical monocyte: 22.7;intermediate monocyte: 17.9;myeloid DC: 12.7;plasmacytoid DC: 27.5" "Group enriched" "Detected in many" 19 "dendritic cells: 27.5;monocytes: 22.7" "Group enriched" "Detected in some" 6 "AN3-CA: 4.3;HEL: 1.3;SH-SY5Y: 4.9" HPA023262 Approved NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 11: Alveolar cells - Smell perception" "HPA023262: AB_1849651" "unprognostic (1.71e-1)" "unprognostic (9.98e-2)" "unprognostic (4.49e-2)" "prognostic favorable (5.33e-5)" "unprognostic (1.67e-2)" "unprognostic (2.85e-2)" "unprognostic (8.98e-2)" "unprognostic (1.34e-2)" "unprognostic (2.43e-1)" "unprognostic (1.29e-1)" "unprognostic (7.85e-2)" "unprognostic (1.63e-1)" "unprognostic (5.53e-3)" "unprognostic (9.24e-2)" "unprognostic (2.64e-2)" "unprognostic (1.44e-2)" "unprognostic (6.87e-2)" 33.4 18.5 15.4 10.1 18.9 68.2 40.4 12.7 19.9 17.2 14.4 14.9 12.0 10.7 7.4 24.2 10.1 23.1 18.7 16.4 15.3 5.7 15.0 21.9 25.7 13.9 15.2 7.6 5.0 4.8 41.7 13.7 6.5 15.4 0.5 133.2 15.3 5.0 13.6 16.1 12.5 14.1 40.4 8.7 4.1 16.0 9.9 5.1 13.4 10.4 21.4 14.9 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 17.9 0.0 0.7 0.0 0.0 12.7 0.0 0.0 0.0 1.2 0.1 0.4 27.5 0.0 7.2 15.4 18.9 12.7 19.9 16.4 15.3 13.9 15.2 13.7 14.1 16.0 14.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GNAS "GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI" ENSG00000087460 "GNAS complex locus" "O95467, P63092, P84996, Q5JWF2" 20 58839718-58911192 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transducer "Cancer-related genes, Cushing syndrome, Disease variant, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 1886.1;Late spermatids: 1756.9;Skeletal myocytes: 1998.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010337, HPA018122, HPA027478, HPA028386" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 39: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Plasma membrane, Cytosol" "CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (3.90e-2)" "unprognostic (4.77e-2)" "unprognostic (8.37e-3)" "unprognostic (2.82e-2)" "unprognostic (4.53e-3)" "unprognostic (8.01e-2)" "unprognostic (4.29e-2)" "prognostic favorable (8.76e-4)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (5.24e-3)" "unprognostic (1.61e-1)" "unprognostic (8.25e-2)" "unprognostic (1.36e-1)" 784.8 1215.3 1564.4 512.6 1524.7 887.4 578.9 1413.1 1768.3 828.5 1373.3 657.1 492.4 611.4 1253.8 883.1 742.9 672.7 1990.6 1557.3 2716.9 625.0 651.1 640.3 769.2 1710.5 1949.4 766.5 1917.7 1799.4 1153.6 884.6 1963.4 577.3 607.3 731.2 2943.9 594.4 2400.4 526.8 527.3 782.4 1598.4 606.6 587.1 357.9 1882.0 854.4 3432.2 2813.1 800.0 687.1 239.3 1483.9 215.6 897.3 1501.9 663.3 2691.8 1822.3 1200.1 1219.1 1635.0 1937.3 1201.8 2480.5 1446.7 911.9 1670.3 2314.3 1305.6 976.1 1499.0 2195.3 1540.9 401.4 784.6 984.9 1651.7 2232.7 1420.7 641.6 483.0 1566.4 1113.6 875.1 1399.1 1561.0 1669.7 1100.6 692.0 1294.6 1319.1 4131.0 1759.5 1452.8 487.9 214.0 894.4 1436.7 1287.3 1589.4 2165.5 1315.8 1818.3 3853.2 2157.6 2117.1 1354.2 1921.8 1570.0 1581.7 1343.3 2210.2 1477.0 688.5 1452.3 1314.0 993.3 1583.2 900.0 473.7 1107.1 217.9 96.7 114.2 68.9 127.3 80.0 103.2 73.4 74.8 129.2 93.6 65.8 82.6 103.4 95.6 150.3 174.9 92.7 100.9 1564.4 1524.7 1413.1 1768.3 1557.3 2716.9 1710.5 1949.4 1963.4 1598.4 1882.0 1483.9 982.6 221.2 258.8 192.0 310.8 130.4 182.0 130.0 205.5 397.8 465.6 684.4 1025.3 237.4 212.2 261.1 56.3 832.6 390.8 357.3 444.1 233.9 734.9 487.7 515.7 518.3 463.1 252.1 232.5 228.9 342.0 380.9 196.3 685.0 138.6 542.3 380.1 256.4 379.1 1886.1 439.7 327.2 181.0 380.4 405.7 1756.9 265.3 437.1 222.3 236.1 204.0 1367.2 137.0 194.5 166.6 339.9 300.0 197.1 309.7 268.1 273.7 153.6 218.0 222.0 210.4 1998.0 560.4 226.0 73.6 240.5 117.8 1211.7 301.8 860.9 304.4 316.5 GNAZ ENSG00000128266 "G protein subunit alpha z" P19086 22 23070519-23125032 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.2" "Cell type enhanced" "Detected in many" "Adipocytes: 32.1;Horizontal cells: 124.5;Rod photoreceptor cells: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.3;SCLC-21H: 39.0;SH-SY5Y: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003011 Enhanced Approved Vesicles NA NA 180000 "Cluster 14: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "HPA003011: AB_1078918" "unprognostic (7.61e-2)" "unprognostic (1.63e-2)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.85e-4)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (3.45e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-3)" "unprognostic (1.68e-2)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (6.63e-2)" "unprognostic (2.82e-1)" "unprognostic (1.30e-1)" 9.2 6.6 30.7 2.8 35.9 1.6 8.4 27.4 36.2 5.4 27.8 14.8 1.7 10.1 2.8 5.0 10.2 11.2 2.4 33.6 24.5 2.0 0.5 1.4 1.8 29.6 30.7 8.9 1.6 7.5 24.1 0.3 32.0 8.5 1.6 33.0 1.8 17.2 1.4 1.4 3.2 11.9 27.0 4.7 11.5 4.3 29.0 0.5 1.5 2.1 1.2 8.0 3.6 35.7 0.1 2.0 6.8 14.3 0.0 0.0 0.4 9.2 18.3 8.9 6.0 0.1 0.1 17.7 0.6 0.8 12.2 0.3 8.4 0.3 6.4 2.2 7.0 1.1 10.2 13.1 0.6 0.0 1.4 0.0 0.3 0.2 0.5 2.2 0.2 1.0 0.2 5.4 0.2 6.4 0.1 0.1 4.1 0.5 5.5 0.1 6.8 2.7 0.1 0.1 39.0 24.0 2.0 4.4 1.9 0.8 1.9 0.2 0.0 7.2 8.2 2.0 0.2 6.6 12.0 9.2 3.7 0.6 2.8 0.9 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.6 0.0 0.0 2.0 30.7 35.9 27.4 36.2 33.6 24.5 29.6 30.7 32.0 27.0 29.0 35.7 32.1 3.2 0.0 4.9 0.7 0.3 0.3 0.4 0.0 12.6 0.8 1.7 1.6 7.2 0.7 3.7 8.4 0.0 0.7 0.3 0.0 2.0 1.5 1.6 0.5 5.0 4.8 2.7 11.0 1.6 0.0 1.1 1.5 0.4 0.0 2.1 2.2 0.4 0.1 124.5 11.0 0.3 2.0 0.0 1.7 2.1 4.1 18.6 1.8 1.0 1.2 19.3 1.0 2.0 16.5 0.7 0.0 4.1 0.1 0.3 0.1 0.9 1.3 37.7 0.0 9.0 2.1 2.0 4.2 0.0 0.4 0.0 0.6 0.9 0.2 0.1 GNG4 ENSG00000168243 "G protein subunit gamma 4" P50150 1 235547685-235650754 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.9;ovary: 32.1;pituitary gland: 32.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 24.4;Enteroendocrine cells: 43.0;Inhibitory neurons: 43.3;Intestinal goblet cells: 16.2;Oligodendrocyte precursor cells: 25.1;Prostatic glandular cells: 24.1;Proximal enterocytes: 24.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.2" "Cell line enhanced" "Detected in many" "NTERA-2: 151.4;SCLC-21H: 158.4;SH-SY5Y: 222.8;U-2197: 67.2" "Region enriched" "Detected in all" 6 "olfactory bulb: 469.3" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.50e-3)" "unprognostic (8.33e-3)" "unprognostic (7.14e-2)" "unprognostic (1.56e-2)" "unprognostic (2.48e-1)" "unprognostic (4.94e-2)" "unprognostic (2.22e-2)" "unprognostic (3.10e-2)" "unprognostic (3.47e-2)" "unprognostic (3.49e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (2.56e-9)" "unprognostic (1.22e-1)" "unprognostic (1.62e-1)" "unprognostic (1.68e-3)" "unprognostic (5.01e-3)" 1.4 11.3 20.0 1.7 25.6 0.1 0.6 7.9 21.0 4.7 3.1 3.6 2.5 9.5 0.1 14.4 3.3 0.5 0.1 15.4 40.9 1.9 0.3 0.1 5.7 21.3 28.2 32.1 5.1 0.0 32.0 1.7 25.4 22.6 3.0 2.4 2.0 0.7 0.1 0.5 5.3 6.6 18.9 0.1 3.1 1.7 33.6 4.9 0.3 0.0 3.4 1.0 2.4 7.3 37.2 2.0 26.4 0.0 0.0 1.3 2.4 0.1 0.4 3.3 4.5 0.1 1.5 0.0 0.3 11.2 9.0 3.3 28.4 1.2 6.7 19.4 10.2 0.1 0.7 14.4 0.4 0.2 12.1 2.4 0.2 0.4 0.9 0.0 0.0 2.0 0.3 0.1 2.1 0.1 7.6 1.2 151.4 0.1 0.1 0.0 13.8 0.7 0.0 1.1 158.4 222.8 0.9 0.3 3.2 1.7 0.2 5.3 0.0 1.7 5.0 67.2 5.2 3.5 0.2 0.0 4.9 0.1 44.5 1.2 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.1 20.0 25.6 7.9 21.0 15.4 40.9 21.3 28.2 25.4 18.9 33.6 7.3 0.1 0.0 0.0 2.9 0.2 0.5 2.6 0.3 0.0 2.3 0.2 0.9 0.5 0.0 1.0 0.0 0.0 7.7 2.7 1.6 0.0 0.0 1.1 1.5 24.4 1.4 43.0 0.0 2.3 9.0 10.0 1.7 0.0 0.8 0.0 3.8 0.0 0.0 0.9 1.7 43.3 16.2 4.1 0.0 3.6 1.0 0.3 1.1 0.0 4.7 1.0 0.4 0.0 25.1 0.8 1.6 1.3 0.4 0.1 24.1 24.5 4.9 0.2 1.3 0.0 0.2 1.6 1.8 4.4 0.0 0.0 6.3 1.1 0.3 4.6 1.5 GNG8 ENSG00000167414 "G protein subunit gamma 8" Q9UK08 19 46634076-46634685 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 105.1;choroid plexus: 32.7" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 12.6;Langerhans cells: 5.1;Melanocytes: 32.0;monocytes: 9.5;Oligodendrocytes: 5.0;Smooth muscle cells: 9.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 6.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 10.8;T-reg: 5.7" "Group enriched" "Detected in many" 5 "B-cells: 10.8;T-cells: 5.7" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 1157.3" "Region enhanced" "Detected in all" "white matter: 20.2" "Low region specificity" "Detected in all" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 10: Non-specific - Unknown function" "unprognostic (7.23e-4)" "unprognostic (4.96e-6)" "unprognostic (9.00e-2)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.14e-5)" "unprognostic (1.94e-1)" "unprognostic (1.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.80e-1)" "unprognostic (9.60e-2)" "unprognostic (9.83e-2)" "unprognostic (5.90e-8)" "unprognostic (2.67e-2)" "unprognostic (1.70e-1)" "unprognostic (4.22e-2)" "unprognostic (4.41e-1)" 0.7 22.0 44.6 5.6 52.5 0.8 0.4 44.7 71.6 5.4 32.7 4.8 1.9 2.5 0.0 0.9 2.4 0.7 10.0 43.0 68.8 2.4 0.4 1.2 4.3 51.1 105.1 1.4 0.1 2.9 7.7 0.2 46.6 1.4 2.1 0.9 0.1 1.7 0.0 0.2 2.7 3.0 42.0 2.9 1.2 1.0 48.9 16.0 0.3 0.0 6.0 1.0 1.4 65.6 0.0 1.6 1.7 0.7 0.0 0.0 0.0 0.8 0.7 0.6 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.9 0.0 0.0 0.0 0.0 89.3 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.3 0.0 0.0 0.0 0.0 0.6 0.8 0.0 1.3 0.9 0.0 0.8 0.0 0.0 264.0 1157.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.9 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 10.8 2.2 1.0 1.7 0.0 0.0 0.0 5.7 4.3 44.6 52.5 44.7 71.6 43.0 68.8 51.1 105.1 46.6 42.0 48.9 65.6 0.0 0.0 0.0 1.0 1.6 0.1 0.1 0.1 0.0 0.0 0.0 0.1 12.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 5.1 3.1 0.0 2.0 32.0 0.0 9.5 0.0 0.0 1.5 5.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 9.0 0.1 0.1 0.0 0.3 0.0 0.9 0.1 0.0 0.1 GPC2 "cerebroglycan, DKFZp547M109, FLJ38962" ENSG00000213420 "Glypican 2" Q8N158 7 100169606-100177381 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "lymphoid tissue: 5.2;skin 1: 5.7;testis: 11.9" "Cell type enhanced" "Detected in many" "Early spermatids: 37.7;Enteroendocrine cells: 10.7;Spermatocytes: 13.6" "Cancer enhanced" "Detected in many" "glioma: 5.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 39.8;AN3-CA: 15.8;BEWO: 14.2;SH-SY5Y: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB025423 Uncertain "Intracellular and membrane" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" "CAB025423: " "unprognostic (4.33e-2)" "unprognostic (5.71e-2)" "unprognostic (1.59e-4)" "unprognostic (3.42e-2)" "unprognostic (1.27e-1)" "unprognostic (2.36e-3)" "unprognostic (6.67e-2)" "unprognostic (1.15e-1)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-4)" "unprognostic (7.25e-4)" "unprognostic (1.67e-4)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (1.05e-1)" "prognostic favorable (9.94e-4)" 0.5 0.3 1.1 1.0 0.9 1.1 0.7 1.1 1.4 1.3 0.6 0.8 0.3 1.8 0.1 0.5 0.9 0.2 0.5 1.1 0.9 0.5 0.1 0.4 1.2 1.2 1.0 1.6 0.2 0.7 0.8 0.1 1.1 0.7 0.4 0.5 0.8 0.2 0.4 5.7 0.9 0.4 1.2 1.1 0.3 11.9 1.0 5.2 0.2 0.0 0.5 0.6 1.0 1.5 0.1 0.2 39.8 15.8 0.0 0.0 14.2 1.3 0.0 0.2 0.3 0.0 0.5 3.5 0.9 0.4 2.3 1.4 1.4 0.5 0.0 0.0 1.2 0.3 0.6 0.1 0.7 0.8 6.1 1.3 0.8 0.9 0.0 0.7 2.0 9.2 1.6 0.0 1.0 0.6 9.7 1.2 7.0 0.7 2.3 10.7 2.9 0.1 0.2 0.7 10.5 43.5 0.8 1.0 1.6 5.6 0.7 0.8 1.5 0.4 6.2 0.9 0.3 1.4 0.5 4.9 0.4 2.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 1.1 1.4 1.1 0.9 1.2 1.0 1.1 1.2 1.0 1.5 0.6 0.0 0.0 1.0 2.2 1.8 1.0 0.6 1.8 0.2 1.1 1.7 2.3 0.0 0.1 1.8 4.2 0.4 0.2 0.4 0.0 1.4 37.7 0.9 2.1 0.8 10.7 2.1 0.2 1.0 0.8 1.6 2.6 0.8 0.0 7.9 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.6 0.4 6.4 0.9 1.0 0.0 1.0 0.6 1.2 2.1 8.0 1.1 1.3 0.4 1.2 0.1 0.8 0.0 0.1 0.4 2.3 0.0 1.8 2.8 13.6 5.7 0.3 3.8 0.4 0.9 1.6 1.1 0.7 GPR22 ENSG00000172209 "G protein-coupled receptor 22" Q99680 7 107470018-107475684 "G-protein coupled receptors, Predicted membrane proteins" "Cilium biogenesis/degradation" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.7;cervix: 2.1;heart muscle: 8.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 15.3;Cardiomyocytes: 57.9;Excitatory neurons: 49.9;Inhibitory neurons: 51.2;Oligodendrocyte precursor cells: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 27 "SH-SY5Y: 2.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "hippocampal formation: 60.4" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (4.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.19e-1)" "unprognostic (5.52e-2)" "unprognostic (7.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.27e-3)" "unprognostic (1.62e-1)" "unprognostic (8.76e-3)" "unprognostic (5.48e-2)" "unprognostic (1.25e-1)" "unprognostic (5.85e-4)" "unprognostic (1.55e-1)" "unprognostic (7.53e-3)" "unprognostic (2.27e-3)" "unprognostic (2.04e-1)" 0.0 0.9 1.0 0.0 1.9 0.0 0.0 2.5 2.7 2.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 8.2 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 2.5 2.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.9 0.1 0.3 0.0 0.0 0.0 15.3 0.0 0.0 57.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.5 1.8 0.4 0.0 0.0 49.9 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 0.1 5.0 51.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 6.5 0.0 0.7 0.0 12.5 7.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 GRAMD1A "FLJ90346, KIAA1533" ENSG00000089351 "GRAM domain containing 1A" Q96CP6 19 34994784-35026471 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008852, HPA012570" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 50: Non-specific - Ribosome" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 3: Monocytes - Immune response regulation" "Plasma membrane" Cytosol "HPA008852: AB_1079203, HPA012570: AB_2112577" "unprognostic (3.09e-2)" "unprognostic (4.62e-2)" "unprognostic (8.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.05e-1)" "unprognostic (2.87e-1)" "unprognostic (3.42e-3)" "unprognostic (5.96e-2)" "unprognostic (4.54e-1)" "unprognostic (5.70e-2)" "unprognostic (1.07e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (7.95e-12)" "unprognostic (2.04e-1)" "unprognostic (4.40e-1)" "unprognostic (2.90e-2)" "unprognostic (4.36e-2)" 37.9 36.9 17.8 28.0 15.9 23.9 31.1 16.4 24.5 33.2 17.5 30.1 15.1 32.5 5.3 11.6 36.2 16.5 30.3 17.4 18.5 27.4 21.2 58.1 28.8 21.8 20.7 38.4 80.8 17.8 29.2 16.8 21.5 32.6 8.4 5.1 55.6 17.0 47.8 14.5 23.3 18.9 18.2 42.1 35.8 16.6 21.5 18.7 25.4 18.9 12.8 35.7 20.1 17.1 17.3 106.0 21.3 41.5 23.9 27.5 19.6 21.6 27.5 21.8 21.6 39.8 11.9 10.8 41.2 25.2 19.3 9.5 22.2 31.9 8.2 48.9 47.3 24.6 25.5 36.8 48.3 21.7 41.1 46.5 19.9 16.1 26.7 36.6 71.5 54.1 31.8 5.7 16.0 13.2 46.5 23.6 38.6 28.4 12.7 47.1 6.9 10.7 24.8 2.5 30.8 64.4 20.0 12.7 33.7 18.4 19.4 20.6 38.9 34.9 22.3 8.0 29.6 8.8 26.3 22.4 23.5 19.6 27.0 23.1 5.7 5.4 3.5 9.6 7.3 0.6 4.6 2.7 5.1 1.2 3.5 5.4 12.7 5.7 19.9 1.7 4.1 3.8 17.8 15.9 16.4 24.5 17.4 18.5 21.8 20.7 21.5 18.2 21.5 17.1 51.0 22.4 37.3 28.1 23.6 20.8 64.4 15.1 18.2 15.8 22.0 18.7 12.3 0.0 16.1 16.5 16.7 13.1 32.3 3.5 3.9 36.8 1.4 15.3 19.9 63.2 39.4 20.4 8.9 57.8 35.8 25.6 10.7 16.5 9.5 39.5 66.4 5.6 53.8 8.4 12.1 15.0 14.2 39.4 81.6 3.0 25.7 37.7 33.8 15.0 146.0 23.1 19.6 12.5 15.1 41.2 9.6 25.2 40.4 68.6 1.4 15.1 11.5 14.9 13.1 15.4 26.0 1.2 5.7 3.4 15.3 33.1 48.1 50.6 19.7 51.9 GRIN1 "GluN1, NMDAR1" ENSG00000176884 "Glutamate ionotropic receptor NMDA type subunit 1" Q05586 9 137139154-137168756 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 49 "brain: 186.7" "Group enriched" "Detected in some" 4 "Excitatory neurons: 132.6;Inhibitory neurons: 134.4" "Cancer enhanced" "Detected in some" "glioma: 1.9;prostate cancer: 1.8" "Region enriched" "Detected in many" 4 "cerebral cortex: 186.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 1.4;REH: 1.9;RPMI-8226: 2.5;SCLC-21H: 5.2;SH-SY5Y: 3.1;T-47d: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067773 Enhanced NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA067773: " "unprognostic (3.58e-2)" "unprognostic (4.51e-1)" "unprognostic (2.68e-2)" "unprognostic (5.48e-4)" "unprognostic (5.20e-2)" "unprognostic (1.25e-1)" "unprognostic (2.34e-2)" "unprognostic (2.81e-2)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.21e-3)" "unprognostic (4.47e-2)" "unprognostic (1.44e-1)" "unprognostic (3.56e-3)" "unprognostic (4.72e-2)" 0.0 0.1 15.7 0.2 46.4 0.0 0.2 0.0 186.7 0.0 0.0 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 35.9 0.0 0.0 0.0 0.1 0.1 1.3 19.5 0.0 0.1 0.2 0.7 0.0 3.8 0.7 0.0 3.7 1.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 1.4 0.0 1.9 0.0 2.5 0.0 0.0 5.2 3.1 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 46.4 0.0 186.7 35.9 0.0 1.3 19.5 3.8 0.0 0.0 35.6 0.0 0.0 0.0 8.5 0.0 0.0 0.3 0.1 0.0 28.0 1.2 0.9 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 1.9 0.2 0.1 0.2 1.8 0.0 132.6 0.4 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.7 134.4 1.8 0.0 0.0 0.0 0.6 0.0 0.2 0.0 9.4 2.0 1.7 0.0 10.1 7.6 0.2 0.1 0.0 0.0 0.7 0.5 0.1 0.3 7.8 0.0 0.0 0.1 0.5 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 GRM7 "GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87" ENSG00000196277 "Glutamate metabotropic receptor 7" Q14831 3 6770001-7741533 "G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cardiomyopathy, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1;parathyroid gland: 4.4" "Group enriched" "Detected in some" 14 "Excitatory neurons: 773.1;Inhibitory neurons: 597.7;Oligodendrocyte precursor cells: 1189.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SH-SY5Y: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015964 Uncertain Cytosol NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA015964: " "unprognostic (2.04e-2)" "unprognostic (7.03e-3)" "unprognostic (1.43e-1)" "unprognostic (9.37e-2)" "unprognostic (8.48e-3)" "unprognostic (2.58e-1)" "unprognostic (7.30e-2)" "unprognostic (3.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.46e-2)" "unprognostic (2.54e-1)" "unprognostic (6.84e-6)" "unprognostic (1.45e-1)" "unprognostic (2.82e-2)" "unprognostic (5.43e-2)" "unprognostic (2.59e-2)" 0.2 2.0 2.8 0.0 2.9 0.0 0.1 0.1 3.8 0.9 0.0 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 3.9 5.1 0.0 0.1 0.1 0.0 2.0 3.0 0.1 0.0 4.4 0.0 0.1 1.7 0.3 0.1 1.1 0.7 0.3 0.0 0.0 0.0 2.3 3.7 0.1 0.0 1.1 5.0 0.3 0.1 0.0 0.0 0.2 0.1 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.9 0.1 3.8 3.9 5.1 2.0 3.0 1.7 3.7 5.0 1.7 0.1 0.0 0.0 29.4 0.0 0.1 1.2 0.1 0.0 24.1 0.1 0.5 1.1 4.3 0.7 0.0 8.4 0.0 0.1 0.0 1.9 0.0 32.7 0.1 2.7 0.2 0.0 0.0 773.1 0.0 0.1 1.6 0.0 0.1 1.3 0.1 0.0 0.0 0.1 1.7 597.7 0.0 0.0 0.0 1.2 41.7 0.3 0.4 0.0 13.1 0.1 1.3 0.0 1189.3 56.9 0.0 0.0 0.0 0.0 0.7 0.0 0.1 8.0 3.5 6.6 0.7 0.4 2.7 0.8 0.0 0.0 0.0 0.1 0.5 0.0 0.7 H3-3A "H3.3A, H3F3, H3F3A" ENSG00000163041 "H3.3 histone A" P84243 1 226061851-226072019 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 600.6;Cytotrophoblasts: 1411.0;Extravillous trophoblasts: 2181.9;Hofbauer cells: 1487.3;Syncytiotrophoblasts: 1616.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 4487.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 4487.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011481, CAB037178, HPA042570" Supported Supported Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: AB_2678056" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (2.19e-3)" "unprognostic (2.83e-2)" "unprognostic (3.74e-1)" "unprognostic (9.83e-3)" "unprognostic (4.71e-2)" "unprognostic (1.77e-3)" "unprognostic (3.69e-2)" "unprognostic (1.29e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (3.66e-2)" "unprognostic (8.03e-3)" "unprognostic (2.21e-3)" "unprognostic (6.03e-2)" 409.6 440.4 240.3 662.2 255.8 2033.8 594.8 262.4 343.4 544.2 244.8 708.3 655.2 492.2 721.3 595.8 565.3 487.7 500.1 229.1 252.3 457.9 537.9 438.9 793.5 273.8 247.1 453.0 435.4 499.7 270.0 490.0 274.4 474.8 790.0 271.6 586.9 382.0 337.1 617.2 672.5 468.6 272.4 539.1 547.2 255.9 246.8 1239.6 480.5 435.5 894.6 597.6 409.0 295.7 751.2 417.0 1589.6 910.2 432.9 498.9 1186.2 337.3 416.2 547.8 429.0 446.2 1214.5 715.3 731.0 427.9 273.5 684.4 802.4 631.9 535.0 445.9 1371.0 889.5 569.9 595.2 427.8 901.4 1026.6 465.6 715.8 385.3 502.1 743.0 826.8 915.7 1271.3 1125.2 626.2 433.8 1791.8 1504.6 2163.0 1881.1 815.7 1286.9 1110.4 1871.4 1159.6 784.3 1542.1 2279.8 991.0 1227.4 842.4 882.3 1399.1 2103.7 471.4 397.1 527.2 532.6 1024.0 523.6 643.4 1178.4 380.2 853.2 874.1 869.5 1043.6 1486.1 378.9 830.2 385.9 722.1 405.2 415.8 791.8 661.7 375.0 423.1 4487.2 442.5 945.8 635.2 636.8 1364.8 240.3 255.8 262.4 343.4 229.1 252.3 273.8 247.1 274.4 272.4 246.8 295.7 600.6 0.0 0.0 0.0 202.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 1411.0 449.2 0.0 0.0 0.0 0.0 0.0 0.0 109.5 0.0 0.0 0.0 0.0 2181.9 188.0 0.0 0.0 0.0 0.0 0.0 0.0 1487.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.8 0.0 0.0 0.0 0.0 1616.9 75.3 0.0 0.0 0.0 HAND1 "bHLHa27, eHand, Hxt, Thing1" ENSG00000113196 "Heart and neural crest derivatives expressed 1" O96004 5 154474972-154478227 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 24.3;intestine: 66.1" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 15.2" "Cancer enriched" "Detected in some" 5 "testis cancer: 2.8" "Region enriched" "Detected in single" 4 "thalamus: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "SH-SY5Y: 119.5;SuSa: 212.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040925, HPA075313" Uncertain Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "Nuclear membrane, Nuclear bodies" "HPA040925: AB_10796563, HPA075313: " "unprognostic (2.37e-2)" "unprognostic (8.29e-2)" "unprognostic (2.46e-3)" "unprognostic (7.23e-2)" "unprognostic (5.21e-2)" "unprognostic (6.38e-3)" 0.2 4.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.1 3.7 0.0 0.0 0.0 0.0 0.5 24.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 14.3 12.3 0.0 0.0 0.0 0.3 1.5 0.1 0.0 0.0 0.0 7.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 119.5 0.0 0.0 0.0 212.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 15.2 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.0 HAND2 "bHLHa26, dHand, Hed, Thing2" ENSG00000164107 "Heart and neural crest derivatives expressed 2" P61296 4 173524969-173530229 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 60.5" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 100.3;Endometrial stromal cells: 317.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 5.5;stomach cancer: 4.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 24 "SH-SY5Y: 410.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019591, CAB025576" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm Vesicles "CAB025576: , HPA019591: AB_2670199" "unprognostic (4.11e-2)" "unprognostic (7.50e-3)" "unprognostic (2.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.95e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-2)" "unprognostic (2.56e-1)" "unprognostic (2.44e-1)" "unprognostic (1.35e-1)" "unprognostic (3.27e-2)" "unprognostic (4.95e-2)" "unprognostic (1.56e-1)" "unprognostic (6.39e-3)" 4.9 28.0 0.0 5.4 0.0 0.0 2.1 0.5 0.0 22.2 0.0 60.5 2.5 33.4 0.3 1.0 16.0 16.2 36.8 0.0 0.0 0.1 5.5 0.0 0.2 0.0 0.0 15.3 4.1 0.0 0.1 20.9 0.2 1.3 4.4 0.0 0.8 1.0 0.2 1.5 11.0 27.3 0.0 1.1 22.1 0.4 0.0 0.4 1.5 1.1 0.8 12.4 5.3 0.0 0.0 0.1 0.0 0.0 16.6 7.7 0.3 2.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 17.3 0.0 0.1 1.7 0.0 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 410.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.3 4.1 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.2 0.0 0.1 0.1 100.3 2.8 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.6 0.2 9.0 317.1 2.7 0.0 0.0 0.0 0.4 1.4 30.4 0.0 5.3 0.0 0.0 6.8 0.1 2.5 0.0 0.0 0.0 0.0 0.0 2.3 0.9 39.4 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.9 0.1 0.3 0.2 0.3 2.3 1.3 0.6 0.0 0.0 HHAT "FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn" ENSG00000054392 "Hedgehog acyltransferase" Q5VTY9 1 210328252-210676296 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 25.8;Excitatory neurons: 47.7;Microglial cells: 20.6;Oligodendrocytes: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "B-cells: 1.8;dendritic cells: 3.7;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HMC-1: 13.6;LHCN-M2: 11.6;RH-30: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA016462 Approved Approved "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA016462: AB_2669360" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (5.02e-3)" "unprognostic (8.89e-3)" "unprognostic (4.81e-2)" "unprognostic (3.32e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (1.67e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-3)" "prognostic favorable (8.47e-7)" "unprognostic (2.55e-1)" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (5.67e-2)" 2.1 6.5 1.1 0.6 1.1 0.4 3.3 0.3 1.6 3.4 3.6 2.3 1.1 2.5 3.1 2.8 2.8 2.2 2.4 1.0 0.4 4.0 2.7 2.1 0.8 0.7 0.8 2.1 2.3 1.7 3.2 1.3 0.6 4.0 1.3 1.7 4.4 2.0 0.3 3.4 2.5 1.1 0.9 2.2 1.8 2.5 0.6 2.0 4.6 0.2 0.8 3.1 2.9 0.9 0.8 0.9 2.3 1.3 1.0 1.3 4.8 1.2 1.1 1.9 3.1 0.2 0.9 0.0 1.2 0.9 3.1 0.6 0.5 0.5 2.2 1.7 1.2 0.0 0.1 1.1 0.2 0.3 13.6 1.2 2.7 1.6 1.2 3.2 0.3 1.2 0.0 0.0 11.6 1.2 0.6 0.0 0.6 0.7 0.1 1.3 12.4 0.0 7.5 2.6 1.9 7.8 2.1 0.0 6.0 5.9 4.0 0.7 1.7 2.8 8.5 1.6 4.7 3.8 0.2 0.0 1.1 0.8 2.3 0.0 0.3 0.0 0.7 0.4 1.3 1.5 0.9 0.8 0.4 1.8 0.0 0.2 0.0 0.1 0.1 3.7 0.2 0.4 1.1 1.1 0.3 1.6 1.0 0.4 0.7 0.8 0.6 0.9 0.6 0.9 2.0 0.0 2.4 25.8 5.3 2.2 5.7 2.8 6.8 0.5 5.8 2.4 2.4 4.3 1.2 9.2 0.0 4.6 13.9 1.9 3.9 2.6 1.2 8.8 2.6 2.0 0.0 0.4 47.7 0.7 3.6 3.0 2.6 5.8 0.0 4.6 3.6 2.5 1.9 0.0 11.8 2.7 4.1 2.9 0.5 0.5 1.2 1.5 0.0 20.6 1.0 15.6 0.0 17.1 26.0 1.2 2.1 0.4 2.2 3.7 2.3 0.6 12.9 0.5 0.0 1.7 1.7 0.3 1.3 3.1 2.6 2.2 2.8 0.4 2.0 5.2 HOXC5 "HOX3, HOX3D" ENSG00000172789 "Homeobox C5" Q00444 12 54033050-54035361 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.6;fallopian tube: 4.1" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 5.2;Fibroblasts: 2.6;Granulosa cells: 2.5;Leydig cells: 2.5;Peritubular cells: 2.6;Skeletal myocytes: 2.6;Smooth muscle cells: 2.5;Spermatocytes: 3.2;Squamous epithelial cells: 2.2" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Group enriched" "Detected in many" 15 "medulla oblongata: 3.4;pons: 3.6;spinal cord: 1.9;white matter: 1.2" "Immune cell enhanced" "Detected in single" "gdT-cell: 3.0" "Lineage enriched" "Detected in single" 31 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "AN3-CA: 7.1;ASC TERT1: 4.8;HSkMC: 4.5;SH-SY5Y: 7.6" "Region enriched" "Detected in single" 46 "pons and medulla: 4.6" "Group enriched" "Detected in some" 5 "medulla oblongata: 1.5;spinal cord: 2.1" HPA026794 Uncertain Supported "Nucleoplasm,Cell Junctions" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Cell Junctions" "HPA026794: AB_10612118" "unprognostic (1.57e-1)" "unprognostic (7.73e-3)" "unprognostic (1.70e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-3)" "unprognostic (2.87e-3)" "unprognostic (6.89e-2)" "unprognostic (9.53e-3)" "unprognostic (1.86e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-3)" "unprognostic (1.17e-2)" "unprognostic (7.53e-3)" "unprognostic (2.19e-3)" "unprognostic (1.08e-2)" 1.0 0.9 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 2.7 0.9 4.1 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.2 3.4 0.1 2.6 0.0 0.0 0.0 0.8 3.6 0.0 0.0 0.0 0.0 0.2 1.2 1.1 0.7 1.5 1.9 0.0 2.1 1.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 1.2 0.8 1.9 0.0 7.1 4.0 4.8 0.0 0.4 0.3 0.8 0.6 3.0 0.4 0.0 0.5 2.1 0.0 1.1 0.1 0.0 0.3 2.4 2.4 0.0 1.0 0.1 0.1 0.0 0.1 4.5 0.4 3.3 0.4 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 7.6 0.5 0.2 3.9 0.9 1.4 0.0 0.0 1.2 0.7 2.6 0.2 0.0 0.0 0.0 0.1 0.1 2.8 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 3.6 1.9 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 5.2 0.0 0.3 0.9 0.1 0.0 0.0 1.8 0.0 0.1 0.8 0.0 1.9 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 2.6 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.6 2.5 3.2 1.0 2.2 0.9 0.3 0.1 1.0 0.1 0.0 HPCAL4 "DKFZp761G122, HLP4" ENSG00000116983 "Hippocalcin like 4" Q9UM19 1 39678648-39691485 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 91.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 39.2;Distal tubular cells: 11.7;Excitatory neurons: 16.4;Inhibitory neurons: 20.0" "Group enriched" "Detected in some" 11 "glioma: 5.4;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 3.0;naive CD4 T-cell: 2.6" "Lineage enriched" "Detected in single" 30 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "Karpas-707: 2.7;SH-SY5Y: 9.1;SK-MEL-30: 2.9;U-2 OS: 1.9;U-266/70: 2.4;U-266/84: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053808 Approved Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Cytosol "HPA053808: AB_2682270" "unprognostic (2.62e-1)" "unprognostic (2.37e-1)" "unprognostic (2.13e-2)" "unprognostic (8.56e-4)" "unprognostic (4.73e-3)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (4.89e-3)" "unprognostic (1.27e-1)" "unprognostic (3.18e-2)" "unprognostic (4.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.62e-3)" "unprognostic (3.78e-3)" "unprognostic (2.77e-2)" "unprognostic (3.97e-2)" "unprognostic (2.63e-1)" 0.0 10.1 75.1 0.8 89.6 0.4 0.0 38.1 89.3 0.0 0.0 0.3 0.2 0.0 0.3 5.2 0.0 0.2 1.1 91.2 38.0 4.7 0.0 0.6 1.0 16.8 29.8 2.9 4.9 0.2 2.1 0.0 30.1 0.3 0.1 10.9 0.1 0.1 3.2 0.1 0.4 0.0 28.1 0.3 0.6 4.6 58.1 0.2 0.1 1.2 0.8 0.1 0.1 43.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 1.4 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.8 9.1 0.2 0.0 2.9 0.1 0.0 0.1 0.0 0.0 1.9 0.0 0.0 2.4 3.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 3.0 0.5 0.1 0.0 2.6 0.9 0.0 0.0 0.0 0.0 2.2 0.9 75.1 89.6 38.1 89.3 91.2 38.0 16.8 29.8 30.1 28.1 58.1 43.8 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 39.2 0.1 0.1 1.5 0.0 0.6 1.8 0.0 0.0 0.0 0.0 11.7 0.0 3.4 0.1 0.0 0.1 0.0 0.0 16.4 0.8 0.0 0.6 0.0 0.7 0.0 0.2 0.0 0.0 0.0 1.7 20.0 0.0 0.0 0.0 0.0 1.2 1.2 0.1 0.0 1.0 0.0 4.9 0.0 1.5 1.3 0.2 0.0 1.5 0.3 0.0 0.0 0.1 0.0 1.4 0.0 0.3 0.1 2.8 0.7 0.0 0.0 0.0 0.9 0.1 0.0 0.0 HS3ST2 3OST2 ENSG00000122254 "Heparan sulfate-glucosamine 3-sulfotransferase 2" Q9Y278 16 22814162-22916338 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 29.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 99.8;Hofbauer cells: 16.9;Inhibitory neurons: 25.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 9.7;SH-SY5Y: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017736 Approved NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA017736: AB_1851095" "unprognostic (4.09e-2)" "unprognostic (2.90e-3)" "unprognostic (5.97e-3)" "unprognostic (3.46e-3)" "prognostic unfavorable (1.57e-4)" "unprognostic (2.00e-1)" "unprognostic (1.05e-1)" "unprognostic (2.17e-3)" "unprognostic (1.83e-1)" "unprognostic (2.75e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "prognostic favorable (1.35e-4)" "unprognostic (4.89e-2)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (3.00e-2)" 3.0 1.2 11.5 0.0 16.8 0.0 2.1 0.8 29.9 1.8 0.5 0.7 0.0 0.7 0.0 0.2 0.6 0.0 1.0 11.7 6.2 0.4 0.6 5.4 0.0 3.9 6.6 0.3 0.2 0.0 0.3 0.1 5.2 1.9 0.2 0.4 3.1 0.0 0.4 2.0 0.5 0.1 2.4 0.3 0.7 0.3 2.6 0.0 1.8 0.1 0.0 1.1 1.1 16.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 16.8 0.8 29.9 11.7 6.2 3.9 6.6 5.2 2.4 2.6 16.3 0.8 0.0 0.0 1.6 0.0 3.6 0.2 0.0 0.0 10.3 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.6 0.1 0.0 0.0 2.3 0.0 0.0 99.8 0.0 0.2 1.9 0.0 0.2 0.0 0.0 0.4 0.2 16.9 0.0 25.7 0.0 0.0 1.0 2.7 1.5 1.2 7.3 0.0 0.0 0.0 0.0 0.0 3.5 1.8 0.9 0.0 5.7 0.0 1.1 0.0 0.0 0.0 0.7 0.0 0.3 5.8 0.1 0.0 0.0 2.0 0.3 0.1 0.0 0.0 0.8 HSD11B1L "HSD1L, SCDR10, SDR26C2" ENSG00000167733 "Hydroxysteroid 11-beta dehydrogenase 1 like" Q7Z5J1 19 5680604-5688523 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 19.0" "Low region specificity" "Detected in all" HPA049078 Supported Vesicles "Secreted in brain" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA049078: AB_2680622" "unprognostic (2.34e-2)" "unprognostic (1.10e-1)" "unprognostic (4.73e-3)" "unprognostic (5.26e-2)" "unprognostic (9.37e-2)" "prognostic favorable (4.38e-4)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-3)" "unprognostic (1.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.75e-1)" "unprognostic (5.77e-2)" "unprognostic (4.52e-1)" "unprognostic (1.73e-2)" 3.9 9.8 46.6 1.3 46.7 2.6 5.1 32.0 58.2 5.5 34.0 8.4 1.6 5.4 5.1 3.7 6.7 3.0 5.9 46.1 41.8 12.4 5.4 4.4 1.4 38.4 36.5 6.7 7.0 7.3 21.2 1.5 37.2 6.1 1.0 6.3 5.8 4.1 10.9 9.3 3.4 1.6 32.9 3.2 6.3 8.1 42.4 1.6 8.6 3.3 1.0 6.0 4.3 39.1 3.6 3.0 11.3 2.1 5.0 5.7 2.2 2.7 4.4 1.1 4.8 1.3 3.3 0.8 5.9 2.2 0.9 1.7 1.4 1.8 1.0 3.2 3.6 2.3 3.0 2.2 3.6 0.9 7.9 5.5 3.9 1.6 1.6 10.4 1.8 5.1 2.4 2.9 4.6 0.3 2.1 2.1 3.0 14.2 4.1 3.6 0.5 3.1 9.5 0.8 3.2 19.0 0.5 1.6 12.8 3.8 2.6 0.7 3.2 2.7 5.0 4.9 2.2 7.6 2.8 0.9 7.7 1.2 2.4 1.5 1.0 0.5 0.6 2.7 0.6 0.5 1.4 1.6 1.0 1.1 1.8 1.7 1.9 0.7 1.8 2.2 0.4 0.9 46.6 46.7 32.0 58.2 46.1 41.8 38.4 36.5 37.2 32.9 42.4 39.1 8.2 0.0 2.6 13.7 2.6 8.2 8.6 12.9 9.6 11.3 23.7 23.1 2.3 10.0 8.6 23.9 14.6 4.7 3.0 4.5 15.6 12.4 9.5 21.8 6.0 6.1 25.7 1.3 24.7 4.7 6.5 8.1 4.6 5.4 10.2 12.4 8.9 4.1 5.1 8.4 20.4 4.6 12.2 2.8 6.0 13.9 7.2 2.4 5.4 1.9 3.1 30.5 1.0 14.1 4.6 4.8 4.3 12.8 0.9 8.4 4.1 33.3 31.2 12.9 0.0 8.1 9.5 10.8 12.7 4.8 10.2 2.9 3.1 16.6 3.7 9.7 HTR1E 5-HT1E ENSG00000168830 "5-hydroxytryptamine receptor 1E" P28566 6 86937528-87016679 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.2;ovary: 4.2" "Group enriched" "Detected in some" 15 "Excitatory neurons: 125.4;Inhibitory neurons: 104.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "PC-3: 1.7;SH-SY5Y: 6.6" "Low region specificity" "Detected in many" HPA004931 Approved NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA004931: AB_1856706" "unprognostic (2.25e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.25e-1)" 0.0 0.0 1.7 0.0 3.0 0.0 0.0 0.0 4.2 0.3 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 2.6 1.3 0.0 0.0 0.0 0.0 0.2 0.3 4.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 1.3 0.3 1.2 0.0 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.0 0.0 4.2 2.6 1.3 0.2 0.3 0.1 0.0 1.2 2.5 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 1.1 0.0 0.0 0.0 125.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 104.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 HTR6 "5-HT6, 5-HT6R" ENSG00000158748 "5-hydroxytryptamine receptor 6" P50406 1 19664875-19680966 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "brain: 9.7" "Cell type enhanced" "Detected in single" "Excitatory neurons: 1.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Group enriched" "Detected in many" 4 "basal ganglia: 9.7;cerebral cortex: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 2.0" "Low region specificity" "Detected in many" HPA068165 Uncertain NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA068165: " "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (7.19e-3)" "unprognostic (3.84e-5)" "unprognostic (1.38e-4)" "unprognostic (2.69e-2)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (5.33e-3)" "unprognostic (8.63e-2)" "unprognostic (5.47e-4)" "unprognostic (1.28e-1)" "unprognostic (2.49e-1)" "unprognostic (6.13e-3)" "unprognostic (2.02e-1)" 0.0 0.0 1.2 0.2 9.7 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 9.7 0.0 2.4 0.7 0.1 0.1 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ICA1 "ICA69, ICAp69" ENSG00000003147 "Islet cell autoantigen 1" Q05084 7 8113184-8262687 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 594.7;Late spermatids: 867.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "T-reg: 29.9" "Lineage enriched" "Detected in many" 9 "T-cells: 29.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.1;MCF7: 42.5;OE19: 48.4;RT4: 49.4;SCLC-21H: 66.1;SH-SY5Y: 105.8;SK-BR-3: 52.1;T-47d: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017646, HPA061452" Approved Supported Vesicles,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 25: Pancreas - Digestion" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Vesicles, Cytosol" "HPA017646: AB_1851382, HPA061452: AB_2684525" "unprognostic (1.39e-1)" "unprognostic (1.37e-1)" "unprognostic (3.74e-1)" "unprognostic (6.83e-3)" "unprognostic (9.49e-2)" "unprognostic (8.57e-3)" "unprognostic (1.37e-2)" "unprognostic (3.54e-1)" "unprognostic (7.61e-2)" "unprognostic (3.42e-1)" "unprognostic (5.84e-2)" "unprognostic (2.62e-1)" "prognostic favorable (4.23e-8)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (4.08e-2)" 15.8 10.4 11.3 5.7 16.2 23.8 21.1 21.5 21.8 16.4 1.2 22.8 13.6 6.8 13.6 9.5 13.7 11.1 44.3 13.4 9.3 16.0 8.8 11.2 13.5 8.0 9.5 1.7 62.7 20.9 19.8 8.2 9.3 22.1 23.5 2.9 37.1 4.9 2.8 12.8 17.8 5.6 5.1 12.4 30.5 24.2 13.3 5.0 14.1 3.3 9.6 13.8 7.4 15.3 0.0 1.5 1.7 0.2 0.2 0.0 4.2 0.0 0.0 0.6 0.2 1.0 47.1 0.3 5.2 0.1 0.9 0.0 0.8 1.9 0.0 0.0 6.8 9.1 0.9 0.0 0.4 9.1 1.8 0.0 3.0 0.0 0.0 0.5 31.5 8.2 26.4 0.0 0.0 42.5 0.4 0.0 9.9 48.4 0.4 0.0 0.0 19.5 19.0 49.4 66.1 105.8 0.0 52.1 0.7 11.6 43.4 14.3 19.8 0.0 0.9 0.2 1.0 14.1 7.5 0.0 0.0 6.9 10.3 1.0 2.4 0.2 0.3 0.8 0.6 0.4 5.4 0.4 2.4 0.7 0.3 0.2 3.4 0.9 0.4 0.6 29.9 1.3 11.3 16.2 21.5 21.8 13.4 9.3 8.0 9.5 9.3 5.1 13.3 15.3 73.4 28.9 24.4 6.5 1.6 20.5 16.2 7.1 9.1 10.4 42.8 28.7 43.2 22.8 20.1 22.0 6.2 2.7 2.1 28.2 43.0 38.4 594.7 34.2 5.8 44.1 77.2 16.4 132.1 74.8 0.8 4.5 56.1 65.4 8.2 11.2 42.1 1.3 23.9 0.0 138.0 80.5 44.7 8.1 9.3 867.0 7.5 9.6 14.2 60.0 6.3 0.8 3.1 49.3 3.9 59.8 53.1 3.0 1.7 53.8 23.8 8.3 17.8 1.7 6.6 1.2 5.6 13.9 9.6 18.4 8.9 2.2 9.5 4.7 41.8 42.7 IFITM10 DSPA3 ENSG00000244242 "Interferon induced transmembrane protein 10" A6NMD0 11 1732406-1750595 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.6;bone marrow: 1.5;brain: 3.2;choroid plexus: 1.8;retina: 1.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 46.0;Bipolar cells: 30.5;granulocytes: 28.5;Hepatic stellate cells: 40.0;Oligodendrocyte precursor cells: 39.7;Respiratory ciliated cells: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.9;hTERT-RPE1: 4.7;MCF7: 4.4;SH-SY5Y: 11.2;SK-MEL-30: 4.0;U-87 MG: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (1.89e-3)" "unprognostic (2.10e-2)" "unprognostic (1.22e-6)" "unprognostic (6.49e-3)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" "unprognostic (3.66e-1)" "unprognostic (4.09e-1)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.68e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-1)" "unprognostic (2.44e-2)" "unprognostic (3.76e-2)" 0.1 2.6 2.1 0.1 2.1 1.5 0.0 3.2 3.0 0.1 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.2 2.4 0.1 0.3 0.2 0.0 2.3 2.2 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 1.5 0.3 0.5 0.2 0.4 0.1 0.0 2.1 0.1 0.0 0.3 2.3 0.0 0.0 0.0 0.1 0.3 0.1 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 11.2 0.0 0.0 4.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.6 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.1 3.2 3.0 2.2 2.4 2.3 2.2 2.4 2.1 2.3 2.2 0.3 3.2 0.6 1.0 1.3 2.2 9.3 46.0 14.2 30.5 0.8 1.7 1.9 1.5 16.4 0.0 0.0 1.8 0.4 8.1 1.9 3.9 0.4 1.2 0.5 1.0 0.0 0.0 10.5 2.6 0.6 5.4 1.1 2.7 28.5 0.0 40.0 1.6 20.6 1.7 11.4 0.9 18.3 5.0 1.1 0.6 0.9 9.3 0.0 1.9 2.6 2.1 3.1 39.7 1.0 2.3 4.2 1.5 1.3 1.3 3.3 0.1 49.4 2.3 0.0 2.4 4.0 0.5 1.3 3.2 0.9 2.6 2.5 0.1 1.9 12.7 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38406528-38424454 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "thyroid gland: 16.5" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 1.8;Excitatory neurons: 2.5;Hofbauer cells: 1.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 2.5;Spermatogonia: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 360.4;NTERA-2: 104.2;RH-30: 97.5;SCLC-21H: 334.3;SH-SY5Y: 332.6;SuSa: 241.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051354 Uncertain Uncertain Nucleoplasm,Vesicles "Secreted to blood" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 0.8 1.5 2.4 0.5 4.2 0.5 0.1 3.4 2.8 0.2 1.4 0.5 0.9 0.7 0.1 0.3 0.3 0.6 1.3 2.6 2.0 0.2 0.3 0.8 0.2 1.5 2.3 0.1 0.9 0.0 1.1 0.6 1.7 0.4 0.3 0.3 0.1 1.6 0.2 0.2 0.6 1.1 1.0 0.1 1.6 2.1 2.8 2.9 16.5 0.0 0.1 0.5 0.1 1.8 0.0 8.6 360.4 0.4 0.0 0.0 0.2 2.4 0.0 0.5 0.3 0.1 0.2 0.1 1.3 0.3 0.0 0.1 44.0 0.0 0.5 0.0 2.7 0.1 1.2 0.2 0.0 1.7 1.2 0.4 0.0 0.0 0.0 0.2 0.0 1.6 0.2 0.2 2.5 0.1 0.3 0.2 104.2 0.5 0.7 0.1 97.5 0.9 0.0 0.2 334.3 332.6 6.4 0.5 0.0 241.3 2.3 2.3 0.4 0.1 7.7 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.7 0.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.2 0.1 0.0 2.4 4.2 3.4 2.8 2.6 2.0 1.5 2.3 1.7 1.0 2.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.3 0.6 0.1 0.0 1.8 0.0 2.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 IGHD3-22 IGHD322 ENSG00000211911 "Immunoglobulin heavy diversity 3-22" 14 105886031-105886061 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.6;lymphoid tissue: 2.7;stomach 1: 3.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "naive B-cell: 48.9" "Lineage enriched" "Detected in many" 7 "B-cells: 48.9" "Cell line enriched" "Detected in single" 13 "SH-SY5Y: 1.3" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 13: SH-SY5Y - Nervous system development" "unprognostic (4.12e-1)" "unprognostic (1.53e-1)" 0.0 0.0 0.1 0.9 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.2 3.1 0.0 0.0 0.7 0.0 0.0 2.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 48.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-43 ENSG00000232216 "Immunoglobulin heavy variable 3-43" A0A0B4J1X8 14 106470264-106470800 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 211.9;stomach 1: 312.2;urinary bladder: 153.0" "Cell type enriched" "Detected in some" 28 "Plasma cells: 557.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 321 "memory B-cell: 29.4;naive B-cell: 39.0" "Lineage enriched" "Detected in single" 366 "B-cells: 39.0" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.8;SH-SY5Y: 2.3" "Immunoglobulin genes" NA NA 4000000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.31e-4)" "unprognostic (2.22e-2)" "prognostic favorable (1.46e-4)" "unprognostic (4.87e-3)" "prognostic favorable (8.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.34e-1)" "unprognostic (4.63e-1)" "unprognostic (7.27e-3)" "unprognostic (4.50e-2)" "unprognostic (8.73e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (1.75e-2)" 9.3 2.3 0.0 23.7 0.3 11.5 43.7 0.0 0.3 46.0 0.0 101.8 102.5 2.0 0.0 10.2 3.5 10.7 0.4 0.0 0.0 2.7 9.8 10.8 4.3 0.7 0.0 4.2 2.2 1.0 0.3 0.1 0.2 2.7 66.1 0.0 58.1 5.4 0.1 1.0 48.3 4.4 0.0 83.7 312.2 0.2 0.1 0.0 3.8 0.0 211.9 153.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.3 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 557.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 IGKV1-33 "IGKV133, O18" ENSG00000242076 "Immunoglobulin kappa variable 1-33" P01594 2 89266494-89268506 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Bence-Jones protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1727.5;stomach 1: 627.3;urinary bladder: 623.3" "Cell type enriched" "Detected in some" 131 "Plasma cells: 2044.1" "Cancer enhanced" "Detected in many" "stomach cancer: 5.5" "Region enriched" "Detected in many" 7 "spinal cord: 12.0" "Group enriched" "Detected in some" 378 "memory B-cell: 369.6;naive B-cell: 441.5" "Lineage enriched" "Detected in many" 411 "B-cells: 441.5" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.7;SCLC-21H: 9.1;SH-SY5Y: 8.8;U-251 MG: 3.5" HPA048721 Approved "Immunoglobulin genes" NA NA "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 55: Plasma cells - Humoral immune response" "HPA048721: " "unprognostic (1.76e-2)" "unprognostic (6.79e-2)" "unprognostic (1.52e-2)" "prognostic favorable (4.58e-5)" "unprognostic (5.06e-2)" "unprognostic (8.55e-3)" "unprognostic (2.31e-1)" "unprognostic (1.63e-2)" "unprognostic (2.57e-1)" "unprognostic (4.66e-1)" 50.5 21.9 0.1 266.2 0.5 139.5 320.5 0.6 1.0 129.8 0.4 471.5 296.2 20.7 2.8 106.2 33.4 187.2 23.2 0.2 1.6 36.7 37.9 130.4 529.5 0.4 1.0 37.0 8.3 1.9 2.7 0.4 0.7 18.7 511.9 0.2 476.4 127.7 0.7 2.5 175.9 14.5 12.0 820.8 627.3 13.5 0.2 381.9 53.9 0.2 1727.5 623.3 26.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.1 1.9 2.7 0.0 0.0 9.1 8.8 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.4 3.5 0.7 0.0 0.2 0.0 0.6 0.0 0.4 0.3 0.4 0.1 0.0 0.1 369.6 0.2 0.1 0.3 441.5 0.2 0.1 1.0 0.2 0.3 0.3 0.2 39.5 0.1 0.5 0.6 1.0 0.2 1.6 0.4 1.0 0.7 12.0 0.2 1.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2044.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 IGLON5 LOC402665 ENSG00000142549 "IgLON family member 5" A6NGN9 19 51311848-51330354 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2;retina: 13.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 24.4;Horizontal cells: 79.1;Inhibitory neurons: 17.6;Spermatogonia: 9.7" "Group enriched" "Detected in many" 5 "glioma: 9.2;ovarian cancer: 3.5;testis cancer: 12.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 35.0;NTERA-2: 16.0;SH-SY5Y: 23.0;SuSa: 9.9;U-2 OS: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041994 Approved "Secreted in brain" NA NA 15000 "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA041994: AB_10794641" "unprognostic (2.09e-1)" "unprognostic (5.76e-2)" "unprognostic (1.80e-2)" "unprognostic (8.87e-3)" "unprognostic (2.33e-1)" "unprognostic (2.66e-1)" "unprognostic (3.47e-4)" "unprognostic (6.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.89e-3)" "unprognostic (1.59e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (5.62e-7)" "unprognostic (1.77e-2)" "unprognostic (9.28e-2)" "unprognostic (1.36e-2)" "unprognostic (1.86e-3)" 1.7 1.7 11.5 0.2 9.0 0.7 0.9 23.4 21.6 0.5 1.1 0.6 0.1 0.1 0.7 4.2 0.1 0.2 0.3 11.7 17.1 0.4 1.9 0.2 0.0 47.2 19.1 1.2 0.2 1.8 1.2 0.4 44.9 0.2 0.0 13.9 0.7 0.7 0.0 0.6 0.3 0.1 16.5 0.1 0.2 8.0 22.2 0.0 0.2 0.0 0.0 0.4 1.2 10.8 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.6 0.0 0.4 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 16.0 0.2 0.0 0.0 0.0 3.5 0.0 0.1 0.1 23.0 0.0 0.0 0.0 9.9 0.2 2.2 0.0 0.0 6.4 0.1 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.5 9.0 23.4 21.6 11.7 17.1 47.2 19.1 44.9 16.5 22.2 10.8 2.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 24.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.9 0.0 0.0 6.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 1.8 0.1 0.3 79.1 17.6 0.0 0.0 0.0 0.0 2.8 0.0 1.1 0.0 3.7 0.0 2.5 0.0 5.5 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.9 0.9 9.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGLV3-19 ENSG00000211663 "Immunoglobulin lambda variable 3-19" P01714 22 22720623-22721145 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1026.7;lymphoid tissue: 1979.7;stomach 1: 1240.2" "Cell type enriched" "Detected in some" 61 "Plasma cells: 3121.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 355 "memory B-cell: 618.3;naive B-cell: 503.7" "Lineage enriched" "Detected in many" 391 "B-cells: 618.3" "Cell line enhanced" "Detected in some" "RPMI-8226: 6.2;SCLC-21H: 9.4;SH-SY5Y: 10.7;U-251 MG: 4.2" "Immunoglobulin genes" NA NA 1200000000 "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (5.92e-5)" "unprognostic (1.52e-2)" "unprognostic (1.60e-3)" "prognostic favorable (6.11e-5)" "unprognostic (1.14e-1)" "unprognostic (1.24e-3)" "unprognostic (9.58e-3)" "unprognostic (3.57e-1)" "unprognostic (1.55e-1)" "unprognostic (1.00e-1)" "unprognostic (3.13e-1)" "unprognostic (3.03e-1)" "prognostic unfavorable (9.37e-10)" "unprognostic (2.10e-1)" "unprognostic (2.31e-1)" "unprognostic (2.44e-1)" "unprognostic (8.52e-2)" 49.1 20.1 0.1 402.2 0.3 185.1 313.5 0.1 2.4 69.2 0.3 1026.7 713.6 19.0 263.4 154.0 65.8 182.4 36.9 0.1 0.3 26.0 57.5 192.2 464.9 1.5 0.4 44.9 11.5 1.3 2.7 0.4 0.4 17.2 912.2 0.0 304.9 62.4 0.9 4.8 385.2 34.9 0.6 714.2 1240.2 6.0 0.4 435.0 55.4 0.0 1979.7 642.5 13.6 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 2.7 0.3 0.0 0.0 0.1 0.9 6.2 0.0 0.0 9.4 10.7 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.4 0.0 4.2 0.8 0.5 0.7 0.0 0.5 0.0 0.4 0.4 1.0 0.5 0.3 0.7 618.3 0.2 0.3 0.5 503.7 0.4 0.3 1.5 0.3 0.4 0.6 0.4 36.2 0.1 0.3 0.1 2.4 0.1 0.3 1.5 0.4 0.4 0.6 0.4 1.1 0.0 0.0 0.0 0.0 51.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.4 15.8 0.0 1.3 0.0 2.2 1.8 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3121.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 IGSF9B "KIAA1030, LINC00947, LOC283174, MIR4697HG" ENSG00000080854 "Immunoglobulin superfamily member 9B" Q9UPX0 11 133896438-133956968 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.8;choroid plexus: 20.2" "Group enriched" "Detected in some" 4 "Excitatory neurons: 25.2;Inhibitory neurons: 11.6;Oligodendrocyte precursor cells: 30.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 38.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 10.0;SCLC-21H: 17.7;SH-SY5Y: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010802 Uncertain Approved "Golgi apparatus,Cell Junctions" NA NA "Cluster 6: Brain - Smell perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Cell Junctions" "HPA010802: AB_1079194" "unprognostic (9.04e-4)" "unprognostic (1.74e-2)" "unprognostic (7.52e-3)" "unprognostic (4.38e-4)" "unprognostic (8.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" "unprognostic (1.38e-1)" "unprognostic (8.10e-2)" "unprognostic (2.81e-1)" "unprognostic (2.99e-4)" "unprognostic (3.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-1)" "unprognostic (9.14e-4)" "unprognostic (3.12e-3)" 1.0 1.4 9.4 1.4 3.8 0.2 0.8 38.8 30.7 2.2 20.2 4.7 0.5 4.8 3.0 2.8 4.6 1.2 6.7 8.3 0.0 0.4 0.0 0.8 0.7 0.0 0.9 1.0 0.9 0.7 2.6 0.6 1.1 2.6 1.3 9.3 0.8 4.1 4.7 2.3 1.3 4.5 0.0 0.9 1.9 3.3 0.0 0.5 2.5 3.5 0.7 2.6 1.6 0.0 0.0 0.6 1.2 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.1 2.6 1.6 0.7 0.6 0.3 3.7 3.9 0.0 0.1 2.8 3.1 0.0 0.0 0.0 0.1 1.0 5.1 0.1 0.0 0.0 0.5 0.5 0.0 4.7 0.0 0.0 0.0 1.9 0.5 0.4 2.5 10.0 0.0 0.0 0.0 0.0 0.9 0.0 17.7 11.1 0.1 0.2 0.0 3.7 1.8 0.0 0.0 1.2 1.3 1.0 0.9 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.4 3.8 38.8 30.7 8.3 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 3.4 0.1 0.2 0.0 2.9 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.4 0.0 0.0 0.9 0.0 0.0 25.2 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 30.7 0.2 0.1 0.1 0.4 0.0 0.2 0.0 0.1 0.0 0.9 0.0 0.2 0.6 0.0 0.3 0.1 4.8 0.0 0.6 0.1 0.2 0.1 IL17RD "FLJ35755, IL-17RD, IL17RLM, SEF" ENSG00000144730 "Interleukin 17 receptor D" Q8NFM7 3 57089982-57170306 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 28.0" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 14.0;Early spermatids: 17.9;Late spermatids: 23.7;Microglial cells: 15.0;Peritubular cells: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 25.0;AN3-CA: 67.9;NTERA-2: 39.2;SH-SY5Y: 102.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039577, HPA043550" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Nucleoplasm "HPA039577: AB_2676580, HPA043550: AB_2678546" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (2.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-2)" "unprognostic (9.62e-2)" "unprognostic (1.17e-2)" "unprognostic (1.60e-1)" "unprognostic (3.72e-1)" "unprognostic (2.11e-3)" "unprognostic (4.79e-2)" "unprognostic (1.25e-1)" "prognostic favorable (2.92e-9)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.63e-3)" "unprognostic (9.58e-3)" 1.9 0.8 4.7 0.9 5.7 0.0 7.4 5.2 4.0 6.0 28.0 5.9 0.4 13.5 10.6 2.4 6.4 3.3 1.9 5.5 6.5 5.7 0.2 0.6 0.3 8.9 8.8 7.4 0.9 9.4 2.3 0.3 5.5 5.1 1.8 0.3 6.0 8.5 0.6 2.0 1.0 12.0 6.2 2.5 1.2 9.7 4.8 0.3 0.5 2.6 0.5 2.8 3.3 6.5 4.0 0.8 25.0 67.9 0.1 0.6 4.0 0.4 0.2 0.3 0.8 0.5 1.9 0.0 0.2 1.4 5.3 0.2 4.8 1.0 0.8 0.0 1.3 0.0 0.0 0.2 0.1 0.0 0.1 1.0 2.6 0.0 0.5 16.6 1.1 0.6 0.0 0.1 1.4 0.5 0.0 0.1 39.2 2.2 1.9 0.0 9.1 0.0 5.2 1.0 0.6 102.0 1.0 1.5 2.9 8.1 0.9 0.0 0.7 1.3 1.6 1.2 4.2 0.0 0.0 0.1 0.7 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 5.7 5.2 4.0 5.5 6.5 8.9 8.8 5.5 6.2 4.8 6.5 1.4 0.0 2.3 11.4 0.0 0.9 2.0 3.1 0.0 0.1 1.5 14.0 1.6 1.5 2.4 0.0 0.0 0.3 0.1 0.1 0.0 3.1 17.9 0.5 5.5 4.0 0.0 0.0 0.6 0.2 0.1 10.1 0.0 1.0 0.0 2.0 1.1 0.1 0.1 0.0 0.9 0.3 2.0 0.0 1.2 23.7 11.5 0.6 0.0 15.0 0.0 0.6 0.0 7.5 2.1 0.7 0.7 25.9 0.0 2.9 0.0 5.0 1.8 0.0 0.0 4.8 1.3 10.6 7.5 1.1 0.9 0.1 0.3 6.5 0.3 0.7 INSL3 "MGC119818, MGC119819, RLF, RLNL" ENSG00000248099 "Insulin like 3" P51460 19 17816512-17821574 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins" Hormone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 409.3" "Cell type enriched" "Detected in some" 19 "Theca cells: 24080.8" "Cancer enriched" "Detected in many" 21 "testis cancer: 39.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.7;PC-3: 2.6;SCLC-21H: 5.2;SH-SY5Y: 4.7" HPA028615 Enhanced "Secreted to blood" NA NA 566000 "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "HPA028615: AB_10600717" "unprognostic (3.25e-1)" "unprognostic (2.25e-4)" "unprognostic (3.50e-5)" "unprognostic (7.04e-2)" "unprognostic (1.74e-4)" "unprognostic (4.60e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.44e-1)" "unprognostic (1.73e-1)" "unprognostic (4.46e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-10)" "unprognostic (6.80e-3)" "unprognostic (1.41e-1)" "unprognostic (8.85e-2)" "unprognostic (1.09e-5)" 0.5 1.6 1.2 4.8 1.3 1.8 0.5 2.3 1.5 0.1 1.3 0.5 1.5 0.3 0.8 0.6 0.8 0.4 0.2 1.4 1.5 0.5 0.4 0.9 2.9 1.2 1.3 29.6 0.2 0.0 0.2 0.3 1.4 0.6 0.0 0.1 0.6 0.0 0.2 0.3 1.7 0.0 1.2 5.2 0.8 409.3 1.5 0.5 0.3 0.4 1.2 0.4 0.3 1.3 0.2 0.6 0.1 0.5 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 1.1 0.1 1.4 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.5 0.0 0.2 0.0 0.0 1.2 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 1.0 0.2 1.1 0.0 1.1 2.6 0.9 0.0 0.1 0.1 0.3 5.2 4.7 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.4 2.1 0.1 0.1 1.3 0.0 0.4 0.2 0.0 0.7 0.4 0.7 0.0 0.9 0.9 0.1 1.1 0.7 1.0 2.2 0.5 0.1 0.1 0.8 0.5 1.2 1.3 2.3 1.5 1.4 1.5 1.2 1.3 1.4 1.2 1.5 1.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.1 6.8 0.0 0.1 3.4 0.0 0.0 0.3 0.0 0.4 42.3 0.0 0.0 0.0 0.9 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 257.1 1240.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 998.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 2.9 5.7 0.0 0.0 0.5 0.8 24080.8 0.0 0.0 INSM2 "IA-6, Mlt1" ENSG00000168348 "INSM transcriptional repressor 2" Q96T92 14 35534164-35537054 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.6;retina: 2.7" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 7.2;Spermatocytes: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 134 "SH-SY5Y: 114.0" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Low region specificity" "Detected in some" "HPA044885, HPA051925" Uncertain Approved Nucleoplasm NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA044885: AB_10794779, HPA051925: AB_2681664" "unprognostic (9.88e-2)" "unprognostic (8.74e-2)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (3.29e-3)" "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (2.26e-3)" "unprognostic (2.60e-3)" "unprognostic (7.51e-2)" "unprognostic (1.75e-2)" "unprognostic (2.36e-3)" "unprognostic (5.00e-1)" 0.0 0.3 0.9 0.0 1.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.6 0.0 0.0 0.0 0.0 1.9 0.8 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 114.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.1 2.2 0.9 3.6 1.9 0.8 2.1 0.3 1.5 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.4 0.0 0.0 0.0 2.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.1 4.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 INSRR IRR ENSG00000027644 "Insulin receptor related receptor" P14616 1 156840063-156859117 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 14.5;kidney: 3.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.9;Cardiomyocytes: 2.3;Early spermatids: 2.8;Spermatocytes: 4.1;Spermatogonia: 5.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "medulla oblongata: 14.5;pons: 13.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 4.6;SH-SY5Y: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA025285 Uncertain NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA025285: AB_1851814" "unprognostic (1.19e-1)" "unprognostic (7.69e-2)" "unprognostic (2.42e-2)" "unprognostic (6.76e-4)" "unprognostic (1.51e-1)" "unprognostic (9.07e-3)" "unprognostic (5.57e-2)" "unprognostic (1.75e-1)" "unprognostic (6.17e-2)" "unprognostic (5.57e-2)" "unprognostic (2.20e-2)" "unprognostic (7.00e-2)" "unprognostic (4.22e-5)" "unprognostic (2.82e-1)" "unprognostic (9.55e-2)" "unprognostic (2.75e-3)" "unprognostic (3.66e-2)" 0.5 1.4 0.0 0.0 0.5 0.0 0.2 1.2 1.9 1.3 0.2 0.1 0.0 0.5 0.0 0.0 0.4 0.0 0.2 0.0 0.5 3.8 0.0 0.0 0.0 14.5 0.6 0.0 0.2 0.0 0.6 0.0 13.4 0.6 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 2.0 0.3 0.3 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.6 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 1.9 0.0 0.5 14.5 0.6 13.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.7 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.1 5.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ISL1 "Isl-1, ISLET1" ENSG00000016082 "ISL LIM homeobox 1" P61371 5 51383448-51394730 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 22.9;seminal vesicle: 19.2;vagina: 15.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 207.5;Cytotrophoblasts: 34.4;Enteroendocrine cells: 91.6;Horizontal cells: 43.7;Syncytiotrophoblasts: 34.2" "Group enriched" "Detected in some" 5 "cervical cancer: 1.1;pancreatic cancer: 4.1;prostate cancer: 2.1;stomach cancer: 1.6;testis cancer: 1.4" "Group enriched" "Detected in many" 5 "hypothalamus: 11.5;thalamus: 6.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 297.1" "Group enriched" "Detected in many" 8 "basal ganglia: 13.8;hypothalamus: 15.0;thalamus: 6.0" "Group enriched" "Detected in some" 9 "basal ganglia: 5.8;hypothalamus: 5.4" "HPA048613, HPA057416" Approved Approved "Nucleoplasm,Nuclear speckles,Mitochondria" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "Nuclear speckles, Mitochondria" "HPA048613: , HPA057416: AB_2683431" "unprognostic (4.97e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-1)" "unprognostic (2.41e-3)" "unprognostic (5.52e-2)" "unprognostic (6.79e-2)" "unprognostic (9.21e-2)" "unprognostic (9.42e-2)" "unprognostic (5.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.48e-1)" "unprognostic (9.11e-3)" "unprognostic (4.39e-3)" 2.9 1.3 0.4 0.0 1.4 0.0 0.1 0.0 1.8 7.8 0.0 1.1 2.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.0 0.5 0.0 4.8 0.0 2.2 7.8 1.2 12.0 2.4 22.9 1.1 19.2 0.0 1.1 0.7 0.1 0.0 0.0 10.0 1.6 6.0 4.3 0.3 0.0 0.4 0.7 15.9 0.2 0.0 0.0 0.0 3.4 0.0 0.0 0.2 3.0 3.8 0.0 0.0 0.3 2.7 0.0 2.5 0.0 0.0 2.2 4.6 3.4 0.0 0.0 7.1 0.0 12.6 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.9 3.2 0.0 3.0 0.0 0.0 0.0 19.1 297.1 0.0 0.0 0.0 11.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 1.8 0.0 11.5 1.0 0.5 1.2 0.0 6.0 0.2 0.0 0.0 0.0 0.0 0.1 1.5 5.1 11.8 0.0 207.5 0.0 0.0 0.2 0.0 2.8 0.0 4.2 34.4 0.0 0.5 0.0 0.1 17.3 0.0 0.0 1.7 91.6 0.0 0.0 0.0 10.9 6.1 11.7 0.0 0.0 0.0 0.0 0.0 2.7 43.7 0.0 1.9 8.2 0.0 0.4 3.2 0.3 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 1.1 0.0 0.0 0.8 11.8 0.0 0.0 4.0 2.5 7.3 0.0 1.0 34.2 0.0 0.0 0.2 5.6 ISLR2 KIAA1465 ENSG00000167178 "Immunoglobulin superfamily containing leucine rich repeat 2" Q6UXK2 15 74100311-74138540 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 32.1;testis: 13.6" "Group enriched" "Detected in some" 5 "Early spermatids: 52.1;Late spermatids: 64.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 32.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "SCLC-21H: 57.9;SH-SY5Y: 86.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012930, HPA067333" Uncertain NA NA 110000 "Cluster 78: Testis - Spermatogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" "HPA012930: AB_2668772, HPA067333: AB_2685824" "unprognostic (1.31e-2)" "unprognostic (3.27e-3)" "unprognostic (1.44e-2)" "unprognostic (8.65e-3)" "unprognostic (1.53e-3)" "unprognostic (7.73e-2)" "unprognostic (6.64e-2)" "unprognostic (1.46e-2)" "unprognostic (9.19e-3)" "unprognostic (1.72e-1)" "unprognostic (2.94e-2)" "unprognostic (2.46e-1)" "unprognostic (2.44e-4)" "unprognostic (1.31e-2)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" 1.7 1.3 9.9 0.6 32.1 0.1 1.6 0.0 16.0 2.7 0.0 1.0 0.6 2.7 0.2 0.7 1.2 1.0 4.6 11.0 3.9 0.3 0.1 0.7 2.1 0.0 0.0 0.2 0.8 0.6 0.6 0.2 0.0 0.4 0.4 1.2 0.7 0.5 2.2 0.6 1.2 1.1 0.0 0.9 0.6 13.6 6.6 0.2 0.4 3.1 0.2 0.4 0.3 8.5 0.0 0.3 5.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 57.9 86.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.2 0.1 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 9.9 32.1 0.0 16.0 11.0 3.9 0.0 0.0 0.0 0.0 6.6 8.5 9.8 0.0 0.6 0.7 0.0 0.1 0.0 0.1 0.6 1.9 0.2 0.3 6.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 52.1 0.3 3.8 3.3 0.0 0.0 5.4 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 64.1 0.3 0.2 0.0 6.5 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 1.4 0.0 0.3 0.4 1.9 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 ISOC1 CGI-111 ENSG00000066583 "Isochorismatase domain containing 1" Q96CN7 5 129094749-129114028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 156.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070307 Approved "Endoplasmic reticulum,Vesicles" NA NA 1900000 "Cluster 44: Non-specific - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 39: Non-specific - Basic cellular processes" "Endoplasmic reticulum, Vesicles" "HPA070307: AB_2686249" "unprognostic (1.67e-1)" "unprognostic (4.46e-2)" "unprognostic (1.29e-1)" "unprognostic (6.42e-3)" "unprognostic (3.87e-2)" "unprognostic (1.91e-1)" "unprognostic (6.32e-2)" "unprognostic (1.90e-1)" "unprognostic (2.47e-1)" "unprognostic (4.19e-2)" "unprognostic (2.00e-2)" "unprognostic (4.18e-1)" "unprognostic (7.09e-3)" "unprognostic (2.49e-1)" "unprognostic (2.65e-1)" "unprognostic (1.65e-2)" "unprognostic (1.32e-2)" 27.8 28.0 11.9 12.8 12.2 12.6 25.5 11.9 13.7 57.2 11.4 19.6 32.1 102.7 21.0 22.1 27.2 15.6 65.7 11.1 16.0 33.6 100.2 14.0 14.6 15.9 16.4 17.1 19.9 15.7 20.5 15.3 13.8 19.7 21.7 14.8 28.4 8.9 17.1 23.5 28.3 64.9 13.8 10.0 20.4 11.1 15.2 18.9 13.3 16.4 16.8 21.3 19.2 15.2 27.7 21.4 21.7 33.5 35.0 18.5 95.7 11.7 10.0 13.1 23.1 75.5 38.2 19.6 28.3 6.9 40.0 14.7 46.5 35.2 24.2 107.5 52.8 39.0 20.9 55.7 24.7 15.6 13.6 12.2 10.5 20.5 17.7 9.4 31.6 30.6 43.0 33.2 11.6 110.2 29.2 25.3 33.5 26.4 57.8 41.5 63.2 19.3 32.9 55.4 36.6 156.9 33.7 42.3 21.6 19.7 34.9 13.0 13.4 14.8 28.1 11.9 38.3 27.5 22.9 32.7 16.5 48.4 17.0 64.0 25.2 38.0 54.0 25.0 61.4 47.7 50.3 57.7 31.5 49.4 43.9 51.8 30.9 61.4 25.3 29.0 69.0 48.9 11.9 12.2 11.9 13.7 11.1 16.0 15.9 16.4 13.8 13.8 15.2 15.2 58.1 12.8 17.2 6.5 18.9 131.8 42.4 28.5 88.2 12.4 33.6 19.8 70.6 34.3 19.3 20.2 10.4 74.7 26.3 19.9 125.2 22.2 1.6 23.5 30.1 16.9 31.8 21.0 1.7 28.1 71.8 33.9 17.3 24.9 18.4 51.0 5.3 84.7 23.9 0.0 5.6 26.6 30.5 8.8 41.0 4.2 13.7 14.3 28.4 4.7 18.9 52.9 18.6 6.0 9.2 16.3 29.8 19.2 36.9 38.5 45.7 96.2 10.6 6.5 0.0 33.7 15.9 6.5 38.1 53.7 84.1 50.9 26.4 79.3 32.8 37.8 ITGA9 "ALPHA-RLC, ITGA4L, RLC" ENSG00000144668 "Integrin subunit alpha 9" Q13797 3 37452115-37823507 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.0;Hepatic stellate cells: 54.3;Inhibitory neurons: 61.0;Leydig cells: 41.3;Microglial cells: 53.4;Oligodendrocyte precursor cells: 93.5;Peritubular cells: 74.9" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 23.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 10.1;HEL: 8.1;SH-SY5Y: 11.8;SuSa: 16.9;WM-115: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030609 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 500000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA030609: AB_10600815" "unprognostic (2.35e-2)" "unprognostic (3.36e-2)" "unprognostic (5.58e-2)" "unprognostic (3.94e-2)" "unprognostic (4.48e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (8.87e-3)" "unprognostic (3.23e-1)" "unprognostic (2.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-2)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-2)" "unprognostic (3.16e-2)" 8.8 15.5 1.9 4.5 1.8 8.5 5.9 0.0 6.2 21.8 3.6 9.6 6.3 10.6 4.0 15.5 5.4 9.4 20.1 7.8 0.7 4.0 14.8 8.9 4.1 0.9 1.3 5.0 1.8 2.6 1.7 9.8 0.4 12.5 6.8 0.7 4.2 10.8 2.8 3.0 9.1 15.8 0.7 22.6 7.5 6.9 5.0 1.8 20.7 9.8 2.4 6.5 4.5 1.2 0.2 0.0 4.3 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 10.1 0.0 3.2 1.4 0.0 0.1 0.2 3.8 0.0 0.0 0.1 0.6 8.1 0.1 0.2 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.4 0.3 0.0 0.2 0.5 11.8 0.1 0.5 0.7 16.9 0.0 3.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 6.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.8 0.0 6.2 7.8 0.7 0.9 1.3 0.4 0.7 5.0 1.2 20.8 0.0 14.7 16.0 0.1 2.5 1.1 0.1 1.2 1.2 1.1 2.9 12.9 2.8 3.1 1.8 0.0 0.2 0.0 0.0 0.0 0.1 1.5 1.4 4.9 21.6 0.0 3.0 82.0 0.0 0.5 7.5 0.0 0.9 6.3 36.2 54.3 1.3 2.8 0.0 61.0 0.1 0.0 31.9 2.2 4.2 41.3 5.7 3.6 53.4 0.1 0.6 0.0 93.5 6.2 0.0 0.0 74.9 0.4 0.2 0.0 0.1 0.0 0.0 0.0 3.2 3.3 0.6 0.9 0.0 1.7 0.3 1.8 25.9 0.4 0.3 JPH4 "JPHL1, KIAA1831" ENSG00000092051 "Junctophilin 4" Q96JJ6 14 23568035-23578790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 126.2;pituitary gland: 66.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 191.4;Horizontal cells: 410.5" "Cancer enhanced" "Detected in some" "glioma: 6.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;myeloid DC: 3.2" "Group enriched" "Detected in many" 8 "dendritic cells: 3.2;monocytes: 2.8" "Group enriched" "Detected in some" 6 "SCLC-21H: 14.2;SH-SY5Y: 35.4;U-2 OS: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045022 Approved Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Cytosol "HPA045022: " "unprognostic (3.30e-2)" "unprognostic (1.91e-3)" "unprognostic (5.05e-3)" "unprognostic (7.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.84e-1)" "unprognostic (3.77e-3)" "unprognostic (5.98e-4)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (3.89e-3)" "unprognostic (1.15e-2)" "unprognostic (3.15e-2)" "unprognostic (2.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.13e-2)" "unprognostic (4.96e-3)" 1.5 11.7 83.7 1.0 88.5 0.2 1.0 25.2 126.2 8.4 0.0 1.7 0.8 24.3 5.2 0.4 13.7 0.5 0.3 115.4 29.3 3.0 0.3 2.5 1.0 14.5 11.0 13.6 0.5 1.8 66.5 0.5 11.2 12.3 0.6 12.5 0.3 36.8 0.2 0.9 1.3 12.9 7.2 2.6 0.9 1.4 31.7 0.3 0.4 0.5 0.6 1.6 6.6 57.2 0.0 0.0 0.7 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.2 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.7 14.2 35.4 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.3 2.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 83.7 88.5 25.2 126.2 115.4 29.3 14.5 11.0 11.2 7.2 31.7 57.2 0.3 0.0 0.6 0.7 0.0 0.0 0.2 0.0 0.0 191.4 0.2 0.1 1.3 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.3 0.3 5.7 1.7 1.8 0.0 22.1 0.0 0.0 1.4 0.0 0.1 5.1 1.2 1.8 0.0 2.0 410.5 18.3 0.2 0.0 1.3 9.3 0.2 10.8 0.9 0.0 0.0 0.1 1.6 0.0 15.6 0.4 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 7.7 13.1 0.1 2.3 0.5 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 KCNH1 "eag, eag1, h-eag, hEAG, Kv10.1" ENSG00000143473 "Potassium voltage-gated channel subfamily H member 1" O95259 1 210676823-211134165 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 17.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 533.5;Inhibitory neurons: 261.0;Oligodendrocytes: 116.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 6.2;RH-30: 10.1;RPTEC TERT1: 6.0;SH-SY5Y: 12.9;SK-MEL-30: 12.9;T-47d: 9.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 34.0;cerebellum: 19.1;cerebral cortex: 23.9;hippocampal formation: 17.9;olfactory bulb: 8.9" "HPA014551, HPA019445, HPA076421" Enhanced Supported Vesicles NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: " "unprognostic (9.12e-2)" "unprognostic (4.82e-3)" "unprognostic (2.63e-1)" "unprognostic (6.70e-2)" "unprognostic (3.56e-1)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (9.36e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.77e-2)" "unprognostic (1.42e-3)" "unprognostic (1.17e-1)" "unprognostic (8.89e-2)" "unprognostic (1.36e-1)" "unprognostic (9.70e-2)" 0.2 0.9 6.8 0.4 9.2 0.0 0.2 9.5 17.9 0.7 2.7 0.5 0.3 0.4 0.2 0.1 0.6 0.2 0.0 11.2 5.3 0.1 0.1 0.0 0.0 4.8 4.4 0.1 0.2 0.0 0.7 0.3 4.0 0.5 0.3 0.3 0.1 0.1 0.2 0.1 0.8 0.2 4.0 0.0 0.5 1.5 4.9 0.2 0.1 0.6 0.0 0.2 0.4 8.3 0.0 2.1 0.4 0.1 0.0 0.1 0.1 1.0 0.2 2.1 2.4 0.0 0.0 0.0 0.0 1.4 2.4 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 6.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 10.1 0.0 6.0 0.0 0.4 12.9 2.4 0.2 12.9 1.7 9.2 0.0 0.0 1.6 0.2 2.0 1.2 0.0 0.0 0.0 0.2 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.8 9.2 9.5 17.9 11.2 5.3 4.8 4.4 4.0 4.0 4.9 8.3 0.2 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 11.2 0.2 2.8 0.1 0.0 0.0 533.5 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 261.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 7.5 0.0 0.0 0.0 19.1 116.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNH8 "elk3, Kv12.1" ENSG00000183960 "Potassium voltage-gated channel subfamily H member 8" Q96L42 3 19148510-19535642 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.0;pituitary gland: 10.7" "Group enriched" "Detected in some" 63 "Oligodendrocyte precursor cells: 331.7;Oligodendrocytes: 989.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 4 "B-cells: 1.4" "Cell line enhanced" "Detected in some" "HAP1: 1.0;OE19: 1.9;SH-SY5Y: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA016586, HPA077537, HPA077773" Approved Supported "Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" "HPA016586: AB_1852127, HPA077537: , HPA077773: " "unprognostic (6.68e-3)" "unprognostic (1.68e-1)" "unprognostic (2.99e-2)" "unprognostic (8.56e-6)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (1.69e-1)" "unprognostic (5.04e-3)" "unprognostic (2.90e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (3.89e-2)" "unprognostic (8.71e-5)" "unprognostic (1.72e-1)" 0.0 1.8 7.3 0.3 11.9 0.2 0.5 6.5 16.0 0.3 2.8 0.6 0.4 0.1 0.1 0.1 0.2 0.4 0.2 6.4 8.8 0.1 0.1 0.0 0.8 8.4 8.8 0.0 1.5 0.1 10.7 0.0 8.2 0.7 0.5 3.4 1.1 0.2 0.0 0.4 1.1 0.1 5.8 1.1 1.4 1.7 9.7 0.4 0.2 0.0 0.7 0.1 0.3 15.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.3 11.9 6.5 16.0 6.4 8.8 8.4 8.8 8.2 5.8 9.7 15.4 0.0 0.0 0.0 2.0 9.7 0.5 1.6 0.0 0.0 4.2 1.1 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 3.2 0.1 0.1 0.1 3.6 0.0 9.3 0.6 0.0 0.1 2.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 10.4 1.5 0.0 0.0 0.0 1.9 0.0 0.1 3.6 1.0 0.0 3.4 0.0 331.7 989.4 0.5 0.2 0.0 0.1 1.5 0.0 0.0 0.0 1.0 0.0 0.2 0.5 1.2 3.4 0.0 0.0 0.1 0.3 0.1 0.6 0.4 KCNJ3 "GIRK1, KGA, Kir3.1" ENSG00000162989 "Potassium inwardly rectifying channel subfamily J member 3" P48549 2 154697855-154858354 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.7" "Group enriched" "Detected in many" 5 "Excitatory neurons: 309.6;Horizontal cells: 124.5;Inhibitory neurons: 431.3" "Group enriched" "Detected in many" 5 "breast cancer: 12.2;renal cancer: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.5;SH-SY5Y: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024231, HPA064138" Uncertain Approved "Plasma membrane,Mitochondria" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria "Plasma membrane" "HPA024231: AB_1855558, HPA064138: " "unprognostic (1.45e-1)" "unprognostic (9.42e-2)" "unprognostic (2.66e-2)" "unprognostic (4.49e-4)" "unprognostic (8.89e-2)" "unprognostic (6.81e-2)" "unprognostic (7.24e-3)" "unprognostic (1.15e-2)" "unprognostic (4.25e-3)" "unprognostic (3.72e-3)" "unprognostic (3.33e-1)" "unprognostic (8.90e-3)" "unprognostic (3.75e-2)" "unprognostic (5.59e-1)" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" 0.5 1.4 5.7 0.1 8.7 0.1 0.3 32.7 17.0 1.6 4.7 0.8 10.7 0.1 1.1 0.1 0.4 1.3 15.1 14.6 3.7 10.5 3.1 0.2 0.0 2.2 4.3 0.1 2.1 10.4 6.8 0.0 2.4 6.5 0.8 5.0 0.0 11.3 5.3 0.1 9.5 0.2 1.6 0.4 0.7 0.4 4.1 0.0 0.1 0.2 0.0 0.4 0.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.4 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.1 0.1 0.1 5.7 8.7 32.7 17.0 14.6 3.7 2.2 4.3 2.4 1.6 4.1 6.4 0.3 0.0 0.0 38.8 0.0 0.8 5.3 0.0 0.0 10.9 3.7 1.7 49.0 5.7 0.0 20.2 14.6 0.0 0.0 0.1 5.9 0.1 0.3 0.0 0.0 1.3 31.1 0.0 309.6 3.2 0.0 5.4 0.0 0.0 0.0 0.0 0.0 1.3 0.1 124.5 431.3 7.0 0.0 0.0 2.1 0.0 6.2 0.6 1.8 5.6 0.0 0.7 0.0 32.6 6.8 0.0 1.2 4.1 0.0 6.1 16.2 8.7 0.0 3.9 0.0 8.0 1.6 0.4 0.3 0.0 1.8 0.0 0.8 1.9 8.4 4.7 KCNQ2 "BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2" ENSG00000075043 "Potassium voltage-gated channel subfamily Q member 2" O43526 20 63400208-63472677 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 91.9" "Cell type enhanced" "Detected in some" "Early spermatids: 16.5;Excitatory neurons: 61.7;Horizontal cells: 13.5;Inhibitory neurons: 37.5;Oligodendrocyte precursor cells: 50.8;Spermatogonia: 28.3" "Cancer enriched" "Detected in some" 9 "glioma: 8.7" "Group enriched" "Detected in many" 4 "amygdala: 55.7;basal ganglia: 37.2;cerebellum: 27.8;cerebral cortex: 91.9;hippocampal formation: 68.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 21.2;AN3-CA: 35.0;NTERA-2: 19.3;SCLC-21H: 67.8;SH-SY5Y: 119.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016642, HPA057112" Enhanced Approved "Endoplasmic reticulum" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Endoplasmic reticulum" "HPA016642: AB_1855555, HPA057112: AB_2683339" "unprognostic (2.35e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-4)" "unprognostic (8.21e-6)" "unprognostic (6.18e-2)" "unprognostic (7.58e-2)" "unprognostic (6.06e-2)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.96e-2)" "unprognostic (9.39e-2)" "unprognostic (1.43e-5)" "unprognostic (4.36e-2)" "unprognostic (1.02e-1)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" 0.0 6.2 55.7 0.1 37.2 0.0 0.0 27.8 91.9 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.3 0.3 0.2 68.1 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 1.1 0.0 19.1 0.0 0.1 1.6 0.0 2.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.2 10.6 1.0 0.0 0.0 0.0 0.0 0.0 0.1 12.9 0.0 0.0 21.2 35.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.6 0.0 8.3 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 19.3 0.5 0.2 0.0 0.0 0.1 0.0 0.0 67.8 119.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 55.7 37.2 27.8 91.9 68.1 0.0 2.6 0.0 0.1 0.0 1.0 12.9 0.6 0.0 0.0 7.2 0.1 0.1 0.0 0.0 0.0 5.7 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 16.5 0.0 0.1 1.0 0.0 0.0 61.7 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.5 37.5 0.2 0.0 0.0 0.0 8.1 0.6 0.1 0.0 1.0 0.0 0.9 0.0 50.8 2.1 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.0 2.5 0.0 0.1 0.1 7.4 28.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 KCTD15 MGC25497 ENSG00000153885 "Potassium channel tetramerization domain containing 15" Q96SI1 19 33795933-33815763 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 44.4;Granulosa cells: 94.8;Hepatic stellate cells: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 1.8;eosinophil: 5.9;intermediate monocyte: 3.3;myeloid DC: 2.5;non-classical monocyte: 4.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.5;granulocytes: 5.9;monocytes: 4.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050822 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA050822: AB_2681250" "unprognostic (1.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.41e-1)" "unprognostic (6.62e-3)" "unprognostic (1.67e-2)" "unprognostic (2.66e-2)" "unprognostic (3.09e-2)" "unprognostic (5.60e-2)" "unprognostic (6.33e-2)" "unprognostic (5.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.65e-8)" "unprognostic (1.40e-1)" "unprognostic (1.89e-3)" "unprognostic (6.13e-2)" "unprognostic (7.30e-2)" 19.2 6.3 29.4 11.3 28.0 6.1 14.2 24.9 34.9 38.8 15.0 41.3 7.0 43.1 3.2 34.8 36.1 10.8 19.1 28.7 29.6 24.7 12.9 24.7 3.0 26.0 30.2 22.7 32.5 4.5 10.3 11.0 24.2 25.0 6.0 15.2 11.6 19.0 6.0 73.2 15.7 20.7 25.8 17.4 23.3 10.5 30.2 1.3 23.0 6.4 4.1 32.0 31.3 23.3 16.7 37.5 33.2 50.8 10.8 5.7 26.2 21.6 4.0 11.7 6.1 21.2 11.1 0.1 47.6 30.3 5.5 19.3 24.3 16.9 4.4 18.1 42.7 68.5 25.3 20.7 29.8 13.3 12.0 11.2 69.4 4.5 26.5 0.0 23.2 9.8 17.3 0.4 2.0 42.0 0.5 37.8 30.4 27.9 62.8 32.0 17.9 6.3 13.3 7.5 25.7 88.0 42.0 59.0 80.0 14.1 43.7 34.7 38.3 54.7 48.9 1.1 3.8 40.9 2.3 27.2 0.1 23.0 68.4 0.6 1.8 5.9 0.0 3.3 0.1 0.0 0.8 0.1 2.5 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.5 0.7 29.4 28.0 24.9 34.9 28.7 29.6 26.0 30.2 24.2 25.8 30.2 23.3 17.8 0.0 1.7 44.4 0.3 15.8 3.3 4.1 10.8 3.5 5.4 5.0 3.2 1.5 2.9 0.0 10.4 0.2 0.4 0.9 3.9 0.7 0.7 3.4 15.1 15.3 1.2 4.2 1.9 8.4 0.4 5.5 1.5 2.5 8.8 94.8 27.8 2.0 1.2 1.7 5.3 3.6 0.0 3.7 5.4 1.9 4.4 3.7 5.4 4.7 3.1 5.0 0.0 11.1 0.3 2.1 1.0 9.1 0.1 3.9 0.3 0.2 0.7 11.7 0.0 3.1 8.7 0.0 1.9 14.3 19.5 0.3 0.7 2.4 1.9 3.1 KIAA0408 ENSG00000189367 KIAA0408 Q6ZU52 6 127438406-127459389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.6;skeletal muscle: 28.3" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 93.0;Alveolar cells type 2: 27.1;Skeletal myocytes: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 10.4;SCLC-21H: 33.3;SH-SY5Y: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044035, HPA053341" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm Cytosol "HPA044035: AB_10964274, HPA053341: AB_2732578" "unprognostic (1.06e-1)" "unprognostic (4.36e-2)" "unprognostic (3.06e-1)" "unprognostic (1.09e-1)" "unprognostic (8.56e-4)" "unprognostic (1.00e-1)" "unprognostic (4.95e-2)" "unprognostic (6.05e-3)" "unprognostic (2.29e-1)" "unprognostic (5.94e-2)" "unprognostic (3.20e-2)" 16.8 2.3 16.9 0.9 18.4 0.0 3.7 20.1 32.6 4.3 8.0 9.7 0.9 2.9 1.8 6.2 2.0 1.6 2.1 18.2 17.4 1.2 0.7 13.2 0.3 16.7 16.9 2.5 0.8 0.0 13.9 0.3 17.2 4.3 3.6 8.7 1.8 1.1 28.3 1.0 4.3 1.8 18.0 2.0 5.4 4.0 17.7 0.3 0.9 10.4 0.2 6.0 3.6 19.6 0.0 2.1 10.4 0.0 0.8 1.7 0.0 0.2 1.3 1.1 2.7 0.0 0.0 0.0 0.0 0.2 7.0 0.0 1.0 0.0 1.6 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.0 4.3 0.0 0.9 0.0 1.2 0.0 0.0 1.2 0.0 4.7 0.0 4.8 0.0 0.0 0.0 2.6 0.0 0.2 0.0 33.3 17.8 0.0 0.0 0.2 0.0 0.0 1.1 0.0 5.3 0.8 0.0 1.9 0.0 0.0 0.0 4.7 0.3 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 18.4 20.1 32.6 18.2 17.4 16.7 16.9 17.2 18.0 17.7 19.6 0.4 93.0 27.1 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.4 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.1 0.7 0.0 0.3 8.4 0.0 0.0 0.0 0.3 0.3 0.6 0.9 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.1 3.6 1.1 0.0 34.3 0.5 1.0 0.1 0.0 0.0 0.1 0.1 3.4 0.0 0.0 KIAA1549 ENSG00000122778 KIAA1549 Q9HCM3 7 138831381-138981389 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 56.3;Excitatory neurons: 92.2;Inhibitory neurons: 54.6;Oligodendrocyte precursor cells: 69.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 20.6;SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019560 Uncertain Approved "Nuclear membrane,Intermediate filaments" NA NA 14000 "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear membrane" "Intermediate filaments" "HPA019560: AB_1852418" "unprognostic (7.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.63e-1)" "unprognostic (6.85e-2)" "unprognostic (2.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.55e-2)" "unprognostic (6.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (2.33e-2)" "unprognostic (8.30e-2)" "prognostic favorable (3.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "unprognostic (2.38e-1)" "unprognostic (1.28e-2)" 0.6 1.7 2.7 0.3 3.0 0.3 1.5 0.0 4.4 1.4 0.0 0.8 0.7 1.7 1.8 0.5 2.2 1.0 1.2 4.3 0.8 3.9 0.4 1.8 0.2 1.6 2.5 1.2 6.3 2.4 1.8 1.3 0.0 1.5 0.7 5.7 2.4 5.5 0.5 0.8 0.7 1.3 1.4 0.3 1.3 1.2 2.5 2.4 0.7 0.8 0.2 1.1 0.6 2.4 4.9 9.2 9.1 14.9 0.1 0.0 4.2 5.2 4.6 2.6 3.4 8.4 2.6 0.0 2.9 8.2 8.6 1.0 5.7 1.4 3.6 2.5 3.8 2.6 11.5 2.2 1.3 3.8 3.2 1.2 2.8 0.9 1.4 3.5 4.8 3.4 1.7 0.1 3.6 4.5 2.9 4.7 7.8 4.1 20.6 6.8 4.5 0.0 1.7 3.3 11.8 21.5 2.6 5.2 2.2 5.1 3.7 2.4 3.3 2.9 2.8 0.1 5.1 0.9 0.0 0.1 4.0 1.4 7.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 3.0 0.0 4.4 4.3 0.8 1.6 2.5 0.0 1.4 2.5 2.4 2.0 0.0 2.2 11.8 0.1 0.5 2.1 1.6 0.6 18.5 6.3 4.6 2.5 0.0 2.9 7.3 56.3 2.5 0.2 0.3 0.0 2.3 0.5 8.5 8.1 4.8 10.8 1.3 92.2 3.2 2.2 3.0 3.6 8.0 16.5 13.8 2.2 0.8 0.5 3.3 54.6 2.5 6.1 0.8 1.2 0.2 1.5 0.5 1.8 26.2 0.0 7.2 0.0 69.9 2.2 5.0 1.4 2.6 1.0 3.1 0.5 8.1 12.2 29.2 6.6 2.2 2.9 0.3 7.2 0.1 0.9 1.5 1.1 2.4 2.9 1.6 KIAA1614 ENSG00000135835 KIAA1614 Q5VZ46 1 180912897-180951614 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 25.3" "Group enriched" "Detected in many" 13 "Bipolar cells: 95.3;Cone photoreceptor cells: 131.3;Rod photoreceptor cells: 176.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.3" "Cell line enhanced" "Detected in many" "RH-30: 17.8;SH-SY5Y: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028227, HPA061684" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "Nuclear membrane, Vesicles" "HPA028227: AB_10601765, HPA061684: AB_2684585" "unprognostic (3.23e-1)" "unprognostic (3.60e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-2)" "unprognostic (1.05e-1)" "unprognostic (3.55e-2)" "unprognostic (8.76e-3)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.15e-2)" "unprognostic (1.57e-1)" "unprognostic (8.61e-5)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.36e-2)" "unprognostic (1.35e-2)" 5.7 1.2 3.8 1.3 3.9 0.4 4.0 15.4 6.1 7.2 4.3 8.4 2.4 8.1 1.3 3.5 6.1 2.5 7.7 4.9 2.4 6.2 0.5 3.6 1.2 3.6 3.2 5.8 1.7 0.3 1.8 2.8 2.9 4.8 0.6 25.3 3.2 2.1 2.0 2.5 2.9 3.1 2.8 2.5 3.2 1.7 4.0 0.3 6.1 0.4 0.4 7.4 4.2 5.3 1.7 0.8 1.4 3.0 4.3 10.5 4.8 3.3 3.8 1.6 0.9 1.6 1.7 0.7 3.0 4.1 0.8 3.2 0.3 0.1 0.5 0.9 1.3 2.4 0.6 2.2 5.9 1.5 1.7 5.0 0.1 0.2 0.1 2.7 2.2 2.5 2.1 1.1 1.4 1.4 2.1 0.6 3.3 0.5 0.4 1.1 17.8 2.5 2.6 1.6 12.2 44.7 1.0 1.1 7.3 1.4 1.3 2.1 5.2 3.4 2.5 4.0 1.3 2.3 3.2 1.6 0.4 1.2 2.3 1.3 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 3.8 3.9 15.4 6.1 4.9 2.4 3.6 3.2 2.9 2.8 4.0 5.3 1.0 0.0 1.8 9.8 0.5 0.4 0.8 0.8 0.6 95.3 0.5 0.6 3.5 1.5 1.3 1.8 131.3 0.3 0.5 0.0 1.9 0.4 4.6 0.8 3.6 2.1 0.0 0.0 5.0 0.2 0.4 3.3 0.0 2.2 1.3 1.6 1.8 0.1 1.8 3.3 1.5 0.0 0.0 0.3 0.4 1.8 7.8 0.5 3.6 1.0 1.0 10.0 0.0 4.5 1.4 0.7 0.0 5.7 0.1 0.4 0.2 1.8 0.1 176.0 6.6 8.4 2.4 0.6 0.6 0.2 0.3 0.3 0.4 0.6 0.1 0.0 KIDINS220 ARMS ENSG00000134313 "Kinase D interacting substrate 220" Q9ULH0 2 8721081-8837630 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Neurogenesis "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 322.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014790 Supported Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA014790: AB_1852460" "unprognostic (3.58e-1)" "unprognostic (1.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-3)" "unprognostic (2.05e-1)" "unprognostic (2.01e-1)" "unprognostic (1.33e-2)" "prognostic favorable (9.64e-4)" "unprognostic (1.68e-1)" "unprognostic (9.21e-2)" "unprognostic (9.74e-2)" "unprognostic (7.39e-2)" "prognostic favorable (9.29e-6)" "unprognostic (4.12e-2)" "unprognostic (1.47e-1)" "unprognostic (9.27e-2)" "unprognostic (1.15e-1)" 21.2 21.6 20.9 14.5 40.6 24.4 19.6 34.9 27.5 22.3 21.6 19.6 11.4 29.3 15.3 15.1 16.6 17.7 21.9 22.1 28.9 22.1 15.7 23.6 13.1 43.9 31.5 37.7 18.8 42.8 16.9 21.4 43.4 20.0 16.5 38.0 14.5 18.0 14.5 16.7 13.8 23.6 35.7 17.1 16.5 10.6 32.0 21.6 20.0 16.7 12.3 16.7 17.9 73.9 13.5 21.3 41.8 26.8 51.4 33.9 21.9 26.2 21.6 16.4 15.0 21.5 13.5 25.2 26.1 39.4 31.5 22.5 37.9 16.1 24.0 36.4 25.7 22.7 15.9 22.6 36.3 23.6 29.9 35.3 24.9 26.1 33.7 25.1 25.9 21.6 44.7 30.8 29.2 14.8 24.2 12.7 22.7 22.3 18.8 22.7 30.7 12.7 21.7 25.4 35.4 59.3 20.8 20.7 23.6 21.7 13.3 26.6 34.4 36.1 19.0 36.6 28.5 22.4 21.1 33.5 21.1 31.2 28.1 4.1 3.4 4.2 3.6 3.9 2.6 1.9 2.6 3.0 2.7 1.8 2.7 3.1 5.3 3.2 4.6 1.8 2.4 2.2 20.9 40.6 34.9 27.5 22.1 28.9 43.9 31.5 43.4 35.7 32.0 73.9 57.1 99.3 115.7 129.6 25.2 32.8 27.6 25.1 19.9 86.2 31.3 25.0 40.2 25.8 48.6 29.5 139.7 21.5 35.0 33.9 0.0 33.3 1.3 32.3 77.8 51.8 43.3 36.4 108.3 23.6 10.0 55.0 39.8 53.1 35.4 144.0 47.8 30.9 28.8 154.8 149.2 23.4 44.7 52.7 46.0 5.9 69.6 45.9 24.9 60.9 44.2 60.5 34.0 162.3 322.2 29.0 29.8 65.5 27.3 25.7 24.5 10.5 34.4 58.0 6.6 65.4 54.2 28.1 23.4 26.4 29.5 10.9 40.2 52.1 23.9 36.0 KIF21A "FEOM1, FLJ20052" ENSG00000139116 "Kinesin family member 21A" Q7Z4S6 12 39293228-39443390 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.3;retina: 77.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 308.6;Cone photoreceptor cells: 308.6;Inhibitory neurons: 221.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 7.1;MAIT T-cell: 3.4;memory CD4 T-cell: 4.4;memory CD8 T-cell: 7.3;naive CD8 T-cell: 4.8;NK-cell: 3.0;T-reg: 2.2" "Group enriched" "Detected in many" 9 "NK-cells: 3.0;T-cells: 7.3" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 187.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022079, HPA058432" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Plasma membrane" Cytosol "CAB022079: , HPA058432: AB_2683717" "unprognostic (1.08e-3)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (7.67e-2)" "unprognostic (1.13e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-3)" "unprognostic (7.77e-2)" "unprognostic (3.17e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.73e-2)" "prognostic favorable (8.07e-8)" "unprognostic (4.05e-2)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (2.34e-2)" 6.5 12.1 37.4 3.9 40.0 0.9 6.2 41.4 51.2 12.3 8.0 11.9 9.0 9.2 5.5 20.9 33.7 6.1 19.2 38.2 55.7 26.5 20.5 5.9 2.9 67.4 46.6 4.5 13.2 16.6 16.0 5.7 70.3 11.2 13.1 77.6 23.9 3.1 15.3 12.7 10.3 8.7 39.3 6.5 12.5 12.5 46.5 2.2 8.8 9.5 5.3 5.9 11.4 44.3 18.5 23.2 31.8 13.7 6.0 3.0 25.4 4.5 2.2 5.9 4.1 42.2 22.4 0.0 14.1 1.9 9.4 16.0 18.5 11.2 5.4 36.1 14.7 0.2 40.6 38.6 4.6 31.0 0.1 2.0 24.4 7.4 35.3 13.4 7.7 7.8 35.4 36.9 4.8 11.1 4.0 0.0 42.8 0.0 20.0 0.1 0.0 21.1 22.3 30.1 43.0 187.6 17.7 27.7 10.8 32.1 32.2 3.9 5.6 3.4 13.7 1.1 13.1 16.7 6.1 0.0 8.1 4.4 2.9 0.0 0.0 0.0 7.1 0.0 3.4 0.5 4.4 7.3 0.0 0.0 1.0 4.8 0.1 3.0 0.0 0.0 2.2 1.0 37.4 40.0 41.4 51.2 38.2 55.7 67.4 46.6 70.3 39.3 46.5 44.3 4.1 38.5 17.5 205.7 5.3 18.5 25.1 25.9 4.6 308.6 10.9 11.0 121.9 22.8 53.9 12.9 308.6 15.3 36.2 30.0 9.8 27.8 108.4 78.1 30.2 5.5 24.0 2.5 189.9 41.3 100.8 17.2 36.2 27.7 13.4 92.7 12.8 44.2 3.8 138.0 221.0 28.7 22.4 2.5 2.2 79.9 3.1 2.4 14.2 23.4 7.8 112.3 25.7 124.1 160.3 37.2 20.0 2.6 30.7 37.5 20.7 53.3 193.9 186.1 0.0 26.1 17.4 57.2 24.0 30.5 30.7 59.1 33.5 17.7 29.3 21.7 KIF26A "DKFZP434N178, KIAA1236" ENSG00000066735 "Kinesin family member 26A" Q9ULI4 14 104138723-104180894 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 22.4;Endothelial cells: 11.9;Enteroendocrine cells: 7.7;Hepatic stellate cells: 13.9;Horizontal cells: 18.5;Spermatogonia: 8.1" "Group enriched" "Detected in many" 5 "stomach cancer: 3.8;testis cancer: 14.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 30.6;MCF7: 24.9;NTERA-2: 20.8;REH: 18.8;SCLC-21H: 19.2;SH-SY5Y: 39.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046882, HPA060346" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Plasma membrane, Cytosol" "HPA046882: AB_2679856, HPA060346: AB_2684259" "unprognostic (3.01e-1)" "unprognostic (3.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.77e-2)" "unprognostic (2.79e-1)" "unprognostic (1.12e-1)" "unprognostic (5.49e-3)" "unprognostic (1.69e-1)" "unprognostic (1.21e-2)" "unprognostic (3.31e-3)" "unprognostic (5.24e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (7.78e-4)" "unprognostic (7.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.12e-2)" "unprognostic (4.68e-3)" 5.0 2.3 2.1 0.7 1.3 2.0 4.6 0.5 1.5 5.0 3.0 2.6 0.4 2.4 0.2 1.4 2.6 0.4 5.7 0.8 1.4 3.8 0.6 2.2 0.3 1.3 1.3 4.1 5.7 0.3 2.9 1.8 1.4 0.8 0.4 0.1 1.0 0.8 2.9 2.8 1.9 0.4 0.9 4.2 1.8 2.8 1.8 0.2 1.5 1.0 0.1 2.0 2.1 0.5 0.0 1.7 1.0 3.9 0.0 0.0 6.7 0.3 0.0 0.0 0.0 3.1 0.0 0.0 5.3 0.0 0.7 2.5 3.1 0.0 0.0 0.0 4.9 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 6.7 0.0 0.0 0.0 24.9 0.0 0.0 20.8 0.2 2.0 18.8 7.9 2.0 0.0 0.0 19.2 39.3 4.4 0.6 0.0 2.5 0.4 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.3 0.5 1.5 0.8 1.4 1.3 1.3 1.4 0.9 1.8 0.5 22.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.3 0.1 3.2 0.0 0.0 1.8 0.0 1.0 0.0 1.3 1.9 0.7 0.4 0.2 4.4 11.9 7.7 4.8 0.5 0.2 0.8 2.1 0.0 0.2 0.0 0.4 13.9 0.2 2.6 18.5 0.7 2.6 0.0 0.3 1.1 0.1 0.0 0.1 1.8 3.7 0.0 0.2 0.0 0.0 0.1 0.2 1.0 0.7 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.7 0.7 0.2 8.1 1.2 1.7 0.4 0.1 0.3 2.8 0.0 KIF26B FLJ10157 ENSG00000162849 "Kinesin family member 26B" Q2KJY2 1 245154985-245709432 "Predicted intracellular proteins" "Developmental protein, Motor protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.2" "Group enriched" "Detected in many" 4 "Inhibitory neurons: 282.0;Oligodendrocyte precursor cells: 378.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 18 "plasmacytoid DC: 1.8" "Lineage enriched" "Detected in single" 18 "dendritic cells: 1.8" "Cell line enhanced" "Detected in some" "HSkMC: 16.5;REH: 15.2;SH-SY5Y: 14.4;U-937: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027709, HPA028478, HPA028561, HPA028562" Enhanced Approved "Plasma membrane,Microtubules" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane, Microtubules" "HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417" "unprognostic (3.66e-1)" "unprognostic (5.67e-2)" "unprognostic (7.90e-3)" "unprognostic (4.50e-3)" "unprognostic (3.23e-2)" "unprognostic (1.49e-1)" "unprognostic (4.17e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (8.30e-3)" "unprognostic (3.63e-1)" "unprognostic (1.38e-1)" "unprognostic (1.13e-2)" "unprognostic (5.77e-2)" "unprognostic (1.17e-4)" "unprognostic (7.22e-3)" 0.1 0.7 2.4 0.3 2.1 0.0 0.4 4.1 3.3 1.1 0.0 0.7 0.1 0.7 0.2 0.2 0.4 0.8 0.5 2.1 3.7 1.0 0.2 1.1 0.2 2.8 6.2 0.1 0.2 0.4 0.4 1.7 3.1 0.8 0.0 0.1 0.4 0.8 0.0 1.2 0.3 0.5 3.2 0.3 0.5 0.5 2.6 0.3 1.0 0.0 0.2 0.4 0.2 1.8 0.0 0.0 2.2 3.9 1.1 1.3 1.5 1.9 2.4 0.1 0.0 2.2 0.0 0.0 3.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.1 0.3 16.5 0.7 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 15.2 0.2 0.0 2.0 0.0 4.0 14.4 0.0 0.0 0.0 2.8 0.0 0.9 0.2 3.3 0.0 0.0 1.1 0.0 0.0 0.0 0.7 7.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 2.4 2.1 4.1 3.3 2.1 3.7 2.8 6.2 3.1 3.2 2.6 1.8 0.1 0.0 0.5 9.8 0.0 0.9 0.1 0.8 0.6 1.0 0.8 1.7 2.3 0.0 1.1 7.3 4.2 2.4 2.8 0.0 0.0 2.0 2.1 4.3 17.7 0.6 0.0 0.0 34.6 4.8 2.8 2.1 1.5 1.1 0.0 1.4 0.0 0.0 0.8 0.0 282.0 0.0 0.0 0.0 0.4 5.6 0.6 0.6 3.6 66.5 0.8 0.5 0.0 378.0 9.8 9.2 0.0 0.0 0.0 0.2 0.2 0.5 2.0 0.4 0.0 0.8 1.5 1.1 2.0 0.5 1.3 2.5 0.3 0.1 0.5 0.0 KIF3C ENSG00000084731 "Kinesin family member 3C" O14782 2 25926598-25982749 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 75.5;retina: 19.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 53.5;Horizontal cells: 42.1;Inhibitory neurons: 45.9;Oligodendrocyte precursor cells: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 54.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035755 Approved "Nuclear membrane,Nuclear bodies,Intermediate filaments" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "Nuclear bodies, Intermediate filaments" "Nuclear membrane" "HPA035755: AB_10602242" "unprognostic (3.95e-1)" "unprognostic (1.40e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.75e-1)" "unprognostic (4.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.53e-2)" "prognostic favorable (1.22e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (3.90e-2)" "unprognostic (3.54e-1)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" 3.1 6.8 28.4 2.3 40.2 1.5 2.9 6.9 75.5 4.0 0.0 5.4 1.3 3.6 1.7 2.2 2.7 3.6 2.9 46.1 18.6 1.6 0.7 2.0 1.2 37.5 10.9 6.8 1.4 3.7 11.7 2.1 32.7 2.9 1.7 19.6 2.2 3.8 1.8 2.5 2.5 4.2 0.0 1.6 2.3 2.3 13.8 2.6 3.0 2.5 1.1 2.7 3.7 37.8 25.7 38.1 19.9 15.4 11.4 13.1 15.9 13.1 6.4 7.7 8.7 6.8 3.8 0.0 10.6 11.9 24.1 2.7 15.2 7.8 5.2 4.5 7.3 9.3 2.6 14.0 6.7 2.3 7.7 9.6 2.3 24.2 4.8 29.6 25.8 7.3 3.3 3.2 8.3 1.8 6.7 3.2 20.5 0.7 11.1 10.4 9.9 1.7 17.7 6.2 24.2 54.4 5.2 2.2 27.3 16.4 0.8 3.1 20.6 13.4 13.7 6.1 12.9 0.8 4.6 3.1 30.4 12.5 11.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.5 0.2 0.0 0.0 0.4 0.3 28.4 40.2 6.9 75.5 46.1 18.6 37.5 10.9 32.7 0.0 13.8 37.8 1.9 0.0 0.0 9.4 0.2 0.5 1.6 1.5 1.2 16.7 2.0 2.4 3.5 2.8 1.1 0.0 6.2 0.6 2.1 0.1 0.0 8.4 3.4 1.0 2.1 5.6 3.0 0.0 53.5 1.4 4.2 2.6 0.5 1.4 7.0 8.8 7.9 0.1 3.5 42.1 45.9 0.3 2.0 4.6 1.1 4.8 1.8 2.6 3.6 12.2 2.0 7.0 0.0 27.6 13.7 10.1 0.0 4.5 1.5 1.0 0.0 1.2 1.3 9.6 6.6 2.8 3.1 0.3 1.6 1.0 0.3 1.2 1.7 5.1 0.2 1.0 LGR5 "FEX, GPR49, GPR67, HG38" ENSG00000139292 "Leucine rich repeat containing G protein-coupled receptor 5" O75473 12 71439798-71586310 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;fallopian tube: 16.8;placenta: 19.0;skeletal muscle: 22.3" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 55.2;Endometrial ciliated cells: 35.7;Glandular and luminal cells: 84.4;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 105.0;Syncytiotrophoblasts: 26.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 26.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Hep G2: 37.1;SH-SY5Y: 104.5" "Region enriched" "Detected in many" 8 "olfactory bulb: 34.1" "Low region specificity" "Detected in many" HPA012530 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" Nucleoplasm "HPA012530: AB_1849329" "unprognostic (5.19e-2)" "unprognostic (3.79e-1)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.49e-3)" "unprognostic (1.52e-1)" "prognostic favorable (5.09e-4)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (3.71e-1)" "unprognostic (8.10e-2)" "unprognostic (2.01e-5)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (6.25e-3)" 1.4 1.6 2.7 0.4 7.6 0.0 1.5 4.6 4.7 1.5 0.1 3.3 5.1 4.0 1.1 0.1 16.8 0.4 0.2 2.9 5.7 0.8 0.9 0.9 0.1 9.5 5.2 0.7 0.0 0.2 1.0 19.0 9.0 1.2 3.6 0.2 1.9 7.3 22.3 2.9 5.5 0.2 6.0 0.0 2.3 0.1 5.6 0.1 0.3 0.8 1.7 0.1 0.4 19.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 13.3 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.5 0.0 11.9 0.0 1.0 37.1 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 12.2 1.6 2.4 0.0 0.0 0.0 14.6 0.2 104.5 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 7.6 4.6 4.7 2.9 5.7 9.5 5.2 9.0 6.0 5.6 19.2 0.0 0.0 0.0 1.3 0.2 0.9 0.0 1.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 55.2 0.0 1.2 0.0 0.0 0.6 35.7 5.3 0.5 4.9 0.0 6.8 0.0 2.3 1.4 0.0 84.4 0.0 0.0 0.0 1.0 6.4 0.0 12.3 3.0 0.0 0.0 1.6 0.2 0.0 0.4 1.8 0.0 0.0 0.0 0.0 45.2 105.0 0.1 0.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 3.4 0.0 0.0 0.0 1.3 26.4 0.5 0.0 20.3 0.0 LHFPL3 LHFPL4 ENSG00000187416 "LHFPL tetraspan subfamily member 3" Q86UP9 7 104328700-104907232 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 30.5;retina: 23.6" "Cell type enriched" "Detected in some" 19 "Oligodendrocyte precursor cells: 4790.3" "Cancer enriched" "Detected in some" 12 "glioma: 27.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.6;SH-SY5Y: 2.1;SK-BR-3: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069691 Approved Vesicles No NA "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Vesicles "HPA069691: AB_2686171" "unprognostic (1.20e-2)" "unprognostic (6.91e-2)" "unprognostic (4.59e-3)" "unprognostic (5.03e-2)" "unprognostic (2.27e-2)" "unprognostic (2.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-2)" "unprognostic (5.81e-2)" "unprognostic (5.99e-3)" "unprognostic (8.50e-3)" "unprognostic (3.07e-1)" "unprognostic (1.33e-1)" 0.0 0.1 20.2 0.1 10.8 0.0 0.0 13.1 7.4 3.3 0.0 0.7 1.4 0.6 0.0 0.0 0.3 0.0 0.0 5.4 15.5 1.4 0.0 1.5 0.0 7.3 14.2 0.1 0.9 0.0 0.0 0.0 7.5 0.2 0.1 23.6 0.0 0.0 0.0 0.2 1.2 0.0 10.2 0.4 0.3 0.1 30.5 0.0 0.0 0.0 0.1 0.0 0.2 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 10.8 13.1 7.4 5.4 15.5 7.3 14.2 7.5 10.2 30.5 9.5 0.0 0.0 0.5 3.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.3 0.2 7.7 0.1 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 245.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.8 0.0 1.3 0.0 4790.3 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 7.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 LHFPL4 GARLH4 ENSG00000156959 "LHFPL tetraspan subfamily member 4" Q7Z7J7 3 9498361-9553822 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 15.5;pituitary gland: 12.2;retina: 9.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 42.4;Cone photoreceptor cells: 18.8;Excitatory neurons: 60.0;Inhibitory neurons: 67.2;Oligodendrocyte precursor cells: 34.2;Rod photoreceptor cells: 17.4" "Group enriched" "Detected in some" 4 "glioma: 6.8;testis cancer: 5.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 13.5;NTERA-2: 4.4;SCLC-21H: 10.0;SH-SY5Y: 12.5;U-266/84: 11.3;WM-115: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041421 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" Nucleoplasm "HPA041421: AB_10796673" "unprognostic (6.81e-2)" "unprognostic (3.65e-2)" "unprognostic (4.50e-1)" "unprognostic (6.62e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.65e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (3.77e-1)" "unprognostic (1.90e-2)" "unprognostic (6.78e-2)" "unprognostic (2.99e-1)" "unprognostic (3.03e-3)" "unprognostic (8.21e-2)" 0.0 2.0 11.1 0.0 11.4 0.0 0.0 7.1 15.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.3 12.7 0.0 0.0 0.0 0.0 10.4 7.4 0.0 0.5 0.1 12.2 0.0 10.2 0.0 0.2 9.3 0.0 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.2 0.7 12.1 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 10.0 12.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.0 11.3 0.0 0.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.1 11.4 7.1 15.5 11.3 12.7 10.4 7.4 10.2 3.3 12.1 9.8 0.4 0.0 0.0 4.6 0.5 0.0 2.9 0.0 0.0 42.4 0.4 0.3 0.8 0.0 0.0 0.0 18.8 0.6 0.6 0.6 0.0 0.3 0.6 0.7 1.1 0.8 1.2 0.0 60.0 0.2 1.4 0.6 0.0 1.3 1.3 0.5 4.2 0.2 0.3 15.2 67.2 0.7 0.0 0.3 0.0 0.7 0.0 0.8 0.0 1.0 0.1 2.0 3.1 34.2 5.6 0.4 1.7 0.0 0.0 6.3 0.8 0.2 0.0 17.4 0.0 2.7 0.4 1.7 1.1 0.0 0.0 1.4 0.4 0.3 0.8 2.5 LINGO2 "LERN3, LRRN6C" ENSG00000174482 "Leucine rich repeat and Ig domain containing 2" Q7L985 9 27948078-28670286 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 7.5;smooth muscle: 8.8" "Group enriched" "Detected in some" 29 "Excitatory neurons: 1591.2;Inhibitory neurons: 988.0" "Cancer enhanced" "Detected in single" "melanoma: 0.8" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 9 "NK-cell: 1.0" "Lineage enriched" "Detected in single" 9 "NK-cells: 1.0" "Cell line enhanced" "Detected in some" "AN3-CA: 2.2;hTERT-HME1: 1.5;SH-SY5Y: 9.1;U-87 MG: 1.6;WM-115: 4.1" "Low region specificity" "Detected in all" "HPA016633, CAB025361" Approved NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "CAB025361: , HPA016633: AB_1853362" "unprognostic (1.27e-1)" "unprognostic (3.58e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-4)" "unprognostic (9.86e-4)" "unprognostic (7.55e-3)" "unprognostic (2.67e-6)" "unprognostic (1.08e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-2)" "unprognostic (3.74e-2)" "unprognostic (8.13e-2)" "unprognostic (1.07e-1)" "unprognostic (4.08e-2)" "unprognostic (2.30e-2)" "unprognostic (1.95e-4)" 0.0 0.4 0.5 0.0 0.8 0.2 0.0 0.0 3.3 0.6 0.0 0.1 0.0 7.5 0.9 0.0 0.4 0.9 0.0 2.9 3.0 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.8 0.6 1.7 0.0 0.6 0.0 2.4 0.0 1.5 0.0 0.1 0.0 8.8 0.1 0.1 0.6 1.7 0.4 0.2 2.9 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.2 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 9.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.5 0.8 0.0 3.3 2.9 3.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 8.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 17.5 0.4 4.6 0.2 1.8 0.0 1591.2 0.0 0.1 1.4 0.0 0.9 1.3 29.6 0.0 0.0 0.2 0.0 988.0 0.0 0.0 0.0 0.0 16.4 0.0 0.1 0.0 43.1 0.1 0.9 5.2 17.6 20.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.3 2.8 1.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 LRFN2 "FIGLER2, KIAA1246, SALM1" ENSG00000156564 "Leucine rich repeat and fibronectin type III domain containing 2" Q9ULH4 6 40391591-40587364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.4;retina: 3.2" "Cell type enhanced" "Detected in some" "Astrocytes: 24.2;Cone photoreceptor cells: 62.6;Excitatory neurons: 111.5;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 49.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 6.4;cerebral cortex: 5.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 1.7;SH-SY5Y: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA076660 Enhanced Supported "Plasma membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "HPA076660: AB_2686812" "unprognostic (1.93e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (4.58e-4)" "unprognostic (3.10e-1)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-3)" "unprognostic (4.94e-2)" "unprognostic (1.80e-1)" "unprognostic (9.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-1)" "unprognostic (2.98e-1)" "unprognostic (1.16e-1)" "unprognostic (2.66e-4)" 0.0 0.3 1.6 0.0 6.4 0.3 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.2 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 1.7 0.0 0.0 0.0 0.1 0.7 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 6.4 0.0 5.9 1.3 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 10.8 0.1 0.3 0.6 0.0 0.1 0.0 62.6 0.4 0.3 0.1 0.0 0.0 1.5 0.0 0.0 0.1 4.2 0.0 111.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 62.8 1.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 3.7 0.0 0.8 0.0 49.8 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 1.9 0.0 1.0 0.0 0.3 0.2 0.0 0.1 0.1 LRRC24 LRRC14OS ENSG00000254402 "Leucine rich repeat containing 24" Q50LG9 8 144522388-144527033 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 13.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 103.2;Cone photoreceptor cells: 73.0;Horizontal cells: 30.3;Late spermatids: 69.0;Rod photoreceptor cells: 86.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.6;SCLC-21H: 2.7;SH-SY5Y: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028171, HPA052250" Enhanced Approved Vesicles NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Vesicles "HPA028171: AB_2672504, HPA052250: AB_2681774" "unprognostic (1.75e-1)" "unprognostic (5.76e-2)" "unprognostic (2.33e-3)" "unprognostic (3.63e-2)" 2.1 3.6 6.2 0.1 6.4 0.3 2.3 4.1 7.8 5.0 0.8 3.1 0.3 4.4 0.2 3.8 5.4 0.1 1.9 5.4 9.0 3.7 3.2 2.7 0.2 10.0 8.3 6.1 3.0 1.2 13.3 0.2 6.5 11.5 0.1 1.4 1.5 0.6 1.2 1.8 2.6 0.2 4.5 2.1 2.4 3.0 5.3 0.3 3.4 0.1 0.0 2.9 3.2 4.8 0.2 0.5 0.4 0.9 0.4 0.3 1.1 0.3 0.4 0.4 0.3 0.1 1.0 0.5 2.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 1.3 0.3 0.6 0.2 0.3 0.0 0.6 0.4 0.2 0.3 0.0 0.2 0.2 0.5 0.6 0.1 0.0 2.6 0.7 1.0 0.1 0.1 0.5 1.1 0.0 0.4 0.1 0.3 2.7 7.4 0.2 0.1 0.2 0.0 2.3 0.8 0.0 0.1 0.7 0.3 0.1 0.5 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 6.4 4.1 7.8 5.4 9.0 10.0 8.3 6.5 4.5 5.3 4.8 0.7 0.0 2.3 8.5 1.0 0.9 0.5 0.0 0.0 103.2 2.3 2.8 0.0 1.5 0.7 1.8 73.0 0.6 0.5 2.1 3.9 0.2 23.7 1.5 1.5 1.1 10.7 0.8 3.8 0.2 0.4 1.4 3.1 1.6 0.0 4.8 0.7 3.1 0.5 30.3 6.5 2.7 0.0 0.8 1.7 69.0 2.8 0.8 5.4 1.0 0.2 18.6 1.0 4.5 2.2 0.3 1.9 3.0 1.2 1.8 1.9 3.6 0.1 86.2 0.0 2.9 1.9 11.2 3.5 1.7 0.4 0.4 0.6 8.4 1.9 0.9 LRRC49 FLJ20156 ENSG00000137821 "Leucine rich repeat containing 49" Q8IUZ0 15 70853239-71053658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 56.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 85.0;Cardiomyocytes: 145.1;Early spermatids: 92.8;Excitatory neurons: 79.1;Inhibitory neurons: 88.4;Late spermatids: 105.3;Spermatocytes: 91.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 24.2;SH-SY5Y: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015596 Uncertain NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA015596: AB_2669230" "unprognostic (9.74e-2)" "unprognostic (7.94e-2)" "unprognostic (3.25e-3)" "unprognostic (1.15e-2)" "unprognostic (6.10e-2)" "unprognostic (3.07e-2)" "unprognostic (1.07e-2)" "unprognostic (1.72e-1)" "unprognostic (3.36e-2)" "unprognostic (9.43e-2)" "unprognostic (7.66e-4)" "unprognostic (3.02e-1)" "unprognostic (5.29e-2)" "unprognostic (7.60e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (3.09e-2)" 2.4 2.8 7.9 0.8 10.4 0.3 2.7 13.7 11.2 6.6 7.3 3.9 0.4 8.7 29.6 1.9 9.0 3.7 56.3 6.7 10.7 4.6 0.5 2.7 0.7 12.2 10.5 11.1 1.4 9.1 11.6 1.0 13.2 5.3 1.7 26.8 1.8 4.8 1.1 1.7 1.7 5.0 5.1 0.8 2.7 11.9 18.8 1.0 4.8 1.7 0.8 4.5 3.8 6.1 2.1 3.9 8.5 14.9 3.8 6.4 0.1 3.6 6.3 2.4 5.8 1.3 1.6 0.0 2.6 1.5 6.0 3.5 8.4 4.3 2.0 0.0 4.5 1.0 4.1 0.1 24.2 0.1 0.5 2.9 1.5 7.2 12.3 12.5 6.5 0.0 0.1 0.0 3.6 0.7 0.0 0.7 5.0 0.3 2.8 0.0 5.7 0.0 8.0 4.5 17.2 18.0 4.3 2.0 4.0 3.1 4.6 1.4 5.9 2.9 9.0 5.4 6.2 1.1 4.3 0.0 6.8 0.2 2.2 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 10.4 13.7 11.2 6.7 10.7 12.2 10.5 13.2 5.1 18.8 6.1 4.3 3.2 3.7 63.3 0.7 2.3 22.9 11.5 5.7 85.0 2.2 3.0 145.1 1.5 13.0 7.3 62.6 0.1 0.1 1.5 5.9 7.0 92.8 30.8 8.0 7.2 18.5 0.0 79.1 0.9 0.1 11.6 2.6 4.3 0.0 8.0 2.5 0.0 0.1 30.3 88.4 1.9 0.0 0.3 0.7 105.3 5.6 0.7 0.0 19.7 0.0 10.9 0.0 63.8 34.1 1.7 1.6 9.8 0.2 11.7 0.3 3.5 54.8 37.3 0.0 7.4 8.0 91.9 11.4 0.7 1.6 0.3 0.8 2.5 1.2 8.0 LRRC4B "DKFZp761A179, HSM, LRIG4" ENSG00000131409 "Leucine rich repeat containing 4B" Q9NT99 19 50516892-50568435 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.2;cervix: 41.3;pituitary gland: 31.9" "Cell type enhanced" "Detected in some" "Astrocytes: 34.9;Bipolar cells: 19.6;Excitatory neurons: 32.1;Inhibitory neurons: 38.5;Oligodendrocyte precursor cells: 29.7;Oligodendrocytes: 48.9" "Group enriched" "Detected in many" 9 "glioma: 36.5;testis cancer: 9.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 8.7;HMC-1: 32.1;REH: 8.7;SH-SY5Y: 27.5;U-2 OS: 25.3;WM-115: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058986 Uncertain NA NA 2700000 "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA058986: AB_2683871" "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (4.46e-2)" "unprognostic (4.48e-2)" "unprognostic (3.56e-1)" "unprognostic (5.39e-4)" "unprognostic (2.70e-2)" "unprognostic (1.11e-1)" "unprognostic (5.28e-2)" "unprognostic (4.61e-3)" "unprognostic (1.11e-3)" "unprognostic (3.41e-1)" "unprognostic (3.15e-5)" "unprognostic (4.29e-2)" "unprognostic (2.61e-1)" "unprognostic (3.64e-1)" "unprognostic (2.17e-1)" 2.8 5.3 54.4 0.9 35.6 0.0 2.1 20.7 61.2 41.3 0.0 2.8 0.8 16.2 0.1 1.9 10.0 1.2 1.8 49.3 33.2 1.8 1.3 5.8 1.3 50.9 47.6 5.1 0.8 0.2 31.9 4.2 33.3 3.3 0.1 1.6 0.8 1.0 0.7 1.2 3.3 1.3 19.9 0.8 2.9 2.4 38.2 0.0 2.6 0.1 0.5 5.8 13.0 38.1 0.0 0.5 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 4.9 0.0 0.7 0.1 0.1 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.0 0.1 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.5 0.0 1.0 0.1 0.0 8.2 0.0 0.0 8.7 0.0 0.1 0.0 0.0 0.0 27.5 0.0 0.0 5.7 0.2 0.0 0.3 0.0 0.0 25.3 0.0 0.0 0.6 0.1 0.1 0.1 0.3 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 35.6 20.7 61.2 49.3 33.2 50.9 47.6 33.3 19.9 38.2 38.1 0.7 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.5 0.9 0.0 0.0 32.1 0.0 0.0 1.3 0.0 0.1 0.0 0.2 0.7 0.0 0.1 10.1 38.5 0.0 0.0 0.0 0.3 2.2 2.8 0.0 0.0 2.8 0.0 1.6 0.0 29.7 48.9 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 5.8 4.8 8.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 LRRN3 "FIGLER5, FLJ11129, NLRR3" ENSG00000173114 "Leucine rich repeat neuronal 3" Q9H3W5 7 111091006-111125454 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.2;thyroid gland: 19.6" "Cell type enhanced" "Detected in many" "Astrocytes: 47.0;Bipolar cells: 29.2;Cardiomyocytes: 24.8;Excitatory neurons: 81.2;Inhibitory neurons: 46.5;Leydig cells: 56.2;Oligodendrocyte precursor cells: 61.3" "Group enriched" "Detected in many" 7 "glioma: 17.5;thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 32.5;naive CD8 T-cell: 30.9" "Lineage enriched" "Detected in single" 70 "T-cells: 32.5" "Cell line enhanced" "Detected in some" "AF22: 24.7;BJ: 14.7;BJ hTERT+: 31.0;GAMG: 15.6;SH-SY5Y: 43.9;SuSa: 13.6;T-47d: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043820, HPA046792" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" "Nucleoplasm, Cytosol" "HPA043820: AB_2678687, HPA046792: AB_2679810" "unprognostic (4.93e-2)" "unprognostic (4.55e-2)" "unprognostic (5.92e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-2)" "unprognostic (4.78e-3)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.84e-2)" "unprognostic (4.85e-3)" "unprognostic (1.08e-2)" "unprognostic (3.29e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (7.23e-2)" 7.2 23.2 11.9 1.2 12.8 0.6 1.7 10.4 14.7 2.5 4.3 0.9 0.4 0.5 2.3 1.3 0.7 1.0 8.0 11.9 10.4 0.4 2.2 7.5 3.0 6.8 8.5 6.3 0.9 0.2 3.0 5.8 8.6 2.6 1.0 6.3 1.2 4.9 4.1 0.3 1.4 0.4 7.7 1.4 0.4 14.9 13.2 10.5 19.6 0.5 3.6 0.8 0.9 8.9 0.0 0.1 24.7 3.1 11.2 4.8 0.1 14.7 31.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 15.6 0.1 1.5 0.0 3.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.3 0.1 0.0 0.1 0.1 6.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.0 43.9 0.0 0.0 0.0 13.6 24.3 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.4 2.7 2.0 0.0 0.1 32.5 30.9 0.2 0.0 0.1 0.0 0.4 6.1 11.9 12.8 10.4 14.7 11.9 10.4 6.8 8.5 8.6 7.7 13.2 8.9 0.8 0.0 4.3 47.0 0.8 0.0 0.0 0.0 0.0 29.2 0.6 0.8 24.8 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 1.1 0.3 0.5 1.2 1.8 0.0 81.2 0.0 0.5 13.3 1.5 0.5 1.3 0.0 1.1 0.0 0.8 3.3 46.5 0.0 0.0 0.0 0.4 4.4 56.2 0.2 1.8 7.5 0.8 11.0 1.0 61.3 7.0 0.0 0.0 16.1 0.0 0.0 0.0 0.1 0.0 3.8 0.0 1.6 1.7 1.1 0.4 0.0 0.1 0.4 10.3 0.5 0.0 0.2 LRRTM1 FLJ32082 ENSG00000162951 "Leucine rich repeat transmembrane neuronal 1" Q86UE6 2 80288351-80304752 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 22.4;salivary gland: 12.8" "Group enriched" "Detected in some" 4 "Endometrial stromal cells: 4.8;Excitatory neurons: 7.2;Inhibitory neurons: 13.2;Oligodendrocyte precursor cells: 10.6;Sertoli cells: 6.6" "Group enriched" "Detected in many" 11 "endometrial cancer: 8.8;ovarian cancer: 16.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046607, HPA062660" Approved Approved "Golgi apparatus" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA046607: , HPA062660: AB_2684824" "unprognostic (2.47e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (5.63e-2)" "unprognostic (6.67e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-1)" "unprognostic (8.16e-2)" "unprognostic (6.03e-3)" "unprognostic (7.10e-4)" "unprognostic (3.16e-2)" "unprognostic (1.90e-1)" "unprognostic (4.96e-4)" 0.5 0.9 6.4 0.3 13.4 0.0 0.1 0.0 10.0 2.2 0.0 3.7 0.6 0.6 0.3 0.3 1.2 0.2 1.3 16.3 5.2 0.3 0.4 0.1 0.0 0.9 9.4 0.3 0.1 0.0 1.9 0.0 2.0 1.0 0.3 0.4 12.8 1.2 0.0 0.1 1.3 0.3 0.2 0.0 0.7 0.2 22.4 0.0 1.6 0.1 0.0 0.6 0.8 4.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 13.4 0.0 10.0 16.3 5.2 0.9 9.4 2.0 0.2 22.4 4.6 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.3 1.0 4.8 0.3 0.0 0.0 7.2 0.7 0.0 0.1 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 10.6 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 6.6 0.0 0.9 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 MAB21L1 CAGR1 ENSG00000180660 "Mab-21 like 1" Q13394 13 35473789-35476689 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein, Nucleotidyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 21.9;retina: 68.7" "Group enriched" "Detected in some" 14 "Bipolar cells: 57.7;Cone photoreceptor cells: 50.1;Horizontal cells: 87.5;Muller glia cells: 151.1;Rod photoreceptor cells: 125.8" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Region enhanced" "Detected in many" "cerebellum: 21.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 36.6;BJ hTERT+: 29.9;BJ hTERT+ SV40 Large T+: 41.7;HBF TERT88: 44.9;hTERT-RPE1: 86.2;SH-SY5Y: 133.5" "Group enriched" "Detected in many" 10 "cerebellum: 40.9;midbrain: 18.6;pons and medulla: 12.4" "Region enhanced" "Detected in all" "cerebellum: 33.0" "HPA049324, HPA059864" Approved Nucleoplasm NA NA "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "HPA049324: AB_2680712, HPA059864: AB_2684147" "unprognostic (4.44e-2)" "unprognostic (2.82e-2)" "unprognostic (2.79e-3)" "unprognostic (3.87e-4)" "unprognostic (5.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-3)" "unprognostic (1.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (3.19e-2)" "unprognostic (6.93e-3)" "unprognostic (1.14e-1)" "unprognostic (3.72e-1)" "unprognostic (2.86e-1)" 2.3 4.3 1.3 0.5 1.2 0.0 7.5 21.9 2.0 0.4 0.3 2.2 0.5 0.1 0.1 0.2 0.1 0.2 0.7 1.6 0.3 0.1 0.0 0.1 0.8 2.8 6.1 0.9 0.1 0.0 0.3 0.0 3.7 1.4 0.5 68.7 2.9 0.3 5.7 2.0 1.1 0.2 3.2 0.4 0.7 0.1 2.1 0.4 1.2 0.6 0.3 0.8 0.9 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 36.6 29.9 41.7 23.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.6 0.1 44.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.1 86.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 3.6 133.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 1.5 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 21.9 2.0 1.6 0.3 2.8 6.1 3.7 3.2 2.1 0.6 2.6 0.0 0.0 0.0 0.0 0.8 0.5 0.6 0.0 57.7 0.2 0.9 0.5 0.0 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.0 2.5 1.2 0.7 0.0 0.1 87.5 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.4 1.8 0.0 0.0 151.1 0.0 1.5 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 125.8 0.0 5.6 3.1 0.0 0.0 0.0 0.6 0.0 0.1 0.5 0.0 0.3 MAML3 "CAGH3, GDN, KIAA1816, MAM2, TNRC3" ENSG00000196782 "Mastermind like transcriptional coactivator 3" Q96JK9 4 139716753-140154184 "Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 125.6;Microglial cells: 355.1;Oligodendrocytes: 150.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "cerebellum: 16.8" "Immune cell enhanced" "Detected in many" "basophil: 12.2" "Group enriched" "Detected in many" 5 "granulocytes: 12.2;NK-cells: 3.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 15.0;SCLC-21H: 15.7;SH-SY5Y: 23.9;WM-115: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037717 Approved Supported "Nuclear speckles" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear speckles" "HPA037717: AB_10794323" "unprognostic (1.83e-1)" "unprognostic (1.28e-1)" "unprognostic (1.17e-1)" "unprognostic (7.83e-3)" "unprognostic (4.73e-2)" "unprognostic (2.63e-1)" "unprognostic (3.36e-2)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (3.89e-1)" "unprognostic (5.52e-3)" "unprognostic (1.73e-1)" "prognostic favorable (7.60e-5)" "unprognostic (3.38e-1)" "unprognostic (1.20e-1)" "unprognostic (7.22e-2)" "unprognostic (2.88e-1)" 3.3 3.4 1.5 2.4 0.9 3.2 3.4 16.8 2.1 5.0 0.1 3.8 4.8 6.7 5.3 5.9 5.5 4.1 2.0 2.2 2.8 2.0 2.6 3.8 2.6 3.4 2.3 8.6 6.8 3.3 4.5 5.0 3.4 4.9 3.9 1.7 5.9 4.5 1.7 7.8 4.5 6.0 2.4 3.3 3.4 3.0 2.2 6.0 4.3 2.1 2.3 3.6 5.1 2.2 0.5 8.1 5.4 2.7 2.1 4.4 4.9 1.0 4.4 0.5 0.3 3.2 2.2 1.8 0.4 0.8 0.3 0.1 2.1 1.8 0.3 0.0 1.2 5.9 1.9 0.3 0.4 2.8 8.7 4.3 1.5 0.1 0.9 3.3 15.0 0.1 1.6 0.0 0.3 0.9 0.5 1.2 1.4 3.6 3.5 3.5 0.5 3.6 2.5 11.2 15.7 23.9 0.0 4.2 5.5 4.2 2.3 0.8 13.1 0.6 1.3 0.1 1.7 2.9 3.5 0.1 0.8 9.2 20.2 12.2 1.5 2.9 0.0 1.1 0.1 0.0 0.0 0.0 1.5 0.4 0.4 0.4 3.6 3.4 0.9 1.2 0.0 1.2 1.5 0.9 16.8 2.1 2.2 2.8 3.4 2.3 3.4 2.4 2.2 2.2 21.2 3.2 11.5 39.5 3.1 8.0 8.1 4.2 7.4 4.6 12.6 9.3 3.0 11.5 8.7 5.5 18.8 5.8 3.9 13.6 5.9 5.1 3.6 12.6 9.4 11.7 14.9 9.4 60.2 5.1 7.3 5.3 8.6 19.9 19.6 34.4 13.2 17.5 7.5 11.8 125.6 12.1 2.0 22.6 13.3 9.0 4.1 19.6 3.6 355.1 18.3 3.1 1.0 7.5 150.8 3.0 14.0 3.8 2.1 5.7 8.2 6.1 7.2 3.7 0.0 2.9 13.7 0.5 2.2 19.0 13.5 8.2 5.3 8.5 11.0 8.9 MAP3K1 "MAPKKK1, MEKK, MEKK1" ENSG00000095015 "Mitogen-activated protein kinase kinase kinase 1" Q13233 5 56815549-56896152 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 210.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 52.5;THP-1: 51.0" "Region enriched" "Detected in all" 6 "olfactory bulb: 18.2" "Low region specificity" "Detected in all" "CAB004500, HPA046509" Approved Approved Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 57: B-cells - Immune response" Cytosol "CAB004500: AB_627926, HPA046509: AB_2679678" "unprognostic (1.77e-1)" "unprognostic (1.71e-2)" "unprognostic (4.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.48e-2)" "unprognostic (5.39e-3)" "unprognostic (5.20e-3)" "unprognostic (2.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-2)" "unprognostic (6.73e-2)" "unprognostic (1.97e-3)" "unprognostic (2.18e-2)" "unprognostic (1.58e-1)" "unprognostic (9.92e-3)" "unprognostic (1.11e-1)" 5.5 3.8 3.0 13.3 2.6 24.0 20.1 4.0 2.1 7.0 6.2 5.4 6.3 7.5 6.6 10.0 9.7 5.7 3.7 2.1 2.7 9.9 6.0 7.5 18.1 3.9 3.2 7.2 9.8 7.1 1.3 11.4 3.7 5.4 6.3 26.9 18.5 8.3 1.7 19.7 6.5 5.7 3.8 20.5 8.1 8.3 3.5 9.9 16.2 4.4 24.0 6.7 6.4 3.9 13.3 7.9 12.1 8.1 1.9 1.5 20.3 2.5 3.3 7.6 10.6 37.1 9.7 11.9 0.9 3.0 6.5 6.7 10.1 4.6 10.5 4.0 4.4 6.6 3.4 17.5 4.7 10.6 17.6 1.9 4.8 2.4 3.8 2.1 3.3 4.0 5.8 20.7 2.0 5.8 7.4 14.2 5.6 6.8 1.0 11.5 8.6 41.1 13.2 13.6 5.1 52.5 7.6 9.5 21.5 10.7 26.0 51.0 9.8 0.7 6.4 2.9 4.7 15.0 8.2 22.1 1.2 6.1 13.2 6.3 3.1 0.7 0.8 4.5 0.7 4.0 2.4 1.1 1.8 3.3 1.5 0.5 1.7 1.7 4.9 1.0 3.8 1.7 3.0 2.6 4.0 2.1 2.1 2.7 3.9 3.2 3.7 3.8 3.5 3.9 20.8 6.4 9.8 17.9 102.5 52.4 15.1 17.1 43.9 14.9 73.2 30.6 3.5 48.6 15.9 36.8 47.9 15.1 31.9 7.3 7.9 18.9 2.0 25.0 20.6 24.0 10.2 14.5 11.7 14.8 8.6 10.7 14.3 43.7 7.6 20.0 21.8 15.0 32.3 28.6 31.8 11.4 6.1 76.0 48.4 3.6 5.3 66.5 37.4 69.3 99.1 11.6 9.2 210.1 12.5 12.9 7.7 1.9 41.5 14.8 10.6 20.7 11.0 38.5 6.6 9.3 11.9 8.6 17.9 69.1 54.7 6.7 31.6 15.4 9.7 12.0 MAP6 "FLJ41346, KIAA1878, MAP6-N, STOP" ENSG00000171533 "Microtubule associated protein 6" Q96JE9 11 75586918-75669038 "Predicted intracellular proteins" Transport Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 76.8;retina: 96.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 81.2;Cone photoreceptor cells: 158.4;Excitatory neurons: 75.8;Horizontal cells: 50.5;Inhibitory neurons: 43.3;Late spermatids: 41.9" "Cancer enhanced" "Detected in many" "glioma: 9.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 37.8;CACO-2: 38.1;HDLM-2: 21.5;SCLC-21H: 62.4;SH-SY5Y: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015442, CAB022600, HPA039061, HPA039062" Enhanced Uncertain "Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Plasma membrane" "CAB015442: AB_2140997, CAB022600: , HPA039061: AB_2676325, HPA039062: AB_2676326" "unprognostic (3.04e-2)" "unprognostic (6.18e-2)" "unprognostic (3.15e-2)" "unprognostic (9.07e-2)" "unprognostic (7.54e-2)" "unprognostic (4.49e-2)" "unprognostic (8.29e-2)" "unprognostic (2.51e-2)" "unprognostic (5.99e-2)" "unprognostic (7.99e-2)" "prognostic favorable (3.41e-4)" "prognostic favorable (9.15e-4)" "unprognostic (2.43e-2)" "unprognostic (3.96e-3)" "unprognostic (8.09e-3)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" 4.8 19.0 68.3 2.0 68.0 0.0 3.5 50.7 70.6 10.6 64.4 23.0 1.7 18.1 21.0 4.2 40.7 6.4 8.6 67.7 71.5 17.0 1.2 7.8 0.7 70.2 64.6 8.0 3.6 22.0 76.8 1.5 70.8 17.8 3.5 96.1 3.6 21.1 1.0 8.1 4.8 13.1 52.9 2.4 10.7 18.6 68.5 0.8 7.9 1.3 0.5 7.1 8.4 59.7 0.2 0.7 37.8 0.1 0.1 0.0 0.0 3.8 0.2 0.3 0.0 38.1 0.1 0.6 1.4 6.3 1.3 0.0 3.4 0.5 0.0 21.5 0.5 0.0 0.0 0.0 1.0 0.0 0.0 2.1 0.5 0.1 0.2 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.9 0.0 2.9 0.0 0.0 0.1 0.1 0.5 62.4 31.7 4.6 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.1 0.1 0.5 0.0 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.3 68.0 50.7 70.6 67.7 71.5 70.2 64.6 70.8 52.9 68.5 59.7 1.2 3.2 3.7 25.8 0.1 0.8 1.7 0.7 0.0 81.2 0.8 1.8 8.4 1.5 3.1 11.0 158.4 0.2 0.2 0.0 1.9 0.1 27.7 28.2 4.6 1.6 13.1 0.0 75.8 0.2 0.0 2.9 0.0 0.8 0.0 0.8 2.2 0.3 0.1 50.5 43.3 0.0 6.1 0.0 1.1 41.9 7.5 0.3 5.4 1.9 0.0 18.7 0.0 13.0 13.3 0.2 0.0 18.4 0.1 1.4 0.0 1.2 25.4 10.2 0.0 1.9 5.7 23.5 4.3 0.1 0.4 0.0 0.3 0.1 0.0 0.4 MAP9 "ASAP, FLJ21159" ENSG00000164114 "Microtubule associated protein 9" Q49MG5 4 155342658-155376970 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.3;parathyroid gland: 33.9" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 114.4;Respiratory ciliated cells: 125.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (8.00e-2)" "unprognostic (1.60e-1)" "unprognostic (6.53e-2)" "unprognostic (6.11e-2)" "unprognostic (2.11e-1)" "unprognostic (5.50e-2)" "unprognostic (2.12e-1)" "unprognostic (3.01e-1)" "unprognostic (7.58e-2)" "unprognostic (2.98e-1)" "unprognostic (1.23e-1)" "unprognostic (1.47e-1)" "unprognostic (4.39e-2)" "unprognostic (2.48e-2)" "unprognostic (1.04e-1)" "unprognostic (4.05e-2)" "unprognostic (9.54e-2)" 4.2 5.8 20.5 3.9 21.4 1.8 4.4 26.4 46.3 5.8 26.2 3.1 0.9 7.3 7.6 2.9 9.6 7.9 7.0 23.5 35.1 9.7 0.7 5.0 3.2 31.6 23.9 6.0 5.5 33.9 7.8 5.1 31.3 12.4 1.8 16.3 2.4 8.9 0.2 0.5 1.6 5.7 20.9 2.4 6.1 12.8 28.7 3.4 15.5 0.8 2.4 3.2 1.6 22.1 0.0 10.3 11.0 9.6 11.7 14.0 2.2 11.3 10.2 6.6 5.7 0.1 0.0 7.5 14.7 8.3 24.6 0.0 11.7 12.0 10.8 0.0 9.4 4.7 0.1 0.0 8.6 0.0 0.0 12.0 6.5 9.3 5.7 20.2 0.0 2.9 0.1 0.0 7.5 4.6 8.8 0.1 8.7 3.7 13.3 0.0 0.0 0.2 22.2 8.9 15.1 43.4 0.0 19.4 0.6 7.3 15.7 0.1 1.6 8.8 15.6 0.2 8.4 9.1 0.0 8.2 25.8 0.0 14.3 0.0 0.0 0.0 2.7 0.3 2.1 2.9 1.5 2.5 0.1 4.8 1.3 1.8 0.1 0.8 0.0 2.6 1.0 0.5 20.5 21.4 26.4 46.3 23.5 35.1 31.6 23.9 31.3 20.9 28.7 22.1 3.8 16.0 37.4 34.6 17.0 1.3 13.4 18.7 12.5 67.0 15.2 20.8 33.1 17.2 25.7 25.8 79.2 9.0 10.2 0.4 33.2 35.4 39.3 114.4 44.8 3.5 21.1 5.0 59.0 16.0 3.4 24.5 13.7 24.7 2.5 16.5 1.8 0.6 1.0 72.3 58.3 0.7 26.4 0.9 0.8 14.1 45.7 2.0 5.4 14.0 1.3 53.5 9.2 23.6 27.4 15.9 0.2 49.2 3.8 11.7 0.0 49.1 125.0 92.5 13.1 28.0 31.1 69.4 53.1 2.8 1.1 2.3 14.2 40.1 0.6 4.1 MAPK8IP2 "IB2, JIP2, PRKM8IPL" ENSG00000008735 "Mitogen-activated protein kinase 8 interacting protein 2" Q13387 22 50600793-50613981 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 84.0;pituitary gland: 35.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 57.8;Enteroendocrine cells: 32.3;Horizontal cells: 99.3;Rod photoreceptor cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 19.3;HEK 293: 11.0;SCLC-21H: 15.7;SH-SY5Y: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034780 Uncertain NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA034780: AB_10670283" "unprognostic (7.82e-2)" "unprognostic (7.62e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (5.80e-2)" "unprognostic (6.72e-2)" "unprognostic (1.18e-1)" "unprognostic (2.90e-1)" "unprognostic (5.23e-2)" "unprognostic (9.19e-2)" "unprognostic (8.57e-3)" "unprognostic (8.78e-3)" "unprognostic (6.33e-3)" "unprognostic (6.77e-2)" "unprognostic (1.72e-1)" "unprognostic (5.29e-2)" "unprognostic (4.75e-2)" 1.4 9.2 54.7 0.3 50.2 0.0 1.4 27.5 67.8 1.4 0.0 2.1 0.2 2.1 0.3 1.2 1.5 0.0 0.4 53.7 35.1 0.7 0.5 0.5 0.0 78.0 27.0 7.0 1.8 2.0 35.2 0.3 84.0 1.9 0.1 9.6 2.8 0.2 0.3 1.5 1.0 0.2 18.6 0.8 1.5 7.1 39.4 0.2 1.0 0.1 0.0 0.3 1.0 49.2 0.3 1.1 4.7 4.1 0.4 0.0 3.7 0.0 0.0 1.0 0.6 2.4 0.8 0.6 1.0 0.0 19.3 0.0 6.6 0.0 0.0 0.3 11.0 0.0 0.4 1.2 0.5 0.0 0.8 0.3 5.5 0.0 0.1 0.0 0.0 0.1 1.1 1.8 0.0 0.0 0.0 0.0 3.4 0.8 1.8 1.1 0.7 0.0 0.0 0.1 15.7 19.8 3.7 4.6 0.2 0.9 0.9 0.0 0.0 0.1 0.1 0.6 0.0 1.1 3.1 0.5 0.5 0.5 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.7 50.2 27.5 67.8 53.7 35.1 78.0 27.0 84.0 18.6 39.4 49.2 0.6 3.2 2.0 6.5 0.1 0.4 1.6 0.5 0.6 57.8 2.3 3.9 2.3 2.8 2.7 0.0 16.7 0.2 0.0 0.5 0.0 3.0 0.6 0.7 1.7 0.7 32.3 0.0 15.6 2.5 1.1 0.7 0.0 1.5 0.0 0.5 0.0 0.3 0.1 99.3 13.1 0.5 4.1 0.0 0.4 1.8 5.9 0.3 7.2 3.7 0.2 11.2 0.0 6.0 3.2 0.7 0.1 0.7 0.1 1.2 0.3 0.7 0.3 26.7 0.0 1.3 1.0 3.4 2.7 0.6 0.6 1.1 0.3 0.5 0.6 0.5 MARCHF11 "MARCH-XI, MARCH11, RNF226" ENSG00000183654 "Membrane associated ring-CH-type finger 11" A6NNE9 5 16067139-16180762 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 82.4" "Cell type enriched" "Detected in single" 30 "Cardiomyocytes: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 83.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (9.91e-3)" "unprognostic (1.08e-1)" "unprognostic (2.98e-1)" "unprognostic (1.50e-1)" "unprognostic (1.54e-1)" "unprognostic (1.52e-1)" "unprognostic (3.55e-2)" 0.1 0.7 4.7 0.0 4.6 0.0 0.3 5.0 6.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 5.7 6.7 0.2 0.1 0.0 0.0 5.7 4.7 0.3 1.3 0.0 9.9 0.0 5.0 0.3 0.0 3.6 1.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.1 82.4 4.8 0.0 0.0 0.0 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 83.8 0.0 0.0 0.0 7.5 0.0 0.0 0.0 1.5 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 4.6 5.0 6.7 5.7 6.7 5.7 4.7 5.0 3.8 4.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBTD1 "FLJ20055, SA49P01" ENSG00000011258 "Mbt domain containing 1" Q05BQ5 17 51177425-51260163 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021876 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA021876: AB_2140367" "unprognostic (1.95e-1)" "unprognostic (1.85e-1)" "unprognostic (6.91e-3)" "unprognostic (3.39e-2)" "unprognostic (1.81e-2)" "unprognostic (2.52e-3)" "unprognostic (1.48e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-2)" "unprognostic (5.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.61e-2)" "unprognostic (7.90e-3)" "unprognostic (1.50e-2)" "unprognostic (3.03e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-3)" 7.2 5.3 4.9 5.4 6.0 10.8 11.4 8.2 6.9 8.6 4.6 7.1 7.9 8.5 7.7 7.2 7.0 5.0 4.5 4.9 5.3 6.1 9.8 6.1 8.7 5.3 5.2 11.8 8.6 5.7 5.5 8.6 5.4 6.8 7.8 10.0 6.9 4.8 6.3 14.4 8.1 5.6 5.1 8.7 8.3 25.4 5.1 14.4 8.3 6.8 7.9 6.9 8.3 7.1 6.6 6.1 32.0 12.9 7.5 8.8 16.7 5.0 6.2 5.3 6.4 7.2 8.3 25.7 11.5 3.8 3.9 6.3 14.8 3.7 9.8 7.4 13.4 26.7 7.5 11.1 5.0 18.0 7.7 7.5 7.0 4.0 7.2 10.5 9.4 22.3 21.0 6.3 4.3 6.7 24.8 18.8 18.1 14.0 5.5 28.4 19.3 12.9 8.0 12.4 20.1 30.7 4.5 8.6 10.7 26.6 12.2 35.0 5.7 5.7 5.8 4.2 5.4 15.4 10.5 22.8 3.4 11.8 3.3 2.6 0.1 0.7 0.2 0.1 0.0 0.4 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.1 0.1 0.3 0.3 0.0 4.9 6.0 8.2 6.9 4.9 5.3 5.3 5.2 5.4 5.1 5.1 7.1 11.2 16.0 15.0 47.7 10.3 17.2 6.5 5.4 17.1 9.0 14.7 11.7 7.3 17.2 7.1 7.3 16.7 7.9 9.6 7.8 1.9 5.4 51.6 11.8 15.0 11.3 13.8 17.7 61.5 5.1 5.1 10.8 17.9 16.0 5.1 18.8 10.4 12.8 5.8 10.1 59.9 13.5 6.1 12.3 8.5 12.4 14.6 11.5 10.6 56.2 16.4 4.1 11.3 78.4 94.9 6.4 9.0 10.5 5.1 10.8 10.1 4.6 6.2 12.0 0.0 10.2 13.0 47.8 19.2 10.5 22.0 8.6 8.6 15.6 12.1 9.7 MCRIP1 "FAM195B, GRAN2, MCRIP" ENSG00000225663 "MAPK regulated corepressor interacting protein 1" C9JLW8 17 81822361-81833302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 116.5;Exocrine glandular cells: 243.8;Extravillous trophoblasts: 154.1;Hofbauer cells: 161.7;Pancreatic endocrine cells: 137.0;Proximal tubular cells: 140.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045542 Approved Approved Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA045542: AB_2679363" "unprognostic (3.11e-3)" "unprognostic (3.82e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-3)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" "unprognostic (3.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (9.08e-3)" "prognostic favorable (2.26e-4)" "unprognostic (2.53e-2)" "unprognostic (3.65e-2)" "unprognostic (4.84e-2)" "unprognostic (1.64e-1)" "unprognostic (2.87e-1)" "unprognostic (1.86e-1)" 93.2 76.0 70.1 18.7 68.1 27.4 87.6 65.7 98.5 98.8 46.6 139.6 9.1 100.8 10.4 35.6 87.3 18.3 150.1 68.0 66.0 97.7 82.6 77.6 24.1 72.8 70.8 94.5 97.6 16.8 94.1 18.1 69.7 108.6 3.7 7.3 54.6 15.6 52.2 46.3 57.3 15.9 65.5 85.1 71.5 168.4 71.6 19.9 85.5 16.5 8.0 106.0 65.2 67.0 25.8 38.0 42.8 44.8 26.7 30.1 32.8 29.7 21.1 34.8 37.8 9.9 24.8 15.6 17.3 24.6 12.7 5.8 5.1 17.0 8.6 17.1 52.5 28.0 7.1 38.4 26.2 18.7 25.4 32.7 16.4 19.7 8.5 18.9 61.3 35.5 22.7 13.0 23.1 16.8 60.2 42.4 27.0 10.2 21.5 24.0 27.4 7.1 11.9 22.7 36.0 111.7 14.9 19.5 93.2 16.3 17.9 25.0 39.8 50.1 55.0 56.0 55.3 6.8 2.3 10.8 46.6 16.6 40.5 65.7 31.8 45.4 37.8 43.2 29.2 23.7 29.6 34.0 29.4 33.8 23.7 27.3 24.9 28.3 46.3 39.9 39.5 40.3 70.1 68.1 65.7 98.5 68.0 66.0 72.8 70.8 69.7 65.5 71.6 67.0 84.9 19.2 35.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 69.4 76.6 0.0 0.0 11.2 38.6 0.0 116.5 57.9 0.0 74.3 113.5 0.0 27.5 48.5 38.9 0.0 0.0 0.0 243.8 154.1 38.3 0.0 37.7 20.2 70.7 0.0 0.0 161.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.6 0.0 0.0 49.1 0.0 0.0 0.0 0.0 137.0 0.0 0.0 6.1 0.0 0.0 140.0 13.8 0.0 0.0 0.0 54.3 0.0 0.0 0.0 0.0 98.6 23.3 50.9 0.0 0.0 MEIS2 "HsT18361, MRG1" ENSG00000134138 "Meis homeobox 2" O14770 15 36889204-37101299 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 522.3;Cone photoreceptor cells: 254.4;Excitatory neurons: 164.7;Hepatic stellate cells: 207.4;Oligodendrocyte precursor cells: 262.4;Oligodendrocytes: 219.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "basophil: 2.9;eosinophil: 2.4" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 114.0;SH-SY5Y: 104.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 68.4;olfactory bulb: 177.4" "HPA003256, CAB004999" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Cytosol "CAB004999: AB_425545, HPA003256: AB_1079356" "unprognostic (4.33e-2)" "unprognostic (1.94e-2)" "unprognostic (6.71e-4)" "unprognostic (2.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.24e-1)" "unprognostic (5.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-1)" "unprognostic (4.73e-2)" "unprognostic (7.97e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.64e-7)" "unprognostic (6.47e-2)" "unprognostic (8.15e-2)" "unprognostic (8.79e-5)" "unprognostic (1.15e-1)" 11.1 21.9 14.4 5.3 50.4 0.0 7.4 11.7 24.9 20.9 0.6 33.2 20.6 37.0 4.1 14.2 23.3 17.8 15.7 16.0 14.7 11.1 6.9 8.4 3.4 19.2 25.7 21.1 13.4 3.5 16.4 8.6 20.0 37.7 6.4 18.8 56.8 21.6 0.7 4.4 8.3 36.3 18.0 7.6 14.1 1.6 11.8 11.1 5.4 9.5 3.4 25.6 13.5 20.3 13.3 12.0 15.3 43.6 16.7 20.6 3.6 28.3 15.6 32.9 18.4 17.2 10.8 7.6 0.7 114.0 20.8 22.4 26.9 7.2 18.1 10.9 17.3 58.8 15.8 13.9 28.6 17.5 57.2 27.3 6.3 22.3 6.6 43.2 19.1 2.8 20.1 0.1 6.4 14.3 0.1 6.7 0.2 15.8 3.9 0.0 11.1 4.1 0.0 25.7 11.9 104.0 10.8 7.1 8.0 16.5 3.4 13.3 27.3 37.6 4.6 10.1 12.1 7.5 8.1 14.6 44.3 9.7 9.6 2.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 50.4 11.7 24.9 16.0 14.7 19.2 25.7 20.0 18.0 11.8 20.3 6.5 0.0 7.3 522.3 3.4 17.5 97.3 14.1 79.1 43.8 21.0 16.3 23.9 77.2 11.4 1.8 254.4 23.3 1.0 1.0 0.0 58.4 15.2 10.5 17.1 67.2 1.8 5.3 164.7 27.1 10.0 61.7 25.5 0.8 63.3 14.9 207.4 9.6 3.4 3.3 5.0 0.4 30.5 6.5 6.1 7.4 47.8 1.1 8.8 21.5 0.6 10.7 0.0 262.4 219.7 25.7 0.3 41.3 1.8 38.3 1.4 0.1 26.5 135.9 32.9 14.7 46.4 3.6 3.1 23.8 6.1 4.5 2.3 31.2 1.0 54.1 MEX3A "RKHD4, RNF162" ENSG00000254726 "Mex-3 RNA binding family member A" A1L020 1 156072013-156082465 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ovary: 4.4" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 16.5;Breast glandular cells: 20.8;Breast myoepithelial cells: 20.2;Granulosa cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 60.4;NTERA-2: 55.7;SCLC-21H: 57.4;SH-SY5Y: 105.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062703 Supported Cytosol NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA062703: AB_2684840" "unprognostic (8.63e-2)" "unprognostic (2.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.55e-3)" "unprognostic (6.18e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (9.23e-8)" "unprognostic (4.25e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.96e-1)" "unprognostic (1.08e-3)" "unprognostic (4.73e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" "unprognostic (4.96e-2)" 0.3 0.1 0.9 0.5 0.8 0.4 1.2 1.1 0.8 2.2 0.3 0.4 0.4 3.2 0.3 0.7 0.8 0.5 0.2 0.8 0.8 0.8 1.0 0.4 0.2 1.1 0.8 4.4 0.4 0.3 0.2 0.3 0.8 0.8 0.4 1.0 1.1 0.3 0.0 0.5 0.3 0.8 1.1 0.2 0.3 0.5 1.0 0.9 0.4 0.0 0.3 0.8 0.8 1.0 1.1 1.9 60.4 15.2 0.7 0.9 7.3 1.5 0.3 2.5 2.2 3.7 0.9 2.0 7.3 0.7 1.5 1.3 26.5 1.2 2.9 3.2 7.4 1.5 3.2 6.3 1.2 0.9 1.3 1.8 2.0 1.2 1.0 6.2 11.7 14.2 14.9 0.2 3.5 4.2 7.4 1.2 55.7 2.6 8.1 23.6 4.9 0.4 2.1 2.9 57.4 105.2 1.8 6.9 3.7 25.2 12.0 4.7 4.2 3.8 9.4 1.1 3.7 1.4 1.0 3.4 0.4 1.9 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 1.1 0.8 0.8 0.8 1.1 0.8 0.8 1.1 1.0 1.0 3.6 0.0 0.5 0.0 0.8 4.0 2.4 3.7 16.5 1.7 20.8 20.2 1.0 0.0 1.7 0.0 10.4 0.8 1.4 0.6 1.9 11.8 0.2 4.3 13.3 7.6 6.0 3.8 0.2 1.5 2.2 4.1 1.1 7.7 0.0 26.8 8.6 6.7 2.2 3.3 0.6 1.8 10.2 1.0 1.5 0.4 5.0 1.2 5.4 0.0 0.0 1.4 0.0 5.5 0.7 3.5 0.2 1.2 0.4 8.3 0.0 11.9 4.3 3.1 0.0 3.4 12.5 0.3 4.3 6.0 3.4 0.3 1.2 4.3 2.5 1.9 MFAP2 "MAGP, MAGP-1" ENSG00000117122 "Microfibril associated protein 2" P55001 1 16974502-16980632 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 81.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 197.8;Fibroblasts: 75.8;Granulosa cells: 93.3;Leydig cells: 53.7;Peritubular cells: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 249.4;ASC TERT1: 249.6;HUVEC TERT2: 263.1;SH-SY5Y: 212.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA007354 Enhanced "Secreted to extracellular matrix" NA NA 210000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" "HPA007354: AB_1079365" "unprognostic (5.10e-2)" "unprognostic (3.81e-2)" "unprognostic (2.62e-1)" "unprognostic (2.92e-2)" "unprognostic (4.86e-1)" "unprognostic (1.53e-3)" "unprognostic (3.72e-3)" "unprognostic (2.21e-1)" "unprognostic (1.85e-2)" "unprognostic (1.98e-1)" "unprognostic (9.45e-3)" "unprognostic (9.12e-2)" "prognostic unfavorable (2.52e-8)" "unprognostic (2.18e-3)" "unprognostic (1.34e-1)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" 36.6 4.2 0.4 13.3 0.6 0.1 22.7 0.5 1.1 81.8 1.6 15.0 5.0 61.4 22.1 6.1 19.0 73.2 13.8 0.5 0.6 9.4 1.6 20.1 4.2 0.7 0.9 35.8 18.8 4.5 13.2 42.4 0.7 22.1 4.8 4.9 16.5 12.1 2.6 27.6 12.1 30.6 0.5 2.7 8.3 11.2 0.7 1.6 9.5 3.0 2.3 22.5 36.7 0.6 0.0 0.2 93.2 0.3 249.4 249.6 6.2 26.3 102.5 39.7 73.7 24.1 1.1 0.0 82.6 89.7 0.1 0.1 7.2 7.7 15.9 0.1 78.0 0.0 37.1 2.1 23.4 0.1 0.1 104.4 18.8 109.4 42.7 113.1 263.1 0.0 0.2 16.2 19.2 12.5 0.1 0.1 108.8 0.5 0.8 1.5 0.0 4.0 0.9 0.3 5.0 212.1 9.0 36.6 9.6 71.1 11.9 13.0 75.6 65.6 128.4 51.7 2.8 0.1 0.3 0.2 53.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.5 1.1 0.5 0.6 0.7 0.9 0.7 0.5 0.7 0.6 5.5 0.0 1.7 0.0 0.1 6.6 7.8 28.7 8.0 0.2 2.1 3.9 0.9 2.8 10.7 3.7 0.0 4.5 0.0 0.1 0.0 1.3 12.9 5.6 28.7 7.1 10.1 0.0 0.0 0.8 197.8 75.8 2.0 8.3 0.0 93.3 1.4 0.0 7.4 0.0 0.0 0.4 12.2 0.0 7.7 7.6 53.7 0.6 17.8 2.8 0.0 27.7 0.0 0.0 0.0 1.9 0.0 63.9 0.5 1.5 0.0 0.0 1.9 0.8 0.0 3.3 14.7 3.2 8.7 0.6 6.3 29.0 0.9 0.5 0.2 1.2 MLLT11 AF1Q ENSG00000213190 "MLLT11 transcription factor 7 cofactor" Q13015 1 151060397-151069544 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 109.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 54.1;Early spermatids: 76.9;Excitatory neurons: 57.9;Late spermatids: 215.6" "Cancer enriched" "Detected in all" 4 "glioma: 29.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 216.7;EFO-21: 164.9;SH-SY5Y: 238.6;U-698: 207.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000540 Uncertain Supported Nucleoplasm,Cytosol No No "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA000540: AB_2666024" "unprognostic (2.96e-2)" "unprognostic (1.98e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (4.26e-5)" "unprognostic (1.69e-1)" "unprognostic (1.96e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.25e-12)" "unprognostic (5.66e-3)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (3.94e-3)" 5.3 19.0 59.4 4.7 61.8 2.0 2.5 41.1 109.3 4.5 8.8 7.2 1.6 10.7 1.3 4.0 6.2 6.0 38.1 66.2 80.6 3.8 2.0 3.8 2.1 63.1 50.5 8.2 3.1 16.2 10.4 1.0 66.1 4.3 3.6 35.6 3.8 1.5 11.3 2.6 4.9 13.8 29.9 4.6 5.1 2.8 49.7 20.6 3.8 10.8 2.1 4.0 3.9 57.1 6.3 31.0 216.7 34.4 3.5 5.8 1.4 11.6 15.2 13.2 24.0 3.0 12.6 10.0 164.9 10.6 35.9 4.5 54.3 13.0 7.6 65.8 14.5 28.9 17.7 0.9 6.9 0.8 1.0 9.9 1.6 73.5 2.9 42.2 100.1 43.3 30.8 2.3 43.6 1.4 106.4 19.0 95.7 0.6 4.4 99.8 28.1 0.6 25.5 1.7 132.8 238.6 0.8 1.3 6.9 142.5 5.3 2.7 65.9 27.0 29.0 9.2 24.7 2.4 3.2 207.1 70.0 0.6 51.7 1.1 0.3 1.4 5.9 0.6 2.7 2.5 3.9 6.2 0.7 1.9 5.3 9.1 1.6 4.0 0.9 1.4 4.1 3.2 59.4 61.8 41.1 109.3 66.2 80.6 63.1 50.5 66.1 29.9 49.7 57.1 1.4 0.0 1.1 11.8 4.2 3.6 5.0 14.6 4.6 54.1 2.5 4.8 10.2 1.5 2.2 3.7 8.4 2.9 15.3 0.1 17.6 3.9 76.9 0.8 11.3 5.2 10.7 6.3 57.9 1.2 2.5 17.5 2.0 0.9 4.5 4.3 4.2 0.4 6.0 37.0 40.6 0.1 16.2 6.6 14.5 215.6 2.1 12.3 5.4 10.3 33.3 20.6 19.6 16.1 14.4 3.0 0.2 3.8 4.8 1.3 0.2 2.4 0.6 26.3 0.0 3.4 30.0 8.6 12.3 2.8 3.4 7.4 9.9 3.0 0.2 4.3 MYO16 "KIAA0865, Myo16b, MYR8, NYAP3, PPP1R107" ENSG00000041515 "Myosin XVI" Q9Y6X6 13 108596152-109208005 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.4" "Group enriched" "Detected in some" 8 "Inhibitory neurons: 460.0;Oligodendrocyte precursor cells: 299.6" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;SH-SY5Y: 4.5;U-2197: 2.7" "Region enhanced" "Detected in all" "olfactory bulb: 72.6" "Low region specificity" "Detected in all" "HPA040110, HPA058769, HPA071948" Uncertain Approved Vesicles NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA040110: AB_10796339, HPA058769: AB_2683814, HPA071948: AB_2686475" "unprognostic (7.55e-3)" "unprognostic (7.74e-3)" "unprognostic (4.52e-4)" "unprognostic (5.12e-3)" "unprognostic (1.38e-1)" "unprognostic (5.81e-2)" "unprognostic (1.20e-2)" "unprognostic (2.16e-1)" "unprognostic (2.53e-1)" "unprognostic (6.50e-2)" "unprognostic (9.01e-3)" "unprognostic (5.29e-2)" "unprognostic (4.68e-4)" "unprognostic (4.26e-2)" "unprognostic (3.21e-2)" "unprognostic (7.06e-2)" "unprognostic (2.34e-2)" 1.4 0.7 2.5 0.2 4.9 0.0 0.2 1.2 3.7 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.9 5.4 1.8 0.0 1.9 0.2 0.2 0.6 1.5 0.0 0.1 0.0 1.7 0.1 2.3 0.2 0.1 0.4 0.1 0.7 0.0 0.1 0.0 0.4 2.6 0.0 0.0 1.1 2.6 0.0 0.0 0.2 0.3 0.0 0.2 0.9 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 4.9 1.2 3.7 5.4 1.8 0.6 1.5 2.3 2.6 2.6 0.9 1.0 0.0 0.6 19.6 0.0 0.3 0.0 0.4 0.0 4.2 0.1 0.3 3.7 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.5 11.3 0.5 1.1 0.1 0.0 3.4 44.6 0.0 0.1 0.8 0.0 0.3 1.3 0.1 0.0 5.9 0.1 0.0 460.0 0.0 0.0 0.0 0.3 11.4 0.9 0.1 1.8 8.4 0.0 2.8 0.0 299.6 4.7 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.4 0.0 0.1 0.1 5.0 7.7 0.0 0.0 0.3 0.3 1.6 0.0 0.0 MYRIP "DKFZp586F1018, exophilin-8, SLAC2-C, SLAC2C" ENSG00000170011 "Myosin VIIA and Rab interacting protein" Q8NFW9 3 39808914-40260321 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 295.6;Inhibitory neurons: 507.3;Microglial cells: 210.8;Oligodendrocyte precursor cells: 98.0" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.1;HUVEC TERT2: 15.6;REH: 3.7;SCLC-21H: 3.2;SH-SY5Y: 9.4;T-47d: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006433 Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "HPA006433: AB_10603023" "unprognostic (1.87e-2)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.89e-2)" "unprognostic (2.36e-1)" "unprognostic (6.03e-2)" "unprognostic (2.57e-3)" "unprognostic (1.34e-3)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (1.91e-1)" "prognostic favorable (3.96e-8)" "unprognostic (7.12e-2)" "unprognostic (2.40e-1)" "unprognostic (8.92e-2)" "unprognostic (6.16e-2)" 4.1 1.0 16.8 1.3 13.3 0.0 3.7 11.1 18.4 5.7 15.4 2.7 1.7 3.2 2.2 1.3 2.8 2.7 2.4 17.3 7.7 1.5 11.5 0.8 1.6 9.2 17.8 3.1 8.9 2.1 2.9 0.1 13.0 2.0 2.6 4.3 12.5 0.8 1.7 1.2 2.4 2.3 4.2 7.2 5.6 0.9 12.0 0.5 1.5 0.5 1.7 1.4 2.6 15.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.2 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.0 0.1 3.7 0.0 0.0 0.4 2.0 3.2 9.4 0.0 0.0 0.0 0.0 3.8 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 13.3 11.1 18.4 17.3 7.7 9.2 17.8 13.0 4.2 12.0 15.0 15.8 0.0 3.2 36.2 0.4 0.8 0.1 0.0 1.2 2.7 0.5 0.3 2.4 5.7 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.1 19.9 1.1 0.7 21.3 0.0 1.7 295.6 2.8 0.0 1.6 3.1 6.2 2.5 14.0 42.8 17.4 0.0 5.0 507.3 11.9 0.0 2.8 0.7 6.1 0.9 0.1 0.0 210.8 0.0 6.6 0.0 98.0 24.5 0.6 0.1 0.0 0.0 1.4 0.1 1.8 0.1 4.2 0.0 0.3 0.7 3.1 0.6 0.1 0.6 0.0 0.3 0.1 0.7 0.1 NANOS1 "NOS1, ZC2HC12A" ENSG00000188613 "Nanos C2HC-type zinc finger 1" Q8WY41 10 119029714-119033730 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 10.2;Cardiomyocytes: 11.3;Cone photoreceptor cells: 10.4;Muller glia cells: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 80.4;SK-BR-3: 46.7;SK-MEL-30: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB012219 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "CAB012219: " "prognostic unfavorable (1.52e-4)" "unprognostic (1.17e-1)" "unprognostic (1.50e-3)" "unprognostic (1.59e-3)" "unprognostic (7.07e-3)" "unprognostic (2.01e-1)" "unprognostic (2.19e-2)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (2.70e-1)" "unprognostic (8.22e-3)" "unprognostic (8.79e-2)" "unprognostic (2.64e-4)" "unprognostic (7.89e-2)" "unprognostic (6.99e-2)" "unprognostic (2.78e-2)" "unprognostic (2.52e-3)" 9.5 11.3 7.4 0.3 7.3 0.2 8.3 7.4 7.7 1.9 5.0 2.9 0.3 2.1 1.7 1.0 1.0 0.2 10.3 5.9 11.8 4.6 0.3 1.1 0.4 8.8 8.9 0.3 2.2 0.3 2.8 6.3 8.5 1.0 0.4 4.1 1.3 0.9 38.6 1.6 0.9 1.8 7.1 0.3 3.4 1.9 9.2 0.3 7.1 1.7 0.3 3.3 1.0 10.9 16.4 1.3 2.2 0.4 7.4 1.1 9.7 0.4 0.5 0.4 0.2 2.0 5.6 8.7 2.2 0.1 0.0 5.8 2.7 2.9 0.7 2.6 6.6 0.2 3.8 1.8 3.5 1.0 0.0 1.5 11.7 0.1 1.6 2.4 0.4 3.0 1.7 1.0 0.5 2.3 2.2 2.8 7.1 3.4 1.3 0.0 2.7 5.9 3.1 1.3 6.3 80.4 4.7 46.7 37.4 12.2 7.4 4.7 0.5 0.0 3.4 0.1 0.8 2.4 8.6 3.2 0.7 2.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 7.4 7.3 7.4 7.7 5.9 11.8 8.8 8.9 8.5 7.1 9.2 10.9 5.7 6.4 1.1 2.0 1.3 0.8 5.0 1.3 0.6 4.1 10.2 6.1 11.3 1.5 1.2 1.8 10.4 6.5 6.3 4.4 0.0 0.6 0.2 3.9 2.8 1.7 3.0 0.0 0.5 0.2 0.4 4.0 1.1 3.7 0.0 2.6 0.7 0.1 0.7 1.7 2.3 3.8 0.0 0.0 2.1 0.1 1.8 0.9 0.0 0.0 0.0 14.7 1.0 2.0 0.2 0.3 0.1 0.7 1.6 2.9 0.2 0.5 1.2 2.1 0.0 7.7 3.9 0.4 1.0 0.8 1.3 1.0 2.9 0.7 2.1 1.3 NAP1L5 DRLM ENSG00000177432 "Nucleosome assembly protein 1 like 5" Q96NT1 4 88695913-88697829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 72.9" "Cell type enhanced" "Detected in many" "Muller glia cells: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SH-SY5Y: 49.6" "Low region specificity" "Detected in all" HPA058227 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm Cytosol "HPA058227: AB_2683644" "unprognostic (1.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (8.54e-3)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-2)" "unprognostic (1.39e-1)" 9.3 27.7 41.3 4.5 35.7 7.2 5.9 24.1 53.9 7.0 11.6 5.7 2.1 7.9 12.9 4.8 5.8 6.7 7.3 34.1 72.9 7.5 6.2 3.6 3.8 38.0 49.1 9.9 3.3 9.0 23.0 6.0 55.3 8.1 3.5 21.0 2.8 10.4 2.8 2.1 2.8 8.0 25.5 4.4 3.9 6.2 37.6 3.8 11.6 4.0 2.7 7.6 3.5 26.7 0.0 1.9 12.4 7.6 17.7 11.3 0.0 13.5 8.2 6.8 10.5 0.0 1.6 0.0 5.4 7.9 3.0 2.6 22.2 5.4 12.2 4.3 0.0 23.8 7.9 1.9 15.4 12.4 15.0 18.0 1.7 8.0 1.2 8.7 12.2 13.1 6.8 0.1 20.1 0.2 15.3 0.9 5.1 6.6 0.0 8.2 3.6 1.4 4.5 5.7 16.4 49.6 0.0 2.4 10.4 13.2 0.0 3.5 8.8 7.7 1.9 4.9 6.8 3.4 0.0 0.0 16.4 0.0 6.1 0.0 0.1 0.1 1.4 0.1 0.9 0.0 0.6 1.0 0.3 0.2 1.2 1.1 0.2 0.5 0.3 0.3 0.7 0.3 41.3 35.7 24.1 53.9 34.1 72.9 38.0 49.1 55.3 25.5 37.6 26.7 6.4 3.2 6.7 8.5 4.2 1.8 3.8 2.2 5.2 32.4 3.0 5.2 5.3 1.5 4.7 5.5 14.6 16.0 12.2 0.6 15.6 1.8 1.0 2.8 13.0 7.2 17.3 10.5 21.2 2.6 2.2 12.8 4.6 3.3 31.1 5.6 16.8 3.0 5.6 15.2 30.8 2.2 2.0 0.9 3.1 0.7 10.8 2.9 5.4 3.7 1.8 36.8 8.2 5.5 7.6 1.0 1.3 18.0 4.3 2.0 0.1 5.9 1.4 16.1 19.7 9.2 14.5 8.6 3.0 2.2 1.4 22.2 9.0 16.3 0.9 2.2 NAT16 "C7orf52, FLJ39237" ENSG00000167011 "N-acetyltransferase 16 (putative)" Q8N8M0 7 101170496-101180293 "Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 2.7;pancreas: 2.3;pituitary gland: 3.6;retina: 6.9;thyroid gland: 1.8" "Cell type enriched" "Detected in some" 36 "Horizontal cells: 292.7" "Cancer enhanced" "Detected in some" "glioma: 1.3;melanoma: 2.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.4;SH-SY5Y: 3.4;SK-MEL-30: 2.7;U-2 OS: 2.9;U-87 MG: 1.7" HPA021918 Uncertain Approved Nucleoplasm NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA021918: AB_1848922" "unprognostic (4.32e-2)" "unprognostic (1.75e-1)" "unprognostic (2.69e-3)" "unprognostic (4.58e-3)" "unprognostic (2.93e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" "unprognostic (1.40e-2)" "unprognostic (2.25e-3)" "unprognostic (2.35e-2)" "unprognostic (4.23e-2)" "unprognostic (2.62e-2)" "unprognostic (5.53e-5)" "unprognostic (7.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.02e-5)" "unprognostic (1.59e-1)" 0.0 0.1 1.5 0.0 1.4 0.2 0.0 0.7 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 2.7 0.0 0.1 0.0 0.0 0.8 1.2 0.0 2.3 0.3 3.6 0.0 0.5 0.0 0.0 6.9 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.4 0.1 2.5 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.1 0.0 2.4 0.0 0.2 0.0 3.4 0.0 0.1 2.7 0.2 0.1 0.0 0.0 0.1 2.9 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 1.5 1.4 0.7 2.7 1.0 2.7 0.8 1.2 0.5 0.2 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.1 0.7 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 292.7 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 5.5 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 NAV2 "FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1" ENSG00000166833 "Neuron navigator 2" Q8IVL1 11 19350724-20121601 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.7;heart muscle: 61.2" "Cell type enhanced" "Detected in many" "Astrocytes: 466.8;Excitatory neurons: 333.8;Inhibitory neurons: 525.7;Oligodendrocyte precursor cells: 863.6;Oligodendrocytes: 354.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 89.9;SH-SY5Y: 81.9;TIME: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011755, HPA011891" Approved Supported Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "HPA011755: AB_1854319, HPA011891: AB_1854318" "unprognostic (7.71e-2)" "unprognostic (2.37e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (1.76e-3)" "unprognostic (3.01e-2)" "unprognostic (3.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.00e-1)" "unprognostic (3.53e-3)" "unprognostic (1.84e-1)" "unprognostic (2.83e-2)" "unprognostic (3.85e-2)" "unprognostic (1.08e-1)" "unprognostic (6.43e-2)" "unprognostic (3.28e-2)" 7.4 1.6 11.6 3.3 18.8 1.8 12.0 16.1 10.8 6.3 3.5 16.2 4.4 7.6 11.1 6.5 4.4 1.8 61.2 9.6 13.8 9.5 14.9 9.5 1.8 55.7 43.7 3.1 8.8 6.0 5.1 14.8 36.5 6.2 4.9 8.7 15.0 9.3 2.6 6.7 4.1 8.5 39.3 1.4 7.2 0.9 27.7 2.5 16.9 9.4 3.9 5.7 7.4 35.6 16.2 4.7 10.2 1.4 33.7 21.6 11.0 13.3 22.6 17.2 13.0 18.2 2.1 0.1 0.6 20.1 28.0 1.9 0.6 10.4 20.1 3.8 1.2 0.4 25.1 20.9 6.1 0.0 0.5 14.1 26.5 8.3 89.9 12.7 23.2 0.1 1.9 8.0 50.2 17.2 0.0 0.1 26.4 5.3 13.1 0.1 47.1 2.6 14.8 4.6 18.2 81.9 10.3 7.9 14.8 54.2 0.3 0.0 65.2 39.6 6.3 47.7 12.7 2.7 2.0 0.1 13.5 0.8 12.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.6 18.8 16.1 10.8 9.6 13.8 55.7 43.7 36.5 39.3 27.7 35.6 5.5 64.1 22.6 466.8 1.4 4.2 23.6 13.8 14.2 4.6 33.6 31.0 14.3 8.6 18.3 20.2 0.0 31.8 0.8 2.8 13.7 20.3 2.6 34.4 4.6 14.5 10.8 0.0 333.8 21.3 23.3 16.5 11.2 62.1 1.3 152.4 11.7 47.0 10.7 26.9 525.7 10.1 18.3 1.4 5.0 7.9 0.9 3.2 16.0 194.9 1.0 28.9 0.0 863.6 354.4 37.5 0.8 4.1 0.4 33.7 1.8 0.4 24.0 2.4 0.0 30.7 17.8 1.5 0.6 23.1 3.7 14.6 1.7 54.7 9.2 17.8 NBEA "BCL8B, FLJ10197, KIAA1544, LYST2" ENSG00000172915 Neurobeachin Q8NFP9 13 34942270-35673022 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 23.5;retina: 65.7" "Group enriched" "Detected in many" 4 "Excitatory neurons: 1016.1;Inhibitory neurons: 953.0;Oligodendrocyte precursor cells: 466.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 33.1;SH-SY5Y: 80.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039730, HPA040385" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA039730: AB_10794202, HPA040385: AB_10795523" "unprognostic (1.80e-2)" "unprognostic (2.90e-1)" "unprognostic (4.99e-2)" "unprognostic (3.89e-4)" "unprognostic (3.59e-1)" "unprognostic (2.04e-1)" "unprognostic (8.75e-2)" "unprognostic (6.95e-3)" "unprognostic (5.01e-1)" "unprognostic (7.43e-2)" "unprognostic (1.03e-3)" "unprognostic (2.45e-1)" "prognostic favorable (7.86e-8)" "unprognostic (2.28e-2)" "unprognostic (9.35e-2)" "unprognostic (1.17e-1)" "unprognostic (6.46e-2)" 2.4 7.2 7.7 1.5 10.7 0.3 4.9 19.0 23.5 3.5 2.8 5.8 1.4 6.1 2.2 3.3 5.5 3.4 6.9 17.4 2.8 4.1 0.6 2.0 1.6 4.1 0.1 6.2 3.1 7.1 8.3 0.6 4.8 6.6 2.5 65.7 4.7 8.4 5.6 1.5 2.5 6.5 0.4 3.2 2.7 3.5 0.0 5.6 6.3 5.7 1.2 3.6 2.8 4.5 0.0 4.5 10.9 6.1 0.7 0.1 0.3 7.0 10.8 7.9 6.6 0.1 1.0 3.0 0.0 12.9 4.7 0.3 3.7 1.5 16.3 1.4 3.6 0.0 3.4 1.2 0.5 1.9 4.7 2.1 1.2 0.1 0.7 33.1 1.8 1.2 0.1 17.6 1.1 1.9 1.1 0.0 4.6 6.2 2.0 1.1 4.7 0.9 9.3 2.1 6.2 80.1 5.4 0.1 3.6 8.1 2.0 0.4 0.1 2.0 1.2 0.0 1.6 1.9 0.5 1.3 5.4 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 7.7 10.7 19.0 23.5 17.4 2.8 4.1 0.1 4.8 0.4 0.0 4.5 19.7 28.9 9.2 132.9 5.2 1.0 5.3 2.7 1.2 124.8 5.0 6.5 51.8 11.5 14.1 9.2 146.0 0.1 4.4 0.3 1.9 9.2 19.3 5.6 18.4 10.1 22.9 0.8 1016.1 1.8 0.1 12.3 2.0 0.6 25.2 20.7 11.0 0.3 0.9 47.1 953.0 2.1 6.1 3.5 3.9 13.6 17.7 3.5 7.2 150.9 1.2 69.1 0.0 466.9 163.7 2.3 0.1 19.2 5.8 8.5 0.2 7.6 56.5 87.0 6.6 22.2 13.1 8.5 8.0 0.3 0.9 0.0 1.2 11.9 1.1 13.5 NBPF15 "MGC8902, NBPF16" ENSG00000266338 "NBPF member 15" Q8N660 1 144421386-144461674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 8 "B-cells: 1.3;NK-cells: 1.3;T-cells: 2.5" "Low cell line specificity" "Detected in many" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 18: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol Microtubules "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "unprognostic (7.10e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" "unprognostic (1.84e-3)" "unprognostic (3.50e-3)" "unprognostic (8.16e-3)" "unprognostic (1.19e-1)" "unprognostic (4.73e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (4.11e-5)" "unprognostic (1.36e-1)" "unprognostic (1.91e-1)" "unprognostic (6.67e-2)" "unprognostic (6.26e-2)" 17.2 13.9 7.8 10.1 8.0 2.3 18.7 11.3 8.5 21.9 7.2 20.4 3.9 17.4 20.2 13.7 20.0 7.6 13.4 7.6 8.3 17.2 36.5 24.1 16.8 7.4 7.3 21.2 21.3 8.9 17.0 9.8 7.2 18.0 7.8 18.6 14.4 7.4 5.6 15.2 19.3 12.0 6.4 28.9 14.2 6.9 8.4 2.4 25.8 2.9 12.3 15.3 17.2 6.2 13.7 9.3 15.8 29.8 18.2 28.6 19.5 24.6 24.2 15.0 15.2 7.9 14.8 7.0 6.6 18.5 16.9 10.5 17.5 8.0 23.0 23.4 9.6 0.4 23.6 9.6 14.0 0.4 6.5 23.8 13.5 17.7 36.4 20.7 21.1 2.7 3.1 20.5 36.0 29.7 0.3 6.0 6.5 5.0 19.8 6.4 9.2 11.1 16.2 12.4 1.4 35.7 10.5 15.7 17.5 20.1 16.2 5.9 22.6 23.7 15.3 21.0 23.5 18.2 21.0 11.8 0.3 0.7 11.4 0.0 0.2 0.0 0.5 0.0 0.8 1.3 1.5 1.1 0.1 0.9 1.8 0.7 0.1 1.3 0.2 0.0 2.5 0.8 7.8 8.0 11.3 8.5 7.6 8.3 7.4 7.3 7.2 6.4 8.4 6.2 5.9 44.8 20.8 5.9 14.8 2.0 1.5 0.7 22.8 2.7 5.1 3.2 10.3 4.3 12.8 1.8 6.2 1.7 4.9 1.6 0.0 6.4 5.3 2.6 9.6 9.7 6.1 1.7 16.9 4.4 3.2 12.2 11.2 3.8 15.2 5.3 6.1 8.9 1.6 3.3 10.4 3.0 0.0 7.5 1.4 1.4 8.7 8.1 1.8 14.0 6.2 3.1 1.0 7.1 3.4 6.6 23.6 10.5 10.3 1.5 1.4 1.0 5.0 7.1 0.0 3.5 8.7 3.7 1.9 17.6 1.3 0.3 8.4 3.8 5.2 0.4 NCAN CSPG3 ENSG00000130287 Neurocan O14594 19 19211958-19252233 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 63 "brain: 73.6" "Cell type enriched" "Detected in some" 6 "Astrocytes: 195.5" "Cancer enriched" "Detected in some" 57 "glioma: 71.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;SCLC-21H: 2.3;SH-SY5Y: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036814 Enhanced "Secreted in brain" NA NA 790000 "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA036814: AB_10673666" "unprognostic (1.02e-2)" "unprognostic (2.84e-3)" "unprognostic (1.92e-1)" "unprognostic (1.56e-2)" "unprognostic (2.35e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (1.03e-3)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "unprognostic (4.58e-3)" "unprognostic (4.38e-2)" "unprognostic (9.09e-6)" "unprognostic (1.10e-2)" "unprognostic (2.79e-2)" "unprognostic (2.91e-1)" "unprognostic (2.58e-2)" 0.0 0.1 52.8 0.0 53.1 0.0 0.0 15.2 73.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.6 44.2 0.0 0.0 0.0 0.0 33.3 32.3 0.0 0.0 0.0 0.3 0.0 38.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.9 61.5 0.1 0.0 0.0 0.0 0.0 0.0 49.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 53.1 15.2 73.6 55.6 44.2 33.3 32.3 38.1 21.5 61.5 49.4 0.0 0.0 0.0 195.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.1 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 15.5 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 8.4 0.0 0.5 0.0 29.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 NEUROG2 "Atoh4, bHLHa8, Math4A, ngn-2, NGN2" ENSG00000178403 "Neurogenin 2" Q9H2A3 4 112513516-112516180 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.3;testis: 1.6" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Breast myoepithelial cells: 3.4;Early spermatids: 1.9;Late spermatids: 1.1;Muller glia cells: 8.1;Spermatocytes: 1.4" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 203.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 10 "hippocampal formation: 12.3" CAB012342 Uncertain NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "CAB012342: " "unprognostic (1.09e-1)" "unprognostic (2.52e-2)" "unprognostic (7.51e-2)" "unprognostic (4.10e-1)" "unprognostic (1.62e-1)" "unprognostic (7.75e-2)" "unprognostic (1.04e-1)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (3.30e-1)" 0.0 0.0 0.8 0.0 1.2 0.0 0.2 1.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.0 2.0 203.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 1.2 2.1 3.3 0.2 0.2 0.1 0.1 0.1 0.2 0.7 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKIRAS2 "DKFZP434N1526, kappaB-Ras2, KBRAS2" ENSG00000168256 "NFKB inhibitor interacting Ras like 2" Q9NYR9 17 42011382-42025644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062861 Approved Nucleoplasm,Nucleoli NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA062861: AB_2684884" "unprognostic (2.53e-1)" "unprognostic (1.09e-3)" "unprognostic (2.31e-2)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (5.56e-4)" "unprognostic (9.37e-3)" "unprognostic (2.89e-2)" "unprognostic (2.56e-1)" "unprognostic (6.96e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (3.25e-2)" "unprognostic (5.42e-3)" 21.7 15.7 14.1 20.8 17.1 25.6 18.4 15.3 15.4 18.8 15.6 20.8 15.2 19.0 11.0 32.7 14.4 17.8 45.8 14.3 12.0 16.9 19.3 16.7 17.8 14.8 13.3 16.0 13.3 19.4 10.8 33.9 13.1 16.1 16.3 13.7 16.2 18.0 50.0 26.6 16.2 26.4 12.1 15.1 16.9 20.8 15.5 22.1 13.5 36.8 19.0 20.8 20.1 15.0 22.4 42.5 57.4 31.1 39.8 26.8 33.7 36.4 28.1 56.6 41.6 43.6 31.3 37.4 57.3 38.6 38.4 47.1 47.3 28.6 29.6 30.6 54.2 32.9 37.1 33.0 62.8 45.8 25.9 41.0 50.8 38.1 29.8 38.6 71.3 47.8 47.1 36.9 33.8 23.7 87.3 30.4 34.4 30.0 30.0 67.9 63.7 35.8 40.3 23.2 68.5 90.0 26.6 84.0 38.6 55.6 51.5 55.5 50.3 36.2 38.8 40.5 41.5 47.4 82.7 30.0 24.6 27.5 52.2 54.5 54.2 46.1 14.2 45.1 14.1 15.4 14.2 14.4 43.5 17.1 14.4 14.0 30.7 27.0 50.0 48.4 13.4 25.2 14.1 17.1 15.3 15.4 14.3 12.0 14.8 13.3 13.1 12.1 15.5 15.0 26.6 16.0 10.3 3.9 19.0 17.0 18.7 27.2 12.5 21.0 19.9 17.1 26.3 10.0 23.8 16.5 20.9 52.3 13.8 19.1 21.5 30.0 27.8 11.9 18.5 27.1 19.2 21.2 5.4 28.1 39.7 20.1 11.2 16.3 14.0 28.1 19.2 15.6 37.9 23.5 4.8 17.5 42.7 31.1 29.1 6.6 19.6 27.8 10.6 5.6 37.2 24.7 14.4 1.5 4.5 30.4 14.7 18.4 13.3 20.8 20.9 19.0 10.9 26.6 6.6 15.3 24.5 34.7 41.3 21.0 25.7 62.3 12.8 23.3 15.2 21.6 NNAT Peg5 ENSG00000053438 Neuronatin Q16517 20 37521206-37523690 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 11 "pituitary gland: 1586.9" "Cell type enhanced" "Detected in many" "Early spermatids: 42.0;Excitatory neurons: 33.9;Late spermatids: 65.5;Muller glia cells: 177.1" "Group enriched" "Detected in many" 16 "glioma: 87.5;testis cancer: 55.0;urothelial cancer: 37.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 22 "SH-SY5Y: 720.8" "Low region specificity" "Detected in all" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "unprognostic (1.18e-2)" "unprognostic (7.41e-3)" "unprognostic (1.85e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (9.66e-4)" "unprognostic (7.08e-2)" "unprognostic (1.42e-1)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (7.52e-2)" "unprognostic (4.94e-2)" "unprognostic (1.64e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-3)" "unprognostic (5.90e-2)" 27.4 15.1 109.4 2.5 141.4 2.5 32.5 15.8 65.2 7.4 56.2 76.2 4.0 4.9 0.2 3.4 3.6 4.7 2.7 105.8 70.9 1.6 2.0 2.1 1.4 45.7 49.7 1.5 1.4 0.0 1586.9 106.5 49.3 4.4 4.0 31.4 6.6 0.6 13.5 5.1 14.6 5.1 22.3 1.4 16.8 5.0 93.5 11.1 2.0 0.3 0.1 14.5 5.6 29.6 2.2 1.7 12.6 1.7 0.0 0.0 4.5 0.5 0.0 0.1 0.0 4.2 2.2 1.0 0.7 0.0 0.2 10.2 0.0 0.0 0.0 0.1 0.3 0.3 12.9 2.4 3.2 1.3 1.1 2.9 0.0 0.0 0.0 0.2 32.5 0.3 0.2 2.4 0.1 1.0 5.7 1.3 0.9 0.3 1.6 0.5 4.0 0.5 0.0 20.6 1.9 720.8 1.1 5.0 0.0 0.6 1.3 0.2 0.8 5.7 0.8 1.6 1.1 0.9 0.2 0.1 1.7 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.4 141.4 15.8 65.2 105.8 70.9 45.7 49.7 49.3 22.3 93.5 29.6 0.3 0.0 0.0 1.6 0.2 4.0 0.8 0.1 19.9 4.5 0.3 5.8 0.1 0.0 0.7 0.0 0.0 0.6 0.3 0.1 0.0 0.2 42.0 0.1 3.0 21.6 0.0 0.0 33.9 0.0 1.1 3.1 0.0 0.1 1.3 2.2 0.0 0.0 1.6 0.0 9.6 0.2 0.0 0.3 1.1 65.5 0.6 0.1 1.8 4.7 0.0 177.1 0.0 2.0 1.8 0.0 0.0 1.2 0.0 2.5 0.0 0.0 1.1 6.5 0.0 1.4 1.9 1.5 5.6 3.6 1.0 0.3 0.1 0.1 0.0 4.8 NOD1 "CARD4, CLR7.1, NLRC1" ENSG00000106100 "Nucleotide binding oligomerization domain containing 1" Q9Y239 7 30424527-30478784 "Human disease related genes, Predicted intracellular proteins" "Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 19.3;Microglial cells: 26.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 11.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074367 Approved Mitochondria NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 19: Lung - Lung function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Mitochondria "HPA074367: AB_2686683" "unprognostic (2.58e-1)" "unprognostic (1.56e-2)" "unprognostic (9.73e-2)" "unprognostic (8.09e-3)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (1.01e-3)" "unprognostic (6.63e-2)" "unprognostic (2.26e-1)" "unprognostic (2.74e-1)" "unprognostic (8.78e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.68e-4)" "unprognostic (6.62e-2)" "unprognostic (1.46e-1)" "prognostic favorable (1.95e-4)" "unprognostic (2.64e-1)" 10.6 2.9 3.0 8.8 3.2 6.8 9.5 2.5 2.6 5.3 4.6 5.3 2.2 6.1 2.6 4.7 6.5 5.4 7.3 2.4 3.2 3.9 2.2 11.9 6.1 7.6 4.9 10.3 1.8 2.7 2.9 12.2 4.7 4.0 4.3 0.6 6.2 3.2 4.0 5.9 5.4 7.3 3.6 11.1 4.8 1.9 5.6 3.5 10.8 4.0 5.0 7.3 5.0 2.8 4.8 2.5 3.5 10.5 2.2 10.3 5.3 3.3 2.3 5.5 7.0 2.2 5.7 6.9 3.8 4.2 6.1 11.2 3.5 5.8 3.7 3.6 3.0 9.7 7.7 2.2 2.8 4.3 7.0 9.6 2.5 3.5 3.0 4.9 18.3 10.1 5.2 2.4 5.0 2.8 6.2 7.7 4.1 5.3 4.5 7.4 4.0 6.3 1.8 3.8 0.6 12.4 4.2 10.7 3.7 4.8 3.6 9.6 7.7 4.8 7.6 6.0 4.5 2.2 8.0 0.3 3.5 15.1 5.1 13.7 3.7 13.5 8.1 5.0 8.9 7.5 5.5 5.3 3.3 10.9 4.9 4.0 2.8 8.5 6.6 8.0 4.8 2.6 3.0 3.2 2.5 2.6 2.4 3.2 7.6 4.9 4.7 3.6 5.6 2.8 19.3 3.2 15.1 7.2 6.6 0.8 0.5 1.0 5.2 2.4 2.9 2.9 4.9 1.5 5.0 5.5 0.0 5.0 6.7 4.5 0.0 1.3 0.2 4.4 1.7 12.0 0.0 3.4 5.3 2.1 2.3 8.2 1.1 4.6 2.5 7.8 13.6 1.3 4.6 0.0 1.4 5.5 2.0 3.1 3.7 0.0 0.6 4.3 5.4 26.2 4.0 0.6 6.2 2.5 1.1 1.7 1.7 1.9 3.1 0.2 1.6 0.5 2.9 0.2 0.0 2.5 5.6 0.0 0.6 5.4 1.8 1.5 5.3 1.0 5.6 0.8 NPPA "ANP, PND" ENSG00000175206 "Natriuretic peptide A" P01160 1 11845709-11848345 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hormone, Vasoactive, Vasodilator" "Atrial fibrillation, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 873 "heart muscle: 60060.6" "Cell type enriched" "Detected in some" 23 "Cardiomyocytes: 62235.0" "Cancer enriched" "Detected in some" 9 "glioma: 7.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 9.6;SH-SY5Y: 9.5" "Region enriched" "Detected in some" 7 "olfactory bulb: 22.8" "Low region specificity" "Detected in all" "HPA058269, HPA064007" Enhanced "Secreted to blood" NA NA 1200000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA058269: AB_2683660, HPA064007: " "unprognostic (1.27e-3)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (2.01e-1)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (9.72e-3)" "unprognostic (2.21e-1)" "unprognostic (5.93e-4)" "unprognostic (2.31e-1)" "unprognostic (1.59e-1)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" 8.3 3.0 1.7 0.7 2.1 0.6 18.0 1.8 2.4 1.2 2.3 5.0 0.2 3.3 12.9 2.8 1.3 0.9 60060.6 2.2 1.5 2.6 5.0 58.1 1.2 1.7 1.5 12.1 68.7 0.9 3.9 5.9 1.4 5.1 0.0 0.4 28.5 0.0 8.9 5.8 6.1 0.7 1.3 3.1 3.6 3.9 1.7 0.5 7.1 0.0 0.0 1.2 3.9 2.0 0.5 0.2 0.3 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.9 0.6 0.8 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.2 0.4 1.0 0.3 1.8 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 1.2 0.0 0.3 0.3 1.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.6 9.6 9.5 0.0 0.0 0.5 0.3 0.3 0.1 0.0 0.4 0.7 0.6 0.1 0.4 0.8 1.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 2.1 1.8 2.4 2.2 1.5 1.7 1.5 1.4 1.3 1.7 2.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62235.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 339.1 0.0 0.0 0.3 0.0 0.0 2684.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 636.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPY PYY4 ENSG00000122585 "Neuropeptide Y" P01303 7 24284188-24291862 "FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Neuropeptide "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adrenal gland: 122.6;brain: 423.9;prostate: 332.8" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 56.7;Prostatic glandular cells: 100.6" "Cancer enriched" "Detected in many" 187 "prostate cancer: 1214.9" "Region enriched" "Detected in all" 7 "hypothalamus: 423.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 34 "SH-SY5Y: 700.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016733, CAB034368, HPA036636, HPA044572, HPA056798" Supported Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 30700000 21000 "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 35: Glandular cells - Unknown function" "Golgi apparatus" "CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371" "unprognostic (2.00e-1)" "prognostic unfavorable (5.78e-4)" "unprognostic (4.15e-1)" "unprognostic (3.76e-2)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "unprognostic (6.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.78e-1)" "unprognostic (2.52e-1)" 1.8 122.6 32.8 12.8 59.0 5.6 2.2 11.0 39.1 1.3 11.3 2.9 9.7 0.3 0.3 2.3 0.5 1.1 0.8 31.7 423.9 0.5 0.2 0.3 0.0 24.2 25.1 0.5 8.8 0.1 4.7 0.0 15.2 332.8 1.9 4.4 0.3 3.9 0.2 0.2 13.1 1.2 18.8 0.0 8.8 1.1 29.2 0.2 0.9 0.2 0.0 1.4 23.8 33.1 0.0 0.0 2.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 2.0 0.0 0.2 20.5 0.0 0.6 0.0 0.0 0.8 700.2 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 59.0 11.0 39.1 31.7 423.9 24.2 25.1 15.2 18.8 29.2 33.1 0.0 0.0 0.0 2.0 0.5 0.1 1.3 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 13.4 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 56.7 0.0 0.0 0.0 0.0 16.1 0.3 0.7 1.8 1.0 0.0 0.8 0.0 2.0 1.9 0.3 0.0 0.4 0.0 100.6 0.0 0.0 0.0 0.7 0.0 15.6 0.3 2.4 2.8 0.0 0.0 5.1 0.3 0.0 0.0 2.0 NPY2R ENSG00000185149 "Neuropeptide Y receptor Y2" P49146 4 155208636-155217078 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.3;breast: 1.6" "Cell type enhanced" "Detected in some" "Breast glandular cells: 3.8;Excitatory neurons: 6.7;Leydig cells: 21.1;Oligodendrocytes: 13.7" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;ASC diff: 2.1;HSkMC: 1.0;SH-SY5Y: 7.5" "Group enriched" "Detected in many" 5 "amygdala: 12.9;basal ganglia: 12.3;hippocampal formation: 46.7;hypothalamus: 23.7" "Region enriched" "Detected in many" 6 "hippocampal formation: 14.2" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (7.08e-2)" "unprognostic (5.50e-2)" "unprognostic (9.35e-2)" 0.3 0.2 2.0 0.2 1.1 0.0 1.6 0.1 2.4 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 3.5 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.5 0.2 0.7 0.0 0.0 0.2 0.3 0.0 0.4 0.1 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.1 0.0 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.1 0.1 2.4 5.3 3.5 1.5 0.6 0.6 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 6.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 37.3;brain: 38.3;epididymis: 34.4;retina: 38.0" "Group enriched" "Detected in many" 7 "Astrocytes: 612.5;Excitatory neurons: 764.5;Inhibitory neurons: 392.4;Oligodendrocyte precursor cells: 1259.2" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 15 "T-cells: 2.0" "Cell line enhanced" "Detected in many" "A549: 99.6;AF22: 94.8;EFO-21: 175.4;HMC-1: 187.9;SH-SY5Y: 115.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted in brain" NA NA 110000000 "Cluster 32: T-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 3.1 37.3 19.8 1.8 31.9 0.3 1.5 2.4 34.6 5.0 0.0 0.8 0.7 2.1 34.4 0.7 3.6 7.3 0.4 33.1 9.4 6.2 0.4 2.3 0.8 2.3 22.7 1.5 29.4 7.3 11.4 7.8 2.0 0.8 0.7 38.0 1.9 14.2 0.2 0.8 0.6 0.7 1.5 4.8 1.8 1.7 38.3 2.8 4.1 0.4 2.7 0.5 0.4 2.6 0.1 99.6 94.8 0.0 11.4 2.2 1.8 0.7 0.4 1.0 1.7 40.7 0.0 0.0 175.4 0.7 1.5 0.4 2.2 1.6 1.0 0.1 12.7 0.0 0.7 1.0 0.2 0.9 187.9 15.5 0.0 0.2 0.6 0.2 61.7 0.2 0.2 0.8 1.5 38.2 0.4 0.3 13.1 60.1 0.0 0.0 27.8 33.3 21.4 0.1 18.6 115.9 1.3 0.0 1.9 3.3 0.2 0.1 66.2 4.2 1.0 0.1 16.4 0.2 0.5 0.9 0.7 0.1 55.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.2 19.8 31.9 2.4 34.6 33.1 9.4 2.3 22.7 2.0 1.5 38.3 2.6 0.2 0.0 0.0 612.5 0.8 0.4 0.1 0.8 1.2 66.2 1.5 0.9 0.7 7.2 0.1 5.5 102.2 3.6 0.0 0.2 3.9 1.6 37.3 10.4 2.4 1.3 0.0 0.0 764.5 12.1 0.2 2.0 3.6 25.0 23.4 4.4 1.4 0.4 0.8 13.5 392.4 0.3 0.0 0.8 0.4 8.3 0.9 0.2 3.6 51.5 0.6 45.1 0.0 1259.2 21.9 3.7 0.0 0.4 2.6 1.2 0.0 3.3 0.1 8.8 0.0 1.0 2.6 1.1 2.7 0.2 0.1 4.4 1.1 34.2 0.0 0.0 NREP "C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17" ENSG00000134986 "Neuronal regeneration related protein" Q16612 5 111662621-111997464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 118.3;Excitatory neurons: 116.1;Theca cells: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "myeloid DC: 24.6;NK-cell: 6.9;plasmacytoid DC: 25.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 425.3;SH-SY5Y: 461.8" "Region enriched" "Detected in all" 5 "cerebellum: 1766.0" "Region enhanced" "Detected in all" "cerebellum: 219.5" HPA000545 Approved Approved Vesicles NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "HPA000545: AB_1845721" "unprognostic (2.85e-2)" "unprognostic (1.00e-2)" "unprognostic (2.30e-1)" "unprognostic (1.48e-3)" "unprognostic (4.37e-1)" "unprognostic (2.26e-1)" "unprognostic (8.16e-3)" "unprognostic (1.58e-1)" "unprognostic (6.45e-3)" "unprognostic (1.32e-1)" "unprognostic (3.76e-2)" "unprognostic (2.02e-1)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (5.76e-3)" 18.9 56.5 50.1 19.4 52.6 36.7 29.3 141.8 71.6 32.3 56.9 28.6 16.9 84.8 17.9 23.0 18.2 65.4 70.9 52.5 44.0 49.5 50.7 27.7 17.3 47.8 52.1 41.8 9.8 8.4 13.3 119.8 50.8 52.7 25.2 107.4 36.1 72.2 179.9 22.1 16.7 54.6 44.6 36.9 25.7 12.7 46.4 168.1 18.6 118.2 18.4 27.5 16.8 54.7 0.6 7.1 425.3 91.5 20.2 46.6 20.3 140.9 83.9 135.7 221.0 0.8 2.8 73.1 44.6 71.3 18.9 0.3 91.0 5.2 69.4 29.5 13.0 57.5 35.2 77.6 28.1 77.0 0.8 45.6 22.5 129.5 44.5 318.6 154.2 81.4 0.6 7.4 143.4 1.6 308.3 53.7 244.1 0.2 33.3 326.3 173.4 19.9 52.2 1.6 96.9 461.8 31.6 2.2 2.9 224.2 17.7 210.6 31.1 163.7 54.1 80.8 15.8 34.6 29.3 92.3 35.6 159.8 32.8 0.0 4.0 0.0 0.0 2.2 0.0 1.6 0.1 0.2 24.6 1.1 1.2 1.6 0.1 6.9 1.0 25.1 0.0 2.2 50.1 52.6 141.8 71.6 52.5 44.0 47.8 52.1 50.8 44.6 46.4 54.7 20.8 6.4 30.8 43.1 3.6 18.1 1.6 4.5 14.2 66.9 12.4 22.6 33.4 8.6 5.7 12.9 87.6 118.3 12.9 2.5 33.2 14.4 2.5 5.4 69.1 38.9 21.6 52.2 116.1 5.5 18.6 31.7 31.1 7.4 5.1 69.9 27.5 10.1 35.5 20.2 51.4 9.3 42.7 10.0 19.0 1.0 8.4 14.9 14.2 17.8 11.5 14.9 5.2 37.2 4.6 8.2 2.0 23.3 0.9 0.7 1.2 61.0 0.5 29.0 13.1 25.4 51.8 0.8 12.6 11.9 12.6 31.5 3.2 150.8 11.3 0.2 NRSN1 "p24, VMP" ENSG00000152954 "Neurensin 1" Q8IZ57 6 24126186-24154900 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 22 "brain: 542.9;choroid plexus: 474.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 139.1;Horizontal cells: 121.1;Inhibitory neurons: 111.9;Oligodendrocyte precursor cells: 69.9" "Cancer enriched" "Detected in single" 17 "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SCLC-21H: 11.2;SH-SY5Y: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019681, HPA061006" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cytosol" "HPA019681: , HPA061006: AB_2684413" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (8.00e-3)" "unprognostic (8.01e-3)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (7.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.40e-3)" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" 0.0 4.9 276.8 0.4 315.2 0.2 0.0 108.9 281.1 0.1 474.7 1.2 0.4 0.2 0.0 0.1 0.0 0.2 0.0 138.2 466.8 0.1 0.0 0.0 0.1 263.2 332.8 0.0 1.2 0.0 23.5 0.0 468.0 0.0 0.4 22.6 0.1 0.0 0.7 0.1 0.3 0.3 194.7 0.1 0.4 0.3 459.9 0.0 0.1 0.0 0.1 0.0 0.1 542.9 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 11.2 9.2 0.0 0.0 0.2 0.1 0.0 0.9 0.1 0.1 0.1 0.0 0.0 0.3 0.5 0.2 0.3 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 276.8 315.2 108.9 281.1 138.2 466.8 263.2 332.8 468.0 194.7 459.9 542.9 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.1 0.0 0.0 139.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 121.1 111.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.2 0.0 23.7 0.0 69.9 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NSG2 "CALY3, HMP19" ENSG00000170091 "Neuronal vesicle trafficking associated 2" Q9Y328 5 174045706-174243501 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 198.5" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 59 "SCLC-21H: 39.5;SH-SY5Y: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046531, HPA056191" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA046531: AB_2732528, HPA056191: AB_2683062" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (3.27e-1)" "unprognostic (3.36e-5)" "unprognostic (1.93e-1)" "unprognostic (2.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.07e-1)" "unprognostic (3.29e-1)" "unprognostic (1.76e-1)" "unprognostic (3.86e-3)" "unprognostic (8.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.02e-2)" "unprognostic (5.20e-2)" "unprognostic (9.31e-4)" "unprognostic (1.55e-1)" 0.5 33.3 115.8 2.6 198.5 0.0 0.1 43.8 152.8 0.0 1.7 6.9 2.3 0.0 0.4 0.1 0.0 0.3 1.0 125.2 171.9 0.7 0.4 0.3 0.0 54.5 82.1 0.1 0.9 0.0 7.0 0.0 101.1 0.2 3.9 39.2 0.1 0.1 0.3 0.1 3.8 1.8 52.4 0.2 3.0 14.7 100.3 0.0 0.6 0.0 0.0 0.1 1.2 47.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 64.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.8 198.5 43.8 152.8 125.2 171.9 54.5 82.1 101.1 52.4 100.3 47.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NSMF NELF ENSG00000165802 "NMDA receptor synaptonuclear signaling and neuronal migration factor" Q6X4W1 9 137447570-137459334 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 361.3" "Cell type enhanced" "Detected in many" "Astrocytes: 71.5;Peritubular cells: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 3.5;intermediate monocyte: 13.8;myeloid DC: 6.3;non-classical monocyte: 12.1" "Group enriched" "Detected in many" 5 "dendritic cells: 6.3;granulocytes: 3.5;monocytes: 13.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044316 Supported Supported Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA044316: AB_10964877" "unprognostic (1.48e-1)" "unprognostic (4.03e-2)" "unprognostic (5.40e-2)" "unprognostic (3.92e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (7.96e-2)" "unprognostic (3.26e-2)" "unprognostic (2.38e-3)" "unprognostic (2.34e-3)" "prognostic favorable (1.85e-6)" "unprognostic (1.97e-2)" "unprognostic (4.14e-2)" "unprognostic (4.61e-2)" "unprognostic (3.97e-2)" 23.1 14.5 167.1 12.6 154.3 12.2 20.3 66.6 361.3 24.2 73.4 22.7 29.9 32.8 10.7 16.3 28.7 9.7 16.1 360.8 115.1 30.8 23.5 19.8 13.0 99.7 153.1 22.5 31.6 17.9 70.6 7.1 75.1 31.2 10.4 12.1 20.2 13.8 8.9 20.6 24.9 13.9 109.9 17.0 23.5 18.9 210.5 8.4 23.9 3.9 10.3 22.2 17.5 105.4 24.4 19.3 33.7 50.4 77.1 36.4 28.9 23.0 30.2 21.5 16.5 51.7 14.3 30.2 30.3 34.0 48.1 72.7 50.0 30.9 12.9 39.7 53.8 23.5 46.7 69.5 41.7 16.2 51.5 41.7 57.9 25.1 58.3 48.5 23.1 0.8 55.0 4.9 29.2 56.4 0.7 69.8 42.9 97.6 51.4 14.6 53.3 68.0 14.9 12.1 135.7 112.8 55.0 30.3 35.7 13.9 21.5 33.0 58.6 37.9 30.9 92.9 39.6 10.3 17.0 45.8 21.6 21.2 35.6 1.6 2.1 3.5 1.5 13.8 0.3 0.2 0.5 0.9 6.3 0.1 0.5 0.7 0.3 0.0 12.1 0.2 0.8 1.8 167.1 154.3 66.6 361.3 360.8 115.1 99.7 153.1 75.1 109.9 210.5 105.4 9.9 0.0 3.9 71.5 5.9 13.6 9.4 3.6 7.4 9.6 14.3 12.4 6.1 11.5 2.3 11.0 8.4 0.4 17.7 40.7 5.9 8.2 7.1 7.6 18.3 9.5 19.2 1.7 24.2 21.4 1.3 11.0 10.2 11.1 2.5 12.0 9.7 26.3 6.7 28.6 14.9 21.3 8.2 8.6 21.2 15.3 23.9 10.5 16.0 15.9 9.8 10.3 6.2 16.1 5.3 21.4 34.3 71.5 8.5 32.6 43.4 29.7 2.9 12.9 13.1 8.3 10.9 3.0 5.9 6.3 14.6 1.5 8.0 11.0 20.5 16.7 NT5C1A "CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201" ENSG00000116981 "5'-nucleotidase, cytosolic IA" Q9BXI3 1 39659121-39672038 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 72.4;tongue: 28.6" "Cell type enhanced" "Detected in single" "Inhibitory neurons: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "SH-SY5Y: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050283, HPA054158" Supported NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA050283: AB_2681072, HPA054158: AB_2682402" "unprognostic (7.85e-2)" "unprognostic (1.60e-1)" "unprognostic (6.19e-1)" "unprognostic (1.51e-3)" "unprognostic (7.19e-2)" "unprognostic (2.87e-1)" "unprognostic (3.34e-1)" "unprognostic (1.32e-1)" "unprognostic (3.29e-2)" "unprognostic (1.81e-2)" 0.2 2.6 1.4 0.1 0.8 0.0 0.0 4.8 5.4 0.2 0.0 0.0 0.0 0.1 0.1 3.0 0.2 0.0 11.4 0.7 1.6 0.4 0.0 0.0 0.0 3.0 3.1 0.1 3.9 0.0 0.0 0.0 2.0 0.5 0.0 0.1 0.1 0.1 72.4 0.0 0.1 0.1 1.4 0.0 0.1 0.2 2.2 0.1 0.0 28.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 17.8 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 4.8 5.4 0.7 1.6 3.0 3.1 2.0 1.4 2.2 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NTN3 NTN2L ENSG00000162068 "Netrin 3" O00634 16 2471297-2474145 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "brain: 2.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HeLa: 1.7;REH: 5.0;SCLC-21H: 5.8;SH-SY5Y: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050817 Uncertain "Secreted in brain" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA050817: AB_2681247" "unprognostic (2.60e-2)" "unprognostic (1.95e-2)" "unprognostic (1.79e-1)" "unprognostic (9.17e-2)" "unprognostic (6.44e-2)" "unprognostic (2.23e-2)" "unprognostic (9.62e-3)" "unprognostic (2.11e-1)" "unprognostic (4.55e-2)" "unprognostic (6.95e-2)" "unprognostic (5.58e-2)" "unprognostic (2.34e-1)" "unprognostic (1.35e-2)" "unprognostic (3.26e-2)" "unprognostic (6.68e-2)" "unprognostic (2.39e-2)" "unprognostic (6.61e-2)" 0.1 0.0 2.2 0.0 1.2 0.0 0.0 0.5 1.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 2.3 0.0 0.2 0.0 0.0 2.1 2.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.7 0.0 1.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.7 0.1 0.0 0.0 5.0 0.1 0.1 0.0 0.0 5.8 3.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.3 0.2 0.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.2 0.5 1.6 1.1 2.3 2.1 2.0 0.8 1.5 2.7 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NTRK2 TRKB ENSG00000148053 "Neurotrophic receptor tyrosine kinase 2" Q16620 9 84668551-85027054 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 230.0;thyroid gland: 116.9" "Cell type enhanced" "Detected in many" "Astrocytes: 1144.3;Excitatory neurons: 750.1;Inhibitory neurons: 877.7;Oligodendrocyte precursor cells: 557.9" "Group enriched" "Detected in many" 5 "glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.7;HaCaT: 3.0;RPTEC TERT1: 9.7;SH-SY5Y: 11.2;SuSa: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007637, CAB010346, HPA074873" Enhanced Supported "Plasma membrane" NA NA 20000000 "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: " "unprognostic (2.75e-3)" "unprognostic (3.48e-2)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (1.29e-2)" "unprognostic (9.16e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (4.25e-2)" "unprognostic (2.18e-2)" "unprognostic (2.66e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-3)" 40.5 2.7 201.9 1.7 177.8 0.1 62.2 133.3 190.6 9.8 69.8 5.9 0.4 3.9 3.9 8.2 5.6 33.3 15.2 173.3 230.0 20.4 1.8 10.0 3.1 119.4 218.9 9.7 34.3 2.5 10.1 1.8 151.7 4.7 3.6 41.2 14.4 19.1 2.9 11.6 1.6 3.3 116.6 10.9 1.9 2.4 222.1 4.0 116.9 13.8 4.3 4.9 12.0 117.7 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 9.7 0.7 0.7 11.2 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 201.9 177.8 133.3 190.6 173.3 230.0 119.4 218.9 151.7 116.6 222.1 117.7 17.4 0.0 0.5 1144.3 0.7 56.6 1.0 1.8 93.9 30.3 144.1 116.8 11.4 0.0 0.2 9.2 6.2 0.0 1.0 8.7 27.4 36.1 1.8 1.2 0.4 8.0 0.0 0.0 750.1 0.7 0.1 76.6 0.0 2.3 0.0 0.1 5.0 0.0 0.2 242.3 877.7 0.7 0.0 0.0 14.2 3.6 104.1 1.4 17.8 65.6 0.6 241.0 0.0 557.9 109.5 0.5 7.0 48.2 0.3 0.9 0.0 7.1 1.7 12.2 124.9 9.9 114.4 0.8 2.3 5.2 24.6 0.0 3.3 0.2 7.2 0.9 NUDCD3 "KIAA1068, NudCL" ENSG00000015676 "NudC domain containing 3" Q8IVD9 7 44379119-44490658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019136, HPA019528, HPA019529" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Plasma membrane, Cytosol" Nucleoplasm "HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374" "unprognostic (3.72e-2)" "unprognostic (9.28e-3)" "unprognostic (2.33e-2)" "unprognostic (2.05e-3)" "unprognostic (2.18e-3)" "unprognostic (2.05e-2)" "unprognostic (4.73e-2)" "unprognostic (2.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "unprognostic (5.62e-2)" "prognostic favorable (9.16e-4)" "unprognostic (3.51e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-1)" "unprognostic (6.50e-2)" 2.9 2.8 6.8 1.3 9.0 2.8 2.8 3.2 7.2 2.5 0.0 2.4 1.2 2.2 2.4 2.7 3.5 2.2 7.5 6.6 5.1 2.2 1.8 2.4 2.2 4.4 5.5 3.1 3.3 3.7 1.8 1.7 5.6 2.8 1.8 4.8 2.4 3.3 8.2 3.1 2.0 3.0 3.9 1.9 2.7 3.9 5.6 2.1 2.7 5.7 2.2 2.3 1.8 6.3 2.6 4.9 3.4 6.3 4.2 3.4 1.3 4.1 4.0 4.8 4.9 3.3 1.8 8.1 3.0 5.5 6.6 3.0 4.8 5.6 2.8 4.8 4.9 2.2 2.9 2.3 3.8 3.9 1.3 3.1 3.7 3.6 4.1 2.8 5.9 2.4 6.1 2.6 3.6 2.3 1.6 3.7 4.3 2.5 6.3 2.3 3.7 3.0 2.7 4.0 3.6 10.6 2.4 4.5 1.8 3.4 3.4 5.7 5.7 3.3 3.4 2.2 3.3 7.3 8.1 4.0 3.6 4.5 5.9 0.6 0.8 0.9 1.0 0.8 1.1 1.0 0.9 0.9 0.7 1.0 0.9 0.9 0.5 0.8 1.0 0.6 1.0 0.9 6.8 9.0 3.2 7.2 6.6 5.1 4.4 5.5 5.6 3.9 5.6 6.3 30.5 12.8 19.2 35.9 26.4 11.3 13.0 16.5 20.5 40.9 29.3 25.3 44.5 17.2 16.0 38.6 54.2 19.6 21.9 22.7 23.5 29.6 87.7 27.4 34.4 25.3 17.4 22.3 59.6 21.6 18.1 23.9 23.9 30.9 9.5 35.8 22.5 32.8 18.3 48.8 58.8 25.1 26.4 17.9 9.5 98.3 30.4 13.9 16.0 46.9 21.2 24.8 34.0 36.2 61.2 27.4 18.8 28.2 14.3 15.9 27.2 26.8 21.9 40.2 32.9 17.8 25.2 106.6 21.1 25.5 16.2 14.4 26.2 18.9 27.8 13.3 NYAP1 "C7orf51, FLJ37538, KIAA1486L" ENSG00000166924 "Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1" Q6ZVC0 7 100483927-100494802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.5;pituitary gland: 22.0" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Bipolar cells: 6.2;Excitatory neurons: 11.1;Granulosa cells: 5.6;Horizontal cells: 13.5;Inhibitory neurons: 10.3" "Cancer enhanced" "Detected in some" "glioma: 4.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.8;HUVEC TERT2: 3.9;SH-SY5Y: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022251 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Golgi apparatus" "HPA022251: AB_1848915" "unprognostic (6.59e-4)" "unprognostic (2.67e-2)" "unprognostic (1.82e-2)" "unprognostic (2.51e-4)" "unprognostic (2.89e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-2)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (3.06e-2)" "unprognostic (4.31e-1)" "unprognostic (8.65e-2)" 2.1 2.5 6.4 0.3 8.4 0.1 1.6 0.0 22.5 2.9 0.0 1.3 0.2 4.6 0.0 1.1 2.2 0.2 0.7 11.4 2.9 1.9 0.4 0.3 0.1 6.6 0.6 5.3 0.9 0.0 22.0 0.3 6.8 2.0 0.1 1.9 0.9 0.9 0.1 1.4 0.8 0.5 0.0 0.8 0.8 9.1 2.0 0.1 0.7 0.1 0.0 0.6 2.0 8.2 0.0 1.1 3.0 1.4 2.0 1.2 0.2 0.1 1.0 0.1 0.4 0.4 0.2 0.0 1.0 0.3 7.8 0.1 0.6 0.1 0.0 1.4 0.2 0.1 0.3 0.2 1.4 0.0 0.8 1.3 0.0 0.4 0.5 0.3 3.9 0.2 0.5 0.1 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 9.4 0.3 0.2 1.0 1.1 0.1 0.0 1.4 0.0 1.9 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.4 0.0 22.5 11.4 2.9 6.6 0.6 6.8 0.0 2.0 8.2 3.2 0.0 0.0 9.4 0.0 0.1 0.2 0.1 0.6 6.2 0.3 1.9 1.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.2 0.4 1.4 0.0 0.8 11.1 0.0 0.0 0.9 0.0 0.4 0.0 5.6 0.7 0.0 0.1 13.5 10.3 0.1 0.0 0.0 0.7 0.7 2.5 0.1 0.0 2.8 0.0 3.3 0.0 2.5 0.6 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.5 0.7 1.3 2.6 0.2 0.1 0.0 0.1 0.8 0.0 0.0 OPRM1 MOR1 ENSG00000112038 "Opioid receptor mu 1" P35372 6 154010496-154246867 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 10.6;testis: 2.8" "Group enriched" "Detected in some" 13 "Early spermatids: 29.2;Excitatory neurons: 41.1;Inhibitory neurons: 23.5;Late spermatids: 29.7;Microglial cells: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 11 "SH-SY5Y: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014509, HPA067435" Enhanced Supported NA NA "Cluster 42: Non-specific - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA014509: AB_1854801, HPA067435: " "unprognostic (7.34e-2)" "unprognostic (6.91e-2)" 0.1 0.8 2.9 0.3 2.5 0.7 0.4 8.8 3.5 0.2 0.0 0.2 0.2 0.3 0.6 1.1 0.2 0.3 0.1 1.5 2.6 0.2 0.2 0.2 0.4 2.2 5.2 0.4 0.2 0.2 0.0 0.2 1.0 0.3 0.2 0.9 0.3 0.2 0.4 0.6 0.2 0.2 1.7 0.4 0.4 2.8 10.6 0.2 0.5 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.3 0.2 0.3 0.2 0.2 0.1 0.2 0.5 0.4 0.2 0.1 0.4 0.2 0.4 0.4 0.2 0.3 0.2 0.3 0.5 0.2 0.3 0.4 0.3 0.2 0.6 0.2 0.5 0.2 0.2 0.3 0.3 0.6 0.4 0.2 0.2 0.4 0.1 0.2 0.1 0.3 0.2 0.2 0.3 0.4 0.4 6.8 0.1 0.2 0.4 0.4 0.3 0.2 0.1 0.4 0.2 0.3 0.1 0.5 0.2 0.3 0.3 0.3 0.2 1.1 0.1 0.3 0.2 0.1 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.7 0.4 0.2 0.4 0.2 0.1 2.9 2.5 8.8 3.5 1.5 2.6 2.2 5.2 1.0 1.7 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 29.7 0.0 0.2 0.0 10.3 0.0 0.0 0.0 1.5 2.0 0.0 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.2 PACC1 "C1orf75, FLJ10874, PAC, TMEM206" ENSG00000065600 "Proton activated chloride channel 1" Q9H813 1 212363928-212414901 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 13.1;Extravillous trophoblasts: 7.0;Hofbauer cells: 28.2;Syncytiotrophoblasts: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008540 Uncertain NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" "HPA008540: AB_10794083" "unprognostic (2.18e-1)" "unprognostic (2.22e-1)" "unprognostic (9.23e-2)" "unprognostic (1.02e-1)" "unprognostic (2.74e-2)" "unprognostic (3.09e-2)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.14e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.06e-3)" "unprognostic (6.33e-2)" "unprognostic (1.02e-1)" "unprognostic (9.10e-2)" "unprognostic (6.98e-2)" 2.9 2.5 15.0 4.0 24.5 5.8 2.6 24.4 22.9 3.0 10.1 2.0 2.0 2.7 1.9 3.9 1.7 2.8 2.4 15.5 18.8 10.2 1.5 3.8 8.0 26.1 22.3 1.7 3.3 3.6 3.4 4.2 25.3 2.9 2.1 6.0 2.7 1.5 2.1 2.3 3.0 2.9 23.0 5.4 1.8 5.6 20.9 8.6 2.0 1.4 5.2 4.4 3.0 35.1 11.6 8.8 13.0 21.6 7.5 4.0 12.9 6.6 5.2 10.8 9.5 7.4 8.4 13.6 5.3 3.3 10.5 10.1 12.5 6.0 10.7 10.3 13.5 12.8 5.8 9.2 10.7 20.8 19.5 3.6 6.2 9.9 7.2 10.8 12.3 19.7 11.8 7.8 7.5 4.6 23.2 21.4 17.3 5.4 11.5 18.9 14.5 13.1 5.5 5.7 20.1 31.2 7.7 11.3 30.2 12.8 16.8 25.2 10.9 7.0 8.0 16.8 17.3 10.2 17.3 19.1 9.4 18.9 19.9 21.3 8.7 5.3 5.3 11.8 7.0 8.5 4.1 6.2 14.4 8.2 5.8 6.4 0.7 7.0 11.0 20.4 6.4 6.2 15.0 24.5 24.4 22.9 15.5 18.8 26.1 22.3 25.3 23.0 20.9 35.1 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 13.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 7.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.2 0.5 0.0 0.0 0.0 PACRG "FLJ32724, Glup, HAK005771, PARK2CRG" ENSG00000112530 "Parkin coregulated" Q96M98 6 162727132-163315492 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 35.7;testis: 29.5" "Cell type enhanced" "Detected in many" "Early spermatids: 310.9;Excitatory neurons: 124.3;Inhibitory neurons: 174.9;Late spermatids: 369.8;Respiratory ciliated cells: 118.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066293 Enhanced NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA066293: AB_2685652" "unprognostic (3.06e-2)" "unprognostic (1.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.56e-2)" "unprognostic (2.48e-1)" "unprognostic (1.84e-1)" "unprognostic (6.26e-4)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (3.34e-1)" "unprognostic (8.31e-3)" "unprognostic (1.48e-1)" "prognostic favorable (2.55e-6)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (8.35e-2)" "unprognostic (2.93e-3)" 0.8 2.5 13.6 1.1 15.2 5.7 2.0 5.9 14.2 2.3 13.2 1.2 1.4 5.3 9.7 3.0 35.7 5.1 13.0 11.9 12.5 10.2 4.8 3.8 1.4 15.1 15.7 4.2 4.3 2.0 23.7 0.4 10.9 3.4 2.4 7.5 2.2 3.6 2.1 4.6 0.8 2.1 9.4 1.8 2.3 29.5 13.5 0.7 4.0 1.3 1.0 4.4 0.9 24.2 0.5 1.7 0.7 1.0 0.0 0.6 1.2 0.4 1.6 0.0 0.3 3.5 0.4 3.2 0.4 0.0 0.3 1.4 0.8 0.0 1.7 0.0 1.1 0.0 1.9 0.0 0.0 0.4 0.5 1.0 0.0 0.5 0.0 0.6 0.0 1.1 0.5 0.7 0.3 0.1 0.2 1.2 0.0 2.8 2.9 0.6 0.0 0.0 3.6 3.6 6.9 3.1 0.0 0.0 0.0 0.2 0.0 1.1 1.2 0.7 0.3 0.0 0.2 1.3 0.5 1.2 0.3 0.8 1.3 2.3 0.7 0.7 0.7 0.2 0.5 0.3 1.1 0.4 0.1 0.6 1.4 0.6 2.5 0.0 0.1 0.5 0.5 0.2 13.6 15.2 5.9 14.2 11.9 12.5 15.1 15.7 10.9 9.4 13.5 24.2 0.3 0.0 1.7 61.0 0.1 0.3 4.2 8.7 2.8 1.3 1.3 3.0 41.0 0.0 8.9 5.5 8.4 0.1 0.0 0.1 54.8 3.4 310.9 67.0 3.1 1.2 6.6 0.0 124.3 7.1 0.1 1.2 0.0 1.9 0.0 0.7 0.7 3.9 0.1 0.0 174.9 0.3 10.2 0.6 0.3 369.8 3.7 0.4 0.0 11.2 0.0 6.0 0.0 59.3 20.0 1.6 1.2 2.6 0.1 3.2 0.0 6.3 118.4 8.1 0.0 1.1 2.2 53.4 6.1 1.1 0.3 0.3 0.3 2.9 0.4 2.7 PANK3 FLJ12899 ENSG00000120137 "Pantothenate kinase 3" Q9H999 5 168548495-168579368 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078669 Approved Approved "Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA078669: " "unprognostic (1.24e-2)" "unprognostic (5.71e-2)" "prognostic favorable (3.94e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-2)" "unprognostic (2.42e-2)" "unprognostic (1.20e-2)" "unprognostic (8.43e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-1)" "unprognostic (9.48e-2)" "unprognostic (2.30e-1)" "unprognostic (3.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (1.97e-3)" "unprognostic (2.01e-1)" 12.5 20.1 6.8 13.5 8.3 17.9 25.5 20.4 10.0 10.5 2.6 27.0 41.5 13.2 9.3 13.1 7.9 10.0 10.3 8.5 7.9 15.0 43.2 10.3 13.1 8.8 8.7 11.3 10.5 21.8 6.3 14.1 8.5 12.8 25.7 18.0 10.5 7.8 7.7 14.9 30.5 11.7 7.6 12.7 16.1 12.5 9.4 14.2 15.2 12.1 12.5 11.5 11.2 10.4 29.0 16.1 65.2 34.9 23.8 27.5 27.5 17.1 18.0 22.3 32.5 26.9 26.1 44.9 27.3 24.3 35.6 20.3 44.2 34.2 40.1 42.1 21.6 23.4 15.2 20.1 27.7 31.1 29.4 22.1 45.4 28.1 31.4 15.8 26.5 33.1 21.5 43.4 31.0 16.0 31.3 14.1 27.7 22.2 12.1 22.3 44.8 18.2 28.1 42.2 30.2 64.4 19.6 31.5 48.9 32.6 41.2 38.8 27.8 29.9 41.3 17.9 36.8 30.0 45.1 32.5 17.8 31.3 23.8 1.1 1.0 0.5 0.5 1.2 0.7 1.4 0.6 0.6 0.6 0.5 0.4 0.7 0.4 0.3 1.7 0.9 0.7 0.3 6.8 8.3 20.4 10.0 8.5 7.9 8.8 8.7 8.5 7.6 9.4 10.4 26.3 25.6 19.3 6.2 18.3 34.3 23.6 27.4 4.6 28.7 59.1 29.0 16.4 17.2 26.4 25.8 27.1 17.6 29.9 114.8 9.8 17.9 12.8 20.4 28.7 24.8 34.2 36.4 23.3 20.1 14.2 22.0 36.7 32.4 15.2 31.4 14.3 94.2 23.0 28.6 22.6 37.5 26.4 33.6 30.5 17.0 16.8 25.0 23.2 10.3 23.1 12.6 14.4 12.5 17.5 23.0 40.4 17.7 17.0 40.1 98.3 27.2 22.7 26.4 26.3 30.7 28.0 42.1 25.1 26.7 56.1 41.9 18.0 42.4 50.6 52.3 PCBP4 "LIP4, MCG10" ENSG00000090097 "Poly(rC) binding protein 4" P57723 3 51957454-51974016 "Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 391.4" "Group enriched" "Detected in many" 5 "Bipolar cells: 374.5;Cone photoreceptor cells: 654.7;Rod photoreceptor cells: 592.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 22 "B-cells: 5.2;granulocytes: 7.0;T-cells: 12.0" "Cell line enhanced" "Detected in all" "SH-SY5Y: 160.4;SK-MEL-30: 140.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057754 Supported Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 54: Non-specific - Microtubule organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "HPA057754: AB_2683517" "unprognostic (7.17e-2)" "unprognostic (8.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.34e-2)" "unprognostic (4.94e-3)" "unprognostic (1.94e-2)" "unprognostic (4.97e-3)" "unprognostic (4.46e-2)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (5.45e-2)" "unprognostic (1.62e-1)" "unprognostic (3.13e-2)" "unprognostic (6.79e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (4.72e-2)" 25.7 26.9 86.3 9.2 111.6 2.6 27.7 100.8 106.8 41.6 75.1 40.2 18.3 39.3 13.4 16.0 31.9 13.0 68.4 87.7 92.1 30.1 20.0 31.2 8.3 116.1 106.6 33.8 20.1 24.1 48.7 8.6 101.9 55.5 9.3 391.4 24.7 22.1 154.1 21.7 24.1 16.8 91.3 22.3 33.3 24.4 106.5 5.7 35.0 96.3 6.5 38.2 30.4 139.9 35.1 11.8 46.3 67.8 20.6 36.6 7.9 78.7 38.1 46.4 29.8 44.2 12.4 1.1 11.5 62.6 41.0 8.1 43.4 27.5 21.7 55.4 7.0 4.4 41.3 46.1 33.2 4.5 32.7 49.8 50.6 29.6 12.9 57.5 23.5 20.1 2.2 15.2 75.3 16.5 1.9 5.4 22.5 22.2 31.5 24.5 22.4 6.2 16.5 24.7 90.3 160.4 21.5 11.6 140.2 12.2 21.5 17.0 47.2 49.3 92.6 15.7 42.8 10.1 7.0 7.2 57.2 9.9 73.5 7.0 0.1 3.8 11.1 0.0 7.8 5.2 10.6 10.9 0.3 2.6 4.8 3.7 0.0 0.1 0.0 0.1 12.0 3.4 86.3 111.6 100.8 106.8 87.7 92.1 116.1 106.6 101.9 91.3 106.5 139.9 14.9 3.2 3.2 27.7 3.8 8.7 16.2 14.2 9.1 374.5 12.4 15.7 7.3 1.5 5.6 9.2 654.7 1.5 6.3 7.7 17.6 31.4 49.8 2.2 15.8 17.3 62.0 0.4 15.0 23.4 1.2 13.0 6.6 4.2 1.3 7.8 15.7 3.6 1.1 42.1 20.8 9.4 16.2 1.0 5.1 101.2 22.4 1.5 23.2 5.6 0.9 88.8 9.2 40.7 65.0 42.3 16.6 16.1 5.3 19.8 21.2 10.7 1.5 592.7 6.6 11.6 17.9 1.4 6.0 4.4 11.8 0.5 9.6 3.6 6.1 11.1 PCDHB14 PCDH-BETA14 ENSG00000120327 "Protocadherin beta 14" Q9Y5E9 5 141223343-141227759 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 15.1;Early spermatids: 8.1;Horizontal cells: 13.5;Peritubular cells: 8.6;Spermatocytes: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 14.4;SiHa: 12.0;U-2197: 8.5" "Low region specificity" "Detected in all" "HPA007692, HPA045248" Uncertain Approved Vesicles NA NA 39000 "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA007692: AB_2667896, HPA045248: AB_10959599" "unprognostic (2.57e-3)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" "unprognostic (8.97e-2)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" "unprognostic (2.11e-2)" "unprognostic (2.38e-2)" "unprognostic (6.60e-2)" "unprognostic (2.57e-2)" "unprognostic (1.13e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (6.09e-4)" "unprognostic (2.58e-1)" "unprognostic (3.12e-2)" "unprognostic (3.77e-2)" "unprognostic (3.90e-2)" 3.1 2.8 2.3 0.8 3.2 0.1 3.5 2.1 4.0 6.0 0.0 4.6 0.3 7.0 2.4 2.0 4.3 1.9 4.4 2.6 1.3 2.1 1.2 3.0 0.4 1.5 2.3 4.7 4.0 3.6 6.2 1.1 0.7 3.1 0.9 2.3 3.6 1.9 1.6 4.4 1.6 2.6 1.6 2.0 1.9 2.5 3.1 0.4 2.2 1.5 0.3 3.5 3.5 3.3 0.0 0.0 3.3 6.3 5.4 6.4 0.4 0.5 5.5 0.5 1.7 0.1 1.0 0.3 4.5 1.5 2.9 0.3 0.7 1.0 0.5 0.0 0.1 0.0 1.3 0.1 0.2 0.3 0.2 1.2 4.7 0.1 0.2 4.8 0.6 0.2 0.0 5.8 2.3 0.5 0.4 0.0 0.4 0.0 1.1 3.8 4.1 0.0 0.1 0.2 7.6 14.4 12.0 0.3 1.3 0.5 6.1 0.5 1.7 2.2 1.9 8.5 2.2 0.0 0.1 0.1 4.5 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.2 2.1 4.0 2.6 1.3 1.5 2.3 0.7 1.6 3.1 3.3 4.1 0.0 4.8 0.0 0.0 0.4 1.1 3.1 0.0 15.1 1.6 2.4 3.3 0.0 3.1 1.8 0.0 0.0 0.2 0.3 0.0 0.9 8.1 0.8 6.3 3.9 3.5 0.0 0.0 2.4 0.0 5.0 0.0 0.9 0.0 1.3 3.3 1.3 0.1 13.5 0.0 0.6 4.1 0.0 0.7 2.1 3.4 0.3 0.0 0.0 0.0 6.8 0.0 0.0 0.0 2.2 0.5 8.6 0.0 0.5 0.0 0.8 0.6 1.3 0.0 6.3 3.9 8.0 0.1 0.7 2.8 0.0 0.2 2.5 0.3 0.7 PCDHB3 PCDH-BETA3 ENSG00000113205 "Protocadherin beta 3" Q9Y5E6 5 141100473-141103827 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 2.8;Cone photoreceptor cells: 2.1;Endometrial stromal cells: 2.6;Horizontal cells: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 11.3;HAP1: 3.5;SH-SY5Y: 15.2;U-138 MG: 5.3" "Low region specificity" "Detected in all" HPA050296 Uncertain Supported Vesicles NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA050296: AB_2681078" "unprognostic (2.72e-2)" "unprognostic (7.47e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-4)" "unprognostic (9.34e-3)" "unprognostic (3.42e-2)" "unprognostic (2.29e-2)" "unprognostic (3.17e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (8.52e-3)" "unprognostic (3.45e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-3)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (5.18e-4)" 1.8 1.2 0.4 0.7 1.1 0.0 1.7 0.6 1.5 1.2 0.0 0.9 0.3 1.5 0.7 0.3 0.9 0.8 1.1 1.0 0.2 1.1 0.1 1.1 0.1 0.3 0.5 1.6 1.2 1.7 1.8 0.4 0.1 1.4 0.5 1.0 0.7 0.5 0.7 0.7 0.5 1.0 0.2 0.4 0.5 3.6 0.6 0.0 0.7 0.9 0.1 0.8 0.9 0.8 0.0 0.0 1.1 3.1 1.9 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.2 1.7 0.0 3.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.3 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.6 15.2 0.0 0.1 0.0 0.5 1.9 0.1 0.0 5.3 0.7 0.5 0.3 0.3 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.6 1.5 1.0 0.2 0.3 0.5 0.1 0.2 0.6 0.8 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.9 0.8 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.9 0.3 0.8 0.4 2.6 1.1 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.2 0.0 0.0 1.8 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.5 0.0 0.1 0.0 0.3 0.0 1.7 1.1 1.8 0.7 0.1 0.3 0.0 0.0 0.4 0.0 0.3 PCDHB4 PCDH-BETA4 ENSG00000081818 "Protocadherin beta 4" Q9Y5E5 5 141121818-141125623 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 9.7;Endometrial stromal cells: 8.2;Fibroblasts: 9.5;Horizontal cells: 8.4;Peritubular cells: 6.4;Skeletal myocytes: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 8.7;SH-SY5Y: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014466 Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane, Cytosol" "Intermediate filaments" "HPA014466: AB_1855058" "unprognostic (2.60e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (8.60e-3)" "unprognostic (4.03e-1)" "unprognostic (6.44e-2)" "unprognostic (2.44e-1)" "unprognostic (8.66e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" "unprognostic (1.44e-1)" "unprognostic (2.82e-3)" "unprognostic (1.11e-3)" "unprognostic (2.17e-1)" "unprognostic (3.32e-4)" "unprognostic (5.18e-3)" 3.2 2.1 2.7 0.7 3.0 0.0 3.4 3.3 3.7 3.6 0.3 2.0 0.6 5.4 3.8 1.5 4.0 2.4 2.3 3.2 4.2 1.5 0.3 2.1 0.4 5.0 3.7 4.2 8.5 1.4 2.7 0.1 5.7 2.4 0.9 1.6 2.1 1.9 1.6 1.3 0.9 3.3 5.0 0.7 1.3 0.5 2.7 0.4 1.5 2.1 0.2 2.1 2.1 6.7 0.0 0.0 0.3 1.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.7 5.8 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 3.0 3.3 3.7 3.2 4.2 5.0 3.7 5.7 5.0 2.7 6.7 9.7 0.0 0.5 0.0 0.0 1.1 0.4 0.2 0.6 4.9 2.6 3.8 1.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 8.2 4.3 0.0 0.0 0.0 1.7 0.0 9.5 0.0 0.3 0.0 0.1 3.6 0.0 0.1 8.4 0.0 0.0 2.0 0.0 1.1 0.0 1.5 0.1 1.8 0.0 0.0 2.0 0.0 0.0 0.0 0.6 0.0 6.4 0.0 0.7 0.0 0.0 2.5 0.6 0.0 8.7 4.0 1.4 0.5 0.0 2.0 0.0 0.0 0.5 0.0 0.4 PCDHB9 "PCDH-BETA9, PCDH3H" ENSG00000177839 "Protocadherin beta 9" Q9Y5E1 5 141187127-141191541 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Bipolar cells: 20.2;Horizontal cells: 10.1;Skeletal myocytes: 6.3" "Cancer enhanced" "Detected in many" "glioma: 3.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;ASC diff: 10.3;ASC TERT1: 9.4;SH-SY5Y: 14.3" HPA013445 Uncertain NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "HPA013445: AB_1855054" "unprognostic (1.85e-2)" "unprognostic (3.27e-2)" "unprognostic (2.73e-1)" "unprognostic (8.97e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.12e-1)" "unprognostic (6.78e-3)" "unprognostic (1.34e-2)" "unprognostic (4.46e-2)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (1.86e-4)" "unprognostic (1.71e-1)" "unprognostic (9.80e-2)" "unprognostic (1.17e-1)" "unprognostic (8.01e-2)" 1.0 0.8 0.6 0.1 1.0 0.1 1.2 1.1 1.9 1.5 0.0 1.1 0.1 2.0 1.8 0.3 1.3 0.7 1.1 1.4 0.2 0.5 0.2 1.1 0.1 0.3 0.6 2.0 0.7 1.1 2.4 0.5 0.4 0.6 0.2 1.2 1.0 0.3 0.4 0.8 0.4 1.2 0.3 0.3 0.5 0.8 0.9 0.2 0.6 1.0 0.1 0.8 0.9 0.9 0.0 0.0 0.9 6.0 10.3 9.4 0.2 0.1 3.5 0.4 0.5 0.0 1.0 0.4 3.9 0.2 2.8 0.0 0.3 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.9 0.0 0.0 1.8 0.0 0.1 0.0 2.7 3.1 0.9 0.6 0.7 0.3 0.0 0.4 2.8 5.4 0.0 0.6 0.1 2.1 14.3 0.6 0.1 1.0 0.4 2.6 0.2 0.9 5.2 0.5 4.7 1.2 0.0 0.0 0.0 3.1 0.2 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 1.0 1.1 1.9 1.4 0.2 0.3 0.6 0.4 0.3 0.9 0.9 1.8 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.0 20.2 0.5 1.4 0.2 1.5 1.3 1.8 0.0 0.0 0.0 0.2 0.0 0.4 1.0 0.2 2.8 1.3 0.0 0.0 0.0 0.8 0.0 1.9 0.0 0.1 0.0 0.0 1.8 0.2 0.1 10.1 0.0 0.1 0.0 0.3 0.0 0.4 1.5 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.5 0.0 1.9 0.0 0.2 0.0 0.3 0.0 0.7 0.0 6.3 1.8 1.0 0.2 0.3 0.0 0.0 0.1 0.3 0.0 0.1 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.3;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.2;Skeletal myocytes: 2.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.3;BJ hTERT+: 20.8;hTERT-RPE1: 10.9;SH-SY5Y: 18.6;T-47d: 8.1" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 0.5 0.4 1.0 0.2 0.9 0.0 0.6 5.9 1.0 1.2 0.0 1.1 0.1 1.3 1.1 0.5 1.0 0.4 1.5 1.1 0.6 0.6 0.4 0.7 0.1 1.5 1.2 1.5 0.7 2.2 0.8 1.3 0.9 0.9 0.3 1.6 0.8 0.8 0.7 1.0 0.4 0.8 1.0 0.4 0.3 0.5 1.3 0.2 1.9 0.5 0.1 0.9 0.7 1.5 0.0 1.6 2.3 0.0 6.6 11.3 0.0 3.3 20.8 4.2 6.1 0.0 0.0 0.5 5.2 0.7 0.2 0.2 0.0 0.1 3.4 0.0 0.3 0.0 0.4 0.2 1.1 0.0 0.0 5.0 0.1 0.0 0.7 10.9 1.7 0.0 0.0 0.1 0.1 0.1 0.6 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.4 18.6 0.0 0.1 0.1 3.7 8.1 0.0 6.7 0.1 0.1 3.1 0.1 0.1 1.9 0.0 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 5.9 1.0 1.1 0.6 1.5 1.2 0.9 1.0 1.3 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.3 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.6 0.0 2.8 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.3 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 31.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.1;Horizontal cells: 3.3" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 9.1;SCLC-21H: 7.3;SH-SY5Y: 14.2;SuSa: 10.0" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.2 1.1 17.3 0.1 12.2 0.0 0.2 19.3 14.6 0.3 0.1 0.6 0.0 0.4 0.2 0.2 0.3 0.2 2.2 12.7 13.9 0.1 0.1 0.4 0.1 12.9 21.9 0.3 0.3 0.0 1.1 0.1 10.3 0.2 0.1 6.6 0.3 0.1 0.7 0.5 0.1 0.2 22.4 0.1 0.2 0.9 14.3 0.0 0.1 0.3 0.2 0.2 0.3 31.4 0.0 0.0 0.9 0.2 0.2 0.7 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.8 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 1.3 0.0 0.0 9.1 0.5 0.0 0.0 0.1 7.3 14.2 0.1 0.0 0.1 10.0 0.1 0.3 0.1 0.8 0.1 0.2 0.6 0.2 0.0 0.2 0.6 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 12.2 19.3 14.6 12.7 13.9 12.9 21.9 10.3 22.4 14.3 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PDZD4 "FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L" ENSG00000067840 "PDZ domain containing 4" Q76G19 X 153802166-153830565 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 150.1" "Cell type enhanced" "Detected in many" "Astrocytes: 12.1;Bipolar cells: 18.0;dendritic cells: 14.0;Excitatory neurons: 11.0;NK-cells: 26.8;Rod photoreceptor cells: 14.1" "Group enriched" "Detected in many" 4 "glioma: 20.1;testis cancer: 10.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 24.4;NTERA-2: 12.4;RH-30: 17.3;SCLC-21H: 29.5;SH-SY5Y: 28.7;U-2 OS: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003878 Enhanced NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 63: NK-cells & T-cells - Immune response" "HPA003878: AB_2162807" "unprognostic (9.18e-3)" "unprognostic (1.25e-1)" "unprognostic (1.11e-4)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (1.85e-2)" "unprognostic (1.92e-3)" "unprognostic (2.17e-1)" "unprognostic (2.32e-3)" "unprognostic (5.90e-2)" "prognostic favorable (2.96e-5)" "unprognostic (2.27e-1)" "unprognostic (2.54e-4)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.83e-2)" "unprognostic (2.87e-2)" 3.7 5.0 98.2 1.9 102.8 2.1 3.4 76.6 150.1 9.5 42.3 23.4 1.6 11.9 1.2 3.8 13.9 2.0 6.1 132.0 46.9 3.9 2.6 4.8 2.0 57.6 48.0 2.7 2.3 2.8 44.1 0.1 59.5 10.4 1.3 14.8 4.1 9.8 3.3 4.3 5.9 4.3 38.2 14.0 7.6 6.0 46.7 1.1 3.5 1.3 0.6 10.0 9.2 89.8 0.0 1.6 24.4 6.4 0.0 0.1 0.0 0.7 0.0 0.7 0.8 0.6 0.0 0.0 0.3 0.0 7.9 0.1 4.5 0.0 0.1 0.0 0.8 0.0 1.9 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.1 0.3 5.0 0.2 0.9 12.4 0.0 0.3 0.1 17.3 0.0 0.0 0.1 29.5 28.7 1.3 0.0 9.2 8.2 2.8 0.3 0.0 0.0 14.1 0.3 1.8 0.0 0.1 0.0 0.1 0.0 7.9 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.2 98.2 102.8 76.6 150.1 132.0 46.9 57.6 48.0 59.5 38.2 46.7 89.8 1.8 0.0 0.0 12.1 0.1 0.3 0.0 0.0 0.6 18.0 0.1 2.4 3.7 0.0 1.3 0.0 6.2 0.0 14.0 0.0 0.0 0.0 0.1 0.2 1.5 3.5 1.8 0.8 11.0 0.2 0.0 0.8 0.5 0.1 1.3 0.2 4.6 0.1 0.0 1.7 8.6 0.0 0.0 1.0 0.0 0.2 0.6 0.1 3.6 4.7 0.2 3.9 26.8 5.5 0.7 0.3 0.0 3.8 3.6 0.2 0.0 0.0 4.4 14.1 0.0 1.7 2.1 0.3 4.1 0.5 0.9 0.0 4.1 0.0 0.0 0.2 PEPD ENSG00000124299 "Peptidase D" P12955 19 33386950-33521791 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Collagen degradation" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 209.5;kidney: 277.7" "Group enriched" "Detected in all" 4 "Proximal enterocytes: 833.0;Proximal tubular cells: 1278.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015599, HPA072045" Enhanced Approved Nucleoplasm NA NA 860000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "HPA015599: AB_1855192, HPA072045: AB_2732194" "unprognostic (1.39e-1)" "unprognostic (2.62e-2)" "unprognostic (2.27e-1)" "unprognostic (4.01e-2)" "unprognostic (2.98e-1)" "unprognostic (6.77e-2)" "unprognostic (2.82e-1)" "unprognostic (3.64e-2)" "unprognostic (3.96e-1)" "unprognostic (5.10e-2)" "unprognostic (1.11e-2)" "unprognostic (1.99e-1)" "prognostic favorable (6.50e-9)" "unprognostic (4.38e-2)" "unprognostic (1.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" 53.2 56.0 28.5 26.9 35.5 14.3 43.6 35.6 30.5 36.9 33.5 44.2 180.5 49.7 9.9 42.8 34.2 31.2 24.3 28.7 30.9 277.7 117.8 38.1 30.7 36.2 30.8 35.9 27.1 29.3 42.5 21.9 36.3 23.6 14.8 11.8 33.6 22.9 35.6 43.1 209.5 24.5 34.6 38.2 33.6 18.3 33.4 20.8 37.0 23.2 21.3 40.1 28.2 43.4 43.2 118.7 26.4 53.1 114.9 44.9 80.6 37.4 65.3 45.6 52.7 104.7 34.2 18.8 53.5 73.2 33.9 11.2 39.5 28.5 23.4 51.3 50.4 107.7 24.6 108.3 91.6 29.6 128.8 63.6 29.0 38.2 18.3 27.8 56.4 34.4 22.7 49.4 44.2 54.3 19.0 11.7 46.2 79.6 48.8 45.3 41.0 51.2 39.4 108.8 40.3 106.4 64.2 31.3 62.5 18.2 25.1 36.3 56.6 48.3 46.6 62.3 41.8 45.2 59.1 13.1 49.5 48.2 65.8 113.7 117.2 8.3 75.5 123.6 65.5 49.6 74.0 69.8 100.6 50.5 47.1 55.6 6.1 55.6 92.5 31.0 76.1 119.6 28.5 35.5 35.6 30.5 28.7 30.9 36.2 30.8 36.3 34.6 33.4 43.4 56.9 22.4 27.4 11.4 29.0 19.4 32.9 36.0 11.4 33.3 16.2 24.4 13.3 52.9 23.8 73.5 4.2 21.4 32.6 17.6 197.6 77.2 8.0 15.0 20.1 50.7 17.3 25.4 19.9 44.2 67.3 38.6 18.3 13.0 57.6 41.9 52.8 180.3 227.2 62.2 14.9 35.6 30.5 59.7 40.9 13.2 49.4 75.3 67.6 15.9 102.2 73.6 34.0 21.6 24.3 33.8 79.3 60.5 31.5 22.9 833.0 1278.3 27.1 33.7 39.5 37.0 43.1 10.2 44.5 34.3 20.3 30.4 33.7 48.7 44.6 22.2 PHF21B "BHC80L, FLJ34161, PHF4" ENSG00000056487 "PHD finger protein 21B" Q96EK2 22 44881162-45010005 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 18.9" "Cell type enhanced" "Detected in some" "Astrocytes: 96.6;Cone photoreceptor cells: 22.9;Horizontal cells: 28.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 29.1;Rod photoreceptor cells: 23.3" "Cancer enhanced" "Detected in some" "glioma: 1.9;prostate cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.2;AN3-CA: 10.0;JURKAT: 8.8;SCLC-21H: 8.7;SH-SY5Y: 37.5;U-2 OS: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053834, HPA074665" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA053834: AB_2682276, HPA074665: " "unprognostic (1.04e-1)" "unprognostic (7.76e-2)" "unprognostic (2.00e-1)" "unprognostic (7.44e-2)" "unprognostic (1.37e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" "unprognostic (3.83e-3)" "unprognostic (1.86e-3)" "unprognostic (2.02e-1)" "unprognostic (9.35e-2)" "unprognostic (2.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.22e-1)" 0.2 1.2 6.7 0.1 7.9 0.0 0.4 4.8 6.1 9.0 1.5 0.2 0.1 3.2 0.4 0.4 2.5 0.1 0.9 5.1 5.1 2.6 0.0 0.1 0.0 8.5 8.3 4.0 0.5 0.9 18.9 0.0 5.2 5.2 0.0 6.1 0.3 0.5 0.2 0.1 0.2 0.7 4.4 0.1 0.6 5.4 6.8 0.2 2.0 0.3 0.0 0.2 3.2 4.7 0.0 0.0 11.2 10.0 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.0 0.1 2.1 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 0.6 0.0 0.0 8.8 0.0 0.0 0.1 0.9 1.3 0.0 6.7 0.0 0.4 0.0 2.6 0.2 0.0 0.1 8.7 37.5 0.0 0.0 0.1 0.7 0.0 0.0 0.0 1.5 8.5 0.0 0.2 0.4 0.0 5.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 7.9 4.8 6.1 5.1 5.1 8.5 8.3 5.2 4.4 6.8 4.7 0.0 0.0 0.0 96.6 0.0 0.1 0.6 0.0 0.0 14.1 0.0 0.3 2.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 1.9 0.0 16.2 0.1 3.2 0.4 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.3 0.0 0.6 0.0 0.0 0.1 28.6 9.1 0.0 0.0 0.0 0.0 41.9 0.6 0.1 0.0 5.6 0.0 5.0 0.0 29.1 9.3 0.1 0.0 1.9 0.0 1.7 0.0 0.0 0.7 23.3 0.0 1.1 0.5 1.2 2.9 0.0 0.0 0.0 0.3 1.9 0.0 0.1 PHOX2A "ARIX, CFEOM2, FEOM2, PMX2A" ENSG00000165462 "Paired like homeobox 2A" O14813 11 72239077-72245664 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 19.9;brain: 18.3" "Cell type enriched" "Detected in single" 4 "Spermatogonia: 2.9" "Cancer enriched" "Detected in some" 9 "ovarian cancer: 9.3" "Region enriched" "Detected in some" 9 "pons: 18.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 226 "SH-SY5Y: 569.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA053810, HPA065621, HPA078004" Enhanced Supported Nucleoplasm No NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367" "unprognostic (5.84e-2)" "unprognostic (8.51e-2)" "unprognostic (5.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "unprognostic (9.92e-4)" "unprognostic (3.03e-2)" 0.3 19.9 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 0.0 0.2 0.0 0.5 0.0 18.3 0.1 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.3 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 569.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 18.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PHOX2B "NBPhox, PMX2B" ENSG00000109132 "Paired like homeobox 2B" Q99453 4 41744082-41748725 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 8.6;brain: 15.2" "Cell type enriched" "Detected in single" 10 "Cardiomyocytes: 1.0" "Not detected" "Not detected" "Region enhanced" "Detected in some" "medulla oblongata: 10.1;pons: 15.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 89 "SH-SY5Y: 132.7" "Region enriched" "Detected in single" 17 "pons and medulla: 5.6" "Group enriched" "Detected in some" 18 "medulla oblongata: 1.4;pons: 2.0" "HPA074325, HPA074941" Enhanced Enhanced Nucleoplasm NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "HPA074325: AB_2686678, HPA074941: AB_2732272" "unprognostic (1.01e-1)" "unprognostic (2.47e-1)" "unprognostic (5.27e-2)" 0.0 8.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 3.7 0.0 0.1 0.0 0.0 0.0 15.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 132.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 3.7 15.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLCD4 ENSG00000115556 "Phospholipase C delta 4" Q9BRC7 2 218607855-218637184 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "retina: 166.0;skeletal muscle: 114.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 139.9;Cone photoreceptor cells: 246.0;Rod photoreceptor cells: 176.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009914, HPA038139, HPA038140" Enhanced Supported "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Cluster 54: Non-specific - Microtubule organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "Endoplasmic reticulum, Plasma membrane" "CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.76e-2)" "unprognostic (5.65e-5)" "unprognostic (7.77e-2)" "unprognostic (1.45e-2)" "unprognostic (7.06e-3)" "unprognostic (2.86e-2)" "unprognostic (3.15e-1)" "unprognostic (8.87e-3)" "unprognostic (7.54e-5)" "unprognostic (3.28e-2)" "unprognostic (2.49e-1)" "unprognostic (1.86e-1)" "unprognostic (6.32e-2)" "unprognostic (8.46e-3)" "unprognostic (3.09e-1)" 1.5 2.7 4.5 0.2 4.4 0.0 1.3 4.5 7.2 1.4 3.5 15.6 0.6 0.6 0.3 4.8 0.6 0.4 1.1 4.5 4.6 10.7 0.6 0.6 0.1 5.6 5.1 0.7 0.5 1.7 9.6 0.2 4.9 4.4 1.7 166.0 2.3 0.3 114.0 1.0 3.3 1.3 4.2 0.3 6.9 9.8 5.0 0.1 1.6 30.4 0.1 20.5 2.0 4.7 0.0 0.9 1.2 0.0 0.3 1.2 1.1 0.0 2.5 0.4 1.3 0.0 0.1 0.0 1.5 0.4 0.4 0.1 0.0 1.5 0.3 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 2.8 0.1 1.9 0.5 4.2 2.8 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.1 4.3 0.0 1.8 20.2 0.3 0.1 0.1 0.2 2.1 0.0 4.5 0.1 0.0 0.2 0.2 0.0 0.0 0.0 4.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 4.4 4.5 7.2 4.5 4.6 5.6 5.1 4.9 4.2 5.0 4.7 0.3 0.0 1.1 7.8 0.1 0.5 0.3 0.9 3.4 139.9 1.5 0.9 1.0 0.0 0.1 0.0 246.0 0.1 0.1 0.0 0.0 0.1 21.4 0.6 0.4 1.5 0.0 0.0 6.7 0.0 13.5 0.7 0.0 1.0 0.0 0.1 0.7 0.0 0.6 8.4 4.9 0.1 0.0 0.0 0.4 33.8 0.3 0.2 0.0 0.0 0.1 9.1 0.0 2.0 2.3 0.7 0.0 0.0 0.0 0.1 0.0 2.2 0.2 176.9 0.0 6.1 1.8 3.6 1.2 0.6 0.1 0.8 0.1 0.0 0.1 0.2 PLCXD3 ENSG00000182836 "Phosphatidylinositol specific phospholipase C X domain containing 3" Q63HM9 5 41306952-41510628 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;heart muscle: 33.2;ovary: 22.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 138.2;Endometrial stromal cells: 58.7;Enteroendocrine cells: 42.4;Inhibitory neurons: 163.5;Microglial cells: 52.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.5;PC-3: 7.5;SH-SY5Y: 34.3;TIME: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046849 Uncertain Approved "Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA046849: AB_2679838" "unprognostic (1.71e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (7.04e-3)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (4.90e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-2)" "unprognostic (3.12e-1)" "unprognostic (6.38e-3)" "unprognostic (2.57e-1)" "unprognostic (2.73e-2)" "unprognostic (2.15e-3)" "unprognostic (5.91e-5)" "unprognostic (5.11e-2)" "unprognostic (6.75e-2)" 3.9 12.7 4.5 0.5 4.1 0.0 2.4 17.8 4.2 2.9 1.1 0.9 0.5 1.1 0.9 0.6 3.4 2.4 33.2 3.4 9.5 5.9 1.6 1.8 1.6 8.2 10.4 22.5 3.6 0.3 5.3 0.1 16.0 1.0 0.6 0.7 0.4 1.0 0.5 0.7 1.2 1.2 7.7 0.2 5.0 0.4 12.1 0.5 1.5 0.7 0.2 1.4 4.0 6.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.8 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.4 34.3 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 4.1 17.8 4.2 3.4 9.5 8.2 10.4 16.0 7.7 12.1 6.3 8.7 0.0 0.0 7.5 0.1 0.1 0.1 0.0 0.0 0.7 0.1 0.0 138.2 5.7 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.3 0.9 1.7 58.7 13.6 42.4 5.3 27.8 0.0 2.0 10.3 0.0 1.1 0.0 33.4 33.2 0.4 0.1 1.7 163.5 2.2 0.0 0.6 0.3 4.4 7.8 0.2 0.0 52.5 0.0 0.4 0.0 7.5 1.3 0.9 0.0 0.4 0.0 0.3 0.1 10.4 0.0 0.2 6.6 0.2 2.9 0.2 0.0 0.2 0.0 0.1 0.3 9.7 0.1 0.1 PLPP7 "C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3" ENSG00000160539 "Phospholipid phosphatase 7 (inactive)" Q8NBV4 9 131289459-131359022 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 91.2;skeletal muscle: 210.1;tongue: 74.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 18.8;Horizontal cells: 8.4;Leydig cells: 5.0;Skeletal myocytes: 7.0" "Cancer enhanced" "Detected in many" "glioma: 5.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 11.1;ASC diff: 11.4;ASC TERT1: 8.6;SCLC-21H: 11.3;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070252 Uncertain Approved Nucleoplasm,Vesicles No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" Vesicles Nucleoplasm "HPA070252: AB_2686242" "unprognostic (2.19e-1)" "unprognostic (3.07e-1)" "unprognostic (3.07e-2)" "unprognostic (2.71e-1)" "unprognostic (8.78e-2)" "unprognostic (7.03e-2)" "unprognostic (1.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.65e-1)" "unprognostic (3.96e-3)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (3.69e-2)" "unprognostic (1.10e-2)" "unprognostic (7.85e-2)" "unprognostic (9.72e-3)" 4.8 9.7 10.0 1.1 11.5 0.4 4.9 16.4 13.9 6.3 1.4 9.6 0.7 6.4 0.6 2.5 5.1 2.1 91.2 10.6 9.1 4.2 0.3 2.1 0.5 11.0 10.7 8.7 2.3 1.2 4.7 0.5 11.1 4.9 0.5 4.0 3.4 2.5 210.1 1.4 3.1 2.7 8.8 2.4 3.1 5.0 11.7 0.4 1.8 74.4 0.3 6.7 4.0 11.0 0.0 0.0 2.2 11.1 11.4 8.6 2.3 1.7 1.2 0.3 0.0 0.0 0.0 0.0 0.3 4.5 2.4 0.0 0.2 0.0 0.1 0.0 1.9 0.0 0.1 3.6 2.8 0.0 0.0 2.9 0.0 3.1 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 11.3 8.7 0.0 0.1 0.0 0.3 0.3 2.8 0.1 0.1 0.7 0.5 0.0 0.0 0.4 0.0 1.9 0.0 1.8 0.0 2.6 0.0 0.0 1.7 0.0 0.4 0.0 0.0 2.3 0.5 0.2 0.2 0.0 1.3 1.5 1.0 0.0 0.9 10.0 11.5 16.4 13.9 10.6 9.1 11.0 10.7 11.1 8.8 11.7 11.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.8 0.1 0.0 0.0 0.0 0.0 1.8 2.1 0.1 0.1 0.0 1.9 0.0 1.4 0.1 1.7 1.4 0.0 1.3 0.0 0.6 0.7 4.1 0.0 0.1 0.0 0.8 1.1 0.0 0.5 8.4 0.0 0.0 0.0 0.3 0.0 1.7 5.0 2.2 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.3 0.0 3.8 0.7 0.0 0.0 2.3 0.0 3.7 0.0 7.0 3.0 0.0 0.1 0.0 0.0 0.0 0.2 1.5 0.0 0.0 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.1;retina: 1.6;testis: 2.0" "Group enriched" "Detected in some" 4 "Bipolar cells: 8.5;Horizontal cells: 3.3;Spermatogonia: 6.9" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 11.9;SH-SY5Y: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: AB_2732631" "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.0 0.4 5.2 0.0 5.8 0.0 0.0 0.1 6.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 4.5 0.0 0.0 0.0 0.0 1.3 3.9 0.0 0.4 0.0 0.2 0.0 2.8 0.0 0.1 1.6 0.0 0.1 0.1 0.0 0.0 0.0 2.0 0.0 0.0 2.0 7.1 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 11.9 0.0 0.0 0.0 0.5 0.1 0.4 21.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 5.8 0.1 6.6 6.1 4.5 1.3 3.9 2.8 2.0 7.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.6 0.0 1.3 0.0 0.1 0.1 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PMFBP1 ENSG00000118557 "Polyamine modulated factor 1 binding protein 1" Q8TBY8 16 72112157-72176878 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 20.9" "Group enriched" "Detected in some" 6 "Early spermatids: 115.6;Late spermatids: 259.5" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "pons: 13.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.0;SH-SY5Y: 10.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA056716, HPA075825" Approved Uncertain "Endoplasmic reticulum" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "HPA056716: AB_2683215, HPA075825: " "unprognostic (1.46e-1)" "unprognostic (3.62e-1)" "unprognostic (5.95e-2)" "unprognostic (1.04e-1)" "unprognostic (2.44e-2)" "unprognostic (7.03e-2)" "unprognostic (1.06e-4)" "unprognostic (1.60e-1)" "unprognostic (3.81e-1)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (2.68e-5)" "unprognostic (9.85e-2)" "unprognostic (2.66e-1)" "unprognostic (9.85e-2)" "unprognostic (8.67e-2)" 1.7 2.2 0.4 1.3 0.9 4.5 1.5 2.5 0.8 1.8 0.5 3.2 2.9 1.7 13.5 2.9 2.0 0.9 3.3 0.8 1.9 3.0 3.1 1.6 2.0 3.5 3.9 2.6 6.5 1.2 2.7 0.6 13.3 3.6 3.3 3.5 1.7 0.3 0.6 4.4 3.9 0.3 1.9 4.7 2.6 20.9 1.0 2.4 2.1 0.0 0.5 1.8 1.9 1.4 0.2 0.4 2.8 2.8 0.0 0.6 1.9 0.6 0.2 0.6 2.1 1.1 2.8 1.9 0.4 0.1 0.1 1.8 1.0 0.1 1.4 0.2 4.3 1.9 3.7 3.1 0.0 4.2 3.2 0.0 0.9 0.1 2.1 0.6 0.8 2.3 0.4 1.7 0.1 2.4 1.1 6.8 0.8 0.1 1.2 2.9 0.2 1.5 0.3 0.8 21.0 10.7 0.0 0.0 0.2 2.0 0.5 2.7 1.8 1.3 2.2 0.6 1.4 3.9 1.5 1.2 0.6 2.8 0.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.9 2.5 0.8 0.8 1.9 3.5 3.9 13.3 1.9 1.0 1.4 0.0 0.0 0.6 1.0 0.3 0.4 0.1 0.1 1.2 0.9 0.1 0.0 0.7 0.0 1.3 0.0 0.0 0.0 0.1 0.3 0.0 0.2 115.6 0.3 0.2 0.3 5.4 0.8 0.7 0.2 0.1 0.6 0.0 0.1 3.8 0.3 0.0 0.1 4.7 30.3 0.7 0.7 0.0 1.9 5.5 259.5 1.2 2.4 0.0 1.0 0.0 1.1 0.0 1.0 1.6 0.1 0.1 1.5 0.0 0.1 0.2 0.6 1.6 0.2 0.0 0.0 0.1 2.9 0.9 0.3 0.0 0.1 1.0 0.0 0.9 0.2 PNMA8C ENSG00000277531 "PNMA family member 8C" A0A1B0GUJ8 19 46424697-46428951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 15.9;pituitary gland: 8.6" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 1.3;Endometrial ciliated cells: 1.3" "Cancer enriched" "Detected in some" 11 "glioma: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 1.1;HMC-1: 2.4;SH-SY5Y: 3.7" "Low region specificity" "Detected in all" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (3.25e-2)" "unprognostic (2.38e-1)" "unprognostic (3.89e-2)" "unprognostic (4.91e-3)" "unprognostic (2.58e-1)" "unprognostic (4.61e-3)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-2)" "unprognostic (2.92e-2)" 0.0 1.1 12.3 0.1 13.0 0.1 0.2 1.6 11.4 0.0 1.5 0.2 0.0 0.1 2.0 0.0 1.2 0.2 0.1 11.0 15.1 0.0 0.0 0.1 0.0 5.9 10.2 0.1 0.0 0.1 8.6 0.0 7.1 0.3 0.0 2.0 0.0 0.4 0.7 0.1 0.1 0.1 5.9 0.0 0.0 0.6 15.9 0.0 0.0 0.0 0.0 0.1 0.0 8.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 12.3 13.0 1.6 11.4 11.0 15.1 5.9 10.2 7.1 5.9 15.9 8.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 PODXL2 "endoglycan, PODLX2" ENSG00000114631 "Podocalyxin like 2" Q9NZ53 3 127629185-127672802 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6;pituitary gland: 59.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 96.3;Early spermatids: 73.5;Horizontal cells: 82.4;Late spermatids: 153.1;Spermatogonia: 80.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 118.1;SCLC-21H: 167.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024934, HPA042265" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Vesicles "CAB024934: , HPA042265: AB_2677920" "unprognostic (2.07e-2)" "unprognostic (2.34e-1)" "unprognostic (7.02e-2)" "unprognostic (1.07e-2)" "unprognostic (9.74e-2)" "unprognostic (1.79e-2)" "unprognostic (8.97e-3)" "unprognostic (1.81e-1)" "unprognostic (3.89e-1)" "unprognostic (2.67e-1)" "unprognostic (4.05e-3)" "unprognostic (3.48e-1)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.67e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-3)" 3.8 17.3 45.0 2.7 39.9 1.8 8.8 34.1 50.9 2.9 1.9 9.4 7.2 4.4 2.3 4.2 4.3 4.5 4.1 42.3 65.6 7.2 1.6 2.0 2.2 49.2 50.9 11.2 13.5 5.3 59.0 1.0 54.6 13.1 8.2 21.6 24.9 2.0 3.2 7.6 6.7 1.8 32.9 2.0 14.1 30.8 53.6 1.9 5.5 1.8 2.7 3.1 2.8 40.5 0.3 13.8 37.5 89.2 0.0 0.0 55.2 4.3 0.2 7.9 1.6 28.7 1.5 34.0 33.3 0.6 12.1 0.2 30.9 0.0 0.7 0.2 63.3 0.7 30.9 29.3 1.2 78.1 75.7 1.5 6.6 0.2 0.0 20.9 2.2 0.2 45.6 0.2 2.9 17.6 0.3 0.3 56.2 7.9 66.6 0.2 1.0 118.1 10.9 3.9 167.0 94.0 40.9 86.3 77.2 3.7 22.0 39.2 0.4 0.2 17.2 1.5 27.3 0.2 0.0 26.9 0.9 50.1 25.1 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.6 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.6 0.5 0.1 45.0 39.9 34.1 50.9 42.3 65.6 49.2 50.9 54.6 32.9 53.6 40.5 1.6 0.0 1.1 10.4 3.4 5.5 3.7 1.3 9.1 96.3 17.5 18.4 0.5 4.3 1.7 9.2 31.3 2.2 4.4 14.3 1.9 6.8 73.5 8.7 2.5 2.2 63.5 5.5 21.3 20.1 5.9 8.2 25.0 12.3 1.3 9.5 0.7 0.7 1.3 82.4 57.7 23.2 4.1 1.3 2.8 153.1 8.7 1.6 21.4 5.6 8.1 19.0 6.2 29.1 12.5 12.9 16.7 5.7 10.4 9.9 10.8 2.9 1.7 49.9 6.6 3.8 9.8 20.4 80.4 10.0 5.5 1.5 3.3 7.5 21.8 3.1 POLR2A "POLR2, POLRA, RPB1" ENSG00000181222 "RNA polymerase II subunit A" 17 7484366-7514616 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.4;lymphoid tissue: 1.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012226, CAB016388, HPA021563, HPA053012" Enhanced Nucleoplasm,Cytosol NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "CAB012226: AB_304749, CAB016388: AB_677353, HPA021563: AB_1855526, HPA053012: AB_2682017" "unprognostic (2.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.58e-1)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (5.43e-2)" "unprognostic (8.77e-3)" "unprognostic (1.48e-1)" "unprognostic (5.19e-3)" "unprognostic (1.81e-1)" "unprognostic (1.52e-1)" "unprognostic (3.70e-2)" "unprognostic (1.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.30e-2)" "unprognostic (1.49e-1)" "unprognostic (4.70e-2)" 0.1 0.7 0.4 1.6 0.2 0.2 0.1 0.3 1.9 0.0 0.8 0.1 0.5 0.1 0.0 0.0 0.2 0.1 0.1 0.7 0.4 0.1 0.0 0.2 0.2 2.4 0.7 0.1 0.0 0.1 0.2 1.1 0.2 0.2 0.3 0.0 0.0 0.5 0.1 0.4 0.0 0.4 0.2 0.0 0.7 1.1 0.2 0.0 0.1 0.0 0.0 1.6 1.0 1.7 0.5 1.5 0.4 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.4 0.0 0.6 1.0 2.1 0.0 0.0 0.3 0.0 0.5 0.0 0.9 0.0 1.6 2.9 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 1.0 0.4 2.1 0.0 0.0 2.5 2.3 1.0 0.0 2.7 3.5 2.8 1.2 0.8 0.0 0.0 0.8 1.6 0.0 1.0 0.5 1.1 2.0 0.4 0.2 1.6 1.1 0.8 1.0 0.0 2.2 0.8 2.0 0.9 2.5 1.1 0.3 0.8 2.2 0.5 1.3 1.0 0.0 2.0 4.2 0.0 3.2 10.1 0.4 0.2 0.3 1.9 0.7 0.4 2.4 0.7 1.1 0.4 1.1 1.6 124.2 22.4 41.6 13.4 68.0 42.8 40.7 33.8 64.3 90.4 56.5 187.1 26.9 38.6 30.3 23.9 110.5 35.9 153.5 55.0 3.9 27.0 25.0 74.9 64.4 57.7 76.7 43.3 18.1 30.2 28.7 53.3 103.0 67.3 42.5 46.0 40.4 29.9 45.4 55.5 14.9 43.9 26.4 42.1 38.3 7.4 37.0 65.7 37.4 19.7 38.2 27.3 26.8 17.6 17.8 32.0 35.9 41.8 62.0 27.9 42.5 13.2 38.4 90.5 6.6 94.4 53.9 58.5 120.2 73.8 41.2 53.8 89.2 49.8 32.6 30.8 POPDC2 POP2 ENSG00000121577 "Popeye domain containing 2" Q9HBU9 3 119636457-119665324 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "heart muscle: 405.4" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 272.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA024255 Enhanced NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA024255: AB_1855545" "unprognostic (1.13e-1)" "unprognostic (1.17e-3)" "unprognostic (8.91e-3)" "unprognostic (9.48e-2)" "unprognostic (5.56e-2)" "unprognostic (7.64e-2)" "unprognostic (2.73e-2)" "unprognostic (2.43e-1)" "unprognostic (3.18e-2)" "unprognostic (1.72e-2)" "unprognostic (5.86e-3)" "unprognostic (1.80e-1)" "unprognostic (1.24e-2)" "unprognostic (6.26e-3)" "unprognostic (1.66e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-2)" 3.6 2.1 0.6 3.8 0.5 0.3 3.3 0.8 0.9 7.9 1.3 95.3 2.8 12.5 2.6 2.0 9.6 10.9 405.4 0.5 0.5 2.4 1.0 2.5 6.7 0.6 0.6 2.0 1.3 8.4 1.3 1.4 0.6 16.3 6.2 0.9 3.3 49.2 77.7 2.8 12.2 24.0 0.5 2.8 10.7 1.0 0.6 1.5 2.4 96.9 2.5 35.3 6.0 0.5 0.1 0.2 0.5 0.0 0.2 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.4 1.0 0.0 0.3 0.1 0.1 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 24.8 0.0 0.0 0.6 2.5 0.0 0.3 0.0 0.2 0.1 0.2 0.1 1.0 0.0 0.2 0.2 0.3 0.5 0.5 0.0 0.7 0.3 0.0 0.4 0.1 0.5 0.4 0.0 0.4 0.8 0.2 0.0 0.2 1.3 0.2 0.7 0.1 0.6 0.5 0.8 0.9 0.5 0.5 0.6 0.6 0.6 0.5 0.6 0.5 4.7 0.0 0.5 1.0 0.6 0.4 0.3 0.5 0.0 3.1 0.9 3.0 272.7 0.0 0.9 0.0 0.0 0.5 2.3 0.4 0.0 0.5 0.3 0.6 0.5 6.4 3.0 0.0 0.8 0.2 0.1 8.0 0.5 0.3 1.3 1.6 1.4 0.2 1.6 1.7 1.2 0.8 0.0 1.0 2.3 0.8 1.2 1.6 0.0 2.8 1.8 1.2 0.0 1.0 1.9 0.5 0.2 1.9 0.0 0.8 0.7 0.3 1.9 2.4 59.2 5.9 11.1 1.0 0.3 0.1 0.6 1.2 1.6 0.6 0.3 0.2 PPM1E "CaMKP-N, KIAA1072, POPX1, PP2CH" ENSG00000175175 "Protein phosphatase, Mg2+/Mn2+ dependent 1E" Q8WY54 17 58755854-58985179 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 39.2;retina: 22.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 220.9;Horizontal cells: 77.4;Inhibitory neurons: 288.4;Oligodendrocyte precursor cells: 109.1" "Cancer enhanced" "Detected in some" "glioma: 2.7;prostate cancer: 3.0" "Group enriched" "Detected in many" 4 "cerebral cortex: 31.6;hippocampal formation: 39.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 12.2;HAP1: 19.9;MOLT-4: 9.9;SCLC-21H: 9.1;SH-SY5Y: 18.7;THP-1: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018462, HPA019263" Approved Approved Nucleoplasm,Nucleoli Yes No "Cluster 46: Basophils - DNA binding" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoli Nucleoplasm "HPA018462: AB_1855623, HPA019263: AB_1855624" "unprognostic (2.50e-2)" "unprognostic (5.75e-2)" "unprognostic (8.12e-2)" "unprognostic (2.99e-2)" "unprognostic (5.30e-1)" "unprognostic (8.19e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (3.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.80e-5)" "unprognostic (4.97e-2)" "unprognostic (1.23e-7)" "unprognostic (1.05e-4)" "unprognostic (1.64e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" 0.1 5.5 5.3 0.1 4.8 0.0 0.1 1.0 31.6 0.2 0.0 0.1 0.1 0.3 0.9 0.0 1.5 0.1 1.0 39.2 7.3 0.7 1.0 0.2 0.2 1.9 4.2 0.2 0.6 0.3 1.3 0.0 3.2 1.4 0.0 22.3 0.2 0.0 0.0 0.0 0.2 0.3 0.3 0.2 0.5 6.7 8.0 0.2 0.1 0.1 0.2 0.1 0.1 2.3 0.0 0.1 12.2 0.6 0.0 0.0 0.9 0.0 0.0 0.9 1.4 0.0 0.0 8.0 0.1 0.1 2.7 0.0 19.9 0.0 0.5 0.2 5.9 0.0 0.2 0.0 1.3 0.6 2.6 0.3 1.6 0.1 0.0 0.6 0.0 4.9 2.1 0.0 0.0 3.6 9.9 0.0 3.5 0.0 1.0 0.0 1.5 0.0 0.0 0.0 9.1 18.7 0.3 0.0 1.3 0.1 0.0 8.7 0.0 0.0 2.2 0.0 2.9 0.1 0.1 5.4 0.3 0.0 2.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.8 1.0 31.6 39.2 7.3 1.9 4.2 3.2 0.3 8.0 2.3 0.1 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 22.0 0.1 0.4 3.3 0.0 1.8 0.0 31.3 0.0 0.0 0.1 0.0 0.0 30.8 3.9 0.1 0.3 3.0 0.0 220.9 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 1.4 0.1 77.4 288.4 0.0 0.0 0.3 0.0 17.6 0.0 0.1 0.0 5.6 0.0 4.2 0.0 109.1 38.4 0.0 0.2 0.4 0.0 1.3 0.0 0.1 0.0 13.8 0.0 0.0 0.5 12.1 2.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788485 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 53.7" "Group enriched" "Detected in some" 9 "Muller glia cells: 35.5;Oligodendrocytes: 54.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HAP1: 5.2;Hep G2: 3.3;NTERA-2: 2.3;SCLC-21H: 8.3;SH-SY5Y: 8.2" "Region enhanced" "Detected in many" "basal ganglia: 18.1" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: AB_2679744, HPA060047: AB_2684194" "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavorable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 5.8 3.0 6.1 2.9 11.3 0.0 3.8 10.8 12.3 17.5 2.5 53.7 2.1 13.9 2.1 8.0 18.3 1.6 8.8 5.2 7.9 2.5 0.8 1.0 0.1 17.1 11.3 5.4 1.3 0.0 0.7 1.0 14.7 15.6 3.7 5.7 5.0 5.0 0.9 3.4 21.6 8.1 12.7 0.2 20.0 1.7 9.1 0.2 1.7 1.4 2.3 11.0 14.4 18.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 5.2 0.0 0.0 0.1 0.3 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.3 8.2 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 11.3 10.8 12.3 5.2 7.9 17.1 11.3 14.7 12.7 9.1 18.4 0.2 0.0 0.0 1.3 0.0 0.5 1.0 0.3 0.6 2.6 0.4 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.4 0.2 0.0 0.0 0.2 0.0 0.0 3.4 2.6 0.6 0.0 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 1.2 2.8 0.1 0.0 0.0 0.0 35.5 0.0 2.0 54.7 0.1 0.0 0.0 1.2 0.7 0.0 0.1 0.0 0.3 0.0 4.9 0.3 0.7 1.4 0.6 0.3 0.0 0.0 0.0 0.0 0.1 PROX1 ENSG00000117707 "Prospero homeobox 1" Q92786 1 213983181-214041510 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.2;liver: 86.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 196.4;Hepatocytes: 285.9;Horizontal cells: 523.3;Paneth cells: 130.6" "Cancer enhanced" "Detected in many" "liver cancer: 15.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 31.4;RH-30: 15.9;SH-SY5Y: 77.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000842, HPA001030, HPA027298" Enhanced Nucleoplasm,Cytosol No No "Cluster 43: B-cells - Humoral immune response" "Cluster 15: Liver - Metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm Cytosol "HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: " "unprognostic (3.07e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (3.42e-1)" "unprognostic (7.71e-2)" "unprognostic (1.39e-1)" "unprognostic (1.45e-2)" "unprognostic (6.59e-2)" "unprognostic (1.85e-2)" "unprognostic (2.31e-1)" "unprognostic (3.29e-3)" "unprognostic (6.64e-2)" "unprognostic (4.56e-6)" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (6.71e-4)" "unprognostic (1.05e-1)" 1.6 10.0 11.0 1.4 21.4 0.0 1.8 24.6 18.2 1.0 0.0 2.6 2.1 1.1 1.2 0.6 2.2 1.9 15.7 23.1 12.4 4.7 86.8 1.2 2.8 18.7 17.3 7.4 15.5 0.1 4.0 0.4 13.9 0.5 2.7 21.2 0.3 0.4 3.6 0.7 2.6 0.8 10.6 7.1 2.1 5.4 30.0 0.2 7.6 2.1 0.7 1.0 0.7 38.2 0.0 0.0 0.6 0.0 0.3 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.7 0.0 0.0 0.3 0.2 2.3 0.0 0.1 0.0 1.0 0.6 0.0 31.4 0.0 0.0 0.2 0.3 0.1 0.0 0.2 0.1 3.5 2.3 5.7 0.0 0.4 0.0 0.4 0.0 1.7 2.0 1.3 0.0 15.9 2.5 0.2 0.5 2.3 77.2 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.2 0.7 0.2 0.9 0.0 0.0 0.0 0.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 21.4 24.6 18.2 23.1 12.4 18.7 17.3 13.9 10.6 30.0 38.2 14.3 0.0 2.3 1.3 1.9 5.9 1.1 0.3 5.7 196.4 4.8 4.7 105.9 102.9 1.3 9.2 2.1 0.0 0.1 3.2 15.6 34.7 52.7 0.1 1.0 36.5 66.9 5.3 2.9 2.7 0.1 8.7 8.6 0.3 0.0 9.3 11.0 285.9 0.9 523.3 66.8 16.5 12.2 4.4 6.6 10.4 1.2 2.2 10.6 8.4 0.0 36.0 0.0 27.2 114.0 3.4 130.6 1.2 0.1 3.9 3.3 0.4 0.9 11.7 0.0 113.6 3.7 2.9 0.4 0.4 4.5 0.0 1.9 29.6 10.5 0.9 PRR18 MGC35308 ENSG00000176381 "Proline rich 18" Q8N4B5 6 166305300-166308448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 127.0" "Cell type enriched" "Detected in some" 5 "Oligodendrocytes: 27.3" "Group enriched" "Detected in some" 5 "glioma: 3.1;liver cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 4.3;SH-SY5Y: 2.5" "Low region specificity" "Detected in all" HPA077250 Enhanced NA NA "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA077250: AB_2732336" "unprognostic (2.91e-1)" "unprognostic (7.18e-2)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (1.44e-1)" "unprognostic (9.65e-2)" "unprognostic (5.60e-3)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.44e-3)" "unprognostic (4.79e-3)" "unprognostic (2.43e-1)" "unprognostic (3.35e-3)" "unprognostic (9.49e-2)" "unprognostic (9.58e-2)" "unprognostic (1.07e-1)" 0.3 0.0 36.1 0.0 90.6 0.0 0.1 38.8 63.8 0.1 10.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 34.3 37.2 0.2 3.3 0.2 0.0 54.5 61.1 0.0 0.2 1.2 0.9 0.0 42.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 32.8 0.0 0.1 0.0 60.2 0.0 0.1 0.0 0.0 0.0 0.0 127.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 2.5 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 90.6 38.8 63.8 34.3 37.2 54.5 61.1 42.6 32.8 60.2 127.0 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.6 2.8 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 27.3 0.1 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 16.3;bone marrow: 57.7" "Group enriched" "Detected in some" 7 "Bipolar cells: 4.8;Horizontal cells: 10.1;Inhibitory neurons: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 225.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: AB_2679642, HPA052681: AB_2681912" "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 16.3 1.3 3.2 0.4 2.7 57.7 8.5 3.2 2.9 2.5 0.7 1.3 0.1 0.5 0.0 2.7 1.1 0.7 1.5 2.0 6.3 0.1 0.4 0.9 0.1 4.7 4.8 1.1 0.3 0.3 0.2 0.0 4.0 0.4 0.2 1.0 1.1 0.8 4.5 2.3 1.2 0.4 3.6 2.1 2.1 0.4 5.1 0.6 0.5 4.5 0.0 0.5 3.0 2.1 0.0 0.1 0.3 0.5 1.3 0.1 3.8 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.4 0.4 0.1 0.0 0.0 4.5 0.1 0.0 0.0 0.2 8.8 0.1 1.3 0.0 0.0 0.1 0.0 0.0 12.8 0.0 0.0 0.0 1.0 2.6 46.6 1.2 0.0 0.1 12.9 0.6 1.0 0.0 0.1 0.5 225.3 0.4 0.2 0.3 1.5 0.1 6.1 0.0 0.0 1.0 0.5 0.1 0.0 0.0 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.7 3.2 2.9 2.0 6.3 4.7 4.8 4.0 3.6 5.1 2.1 0.4 0.0 0.0 1.0 0.0 0.6 0.1 0.2 0.6 4.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.1 0.2 10.1 12.6 0.0 0.0 0.0 0.7 0.0 0.9 0.1 0.0 0.0 0.1 1.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.3 0.0 0.8 1.2 0.3 0.3 0.1 0.0 0.0 0.1 PRSS12 "BSSP-3, MRT1" ENSG00000164099 "Serine protease 12" P56730 4 118280038-118353003 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Club cells: 34.3;Cytotrophoblasts: 48.0;Respiratory ciliated cells: 76.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 70.2;SH-SY5Y: 215.4;THP-1: 100.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035054 Uncertain Approved "Nucleoplasm,Actin filaments" "Secreted - unknown location" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 47: Cytotrophoblasts - Unknown function" "Actin filaments" Nucleoplasm "HPA035054: AB_10603990" "unprognostic (4.30e-2)" "unprognostic (1.04e-2)" "unprognostic (2.55e-1)" "unprognostic (4.41e-2)" "prognostic favorable (2.66e-4)" "prognostic favorable (1.03e-4)" "unprognostic (4.21e-1)" "unprognostic (3.48e-2)" "unprognostic (7.83e-2)" "unprognostic (6.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.29e-1)" "unprognostic (1.85e-1)" "unprognostic (9.55e-2)" "unprognostic (1.09e-1)" 0.6 0.5 1.4 1.6 0.9 0.1 2.2 0.6 1.3 14.5 14.4 6.7 2.7 1.9 0.6 3.2 10.5 9.8 0.0 2.7 0.5 0.8 0.6 7.6 0.1 0.5 1.9 1.6 7.7 0.1 0.6 10.6 0.7 1.4 6.4 0.3 2.5 2.0 0.2 5.9 4.8 1.3 0.5 0.0 9.2 10.0 1.2 1.0 0.2 1.2 5.7 3.8 12.6 0.5 5.2 0.2 1.8 0.0 0.2 13.3 0.1 46.0 41.5 9.7 16.1 0.1 18.7 0.0 0.2 70.2 4.9 0.8 31.1 9.5 12.7 0.2 7.2 0.0 3.6 0.0 1.4 0.0 0.2 4.1 17.5 3.4 9.9 31.2 0.1 0.6 0.0 0.0 8.0 0.3 0.5 9.6 2.2 36.4 2.9 0.0 38.7 0.0 0.0 7.0 5.1 215.4 0.0 0.2 3.0 30.9 0.0 100.6 0.0 19.2 2.8 12.2 9.1 1.0 0.1 0.0 1.0 3.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.6 1.3 2.7 0.5 0.5 1.9 0.7 0.5 1.2 0.5 0.3 6.4 4.6 0.7 0.2 8.4 0.8 16.4 2.2 0.6 0.8 0.8 1.4 10.0 34.3 1.8 0.0 48.0 0.0 26.8 0.0 0.4 9.9 19.7 16.8 0.9 5.3 0.0 10.5 10.2 4.5 7.1 17.9 2.6 7.0 3.3 0.0 0.4 3.8 0.0 14.3 2.7 10.2 0.0 4.2 18.3 0.0 0.4 5.4 7.5 0.0 0.0 0.0 0.5 0.2 8.1 12.8 0.0 0.2 0.4 9.4 0.6 76.1 0.2 0.0 0.6 4.9 10.1 13.3 3.6 4.3 11.9 0.7 21.8 5.3 4.7 PSD "EFA6, EFA6A, KIAA2011, PSD1, TYL" ENSG00000059915 "Pleckstrin and Sec7 domain containing" A5PKW4 10 102402617-102421539 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 233.9;intestine: 261.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 50.7;Cone photoreceptor cells: 95.9;Endometrial stromal cells: 47.7;Excitatory neurons: 41.1;Inhibitory neurons: 29.9;Rod photoreceptor cells: 70.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 7.7;MOLT-4: 4.4;SCLC-21H: 7.4;SH-SY5Y: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059237 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "Plasma membrane, Cytosol" "HPA059237: AB_2683954" "unprognostic (2.43e-1)" "unprognostic (1.74e-1)" "unprognostic (5.62e-3)" "unprognostic (1.53e-1)" "unprognostic (3.16e-2)" "unprognostic (2.90e-2)" "unprognostic (7.73e-3)" "unprognostic (1.75e-1)" "unprognostic (9.59e-2)" "unprognostic (7.59e-2)" "unprognostic (2.24e-3)" "unprognostic (4.71e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (8.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" 1.2 9.1 159.5 3.8 151.7 0.7 1.5 7.8 233.9 53.8 0.0 261.8 6.1 78.3 1.4 1.6 46.2 8.9 4.4 220.9 63.9 2.8 2.4 1.2 0.9 23.8 25.4 15.3 5.0 1.5 99.4 0.8 27.3 4.3 3.5 36.8 1.0 1.2 0.4 1.6 41.4 17.7 14.9 1.5 44.2 12.4 70.2 1.4 1.1 0.0 0.4 105.7 14.7 87.6 0.2 0.0 3.0 2.7 1.1 0.6 0.3 0.2 0.0 0.1 0.0 2.1 0.3 0.2 1.8 0.0 0.2 0.2 0.1 0.0 0.0 0.3 0.2 0.1 0.1 0.1 1.6 0.0 0.1 7.7 0.2 0.5 0.1 1.2 0.0 1.0 0.4 0.7 0.0 1.7 4.4 0.2 0.4 0.3 0.0 1.2 0.0 0.1 0.0 0.1 7.4 6.4 0.1 0.1 0.2 0.2 0.5 0.4 0.0 2.2 3.5 0.2 0.0 1.9 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 159.5 151.7 7.8 233.9 220.9 63.9 23.8 25.4 27.3 14.9 70.2 87.6 0.7 3.2 0.5 6.8 1.0 0.6 0.3 0.3 0.0 50.7 1.1 0.5 1.5 2.8 1.5 0.0 95.9 0.2 0.6 0.8 1.9 0.2 6.6 4.8 47.7 1.0 18.0 0.0 41.1 1.9 0.2 4.0 2.6 1.8 0.0 0.4 0.0 1.3 0.7 13.5 29.9 0.9 0.0 0.6 0.7 2.7 3.7 0.5 0.0 3.7 0.1 13.2 0.0 9.0 2.4 0.7 1.4 4.1 0.1 0.4 1.3 1.2 0.5 70.8 0.0 2.0 1.1 4.0 3.7 0.7 0.1 0.7 1.9 8.8 1.3 0.1 PXDNL "FLJ25471, PMR1" ENSG00000147485 "Peroxidasin like" A1KZ92 8 51319577-51809445 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrogen peroxide" "Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "heart muscle: 45.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 42.2;Early spermatids: 43.8;Excitatory neurons: 25.2;Inhibitory neurons: 68.8;Microglial cells: 16.9;Muller glia cells: 18.6;Spermatocytes: 24.2" "Group enriched" "Detected in some" 4 "breast cancer: 1.7;glioma: 0.7;renal cancer: 0.8;testis cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 7.7;Daudi: 5.9;SH-SY5Y: 6.1" HPA007919 Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Cytosol" "HPA007919: AB_1855966" "prognostic unfavorable (3.27e-5)" "unprognostic (4.59e-4)" "unprognostic (5.57e-3)" "unprognostic (2.83e-3)" "unprognostic (2.71e-1)" "unprognostic (5.14e-2)" "unprognostic (1.18e-1)" "unprognostic (7.18e-3)" "unprognostic (1.85e-1)" "unprognostic (1.15e-1)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-4)" "unprognostic (2.28e-2)" "unprognostic (3.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.97e-4)" 1.6 0.1 0.2 0.2 0.1 0.0 0.2 0.2 0.6 0.1 0.0 0.1 0.0 0.1 9.4 0.2 0.0 0.1 45.3 0.2 0.3 1.6 0.0 0.2 0.3 0.5 0.6 0.1 0.0 0.2 0.0 0.0 0.8 0.2 0.1 2.9 0.3 0.0 1.4 0.2 0.2 0.0 0.1 0.4 0.0 5.0 0.2 0.5 0.3 2.1 0.5 0.0 0.0 0.4 0.5 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.6 0.2 0.3 0.5 0.6 0.8 0.1 0.2 0.4 0.3 0.0 0.0 10.7 0.0 0.1 0.1 0.0 0.0 1.2 3.7 0.1 42.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.9 0.0 43.8 0.0 0.0 0.3 0.0 0.0 25.2 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 68.8 0.0 0.0 0.0 0.0 6.3 0.0 0.1 0.0 16.9 0.0 18.6 0.0 14.1 14.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.8 24.2 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 PYGO2 ENSG00000163348 "Pygopus family PHD finger 2" Q9BRQ0 1 154957026-154963853 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023689, HPA074813" Supported Supported "Nucleoplasm,Plasma membrane" No No "Cluster 26: Non-specific - Mitochondria" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Plasma membrane" "HPA023689: AB_1855974, HPA074813: " "unprognostic (1.49e-2)" "unprognostic (1.33e-1)" "unprognostic (6.96e-3)" "unprognostic (2.58e-2)" "unprognostic (5.85e-2)" "unprognostic (4.32e-3)" "prognostic unfavorable (3.88e-6)" "unprognostic (2.45e-1)" "unprognostic (2.07e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (3.74e-1)" "unprognostic (7.40e-3)" "unprognostic (1.63e-2)" "unprognostic (2.81e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.76e-4)" 14.6 30.6 30.0 16.7 30.3 6.5 15.3 29.3 29.8 21.4 21.1 23.5 19.0 19.1 23.5 24.2 20.3 12.7 15.5 29.9 34.0 24.7 20.1 15.7 26.5 30.5 30.8 27.2 18.1 27.5 32.4 16.3 29.1 23.5 15.3 12.7 23.2 23.3 18.9 22.4 24.4 15.7 29.8 28.2 21.6 16.1 35.3 22.5 26.2 15.9 27.8 21.2 20.0 32.3 28.1 19.4 40.4 36.0 39.8 19.5 37.0 17.1 23.0 26.5 22.7 26.1 34.2 34.9 26.4 19.9 28.7 37.2 35.6 23.7 17.4 34.7 25.1 27.9 32.7 23.6 18.5 25.8 23.9 16.2 33.8 23.9 20.0 30.0 16.5 52.5 37.1 57.6 25.2 42.8 36.0 30.0 43.3 55.7 34.2 40.2 25.7 55.6 27.1 26.1 48.4 71.8 27.0 48.5 34.9 39.1 59.7 45.9 14.1 23.5 35.1 25.6 25.1 56.8 54.3 37.1 19.6 32.4 31.8 2.3 3.9 10.9 8.0 6.5 10.0 6.9 10.3 10.7 4.1 7.5 11.0 8.7 3.8 6.3 8.4 3.9 5.8 6.2 30.0 30.3 29.3 29.8 29.9 34.0 30.5 30.8 29.1 29.8 35.3 32.3 7.0 9.6 4.9 5.5 12.6 5.5 3.8 5.8 7.4 11.8 14.3 10.0 5.3 5.7 7.4 12.9 2.1 15.5 14.1 10.3 19.6 6.2 3.4 5.7 7.5 6.8 5.4 12.4 6.3 5.9 12.6 5.8 9.7 7.4 0.0 9.3 7.1 9.4 6.5 21.9 4.3 10.6 6.1 6.6 3.5 2.2 9.0 5.6 5.4 6.5 6.4 10.6 8.2 5.5 4.7 9.7 9.1 9.1 11.5 4.9 12.0 9.8 4.0 6.0 6.6 5.4 6.9 5.9 12.2 9.8 5.3 11.6 11.7 9.3 8.4 3.7 RAB39A RAB39 ENSG00000179331 "RAB39A, member RAS oncogene family" Q14964 11 107928448-107963482 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;lymphoid tissue: 3.0" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Excitatory neurons: 5.2;Inhibitory neurons: 8.8;Microglial cells: 20.6;Spermatocytes: 6.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 11.6;NTERA-2: 8.6;RPMI-8226: 15.5;SCLC-21H: 27.8;SH-SY5Y: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042505 Uncertain NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA042505: AB_2678030" "unprognostic (1.45e-1)" "unprognostic (1.48e-2)" "unprognostic (1.83e-1)" "unprognostic (3.40e-2)" "unprognostic (4.99e-1)" "unprognostic (4.30e-2)" "unprognostic (4.26e-3)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (7.36e-2)" "unprognostic (4.22e-3)" "unprognostic (2.24e-2)" "unprognostic (1.41e-3)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (5.02e-2)" "unprognostic (2.43e-1)" 0.7 0.9 1.7 2.9 1.4 0.6 0.3 3.1 3.2 0.2 0.2 0.5 0.5 0.2 0.0 0.3 0.2 0.8 0.2 3.2 3.9 0.6 0.6 0.9 2.1 3.1 2.6 0.2 0.3 0.2 0.4 1.2 3.5 0.2 0.8 1.1 0.2 0.1 0.0 0.3 0.7 0.7 2.6 3.0 0.6 0.8 2.2 2.6 0.3 0.1 1.4 0.9 0.0 2.3 0.0 1.8 7.3 0.1 0.0 0.0 0.9 0.1 0.0 0.8 0.6 0.0 0.0 0.4 0.1 0.0 11.6 0.0 7.4 0.0 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.5 6.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.2 0.0 4.0 15.5 0.1 0.0 27.8 17.1 0.0 0.0 0.4 1.6 0.4 3.0 0.0 0.1 1.9 0.0 1.3 0.1 4.3 0.0 0.4 1.7 4.1 0.1 1.4 0.0 0.0 2.2 0.0 0.8 0.0 0.0 1.0 0.5 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.4 1.7 1.4 3.1 3.2 3.2 3.9 3.1 2.6 3.5 2.6 2.2 2.3 0.0 0.0 1.1 0.7 0.8 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 1.8 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 8.8 0.0 0.0 4.1 3.7 0.8 0.0 4.1 0.0 20.6 1.8 0.0 0.0 4.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 6.4 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RADIL "FLJ10324, KIAA1849, RASIP2" ENSG00000157927 "Rap associating with DIL domain" Q96JH8 7 4797055-4883716 "Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.0" "Cell type enhanced" "Detected in many" "Astrocytes: 10.1;Early spermatids: 9.2;Horizontal cells: 13.5;Microglial cells: 14.0;Spermatocytes: 17.0;Spermatogonia: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.8;HEK 293: 6.5;NTERA-2: 7.3;SCLC-21H: 8.9;SH-SY5Y: 19.0;U-2197: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051776 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear membrane" "HPA051776: AB_2681605" "unprognostic (6.77e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.80e-2)" "unprognostic (1.80e-2)" "unprognostic (1.21e-1)" "unprognostic (9.74e-4)" "unprognostic (4.63e-2)" "unprognostic (3.48e-1)" "unprognostic (2.83e-2)" "unprognostic (7.89e-4)" "unprognostic (5.32e-2)" "unprognostic (1.49e-4)" "unprognostic (5.10e-3)" "unprognostic (2.46e-1)" "unprognostic (3.33e-3)" "unprognostic (4.28e-3)" 3.4 0.5 2.2 0.2 1.9 0.0 3.3 11.0 3.6 4.1 0.4 3.4 0.2 3.2 0.2 0.8 3.7 0.7 4.8 1.8 4.0 0.4 0.1 4.5 0.1 3.3 3.7 1.5 3.3 0.3 2.9 2.6 3.4 2.0 0.2 0.3 1.1 1.2 2.8 1.2 1.3 1.0 2.8 0.5 1.3 8.2 2.7 0.2 2.5 2.0 0.1 2.3 2.9 1.7 0.0 2.1 4.4 7.8 0.2 1.9 0.0 1.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.8 1.5 0.0 3.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.7 4.2 0.0 0.4 1.9 0.0 0.0 7.3 0.1 1.6 5.0 0.5 0.0 0.0 0.0 8.9 19.0 0.0 0.0 0.0 1.8 3.2 0.6 0.0 0.0 0.0 6.1 1.9 0.2 0.4 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.9 11.0 3.6 1.8 4.0 3.3 3.7 3.4 2.8 2.7 1.7 1.8 3.2 1.5 10.1 0.0 0.8 0.0 0.0 0.6 2.1 3.4 1.8 2.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.2 1.1 2.6 2.2 0.0 0.0 2.6 1.7 0.0 3.9 0.0 0.1 0.0 0.2 0.4 0.0 0.1 13.5 3.6 0.3 0.0 0.6 1.2 5.1 3.4 1.0 7.2 14.0 0.0 4.7 0.0 7.1 3.5 0.3 0.1 3.8 0.0 0.4 0.0 0.0 1.5 0.9 6.6 4.7 4.1 17.0 11.7 0.0 0.6 0.1 2.1 0.3 0.0 0.0 RAMP1 ENSG00000132329 "Receptor activity modifying protein 1" O60894 2 237858893-237912106 "FDA approved drug targets, Predicted membrane proteins, Transporters" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 706.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 190.0;Endometrial stromal cells: 546.4;Exocrine glandular cells: 278.2;monocytes: 433.5" "Cancer enhanced" "Detected in all" "prostate cancer: 152.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 18 "NK-cell: 70.1" "Lineage enriched" "Detected in many" 18 "NK-cells: 70.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.4;HDLM-2: 146.0;PC-3: 173.8;SH-SY5Y: 201.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057814 Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoplasm, Nuclear membrane" "HPA057814: AB_2683536" "unprognostic (1.13e-2)" "unprognostic (5.96e-2)" "unprognostic (3.03e-3)" "unprognostic (3.69e-1)" "unprognostic (4.29e-1)" "unprognostic (1.75e-1)" "prognostic favorable (7.61e-4)" "unprognostic (2.54e-1)" "unprognostic (3.49e-1)" "unprognostic (5.45e-3)" "unprognostic (2.32e-1)" "unprognostic (1.43e-1)" "unprognostic (2.46e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (2.08e-3)" 18.7 29.2 170.9 21.0 171.2 0.9 7.4 168.7 253.4 362.4 153.7 349.6 57.5 706.0 25.0 9.4 256.6 28.5 287.6 176.0 181.8 26.0 82.7 32.5 6.6 198.8 164.5 45.2 225.0 1.4 15.2 8.6 163.0 142.2 6.4 0.8 10.0 54.6 212.3 11.6 73.5 125.4 171.7 12.3 103.4 5.1 183.5 2.9 6.8 68.8 2.9 171.4 75.1 173.2 29.8 0.0 0.5 0.0 12.4 17.9 1.1 2.1 3.6 1.7 1.5 0.0 47.4 0.3 0.4 0.9 0.1 0.2 7.6 0.1 0.2 146.0 4.0 0.1 0.0 1.2 40.6 0.0 0.2 15.6 22.3 0.1 0.3 0.2 0.0 0.0 0.0 0.3 3.7 2.7 0.1 1.3 0.4 0.1 173.8 0.0 1.5 0.8 0.0 0.0 1.5 201.7 3.5 0.0 0.1 1.8 1.3 0.1 0.0 0.8 0.6 0.4 0.5 0.3 0.3 0.0 0.6 0.1 2.7 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.6 0.1 1.0 0.0 0.5 0.2 0.4 70.1 0.0 0.2 0.0 3.4 170.9 171.2 168.7 253.4 176.0 181.8 198.8 164.5 163.0 171.7 183.5 173.2 1.0 0.0 1.5 64.9 3.1 11.6 13.2 26.9 10.2 2.0 4.4 4.4 190.0 78.6 43.8 11.0 0.0 3.0 44.0 2.1 0.0 62.7 0.2 26.5 546.4 6.2 115.4 4.4 14.2 278.2 5.5 41.7 31.1 11.3 1.3 0.6 30.7 104.0 22.7 1.7 19.2 73.7 10.2 3.1 50.3 0.6 8.4 20.3 64.0 13.1 433.5 6.9 61.8 71.9 11.5 63.5 87.7 11.3 1.9 66.1 96.8 0.2 97.0 2.7 6.6 16.6 78.6 0.3 5.8 2.6 5.8 2.3 7.3 0.5 105.8 28.5 RAP1GAP2 "GARNL4, KIAA1039" ENSG00000132359 "RAP1 GTPase activating protein 2" Q684P5 17 2755705-3037741 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.7;pancreas: 37.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 132.8;Inhibitory neurons: 67.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 12 "amygdala: 10.6;basal ganglia: 13.6;cerebral cortex: 11.0;hippocampal formation: 17.9;white matter: 11.9" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022148, HPA022896" Approved Supported "Nuclear membrane,Cytosol" NA NA 21000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear membrane, Cytosol" "HPA022148: AB_1849474, HPA022896: AB_1849476" "unprognostic (1.85e-3)" "unprognostic (1.02e-2)" "unprognostic (8.92e-2)" "unprognostic (5.39e-1)" "unprognostic (4.04e-2)" "unprognostic (3.92e-1)" "unprognostic (6.52e-5)" "unprognostic (1.18e-2)" "unprognostic (2.91e-1)" "unprognostic (2.22e-1)" "unprognostic (1.66e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.36e-6)" "unprognostic (3.44e-2)" "unprognostic (6.38e-2)" "unprognostic (9.33e-2)" "unprognostic (7.50e-2)" 1.8 6.4 10.6 4.1 13.6 27.7 4.4 0.9 11.0 3.9 0.0 7.9 8.7 4.1 1.1 3.1 8.1 4.0 14.5 17.9 1.1 5.2 0.6 3.5 2.9 0.0 0.0 4.6 37.3 4.2 5.1 4.9 0.0 3.8 8.1 7.2 10.9 4.7 0.8 3.3 8.2 3.3 0.0 3.9 22.4 3.2 0.0 2.8 2.5 2.0 2.5 2.0 2.5 11.9 8.1 9.9 1.9 8.1 0.0 0.0 15.9 10.7 5.0 1.3 1.2 21.9 3.5 3.0 2.9 1.4 13.5 11.0 6.4 20.0 0.4 0.0 6.9 3.7 14.1 9.9 1.9 0.8 3.9 0.5 17.0 5.5 13.9 7.2 0.2 3.7 21.4 1.4 0.0 9.1 3.1 2.0 11.7 3.9 9.5 13.4 6.9 7.8 5.9 4.1 21.6 52.3 15.5 15.8 6.9 7.4 7.8 2.3 2.4 9.1 14.3 1.6 9.1 0.0 0.0 1.2 0.5 6.9 15.1 0.9 1.4 2.1 2.8 2.7 1.1 0.2 0.9 2.1 1.0 0.2 0.1 1.0 4.2 1.9 3.9 1.7 1.0 1.4 10.6 13.6 0.9 11.0 17.9 1.1 0.0 0.0 0.0 0.0 0.0 11.9 1.5 6.4 2.5 13.7 5.6 2.0 6.6 1.8 1.2 23.6 9.9 7.6 20.2 11.5 2.8 12.9 33.3 7.5 27.2 15.2 9.8 6.0 6.1 9.2 6.8 1.6 48.1 0.8 132.8 12.0 6.0 2.2 18.8 9.2 6.3 3.0 3.6 0.8 3.4 37.0 67.9 21.7 8.2 11.1 4.3 8.3 1.8 11.0 3.6 47.8 12.0 2.1 35.0 8.0 4.2 12.4 24.1 1.5 6.4 16.5 5.7 0.8 4.2 4.6 0.0 7.9 2.5 0.4 3.4 2.8 0.4 3.4 8.2 1.5 14.0 11.3 RASL11B ENSG00000128045 "RAS like family 11 member B" Q9BPW5 4 52862317-52866835 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.6;ovary: 66.4" "Cell type enhanced" "Detected in many" "Collecting duct cells: 33.1;Cytotrophoblasts: 102.6;Extravillous trophoblasts: 62.2;Granulosa cells: 26.6;Peritubular cells: 68.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 14.1;CACO-2: 11.1;NTERA-2: 15.2;RPTEC TERT1: 10.2;SH-SY5Y: 38.5;SuSa: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057803 Uncertain Approved "Nuclear bodies" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 47: Cytotrophoblasts - Unknown function" "Nuclear bodies" "HPA057803: AB_2683533" "unprognostic (1.60e-1)" "unprognostic (1.95e-1)" "unprognostic (7.32e-3)" "unprognostic (1.19e-1)" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (1.22e-1)" "unprognostic (7.66e-2)" "unprognostic (7.45e-3)" "unprognostic (4.95e-2)" "unprognostic (9.71e-2)" "unprognostic (8.72e-2)" "unprognostic (7.20e-4)" "unprognostic (7.17e-2)" "unprognostic (1.35e-1)" "unprognostic (5.00e-6)" "unprognostic (1.10e-1)" 2.0 2.0 3.1 0.5 3.8 0.0 1.1 2.8 5.8 4.5 0.1 0.9 0.0 9.8 2.7 0.5 4.1 0.9 14.7 5.2 3.2 17.9 0.6 1.0 0.8 0.3 0.4 66.4 0.9 7.9 0.7 4.7 0.2 2.0 0.1 0.3 1.4 9.1 0.4 3.8 0.9 1.9 0.2 27.6 4.1 5.9 1.4 0.1 1.0 0.1 0.9 2.2 4.9 3.2 0.3 0.0 5.9 0.0 5.2 2.4 14.1 0.1 0.1 0.3 0.0 11.1 0.0 0.0 0.5 0.0 0.1 0.0 0.7 3.5 0.0 0.0 1.4 0.5 0.0 0.0 1.0 0.0 0.4 2.5 6.2 0.0 0.2 0.0 0.0 0.3 0.7 0.0 0.0 1.3 1.1 0.0 15.2 1.3 0.2 0.0 6.8 0.0 10.2 1.5 3.2 38.5 0.2 2.6 1.3 10.1 1.5 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.2 0.0 0.0 3.1 3.8 2.8 5.8 5.2 3.2 0.3 0.4 0.2 0.2 1.4 3.2 1.1 6.4 0.0 0.3 0.9 0.9 1.5 2.8 0.0 4.9 7.5 6.5 5.3 0.0 1.8 33.1 0.0 102.6 1.5 7.1 0.0 1.5 0.4 1.6 6.9 1.2 0.0 0.0 2.7 0.5 62.2 4.6 9.7 2.7 0.0 26.6 1.1 0.0 8.0 0.0 1.1 3.6 0.0 0.3 1.7 3.3 24.2 0.8 0.0 4.7 0.6 1.9 0.0 0.5 0.9 0.5 5.6 68.4 0.1 0.5 1.6 0.1 0.1 1.2 0.0 5.8 5.7 4.6 10.9 1.2 0.4 23.1 0.9 6.1 2.8 0.2 RBMS3 ENSG00000144642 "RNA binding motif single stranded interacting protein 3" Q6XE24 3 28574791-30010391 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 331.1;Inhibitory neurons: 655.9;Microglial cells: 1013.7;Oligodendrocyte precursor cells: 229.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 5.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 9 "dendritic cells: 3.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 20.7;WM-115: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034719 Uncertain Approved Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA034719: AB_10670172" "unprognostic (8.39e-2)" "unprognostic (2.54e-2)" "unprognostic (1.02e-1)" "unprognostic (7.08e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" "unprognostic (3.13e-2)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.90e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.25e-3)" "unprognostic (3.81e-2)" "unprognostic (8.48e-2)" "unprognostic (3.24e-4)" 15.8 8.6 6.5 2.1 7.2 0.1 12.2 9.5 5.8 9.9 12.0 8.1 1.4 6.2 6.7 3.1 9.8 6.7 14.3 2.1 21.4 5.1 3.7 12.6 2.7 12.6 15.7 11.6 2.0 4.9 3.2 10.4 9.0 6.4 2.6 0.4 4.7 8.7 6.4 3.8 4.0 4.5 6.3 6.6 4.3 2.2 11.1 5.5 15.3 10.8 1.7 8.1 7.3 2.6 2.2 0.2 10.2 0.1 19.6 12.5 0.0 5.7 3.6 5.9 6.8 0.0 0.4 0.0 6.1 20.7 1.8 0.2 0.5 3.8 10.9 0.0 1.1 5.9 8.7 0.0 19.9 0.1 0.0 11.8 2.6 10.5 12.3 8.4 7.9 0.0 0.0 0.0 7.4 0.0 0.1 0.0 0.3 0.0 0.4 0.4 7.5 0.0 2.2 0.0 0.0 19.4 13.7 0.0 0.7 4.6 0.0 0.0 17.1 11.1 11.6 13.5 11.7 0.0 0.0 0.8 1.5 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.9 0.3 0.0 6.5 7.2 9.5 5.8 2.1 21.4 12.6 15.7 9.0 6.3 11.1 2.6 100.9 118.6 18.8 331.1 0.6 8.3 25.5 23.0 2.2 0.4 2.7 19.8 16.2 31.5 21.3 9.2 0.0 16.4 5.9 0.0 0.0 5.3 35.1 2.8 7.0 54.4 0.0 0.0 20.7 1.2 3.0 96.8 2.0 4.6 5.1 19.8 129.9 1.9 2.8 0.0 655.9 0.0 6.1 30.3 14.1 18.8 159.7 2.7 7.2 1013.7 0.6 0.0 0.0 229.2 8.9 0.4 0.0 110.6 0.1 24.3 0.0 2.9 10.5 0.0 111.7 154.6 73.5 1.2 1.5 2.4 7.2 9.6 2.9 22.4 0.0 4.7 RBP1 "CRABP-I, CRBP, CRBP1, CRBPI, RBPC" ENSG00000114115 "Retinol binding protein 1" P09455 3 139517434-139539829 "Metabolic proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 1366.7;pancreas: 632.7" "Group enriched" "Detected in many" 4 "Granulosa cells: 5988.6;Theca cells: 3228.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "SH-SY5Y: 835.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 64.4" "HPA007338, CAB018603, CAB019276" Enhanced Approved Nucleoplasm,Cytosol NA NA 41000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Cytosol Nucleoplasm "CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814" "unprognostic (9.62e-3)" "unprognostic (7.67e-2)" "unprognostic (9.53e-3)" "unprognostic (5.17e-1)" "unprognostic (7.48e-3)" "unprognostic (2.27e-2)" "unprognostic (6.29e-2)" "unprognostic (1.16e-1)" "unprognostic (7.12e-2)" "unprognostic (3.91e-3)" "unprognostic (2.74e-2)" "unprognostic (8.86e-2)" "unprognostic (1.11e-3)" "unprognostic (2.60e-2)" "unprognostic (1.71e-1)" "unprognostic (4.50e-2)" "unprognostic (1.28e-3)" 23.7 377.1 64.6 18.4 65.2 1.3 49.5 64.9 72.7 53.8 251.4 30.3 32.3 180.2 64.2 35.4 390.2 182.9 60.1 65.5 67.8 46.9 140.8 26.8 18.6 83.1 69.0 1366.7 632.7 46.8 257.8 63.6 64.7 44.8 14.2 23.2 50.2 41.3 15.2 31.3 26.2 119.3 68.2 47.0 29.3 56.1 75.2 9.4 23.0 15.5 12.0 65.7 24.3 67.5 7.8 2.9 7.4 164.2 0.3 0.0 0.9 0.1 0.0 0.0 0.1 0.4 76.1 0.0 53.8 0.1 2.6 0.1 38.2 0.5 0.0 0.1 5.3 0.1 2.7 75.5 155.1 0.2 0.1 3.0 0.0 0.1 0.0 160.9 0.0 0.0 0.2 29.9 0.2 0.0 0.2 0.5 18.4 0.2 0.0 0.1 32.0 0.5 0.1 0.1 19.6 835.4 35.3 0.1 0.1 13.9 3.2 1.1 0.0 0.3 120.0 0.2 0.3 0.6 0.5 0.5 1.3 0.0 2.3 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 64.6 65.2 64.9 72.7 65.5 67.8 83.1 69.0 64.7 68.2 75.2 67.5 24.8 32.1 5.9 8.8 3.5 17.6 53.5 91.9 2.8 26.3 70.4 47.8 21.4 77.2 30.3 23.9 2.1 3.2 1.0 0.1 13.7 1013.0 4.8 199.6 961.4 103.8 43.1 13.5 0.5 1042.7 6.2 158.8 19.9 58.1 0.0 5988.6 343.7 6.9 16.5 3.3 0.3 2.3 42.7 10.6 3.4 16.2 27.1 25.1 8.8 5.6 13.5 159.9 0.0 4.0 16.0 563.0 0.0 4.5 2.9 56.6 2.6 4.7 10.3 7.2 26.3 220.9 534.7 11.6 4.9 6.2 34.9 3.8 10.2 3228.5 2.7 32.7 RD3 "C1orf36, LCA12" ENSG00000198570 "Retinal degeneration 3, GUCY2D regulator" Q7Z3Z2 1 211476522-211492162 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "retina: 47.2" "Group enriched" "Detected in some" 10 "Bipolar cells: 82.7;Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 66.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.6;HMC-1: 14.4;SH-SY5Y: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029941, HPA029943" Enhanced NA NA "Cluster 79: Retina - Phototransduction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA029941: AB_2732449, HPA029943: AB_2732450" "unprognostic (1.42e-1)" "unprognostic (2.75e-2)" "unprognostic (1.14e-2)" "unprognostic (6.07e-2)" "unprognostic (2.96e-2)" "unprognostic (2.18e-1)" "unprognostic (9.54e-2)" "unprognostic (7.87e-2)" "unprognostic (1.15e-1)" "unprognostic (4.80e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-2)" 0.0 0.7 0.1 0.0 0.2 0.2 0.0 0.5 0.3 0.2 0.8 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.7 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.1 0.7 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.7 0.0 0.0 0.5 0.0 0.0 0.0 100.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 REC8 "kleisin-alpha, REC8L1, Rec8p" ENSG00000100918 "REC8 meiotic recombination protein" O95072 14 24171853-24180257 "Plasma proteins, Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 68.9" "Cell type enhanced" "Detected in many" "Early spermatids: 150.6;Gastric mucus-secreting cells: 73.9;Late spermatids: 74.5;Respiratory ciliated cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 10.8;HHSteC: 8.7;MOLT-4: 11.7;SH-SY5Y: 47.4;SuSa: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031727, HPA031729" Approved Approved Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA031727: AB_10602920, HPA031729: AB_10669915" "prognostic favorable (2.19e-4)" "unprognostic (2.57e-2)" "unprognostic (2.15e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (5.10e-3)" "unprognostic (1.00e-1)" "unprognostic (1.21e-2)" "unprognostic (3.16e-1)" "unprognostic (1.31e-1)" "prognostic favorable (5.57e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.41e-7)" "unprognostic (8.98e-2)" "unprognostic (2.12e-1)" "unprognostic (1.88e-2)" "unprognostic (6.40e-3)" 9.8 6.1 3.3 2.1 3.2 6.6 2.5 5.2 3.9 6.3 5.3 8.5 1.3 7.1 0.1 2.7 14.9 8.8 2.8 3.4 4.5 12.4 3.3 9.5 3.1 8.9 4.8 3.9 2.7 0.2 68.9 0.6 8.9 7.3 0.4 1.9 4.7 6.2 0.9 1.7 7.3 2.4 3.6 13.6 25.7 29.9 5.3 10.1 3.5 0.3 3.1 4.0 3.7 4.4 0.1 0.2 10.8 0.1 0.4 0.5 0.6 0.4 0.5 1.0 0.8 0.1 1.2 0.2 0.1 0.0 0.6 0.5 0.3 0.0 0.7 1.0 0.2 0.4 0.7 0.0 8.7 0.2 1.5 4.8 0.5 0.4 0.1 4.1 1.9 0.4 0.1 1.4 0.0 0.2 11.7 1.8 3.4 0.0 0.1 0.2 0.0 0.1 0.4 0.4 0.2 47.4 0.0 0.1 0.4 26.0 0.2 0.5 0.4 0.0 0.2 0.3 0.1 1.7 0.5 0.1 0.0 0.2 0.2 2.2 0.1 9.7 4.7 1.1 5.4 1.6 1.7 2.7 3.2 1.7 0.7 2.4 0.1 2.8 5.8 5.2 2.9 1.2 3.3 3.2 5.2 3.9 3.4 4.5 8.9 4.8 8.9 3.6 5.3 4.4 9.5 12.8 10.8 3.6 6.8 1.9 4.4 15.8 8.6 14.9 2.8 2.0 2.0 25.8 14.8 27.6 0.0 1.4 10.2 5.1 5.9 2.9 150.6 43.5 10.6 4.8 4.8 25.9 3.8 2.7 3.2 10.0 73.9 21.9 3.8 7.9 3.6 2.1 2.3 6.7 5.1 2.5 10.2 5.7 3.9 74.5 4.7 6.6 1.8 2.8 4.0 21.1 2.1 5.5 4.6 5.0 0.7 3.0 11.0 1.5 4.1 24.7 51.4 2.0 0.0 3.7 3.9 8.3 43.4 1.3 2.0 0.4 11.3 33.8 2.4 4.0 RET "CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51" ENSG00000165731 "Ret proto-oncogene" P07949 10 43077064-43130351 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 20.8;brain: 27.3;parathyroid gland: 31.8" "Group enriched" "Detected in some" 4 "Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1" "Cancer enhanced" "Detected in many" "breast cancer: 11.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "midbrain: 53.3;spinal cord: 19.4" "CAB002581, HPA008356, HPA008495" Approved Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" No NA 2100000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Cytosol" "Plasma membrane" "CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: " "unprognostic (7.94e-2)" "unprognostic (3.68e-2)" "unprognostic (4.49e-1)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (9.13e-4)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (2.86e-1)" "unprognostic (2.01e-1)" "unprognostic (1.54e-3)" "unprognostic (4.43e-1)" "unprognostic (9.35e-5)" "unprognostic (1.64e-3)" "unprognostic (8.28e-2)" "unprognostic (3.67e-3)" "unprognostic (2.02e-2)" 1.8 20.8 1.0 1.3 0.9 0.4 1.1 5.1 5.6 1.0 0.2 3.4 1.4 0.6 0.3 0.4 0.5 0.6 2.2 0.3 5.5 0.9 3.0 0.4 0.6 14.4 27.3 0.4 1.3 31.8 5.3 0.5 12.0 1.8 1.4 4.7 5.1 2.0 5.9 0.9 1.4 1.0 4.8 0.2 2.2 2.7 7.6 1.6 0.8 3.1 0.2 0.6 1.4 5.8 0.1 0.4 0.1 1.7 0.0 0.0 0.1 0.7 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 5.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.6 0.0 42.2 7.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 329.3 0.1 0.0 0.1 0.5 4.1 95.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.0 1.0 0.9 5.1 5.6 0.3 5.5 14.4 27.3 12.0 4.8 7.6 5.8 0.4 0.0 0.5 1.6 0.0 0.3 0.8 0.0 0.0 1.7 6.0 0.5 2.1 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 1.5 0.0 0.3 1.1 0.0 0.0 4.2 0.2 2.3 6.8 0.0 0.0 1.3 0.5 0.0 1.2 0.1 79.1 8.6 1.9 26.4 0.0 0.6 1.5 0.3 0.5 0.0 1.0 0.0 0.8 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 1.7 0.0 23.1 1.2 1.1 4.7 0.0 0.6 0.0 0.2 0.3 0.2 0.1 RFTN1 "FLJ23866, KIAA0084, MIG2, Raftlin" ENSG00000131378 "Raftlin, lipid raft linker 1" Q14699 3 16313574-16514026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 117.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 87.6;monocytes: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 151.7;Daudi: 122.9;HDLM-2: 177.5;SH-SY5Y: 132.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048725 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 3: Monocytes - Immune response regulation" "HPA048725: AB_2680502" "unprognostic (1.98e-1)" "unprognostic (5.82e-2)" "unprognostic (1.44e-1)" "unprognostic (1.61e-1)" "unprognostic (5.92e-2)" "unprognostic (1.19e-2)" "unprognostic (1.87e-1)" "unprognostic (7.55e-3)" "unprognostic (9.99e-3)" "unprognostic (7.24e-2)" "unprognostic (2.75e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.29e-7)" "unprognostic (6.19e-2)" "unprognostic (1.49e-2)" "unprognostic (2.88e-2)" "unprognostic (2.81e-1)" 57.2 11.2 15.1 44.7 18.3 13.3 33.2 13.6 22.7 28.2 15.8 15.2 9.3 36.6 4.9 14.5 26.0 15.4 44.7 18.3 20.2 18.4 24.8 46.9 117.0 21.7 14.9 30.4 4.7 9.0 7.4 51.0 16.1 16.4 14.1 11.4 11.3 10.3 25.5 17.1 22.8 31.3 13.9 45.5 11.8 7.0 15.2 73.2 53.4 26.6 117.4 26.2 14.5 17.5 0.1 2.9 5.3 0.0 151.7 75.7 7.7 38.8 65.9 19.3 15.6 21.5 1.0 122.9 18.6 71.2 4.3 0.6 0.1 51.4 25.5 177.5 9.0 19.8 4.9 0.3 78.6 14.7 10.8 111.3 3.4 60.7 19.0 67.5 40.5 19.8 0.5 0.4 47.0 6.6 31.3 5.0 3.5 0.0 1.4 29.6 60.8 15.0 8.0 0.1 0.1 132.6 1.3 1.3 7.2 7.4 0.2 12.2 59.9 47.3 23.0 47.8 16.8 0.4 0.5 82.5 22.0 38.6 19.2 56.0 19.6 13.2 35.3 46.4 18.1 16.3 27.2 37.6 33.6 32.0 18.4 27.8 1.2 80.1 81.7 25.8 60.4 38.3 15.1 18.3 13.6 22.7 18.3 20.2 21.7 14.9 16.1 13.9 15.2 17.5 37.9 22.4 40.0 8.1 51.2 6.5 0.3 2.3 0.0 3.2 0.7 1.5 14.3 5.7 6.9 0.0 0.0 6.2 61.1 0.1 0.0 7.2 38.0 2.6 51.8 34.4 1.2 10.3 87.6 0.9 1.1 32.4 3.1 2.0 24.7 2.1 36.0 7.2 10.5 0.0 16.5 0.0 0.0 17.6 63.6 12.2 18.6 27.0 10.6 19.7 143.8 37.2 64.9 3.0 2.4 0.9 0.1 8.6 43.2 0.6 0.0 0.4 3.3 3.2 0.0 28.2 35.2 2.8 2.4 0.8 5.1 2.5 39.5 12.6 0.3 0.4 RGS11 ENSG00000076344 "Regulator of G protein signaling 11" O94810 16 268301-275980 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.2;pituitary gland: 56.4" "Cell type enhanced" "Detected in many" "Astrocytes: 31.0;Bipolar cells: 69.7;Cone photoreceptor cells: 120.9;Excitatory neurons: 31.9;Inhibitory neurons: 33.6;Oligodendrocytes: 28.0;Rod photoreceptor cells: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.1;ASC TERT1: 2.2;fHDF/TERT166: 2.0;HHSteC: 3.1;hTERT-RPE1: 2.4;SCLC-21H: 3.0;SH-SY5Y: 2.3;T-47d: 2.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041692, HPA043039" Uncertain NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA041692: AB_2677619, HPA043039: AB_2678282" "unprognostic (8.39e-2)" "unprognostic (1.97e-1)" "unprognostic (5.46e-2)" "unprognostic (4.55e-3)" "unprognostic (1.46e-1)" "unprognostic (8.50e-2)" "unprognostic (7.48e-2)" "unprognostic (2.02e-1)" "unprognostic (2.93e-1)" "unprognostic (6.56e-2)" "prognostic favorable (1.24e-4)" "unprognostic (1.70e-1)" "unprognostic (1.48e-3)" "unprognostic (6.91e-3)" "unprognostic (2.27e-1)" "unprognostic (1.20e-1)" "unprognostic (1.04e-1)" 14.7 4.5 13.4 1.0 14.8 0.0 8.4 21.8 40.2 8.8 7.5 21.7 7.1 4.2 0.3 7.4 4.5 0.9 22.3 13.4 11.2 5.4 2.4 9.0 0.4 15.4 14.2 0.8 16.8 4.4 56.4 2.6 15.3 19.2 0.7 8.9 3.8 2.7 2.2 2.5 6.9 1.1 10.2 3.4 15.0 0.8 12.8 0.0 4.2 1.1 0.0 9.2 8.8 14.4 0.0 0.0 0.0 0.0 2.1 2.2 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 1.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.5 0.0 0.0 0.0 0.2 0.0 0.0 3.0 2.3 1.2 0.0 0.5 0.0 2.5 0.0 1.6 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 14.8 21.8 40.2 13.4 11.2 15.4 14.2 15.3 10.2 12.8 14.4 1.8 0.0 0.0 31.0 0.1 0.1 0.2 0.1 0.6 69.7 1.0 0.6 7.5 1.5 0.0 0.0 120.9 0.1 0.3 0.9 0.0 0.1 0.0 1.9 5.2 1.8 10.3 0.0 31.9 1.0 0.2 8.6 3.1 3.3 0.0 0.4 6.1 0.0 0.2 10.1 33.6 0.4 2.0 0.0 1.1 0.0 0.9 0.2 1.8 4.7 0.6 3.3 0.0 18.1 28.0 0.4 7.1 1.9 0.0 0.5 5.8 0.0 0.0 67.5 0.0 1.5 7.2 0.5 1.5 0.3 0.6 0.8 0.3 0.1 1.4 0.1 RGS5 ENSG00000143248 "Regulator of G protein signaling 5" O15539 1 163111121-163321791 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Sertoli cells: 5114.5;Smooth muscle cells: 1592.3" "Cancer enhanced" "Detected in all" "renal cancer: 226.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 1303.0;OE19: 692.4;SH-SY5Y: 4234.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001821 Supported Supported Vesicles,Cytosol NA NA "Cluster 30: Non-specific - Translation" "Cluster 39: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol Vesicles "HPA001821: AB_1079806" "unprognostic (3.75e-1)" "unprognostic (3.93e-3)" "unprognostic (2.31e-1)" "unprognostic (6.91e-2)" "unprognostic (2.50e-2)" "unprognostic (1.32e-3)" "unprognostic (1.65e-2)" "unprognostic (7.38e-2)" "unprognostic (3.54e-3)" "unprognostic (2.19e-1)" "unprognostic (1.53e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.17e-4)" "unprognostic (3.81e-3)" "unprognostic (7.05e-2)" "unprognostic (6.08e-2)" "unprognostic (1.41e-1)" 138.1 312.4 75.5 29.7 87.2 0.1 58.4 84.2 136.5 160.5 73.1 95.7 64.5 73.7 63.1 71.8 65.5 142.7 238.2 65.9 90.7 88.1 34.1 55.5 33.8 95.6 89.1 19.5 30.6 83.3 45.4 19.9 108.2 75.1 42.9 15.3 27.8 190.0 116.5 21.8 75.8 278.0 68.8 16.7 93.5 40.5 99.6 21.2 164.7 236.8 39.4 136.1 60.5 83.7 0.4 0.0 62.9 8.0 1.3 3.0 2.6 1.1 4.4 2.0 1.3 5.3 1.6 0.5 9.2 1.1 0.7 0.4 0.8 0.8 3.3 3.0 1.0 1.3 0.9 0.1 2.6 0.8 0.7 2.0 1.9 2.1 2.6 14.3 1303.0 0.3 0.2 1.2 4.7 0.0 0.9 2.2 38.7 692.4 1.4 0.4 0.1 3.6 0.7 0.0 5.2 4234.9 0.9 0.0 1.5 185.8 0.0 1.3 5.3 1.0 2.3 0.9 2.0 1.5 1.2 0.4 1.4 0.2 2.9 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.5 0.2 0.1 0.2 0.4 0.4 0.1 0.2 0.1 0.0 0.2 0.1 75.5 87.2 84.2 136.5 65.9 90.7 95.6 89.1 108.2 68.8 99.6 83.7 458.3 3.2 5.6 61.4 1.7 17.1 6.0 1.0 0.6 1.8 9.8 12.1 0.0 0.0 7.3 1.8 4.2 1.5 2.4 0.3 1.9 1.0 32.7 3.4 11.6 353.7 0.0 0.0 24.4 1.1 0.8 43.0 223.3 8.1 1.3 0.9 0.0 0.0 1.2 0.0 60.5 0.2 0.0 0.0 26.3 17.0 6.8 11.9 23.2 80.6 0.6 2.6 0.0 25.1 69.7 3.9 0.2 2.6 0.4 12.7 0.2 2.5 5.9 5.8 5114.5 44.9 1592.3 5.7 1.7 5.2 12.6 1.2 5.8 5.5 0.2 7.0 RIIAD1 "C1orf230, FLJ36032, NCRNA00166" ENSG00000178796 "Regulatory subunit of type II PKA R-subunit domain containing 1" A6NNX1 1 151710433-151729805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 24.9;pituitary gland: 34.7;testis: 16.9" "Cell type enhanced" "Detected in many" "Early spermatids: 88.9;Endometrial ciliated cells: 133.2;Enteroendocrine cells: 46.2;Late spermatids: 57.1;Respiratory ciliated cells: 73.9;Spermatocytes: 30.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;SCLC-21H: 1.6;SH-SY5Y: 2.7" "Low region specificity" "Detected in all" HPA045703 Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Cytosol Nucleoplasm "HPA045703: AB_10965795" "unprognostic (8.28e-3)" "unprognostic (3.42e-1)" "unprognostic (8.21e-2)" "prognostic favorable (5.46e-4)" "unprognostic (1.06e-2)" "unprognostic (3.09e-1)" "unprognostic (8.99e-2)" "unprognostic (3.20e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-2)" "unprognostic (3.65e-3)" "unprognostic (8.50e-2)" "unprognostic (1.57e-3)" "unprognostic (2.79e-2)" "unprognostic (3.06e-2)" "unprognostic (2.48e-4)" 0.0 1.6 1.9 0.0 2.5 0.0 0.0 3.5 2.5 1.4 0.4 1.0 0.0 0.8 0.1 0.1 24.9 0.0 0.4 2.2 2.5 0.8 0.0 2.4 0.0 1.2 0.9 0.1 0.8 0.1 34.7 0.0 0.5 0.4 0.3 4.8 0.0 0.4 0.1 0.0 0.3 0.3 0.3 0.0 0.9 16.9 2.3 0.0 0.0 0.0 0.0 0.3 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 2.7 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.5 3.5 2.5 2.2 2.5 1.2 0.9 0.5 0.3 2.3 1.1 0.0 19.2 1.5 0.0 0.0 0.0 0.0 1.0 0.0 8.5 1.1 0.4 15.7 0.0 9.3 5.5 16.7 0.0 0.0 0.1 3.9 3.8 88.9 133.2 0.8 0.4 46.2 0.0 1.8 0.9 0.0 1.2 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 1.1 3.2 0.0 0.0 0.0 57.1 0.6 0.2 3.6 0.0 0.0 0.8 0.0 1.0 0.2 0.4 0.1 1.5 0.0 0.1 0.1 3.0 73.9 3.0 0.0 0.5 1.8 30.1 8.9 0.0 0.0 0.0 0.2 0.1 0.8 0.0 RIMBP2 "KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2" ENSG00000060709 "RIMS binding protein 2" O15034 12 130396137-130716281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;parathyroid gland: 24.6;pituitary gland: 32.2" "Group enriched" "Detected in some" 4 "Enteroendocrine cells: 75.5;Excitatory neurons: 128.2;Inhibitory neurons: 191.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 28.9;SH-SY5Y: 55.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041494, HPA044114" Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Golgi apparatus, Cytosol" "HPA041494: , HPA044114: AB_2678815" "unprognostic (4.15e-4)" "unprognostic (9.77e-3)" "unprognostic (1.20e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-3)" "unprognostic (3.63e-1)" "unprognostic (1.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.86e-1)" "unprognostic (6.41e-3)" "unprognostic (5.27e-2)" "unprognostic (2.07e-1)" "unprognostic (1.03e-1)" "unprognostic (4.73e-2)" 0.6 14.5 6.3 0.9 11.3 0.2 0.2 0.0 17.5 7.2 17.3 1.5 2.9 2.7 2.5 0.5 7.8 0.9 0.0 25.9 19.2 5.9 0.2 0.4 0.1 1.7 19.6 2.1 2.5 24.6 32.2 0.0 20.6 1.1 1.8 11.2 0.3 1.3 0.2 2.7 2.5 2.4 0.1 1.0 5.9 2.6 0.9 0.3 0.6 3.9 0.1 0.3 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 5.5 0.0 0.0 0.0 0.4 7.3 0.0 0.0 28.9 55.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 11.3 0.0 17.5 25.9 19.2 1.7 19.6 20.6 0.1 0.9 2.7 0.4 0.0 0.0 5.9 0.0 2.0 0.1 0.0 0.6 19.4 0.0 0.1 1.4 0.0 0.0 0.0 31.3 0.0 0.0 0.4 0.0 0.0 3.8 3.0 1.4 0.4 75.5 0.0 128.2 0.0 0.0 0.7 4.1 6.4 0.0 0.0 0.0 0.0 0.0 10.1 191.4 2.6 6.1 0.0 0.5 2.1 0.9 0.0 0.0 1.0 0.0 3.2 0.0 19.6 5.3 0.1 0.1 0.7 0.0 0.1 0.0 0.1 0.7 14.0 0.0 0.0 0.2 1.7 1.5 0.1 0.6 0.0 0.1 0.0 0.8 0.0 RIPPLY2 "C6orf159, dJ237I15.1" ENSG00000203877 "Ripply transcriptional repressor 2" Q5TAB7 6 83853266-83857515 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.2;choroid plexus: 9.6;pituitary gland: 11.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 12.0;Excitatory neurons: 10.0;Horizontal cells: 11.8;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 13.0;Rod photoreceptor cells: 8.5" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 19.1;HEL: 6.2;SCLC-21H: 26.0;SH-SY5Y: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047454 Uncertain NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA047454: AB_2680053" "unprognostic (2.09e-1)" "unprognostic (7.43e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-3)" "unprognostic (2.69e-3)" "unprognostic (3.66e-1)" "unprognostic (6.94e-3)" "unprognostic (2.30e-1)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" 0.3 1.4 13.8 0.2 14.4 0.0 0.2 17.9 21.2 0.9 9.6 1.3 0.2 0.8 0.0 0.2 0.5 0.3 0.2 14.6 14.6 0.2 0.0 0.1 0.0 13.9 12.7 0.4 1.1 0.0 11.2 0.0 13.8 0.7 0.2 4.2 0.1 0.4 0.3 0.1 0.4 0.3 13.3 0.0 0.7 0.8 13.5 0.0 0.2 0.0 0.0 1.4 0.5 14.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 19.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 1.5 0.0 0.0 1.1 26.0 17.7 1.3 0.1 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 14.4 17.9 21.2 14.6 14.6 13.9 12.7 13.8 13.3 13.5 14.2 0.2 0.0 0.0 2.0 0.0 0.0 0.4 0.3 1.8 12.0 0.0 0.1 3.5 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.3 1.8 0.0 10.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 10.5 0.0 4.1 0.0 0.3 0.5 0.3 0.0 0.0 1.0 0.0 1.4 0.0 13.0 4.6 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 8.5 0.0 2.9 1.0 0.8 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 RNF150 KIAA1214 ENSG00000170153 "Ring finger protein 150" Q9ULK6 4 140859807-141212877 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 112.6;Excitatory neurons: 184.5;Inhibitory neurons: 174.3;Microglial cells: 114.3;Oligodendrocyte precursor cells: 285.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 19.7;fHDF/TERT166: 27.1;SH-SY5Y: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037987 Uncertain "Intracellular and membrane" NA NA "Cluster 54: Non-specific - Microtubule organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA037987: AB_10669512" "prognostic favorable (1.41e-4)" "unprognostic (1.95e-2)" "unprognostic (8.26e-3)" "unprognostic (2.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.38e-2)" "unprognostic (2.38e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (9.32e-2)" "unprognostic (3.10e-3)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (3.88e-3)" "unprognostic (9.68e-2)" "unprognostic (1.32e-3)" "unprognostic (2.41e-2)" 11.3 12.4 6.8 1.7 12.5 0.3 3.1 7.5 7.7 8.0 0.0 16.5 1.0 11.9 10.8 6.8 12.4 3.4 14.9 7.7 8.1 8.3 0.9 1.3 3.3 1.3 1.3 10.8 2.0 0.5 7.8 1.9 6.1 8.3 3.8 31.8 31.7 11.1 18.7 0.9 3.7 12.2 1.9 5.4 4.0 1.4 5.6 2.0 6.2 12.5 3.1 6.5 3.9 2.0 0.3 0.5 4.8 4.2 19.7 1.4 0.2 6.8 3.5 2.5 1.2 0.0 0.1 0.0 0.9 27.1 0.1 0.1 9.8 0.1 1.3 0.1 4.6 0.0 8.9 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.2 1.6 0.0 4.8 0.0 0.1 0.9 0.1 4.7 0.2 2.2 0.0 1.8 2.6 12.4 0.1 2.8 0.0 2.0 37.0 0.7 0.3 1.9 2.5 0.1 0.1 0.1 12.6 5.2 8.7 3.1 0.3 0.1 0.0 0.2 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 12.5 7.5 7.7 7.7 8.1 1.3 1.3 6.1 1.9 5.6 2.0 0.8 0.0 0.5 65.6 0.0 1.1 0.7 0.3 3.4 53.9 3.1 7.4 72.5 1.5 2.2 11.0 112.6 1.3 0.0 0.1 1.9 0.4 4.6 17.8 43.9 2.7 1.8 0.0 184.5 0.5 0.1 10.0 0.0 22.8 0.0 11.4 2.2 0.2 0.7 26.9 174.3 0.0 0.0 0.6 2.9 2.7 28.6 2.0 0.0 114.3 0.0 13.4 0.0 285.5 5.7 0.1 0.0 18.0 0.0 1.1 0.0 1.0 0.2 69.1 13.1 34.5 17.4 0.0 2.0 0.5 0.6 0.4 0.4 47.6 0.0 0.1 RNF165 "Ark2C, ARKL2, RNF111L2" ENSG00000141622 "Ring finger protein 165" Q6ZSG1 18 46326809-46463140 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.6;retina: 18.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 44.0;Cone photoreceptor cells: 100.1;Excitatory neurons: 47.4;Horizontal cells: 80.8;Inhibitory neurons: 34.4;NK-cells: 41.2;Oligodendrocyte precursor cells: 35.7;Rod photoreceptor cells: 49.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 10.1;HaCaT: 7.3;HeLa: 7.5;RPMI-8226: 6.4;SCLC-21H: 13.9;SH-SY5Y: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041615, HPA047798" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Plasma membrane" "HPA041615: AB_2677582, HPA047798: AB_2680158" "unprognostic (6.46e-3)" "unprognostic (7.25e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-5)" "unprognostic (3.43e-1)" "unprognostic (4.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.04e-3)" "unprognostic (1.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.87e-5)" "unprognostic (3.53e-3)" "unprognostic (1.90e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" 0.6 0.5 3.1 0.3 3.7 0.3 0.7 7.6 6.4 0.6 0.0 0.4 0.0 0.2 1.9 1.2 1.2 0.3 1.0 4.7 0.2 1.6 5.2 0.3 0.2 0.0 0.3 0.0 0.3 2.4 4.1 0.2 0.0 2.2 0.1 18.2 0.8 1.3 1.5 1.2 0.3 0.1 0.1 2.0 0.2 0.5 1.3 0.9 4.0 0.8 0.4 0.3 0.5 1.9 1.6 0.1 10.1 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 7.3 0.5 1.0 0.0 0.0 1.1 0.1 7.5 0.0 0.0 3.4 0.0 0.0 0.8 0.0 0.0 0.4 0.0 2.3 0.0 0.2 0.0 0.0 2.6 0.9 1.7 0.4 1.3 2.7 0.6 6.4 0.7 2.2 13.9 13.2 2.0 0.0 0.0 0.9 0.3 0.5 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 3.8 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 3.1 3.7 7.6 6.4 4.7 0.2 0.0 0.3 0.0 0.1 1.3 1.9 9.1 3.2 1.7 1.6 0.3 2.7 9.5 12.9 28.5 44.0 2.9 7.2 8.4 1.5 2.8 0.0 100.1 0.2 10.0 0.2 3.9 0.0 3.8 1.5 9.3 5.0 0.0 0.0 47.4 0.0 0.3 2.4 0.0 0.6 0.0 0.0 1.8 8.9 0.1 80.8 34.4 0.0 2.0 1.9 1.3 5.1 2.5 0.4 1.8 1.9 0.3 5.0 41.2 35.7 1.8 0.1 0.0 4.1 0.4 5.0 0.1 0.1 0.6 49.1 0.0 4.5 0.7 0.4 0.9 3.7 2.0 0.3 3.2 3.2 0.0 2.4 RPH3A "exophilin-1, KIAA0985, rabphilin" ENSG00000089169 "Rabphilin 3A" Q9Y2J0 12 112570380-112898881 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 85.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 24.5;Excitatory neurons: 71.6;Inhibitory neurons: 100.6" "Cancer enriched" "Detected in some" 5 "glioma: 4.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 6.3" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;monocytes: 6.3" "Cell line enhanced" "Detected in many" "RPMI-8226: 7.4;SH-SY5Y: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002475 Enhanced NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA002475: AB_1079837" "unprognostic (5.50e-2)" "unprognostic (3.19e-1)" "unprognostic (3.72e-3)" "unprognostic (5.90e-2)" "unprognostic (7.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (6.39e-2)" "unprognostic (6.75e-2)" "unprognostic (3.73e-2)" "unprognostic (1.42e-1)" "unprognostic (5.85e-2)" "unprognostic (3.92e-2)" "unprognostic (2.08e-2)" "unprognostic (2.70e-2)" "unprognostic (7.46e-2)" 0.5 3.6 15.0 1.5 23.9 20.7 0.8 23.8 85.5 0.3 0.0 0.8 1.0 1.3 2.4 0.9 0.6 1.9 0.6 16.8 14.4 0.6 0.8 0.5 3.4 27.2 24.0 0.8 2.4 0.2 0.4 1.3 7.7 0.7 1.2 9.7 0.9 0.4 0.6 2.1 1.1 1.3 17.3 1.8 0.6 1.4 50.1 0.6 1.1 0.4 1.9 0.8 0.2 46.0 0.7 0.3 0.7 1.2 0.3 0.5 2.0 0.0 0.4 0.5 0.1 0.6 1.0 1.1 0.3 0.0 0.6 2.0 0.3 0.5 0.9 0.4 1.4 1.9 3.2 2.1 0.4 1.1 1.8 0.6 0.2 1.3 1.0 0.7 0.0 0.3 0.1 2.7 1.8 0.7 0.6 1.5 1.1 0.2 1.1 0.0 0.9 7.4 0.0 1.5 0.9 16.5 0.2 0.1 0.1 1.6 0.7 0.1 0.1 1.6 1.2 1.5 0.9 1.2 0.3 1.1 1.0 0.8 0.4 1.2 6.3 0.2 0.2 3.0 0.1 0.3 0.1 0.2 0.6 0.8 0.2 0.3 2.3 0.5 4.6 0.2 0.0 1.8 15.0 23.9 23.8 85.5 16.8 14.4 27.2 24.0 7.7 17.3 50.1 46.0 0.0 0.0 0.0 5.5 0.2 0.0 0.0 0.0 0.0 24.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.2 0.0 0.0 71.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 100.6 0.0 0.0 1.2 0.0 7.2 0.0 3.2 0.0 2.8 5.8 1.2 0.0 12.5 3.8 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPRD1A "FLJ10656, HsT3101, P15RS" ENSG00000141425 "Regulation of nuclear pre-mRNA domain containing 1A" Q96P16 18 35984387-36067576 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 233.0;Late spermatids: 362.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040602 Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA040602: AB_10673137" "unprognostic (2.06e-1)" "unprognostic (9.14e-2)" "unprognostic (1.41e-3)" "unprognostic (2.22e-1)" "unprognostic (9.92e-3)" "unprognostic (2.69e-1)" "unprognostic (2.93e-3)" "unprognostic (1.68e-1)" "unprognostic (2.80e-2)" "unprognostic (3.94e-3)" "unprognostic (1.13e-1)" "unprognostic (1.89e-1)" "unprognostic (5.50e-3)" "unprognostic (7.95e-2)" "unprognostic (6.78e-3)" "unprognostic (1.49e-1)" "unprognostic (4.30e-1)" 23.3 34.8 40.6 16.4 44.4 11.3 24.7 40.7 59.9 21.1 34.6 29.6 19.0 25.7 115.2 23.6 25.3 18.5 29.1 45.5 43.2 26.7 21.8 19.2 19.5 39.5 40.3 24.1 23.4 26.1 27.8 17.8 40.0 29.6 20.5 41.5 28.3 28.9 54.7 20.9 19.0 21.3 41.4 22.3 21.3 28.0 42.6 19.9 32.1 46.5 19.3 27.6 20.0 44.4 31.6 34.1 57.0 60.8 30.6 35.8 35.5 55.6 54.5 31.7 44.5 9.4 34.2 44.1 57.2 40.7 16.9 51.2 64.1 56.3 44.7 39.2 36.6 46.9 48.9 37.0 53.9 78.9 24.3 27.6 73.7 30.2 85.4 39.8 46.0 51.5 42.8 46.7 41.1 39.3 42.4 33.3 45.9 16.2 24.4 34.7 18.3 70.8 48.4 66.9 99.1 83.4 46.5 25.7 48.3 46.2 35.2 55.9 56.4 33.0 20.6 17.7 46.0 52.5 77.6 45.0 33.6 64.1 33.9 0.7 4.7 2.2 2.9 6.3 4.4 5.0 4.0 3.4 7.8 5.4 5.0 4.0 3.5 7.0 4.2 5.4 2.3 3.3 40.6 44.4 40.7 59.9 45.5 43.2 39.5 40.3 40.0 41.4 42.6 44.4 19.0 32.1 20.7 54.9 40.6 34.4 35.9 23.6 54.7 49.6 29.9 22.2 39.4 17.2 21.0 35.0 31.3 17.1 28.7 13.6 27.4 21.0 233.0 36.3 30.2 23.1 28.8 24.6 105.0 19.9 17.6 19.0 25.0 52.5 13.3 50.7 20.7 29.3 9.8 37.0 91.0 16.7 22.4 20.1 24.2 362.4 22.1 18.8 30.2 58.1 18.1 32.2 18.6 84.9 98.5 20.4 25.2 23.0 33.1 41.5 17.8 26.2 20.3 50.8 13.1 26.1 27.0 39.5 42.2 45.2 38.2 14.6 21.9 51.9 22.2 38.2 RTL1 "HUR1, Mar1, MART1, PEG11, SIRH2" ENSG00000254656 "Retrotransposon Gag like 1" A6NKG5 14 100879753-100903722 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 1.6;brain: 7.7;placenta: 2.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "SH-SY5Y: 572.5" "Low region specificity" "Detected in many" "HPA066979, HPA077601" Enhanced Approved Cytosol No NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" Cytosol "HPA066979: AB_2685759, HPA077601: " "unprognostic (1.61e-1)" "unprognostic (3.30e-1)" "unprognostic (1.26e-1)" "unprognostic (1.42e-3)" "unprognostic (2.10e-1)" 0.1 1.6 1.6 0.0 0.7 0.0 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.7 0.0 0.0 0.0 0.0 3.4 4.2 0.6 0.1 0.0 0.2 2.9 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 18.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 572.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 0.9 1.3 1.2 7.7 3.4 4.2 7.7 0.2 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RTL5 "KIAA2001, Mar5, Mart5, RGAG4, SIRH8" ENSG00000242732 "Retrotransposon Gag like 5" Q5HYW3 X 72127110-72131901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 7.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.6;Breast myoepithelial cells: 5.0;Endometrial ciliated cells: 3.8;Endometrial stromal cells: 8.9;Theca cells: 7.0" "Cancer enhanced" "Detected in all" "thyroid cancer: 13.4" "Region enhanced" "Detected in many" "cerebellum: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.7;AN3-CA: 4.2;SCLC-21H: 5.0;SH-SY5Y: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003652 Approved Approved Nucleoplasm NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA003652: AB_1079805" "unprognostic (7.97e-2)" "unprognostic (1.31e-2)" "unprognostic (5.29e-3)" "unprognostic (2.98e-2)" "unprognostic (3.93e-2)" "unprognostic (3.64e-1)" "unprognostic (4.20e-1)" "prognostic favorable (7.30e-4)" "unprognostic (1.62e-1)" "unprognostic (2.82e-1)" "prognostic favorable (3.41e-4)" "unprognostic (4.23e-1)" "unprognostic (4.18e-3)" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" 1.3 1.3 1.0 0.3 1.0 0.2 1.2 3.4 0.8 2.3 1.8 2.2 0.4 2.6 2.0 0.5 2.2 1.1 0.8 0.5 1.2 1.4 0.8 1.4 0.3 0.1 0.0 2.8 0.6 1.1 7.2 1.0 0.2 1.5 0.4 0.7 0.8 1.3 0.3 0.4 1.0 1.2 0.0 0.8 1.9 1.4 1.2 0.1 3.8 0.4 0.1 1.7 1.5 0.1 0.0 0.1 3.7 4.2 0.9 1.1 0.2 1.4 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.3 0.6 0.0 0.8 0.1 0.7 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 7.0 0.2 0.0 0.0 1.5 0.1 0.0 0.4 0.5 0.4 0.9 0.0 0.1 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 3.4 0.8 0.5 1.2 0.1 0.0 0.2 0.0 1.2 0.1 2.9 3.2 3.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 5.0 0.0 0.0 1.8 0.0 0.0 0.1 2.7 0.0 1.9 0.1 0.0 3.8 8.9 0.6 0.0 0.0 0.0 0.0 0.4 2.0 0.0 2.3 2.5 0.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 2.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.3 1.1 7.0 0.0 0.0 RTN1 NSP ENSG00000139970 "Reticulon 1" Q16799 14 59595976-59870776 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 160.6;pituitary gland: 60.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 495.8;Horizontal cells: 240.6;Inhibitory neurons: 394.3;Oligodendrocyte precursor cells: 188.0;Oligodendrocytes: 247.7" "Cancer enhanced" "Detected in many" "glioma: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.9;intermediate monocyte: 3.1;myeloid DC: 5.4" "Group enriched" "Detected in many" 14 "dendritic cells: 5.4;monocytes: 3.1" "Group enriched" "Detected in some" 4 "HEL: 61.7;SCLC-21H: 71.8;SH-SY5Y: 115.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002745, HPA040945, HPA044249" Enhanced Supported "Nuclear bodies,Endoplasmic reticulum" NA NA 150000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Endoplasmic reticulum" "Nuclear bodies" "CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874" "unprognostic (9.40e-3)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (4.24e-2)" "unprognostic (3.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (2.79e-1)" "prognostic favorable (3.69e-4)" "unprognostic (5.79e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.75e-1)" "unprognostic (6.71e-2)" "unprognostic (1.62e-2)" 11.1 12.0 111.1 9.3 127.5 0.4 7.2 57.0 134.7 2.2 0.0 7.6 2.5 1.3 0.4 1.6 12.8 5.5 0.9 133.0 160.6 1.6 1.0 6.4 2.7 37.5 24.9 0.7 4.0 17.4 60.1 2.4 46.7 6.4 2.8 34.1 3.4 1.9 0.8 3.2 4.1 2.4 10.8 18.3 3.9 2.3 68.3 1.0 2.5 0.7 1.8 1.9 3.6 50.2 0.0 0.0 0.7 1.0 2.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.1 0.4 0.0 2.1 61.7 0.0 0.0 3.4 0.1 0.2 0.0 0.1 0.0 2.1 0.0 0.5 0.4 0.0 0.3 0.7 0.3 0.0 0.0 4.9 0.0 0.0 0.0 0.6 0.1 0.0 0.0 71.8 115.1 14.9 0.0 0.0 0.2 0.0 0.0 0.0 9.9 2.8 0.1 5.6 0.0 0.0 0.0 19.4 4.4 0.7 0.0 2.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.7 111.1 127.5 57.0 134.7 133.0 160.6 37.5 24.9 46.7 10.8 68.3 50.2 1.0 0.0 1.1 64.3 0.5 4.8 0.4 0.0 0.0 34.1 11.4 4.3 1.0 1.5 0.6 0.0 25.0 1.2 1.4 0.8 0.0 0.0 16.2 23.5 0.3 2.9 54.2 0.8 495.8 0.0 5.0 1.5 5.6 0.4 0.0 0.2 0.0 0.5 17.8 240.6 394.3 3.6 0.0 14.4 59.7 21.4 2.8 23.8 10.6 87.1 22.8 14.3 0.0 188.0 247.7 1.4 0.1 1.2 0.1 5.8 0.8 0.9 0.7 33.3 0.0 10.7 2.5 2.3 3.8 0.2 6.5 2.5 0.7 0.1 0.5 0.3 RUNDC3A "RAP2IP, RPIP8" ENSG00000108309 "RUN domain containing 3A" Q59EK9 17 44308413-44318670 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 208.4;pituitary gland: 98.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 55.4;Early spermatids: 24.4;Enteroendocrine cells: 39.0;Excitatory neurons: 46.1;Horizontal cells: 32.0;Inhibitory neurons: 30.4;Late spermatids: 83.4" "Group enriched" "Detected in many" 5 "glioma: 8.6;pancreatic cancer: 3.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 62.5;SH-SY5Y: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023548, HPA070733" Enhanced Supported Enhanced Vesicles NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Vesicles "HPA023548: AB_1856069, HPA070733: AB_2732162" "unprognostic (3.66e-2)" "unprognostic (3.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.58e-3)" "unprognostic (3.04e-1)" "unprognostic (2.02e-1)" "unprognostic (3.87e-3)" "unprognostic (2.29e-1)" "unprognostic (4.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.42e-3)" "unprognostic (1.34e-1)" "unprognostic (8.87e-3)" "unprognostic (1.07e-2)" "unprognostic (5.17e-2)" "unprognostic (9.39e-2)" "unprognostic (1.84e-1)" 0.3 14.3 149.2 0.4 159.5 2.3 0.3 93.0 208.4 0.2 45.6 3.4 1.2 0.5 0.2 0.8 0.2 0.3 1.8 169.4 105.3 1.8 0.2 0.4 0.2 108.0 106.4 0.8 3.8 3.1 98.3 1.5 108.5 0.8 0.6 31.2 0.3 0.3 0.1 7.9 1.3 0.5 79.2 1.6 2.3 15.2 109.4 0.4 1.4 0.3 0.1 0.2 0.7 135.7 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 4.3 0.0 1.4 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 8.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.9 0.2 0.0 0.5 0.3 0.3 0.1 0.1 1.1 0.3 0.1 62.5 40.3 0.3 0.0 0.3 0.1 0.5 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.2 159.5 93.0 208.4 169.4 105.3 108.0 106.4 108.5 79.2 109.4 135.7 0.1 0.0 0.6 17.3 0.0 0.3 0.3 0.0 0.0 55.4 0.2 0.3 1.1 0.0 0.0 0.0 6.2 0.0 0.0 0.0 3.9 1.3 24.4 0.2 0.3 0.2 39.0 18.7 46.1 3.1 0.0 1.0 0.0 0.2 0.0 0.5 0.4 0.0 0.2 32.0 30.4 0.5 4.1 0.3 0.5 83.4 1.5 0.3 0.0 4.7 0.1 6.5 1.0 16.1 12.5 1.0 1.2 3.4 0.0 0.4 0.0 0.8 0.0 16.8 0.0 0.8 0.5 1.4 1.3 0.0 0.4 0.1 0.1 3.0 0.1 0.3 SBK1 Sbk ENSG00000188322 "SH3 domain binding kinase 1" Q52WX2 16 28259246-28323849 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.8;skeletal muscle: 44.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 81.3;Excitatory neurons: 38.2;Granulosa cells: 26.3;NK-cells: 36.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 28.8;AN3-CA: 20.9;NTERA-2: 29.6;REH: 32.6;SCLC-21H: 45.5;SH-SY5Y: 42.6" "Region enriched" "Detected in all" 5 "cerebellum: 275.9" "Low region specificity" "Detected in all" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (5.15e-2)" "prognostic favorable (6.88e-4)" "unprognostic (2.08e-1)" "unprognostic (6.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.71e-2)" "unprognostic (5.71e-3)" "unprognostic (3.66e-3)" "unprognostic (1.17e-1)" "unprognostic (1.62e-2)" "unprognostic (2.87e-2)" "unprognostic (6.38e-2)" "unprognostic (1.19e-3)" "unprognostic (3.99e-2)" "unprognostic (3.50e-2)" "unprognostic (7.91e-2)" "unprognostic (5.03e-3)" 0.1 2.4 8.0 0.9 7.0 1.3 0.8 26.8 15.0 0.7 0.0 0.3 0.3 0.9 0.4 0.6 0.7 0.2 2.1 11.6 6.7 1.8 0.2 0.8 1.7 6.6 7.6 0.5 1.9 2.9 5.6 0.0 6.7 1.5 0.3 5.0 2.7 0.2 44.1 1.1 0.6 0.1 3.2 1.9 0.8 2.5 12.8 10.0 2.5 9.1 0.8 0.3 0.3 7.9 0.3 0.4 28.8 20.9 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.2 1.4 0.7 0.2 0.0 0.4 0.5 8.8 0.2 0.1 3.0 1.2 0.1 0.3 0.9 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.2 0.2 11.2 0.0 1.8 0.0 3.6 14.0 0.3 29.6 1.9 0.2 32.6 1.6 0.6 0.1 1.8 45.5 42.6 0.8 2.7 0.4 3.5 3.3 0.1 0.8 0.1 4.3 0.4 0.2 0.3 0.0 0.5 0.1 0.5 1.6 0.3 0.0 0.0 1.5 0.0 0.5 0.0 0.4 0.8 0.0 0.1 0.4 1.0 0.0 0.7 0.0 0.0 0.5 0.1 8.0 7.0 26.8 15.0 11.6 6.7 6.6 7.6 6.7 3.2 12.8 7.9 0.2 3.2 0.5 1.0 0.6 0.6 0.7 1.4 3.4 13.0 6.3 2.9 3.6 2.8 2.5 0.0 81.3 0.0 11.1 0.1 1.9 8.2 1.2 2.4 0.3 0.3 6.0 0.4 38.2 5.6 0.0 0.4 0.0 1.8 0.0 26.3 0.0 0.2 0.1 0.0 13.8 0.8 4.1 0.0 0.8 3.9 0.6 0.4 0.0 0.0 0.7 4.1 36.0 5.0 1.7 3.6 0.0 0.0 2.3 1.5 0.1 0.7 1.7 2.7 0.0 2.5 2.7 2.4 2.1 1.0 0.1 0.1 5.6 0.2 1.2 0.4 SCAMP5 MGC24969 ENSG00000198794 "Secretory carrier membrane protein 5" Q8TAC9 15 74957219-75021495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 179.9;parathyroid gland: 103.1;retina: 283.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 113.3;Cone photoreceptor cells: 125.1;Enteroendocrine cells: 62.5;Excitatory neurons: 75.1;Horizontal cells: 70.7;Inhibitory neurons: 99.3;Rod photoreceptor cells: 168.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 33 "plasmacytoid DC: 27.7" "Lineage enriched" "Detected in single" 33 "dendritic cells: 27.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 88.1;SH-SY5Y: 49.3;THP-1: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046645 Enhanced NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA046645: AB_2679734" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-2)" "unprognostic (2.74e-1)" "unprognostic (4.46e-2)" "unprognostic (2.56e-1)" "unprognostic (4.13e-1)" "unprognostic (2.34e-1)" "unprognostic (8.37e-2)" "prognostic favorable (5.67e-5)" "unprognostic (9.82e-2)" "prognostic favorable (1.34e-6)" "unprognostic (7.27e-2)" "unprognostic (3.01e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-2)" 3.0 20.6 106.7 4.3 125.2 2.6 3.1 75.1 179.9 2.8 12.5 5.8 41.6 5.7 3.6 1.5 5.0 5.6 5.5 128.7 74.8 16.7 4.2 2.8 7.9 113.9 67.4 6.0 53.4 103.1 67.7 6.7 112.5 4.6 4.9 283.7 7.2 2.7 0.6 2.1 30.4 3.2 35.8 8.5 15.6 10.7 80.6 4.4 6.5 0.8 10.0 5.9 1.8 124.4 1.5 17.8 3.8 12.6 0.3 0.2 0.5 0.4 0.6 4.0 1.4 4.9 8.9 28.0 8.5 1.1 3.3 1.2 15.6 1.1 1.4 4.4 2.0 3.5 2.1 25.8 2.7 0.4 11.5 1.3 2.1 1.0 0.3 2.8 1.7 10.1 0.2 22.1 1.0 15.1 1.1 10.2 13.4 2.1 7.1 0.4 3.2 6.7 1.0 8.6 88.1 49.3 19.8 13.6 27.6 2.7 7.7 34.0 1.1 1.2 8.2 1.6 1.3 1.8 2.4 2.6 3.0 21.2 4.3 0.6 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.8 0.4 0.1 27.7 0.0 0.4 106.7 125.2 75.1 179.9 128.7 74.8 113.9 67.4 112.5 35.8 80.6 124.4 2.2 0.0 1.1 14.7 2.5 0.3 0.5 0.4 2.8 113.3 3.2 2.7 3.0 7.2 0.4 5.5 125.1 0.1 35.5 2.9 1.9 4.4 0.5 0.4 0.7 3.6 62.5 0.0 75.1 43.3 0.3 1.9 12.8 0.3 0.0 4.1 6.8 0.6 13.8 70.7 99.3 5.0 0.0 6.9 0.2 0.7 2.1 2.0 1.8 6.5 0.4 29.9 0.0 32.2 26.2 6.8 5.3 6.4 8.9 0.8 34.0 13.0 2.7 168.0 0.0 0.9 2.8 1.8 4.7 1.7 0.1 0.1 0.6 2.0 2.7 0.3 SCG5 "7B2, SGNE1, SgV" ENSG00000166922 "Secretogranin V" P05408 15 32641676-32697098 "Predicted secreted proteins" Transport "Chaperone, Neuropeptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 133.0;pituitary gland: 402.7" "Cell type enriched" "Detected in many" 4 "Enteroendocrine cells: 470.8" "Group enriched" "Detected in many" 5 "glioma: 38.2;pancreatic cancer: 82.9;thyroid cancer: 22.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 26.9;HSkMC: 33.5;NTERA-2: 15.3;SCLC-21H: 31.5;SH-SY5Y: 36.4;U-87 MG: 47.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013136, HPA074618" Enhanced "Secreted to blood" NA NA 100000 "Cluster 32: T-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "HPA013136: AB_1856657, HPA074618: AB_2732262" "unprognostic (1.71e-1)" "unprognostic (9.87e-2)" "unprognostic (7.94e-2)" "unprognostic (1.30e-2)" "unprognostic (3.59e-3)" "prognostic unfavorable (9.64e-4)" "unprognostic (2.69e-1)" "unprognostic (1.27e-3)" "unprognostic (4.69e-2)" "unprognostic (1.97e-1)" "unprognostic (5.62e-3)" "unprognostic (3.92e-1)" "prognostic unfavorable (4.51e-9)" "unprognostic (3.57e-2)" "unprognostic (8.13e-2)" "unprognostic (3.08e-3)" "unprognostic (8.88e-2)" 1.7 61.1 54.0 3.3 62.0 0.3 3.7 52.2 100.4 1.0 77.3 7.9 17.9 5.3 42.5 0.5 3.4 5.5 1.3 58.9 75.1 0.9 3.6 3.8 1.3 56.5 48.3 3.2 133.0 73.7 402.7 0.3 58.7 5.0 9.8 26.7 0.2 0.9 0.2 1.3 5.6 6.7 57.7 0.5 37.8 5.3 56.3 0.3 5.8 0.1 0.3 2.6 2.7 58.9 0.5 0.2 0.1 0.2 0.6 4.5 0.1 4.2 0.4 0.4 0.4 0.1 0.0 0.5 1.9 0.4 1.7 1.2 0.5 0.2 1.2 0.7 0.3 0.6 0.0 0.1 26.9 0.2 0.7 33.5 0.1 0.8 0.4 0.9 0.7 1.0 0.3 0.6 0.8 0.0 0.3 0.3 15.3 0.1 0.8 0.1 0.4 0.6 0.4 0.0 31.5 36.4 0.2 0.0 0.2 0.4 0.1 0.4 0.0 5.2 3.8 0.3 0.5 0.6 2.3 0.4 47.2 1.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 62.0 52.2 100.4 58.9 75.1 56.5 48.3 58.7 57.7 56.3 58.9 0.2 0.0 0.5 20.2 0.3 0.6 0.2 6.2 0.0 51.0 0.5 16.5 0.4 0.0 3.9 0.0 2.1 0.2 0.1 1.1 0.0 0.6 52.1 3.7 19.3 1.1 470.8 0.0 82.8 78.3 0.3 17.9 23.0 0.6 2.5 51.4 0.4 11.9 6.0 50.5 97.8 14.5 97.6 0.6 0.8 80.0 2.1 1.6 3.6 20.6 0.6 15.6 0.0 52.3 79.7 22.9 1.1 7.9 0.3 1.4 0.5 0.0 0.5 32.6 0.0 0.3 34.2 39.2 2.9 0.1 0.3 0.3 0.3 51.8 2.4 1.0 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 81.0;choroid plexus: 28.9;heart muscle: 80.4;skeletal muscle: 101.3;tongue: 92.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 14.2;Horizontal cells: 15.2;Skeletal myocytes: 7.0" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 6.9" "Group enriched" "Detected in many" 46 "dendritic cells: 6.9;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "AF22: 27.0;AN3-CA: 49.2;HUVEC TERT2: 58.3;NTERA-2: 29.8;SH-SY5Y: 167.0" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: AB_2732142" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favorable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 2.9 46.5 0.2 56.3 0.8 1.2 52.6 55.0 2.5 28.9 11.1 1.0 3.9 0.7 3.4 2.3 1.9 80.4 50.0 48.7 2.5 0.7 2.9 0.5 51.0 48.2 0.5 0.4 0.2 11.8 10.9 52.6 5.6 1.1 3.6 1.9 1.4 101.3 0.4 3.6 5.4 55.6 4.8 4.6 1.9 46.9 0.8 0.8 92.8 0.2 0.7 1.2 81.0 0.1 0.0 27.0 49.2 0.0 0.2 0.0 0.2 0.1 0.1 1.1 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 2.4 0.0 1.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.7 1.1 0.3 11.2 0.4 58.3 0.0 0.0 0.1 3.5 0.0 0.0 0.0 29.8 0.0 0.0 0.0 5.5 0.0 1.3 0.0 0.0 167.0 0.0 0.0 0.2 7.0 0.0 3.1 10.9 0.6 1.5 0.4 2.5 2.1 0.0 0.0 0.7 2.0 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 46.5 56.3 52.6 55.0 50.0 48.7 51.0 48.2 52.6 55.6 46.9 81.0 4.5 6.4 1.7 0.0 0.1 0.4 4.8 2.5 1.2 5.4 0.6 0.8 14.2 0.0 2.2 3.7 2.1 1.5 2.7 0.1 0.0 0.3 0.0 4.4 0.4 6.0 0.0 2.1 0.0 0.2 0.5 1.6 0.0 3.1 0.0 0.1 2.2 0.5 0.2 15.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 3.6 0.0 0.0 3.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.6 0.0 1.4 3.7 0.6 0.0 7.0 2.9 0.0 0.4 0.4 0.6 0.8 0.2 0.2 0.0 1.4 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.2;pituitary gland: 28.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 31.6;Excitatory neurons: 58.8;Horizontal cells: 20.2;Inhibitory neurons: 35.7;Late spermatids: 31.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Group enriched" "Detected in many" 8 "amygdala: 34.3;basal ganglia: 40.6;cerebral cortex: 49.7;hippocampal formation: 54.2;white matter: 15.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.8;GAMG: 1.8;hTCEpi: 5.8;RH-30: 2.0;SCLC-21H: 5.5;SH-SY5Y: 4.5" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "hippocampal formation: 166.1" HPA041707 Approved "Intermediate filaments,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Intermediate filaments" Cytosol "HPA041707: AB_2732493" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 1.9 8.4 34.3 0.6 40.6 0.4 1.8 0.0 49.7 1.0 0.0 1.4 0.8 1.5 0.7 0.7 1.2 0.5 1.4 54.2 2.4 1.4 0.1 1.0 0.3 0.0 4.7 1.0 1.1 4.4 28.0 0.1 0.5 0.8 0.8 10.0 0.7 0.5 14.1 1.5 1.3 1.4 0.9 0.5 0.7 2.2 0.9 0.2 4.1 3.3 0.2 0.8 1.0 15.3 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.9 0.1 1.8 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 5.8 0.1 0.1 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.0 0.0 0.0 0.1 5.5 4.5 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 34.3 40.6 0.0 49.7 54.2 2.4 0.0 4.7 0.5 0.9 0.9 15.3 7.7 0.0 0.5 3.9 0.0 5.7 1.1 0.0 1.2 31.6 1.3 1.0 2.1 0.0 0.0 1.8 6.2 0.1 0.0 0.3 0.0 0.3 13.9 0.2 0.3 13.0 4.2 0.0 58.8 1.0 0.1 1.5 0.0 0.2 0.0 1.4 5.3 0.0 0.2 20.2 35.7 0.0 0.0 0.0 2.3 31.3 0.0 0.4 0.0 5.6 0.0 6.3 1.0 4.5 2.5 0.3 0.0 0.4 0.0 1.0 0.1 0.5 0.0 6.0 6.6 5.7 0.8 1.0 2.0 0.4 5.5 0.0 0.1 1.4 0.1 0.5 SCRN3 FLJ23142 ENSG00000144306 "Secernin 3" Q0VDG4 2 174395730-174429575 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034689, HPA034690" Approved Approved Vesicles,Cytosol NA NA 27000 "Cluster 1: Neutrophils - Mixed function" "Cluster 8: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Vesicles, Cytosol" "HPA034689: AB_2674282, HPA034690: AB_10670574" "unprognostic (5.39e-3)" "unprognostic (4.58e-2)" "unprognostic (2.06e-2)" "unprognostic (3.58e-1)" "unprognostic (1.91e-1)" "unprognostic (1.89e-1)" "unprognostic (9.89e-2)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (5.85e-2)" "unprognostic (8.81e-2)" "unprognostic (1.30e-1)" "unprognostic (6.62e-3)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" 16.4 16.4 11.8 9.9 14.4 5.2 13.5 14.7 16.0 9.5 7.0 12.9 18.5 11.9 11.4 16.2 10.4 11.2 26.0 10.8 13.6 20.2 22.0 12.2 11.4 14.6 13.4 13.2 14.7 27.7 14.0 13.1 13.6 15.2 13.2 22.8 11.0 12.5 40.5 13.8 14.3 14.0 12.9 11.8 12.4 10.6 14.1 12.4 20.3 35.8 12.1 10.4 8.3 18.5 15.9 9.7 25.8 22.8 18.8 21.1 13.7 24.1 19.0 18.2 22.0 9.6 11.4 3.0 15.6 24.2 14.0 15.5 19.3 21.1 23.9 34.8 17.8 29.7 21.1 7.5 27.8 22.8 15.0 23.5 25.4 34.4 24.5 20.4 21.8 16.7 20.2 11.1 25.0 18.0 18.9 22.2 12.0 35.4 41.0 9.3 25.7 17.5 21.2 16.5 16.0 44.5 16.6 16.2 30.7 26.4 21.8 21.7 15.7 20.9 10.9 25.6 21.0 29.4 32.8 0.5 22.9 11.2 21.8 7.2 5.2 2.2 4.8 3.3 3.4 8.6 5.1 4.6 5.1 11.0 7.8 6.3 20.0 6.9 4.3 8.0 5.6 2.6 11.8 14.4 14.7 16.0 10.8 13.6 14.6 13.4 13.6 12.9 14.1 18.5 7.8 9.6 15.6 18.6 7.0 3.6 12.1 23.7 12.5 12.8 7.9 6.3 22.8 4.3 12.5 9.2 10.4 10.7 3.8 8.4 13.7 9.1 5.1 9.4 8.3 6.0 6.0 11.6 21.0 9.8 6.3 6.9 11.2 5.4 8.8 9.5 8.6 8.7 9.3 18.5 26.3 7.3 20.3 5.8 2.2 4.0 4.7 6.2 3.6 6.5 6.1 22.6 7.2 27.6 25.7 12.2 4.0 6.8 10.3 5.4 9.9 12.5 13.6 15.0 0.0 8.2 7.1 18.9 7.1 20.4 4.8 6.8 5.8 13.0 6.4 9.7 SETD6 FLJ21148 ENSG00000103037 "SET domain containing 6, protein lysine methyltransferase" Q8TBK2 16 58515479-58523842 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041481, HPA053546" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA041481: AB_10804004, HPA053546: AB_2682182" "unprognostic (1.32e-1)" "unprognostic (2.98e-3)" "unprognostic (3.35e-1)" "unprognostic (2.81e-1)" "unprognostic (7.90e-3)" "unprognostic (1.95e-1)" "unprognostic (1.93e-3)" "unprognostic (1.65e-1)" "unprognostic (3.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (3.74e-3)" "unprognostic (2.14e-1)" "unprognostic (3.73e-1)" "unprognostic (5.93e-3)" "unprognostic (1.55e-1)" 8.6 12.4 3.8 2.9 3.6 2.6 9.1 8.9 4.6 9.4 3.9 8.4 3.8 8.4 5.4 13.4 9.7 2.7 11.3 3.9 3.8 12.5 13.5 7.0 4.6 3.8 3.5 9.1 19.6 6.5 12.5 2.5 3.9 10.9 4.3 7.9 11.1 5.9 15.0 14.6 9.2 3.3 3.5 10.6 11.4 12.7 3.8 2.8 12.2 3.9 4.4 8.3 10.8 3.8 2.5 6.1 1.3 10.7 4.3 2.8 15.9 4.0 5.4 7.1 3.8 10.1 6.1 19.9 5.4 4.6 0.9 8.1 9.0 6.3 4.9 2.2 23.6 0.9 11.0 17.2 4.3 14.4 7.8 3.8 13.2 5.6 8.8 4.8 4.5 0.2 14.7 2.6 1.5 10.1 0.3 17.7 21.0 9.7 9.6 0.4 2.5 26.7 7.3 0.4 19.6 12.6 16.8 15.9 7.8 6.2 10.0 2.0 3.7 2.5 6.0 3.1 7.3 11.7 8.1 13.7 5.3 6.9 4.6 2.5 1.1 0.2 2.0 1.5 1.4 1.5 1.6 2.2 1.8 1.5 2.0 2.2 0.7 4.4 1.6 2.0 1.6 1.3 3.8 3.6 8.9 4.6 3.9 3.8 3.8 3.5 3.9 3.5 3.8 3.8 5.2 6.4 6.9 6.8 7.1 13.9 10.5 7.5 13.6 14.3 12.0 11.0 7.6 17.2 8.5 9.2 14.6 17.5 8.6 5.3 1.9 10.1 9.2 10.8 6.9 6.8 4.8 10.3 11.5 12.2 9.9 8.4 8.2 10.0 1.3 14.9 4.2 7.9 3.5 11.8 11.3 5.0 2.0 3.5 5.6 16.9 9.0 3.4 5.4 5.6 5.6 15.0 6.2 7.5 4.7 6.1 4.2 10.1 6.8 13.8 6.5 9.4 12.0 13.4 13.1 10.1 7.4 15.0 22.9 12.1 12.1 12.6 7.1 6.1 7.4 6.2 SH2D7 LOC646892 ENSG00000183476 "SH2 domain containing 7" A6NKC9 15 78077808-78104909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "intestine: 2.1;testis: 3.1" "Group enriched" "Detected in some" 4 "Early spermatids: 21.1;Late spermatids: 35.1" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA051320, HPA058382, HPA076728" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 45: Intestine - Brush border" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" Nucleoli "Nucleoplasm, Cytosol" "HPA051320: AB_2681439, HPA058382: , HPA076728: " "unprognostic (1.22e-2)" "unprognostic (4.31e-2)" "unprognostic (2.24e-1)" "unprognostic (1.24e-2)" "unprognostic (2.53e-1)" "unprognostic (1.42e-1)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-3)" "unprognostic (4.73e-2)" "unprognostic (2.92e-1)" "unprognostic (2.32e-3)" "unprognostic (5.15e-3)" "unprognostic (1.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 1.6 2.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.1 1.7 0.1 0.2 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.7 1.3 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 21.1 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.0 3.0 0.0 0.0 0.4 0.0 SHC1 "p66, SHC, ShcA" ENSG00000160691 "SHC adaptor protein 1" P29353 1 154962298-154974395 "Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Growth regulation, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001844, CAB005374, CAB016305" Supported Enhanced Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "CAB005374: AB_632395, CAB016305: AB_628249, HPA001844: AB_1856826" "unprognostic (4.12e-2)" "prognostic unfavorable (6.74e-4)" "unprognostic (1.10e-2)" "unprognostic (3.77e-2)" "unprognostic (6.40e-2)" "unprognostic (4.08e-3)" "unprognostic (2.94e-3)" "prognostic unfavorable (1.92e-4)" "unprognostic (9.13e-2)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.22e-16)" "unprognostic (7.19e-2)" "unprognostic (1.40e-1)" "unprognostic (9.21e-2)" "unprognostic (1.31e-1)" 147.4 103.8 30.9 90.3 29.8 72.8 126.7 28.9 32.0 91.3 32.2 71.8 72.1 86.0 53.7 73.5 87.5 88.8 67.0 28.0 33.2 71.4 94.5 106.3 50.6 36.2 32.6 70.7 57.7 61.8 120.5 77.0 36.4 85.0 70.9 16.5 58.7 70.2 63.3 59.2 73.0 107.6 32.7 72.8 69.7 23.3 39.5 47.4 86.4 56.2 52.8 96.6 83.2 30.4 110.8 223.7 168.9 272.3 180.6 359.3 88.6 393.5 355.3 223.6 168.7 80.2 258.5 59.3 314.0 476.4 64.1 92.9 45.5 389.6 200.2 72.7 25.0 152.0 185.7 143.9 471.1 49.3 164.8 538.3 452.4 279.4 344.0 605.8 497.7 25.0 68.2 461.3 473.8 90.0 56.8 29.8 147.9 89.7 94.2 51.1 56.1 122.6 107.1 82.5 21.6 582.1 234.8 130.2 126.3 293.3 189.8 102.9 595.6 349.6 217.5 75.1 209.0 206.6 146.2 101.7 341.4 65.9 463.5 32.4 36.7 58.0 39.0 47.7 38.7 22.4 30.7 34.6 38.0 20.8 24.6 22.4 29.2 23.2 48.2 17.5 24.6 39.1 30.9 29.8 28.9 32.0 28.0 33.2 36.2 32.6 36.4 32.7 39.5 30.4 86.0 28.9 23.6 7.5 14.1 35.7 54.5 76.5 40.9 5.1 24.0 30.6 2.2 20.0 19.1 5.5 6.2 25.7 13.1 44.1 7.9 29.0 0.7 14.7 58.8 88.0 12.6 16.0 5.4 28.0 58.0 36.3 26.0 26.9 17.7 16.8 77.8 44.5 23.3 25.2 3.7 24.5 34.6 22.3 25.1 2.7 23.0 19.5 17.8 2.8 14.5 8.7 11.3 4.5 2.1 34.0 27.6 34.6 29.1 53.5 34.4 9.6 13.0 7.4 19.7 22.7 35.7 3.8 4.9 26.9 36.4 60.9 16.2 24.5 22.4 50.0 SHC2 "SCK, SHCB, SLI" ENSG00000129946 "SHC adaptor protein 2" P98077 19 416583-460996 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 109.8" "Cell type enhanced" "Detected in many" "Adipocytes: 44.8;Hepatic stellate cells: 45.3;Hepatocytes: 56.7;Horizontal cells: 48.8;Oligodendrocyte precursor cells: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.9;HHSteC: 5.6;SCLC-21H: 12.6;SH-SY5Y: 11.4" HPA006136 Approved Approved Cytosol NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 2: Hepatocytes - Metabolism" Cytosol "HPA006136: AB_1856827" "unprognostic (2.54e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (4.58e-4)" "unprognostic (6.40e-2)" "unprognostic (1.64e-1)" "unprognostic (1.50e-1)" "unprognostic (6.71e-2)" "unprognostic (9.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.36e-1)" "prognostic favorable (8.53e-4)" "unprognostic (4.45e-2)" "unprognostic (5.30e-2)" "unprognostic (1.99e-2)" "unprognostic (3.37e-1)" "unprognostic (8.86e-2)" "unprognostic (4.43e-2)" 16.0 19.9 21.4 1.6 17.9 0.1 17.5 9.5 31.1 28.2 5.1 22.0 6.3 24.2 2.0 5.0 23.6 10.9 18.2 17.0 32.0 12.2 63.8 17.3 1.7 24.9 18.6 14.1 109.8 7.0 48.0 7.6 19.6 32.6 0.4 1.2 24.5 5.1 5.0 10.2 10.6 2.9 15.7 26.6 21.4 9.6 29.0 0.3 32.7 1.2 0.3 10.0 11.7 19.0 0.0 0.1 0.4 0.1 0.0 0.0 0.6 0.5 2.5 0.3 0.0 0.0 0.4 0.0 4.9 0.0 1.2 0.4 1.1 0.0 0.0 1.1 1.7 0.0 0.0 2.8 5.6 0.0 1.9 0.3 0.0 0.0 0.0 2.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 1.9 0.0 12.6 11.4 0.0 0.0 0.0 2.3 0.3 2.0 0.0 0.5 3.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 17.9 9.5 31.1 17.0 32.0 24.9 18.6 19.6 15.7 29.0 19.0 44.8 6.4 8.8 33.3 0.5 1.9 2.0 0.8 0.6 11.4 11.3 10.0 9.9 18.6 1.5 0.0 2.1 0.1 0.9 0.1 0.0 25.2 2.5 2.8 4.9 16.6 8.4 2.7 22.1 38.5 0.1 9.5 3.6 4.1 0.0 15.4 45.3 56.7 0.9 48.8 33.1 3.5 6.1 5.3 1.7 7.2 9.0 0.4 8.8 15.0 1.0 29.5 0.0 49.8 28.4 21.1 0.1 11.3 0.2 11.3 0.3 0.4 1.4 3.5 0.0 4.5 13.8 14.7 11.0 0.4 3.1 0.0 1.0 1.6 0.9 3.7 SHD ENSG00000105251 "Src homology 2 domain containing transforming protein D" Q96IW2 19 4279266-4290722 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 10.0;heart muscle: 17.8" "Cell type enhanced" "Detected in some" "Distal enterocytes: 137.5;Hepatocytes: 57.3;Intestinal goblet cells: 54.6;Paneth cells: 78.8;Proximal enterocytes: 43.1;Undifferentiated cells: 49.4" "Cancer enhanced" "Detected in some" "glioma: 11.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 178 "plasmacytoid DC: 17.8" "Lineage enriched" "Detected in single" 178 "dendritic cells: 17.8" "Group enriched" "Detected in some" 45 "RH-30: 58.4;SH-SY5Y: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017955 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "Centriolar satellite, Cytosol" "HPA017955: AB_1856828" "unprognostic (2.41e-3)" "unprognostic (7.68e-3)" "unprognostic (4.77e-3)" "unprognostic (3.67e-2)" "unprognostic (3.48e-2)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "unprognostic (1.43e-1)" "unprognostic (5.93e-2)" "unprognostic (3.73e-1)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (3.48e-1)" "unprognostic (1.21e-1)" "unprognostic (5.21e-2)" "unprognostic (9.69e-2)" "unprognostic (8.16e-4)" 0.0 0.1 4.2 0.6 3.6 0.7 0.0 7.0 8.6 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.1 17.8 2.4 9.6 0.0 1.5 0.0 0.6 7.4 6.4 0.0 0.0 0.1 0.2 0.0 5.6 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.2 0.0 4.6 0.1 0.0 0.1 10.0 0.1 0.0 1.7 0.3 0.1 0.0 6.0 0.0 0.0 0.7 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.2 58.4 0.1 0.0 0.0 0.5 193.2 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 4.2 3.6 7.0 8.6 2.4 9.6 7.4 6.4 5.6 4.6 10.0 6.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 1.8 21.7 137.5 1.9 0.0 0.1 0.1 0.0 0.2 13.2 5.3 2.8 0.0 0.6 0.4 0.0 0.1 8.9 0.0 0.7 57.3 0.4 10.1 4.2 54.6 0.0 0.6 0.0 0.4 0.0 0.6 0.0 1.0 0.2 0.9 0.0 9.0 0.3 0.0 78.8 0.0 0.0 0.0 43.1 0.0 0.0 0.4 0.0 2.5 0.1 0.0 2.9 0.0 0.0 4.4 0.8 0.0 49.4 0.0 SLC10A4 MGC29802 ENSG00000145248 "Solute carrier family 10 member 4" Q96EP9 4 48483343-48489526 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 36.8" "Cell type enriched" "Detected in some" 4 "Inhibitory neurons: 16.2" "Group enriched" "Detected in many" 4 "endometrial cancer: 1.8;glioma: 5.9" "Region enhanced" "Detected in many" "midbrain: 36.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 9.2;HEL: 5.3;K-562: 13.1;SH-SY5Y: 32.1" "Group enriched" "Detected in many" 4 "basal ganglia: 26.2;hypothalamus: 10.7;midbrain: 26.5;pons and medulla: 13.2;thalamus: 8.4" "Group enriched" "Detected in many" 5 "basal ganglia: 14.2;midbrain: 56.7;pons: 23.5;spinal cord: 44.7" HPA028835 Uncertain Supported NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA028835: AB_10603025" "unprognostic (4.06e-1)" "unprognostic (1.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.46e-2)" "unprognostic (5.41e-2)" "unprognostic (3.67e-1)" "unprognostic (1.86e-1)" "unprognostic (4.08e-3)" "unprognostic (9.98e-3)" "unprognostic (1.46e-1)" "unprognostic (3.50e-1)" "unprognostic (5.14e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (8.73e-2)" 0.1 2.7 0.5 0.2 1.8 1.1 0.1 0.0 4.6 0.9 0.0 1.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.2 9.0 0.2 0.1 0.2 0.0 8.6 36.8 0.1 0.1 0.0 6.7 0.0 23.3 0.2 0.1 0.1 1.4 0.0 0.1 0.1 0.4 0.1 0.6 0.1 0.5 0.4 3.8 0.0 0.4 0.0 0.0 0.1 0.6 2.6 0.0 3.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 1.0 0.0 9.2 0.0 0.1 0.0 2.8 5.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.9 32.1 0.4 0.0 0.1 0.3 0.0 4.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.0 4.6 0.2 9.0 8.6 36.8 23.3 0.6 3.8 2.6 0.4 0.0 3.2 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.1 1.7 0.1 0.2 0.4 0.0 3.0 0.6 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 16.2 0.0 0.0 0.0 0.4 2.4 0.3 0.0 0.0 1.0 0.1 0.0 0.0 4.0 0.5 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.7 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 SLC18A1 "CGAT, VAT1, VMAT1" ENSG00000036565 "Solute carrier family 18 member A1" P54219 8 20144855-20183206 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "adrenal gland: 25.1" "Cell type enriched" "Detected in some" 27 "Enteroendocrine cells: 139.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.8" "Region enriched" "Detected in single" 19 "midbrain: 3.9" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 2.8" "Lineage enriched" "Detected in single" 19 "monocytes: 2.8" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 67.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA006877, HPA063797" Enhanced NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "HPA006877: AB_2667690, HPA063797: AB_2685125" "unprognostic (8.03e-4)" "unprognostic (1.02e-1)" "unprognostic (3.75e-3)" "unprognostic (3.50e-1)" "unprognostic (6.61e-2)" "unprognostic (3.09e-3)" "unprognostic (1.67e-1)" "unprognostic (2.16e-2)" "unprognostic (3.45e-2)" "unprognostic (1.48e-1)" "unprognostic (1.32e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-2)" "unprognostic (8.25e-2)" "unprognostic (4.41e-2)" "unprognostic (2.06e-1)" "unprognostic (1.05e-1)" 0.1 25.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 1.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 3.8 67.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 3.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 139.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 SLC18A3 VACHT ENSG00000187714 "Solute carrier family 18 member A3" Q16572 10 49610310-49612720 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 25.6" "Cell type enriched" "Detected in some" 4 "Fibroblasts: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 7.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "spinal cord: 78.1" CAB079011 Supported NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" "CAB079011: " "unprognostic (2.14e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (9.39e-2)" "unprognostic (4.55e-2)" "unprognostic (3.00e-1)" "unprognostic (5.85e-3)" "unprognostic (7.56e-2)" "unprognostic (1.16e-1)" 0.0 0.0 0.7 0.3 2.0 0.0 0.0 0.0 19.7 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 18.9 8.0 0.0 0.0 0.0 1.2 0.4 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 3.6 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 6.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.0 0.0 19.7 0.1 4.9 18.9 8.0 25.6 3.6 0.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 SLC22A17 "BOCT, BOIT, NGALR" ENSG00000092096 "Solute carrier family 22 member 17" Q8WUG5 14 23346306-23352912 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 304.0;choroid plexus: 372.6;pituitary gland: 149.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 71.4;Horizontal cells: 201.9;Inhibitory neurons: 111.1;Muller glia cells: 74.2;Oligodendrocyte precursor cells: 120.6" "Cancer enhanced" "Detected in all" "glioma: 51.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.7;AN3-CA: 31.4;ASC diff: 23.2;SH-SY5Y: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002728 Uncertain NA NA "Cluster 32: T-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA002728: AB_1079998" "unprognostic (9.34e-2)" "unprognostic (2.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.23e-3)" "unprognostic (2.85e-2)" "unprognostic (1.07e-1)" "unprognostic (2.31e-2)" "unprognostic (1.26e-2)" "unprognostic (4.23e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.73e-4)" "unprognostic (1.78e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (3.50e-2)" "unprognostic (1.23e-2)" "unprognostic (3.87e-2)" 7.3 30.1 159.4 3.9 159.6 0.6 11.8 98.0 159.1 25.4 372.6 24.6 4.6 14.8 10.3 4.4 19.1 6.4 22.0 145.5 304.0 16.3 2.5 8.3 3.4 165.6 143.8 17.0 17.2 11.4 149.1 5.0 145.5 39.8 2.4 26.4 25.4 25.7 1.5 7.6 10.2 7.0 125.5 4.2 13.3 8.9 231.8 1.7 19.1 2.7 1.6 15.2 17.9 139.5 0.0 1.9 20.7 31.4 23.2 11.4 3.4 7.5 11.6 2.5 1.9 0.0 1.9 0.0 2.8 11.0 6.6 0.4 0.7 0.5 0.0 0.0 1.4 4.4 0.0 0.2 13.1 0.0 4.4 16.7 1.2 2.6 0.0 11.3 0.8 9.1 0.0 0.2 3.8 3.2 0.1 0.2 11.3 0.0 0.0 0.0 0.7 0.2 0.0 2.0 19.9 41.5 5.8 0.0 0.0 4.0 3.5 0.6 0.0 2.9 8.9 16.6 0.0 0.1 3.2 0.0 1.9 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 159.4 159.6 98.0 159.1 145.5 304.0 165.6 143.8 145.5 125.5 231.8 139.5 7.7 0.0 2.7 46.7 2.3 12.6 18.6 2.6 12.5 53.0 23.4 30.1 10.0 2.8 5.5 20.2 43.8 2.4 1.0 0.0 1.9 0.7 0.2 1.8 10.6 12.0 20.8 1.7 71.4 1.3 4.9 21.7 3.6 0.6 4.5 12.0 16.8 0.9 1.0 201.9 111.1 0.0 0.0 0.6 5.1 2.3 21.1 1.2 7.2 19.7 0.7 74.2 0.0 120.6 49.2 1.5 0.0 42.9 9.2 31.3 0.0 16.9 3.2 69.0 0.0 14.1 18.0 1.1 2.3 3.0 10.9 4.8 2.0 4.5 0.3 6.1 SLC29A4 "ENT4, FLJ34923" ENSG00000164638 "Solute carrier family 29 member 4" Q7RTT9 7 5274369-5306912 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 43.3;choroid plexus: 55.5" "Group enriched" "Detected in many" 5 "Enteroendocrine cells: 103.2;Horizontal cells: 168.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 49.2;SH-SY5Y: 70.7;U-2 OS: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052829 Approved "Microtubules,Cytokinetic bridge" Yes No "Cluster 40: NK-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "Microtubules, Cytokinetic bridge" "HPA052829: AB_2681967" "unprognostic (6.04e-2)" "unprognostic (1.22e-2)" "unprognostic (8.49e-5)" "unprognostic (2.53e-1)" "unprognostic (1.47e-3)" "unprognostic (4.24e-2)" "unprognostic (9.59e-3)" "unprognostic (2.05e-1)" "unprognostic (2.55e-2)" "unprognostic (5.73e-2)" "prognostic favorable (4.52e-4)" "unprognostic (2.06e-1)" "unprognostic (3.02e-2)" "unprognostic (3.24e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-3)" "unprognostic (6.60e-2)" 43.3 8.2 13.2 0.7 16.2 0.6 13.3 16.0 20.0 4.9 55.5 3.1 4.6 5.4 5.0 1.1 4.0 1.6 3.7 26.3 28.5 7.9 9.2 0.9 0.2 23.2 26.1 2.2 15.4 1.7 3.6 0.6 23.6 5.8 1.8 4.1 1.3 0.7 2.6 3.0 5.5 1.8 17.2 1.6 6.5 2.6 30.0 0.3 9.7 0.4 0.1 2.4 2.0 7.4 0.0 21.7 12.6 49.2 0.6 0.2 2.4 1.8 0.1 1.6 0.9 12.3 0.4 0.0 2.4 1.9 8.1 0.3 4.8 0.4 0.5 0.1 2.8 0.2 0.7 18.3 3.8 0.2 3.0 1.5 16.2 0.3 0.9 2.9 1.5 4.5 3.6 0.1 1.2 10.8 2.0 0.9 16.0 1.5 1.3 8.3 2.1 1.9 3.2 0.5 8.4 70.7 1.3 4.4 0.9 10.7 5.5 5.9 0.7 17.3 23.4 1.6 0.5 1.1 0.0 0.1 2.2 0.7 8.0 0.8 0.3 0.2 0.2 0.1 0.4 0.2 0.1 0.2 0.1 0.4 0.2 0.2 1.3 1.6 0.1 0.3 0.1 0.1 13.2 16.2 16.0 20.0 26.3 28.5 23.2 26.1 23.6 17.2 30.0 7.4 0.5 3.2 0.5 8.8 0.0 0.1 0.2 0.1 0.0 6.9 0.7 0.6 2.5 0.0 0.2 0.0 16.7 0.3 0.2 6.3 0.0 5.3 0.1 3.3 3.0 0.6 103.2 0.0 2.4 0.2 0.4 2.2 2.0 0.7 0.0 25.7 0.0 1.0 0.4 168.2 14.3 4.4 0.0 0.3 0.7 0.7 0.3 0.3 0.0 0.0 0.1 4.8 0.0 4.0 0.6 1.4 0.5 0.4 0.1 2.3 0.8 0.2 1.4 1.6 0.0 0.5 2.2 0.4 4.2 0.1 0.3 0.3 0.3 1.7 1.0 0.2 SLC30A9 "C4orf1, GAC63, HUEL, ZNT9" ENSG00000014824 "Solute carrier family 30 member 9" Q6PML9 4 41990502-42090461 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transcription, Transcription regulation, Transport, Zinc transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004014 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 39: Non-specific - Basic cellular processes" "HPA004014: AB_1080005" "unprognostic (4.26e-2)" "unprognostic (2.20e-1)" "unprognostic (1.31e-3)" "unprognostic (1.44e-2)" "unprognostic (1.14e-1)" "unprognostic (1.01e-1)" "unprognostic (3.19e-2)" "unprognostic (1.82e-1)" "unprognostic (2.63e-2)" "unprognostic (1.43e-1)" "unprognostic (1.55e-1)" "unprognostic (6.99e-2)" "prognostic favorable (2.86e-14)" "unprognostic (4.67e-2)" "unprognostic (1.34e-1)" "unprognostic (2.22e-2)" "unprognostic (1.39e-2)" 8.8 15.4 11.4 6.9 12.4 5.8 13.8 12.0 16.1 11.8 12.2 13.4 12.6 10.3 16.0 9.3 9.9 8.6 21.1 12.8 11.9 30.5 14.2 8.9 7.4 11.1 11.3 11.1 12.9 22.7 14.6 9.4 11.6 13.6 13.9 19.8 12.2 10.0 14.7 9.6 11.6 8.5 10.9 7.9 12.9 6.8 11.5 9.1 17.3 20.5 7.8 9.5 8.0 11.7 12.7 6.2 20.3 23.2 15.3 21.3 11.4 17.3 20.8 14.8 17.5 6.4 16.2 13.0 12.2 20.0 19.1 6.3 17.3 14.3 21.1 4.4 10.2 14.9 10.7 10.9 27.1 20.8 10.3 17.0 14.4 12.7 16.5 23.8 16.3 12.9 20.4 6.0 26.2 6.1 12.0 19.6 15.6 19.7 8.5 5.9 18.4 10.8 30.2 10.6 22.5 25.3 12.3 13.5 15.9 14.3 17.2 15.5 17.7 17.4 10.1 17.6 20.3 11.9 9.5 12.3 23.8 17.4 15.5 3.1 1.8 1.0 1.2 2.3 1.3 1.3 1.3 1.5 2.5 1.1 1.7 1.4 0.8 2.1 1.9 1.8 1.6 1.4 11.4 12.4 12.0 16.1 12.8 11.9 11.1 11.3 11.6 10.9 11.5 11.7 19.7 48.1 44.5 48.3 26.5 15.2 22.8 24.7 24.5 34.9 30.3 16.9 90.7 32.9 33.8 38.6 25.0 44.4 11.4 33.8 103.7 35.9 7.1 27.3 29.2 22.1 33.5 32.2 70.0 36.4 34.0 27.7 37.8 26.8 34.2 33.3 21.4 25.4 24.2 50.5 74.7 36.7 30.5 22.2 21.1 8.7 20.8 23.8 24.9 43.1 28.0 29.7 9.2 63.3 84.7 34.3 17.4 22.6 35.8 27.1 25.5 111.7 43.6 39.3 6.6 29.3 28.1 16.1 18.0 40.8 22.7 49.4 21.2 44.8 38.3 24.2 SLC35D3 FRCL1 ENSG00000182747 "Solute carrier family 35 member D3" Q5M8T2 6 136922301-136925660 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "brain: 5.3" "Cell type enriched" "Detected in single" 9 "Ionocytes: 8.2" "Group enriched" "Detected in some" 5 "colorectal cancer: 3.3;stomach cancer: 0.9" "Group enriched" "Detected in many" 7 "basal ganglia: 3.4;cerebral cortex: 1.5;hypothalamus: 5.2;midbrain: 2.1;thalamus: 5.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 15.4" "Group enriched" "Detected in many" 5 "basal ganglia: 29.6;olfactory bulb: 8.5" "Region enriched" "Detected in many" 6 "basal ganglia: 20.1" "HPA030431, HPA067497" Uncertain Approved "Centriolar satellite" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 51: Myeloid cells - Hemostasis" "Centriolar satellite" "HPA030431: AB_10601716, HPA067497: AB_2685854" "unprognostic (6.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.43e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.48e-1)" "unprognostic (9.94e-2)" "unprognostic (7.36e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (4.45e-1)" "unprognostic (1.03e-1)" 0.0 0.9 0.4 0.0 3.4 0.2 0.0 0.0 1.5 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.4 0.0 0.3 2.1 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 15.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 3.4 0.0 1.5 0.0 5.2 0.3 2.1 0.2 0.2 5.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.1 SLC36A4 "FLJ38932, PAT4" ENSG00000180773 "Solute carrier family 36 member 4" Q6YBV0 11 93144174-93197991 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017887 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus, Plasma membrane, Cytosol" "HPA017887: AB_2190238" "unprognostic (1.23e-2)" "unprognostic (1.08e-1)" "unprognostic (2.17e-3)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" "unprognostic (8.77e-2)" "unprognostic (1.08e-3)" "unprognostic (7.83e-3)" "unprognostic (3.06e-2)" "unprognostic (7.97e-2)" "unprognostic (2.09e-2)" "unprognostic (8.04e-3)" "unprognostic (7.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.74e-1)" "unprognostic (9.45e-3)" "unprognostic (4.20e-2)" 5.8 7.4 4.2 9.3 4.6 19.4 4.6 8.1 5.8 5.1 6.2 5.4 2.0 7.1 2.1 5.3 4.8 5.7 6.0 4.0 8.5 9.4 7.8 6.0 5.3 7.2 6.9 5.7 5.7 6.5 7.7 6.2 7.7 4.9 6.4 15.3 3.7 5.9 2.4 4.1 3.1 8.1 5.5 4.1 4.3 4.3 6.1 7.3 8.8 2.3 6.7 6.9 3.6 7.0 10.4 18.2 36.5 7.3 12.7 25.6 20.5 17.6 29.2 25.6 31.0 14.6 33.1 12.5 9.9 16.5 13.3 12.5 11.4 6.5 23.4 21.1 13.3 14.5 35.3 9.8 10.0 36.6 20.6 12.4 20.0 14.9 9.2 12.0 14.0 17.6 1.3 0.2 26.5 2.6 16.3 27.4 14.8 4.0 18.4 7.2 21.7 5.1 8.7 15.1 33.6 43.8 25.7 9.9 6.4 26.4 18.0 10.6 15.7 48.0 14.8 28.6 26.0 5.1 10.9 0.0 10.9 15.0 25.4 0.1 4.9 5.3 0.8 2.6 1.0 0.9 0.6 1.0 1.9 1.0 1.5 1.0 1.5 0.5 1.7 0.7 0.5 1.1 4.2 4.6 8.1 5.8 4.0 8.5 7.2 6.9 7.7 5.5 6.1 7.0 11.9 12.8 11.5 35.9 29.5 30.7 43.2 9.7 25.6 21.2 10.3 8.0 11.5 20.0 7.1 20.2 22.9 10.7 13.6 3.1 35.2 24.4 9.9 15.5 19.2 18.5 27.6 5.5 66.8 43.6 25.8 21.9 18.8 5.7 4.5 29.0 13.2 9.1 13.6 26.9 71.0 19.6 10.2 52.3 47.1 4.2 18.0 50.1 21.4 27.2 42.8 20.7 13.4 45.2 59.4 33.2 6.3 15.4 22.1 70.4 0.4 16.2 20.8 24.2 6.6 18.0 18.1 7.3 3.3 11.8 32.0 16.3 15.7 20.6 4.3 30.6 SLC44A5 "CTL5, MGC34032" ENSG00000137968 "Solute carrier family 44 member 5" Q8NCS7 1 75202131-75611116 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 10.7" "Group enriched" "Detected in many" 4 "Excitatory neurons: 274.5;Inhibitory neurons: 563.3;Oligodendrocyte precursor cells: 265.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 7.7;RPTEC TERT1: 7.4;SH-SY5Y: 11.5;SuSa: 11.7;TIME: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047455, HPA051011" Uncertain Approved Cytosol NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA047455: AB_2680054, HPA051011: AB_2681309" "unprognostic (9.00e-2)" "unprognostic (1.91e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-3)" "unprognostic (4.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (5.78e-3)" "unprognostic (6.41e-2)" "unprognostic (9.19e-2)" "prognostic unfavorable (6.52e-4)" "unprognostic (1.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" "unprognostic (4.30e-1)" 0.3 0.7 1.5 0.5 1.9 0.3 5.5 0.0 3.4 1.1 0.0 2.1 1.2 0.7 0.4 6.6 3.6 1.0 2.5 2.3 1.7 2.0 1.0 0.6 0.5 2.6 1.6 1.1 1.7 3.7 3.1 3.8 2.8 0.8 2.7 2.5 1.4 0.2 1.6 10.7 1.4 0.2 2.0 0.8 1.5 4.5 2.3 2.5 0.7 1.5 2.1 1.6 2.0 1.2 0.2 0.2 4.6 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.7 0.0 0.0 2.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.7 0.6 1.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.4 2.7 2.7 0.0 0.0 1.9 0.0 4.7 3.2 0.6 0.0 0.0 2.3 7.4 5.2 1.1 11.5 0.0 4.8 0.0 11.7 0.2 0.0 14.7 0.4 1.3 0.0 1.5 2.1 2.1 3.2 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.5 1.9 0.0 3.4 2.3 1.7 2.6 1.6 2.8 2.0 2.3 1.2 0.1 0.0 1.1 12.4 0.4 1.9 1.0 0.4 0.0 4.0 2.9 1.7 0.8 0.0 1.0 0.0 0.0 9.1 0.0 2.0 0.0 0.1 86.9 1.0 0.1 0.6 2.4 0.0 274.5 0.9 3.9 0.4 0.0 0.3 0.0 20.1 7.5 0.0 1.1 0.0 563.3 1.0 0.0 0.0 0.2 35.2 0.9 0.1 0.0 6.5 0.0 0.0 0.0 265.4 10.1 0.2 0.2 0.0 0.1 1.1 0.0 0.1 2.5 0.8 0.0 0.6 0.2 0.4 0.4 0.9 6.7 3.8 0.1 0.5 1.2 3.6 SLC6A2 "NAT1, NET, NET1, SLC6A5" ENSG00000103546 "Solute carrier family 6 member 2" P23975 16 55655604-55706192 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 149.4" "Group enriched" "Detected in some" 4 "Early spermatids: 4.3;Extravillous trophoblasts: 10.6;Late spermatids: 4.4;Spermatocytes: 11.5;Syncytiotrophoblasts: 5.6" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Region enriched" "Detected in some" 10 "pons: 149.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 29 "SH-SY5Y: 489.1" "Region enriched" "Detected in some" 4 "pons and medulla: 7.8" "Region enriched" "Detected in single" 19 "pons: 13.8" "HPA004057, HPA076311, CAB078195" Enhanced Supported Approved Mitochondria,Cytosol NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol Mitochondria "CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307" "unprognostic (9.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.26e-4)" "unprognostic (4.07e-1)" "unprognostic (4.16e-1)" "unprognostic (8.38e-2)" "unprognostic (2.97e-2)" "unprognostic (3.29e-1)" "unprognostic (2.31e-1)" "unprognostic (3.27e-1)" "unprognostic (2.12e-2)" "unprognostic (2.95e-2)" "unprognostic (1.72e-1)" "unprognostic (6.02e-2)" "unprognostic (8.48e-2)" "unprognostic (1.43e-2)" 0.9 21.7 0.1 0.0 0.1 0.0 0.8 0.0 0.2 2.4 0.0 0.2 0.1 5.4 0.2 0.2 0.5 0.1 0.0 0.1 0.0 0.4 0.4 0.1 0.0 3.8 14.6 0.1 0.0 0.5 0.0 12.6 149.4 0.2 0.3 0.0 1.9 0.6 0.0 13.3 0.2 0.8 0.1 0.0 0.1 6.2 0.0 0.1 0.0 0.0 0.1 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.7 489.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 3.8 14.6 149.4 0.1 0.0 0.5 1.8 0.0 0.0 0.0 0.0 1.5 0.2 0.4 0.0 0.0 0.3 0.1 0.8 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 10.6 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.5 4.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 11.5 0.3 0.0 0.4 5.6 0.0 0.0 0.0 0.1 SLC8A3 NCX3 ENSG00000100678 "Solute carrier family 8 member A3" P57103 14 70044215-70189070 "Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 10.8;retina: 9.6;skeletal muscle: 20.6;tongue: 9.4" "Group enriched" "Detected in some" 9 "Bipolar cells: 32.8;Excitatory neurons: 80.5;Inhibitory neurons: 129.4;Oligodendrocyte precursor cells: 107.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.2;LHCN-M2: 7.9;SH-SY5Y: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.65e-1)" "unprognostic (5.53e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.69e-1)" "unprognostic (3.46e-3)" "unprognostic (4.74e-2)" "unprognostic (1.64e-1)" "unprognostic (1.45e-3)" "unprognostic (8.53e-2)" "unprognostic (5.86e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (3.38e-1)" 0.3 1.2 7.1 0.3 6.0 0.3 0.2 1.7 6.6 0.4 0.0 0.3 0.3 0.2 0.2 0.3 0.1 0.4 0.6 5.3 7.7 0.1 0.1 0.6 0.2 6.1 7.6 0.0 0.2 0.7 0.9 0.1 7.1 0.3 0.2 9.6 0.3 0.1 20.6 0.3 0.4 0.3 5.4 0.1 0.3 0.1 10.8 0.2 0.0 9.4 0.2 1.2 0.2 4.7 0.0 0.0 4.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 24.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 6.0 1.7 6.6 5.3 7.7 6.1 7.6 7.1 5.4 10.8 4.7 0.0 0.0 0.6 2.9 0.0 0.1 0.0 0.0 0.0 32.8 0.0 0.0 1.4 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 80.5 0.0 0.4 0.2 0.0 0.0 8.8 0.0 0.0 0.0 0.1 8.4 129.4 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 4.7 0.0 0.8 0.0 107.1 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 SMAD9 "MADH6, MADH9, SMAD8, SMAD8/9" ENSG00000120693 "SMAD family member 9" O15198 13 36844831-36920765 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 38.7" "Cell type enhanced" "Detected in many" "Astrocytes: 48.0;Enteroendocrine cells: 51.6;Glandular and luminal cells: 73.4;Hepatic stellate cells: 43.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 12.9;HEK 293: 12.3;SH-SY5Y: 40.2" "Low region specificity" "Detected in all" "CAB009119, HPA031162" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "CAB009119: AB_2286517, HPA031162: AB_2673767" "unprognostic (2.88e-1)" "unprognostic (1.38e-1)" "unprognostic (9.68e-3)" "unprognostic (3.50e-3)" "prognostic favorable (5.99e-4)" "unprognostic (1.30e-1)" "unprognostic (1.34e-1)" "unprognostic (3.71e-3)" "unprognostic (4.23e-2)" "unprognostic (6.62e-2)" "unprognostic (4.07e-3)" "unprognostic (3.74e-2)" "unprognostic (9.70e-2)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.47e-2)" 4.0 2.6 10.7 2.8 7.8 0.1 1.6 10.7 6.8 4.8 1.2 5.1 2.3 8.9 9.8 4.2 4.3 7.0 5.6 10.3 16.3 3.2 0.9 4.9 2.2 17.2 10.9 9.2 0.9 2.4 1.9 6.5 16.9 13.9 5.3 7.0 21.0 11.2 3.0 1.5 2.5 6.7 15.5 0.9 3.7 2.3 9.6 0.5 38.7 5.1 2.9 3.3 2.1 21.3 0.0 0.1 0.8 8.6 2.6 1.1 0.3 10.5 1.1 2.7 1.7 0.0 0.2 0.2 7.2 12.9 0.9 0.4 9.3 0.2 2.8 0.3 12.3 0.0 4.4 6.6 2.4 0.8 0.1 4.4 0.8 0.0 0.0 5.7 5.3 1.1 0.1 0.0 6.0 0.6 0.1 0.8 1.2 0.3 1.1 0.2 9.2 0.0 0.0 1.5 7.6 40.2 1.9 0.2 0.5 2.3 0.6 0.4 9.6 4.0 3.5 2.4 2.6 0.1 0.0 0.1 2.8 0.3 0.6 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 10.7 7.8 10.7 6.8 10.3 16.3 17.2 10.9 16.9 15.5 9.6 21.3 22.5 28.9 11.5 48.0 0.4 2.8 4.3 1.8 1.8 13.1 2.5 2.2 5.9 2.8 6.9 11.0 4.2 0.2 0.2 3.3 1.9 0.3 0.1 30.3 14.0 26.7 51.6 0.0 18.1 0.2 0.6 11.6 3.6 73.4 0.0 19.7 43.9 0.1 0.1 0.0 33.0 15.6 8.2 2.2 1.9 0.3 18.6 1.1 0.0 31.9 0.0 20.4 0.0 14.1 39.3 0.5 3.4 15.1 0.0 17.2 0.0 7.3 1.6 3.2 0.0 7.2 10.1 1.2 14.1 0.2 1.8 0.3 1.4 0.5 5.7 1.2 SMIM18 ENSG00000253457 "Small integral membrane protein 18" P0DKX4 8 30638580-30646064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.4;pituitary gland: 5.4;retina: 3.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 12.3;Excitatory neurons: 2.9;Horizontal cells: 5.0;Inhibitory neurons: 5.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 5.5;Proximal tubular cells: 4.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066648 Supported Uncertain Nucleoplasm,Centrosome NA NA "Cluster 46: Basophils - DNA binding" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm Centrosome "HPA066648: AB_2685697" "unprognostic (2.19e-2)" "unprognostic (9.37e-2)" "unprognostic (3.31e-1)" "unprognostic (4.24e-2)" "unprognostic (1.66e-1)" "unprognostic (2.60e-1)" "unprognostic (7.29e-2)" "unprognostic (4.70e-1)" "unprognostic (8.91e-3)" "unprognostic (1.05e-1)" "unprognostic (2.36e-1)" "unprognostic (6.08e-2)" "unprognostic (4.01e-3)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (4.14e-1)" 0.0 0.9 2.2 0.0 1.9 0.9 0.0 4.0 3.7 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 3.8 0.9 0.0 0.0 0.0 2.3 4.4 0.0 0.4 0.0 5.4 0.0 3.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 1.2 0.6 0.6 1.1 0.4 1.1 0.9 0.7 0.6 0.3 0.9 0.9 1.3 0.7 0.0 0.8 1.4 1.0 0.1 2.2 1.9 4.0 3.7 2.0 3.8 2.3 4.4 3.0 1.7 2.7 1.6 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.2 0.1 1.8 0.0 2.9 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 5.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.9 0.0 5.5 1.1 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 SNAP25 "bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25" ENSG00000132639 "Synaptosome associated protein 25" P60880 20 10218830-10307418 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters" "Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 20 "brain: 1658.7;retina: 492.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 559.2;Excitatory neurons: 1015.8;Inhibitory neurons: 552.8;Rod photoreceptor cells: 254.4" "Cancer enriched" "Detected in many" 4 "glioma: 28.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 23.8;SCLC-21H: 78.2;SH-SY5Y: 46.6;U-87 MG: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000360, HPA001830, HPA071013" Enhanced Supported Approved "Vesicles,Plasma membrane" NA NA 9000 "Cluster 6: Brain - Smell perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" Vesicles "CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: " "unprognostic (1.64e-3)" "unprognostic (7.26e-3)" "unprognostic (4.36e-2)" "unprognostic (2.49e-7)" "unprognostic (6.86e-3)" "unprognostic (5.87e-3)" "unprognostic (1.15e-2)" "unprognostic (9.94e-2)" "unprognostic (3.13e-1)" "unprognostic (5.82e-3)" "unprognostic (4.80e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "unprognostic (6.18e-3)" "unprognostic (2.48e-1)" "unprognostic (6.28e-3)" "unprognostic (1.02e-2)" 1.5 43.6 251.0 4.1 383.5 0.2 4.4 598.0 1658.7 0.8 0.0 5.7 3.7 7.9 12.9 0.5 7.7 2.3 3.2 420.4 142.2 1.4 1.0 1.8 0.4 427.4 24.7 6.9 6.3 1.2 54.3 0.6 386.6 3.2 2.3 492.0 0.5 19.6 0.8 0.7 3.9 8.1 38.1 0.2 6.3 3.6 147.6 0.5 0.7 0.1 0.4 1.1 1.6 726.9 0.0 4.7 3.9 0.0 0.4 0.1 0.0 2.0 0.0 4.8 1.4 0.0 0.0 0.0 4.3 0.0 3.4 0.8 0.6 0.0 9.6 0.5 0.3 0.0 6.8 0.7 3.5 0.0 0.5 4.4 0.0 3.9 0.0 10.7 0.0 2.8 0.0 23.8 1.6 0.0 0.0 0.0 0.8 3.0 0.0 0.0 0.0 0.1 0.9 0.0 78.2 46.6 0.7 0.1 0.0 2.4 0.0 6.5 0.0 5.0 6.8 0.0 2.3 0.1 12.9 0.1 56.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 251.0 383.5 598.0 1658.7 420.4 142.2 427.4 24.7 386.6 38.1 147.6 726.9 0.5 0.0 0.0 117.2 0.0 0.8 1.4 0.1 0.0 559.2 0.2 1.3 0.5 8.6 0.0 0.0 106.3 0.0 0.2 0.0 0.0 0.2 16.3 0.1 0.7 5.2 43.5 0.0 1015.8 0.0 0.1 3.9 0.0 0.2 0.0 0.6 0.0 0.2 0.1 65.6 552.8 3.4 0.0 0.0 0.4 83.3 17.1 0.1 1.8 120.9 0.0 71.9 0.0 179.4 113.3 1.0 2.6 68.8 0.0 0.6 0.1 3.0 0.0 254.4 0.0 0.0 1.3 1.1 0.4 0.0 0.9 0.0 0.0 2.6 0.1 0.1 SNAP91 "AP180, CALM, KIAA0656" ENSG00000065609 "Synaptosome associated protein 91" O60641 6 83552880-83709691 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 80.8;pituitary gland: 25.8;retina: 91.8" "Cell type enhanced" "Detected in some" "Astrocytes: 91.1;Excitatory neurons: 336.6;Inhibitory neurons: 296.9;Oligodendrocyte precursor cells: 209.1;Oligodendrocytes: 89.0" "Cancer enhanced" "Detected in some" "glioma: 2.5;prostate cancer: 2.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 25 "plasmacytoid DC: 2.8" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.8" "Group enriched" "Detected in some" 10 "GAMG: 7.4;SCLC-21H: 23.7;SH-SY5Y: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009745, HPA029632, HPA029633" Enhanced Uncertain Centrosome,Cytosol NA NA 28000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Centrosome, Cytosol" "CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615" "unprognostic (1.07e-2)" "unprognostic (1.74e-1)" "unprognostic (7.55e-3)" "unprognostic (3.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (4.54e-4)" "unprognostic (6.99e-2)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (2.15e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" 0.3 7.9 42.1 1.0 52.0 0.0 0.6 61.2 80.8 1.1 0.0 1.2 0.3 0.7 0.1 0.1 0.7 1.0 0.7 51.3 31.6 0.1 0.0 0.3 3.0 40.9 11.1 2.1 1.5 1.1 25.8 0.5 41.1 3.1 0.6 91.8 0.5 0.6 0.2 0.1 0.8 0.7 7.2 1.4 0.9 12.1 23.0 0.3 0.9 1.5 1.9 0.4 0.4 40.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 7.4 0.3 1.0 0.0 0.0 0.4 1.4 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.2 0.3 23.7 14.7 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 42.1 52.0 61.2 80.8 51.3 31.6 40.9 11.1 41.1 7.2 23.0 40.8 0.0 0.0 0.0 91.1 0.0 0.0 0.0 0.0 0.0 49.8 0.1 0.0 1.3 0.0 0.0 0.0 62.6 1.5 0.1 0.1 0.0 0.0 23.9 0.2 1.4 0.3 0.0 0.0 336.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 32.0 296.9 0.0 0.0 0.0 0.0 12.8 0.9 0.0 0.0 31.9 0.0 10.9 0.0 209.1 89.0 0.4 0.0 1.2 0.0 0.5 0.0 0.0 0.0 59.8 0.0 0.0 0.1 29.6 4.8 0.0 0.0 4.4 0.0 0.1 0.0 0.0 SNX7 ENSG00000162627 "Sorting nexin 7" Q9UNH6 1 98661701-98760500 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037419 Enhanced Approved "Vesicles,Cell Junctions" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "Cell Junctions" "HPA037419: AB_10671754" "unprognostic (3.19e-1)" "unprognostic (2.18e-1)" "prognostic favorable (5.10e-5)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (9.59e-7)" "unprognostic (1.53e-2)" "unprognostic (2.64e-1)" "unprognostic (1.41e-2)" "unprognostic (1.19e-3)" "unprognostic (1.88e-1)" "unprognostic (7.95e-3)" "unprognostic (1.68e-1)" "unprognostic (1.45e-1)" "unprognostic (8.65e-2)" "unprognostic (1.77e-1)" 19.5 13.8 10.2 7.5 9.5 0.1 17.1 8.6 9.9 20.6 7.5 30.1 23.5 19.4 12.6 16.6 15.6 16.2 22.1 10.1 13.6 24.9 12.8 11.3 3.4 11.6 12.7 11.3 13.7 15.1 8.4 16.8 10.7 14.3 29.9 3.2 14.1 16.4 5.4 11.0 22.9 25.8 9.8 5.4 16.9 15.7 16.4 3.6 12.2 10.9 4.7 20.3 14.3 10.8 50.4 26.7 15.8 21.6 54.9 86.3 8.9 31.3 56.6 45.9 59.2 15.6 18.4 0.0 39.7 77.1 37.7 14.2 16.8 44.4 45.5 0.2 32.3 0.0 41.2 27.1 32.4 0.0 0.0 43.5 46.8 37.8 16.5 51.7 64.9 0.7 0.0 0.1 73.3 10.3 0.4 0.0 15.2 20.0 38.0 0.0 35.4 0.1 45.3 39.8 7.8 93.5 41.6 39.0 23.7 26.2 0.0 1.8 44.9 44.7 24.8 35.0 64.2 0.0 0.1 0.1 63.3 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.2 9.5 8.6 9.9 10.1 13.6 11.6 12.7 10.7 9.8 16.4 10.8 14.1 19.2 6.7 23.2 0.5 14.7 44.7 60.0 9.6 0.7 16.3 23.0 49.1 27.1 22.0 23.9 0.0 34.1 0.1 37.4 37.2 47.0 19.3 29.4 33.0 17.8 21.0 0.0 18.3 80.7 33.8 37.9 20.9 19.6 1.3 22.4 17.9 12.0 12.9 3.3 25.7 26.6 48.8 2.1 13.7 23.9 34.2 5.0 35.6 12.2 37.2 12.8 0.0 58.8 8.2 56.8 25.7 52.6 0.1 28.5 34.1 69.0 27.2 0.8 32.9 23.1 36.2 15.5 10.5 27.1 16.3 14.1 1.6 30.2 49.1 57.3 SOGA3 "C6orf174, dJ403A15.3" ENSG00000214338 "SOGA family member 3" Q5TF21 6 127472794-127519191 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.6" "Group enriched" "Detected in some" 9 "Excitatory neurons: 78.1;Inhibitory neurons: 57.4;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 32.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.3;SCLC-21H: 28.9;SH-SY5Y: 16.9" "HPA035388, HPA035389" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Cytosol" "HPA035388: AB_2674601, HPA035389: AB_10669857" "unprognostic (1.70e-1)" "unprognostic (3.56e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (8.58e-3)" "unprognostic (8.45e-2)" "unprognostic (7.31e-4)" "unprognostic (5.65e-3)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" "unprognostic (1.59e-1)" "unprognostic (3.30e-2)" "unprognostic (1.72e-1)" "unprognostic (8.26e-3)" 0.3 0.9 2.3 0.6 2.5 0.0 0.1 2.4 6.6 0.4 0.0 0.3 0.1 0.7 0.0 0.8 0.3 0.7 0.2 2.6 1.7 0.2 0.1 1.0 0.2 3.8 1.2 1.2 0.6 0.0 2.0 0.4 1.9 0.4 0.2 1.2 0.4 0.1 0.1 0.3 0.6 0.1 0.7 0.4 1.3 0.7 3.8 0.0 0.6 0.1 0.0 0.4 0.3 4.4 0.3 4.2 9.3 1.5 0.0 0.8 0.4 0.9 1.1 1.2 2.9 0.3 0.4 0.6 0.3 0.2 7.3 0.0 1.0 0.0 0.7 1.1 0.1 0.8 0.0 0.1 0.0 0.4 0.2 1.5 0.0 4.4 0.0 1.0 0.0 1.5 0.4 0.2 0.7 0.7 6.5 0.0 4.3 0.0 1.0 0.6 2.2 0.0 0.2 0.0 28.9 16.9 0.0 0.0 0.2 1.1 0.0 0.4 0.2 6.8 1.5 0.5 2.2 0.3 0.1 0.1 5.4 1.5 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 2.5 2.4 6.6 2.6 1.7 3.8 1.2 1.9 0.7 3.8 4.4 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 78.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 57.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 44.2 32.9 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.2 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 SORCS1 ENSG00000108018 "Sortilin related VPS10 domain containing receptor 1" Q8WY21 10 106573663-107164534 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;thyroid gland: 11.0" "Group enriched" "Detected in some" 7 "Excitatory neurons: 522.2;Inhibitory neurons: 179.7;Oligodendrocyte precursor cells: 381.5" "Cancer enhanced" "Detected in some" "melanoma: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "RH-30: 80.8;SH-SY5Y: 104.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011948 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cytosol" "HPA011948: AB_1857366" "unprognostic (5.86e-3)" "unprognostic (8.45e-3)" "unprognostic (1.55e-2)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (2.92e-2)" "unprognostic (3.52e-2)" "unprognostic (5.58e-2)" "unprognostic (6.82e-3)" "unprognostic (5.81e-2)" "unprognostic (6.48e-4)" "unprognostic (2.51e-2)" "unprognostic (8.89e-3)" "unprognostic (2.22e-1)" "unprognostic (2.69e-4)" 0.6 3.1 3.0 1.9 6.2 0.0 1.3 0.0 10.3 2.5 0.0 9.4 0.7 1.1 0.3 0.9 1.6 1.1 3.1 5.4 5.8 4.7 0.1 0.1 1.0 0.6 4.5 0.7 1.6 0.0 0.9 0.0 2.7 2.2 1.9 9.6 1.1 2.5 0.3 1.5 3.6 1.4 0.5 0.8 2.5 1.2 5.8 1.0 11.0 1.7 1.5 3.6 2.8 6.6 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 80.8 0.1 0.0 0.0 0.0 104.9 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.6 6.1 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 6.2 0.0 10.3 5.4 5.8 0.6 4.5 2.7 0.5 5.8 6.6 0.0 0.0 0.5 7.2 0.0 0.6 0.0 0.0 1.2 2.0 0.1 0.5 2.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 16.6 0.1 4.9 0.2 0.0 0.0 522.2 0.0 0.0 3.6 0.0 0.1 0.0 1.0 0.0 0.0 0.2 1.7 179.7 0.0 0.0 0.3 0.3 5.2 0.0 0.2 1.8 26.2 0.0 49.1 0.0 381.5 10.0 0.1 0.0 0.4 0.0 0.0 0.0 2.2 0.0 2.1 0.0 1.0 0.3 0.2 1.9 0.2 0.1 0.0 0.3 0.0 0.0 0.0 SOX11 ENSG00000176887 "SRY-box transcription factor 11" P35716 2 5692384-5701385 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 5.0" "Cell type enhanced" "Detected in some" "Breast glandular cells: 6.4;Breast myoepithelial cells: 8.6;Cardiomyocytes: 13.9;Inhibitory neurons: 8.4;Oligodendrocyte precursor cells: 21.6;Skeletal myocytes: 38.8" "Cancer enhanced" "Detected in many" "glioma: 8.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 47.2;NTERA-2: 23.6;REH: 17.9;RH-30: 18.2;SCLC-21H: 29.1;SH-SY5Y: 44.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000448, HPA000536, CAB056152, CAB056153" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Plasma membrane" "CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060" "unprognostic (2.17e-2)" "unprognostic (2.02e-2)" "unprognostic (1.44e-2)" "unprognostic (7.35e-6)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (4.04e-8)" "unprognostic (2.79e-2)" "unprognostic (7.27e-2)" "unprognostic (3.17e-1)" "unprognostic (3.35e-3)" "unprognostic (2.42e-1)" "unprognostic (8.45e-8)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (5.50e-3)" "unprognostic (7.47e-2)" 0.0 0.0 2.3 0.0 2.8 0.0 0.0 1.3 1.9 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 5.0 0.0 0.0 0.0 0.0 2.5 2.9 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.2 3.2 0.1 0.0 0.0 4.6 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 1.5 0.0 2.3 0.0 0.0 4.4 0.0 0.0 0.0 23.6 0.0 0.0 17.9 18.2 0.7 0.0 0.0 29.1 44.0 0.0 0.3 0.0 8.2 0.0 0.0 0.0 0.6 0.2 0.0 0.0 3.3 0.6 1.2 0.0 0.0 11.1 0.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 2.3 2.8 1.3 1.9 1.3 5.0 2.5 2.9 2.0 3.2 4.6 3.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.1 6.4 8.6 13.9 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 5.7 0.9 0.0 0.8 1.2 0.0 0.0 0.4 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.4 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 1.0 0.0 0.5 0.0 21.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 38.8 1.1 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.0 SRRM3 FLJ37078 ENSG00000177679 "Serine/arginine repetitive matrix 3" 7 76201896-76287288 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 56.0;retina: 27.2" "Group enriched" "Detected in many" 7 "Bipolar cells: 153.1;Cone photoreceptor cells: 479.6;Excitatory neurons: 139.1;Horizontal cells: 171.6;Inhibitory neurons: 144.4;Rod photoreceptor cells: 421.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SCLC-21H: 10.9;SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019337 Approved "Plasma membrane,Intermediate filaments,Microtubules" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane" "Intermediate filaments, Microtubules" "HPA019337: AB_1848909" "unprognostic (1.65e-1)" "unprognostic (1.96e-1)" "unprognostic (8.37e-3)" "unprognostic (4.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (6.51e-2)" "unprognostic (1.89e-3)" "unprognostic (1.62e-2)" "unprognostic (5.07e-3)" "unprognostic (6.37e-2)" "unprognostic (3.73e-3)" "unprognostic (5.05e-1)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.15e-2)" 0.0 2.1 6.0 0.1 13.2 0.0 0.0 56.0 30.7 0.1 0.0 0.3 0.1 0.2 0.2 0.1 0.0 0.0 0.1 4.8 0.2 0.0 0.0 0.0 0.0 41.5 3.2 0.2 0.3 0.3 8.9 0.0 40.1 0.1 0.1 27.2 0.1 0.0 0.1 0.0 0.1 0.0 1.6 0.0 0.4 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.3 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 8.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 13.2 56.0 30.7 4.8 0.2 41.5 3.2 40.1 1.6 0.9 4.7 0.3 0.0 0.0 8.1 0.0 2.0 6.4 1.9 7.4 153.1 1.8 0.5 6.9 1.5 1.2 0.0 479.6 0.4 0.0 0.2 0.0 2.0 22.2 0.5 4.2 1.2 12.1 0.0 139.1 2.4 8.1 4.8 0.5 1.0 0.0 12.0 1.8 0.0 0.5 171.6 144.4 0.1 2.0 0.0 0.8 32.2 2.1 0.2 3.6 5.6 0.0 15.9 0.0 18.6 4.9 0.9 0.1 2.2 0.0 2.2 0.0 0.4 0.2 421.8 0.0 1.2 2.0 8.6 3.1 4.9 1.1 2.2 0.1 0.2 0.0 4.9 ST8SIA3 SIAT8C ENSG00000177511 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3" O43173 18 57352557-57371731 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.7;pituitary gland: 8.1;retina: 7.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 29.9;Excitatory neurons: 74.9;Horizontal cells: 63.9;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 22.1" "Group enriched" "Detected in some" 11 "glioma: 0.9;pancreatic cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "NTERA-2: 4.4;SCLC-21H: 8.6;SH-SY5Y: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063398, HPA066783" Enhanced Supported "Golgi apparatus" No NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA063398: AB_2685004, HPA066783: AB_2685721" "unprognostic (1.75e-1)" "unprognostic (7.85e-2)" "unprognostic (1.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.82e-1)" 0.0 4.3 8.0 0.0 21.7 0.0 0.0 6.7 15.6 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.9 0.0 12.5 14.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 8.1 0.0 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 9.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 21.7 6.7 15.6 12.5 14.5 0.0 0.0 0.0 0.0 2.1 4.9 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 1.6 5.7 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 63.9 56.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 4.7 0.0 1.2 0.0 22.1 3.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STAC STAC1 ENSG00000144681 "SH3 and cysteine rich domain" Q99469 3 36380503-36548007 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 13.8" "Cell type enhanced" "Detected in some" "Distal tubular cells: 5.9;Early spermatids: 5.2;granulocytes: 6.3;Granulosa cells: 12.5;Late spermatids: 5.3;Muller glia cells: 21.6;Smooth muscle cells: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.5;NK-cell: 1.3;T-reg: 1.5" "Group enriched" "Detected in many" 5 "granulocytes: 1.5;NK-cells: 1.3;T-cells: 1.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 46.8;HaCaT: 34.1;SH-SY5Y: 49.1;U-251 MG: 30.3;U-87 MG: 48.1" "Low region specificity" "Detected in many" HPA035143 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Plasma membrane" "HPA035143: AB_10603892" "unprognostic (5.29e-2)" "unprognostic (7.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-6)" "unprognostic (4.24e-2)" "unprognostic (1.83e-2)" "unprognostic (3.06e-2)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-3)" "unprognostic (1.77e-3)" "unprognostic (5.82e-2)" "unprognostic (8.07e-2)" "unprognostic (1.73e-4)" "unprognostic (8.93e-2)" "unprognostic (1.95e-1)" "unprognostic (7.94e-3)" 2.8 5.1 1.4 0.6 1.9 0.4 1.9 3.6 3.9 7.0 5.0 3.6 0.1 1.4 0.3 2.1 3.2 2.7 0.7 0.8 4.3 2.5 0.9 11.1 0.4 2.3 2.5 2.5 0.1 10.1 1.1 0.3 6.9 13.8 0.7 5.8 1.3 4.4 1.6 1.2 0.4 3.4 1.9 0.6 0.9 1.9 2.1 0.7 0.5 5.3 0.2 3.7 2.2 0.5 7.7 3.3 1.6 0.0 6.5 2.1 0.1 19.9 0.4 4.0 4.6 0.0 0.0 0.0 7.8 46.8 13.0 34.1 2.4 8.2 4.1 0.0 7.2 1.1 10.0 0.2 0.0 20.3 0.4 2.4 0.2 0.1 0.7 27.6 0.0 1.8 0.0 0.4 0.5 0.0 4.1 0.2 13.8 0.0 3.0 0.0 0.0 0.0 10.8 0.0 6.2 49.1 7.9 5.2 0.1 13.6 0.0 2.0 8.5 0.5 19.1 0.6 30.3 0.0 0.0 0.0 48.1 7.9 8.3 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.5 0.0 1.4 1.9 3.6 3.9 0.8 4.3 2.3 2.5 6.9 1.9 2.1 0.5 0.9 0.0 0.5 0.3 0.0 0.0 0.0 0.5 0.0 0.7 2.3 0.8 0.9 0.0 1.3 0.0 0.0 0.0 0.1 0.0 5.9 0.2 5.2 0.9 0.5 0.4 0.0 2.1 0.6 0.0 0.1 1.5 0.0 2.1 6.3 12.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.2 5.3 0.0 4.8 0.0 0.0 0.0 21.6 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.4 5.0 1.8 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 STARD4 ENSG00000164211 "StAR related lipid transfer domain containing 4" Q96DR4 5 111496033-111512590 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046177, HPA048081" Approved Approved "Plasma membrane" NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 9: Intestine - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 15: Hepatocytes - Hemostasis" "Plasma membrane" "HPA046177: AB_2679570, HPA048081: AB_2680253" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (1.01e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.26e-1)" "unprognostic (6.27e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (2.00e-1)" "unprognostic (3.82e-3)" "unprognostic (4.01e-3)" "prognostic unfavorable (2.84e-4)" 6.2 15.8 8.3 15.9 15.8 19.4 3.9 25.2 12.6 10.2 11.5 14.7 40.8 7.7 16.2 8.5 5.0 9.7 15.0 9.5 10.6 8.5 34.1 20.9 12.6 16.0 16.7 6.5 6.1 14.4 8.2 27.3 13.8 20.7 16.9 12.0 6.6 9.9 1.5 2.5 35.7 6.9 10.1 12.1 17.9 6.8 14.8 7.2 9.0 1.7 10.1 7.7 9.2 11.3 20.6 10.0 48.2 29.4 42.4 84.0 16.3 21.0 46.6 29.8 89.1 37.7 59.9 24.5 8.4 13.4 89.0 9.1 24.8 71.8 28.8 23.7 10.4 19.1 33.3 22.8 46.4 9.5 11.7 44.6 48.3 64.1 47.6 35.6 56.6 23.5 10.7 46.5 20.8 3.9 23.7 17.3 16.6 0.6 5.5 5.4 53.3 22.5 44.6 6.7 27.2 105.6 0.0 12.3 19.0 32.1 16.0 30.4 84.4 25.6 22.9 17.2 8.9 15.9 15.8 21.6 24.3 34.8 13.2 7.1 1.4 0.9 2.5 2.1 1.3 1.7 1.2 1.9 1.8 1.7 1.2 1.9 0.0 2.1 1.5 1.3 0.8 1.4 8.3 15.8 25.2 12.6 9.5 10.6 16.0 16.7 13.8 10.1 14.8 11.3 8.2 25.6 34.8 16.0 13.1 1.0 1.4 35.0 1.2 10.8 1.6 0.4 17.8 8.6 18.1 9.2 8.4 15.6 24.8 37.3 1.9 7.8 9.4 6.7 3.5 20.2 21.4 3.6 38.8 9.2 6.0 6.0 15.8 11.5 32.3 6.5 5.0 39.9 20.3 6.7 20.8 32.5 22.4 19.6 26.7 8.3 7.2 27.8 3.6 20.6 5.7 7.1 9.2 20.1 23.6 10.0 30.0 7.9 17.6 3.3 30.1 5.7 9.5 7.6 19.7 2.4 15.2 8.7 9.4 6.8 2.6 14.1 14.5 38.2 23.0 5.2 STMN2 "SCG10, SCGN10" ENSG00000104435 "Stathmin 2" Q93045 8 79611117-79666158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 524.1" "Group enriched" "Detected in some" 4 "Excitatory neurons: 182.2;Horizontal cells: 148.0;Inhibitory neurons: 133.0;Rod photoreceptor cells: 53.4" "Group enriched" "Detected in many" 5 "glioma: 26.1;pancreatic cancer: 10.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 13 "plasmacytoid DC: 2.2" "Lineage enriched" "Detected in single" 13 "dendritic cells: 2.2" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 663.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026922 Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "Endoplasmic reticulum" "HPA026922: AB_1857605" "unprognostic (4.41e-1)" "unprognostic (3.35e-2)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (8.20e-2)" "unprognostic (9.48e-2)" "unprognostic (1.82e-1)" "unprognostic (6.08e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-13)" "unprognostic (1.14e-1)" "unprognostic (3.86e-1)" "unprognostic (5.77e-3)" "unprognostic (9.59e-2)" 5.8 68.6 161.3 9.6 148.3 0.1 2.8 162.9 524.1 8.4 0.0 22.0 13.9 1.1 0.0 1.0 0.1 3.5 1.0 135.7 343.1 0.2 0.9 0.3 0.7 213.6 140.1 0.5 4.7 0.0 8.9 0.1 257.5 2.6 28.9 87.0 0.9 1.7 0.3 11.5 18.5 6.3 60.9 4.5 5.4 1.9 148.2 0.3 0.2 0.3 1.4 0.4 5.0 165.0 0.0 0.0 5.6 0.0 0.9 0.2 0.3 72.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 59.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 64.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 60.5 663.5 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 161.3 148.3 162.9 524.1 135.7 343.1 213.6 140.1 257.5 60.9 148.2 165.0 0.1 0.0 0.0 26.1 0.0 1.0 0.0 0.0 0.0 27.8 0.0 0.3 0.1 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 18.2 0.0 1.5 1.4 24.9 0.0 182.2 0.0 0.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 148.0 133.0 0.0 0.0 0.0 2.0 8.2 0.3 0.0 1.8 19.7 0.0 16.3 0.0 19.1 23.5 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 53.4 0.0 0.0 0.6 0.5 0.7 0.0 0.9 0.0 0.1 0.0 0.0 0.5 SULT1C4 "SULT1C, SULT1C2" ENSG00000198075 "Sulfotransferase family 1C member 4" O75897 2 108377911-108388989 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 13.3;Cholangiocytes: 37.1;Endothelial cells: 13.2;Granulosa cells: 15.3;Hepatic stellate cells: 17.9;Muller glia cells: 12.3;Oligodendrocyte precursor cells: 17.6" "Group enriched" "Detected in many" 6 "glioma: 7.1;renal cancer: 20.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.5;HUVEC TERT2: 10.7;SH-SY5Y: 42.0;SuSa: 11.6" "Low region specificity" "Detected in many" HPA034530 Approved Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA034530: AB_10670170" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-1)" "unprognostic (2.89e-1)" "unprognostic (5.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.35e-2)" "unprognostic (5.77e-2)" "unprognostic (1.56e-3)" "unprognostic (1.68e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-3)" "prognostic favorable (9.99e-7)" "unprognostic (1.79e-2)" "unprognostic (2.96e-2)" "unprognostic (1.85e-2)" "unprognostic (1.38e-1)" 6.2 2.0 15.5 1.1 16.1 0.5 5.2 16.9 17.2 21.9 12.9 3.4 1.5 11.1 8.0 2.3 9.3 27.1 10.9 13.6 18.9 18.2 3.7 10.3 1.8 18.8 27.3 27.9 2.9 1.0 5.2 13.0 20.4 6.6 2.2 8.6 1.6 8.9 3.1 0.7 3.2 5.5 18.1 1.4 2.0 1.4 19.0 5.0 4.5 6.2 1.3 3.8 5.3 15.8 0.0 0.1 9.5 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 1.2 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 42.0 0.0 0.0 0.0 11.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 15.5 16.1 16.9 17.2 13.6 18.9 18.8 27.3 20.4 18.1 19.0 15.8 13.3 0.0 0.5 10.4 0.0 0.3 0.7 0.0 0.0 2.0 0.4 0.3 0.7 37.1 0.0 9.2 0.0 0.3 0.0 0.0 0.0 0.3 5.9 10.9 3.1 13.2 0.0 2.7 0.6 0.2 0.1 4.9 0.0 3.8 0.0 15.3 17.9 0.0 0.9 1.7 0.5 0.0 0.0 1.3 1.0 1.1 1.5 0.4 0.0 7.5 0.1 12.3 0.0 17.6 0.4 0.1 0.0 4.5 1.4 0.7 0.0 7.7 0.0 1.0 0.0 1.4 1.8 0.6 0.7 0.0 0.4 0.3 0.2 7.2 0.0 0.2 SV2C ENSG00000122012 "Synaptic vesicle glycoprotein 2C" Q496J9 5 76083383-76353939 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 55.7" "Group enriched" "Detected in some" 4 "Excitatory neurons: 85.0;Inhibitory neurons: 82.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 15 "basophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Group enriched" "Detected in some" 5 "Karpas-707: 9.1;SCLC-21H: 3.7;SH-SY5Y: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040722, HPA040770" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Vesicles" "HPA040722: AB_10795624, HPA040770: AB_10805828" "unprognostic (7.91e-2)" "unprognostic (2.33e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.07e-1)" "unprognostic (9.93e-2)" "unprognostic (1.09e-2)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" 0.0 1.2 4.7 0.2 31.4 0.1 0.2 11.1 32.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.1 0.0 55.7 0.0 0.0 0.0 0.0 26.1 39.5 0.5 0.1 0.0 0.4 0.0 42.2 0.1 0.1 4.3 0.3 0.2 0.0 0.0 0.2 0.2 9.1 0.0 0.5 0.1 20.2 0.0 0.0 0.0 0.0 0.0 0.1 10.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 8.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 31.4 11.1 32.0 0.0 55.7 26.1 39.5 42.2 9.1 20.2 10.2 0.5 0.0 0.0 5.5 0.1 0.0 0.7 0.4 0.0 5.4 0.7 0.1 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 2.5 0.6 0.4 19.8 0.0 85.0 0.2 0.0 0.1 0.0 2.1 0.0 0.5 0.7 0.0 0.1 0.0 82.6 0.6 2.0 0.6 0.3 0.8 0.0 0.2 3.6 2.8 0.0 1.0 0.0 3.0 3.1 0.0 0.2 0.0 0.3 0.6 0.0 0.0 0.1 5.6 0.0 0.2 0.4 0.2 0.7 0.0 0.1 0.0 0.2 0.8 0.2 1.5 SYN2 "SYNII, SYNIIa, SYNIIb" ENSG00000157152 "Synapsin II" Q92777 3 12004388-12192032 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Schizophrenia "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 96.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 338.3;Inhibitory neurons: 543.3;Oligodendrocyte precursor cells: 128.2" "Cancer enhanced" "Detected in many" "glioma: 4.5" "Group enriched" "Detected in many" 5 "amygdala: 67.0;basal ganglia: 77.7;cerebral cortex: 96.8;hippocampal formation: 92.9;white matter: 44.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.3;HMC-1: 4.5;NTERA-2: 3.3;SCLC-21H: 2.7;SH-SY5Y: 11.1;SuSa: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037012, CAB079005" Supported Approved Nucleoplasm NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "CAB079005: , HPA037012: AB_2675431" "unprognostic (1.62e-3)" "unprognostic (1.60e-2)" "unprognostic (7.54e-2)" "unprognostic (9.87e-3)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (6.32e-3)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-4)" "unprognostic (9.94e-2)" "unprognostic (7.35e-2)" "unprognostic (1.78e-2)" 7.0 3.1 67.0 0.4 77.7 0.1 7.1 3.8 96.8 1.4 0.0 2.3 0.4 2.0 1.0 0.3 1.2 0.4 1.0 92.9 2.9 1.5 0.0 1.1 0.0 13.4 0.0 1.5 0.5 4.1 3.4 2.8 10.8 0.5 0.5 7.8 2.4 0.2 0.9 2.5 1.6 1.8 0.0 0.6 1.8 3.6 15.3 0.1 0.2 0.4 0.0 0.3 1.3 44.9 0.0 0.2 0.0 0.0 1.8 0.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.2 1.0 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.1 0.2 0.0 0.0 0.0 0.0 0.2 2.7 11.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.0 77.7 3.8 96.8 92.9 2.9 13.4 0.0 10.8 0.0 15.3 44.9 43.4 0.0 0.0 7.8 0.0 0.0 0.4 0.0 0.6 13.9 0.4 2.4 1.4 0.0 0.0 0.0 6.2 1.7 0.1 0.0 0.0 0.0 0.6 0.2 0.1 4.5 0.0 0.0 338.3 0.0 0.4 0.9 0.0 0.3 0.0 0.2 0.7 0.0 0.6 13.5 543.3 0.0 0.0 1.8 0.0 1.8 0.0 0.3 0.0 4.7 0.1 2.5 0.0 128.2 8.3 0.3 0.0 0.0 0.0 0.3 0.0 2.7 0.0 3.7 0.0 0.7 0.7 4.9 6.9 0.0 0.0 0.8 0.1 0.1 0.0 0.2 SYNJ2BP Arip2 ENSG00000213463 "Synaptojanin 2 binding protein" P57105 14 70366499-70417090 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 140.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000866 Approved Supported Approved Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 8: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" Mitochondria "HPA000866: AB_2276678" "unprognostic (2.68e-1)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "unprognostic (1.28e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.60e-2)" "unprognostic (5.70e-2)" "unprognostic (6.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.44e-2)" "prognostic favorable (1.11e-16)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (5.35e-3)" "unprognostic (1.14e-2)" 10.2 10.1 10.3 7.3 10.1 1.3 9.9 9.3 10.0 8.1 13.3 13.7 19.6 9.0 7.9 8.2 7.2 8.4 14.9 8.4 9.3 21.7 20.3 9.5 6.6 10.0 9.8 7.2 7.4 24.9 6.6 9.3 9.8 12.9 15.1 16.4 9.5 11.9 28.7 5.7 16.0 10.7 10.8 9.1 15.5 3.9 10.6 5.1 11.2 29.3 6.4 8.6 6.1 9.7 14.0 9.1 15.3 10.3 11.7 13.4 10.6 10.8 11.1 7.4 8.3 8.7 12.8 0.0 10.0 12.7 7.5 11.6 15.7 11.6 17.5 1.9 8.0 5.2 13.9 11.4 10.3 0.0 1.7 10.5 9.2 9.4 5.3 13.1 16.6 5.8 3.1 2.7 13.4 10.2 7.2 2.1 11.1 13.9 10.9 9.0 22.4 3.9 16.0 20.7 11.1 19.4 14.6 12.0 8.8 9.9 22.7 3.6 18.5 17.7 12.1 6.9 8.7 3.7 15.0 0.0 15.6 1.8 14.9 0.3 3.0 0.1 2.3 3.1 2.7 2.5 2.8 2.7 3.0 2.0 3.8 3.1 0.3 2.3 2.1 1.9 2.3 1.1 10.3 10.1 9.3 10.0 8.4 9.3 10.0 9.8 9.8 10.8 10.6 9.7 36.6 38.5 46.6 0.0 17.8 6.0 28.7 49.4 9.1 44.9 25.9 15.4 89.4 48.6 43.3 75.4 81.3 38.3 13.1 50.1 140.8 49.0 36.9 56.0 26.5 38.4 19.8 5.7 0.0 39.2 31.5 21.7 21.9 85.7 9.5 33.5 37.1 50.4 24.7 30.3 0.0 41.2 44.7 23.6 9.1 9.8 30.4 16.9 14.2 0.0 28.8 37.1 28.8 0.0 0.0 35.7 43.5 41.3 4.2 25.8 87.3 77.0 31.5 88.0 26.3 37.6 27.8 68.9 12.9 12.5 4.8 10.9 17.4 25.0 62.6 30.3 SYNPO2 MYOPODIN ENSG00000172403 "Synaptopodin 2" Q9UMS6 4 118850688-119061247 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 991.6;tongue: 493.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1" "Group enriched" "Detected in all" 5 "prostate cancer: 25.7;stomach cancer: 27.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2" "Region enriched" "Detected in all" 4 "thalamus: 27.1" "Low region specificity" "Detected in all" "HPA030665, CAB037231, HPA049707, HPA068563" Enhanced Enhanced "Vesicles,Actin filaments" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Vesicles, Actin filaments" "CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006" "unprognostic (1.50e-2)" "unprognostic (1.73e-2)" "unprognostic (5.32e-2)" "unprognostic (1.50e-2)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (5.71e-4)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (1.39e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (1.82e-2)" "unprognostic (1.35e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.91e-4)" 57.5 10.8 6.1 47.4 7.9 0.3 35.9 4.1 5.7 55.0 2.2 346.4 34.3 137.1 33.4 197.1 89.5 50.0 66.8 10.7 13.3 8.7 7.0 16.2 10.5 5.4 7.5 39.0 3.8 3.6 7.5 20.8 6.1 180.5 58.0 1.2 16.0 267.4 991.6 17.9 75.5 244.4 9.2 10.2 126.2 6.7 5.8 14.3 16.0 493.5 6.5 226.5 54.0 12.0 0.2 4.2 0.2 0.0 10.5 3.5 0.7 13.4 14.1 0.4 0.5 0.0 0.7 1.5 0.1 57.8 0.9 0.2 0.4 0.3 0.7 5.9 0.1 0.8 1.3 0.0 2.4 0.1 0.2 14.5 0.3 4.0 0.2 3.7 0.2 0.2 0.0 0.7 18.5 0.3 0.7 7.2 1.4 0.0 0.0 0.5 1.5 0.4 0.2 0.3 0.4 83.2 0.4 0.3 0.1 3.3 0.0 7.0 0.4 0.6 0.1 0.2 0.1 0.1 0.3 0.1 1.1 0.6 0.2 0.8 0.1 0.5 0.2 0.0 0.4 0.3 0.4 0.2 0.0 0.4 0.4 0.3 0.2 0.3 0.1 0.0 0.5 0.1 6.1 7.9 4.1 5.7 10.7 13.3 5.4 7.5 6.1 9.2 5.8 12.0 25.5 3.2 1.1 42.7 1.1 13.5 17.9 3.7 46.1 2.5 6.3 30.7 135.4 0.0 0.3 1.8 0.0 1.4 0.5 0.1 0.0 0.1 2.2 6.9 130.0 11.3 0.0 1.7 149.6 1.8 0.5 41.5 0.5 10.6 0.0 16.1 13.9 0.4 1.4 0.0 31.5 0.2 0.0 0.9 11.4 7.0 27.1 3.8 5.4 76.8 12.9 0.0 0.0 6.0 3.0 0.2 0.4 101.5 0.8 24.9 0.1 0.3 2.5 0.5 131.5 93.4 206.1 1.3 0.5 5.3 8.1 0.8 2.6 33.4 0.2 4.0 SYT1 "P65, SVP65, SYT" ENSG00000067715 "Synaptotagmin 1" P21579 12 78863993-79452008 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 403.3;retina: 197.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 1287.6;Cone photoreceptor cells: 894.5;Excitatory neurons: 3753.2;Inhibitory neurons: 2910.4;Rod photoreceptor cells: 905.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 10 "amygdala: 113.1;basal ganglia: 153.7;cerebral cortex: 403.3;hippocampal formation: 134.2;white matter: 146.0" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.0;naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 39.4;hTERT-RPE1: 37.1;LHCN-M2: 31.9;SH-SY5Y: 30.9;WM-115: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008394, HPA064788" Enhanced Supported NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA008394: AB_1857696, HPA064788: AB_2685351" "unprognostic (1.02e-3)" "unprognostic (2.55e-1)" "unprognostic (4.21e-3)" "unprognostic (3.77e-2)" "unprognostic (3.16e-2)" "unprognostic (3.68e-5)" "unprognostic (2.78e-2)" "unprognostic (1.83e-2)" "unprognostic (7.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-1)" "unprognostic (6.14e-3)" "unprognostic (3.05e-8)" "unprognostic (2.89e-2)" "unprognostic (8.26e-2)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" 0.5 21.7 113.1 2.2 153.7 0.6 0.7 19.7 403.3 1.4 0.0 4.4 1.5 9.9 0.7 0.7 0.8 1.3 0.2 134.2 2.0 1.9 1.9 0.9 0.3 0.0 0.0 5.2 0.3 0.0 6.4 2.6 3.0 6.6 2.8 197.7 0.2 5.5 0.2 0.2 3.4 25.2 0.0 2.6 1.3 0.7 12.5 0.5 0.3 0.5 0.3 1.6 2.5 146.0 0.0 19.2 14.2 0.0 1.4 4.0 0.0 1.4 1.7 1.0 1.1 1.0 0.5 0.0 2.8 0.2 5.0 0.6 0.3 2.2 1.6 0.3 0.7 1.0 0.5 0.0 3.6 0.0 0.3 1.1 1.4 5.2 39.4 37.1 13.6 0.7 0.7 2.2 31.9 3.1 1.8 0.0 10.3 2.1 5.3 0.0 14.3 0.0 0.0 5.5 18.8 30.9 0.0 2.4 0.3 9.5 6.8 0.0 5.4 2.0 0.7 0.0 6.2 3.4 8.0 0.1 4.5 0.0 29.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.1 153.7 19.7 403.3 134.2 2.0 0.0 0.0 3.0 0.0 12.5 146.0 2.2 0.0 0.6 124.7 9.0 0.9 0.1 0.0 0.0 1287.6 0.2 3.4 0.6 0.0 1.3 0.0 894.5 5.6 0.1 0.1 0.0 0.0 1.4 0.6 20.2 10.4 96.9 1.3 3753.2 0.2 2.2 5.9 0.0 0.7 0.0 0.7 1.8 0.1 13.9 62.2 2910.4 0.1 0.0 4.7 7.2 2.9 69.3 1.6 1.8 137.7 0.0 337.7 0.0 126.2 105.1 0.1 7.6 4.5 8.5 11.5 0.1 0.1 0.0 905.8 0.0 0.0 6.7 1.5 5.7 0.2 0.6 5.9 0.4 1.8 0.1 0.3 SYT4 "HsT1192, KIAA1342" ENSG00000132872 "Synaptotagmin 4" Q9H2B2 18 43267892-43277535 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.7;pituitary gland: 30.7;retina: 25.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 66.8;Cone photoreceptor cells: 22.9;Enteroendocrine cells: 28.7;Excitatory neurons: 50.9;Fibroblasts: 23.0;Inhibitory neurons: 34.1" "Group enriched" "Detected in some" 5 "glioma: 2.0;pancreatic cancer: 4.1;prostate cancer: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 245.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010574 Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Vesicles, Plasma membrane" "HPA010574: AB_2668309" "unprognostic (2.91e-3)" "unprognostic (2.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (7.67e-3)" "unprognostic (5.30e-3)" "unprognostic (3.95e-2)" "unprognostic (1.23e-3)" "unprognostic (3.61e-1)" "unprognostic (3.80e-2)" 3.7 15.9 21.5 1.4 18.6 0.1 0.0 74.7 42.6 0.0 0.0 1.2 0.8 0.0 0.0 0.1 0.0 0.0 1.3 18.6 50.4 0.1 0.0 0.9 0.0 10.5 15.3 0.5 3.7 0.0 30.7 0.1 39.3 0.6 0.8 25.2 0.1 8.3 0.0 0.0 0.7 0.6 13.5 0.0 3.2 1.6 18.3 0.4 0.3 0.0 0.0 0.0 0.5 10.9 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 245.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 18.6 74.7 42.6 18.6 50.4 10.5 15.3 39.3 13.5 18.3 10.9 0.0 0.0 1.1 8.8 0.0 0.1 0.0 0.0 0.0 66.8 0.0 0.0 3.6 0.0 2.5 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 28.7 0.0 50.9 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.4 0.0 2.5 0.0 7.5 7.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 10.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.1 TAGLN3 "NP22, NP25" ENSG00000144834 "Transgelin 3" Q9UI15 3 111998739-112013887 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 442.4;choroid plexus: 172.3;pituitary gland: 100.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 104.3;Excitatory neurons: 78.1;Horizontal cells: 297.8;Inhibitory neurons: 49.3;Rod photoreceptor cells: 50.7" "Cancer enriched" "Detected in many" 4 "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 104.1;RPTEC TERT1: 41.6;SCLC-21H: 55.5;SH-SY5Y: 94.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062620 Enhanced NA NA 9000000 "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA062620: AB_2684810" "unprognostic (1.55e-2)" "unprognostic (2.28e-1)" "unprognostic (1.81e-1)" "unprognostic (1.36e-3)" "unprognostic (4.28e-1)" "unprognostic (4.07e-1)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (8.92e-2)" "unprognostic (6.82e-3)" "unprognostic (2.51e-1)" "unprognostic (5.49e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (8.60e-2)" "unprognostic (7.67e-3)" 0.3 33.5 291.3 1.5 313.2 0.0 0.1 250.3 442.4 0.0 172.3 11.4 0.6 0.0 0.0 0.2 0.0 0.2 0.6 318.0 310.2 4.5 0.3 0.5 0.2 300.5 235.8 0.3 5.6 0.0 100.9 0.0 292.8 0.5 2.3 74.3 0.2 0.2 0.2 0.6 2.4 1.1 212.3 0.1 3.3 0.3 254.2 1.3 0.4 0.0 0.2 0.2 1.1 309.3 0.0 0.0 104.1 0.2 0.0 0.0 0.1 2.6 1.9 0.1 0.1 0.4 0.2 0.0 3.8 0.0 0.1 0.7 0.1 7.2 1.4 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.5 0.0 0.0 0.8 0.4 0.0 0.1 0.0 4.0 0.0 9.0 15.1 2.8 0.0 41.6 0.0 55.5 94.5 0.0 0.1 0.0 2.1 0.1 0.3 0.0 0.3 0.3 0.0 0.3 0.1 0.1 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 291.3 313.2 250.3 442.4 318.0 310.2 300.5 235.8 292.8 212.3 254.2 309.3 0.1 0.0 0.0 16.6 0.0 0.8 1.2 1.0 0.0 104.3 0.2 0.3 0.7 0.0 1.8 5.5 8.4 0.0 0.1 0.0 0.0 0.1 2.6 0.2 0.0 1.1 5.3 0.0 78.1 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 297.8 49.3 0.0 30.5 0.0 0.0 0.9 0.0 0.4 0.0 15.0 0.0 16.3 0.0 32.2 18.8 2.3 0.0 0.0 0.0 1.1 0.0 31.9 12.8 50.7 0.0 0.4 0.5 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.9 TBX20 ENSG00000164532 "T-box transcription factor 20" Q9UMR3 7 35202430-35254100 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "heart muscle: 35.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "medulla oblongata: 1.2;pons: 3.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.2;HEL: 3.2;HHSteC: 3.4;HMC-1: 3.9;RH-30: 3.8;SH-SY5Y: 7.4;WM-115: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA007840 Approved "Nucleoli fibrillar center" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoli fibrillar center" "HPA007840: " "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.87e-2)" "unprognostic (8.47e-2)" "unprognostic (3.95e-2)" "unprognostic (2.75e-1)" "unprognostic (1.74e-1)" "unprognostic (9.75e-2)" 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 35.9 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.5 3.7 3.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.7 2.3 0.0 0.4 0.0 0.1 0.2 3.2 0.0 0.0 1.7 2.5 3.2 0.9 0.0 3.4 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 3.8 0.0 0.0 0.0 0.2 7.4 0.3 0.0 0.0 1.9 0.0 2.9 0.0 0.0 0.1 2.7 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 TCAF1 "FAM115A, KIAA0738" ENSG00000198420 "TRPM8 channel associated factor 1" Q9Y4C2 7 143851375-143902198 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 251.7;Syncytiotrophoblasts: 521.5;Theca cells: 377.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011732 Approved Approved "Nuclear bodies,Vesicles,Cell Junctions" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 28: Placenta - Pregnancy" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "Cell Junctions" "Nuclear bodies, Vesicles" "HPA011732: AB_2668526" "unprognostic (1.57e-1)" "unprognostic (7.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.11e-1)" "unprognostic (2.73e-1)" "unprognostic (7.00e-2)" "unprognostic (5.70e-3)" "unprognostic (3.07e-2)" "unprognostic (4.93e-2)" "prognostic favorable (5.93e-4)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (3.95e-3)" "unprognostic (6.45e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.89e-1)" 29.0 46.5 22.7 12.9 51.4 4.7 21.7 15.1 30.3 27.5 2.7 18.8 12.2 32.2 15.2 15.1 22.2 19.3 23.7 29.4 42.7 14.8 29.3 19.0 8.4 15.4 13.4 39.9 19.4 35.1 27.2 81.1 19.8 36.2 20.3 28.0 15.8 19.8 17.5 16.9 15.8 30.6 11.5 11.7 21.7 9.4 31.0 17.1 26.8 55.7 9.0 14.8 13.4 20.1 47.2 29.0 90.1 93.7 57.9 55.7 55.1 54.3 64.9 42.4 56.3 60.5 33.0 0.2 25.2 63.3 54.5 29.7 34.8 35.7 46.5 25.7 26.0 25.7 15.7 54.0 39.7 0.3 16.2 58.2 31.5 50.0 18.4 66.8 53.4 32.2 43.2 4.5 83.2 70.7 42.3 15.9 27.6 52.0 17.4 26.0 60.7 6.2 33.7 37.5 25.6 153.1 55.5 34.2 25.7 63.7 51.5 4.0 48.8 44.6 28.5 42.2 32.7 14.0 19.2 0.4 81.9 7.6 62.3 0.4 1.5 0.9 4.7 1.8 3.3 1.6 2.8 3.1 2.9 1.6 2.4 3.0 0.4 4.4 3.1 1.4 2.3 2.5 22.7 51.4 15.1 30.3 29.4 42.7 15.4 13.4 19.8 11.5 31.0 20.1 36.3 44.8 37.1 30.3 7.3 0.0 15.0 0.0 16.5 47.7 29.4 38.6 43.0 31.5 14.9 3.7 25.0 251.7 15.2 18.7 0.0 30.9 2.4 27.6 62.7 35.1 19.4 22.1 71.2 35.6 43.7 54.6 20.9 40.5 7.6 167.5 34.6 83.6 32.9 30.3 63.1 29.3 0.0 10.5 0.0 3.5 53.1 12.2 0.0 29.0 10.8 27.5 20.6 57.3 43.7 49.9 15.4 56.4 8.4 27.3 20.1 8.9 8.0 26.7 13.1 72.1 53.3 13.3 11.7 14.1 0.0 521.5 10.4 377.5 23.5 24.3 TCEAL5 WEX4 ENSG00000204065 "Transcription elongation factor A like 5" Q5H9L2 X 103273691-103276750 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 67.3;choroid plexus: 35.5;pituitary gland: 62.2;retina: 23.5;testis: 60.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 43.4;Granulosa cells: 16.5;Late spermatids: 22.1;Muller glia cells: 75.5;Peritubular cells: 35.7" "Cancer enhanced" "Detected in many" "glioma: 13.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 9.0;SH-SY5Y: 28.0" "Low region specificity" "Detected in all" "HPA045564, HPA058982" Supported Approved Nucleoplasm NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (1.30e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (9.68e-2)" "unprognostic (8.75e-4)" "unprognostic (1.21e-1)" "unprognostic (8.11e-2)" "prognostic favorable (8.60e-4)" "unprognostic (1.28e-2)" "unprognostic (1.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.74e-1)" "unprognostic (6.30e-2)" "unprognostic (6.03e-4)" 0.9 10.5 56.5 0.9 54.9 0.0 2.1 55.4 67.3 6.2 35.5 2.2 0.6 5.6 6.8 0.3 2.4 0.8 2.7 52.9 55.2 0.3 0.1 0.3 0.0 50.8 52.6 5.2 0.9 0.0 62.2 0.0 49.5 3.3 0.7 23.5 1.1 4.1 0.1 0.4 1.2 3.3 44.9 0.0 1.0 60.0 50.3 0.6 2.3 0.7 0.0 1.5 3.8 55.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.5 54.9 55.4 67.3 52.9 55.2 50.8 52.6 49.5 44.9 50.3 55.4 0.1 0.0 0.0 2.9 0.0 0.1 0.5 0.0 1.8 43.4 0.3 9.5 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.4 0.3 7.5 0.6 0.0 0.0 7.0 0.0 0.4 7.6 0.0 0.2 0.0 16.5 0.0 0.0 0.3 1.7 7.7 0.0 0.0 0.0 1.7 22.1 8.4 0.7 0.0 2.8 0.0 75.5 0.0 7.1 2.8 0.0 0.0 35.7 0.0 0.2 0.0 0.3 0.0 6.8 0.0 6.9 1.4 7.6 1.9 0.1 0.3 0.4 0.1 0.2 0.0 0.2 TCF4 "bHLHb19, E2-2, ITF2, SEF2-1B" ENSG00000196628 "Transcription factor 4" P15884 18 55222185-55664787 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Corneal dystrophy, Disease variant, Epilepsy, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.1" "Cell type enhanced" "Detected in many" "Adipocytes: 820.0;Endothelial cells: 574.5;Inhibitory neurons: 1177.6;Oligodendrocyte precursor cells: 719.8;Oligodendrocytes: 573.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 65.1" "Group enriched" "Detected in many" 14 "memory B-cell: 173.6;naive B-cell: 146.8;plasmacytoid DC: 559.8" "Group enriched" "Detected in many" 33 "B-cells: 173.6;dendritic cells: 559.8" "Cell line enhanced" "Detected in many" "HDLM-2: 140.4;SH-SY5Y: 157.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020722, HPA025958" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Cytosol" "CAB020722: , HPA025958: AB_1857849" "unprognostic (2.11e-1)" "unprognostic (9.10e-2)" "unprognostic (8.69e-2)" "unprognostic (7.89e-3)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (3.03e-2)" "unprognostic (8.64e-2)" "unprognostic (1.79e-2)" "unprognostic (3.29e-2)" "unprognostic (2.77e-1)" "unprognostic (8.44e-2)" "prognostic unfavorable (7.24e-5)" "unprognostic (1.99e-3)" "unprognostic (2.68e-2)" "unprognostic (2.76e-3)" "prognostic unfavorable (9.95e-4)" 20.3 9.6 3.7 12.8 12.5 9.5 11.6 65.1 26.5 28.5 0.0 7.4 5.1 23.0 2.1 9.7 13.4 17.4 17.5 29.8 0.0 4.4 4.4 15.5 14.7 5.5 1.0 25.9 5.8 8.0 6.5 28.9 3.9 6.6 7.9 14.0 6.8 10.2 6.1 6.4 5.0 24.1 2.2 13.1 6.0 15.4 2.4 9.8 13.3 16.7 14.7 13.1 7.3 14.4 0.1 4.1 36.8 11.4 8.5 14.4 0.1 18.4 40.6 13.2 17.2 23.1 3.6 28.8 0.1 41.9 2.7 4.5 17.9 17.1 9.2 140.4 13.9 12.1 0.1 0.0 4.0 5.3 2.8 19.6 5.3 18.5 0.7 9.1 45.8 1.6 19.5 22.0 11.0 0.0 7.6 0.0 10.4 0.1 2.4 41.6 14.9 65.4 0.0 0.9 12.6 157.7 0.0 1.5 0.0 11.1 1.6 1.3 49.1 48.5 17.4 2.1 14.6 16.3 32.2 25.7 11.0 5.2 15.5 0.9 7.4 0.8 0.9 8.3 0.7 173.6 0.2 0.5 20.6 146.8 0.5 0.3 1.8 11.2 7.4 559.8 0.7 11.3 3.7 12.5 65.1 26.5 29.8 0.0 5.5 1.0 3.9 2.2 2.4 14.4 820.0 6.4 13.1 501.1 217.4 117.0 37.8 34.0 80.8 293.0 6.5 23.4 35.5 4.3 32.6 22.0 83.4 1.8 446.8 0.1 0.0 1.5 103.2 17.5 201.4 574.5 5.4 34.2 503.8 7.1 1.5 296.7 1.5 12.2 13.9 105.7 316.3 6.6 39.6 25.2 1177.6 0.3 26.4 112.4 129.2 116.3 205.3 80.4 64.0 474.1 32.7 372.8 13.4 719.8 573.6 2.1 0.1 182.1 131.7 20.8 0.0 2.3 25.9 54.7 236.7 304.5 221.0 8.7 14.5 47.5 84.4 2.6 15.1 164.8 0.2 17.8 TECTA "DFNA12, DFNA8, DFNB21" ENSG00000109927 "Tectorin alpha" O75443 11 121101243-121191490 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Hearing "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Astrocytes: 5.2;Cone photoreceptor cells: 4.2;Early spermatids: 5.6;Excitatory neurons: 9.9;Hepatic stellate cells: 8.9;Inhibitory neurons: 7.2;Oligodendrocyte precursor cells: 5.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;SH-SY5Y: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA018870 Approved "Secreted in other tissues" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA018870: AB_1857879" "unprognostic (1.12e-3)" "unprognostic (2.42e-1)" "unprognostic (1.42e-2)" "unprognostic (1.45e-2)" "unprognostic (4.30e-2)" "unprognostic (3.11e-1)" "unprognostic (3.00e-2)" "unprognostic (3.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.39e-6)" "unprognostic (1.22e-1)" "unprognostic (4.15e-3)" "unprognostic (6.97e-3)" "unprognostic (1.12e-1)" "unprognostic (3.28e-2)" "unprognostic (4.19e-2)" 0.3 0.5 1.6 0.2 2.1 0.2 0.3 1.0 1.6 0.3 1.5 0.5 0.1 0.3 0.6 0.1 0.3 0.3 1.1 1.3 2.0 0.5 0.4 0.4 0.1 1.5 1.4 0.7 0.3 0.8 1.3 0.2 1.5 0.5 0.1 1.1 0.3 0.5 0.8 0.1 0.2 0.2 0.9 0.3 0.3 0.9 1.6 0.2 0.7 0.4 0.1 0.3 0.2 1.9 0.0 0.0 1.1 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.7 1.7 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 1.0 1.6 1.3 2.0 1.5 1.4 1.5 0.9 1.6 1.9 0.5 3.2 0.5 5.2 0.1 0.0 0.1 0.0 0.0 1.8 0.2 0.3 1.9 1.5 0.6 0.0 4.2 0.0 0.2 0.0 0.0 0.2 5.6 0.6 0.3 0.5 0.0 0.0 9.9 0.4 0.1 0.4 0.0 0.3 0.0 0.6 8.9 0.6 0.1 0.0 7.2 0.0 0.0 0.3 0.0 2.7 0.3 0.2 0.0 1.0 0.2 0.9 0.0 5.0 2.8 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.2 0.7 0.0 1.9 0.4 0.9 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 TFAP2B AP2-B ENSG00000008196 "Transcription factor AP-2 beta" Q92481 6 50818723-50847619 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 33.3;retina: 14.8" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 145.7;Bipolar cells: 76.4;Horizontal cells: 437.4;Melanocytes: 106.7" "Cancer enriched" "Detected in some" 8 "breast cancer: 12.1" "Group enriched" "Detected in many" 6 "cerebellum: 3.5;medulla oblongata: 3.9;midbrain: 9.0;pons: 10.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 109.6;SH-SY5Y: 208.1" "Region enhanced" "Detected in many" "cerebellum: 10.0" "Low region specificity" "Detected in many" "HPA034683, HPA062942" Enhanced Approved Nucleoplasm NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA034683: AB_10670966, HPA062942: AB_2684909" "unprognostic (2.02e-1)" "unprognostic (2.29e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-4)" "unprognostic (9.76e-2)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (4.57e-1)" "unprognostic (6.58e-6)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (7.17e-3)" 0.1 3.4 0.0 0.0 0.0 0.0 8.2 3.5 0.1 0.1 0.0 0.1 0.0 0.0 33.3 3.9 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 3.9 9.0 0.0 0.0 0.0 0.6 0.2 10.2 0.0 0.0 14.8 6.4 0.7 0.0 8.6 0.0 0.0 0.6 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 109.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 35.5 0.1 0.2 208.1 0.0 0.8 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.1 3.9 9.0 10.2 0.6 1.1 0.2 0.2 0.0 0.0 0.0 0.0 11.7 0.0 0.0 145.7 76.4 43.0 29.7 0.9 0.0 0.0 51.5 8.4 14.9 0.1 0.0 54.8 0.0 17.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 437.4 0.0 0.0 0.0 0.0 1.5 2.0 0.0 0.5 106.7 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.7 0.0 11.8 0.0 0.0 0.3 1.9 0.6 31.1 4.3 4.9 0.2 0.0 0.0 0.0 TLX2 "Enx, HOX11L1, NCX" ENSG00000115297 "T cell leukemia homeobox 2" O43763 2 74513463-74517148 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.0;retina: 3.1" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 20.9;Rod photoreceptor cells: 18.0;Spermatocytes: 4.3;Spermatogonia: 7.4" "Cancer enhanced" "Detected in single" "cervical cancer: 0.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "SH-SY5Y: 64.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA062254 Approved Nucleoplasm NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA062254: AB_2684727" "unprognostic (7.30e-2)" "unprognostic (3.03e-4)" "unprognostic (9.54e-4)" "unprognostic (2.86e-2)" "unprognostic (2.33e-1)" "unprognostic (1.69e-2)" "unprognostic (6.77e-2)" "unprognostic (1.36e-1)" "unprognostic (9.00e-2)" "unprognostic (3.91e-2)" "unprognostic (1.39e-1)" "unprognostic (5.40e-1)" "unprognostic (3.92e-7)" "unprognostic (2.51e-1)" "unprognostic (6.86e-2)" "unprognostic (5.04e-2)" "unprognostic (1.18e-1)" 0.0 2.0 1.0 0.2 0.3 0.0 0.0 0.4 0.8 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.2 1.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.9 0.0 3.4 0.0 0.0 0.0 0.0 4.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.0 3.2 0.0 0.1 0.1 0.0 0.0 0.0 1.4 3.8 0.2 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.4 0.8 0.1 0.1 0.5 0.4 0.4 0.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 20.9 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 4.3 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TLX3 "HOX11L2, RNX" ENSG00000164438 "T cell leukemia homeobox 3" O43711 5 171309248-171312139 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "brain: 9.0" "Cell type enriched" "Detected in some" 6 "Extravillous trophoblasts: 7.7" "Cancer enhanced" "Detected in some" "cervical cancer: 1.7" "Group enriched" "Detected in many" 6 "cerebellum: 9.0;medulla oblongata: 2.3;spinal cord: 5.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 25.9" "Region enriched" "Detected in single" 7 "cerebellum: 2.2" "Region enriched" "Detected in some" 8 "cerebellum: 15.5" "HPA030504, HPA060957, HPA069359" Enhanced Enhanced Nucleoplasm NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130" "unprognostic (3.52e-2)" "unprognostic (2.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.11e-1)" "unprognostic (9.80e-2)" "unprognostic (2.76e-2)" "unprognostic (4.48e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.2 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.4 0.0 0.0 2.3 0.6 1.0 5.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397775 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 35.2;skeletal muscle: 23.1" "Cell type enhanced" "Detected in many" "Astrocytes: 209.9;Excitatory neurons: 357.3;Inhibitory neurons: 475.3;Oligodendrocyte precursor cells: 480.0" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 24.2;LHCN-M2: 13.8;SCLC-21H: 21.0;SH-SY5Y: 92.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 55000 "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: AB_2684993" "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 1.4 11.3 6.3 1.5 9.6 0.2 1.5 3.4 10.0 2.0 3.2 1.5 0.4 2.4 0.6 9.6 1.7 0.8 6.8 9.6 2.9 0.4 0.1 11.0 1.7 0.0 4.1 0.3 0.3 3.0 2.2 2.4 4.0 1.0 1.3 35.2 1.3 2.0 23.1 1.4 1.6 5.5 0.0 1.3 1.3 13.9 7.9 1.3 3.1 7.0 2.3 8.3 0.8 0.8 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.1 1.0 0.0 0.0 0.1 0.2 0.0 0.7 1.0 1.8 8.5 0.0 0.0 0.0 0.0 24.2 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 13.8 0.7 0.1 0.3 3.8 0.0 0.0 0.0 4.8 0.1 1.1 0.0 21.0 92.6 0.0 0.1 0.3 5.5 0.2 0.0 0.0 0.1 0.1 0.0 3.4 1.3 0.0 0.7 1.8 0.0 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 9.6 3.4 10.0 9.6 2.9 0.0 4.1 4.0 0.0 7.9 0.8 0.6 3.2 4.6 209.9 0.0 2.4 0.5 0.2 0.0 10.4 1.3 2.8 1.7 1.5 5.0 0.0 102.2 1.8 0.0 0.0 0.0 0.0 80.6 1.0 0.6 1.3 0.0 0.0 357.3 0.4 8.6 4.6 4.1 0.2 1.3 5.5 0.4 0.0 0.3 1.7 475.3 0.0 0.0 0.0 0.8 38.2 0.9 0.1 0.0 33.7 0.0 5.7 0.0 480.0 22.2 0.3 0.0 0.7 1.2 0.2 0.0 0.0 0.0 57.6 0.0 6.8 3.3 17.2 11.2 0.0 1.6 1.1 1.0 4.9 0.0 0.4 TMEM130 "DKFZp761L1417, FLJ42643" ENSG00000166448 "Transmembrane protein 130" Q8N3G9 7 98846488-98870771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 37.1;brain: 141.0;pituitary gland: 100.3;testis: 37.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 51.2;Excitatory neurons: 43.8;Inhibitory neurons: 53.9" "Cancer enhanced" "Detected in many" "renal cancer: 9.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.7;EFO-21: 6.4;GAMG: 6.9;hTERT-RPE1: 11.0;NTERA-2: 3.8;SH-SY5Y: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012928 Uncertain Supported "Golgi apparatus" NA NA 9400 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "HPA012928: AB_1858085" "unprognostic (1.36e-2)" "unprognostic (1.33e-3)" "unprognostic (3.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.61e-3)" "unprognostic (3.23e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "unprognostic (4.69e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-3)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.17e-2)" "unprognostic (1.73e-1)" 0.5 37.1 63.7 1.5 64.2 0.6 1.2 0.0 116.6 3.2 0.0 3.9 0.8 1.1 9.4 1.6 1.0 1.8 0.6 67.3 141.0 3.4 0.1 6.2 2.3 11.6 8.2 0.9 0.8 2.7 100.3 0.5 17.0 2.4 1.2 17.9 0.4 6.7 2.0 0.4 1.5 0.8 7.2 0.7 1.4 37.4 55.7 1.8 0.5 0.1 0.3 0.9 4.9 42.4 0.0 0.6 0.0 0.0 0.2 0.0 0.3 2.9 6.7 0.5 0.4 0.1 0.1 0.1 6.4 1.7 6.9 0.1 0.0 0.0 0.1 0.2 0.3 0.1 0.3 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 11.0 0.3 0.2 0.1 0.4 0.3 0.5 0.1 0.2 3.8 0.0 0.2 0.1 0.0 0.6 0.0 0.1 0.4 7.8 0.1 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.2 0.1 0.4 0.4 0.2 0.8 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 1.6 0.3 0.2 0.2 0.1 0.1 63.7 64.2 0.0 116.6 67.3 141.0 11.6 8.2 17.0 7.2 55.7 42.4 0.1 0.0 0.0 2.6 0.0 0.4 0.4 0.1 0.0 51.2 0.3 0.4 1.0 1.5 2.0 1.8 2.1 0.1 1.5 0.1 0.0 0.0 1.6 0.1 0.2 0.5 0.0 0.0 43.8 0.2 0.1 2.1 0.0 0.2 0.0 0.5 0.7 0.0 0.1 0.0 53.9 0.0 2.0 0.0 1.2 2.7 0.9 0.3 0.0 3.7 0.0 1.7 0.0 11.6 4.2 0.0 0.0 6.8 0.0 0.3 0.2 0.1 0.3 4.3 0.0 0.6 0.8 0.6 0.6 0.0 0.3 0.3 0.2 0.0 0.1 0.2 TMEM145 FLJ90805 ENSG00000167619 "Transmembrane protein 145" Q8NBT3 19 42313309-42325064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 67.8;pituitary gland: 18.3;retina: 28.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 64.5;Cone photoreceptor cells: 29.2;Excitatory neurons: 26.5;Horizontal cells: 69.0;Inhibitory neurons: 54.3;Rod photoreceptor cells: 33.0" "Cancer enriched" "Detected in many" 5 "glioma: 8.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 6.8;neutrophil: 14.2" "Lineage enriched" "Detected in many" 11 "granulocytes: 14.2" "Cell line enhanced" "Detected in many" "HMC-1: 13.7;PC-3: 11.6;SCLC-21H: 26.2;SH-SY5Y: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060462 Enhanced Approved Approved Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Vesicles "HPA060462: AB_2684285" "unprognostic (9.56e-3)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" "unprognostic (6.62e-2)" "unprognostic (2.14e-1)" "unprognostic (4.27e-3)" "unprognostic (1.53e-2)" "unprognostic (9.85e-2)" "unprognostic (4.20e-4)" "unprognostic (7.35e-2)" "unprognostic (7.64e-2)" "unprognostic (2.30e-1)" "unprognostic (6.31e-2)" 1.0 4.3 17.7 0.7 21.0 2.0 0.7 67.8 37.3 0.2 0.1 0.8 1.2 0.6 1.0 0.5 0.6 0.8 0.9 16.5 15.6 0.5 0.7 0.3 1.1 17.8 20.0 0.6 2.5 1.8 18.3 0.2 18.2 0.5 0.6 28.8 0.5 0.5 1.8 2.3 0.6 0.6 10.7 0.9 1.2 4.2 19.2 0.4 0.7 0.8 0.5 0.6 0.2 21.0 0.7 3.2 2.4 7.3 0.2 0.2 1.0 0.3 0.1 1.1 3.0 0.6 0.9 1.9 0.3 1.2 0.7 0.3 1.7 0.6 1.5 8.5 2.0 3.5 3.5 3.1 0.2 2.0 13.7 0.7 0.6 0.4 0.8 0.2 1.4 1.0 1.9 6.6 0.1 0.7 0.5 2.5 1.7 2.4 11.6 0.3 0.8 6.2 0.1 1.3 26.2 12.7 1.2 0.9 1.7 0.2 2.3 2.1 0.5 2.0 2.3 1.6 0.9 1.4 4.2 1.9 0.9 1.4 6.1 6.8 0.9 1.0 0.6 0.8 0.3 1.2 0.6 0.4 0.3 1.2 0.6 0.9 14.2 0.8 0.8 0.8 0.5 1.2 17.7 21.0 67.8 37.3 16.5 15.6 17.8 20.0 18.2 10.7 19.2 21.0 0.5 0.0 0.0 16.3 0.1 0.3 0.4 0.0 0.0 64.5 0.7 0.9 0.5 0.0 0.0 0.0 29.2 0.0 0.1 0.2 0.0 0.2 0.3 0.1 0.1 0.8 0.0 0.0 26.5 0.2 0.1 0.1 0.0 0.2 1.3 0.1 1.1 0.0 0.4 69.0 54.3 0.0 0.0 0.6 0.3 0.2 0.0 0.2 5.4 1.0 0.0 10.3 2.1 15.1 5.7 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.0 33.0 0.0 1.4 0.3 9.5 17.9 0.0 0.1 0.0 0.1 1.4 0.1 0.1 TMEM198 "MGC99813, TMEM198A" ENSG00000188760 "Transmembrane protein 198" Q66K66 2 219543663-219550595 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.0" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 19.2;Horizontal cells: 21.9;Muller glia cells: 10.9;Proximal enterocytes: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 20.0;SH-SY5Y: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042385, HPA062897" Enhanced Approved Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Vesicles "HPA042385: AB_2677972, HPA062897: " "unprognostic (2.59e-2)" "unprognostic (8.51e-2)" "unprognostic (5.97e-3)" "unprognostic (2.77e-1)" "unprognostic (4.43e-2)" "unprognostic (8.09e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (4.28e-1)" "unprognostic (2.06e-1)" "prognostic favorable (6.89e-4)" "unprognostic (6.39e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" 3.2 8.2 10.8 1.4 9.7 0.1 3.0 12.1 19.4 4.6 2.3 2.7 8.9 5.2 1.0 2.0 3.6 1.8 4.4 21.0 8.4 4.0 4.3 3.2 0.7 7.7 7.4 14.7 12.0 3.1 18.3 1.1 6.0 4.2 0.6 2.5 3.8 1.8 2.8 1.5 4.4 1.6 7.4 2.2 4.6 5.9 8.5 0.5 4.0 2.0 0.7 3.8 2.0 8.8 0.6 0.1 5.6 9.6 1.1 1.0 4.9 2.8 1.5 2.3 2.0 12.5 1.6 2.6 2.7 1.8 5.8 3.5 2.0 1.4 0.4 8.7 2.4 2.0 2.9 10.4 1.6 0.7 4.7 2.4 0.8 1.1 2.7 2.5 0.0 1.8 7.8 8.1 1.4 1.2 0.1 0.6 7.3 1.0 0.9 0.2 3.4 2.9 1.4 1.4 20.0 17.4 0.7 2.0 5.0 1.0 0.2 4.0 0.1 2.5 1.0 2.3 1.2 7.7 2.4 2.7 2.3 0.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 10.8 9.7 12.1 19.4 21.0 8.4 7.7 7.4 6.0 7.4 8.5 8.8 0.3 0.0 1.1 2.0 0.8 0.1 1.4 1.4 1.2 9.3 3.5 4.3 1.8 4.3 0.6 0.0 2.1 1.0 0.4 0.4 1.9 3.9 0.8 0.3 2.6 0.4 19.2 0.0 4.9 7.9 0.9 3.9 1.5 0.6 0.0 1.6 0.0 1.6 0.3 21.9 4.8 2.4 2.0 0.3 0.9 1.4 2.8 0.0 1.8 0.0 0.6 10.9 0.0 3.0 1.2 1.5 4.0 4.9 1.1 0.8 12.4 1.8 0.6 7.4 0.0 1.6 2.8 8.4 4.2 0.4 0.1 2.9 0.4 5.5 0.5 0.4 TMEM229A ENSG00000234224 "Transmembrane protein 229A" B2RXF0 7 124030921-124033067 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.6;intestine: 8.4;testis: 5.3" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Bipolar cells: 3.7;Oligodendrocytes: 11.4;Proximal enterocytes: 10.0" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 44 "SH-SY5Y: 130.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056391 Uncertain Approved "Plasma membrane" NA NA "Cluster 45: Intestine - Brush border" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 45: Enterocytes - Digestion" "Plasma membrane" "HPA056391: AB_2683114" "unprognostic (2.52e-2)" "unprognostic (3.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.50e-1)" "unprognostic (2.89e-2)" "unprognostic (8.21e-2)" "unprognostic (4.74e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 0.0 1.0 7.5 0.0 11.0 0.0 0.0 9.8 9.0 0.1 2.5 0.1 8.4 0.1 0.4 0.0 0.6 0.0 0.2 7.7 9.6 0.0 0.0 0.0 0.0 9.1 12.6 0.2 0.0 0.8 0.9 0.1 9.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 3.9 0.1 7.9 0.1 1.8 5.3 10.2 0.0 0.0 0.0 0.0 0.3 0.0 11.7 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 130.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 11.0 9.8 9.0 7.7 9.6 9.1 12.6 9.0 7.9 10.2 11.7 0.0 0.0 0.0 9.4 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.9 0.2 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.2 0.0 2.0 11.4 0.0 2.5 0.0 0.0 0.1 10.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 1.2 0.7 0.2 TMEM237 "ALS2CR4, JBTS14" ENSG00000155755 "Transmembrane protein 237" Q96Q45 2 201620184-201643570 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 89.3" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 81.7;Rod photoreceptor cells: 160.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052596, HPA054732" Enhanced NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 79: Retina - Phototransduction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA052596: AB_2681879, HPA054732: AB_2682587" "unprognostic (1.70e-1)" "unprognostic (7.10e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (1.73e-1)" "unprognostic (4.06e-1)" "unprognostic (8.30e-6)" "unprognostic (4.15e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (7.96e-6)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" 4.1 15.1 6.3 1.7 6.5 2.3 11.0 7.1 7.8 5.0 6.0 3.0 0.8 6.0 4.6 6.0 5.8 4.1 7.7 6.8 6.7 5.4 1.9 5.1 2.3 6.9 6.9 8.4 1.9 5.0 3.0 5.2 7.2 7.8 3.7 89.3 5.1 4.8 7.7 18.5 1.8 5.8 7.1 1.4 2.2 3.0 6.4 7.0 4.6 9.2 3.1 4.1 3.4 6.8 3.7 7.2 32.3 16.4 7.8 10.1 3.1 22.6 9.9 14.7 28.4 5.9 5.3 3.7 6.9 21.9 12.7 6.8 5.6 24.4 27.1 6.9 20.6 10.7 21.4 19.4 15.1 10.4 2.1 9.0 5.0 20.4 5.1 24.8 25.5 23.4 7.8 13.0 29.8 5.2 29.7 16.3 32.7 1.9 23.8 43.9 30.8 7.6 12.2 9.7 33.7 47.4 21.4 8.4 12.6 20.3 12.5 18.7 6.8 26.8 7.3 8.6 9.5 6.0 14.9 11.4 22.7 9.7 17.0 0.0 0.0 0.0 1.0 1.1 0.9 0.7 1.0 1.6 1.3 0.1 1.1 1.4 0.0 0.9 0.7 0.3 1.8 0.5 6.3 6.5 7.1 7.8 6.8 6.7 6.9 6.9 7.2 7.1 6.4 6.8 6.8 6.4 9.6 12.4 1.6 71.2 81.7 46.7 50.7 33.3 17.1 41.4 20.2 2.8 18.9 18.4 41.7 21.0 3.1 0.6 13.7 11.1 8.9 16.3 10.9 11.6 4.8 8.6 16.5 7.6 26.8 25.8 3.1 7.7 5.1 19.9 10.4 2.7 9.4 32.0 15.3 4.5 18.3 2.2 12.2 7.0 21.8 2.9 12.4 4.7 5.7 38.5 0.0 14.1 10.8 6.5 1.9 21.4 3.0 36.9 0.7 3.9 19.8 160.3 6.6 33.2 20.6 33.3 22.0 30.0 45.3 15.1 4.2 39.8 5.3 29.2 TMEM240 "C1orf70, SCA21" ENSG00000205090 "Transmembrane protein 240" Q5SV17 1 1534778-1540624 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 6.5;Excitatory neurons: 15.5;Inhibitory neurons: 15.1;Oligodendrocyte precursor cells: 8.0;Sertoli cells: 6.6" "Cancer enhanced" "Detected in many" "glioma: 3.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 8.5;SCLC-21H: 9.3;SH-SY5Y: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066721 Supported NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA066721: AB_2732750" "unprognostic (2.24e-1)" "unprognostic (1.87e-1)" "unprognostic (5.52e-5)" "unprognostic (2.31e-1)" "unprognostic (2.47e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" "unprognostic (3.85e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "prognostic favorable (2.52e-4)" "unprognostic (9.13e-2)" "unprognostic (7.96e-3)" "unprognostic (9.50e-4)" "unprognostic (2.64e-1)" "unprognostic (8.38e-2)" "unprognostic (1.93e-1)" 4.1 3.5 10.9 0.6 12.2 0.1 3.9 17.1 22.8 14.8 2.5 17.4 0.4 15.1 0.9 2.9 10.6 1.0 8.2 13.1 7.6 3.6 1.2 4.2 0.4 7.1 8.1 16.1 1.3 1.4 15.1 1.6 7.3 9.5 0.5 1.3 2.5 3.3 3.8 2.7 4.9 2.1 5.4 4.0 5.7 3.0 8.5 0.3 5.3 1.2 0.2 10.8 8.6 9.6 0.9 1.0 5.7 0.7 0.8 3.8 1.4 3.8 2.1 3.5 2.0 0.0 0.4 0.7 0.7 1.9 0.2 2.2 0.0 0.2 0.5 3.5 8.5 0.5 3.6 1.3 7.5 0.0 0.8 5.2 1.8 1.4 0.3 4.3 3.5 0.6 1.1 0.3 0.0 0.2 0.6 0.9 3.9 0.1 1.2 3.3 1.1 0.7 0.4 0.0 9.3 11.2 1.4 0.4 4.0 0.1 0.6 0.0 1.9 0.5 1.7 0.7 1.7 1.6 0.4 0.4 1.9 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 12.2 17.1 22.8 13.1 7.6 7.1 8.1 7.3 5.4 8.5 9.6 0.7 0.0 0.0 6.5 0.2 0.0 0.3 0.0 1.2 3.1 0.4 0.5 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.2 1.6 0.4 0.0 0.0 15.5 0.0 0.1 0.8 0.0 0.2 0.0 1.6 0.7 0.0 0.1 3.3 15.1 0.6 0.0 0.0 0.0 0.0 1.2 0.2 0.0 1.0 0.0 4.5 1.0 8.0 4.4 0.1 0.2 2.2 0.3 0.2 0.1 0.1 0.0 0.5 6.6 0.2 0.9 0.1 0.5 0.1 0.0 0.0 0.2 1.4 0.3 0.1 TNR ENSG00000116147 "Tenascin R" Q92752 1 175315194-175743616 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 31.3;retina: 16.2" "Group enriched" "Detected in some" 6 "Horizontal cells: 580.5;Oligodendrocyte precursor cells: 2288.6" "Cancer enriched" "Detected in single" 46 "glioma: 9.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 1.9;U-937: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022343, HPA027134, HPA027150, HPA029859" Enhanced "Secreted in brain" NA NA 58000 "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916" "unprognostic (1.04e-1)" "unprognostic (7.43e-2)" "unprognostic (3.11e-2)" "unprognostic (1.12e-3)" "unprognostic (2.38e-1)" "unprognostic (1.51e-2)" "unprognostic (9.66e-2)" "unprognostic (2.57e-2)" "unprognostic (5.79e-2)" "unprognostic (5.06e-2)" "unprognostic (3.03e-3)" "unprognostic (7.26e-4)" "unprognostic (4.48e-4)" "unprognostic (3.26e-3)" "unprognostic (3.83e-1)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" 0.0 1.4 30.7 0.2 24.3 0.1 0.0 15.2 26.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 31.3 27.7 0.0 0.4 0.5 0.2 23.3 16.4 0.0 0.4 0.0 2.7 0.0 20.3 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.4 0.0 20.8 0.2 0.3 0.4 18.2 0.1 0.1 0.0 0.3 0.0 0.0 30.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 30.7 24.3 15.2 26.3 31.3 27.7 23.3 16.4 20.3 20.8 18.2 30.5 0.0 0.0 0.0 20.2 2.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 226.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 580.5 179.6 0.0 0.0 0.0 0.3 1.6 0.0 0.1 0.0 3.7 0.0 1.8 0.0 2288.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 3.8 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 TP73 P73 ENSG00000078900 "Tumor protein p73" O15350 1 3652516-3736201 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 8.0;fallopian tube: 6.7;skin 1: 6.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 13.0;Basal squamous epithelial cells: 16.5;Early spermatids: 21.8;Endometrial ciliated cells: 31.0;Late spermatids: 15.7;Respiratory ciliated cells: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 15.0;RH-30: 11.6;SCLC-21H: 18.0;U-698: 18.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002514, CAB003022, HPA027314, HPA044516" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971" "unprognostic (5.71e-3)" "prognostic favorable (2.98e-4)" "unprognostic (2.71e-1)" "prognostic favorable (1.82e-4)" "unprognostic (5.58e-2)" "prognostic favorable (9.50e-4)" "unprognostic (5.25e-2)" "unprognostic (2.18e-1)" "unprognostic (4.27e-1)" "unprognostic (1.99e-1)" "unprognostic (5.33e-2)" "unprognostic (3.99e-1)" "unprognostic (1.26e-7)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (7.33e-2)" "unprognostic (1.65e-1)" 0.0 0.0 0.7 0.7 0.5 0.5 0.8 4.2 0.5 1.4 8.0 0.2 0.0 0.1 0.1 3.7 6.7 0.0 0.1 0.8 0.7 0.1 0.2 0.9 1.0 2.4 2.9 0.1 0.8 0.1 0.3 0.0 1.4 2.6 0.1 0.2 2.9 0.3 0.2 6.6 0.2 0.0 1.4 0.7 0.3 0.7 0.7 1.6 0.2 0.0 1.4 0.1 2.9 1.0 2.6 0.1 0.3 7.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.9 4.0 2.6 2.0 0.0 0.9 4.3 2.7 0.9 0.0 0.8 8.7 0.2 3.9 2.6 0.0 0.0 2.9 0.0 1.7 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.8 1.9 15.0 2.0 0.5 0.0 0.1 0.0 11.6 0.1 0.3 3.8 18.0 8.4 0.4 0.0 0.8 0.0 10.9 9.2 0.0 2.9 7.5 0.0 5.8 3.3 0.7 18.5 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 4.2 0.5 0.8 0.7 2.4 2.9 1.4 1.4 0.7 1.0 0.0 0.0 1.5 0.0 1.2 3.1 3.8 13.0 16.5 0.5 0.2 2.5 1.5 0.0 7.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 21.8 31.0 0.3 0.3 2.4 3.2 0.1 0.2 0.4 0.4 0.0 0.7 0.0 0.1 0.4 0.2 0.3 0.0 0.1 0.5 2.0 0.0 1.3 15.7 0.6 0.1 1.8 0.0 0.0 0.2 0.0 2.5 0.1 0.2 0.0 0.0 6.8 0.2 0.0 0.1 35.8 0.1 0.0 0.0 2.6 0.1 0.4 1.6 2.3 0.3 0.4 0.1 0.3 0.2 TRIL KIAA0644 ENSG00000255690 "TLR4 interactor with leucine rich repeats" Q7L0X0 7 28953358-28958330 "Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 68.0" "Cell type enriched" "Detected in many" 4 "Astrocytes: 72.1" "Cancer enhanced" "Detected in many" "glioma: 20.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 22.2;SH-SY5Y: 40.0;SK-BR-3: 35.7;T-47d: 15.8" "Low region specificity" "Detected in all" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (1.26e-3)" "unprognostic (3.29e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-2)" "unprognostic (8.77e-2)" "prognostic unfavorable (8.52e-4)" "unprognostic (4.27e-3)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (2.07e-2)" 4.7 2.3 40.8 0.6 61.3 0.0 4.1 57.4 35.0 2.9 7.3 2.0 2.0 3.6 1.7 2.4 2.3 1.0 4.3 32.5 40.8 5.9 0.6 2.6 0.4 58.2 65.2 1.6 0.5 0.8 1.6 1.1 46.1 1.9 1.8 1.0 8.2 1.4 3.1 1.9 2.4 3.4 49.7 2.6 2.3 0.5 68.0 0.4 2.9 0.7 0.3 2.3 3.5 35.9 0.0 0.0 22.2 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 6.1 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.8 40.0 0.1 35.7 0.0 3.2 15.8 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 61.3 57.4 35.0 32.5 40.8 58.2 65.2 46.1 49.7 68.0 35.9 7.0 12.8 5.3 72.1 0.0 0.0 0.2 0.0 4.0 0.4 7.4 11.0 2.7 0.0 0.6 1.8 0.0 0.2 0.0 0.1 3.9 0.1 0.0 0.4 0.2 4.3 0.0 0.0 0.7 0.0 1.9 15.9 0.0 1.1 0.0 0.2 2.5 0.4 0.1 6.7 0.6 0.4 0.0 0.0 0.0 0.2 1.2 0.5 0.0 5.6 0.0 17.1 0.0 13.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 1.8 0.0 0.8 13.1 15.2 4.9 0.5 0.7 2.2 0.0 0.1 0.1 2.0 0.8 0.1 TRIM36 "HAPRIN, RBCC728, RNF98" ENSG00000152503 "Tripartite motif containing 36" Q9NQ86 5 115124762-115180546 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "retina: 44.2;testis: 174.3" "Group enriched" "Detected in many" 26 "Early spermatids: 2120.7;Late spermatids: 4980.3" "Cancer enhanced" "Detected in many" "prostate cancer: 9.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 5.8;non-classical monocyte: 6.5" "Group enriched" "Detected in many" 48 "dendritic cells: 5.8;granulocytes: 3.2;monocytes: 6.5" "Cell line enhanced" "Detected in many" "RH-30: 24.5;SCLC-21H: 28.3;SH-SY5Y: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061321 Approved Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Cytosol" "HPA061321: AB_2684479" "unprognostic (6.36e-2)" "unprognostic (2.99e-1)" "unprognostic (4.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.31e-2)" "unprognostic (5.33e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (1.84e-1)" "unprognostic (1.90e-1)" "unprognostic (2.82e-13)" "unprognostic (4.95e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-1)" "unprognostic (6.80e-3)" 0.5 1.3 13.2 1.6 16.7 0.5 4.4 3.9 14.2 2.4 8.7 7.5 14.1 0.9 0.6 0.3 2.2 0.5 0.2 16.1 15.7 0.3 0.4 1.8 0.3 17.0 10.5 4.7 1.6 0.2 13.4 1.1 16.1 10.0 7.5 44.2 0.5 0.6 0.2 0.6 13.8 0.8 10.2 0.5 4.6 174.3 12.7 0.7 0.2 0.4 0.4 0.4 1.3 20.0 3.6 0.9 1.6 8.4 0.2 0.1 2.0 0.7 2.8 1.5 1.7 1.2 1.7 0.0 1.4 0.1 11.9 1.1 7.9 1.5 1.1 0.6 2.7 6.0 3.3 1.7 0.3 6.0 4.8 0.1 1.4 0.7 2.0 1.9 0.1 11.2 0.2 7.9 2.3 4.6 1.6 5.4 6.7 0.6 3.8 1.3 24.5 1.9 0.9 0.1 28.3 19.6 5.3 0.5 3.2 0.8 5.8 7.4 0.7 2.3 1.8 1.7 2.7 1.2 0.8 0.0 2.5 3.4 1.1 0.0 1.2 3.2 0.0 1.3 0.0 0.0 0.0 0.0 5.8 0.1 0.0 0.0 0.3 0.0 6.5 1.2 0.0 0.6 13.2 16.7 3.9 14.2 16.1 15.7 17.0 10.5 16.1 10.2 12.7 20.0 0.4 0.0 3.4 1.0 0.1 2.3 0.6 0.2 0.6 5.0 14.8 9.3 2.3 0.0 0.5 1.8 56.3 0.0 1.8 27.6 0.0 0.4 2120.7 3.3 0.3 2.0 3.5 0.0 39.7 1.8 0.5 1.4 6.6 1.1 1.3 0.1 0.4 0.0 2.8 5.0 14.0 15.8 2.0 1.9 18.1 4980.3 14.9 6.0 8.8 29.0 3.4 6.9 0.0 2.5 53.4 1.5 20.4 12.8 0.1 12.1 28.2 0.2 5.0 76.8 6.6 2.0 2.3 136.2 26.9 1.2 1.3 0.3 0.7 0.1 8.8 0.2 TRIM46 "FLJ23229, TRIFIC" ENSG00000163462 "Tripartite motif containing 46" Q7Z4K8 1 155173787-155184971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.9;Early spermatids: 6.5;Excitatory neurons: 13.1;Inhibitory neurons: 9.7;Late spermatids: 7.5;Oligodendrocytes: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055583 Enhanced NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 30: Mammary glandular cells - Lactation" "HPA055583: AB_2732599" "unprognostic (1.06e-1)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "prognostic unfavorable (2.61e-7)" "unprognostic (1.75e-1)" "unprognostic (7.26e-2)" "unprognostic (1.59e-2)" "unprognostic (4.65e-2)" "unprognostic (4.09e-1)" "unprognostic (2.88e-2)" "unprognostic (2.18e-3)" "unprognostic (1.24e-1)" "unprognostic (2.29e-12)" "unprognostic (8.58e-2)" "unprognostic (2.45e-1)" "unprognostic (2.70e-1)" "unprognostic (1.72e-2)" 0.6 0.4 8.3 0.5 9.2 0.3 0.5 8.4 10.1 1.1 4.0 0.8 0.3 3.1 3.3 0.4 2.3 0.4 0.3 9.4 7.6 0.6 0.1 0.5 0.5 7.3 6.3 0.3 0.5 0.1 4.9 0.1 7.5 1.1 0.1 1.1 0.4 0.8 0.1 0.3 0.7 0.9 6.2 1.0 1.0 1.9 7.9 1.1 0.3 0.0 0.2 0.5 0.9 8.8 1.7 2.2 1.5 0.1 0.3 1.3 0.1 1.6 1.7 1.9 2.2 0.0 0.8 0.7 1.1 2.0 0.4 1.8 0.0 0.7 0.6 3.9 0.7 1.3 2.6 0.1 0.8 0.4 4.1 1.4 0.4 2.0 0.7 4.5 2.5 4.1 0.0 3.2 1.0 1.1 2.4 0.2 5.7 0.2 2.3 4.1 0.1 0.8 0.3 0.0 3.9 9.3 0.7 0.5 1.2 0.6 2.8 3.4 3.7 3.8 1.2 0.2 0.8 3.2 1.2 0.7 4.0 0.6 1.1 0.4 0.0 0.0 0.2 0.1 0.2 0.0 0.4 0.4 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.7 0.1 8.3 9.2 8.4 10.1 9.4 7.6 7.3 6.3 7.5 6.2 7.9 8.8 0.2 0.0 0.0 1.0 0.3 0.4 0.8 0.2 0.0 6.9 2.9 1.8 1.1 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.7 6.5 2.9 0.4 0.7 1.8 0.8 13.1 0.2 0.0 0.8 1.5 3.9 0.0 0.1 0.4 0.0 0.8 0.0 9.7 0.0 0.0 0.0 1.0 7.5 0.3 0.2 0.0 0.0 2.6 0.6 2.1 3.0 9.8 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 1.6 0.0 1.4 0.9 1.3 0.4 0.0 0.0 0.0 1.9 0.0 0.0 0.8 TSPEAR "C21orf29, DFNB98, MGC11251, TSP-EAR" ENSG00000175894 "Thrombospondin type laminin G domain and EAR repeats" Q8WU66 21 44497893-44711572 "Disease related genes, Human disease related genes, Predicted secreted proteins" Hearing "Deafness, Disease variant, Ectodermal dysplasia, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 1.0;testis: 1.0" "Cell type enhanced" "Detected in some" "Astrocytes: 1.3;Early spermatids: 3.3;Excitatory neurons: 1.1;Oligodendrocytes: 1.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 1.7;U-2 OS: 1.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory bulb: 1.0" "CAB034203, CAB034204, HPA052995" Uncertain "Secreted in other tissues" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" "CAB034203: AB_1567654, CAB034204: AB_1567655, HPA052995: AB_2682008" "unprognostic (8.61e-3)" "unprognostic (2.45e-1)" "unprognostic (1.86e-4)" "unprognostic (7.87e-3)" "unprognostic (4.08e-2)" "unprognostic (1.00e-3)" "unprognostic (7.92e-3)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.15e-2)" "unprognostic (3.86e-4)" "unprognostic (2.13e-2)" "unprognostic (4.80e-7)" "unprognostic (2.08e-1)" "unprognostic (1.69e-1)" "unprognostic (1.88e-2)" "unprognostic (2.98e-2)" 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.0 1.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 1.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 TSPYL5 KIAA1750 ENSG00000180543 "TSPY like 5" Q86VY4 8 97273488-97277928 "Predicted intracellular proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.7" "Group enriched" "Detected in many" 8 "Early spermatids: 172.9;Late spermatids: 419.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 34.9;K-562: 30.5;SCLC-21H: 60.8;SH-SY5Y: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031347 Enhanced Approved "Golgi apparatus,Cytosol" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Golgi apparatus" "HPA031347: AB_10601454" "prognostic favorable (1.21e-4)" "unprognostic (5.13e-2)" "unprognostic (4.90e-2)" "unprognostic (1.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.06e-1)" "unprognostic (1.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "unprognostic (3.46e-2)" "unprognostic (1.25e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.40e-5)" "unprognostic (3.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.31e-2)" "unprognostic (3.13e-1)" 6.0 8.6 11.1 4.3 12.6 1.2 12.1 6.7 11.4 11.4 0.8 9.7 1.8 15.2 15.5 4.5 12.4 6.6 12.4 10.0 17.6 10.0 1.7 7.2 6.2 10.3 8.6 25.2 8.7 8.1 11.8 4.3 12.5 15.3 3.2 11.3 9.7 18.3 12.9 4.1 4.1 14.3 7.6 7.3 8.4 44.7 14.4 7.4 8.3 10.5 7.3 9.7 4.6 8.7 0.0 15.9 0.0 0.0 0.4 0.4 0.1 12.4 0.0 12.2 7.9 0.0 0.5 0.0 16.8 14.8 0.0 4.4 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 19.4 0.0 17.2 0.0 0.0 0.2 34.9 30.5 0.0 0.5 23.4 0.0 0.0 0.0 0.0 0.2 23.1 0.0 0.1 10.2 0.1 60.8 47.1 0.0 4.1 0.0 8.2 0.0 1.9 0.0 0.0 26.2 0.1 0.0 14.4 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.3 0.2 0.1 0.0 0.2 0.0 0.5 0.2 0.0 11.1 12.6 6.7 11.4 10.0 17.6 10.3 8.6 12.5 7.6 14.4 8.7 7.5 6.4 4.1 0.0 5.5 2.3 4.5 0.7 6.8 12.5 9.9 8.8 16.3 2.8 2.1 9.2 20.9 0.2 2.6 0.0 5.9 5.8 172.9 6.4 13.7 9.8 2.4 3.4 0.0 3.5 0.1 12.1 10.2 2.6 0.0 19.2 6.4 0.8 6.3 8.4 0.0 0.3 2.0 5.0 5.9 419.0 24.5 4.6 7.2 0.0 2.2 13.1 0.0 0.0 0.0 3.7 0.0 21.1 0.8 7.8 0.0 1.4 4.1 12.2 6.6 12.4 9.3 35.5 31.0 5.6 1.6 0.1 1.3 9.9 0.3 4.1 TTC8 "BBS8, RP51" ENSG00000165533 "Tetratricopeptide repeat domain 8" Q8TAM2 14 88824153-88881078 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 66.8;Theca cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 13.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.8" "Cell line enhanced" "Detected in all" "SH-SY5Y: 118.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.19e-2)" "unprognostic (1.08e-1)" "unprognostic (5.47e-2)" "prognostic favorable (1.69e-5)" "unprognostic (1.49e-1)" "unprognostic (7.10e-2)" "unprognostic (5.00e-3)" "unprognostic (1.54e-1)" "unprognostic (2.19e-1)" "prognostic favorable (7.77e-4)" "unprognostic (3.54e-2)" "unprognostic (2.51e-1)" "prognostic favorable (4.89e-4)" "unprognostic (1.65e-2)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (3.80e-2)" 8.3 38.9 13.9 6.6 14.6 9.3 18.6 11.8 14.2 15.5 20.4 9.4 6.0 13.5 35.9 13.0 23.2 15.5 11.5 14.9 19.3 13.6 13.2 8.9 4.3 14.0 14.4 68.9 12.0 22.5 22.4 6.8 12.7 23.6 9.9 37.4 10.0 18.6 2.6 8.8 5.8 14.4 13.3 6.8 8.4 23.7 16.5 5.9 37.1 4.2 5.0 16.4 5.0 13.4 19.8 28.1 16.7 16.2 35.1 43.5 14.0 24.0 37.6 31.8 21.5 7.9 37.2 8.7 20.6 30.3 19.3 28.5 18.1 19.4 32.2 6.6 7.3 5.5 9.1 11.1 25.4 10.6 1.9 27.3 23.9 23.0 19.9 30.4 19.3 11.6 20.5 9.8 27.3 33.9 10.9 10.2 8.9 10.3 27.0 3.3 23.0 5.2 31.3 30.6 19.6 118.5 38.0 21.3 22.4 11.5 52.6 8.3 11.7 22.6 11.9 20.2 16.6 1.2 6.8 3.8 33.3 2.8 9.9 13.8 0.7 3.8 0.4 0.9 0.6 0.4 0.5 0.5 1.9 2.2 0.2 0.4 0.7 1.7 1.5 0.7 0.0 0.5 13.9 14.6 11.8 14.2 14.9 19.3 14.0 14.4 12.7 13.3 16.5 13.4 3.7 3.2 9.0 38.8 2.1 8.8 8.0 12.3 19.4 17.0 11.7 9.1 6.0 10.0 11.2 9.2 39.6 10.2 0.6 4.3 13.7 13.5 8.1 24.1 10.6 4.9 10.8 4.8 51.1 6.2 9.7 12.8 6.1 11.7 0.0 66.8 5.3 8.0 6.7 20.2 53.4 6.1 6.1 3.5 6.6 7.4 19.6 4.4 7.2 14.0 0.4 12.5 1.0 51.3 21.3 7.8 2.4 25.2 3.7 4.9 2.3 15.5 28.3 41.7 19.7 5.8 12.2 14.6 6.9 8.3 6.5 1.8 1.2 69.0 6.6 4.7 TUBB3 "beta-4, CFEOM3, CFEOM3A, FEOM3" ENSG00000258947 "Tubulin beta 3 class III" Q13509 16 89921392-89938761 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 313.3" "Cell type enhanced" "Detected in some" "Astrocytes: 20.2;Ductal cells: 28.7;Excitatory neurons: 37.9;Exocrine glandular cells: 21.4;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 45.1;Pancreatic endocrine cells: 49.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "naive B-cell: 2.5" "Lineage enriched" "Detected in single" 9 "B-cells: 2.5" "Cell line enhanced" "Detected in many" "A549: 421.3;SCLC-21H: 424.9;SH-SY5Y: 433.8" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA 89000000 "Cluster 24: B-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 1: Pancreatic cells - Digestion" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (7.08e-2)" "unprognostic (3.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (8.01e-2)" "unprognostic (3.12e-2)" "unprognostic (4.04e-3)" "unprognostic (1.12e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (7.57e-2)" "unprognostic (1.27e-3)" "unprognostic (3.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.91e-2)" 5.7 24.8 99.4 12.1 93.3 3.4 2.1 100.5 127.6 3.3 0.0 18.4 3.7 9.7 0.2 3.6 2.3 8.8 5.5 88.6 313.3 13.3 0.9 4.1 7.1 208.8 132.7 3.9 3.2 0.4 55.1 1.8 266.2 3.0 2.6 24.8 10.6 0.4 0.6 5.2 8.0 12.7 74.2 1.3 7.2 38.0 183.4 1.0 2.5 0.3 5.2 7.3 5.3 82.5 30.1 421.3 152.6 173.9 17.9 170.8 6.8 181.0 31.0 105.8 48.2 57.2 53.5 89.6 93.6 136.8 74.3 112.1 148.9 26.7 26.3 22.7 15.5 0.7 32.5 383.7 6.0 0.0 67.6 98.4 7.9 161.9 14.0 136.8 88.4 5.9 9.2 2.5 122.3 288.6 1.2 31.5 274.3 11.2 237.3 0.1 54.1 9.5 131.8 8.1 424.9 433.8 251.2 4.4 137.1 27.5 15.0 1.9 110.9 142.8 156.9 197.3 185.3 1.4 19.6 35.2 150.2 11.5 260.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 99.4 93.3 100.5 127.6 88.6 313.3 208.8 132.7 266.2 74.2 183.4 82.5 0.4 0.0 0.0 20.2 0.0 0.0 0.0 0.0 3.4 1.8 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 28.7 8.2 0.5 2.6 3.8 4.9 0.0 37.9 21.4 0.7 6.1 27.0 0.7 0.0 0.0 0.0 0.0 0.2 5.0 45.1 0.1 0.0 0.0 0.0 16.8 0.3 0.2 0.0 9.4 0.0 0.3 0.0 16.1 9.2 49.2 0.0 0.4 0.4 0.0 0.0 0.1 0.0 1.4 0.0 0.0 5.1 0.2 0.4 3.0 0.0 1.0 0.1 0.0 0.2 0.0 TWIST1 "ACS3, bHLHa38, BPES2, BPES3, CRS, CRS1, H-twist, SCS, TWIST" ENSG00000122691 "Twist family bHLH transcription factor 1" Q15672 7 19020991-19117636 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 25.2" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 92.8;Fibroblasts: 73.4;Langerhans cells: 30.3;Smooth muscle cells: 34.4;Theca cells: 29.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 6 "SH-SY5Y: 263.5" "Low region specificity" "Detected in single" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (4.58e-2)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (3.62e-1)" "unprognostic (1.29e-2)" "unprognostic (9.80e-3)" "unprognostic (1.78e-2)" "unprognostic (1.57e-2)" "unprognostic (8.51e-3)" "unprognostic (5.91e-2)" "unprognostic (8.99e-3)" "unprognostic (3.69e-1)" "unprognostic (1.29e-9)" "unprognostic (8.55e-3)" "unprognostic (1.54e-1)" "unprognostic (6.83e-3)" "unprognostic (1.97e-2)" 22.1 4.9 2.2 1.3 1.8 0.0 25.2 1.5 2.6 6.4 2.7 2.7 0.0 18.9 0.6 5.9 3.0 7.2 4.5 1.9 1.6 0.8 0.2 0.6 2.4 1.8 2.3 6.4 0.4 0.2 7.1 12.6 2.0 2.7 0.4 0.0 8.1 0.8 1.5 16.0 0.7 5.0 1.8 0.0 5.4 2.7 2.0 0.5 3.7 1.9 1.6 8.3 5.0 2.2 1.6 2.0 8.9 0.0 45.0 18.4 0.2 38.3 17.8 28.9 37.7 0.0 0.0 0.0 4.0 32.0 6.9 0.0 3.7 3.0 19.0 8.5 10.1 0.0 3.9 0.0 26.8 10.0 0.1 44.8 9.9 6.0 15.7 8.6 0.0 0.5 0.0 0.0 31.0 0.0 0.0 0.5 3.9 0.0 15.7 0.0 0.0 0.0 0.0 0.0 15.9 263.5 6.2 0.0 8.2 5.6 0.8 12.4 0.2 35.5 0.1 28.3 6.6 0.0 0.0 0.0 19.4 0.0 45.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.8 1.5 2.6 1.9 1.6 1.8 2.3 2.0 1.8 2.0 2.2 10.3 0.0 0.0 0.7 0.1 12.5 0.2 2.9 1.8 0.0 0.5 3.3 0.9 0.0 0.5 0.0 0.0 0.3 0.1 0.1 1.9 0.0 0.2 11.5 92.8 3.8 0.0 0.0 5.2 0.0 0.2 73.4 0.0 13.3 0.0 2.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 30.3 0.8 2.1 0.9 12.4 7.5 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.3 0.3 0.0 1.6 34.4 0.5 4.7 0.6 8.5 1.4 2.2 29.9 0.1 0.4 UBE2D4 HBUCE1 ENSG00000078967 "Ubiquitin conjugating enzyme E2 D4 (putative)" Q9Y2X8 7 43926436-43956136 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 32.5" "Cell type enhanced" "Detected in many" "Distal tubular cells: 54.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 30.2" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (9.95e-3)" "unprognostic (6.76e-2)" "unprognostic (6.87e-2)" "unprognostic (8.94e-2)" "unprognostic (8.24e-2)" "unprognostic (5.24e-2)" "unprognostic (2.42e-1)" "unprognostic (3.58e-3)" "unprognostic (4.74e-2)" "unprognostic (5.04e-2)" "prognostic favorable (4.86e-4)" "prognostic favorable (5.77e-4)" "prognostic favorable (6.51e-4)" "unprognostic (1.11e-1)" "unprognostic (8.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.34e-1)" 5.8 8.3 11.7 2.4 12.2 2.2 5.0 14.2 17.6 4.6 9.8 6.5 2.4 4.5 5.7 5.2 4.5 3.4 10.9 12.3 11.2 6.9 10.7 4.4 2.7 12.0 11.7 5.1 10.0 4.6 5.1 2.8 11.9 5.7 2.9 6.9 5.6 4.4 32.5 4.9 3.9 4.4 11.8 4.7 4.6 3.0 11.5 2.7 4.9 27.8 2.7 5.3 5.2 12.7 4.9 4.0 2.4 11.0 11.0 4.5 1.8 2.3 5.8 2.9 3.7 2.1 5.6 4.6 6.3 6.3 8.1 5.3 3.1 2.5 4.4 10.5 5.4 5.0 5.8 5.4 4.1 10.9 9.8 3.4 5.2 3.3 5.0 4.2 3.6 5.5 5.6 9.2 4.0 3.0 6.5 6.1 5.4 5.9 5.1 4.0 3.3 7.1 6.2 5.9 8.8 30.2 5.0 9.7 3.8 4.4 4.9 3.3 3.2 1.9 6.0 4.1 6.9 13.5 10.8 2.2 5.7 14.2 10.9 10.2 14.5 17.5 11.1 23.8 11.4 12.8 13.5 12.5 15.1 12.7 16.2 13.4 1.4 9.9 28.7 13.0 12.6 8.8 11.7 12.2 14.2 17.6 12.3 11.2 12.0 11.7 11.9 11.8 11.5 12.7 14.9 0.0 6.5 8.8 10.4 6.2 9.1 9.4 4.0 9.6 24.3 24.3 24.6 14.3 10.0 16.5 2.1 11.9 11.9 8.4 54.8 18.7 6.2 8.9 7.2 12.9 18.7 9.9 14.2 28.4 20.3 14.9 8.2 8.7 4.5 11.1 12.5 25.4 27.4 11.8 13.5 8.0 8.2 11.6 14.1 10.7 12.2 12.5 16.0 8.4 18.4 18.8 5.2 20.1 12.1 14.1 7.6 21.8 11.2 12.1 15.5 52.0 5.5 11.6 6.6 23.0 10.5 15.6 9.6 10.8 11.2 7.7 8.8 16.5 8.4 12.3 UNC5C ENSG00000182168 "Unc-5 netrin receptor C" O95185 4 95162504-95549206 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.5" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 2078.8" "Cancer enriched" "Detected in many" 4 "thyroid cancer: 6.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 82.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 310000 "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (1.55e-1)" "unprognostic (2.72e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (3.03e-1)" "unprognostic (3.20e-1)" "unprognostic (3.48e-1)" "unprognostic (3.40e-1)" "unprognostic (3.12e-1)" "unprognostic (1.11e-3)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (2.70e-5)" "unprognostic (1.25e-2)" "unprognostic (1.16e-1)" "unprognostic (1.86e-1)" "unprognostic (3.62e-4)" 1.9 9.0 8.9 1.0 17.2 0.0 1.3 7.0 17.4 1.8 0.0 2.9 1.4 2.4 1.7 0.6 1.9 2.0 3.1 6.6 15.4 1.1 1.0 2.5 0.5 18.1 8.7 2.8 0.3 0.1 1.2 1.8 21.4 3.3 3.4 6.4 6.3 3.9 0.1 0.2 1.9 2.0 8.0 4.2 2.1 2.6 16.4 1.9 11.9 0.4 0.3 2.6 1.6 40.5 0.0 0.5 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 4.2 0.0 0.2 0.0 1.1 0.2 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 82.9 0.0 0.0 0.2 4.8 0.3 12.3 0.0 0.1 1.2 0.0 7.9 0.0 0.0 0.0 0.1 9.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 17.2 7.0 17.4 6.6 15.4 18.1 8.7 21.4 8.0 16.4 40.5 0.7 0.0 0.0 105.4 0.0 0.1 0.1 0.1 0.0 1.9 0.7 1.5 1.7 0.0 0.2 1.8 0.0 0.5 0.0 2.6 0.0 0.0 0.7 0.5 3.4 0.7 1.2 0.0 326.1 0.0 0.1 4.6 0.0 1.2 0.0 20.2 0.4 0.0 1.8 0.0 448.3 0.5 0.0 0.8 0.0 0.8 21.1 0.4 1.8 57.1 0.0 1.3 0.0 308.1 2078.8 0.0 26.9 11.7 0.0 0.3 0.0 0.1 0.0 12.5 6.6 0.3 4.6 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.1 0.0 UNC80 "C2orf21, FLJ33496, KIAA1843, UNC-80" ENSG00000144406 "Unc-80 homolog, NALCN channel complex subunit" Q8N2C7 2 209771832-209999300 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.0;pituitary gland: 13.6;retina: 18.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 117.7;Excitatory neurons: 432.0;Inhibitory neurons: 354.7;Oligodendrocyte precursor cells: 290.5" "Cancer enhanced" "Detected in some" "glioma: 0.8;prostate cancer: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 2.5;SCLC-21H: 4.0;SH-SY5Y: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042472, HPA050959" Enhanced Approved "Nuclear bodies,Vesicles" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear bodies" Vesicles "HPA042472: AB_10965318, HPA050959: " "unprognostic (7.91e-3)" "unprognostic (2.25e-4)" "unprognostic (1.44e-2)" "unprognostic (3.20e-4)" "unprognostic (1.92e-1)" "unprognostic (3.40e-2)" "unprognostic (3.31e-3)" "unprognostic (5.36e-2)" "unprognostic (5.16e-1)" "unprognostic (7.85e-2)" "unprognostic (5.24e-3)" "unprognostic (8.94e-2)" "unprognostic (1.50e-2)" "unprognostic (1.51e-2)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" "unprognostic (7.40e-3)" 0.0 3.9 6.4 0.0 9.9 0.0 0.0 15.6 21.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.4 1.1 0.0 6.9 4.9 0.1 0.0 0.1 0.0 6.7 1.5 0.5 1.0 0.2 13.6 0.0 5.8 0.9 0.1 18.9 0.1 0.2 0.0 0.1 0.1 0.2 1.1 0.2 0.4 3.5 2.6 0.1 0.3 0.0 0.0 0.2 0.0 5.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 9.9 15.6 21.0 6.9 4.9 6.7 1.5 5.8 1.1 2.6 5.0 0.2 0.0 1.1 49.0 0.0 0.8 0.3 1.9 0.0 117.7 0.2 0.1 2.1 0.0 0.7 0.0 66.7 0.0 0.0 0.0 0.0 0.0 31.9 1.1 1.7 0.5 0.0 0.0 432.0 0.0 0.0 1.1 0.0 0.1 1.3 0.6 0.0 0.0 0.1 52.2 354.7 0.0 0.0 0.0 0.0 10.5 0.9 0.3 0.0 10.3 0.0 26.6 0.0 290.5 12.8 0.1 0.0 1.9 0.0 1.2 0.0 0.2 0.8 75.6 0.0 0.2 0.1 7.5 3.8 0.0 0.1 0.0 0.0 15.1 0.0 0.3 VIP ENSG00000146469 "Vasoactive intestinal peptide" P01282 6 152750797-152759765 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 72.2;lymphoid tissue: 155.5" "Group enriched" "Detected in some" 5 "Inhibitory neurons: 80.6;Melanocytes: 28.4" "Group enriched" "Detected in some" 6 "colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 2.7;TIME: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA017324, CAB018649, HPA072701, CAB079780" Supported Supported Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 122000 "Cluster 14: B-cells - Humoral immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Endoplasmic reticulum" "CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550" "unprognostic (9.58e-2)" "unprognostic (2.29e-2)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (3.33e-2)" "unprognostic (2.48e-2)" "unprognostic (7.21e-2)" "unprognostic (2.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (3.62e-1)" "unprognostic (2.92e-3)" "unprognostic (7.47e-2)" "unprognostic (1.94e-1)" "unprognostic (1.30e-1)" "unprognostic (5.90e-2)" 2.7 12.2 5.5 155.5 7.9 0.1 1.9 4.9 10.9 1.8 4.6 72.2 16.6 1.2 0.4 4.3 1.5 3.7 4.3 7.3 28.7 2.5 1.1 3.4 0.4 6.9 40.0 0.8 8.3 0.3 0.8 0.6 7.7 2.7 61.4 1.0 0.5 0.5 1.4 0.4 45.8 41.6 4.8 9.7 22.2 1.0 11.9 0.1 2.3 1.7 0.1 1.6 9.4 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 7.9 4.9 10.9 7.3 28.7 6.9 40.0 7.7 4.8 11.9 5.9 2.5 0.0 0.0 3.3 0.2 0.4 0.0 0.0 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 80.6 0.0 0.0 0.3 0.0 6.5 0.0 0.0 28.4 4.7 0.0 0.0 0.0 2.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VPS28 ENSG00000160948 "VPS28 subunit of ESCRT-I" Q9UK41 8 144423601-144428563 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.8;SH-SY5Y: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024688, HPA024745" Supported NA NA 63000 "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA024688: AB_1858766, HPA024745: AB_1858765" "unprognostic (2.87e-2)" "unprognostic (1.87e-1)" "unprognostic (1.27e-1)" "prognostic favorable (9.93e-4)" "unprognostic (3.18e-1)" "unprognostic (2.03e-1)" "unprognostic (9.29e-2)" "unprognostic (7.94e-3)" "unprognostic (1.54e-2)" "unprognostic (2.00e-2)" "unprognostic (7.92e-2)" "unprognostic (6.85e-2)" "unprognostic (3.15e-1)" "unprognostic (2.93e-1)" "unprognostic (1.55e-1)" "unprognostic (1.27e-1)" "unprognostic (2.37e-2)" 132.8 137.6 0.1 0.0 0.1 0.0 132.9 0.0 0.3 147.7 0.0 150.5 0.0 133.7 0.0 138.0 127.3 0.1 177.5 0.1 0.2 173.8 162.7 123.1 0.1 0.1 0.2 159.6 146.5 0.0 129.3 0.1 0.5 136.3 0.0 0.7 119.7 0.2 197.7 150.4 140.0 0.0 0.0 144.9 154.1 151.8 0.1 0.0 144.5 1.1 0.0 128.7 135.4 0.2 0.2 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.1 0.2 0.5 0.0 0.1 0.2 189.6 112.2 128.6 32.3 126.9 103.2 138.6 180.0 105.9 91.9 139.0 171.2 70.1 131.5 133.9 169.2 60.5 166.4 126.6 387.2 273.9 264.5 208.6 130.4 131.5 149.7 172.7 139.3 20.1 251.1 160.9 142.9 154.9 164.9 185.5 191.5 142.1 141.4 250.7 57.2 25.9 256.8 128.1 178.9 155.9 183.1 198.8 172.1 188.5 22.5 285.8 168.6 144.1 20.1 32.3 287.3 462.2 156.1 112.8 128.9 561.9 526.5 134.6 121.8 157.8 140.0 206.5 232.1 127.2 142.7 133.5 112.7 160.9 275.7 206.0 168.8 VPS37D "MGC35352, WBSCR24" ENSG00000176428 "VPS37D subunit of ESCRT-I" Q86XT2 7 73667831-73672112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 13.0;Collecting duct cells: 11.0;Distal tubular cells: 9.8;Muller glia cells: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040978 Uncertain Approved Vesicles NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Vesicles "HPA040978: AB_10805833" "unprognostic (2.98e-2)" "unprognostic (2.17e-1)" "unprognostic (1.13e-2)" "unprognostic (7.85e-2)" "unprognostic (1.93e-1)" "unprognostic (3.85e-2)" "unprognostic (2.54e-1)" "unprognostic (3.94e-1)" "unprognostic (8.80e-2)" "unprognostic (1.97e-1)" "prognostic favorable (2.07e-5)" "unprognostic (4.19e-2)" "prognostic favorable (5.80e-9)" "unprognostic (9.63e-2)" "unprognostic (1.67e-1)" "unprognostic (1.25e-2)" "unprognostic (1.43e-1)" 1.8 1.3 8.4 0.3 8.7 0.2 2.4 7.9 12.1 6.1 3.5 3.1 1.8 3.7 2.8 0.8 3.6 1.4 2.3 8.9 7.9 11.3 9.6 1.0 0.2 7.9 7.3 4.2 4.0 2.7 3.3 0.3 8.0 3.7 0.2 1.6 3.2 2.0 1.3 2.5 1.9 0.7 6.3 0.9 2.1 7.1 8.6 0.3 3.4 0.5 0.1 2.2 2.8 7.0 0.5 2.3 1.8 3.8 1.2 2.4 1.1 1.0 1.5 0.8 1.0 0.2 0.7 0.8 0.9 1.3 2.1 0.3 1.9 0.9 0.2 0.3 2.0 0.0 0.2 2.6 3.2 0.0 1.1 1.9 0.5 1.1 0.3 3.5 0.9 3.2 1.1 0.2 1.1 2.8 0.6 0.0 1.2 0.7 3.3 0.1 0.0 0.1 3.0 0.2 3.7 11.8 0.0 1.6 2.3 0.3 3.8 0.1 1.3 2.2 3.0 1.3 0.8 1.4 0.1 1.1 5.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 8.7 7.9 12.1 8.9 7.9 7.9 7.3 8.0 6.3 8.6 7.0 2.4 0.0 0.0 1.3 0.2 1.0 0.8 0.3 0.6 13.0 3.4 3.8 1.8 1.5 0.1 11.0 0.0 0.2 0.1 0.2 9.8 4.0 1.1 3.6 3.1 1.1 4.9 0.0 1.6 0.8 0.4 1.6 0.0 5.1 0.0 5.9 1.8 5.3 0.1 0.0 2.7 0.4 2.0 0.0 0.4 0.9 1.8 0.2 5.4 1.0 0.6 13.9 0.0 1.0 0.9 1.8 1.4 2.6 0.3 1.0 2.0 8.3 0.2 5.3 0.0 0.9 2.7 0.6 8.3 0.1 1.1 0.3 0.2 0.9 0.7 0.4 VPS45 "h-vps45, H1, VPS45A, VPS45B" ENSG00000136631 "Vacuolar protein sorting 45 homolog" Q9NRW7 1 150067279-150145329 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 202.8;Late spermatids: 267.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027425, HPA027441" Uncertain Approved Microtubules NA NA "Cluster 44: Non-specific - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" Microtubules "HPA027425: AB_10599415, HPA027441: AB_10602284" "unprognostic (1.57e-1)" "unprognostic (2.75e-1)" "unprognostic (2.03e-1)" "unprognostic (5.51e-2)" "unprognostic (1.56e-2)" "unprognostic (8.36e-3)" "prognostic unfavorable (6.57e-6)" "unprognostic (4.76e-2)" "unprognostic (2.94e-2)" "unprognostic (2.65e-3)" "unprognostic (2.52e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.49e-2)" "unprognostic (1.58e-1)" "unprognostic (1.72e-1)" "unprognostic (2.32e-2)" 19.1 26.8 32.3 12.0 34.6 6.6 17.8 40.2 43.0 20.1 27.7 22.0 12.6 18.7 22.5 16.7 16.1 13.7 38.6 34.0 33.2 21.1 12.5 15.4 13.5 30.6 31.4 14.0 11.1 26.4 19.1 17.3 31.5 18.8 17.2 29.2 14.3 20.1 19.3 16.5 15.3 25.2 31.5 16.2 17.4 11.0 32.9 17.0 19.8 16.6 15.3 18.5 15.9 32.8 31.5 24.3 40.9 27.0 37.1 29.4 19.0 44.7 23.7 45.3 37.4 17.7 26.1 19.3 26.5 37.0 19.9 26.0 42.4 27.0 49.0 38.7 31.1 24.6 33.5 16.8 24.7 17.6 30.2 25.8 24.8 43.5 22.8 29.7 37.1 38.6 34.4 28.3 40.0 53.5 34.7 17.5 28.4 28.7 38.4 23.7 41.9 27.4 31.2 30.0 28.5 59.7 34.9 29.8 46.9 46.2 48.9 45.6 32.6 20.8 25.1 18.7 31.3 21.3 49.4 18.9 30.9 24.4 30.2 23.6 26.6 4.7 16.0 28.0 15.0 15.6 13.6 15.1 25.9 12.8 13.2 13.9 2.5 14.1 19.9 14.6 16.8 18.4 32.3 34.6 40.2 43.0 34.0 33.2 30.6 31.4 31.5 31.5 32.9 32.8 9.4 12.8 14.0 85.8 11.9 7.4 8.2 12.7 13.1 20.9 11.0 10.2 44.0 8.6 11.0 16.5 18.8 20.9 12.5 8.3 7.9 12.3 202.8 9.7 14.2 10.4 7.8 4.6 79.4 7.2 9.5 14.7 12.8 10.1 6.3 24.6 12.1 7.2 19.0 30.3 90.2 8.1 14.2 18.0 8.6 267.9 21.5 13.6 10.6 45.9 19.7 17.9 6.2 92.5 59.5 11.4 11.6 14.7 8.4 6.4 13.6 9.2 11.5 23.8 32.9 7.3 17.1 18.1 15.1 11.6 7.7 14.8 11.2 21.2 9.7 7.9 VSTM2A "MGC33530, VSTM2" ENSG00000170419 "V-set and transmembrane domain containing 2A" Q8TAG5 7 54542325-54571080 "Plasma proteins, Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 10.2;brain: 31.3;prostate: 9.7;retina: 14.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 42.0;Enteroendocrine cells: 7.3;Excitatory neurons: 12.5;Fibroblasts: 10.9;Inhibitory neurons: 30.1" "Cancer enhanced" "Detected in some" "breast cancer: 4.6;glioma: 3.0" "Region enhanced" "Detected in many" "cerebral cortex: 31.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 4.2;SH-SY5Y: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA 31000 "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (1.15e-1)" "unprognostic (1.02e-1)" "unprognostic (1.89e-1)" "unprognostic (1.14e-2)" "unprognostic (4.66e-1)" "prognostic favorable (5.34e-4)" "unprognostic (4.34e-2)" "unprognostic (6.79e-2)" "unprognostic (7.15e-2)" 0.0 10.2 4.4 0.0 9.9 0.0 0.3 0.0 31.3 0.0 0.0 4.4 1.4 0.0 0.0 0.0 0.0 0.1 0.0 10.5 6.6 0.0 0.0 0.0 0.0 2.2 1.5 0.0 0.6 0.0 0.3 0.0 0.0 9.7 4.0 14.3 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 4.7 0.4 13.7 0.0 0.2 0.2 0.0 0.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 9.9 0.0 31.3 10.5 6.6 2.2 1.5 0.0 0.7 13.7 2.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 42.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 7.3 0.0 12.5 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 2.2 0.0 2.5 0.5 0.0 1.1 0.0 0.0 0.2 0.0 0.1 0.7 4.1 0.0 0.2 2.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.3 WDR35 "FAP118, IFT121, IFTA1, KIAA1336, MGC33196" ENSG00000118965 "WD repeat domain 35" Q9P2L0 2 19910263-19990105 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "basophil: 2.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044147 Approved NA NA "Cluster 34: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "HPA044147: AB_10970242" "unprognostic (2.51e-1)" "unprognostic (4.93e-2)" "unprognostic (9.13e-2)" "unprognostic (4.01e-2)" "unprognostic (3.66e-2)" "unprognostic (2.79e-1)" "unprognostic (2.94e-3)" "unprognostic (3.08e-2)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (3.01e-2)" "unprognostic (3.68e-2)" "unprognostic (6.98e-2)" "unprognostic (2.17e-2)" "unprognostic (5.03e-2)" "unprognostic (1.02e-1)" "unprognostic (2.71e-1)" 3.6 5.1 4.3 2.7 4.4 2.0 7.8 4.1 4.7 6.6 10.0 4.9 1.7 9.3 7.2 2.9 11.3 3.5 3.3 4.1 5.5 7.9 2.0 4.5 2.7 5.5 5.5 9.6 3.8 14.4 9.0 2.7 5.1 5.5 3.0 12.6 3.0 6.3 2.5 3.4 3.0 6.2 4.9 2.0 3.7 10.6 6.0 4.8 8.8 2.6 2.6 4.4 3.7 5.7 8.3 10.4 9.9 9.5 7.6 7.4 0.5 4.2 7.4 6.0 4.3 3.2 3.6 0.0 1.8 4.7 5.0 2.6 10.6 10.3 9.9 1.6 8.2 8.1 6.6 10.0 6.6 15.8 3.1 9.0 7.2 10.7 15.2 10.8 7.4 3.3 13.1 2.3 6.1 3.0 2.3 11.4 11.9 1.5 10.0 0.0 7.1 3.5 12.8 4.7 18.6 21.9 6.9 4.6 12.3 4.7 4.9 3.4 7.7 6.8 3.3 9.4 12.4 4.7 8.3 0.0 12.7 1.1 6.8 2.9 0.1 0.3 0.5 0.0 0.1 0.4 0.3 0.3 0.2 0.6 0.3 0.4 0.2 0.4 0.0 0.1 0.4 0.2 4.3 4.4 4.1 4.7 4.1 5.5 5.5 5.5 5.1 4.9 6.0 5.7 2.9 3.2 9.0 36.6 5.7 3.3 3.5 5.0 2.2 6.5 5.8 7.2 10.8 11.5 7.2 11.0 2.1 0.2 2.9 0.3 0.0 3.3 1.9 16.1 13.1 3.1 6.0 7.8 30.0 4.0 1.0 9.7 5.1 4.0 9.5 9.4 3.6 2.4 1.3 6.7 21.9 1.5 4.1 0.9 2.8 3.5 10.2 2.0 3.6 18.7 1.1 10.0 2.1 25.1 27.6 6.3 0.7 10.9 2.4 2.0 0.7 5.6 28.6 15.2 6.6 14.6 7.4 28.8 9.0 2.2 2.6 0.3 5.4 9.0 1.5 1.1 XKR5 ENSG00000275591 "XK related 5" Q6UX68 8 6808517-6835524 "Predicted membrane proteins, Transporters" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.8;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "unprognostic (8.95e-2)" "unprognostic (1.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.46e-2)" "unprognostic (1.78e-1)" "unprognostic (6.73e-2)" "unprognostic (9.91e-2)" "unprognostic (2.16e-3)" "unprognostic (1.30e-1)" "unprognostic (7.91e-3)" "unprognostic (3.13e-2)" "unprognostic (9.19e-2)" "unprognostic (1.03e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-2)" "unprognostic (4.06e-2)" 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.3 0.2 0.7 0.2 0.0 0.1 0.4 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 2.8 0.5 0.0 0.0 0.1 0.9 0.2 0.5 0.8 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.4 0.0 0.1 0.4 1.7 0.1 0.0 0.1 0.5 0.1 0.1 0.2 1.3 3.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 XPR1 "SLC53A1, SYG1, X3" ENSG00000143324 "Xenotropic and polytropic retrovirus receptor 1" Q9UBH6 1 180632022-180890279 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Host cell receptor for virus entry, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 100.9;Excitatory neurons: 118.2;Inhibitory neurons: 102.5;Microglial cells: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 145.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016557 Supported NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA016557: AB_2669382" "unprognostic (2.65e-1)" "unprognostic (2.68e-2)" "unprognostic (1.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.86e-1)" "unprognostic (1.30e-3)" "prognostic unfavorable (3.04e-4)" "unprognostic (2.76e-1)" "unprognostic (2.59e-1)" "unprognostic (3.78e-2)" "unprognostic (4.72e-2)" "unprognostic (6.44e-2)" "unprognostic (8.82e-2)" "unprognostic (7.04e-2)" "unprognostic (1.38e-1)" "unprognostic (2.59e-1)" "unprognostic (8.44e-2)" 7.7 9.0 6.4 7.3 7.8 6.2 6.6 4.5 8.0 19.3 13.8 9.2 11.0 10.9 7.4 7.2 15.3 8.5 30.3 5.3 10.5 20.3 6.3 10.1 5.9 5.6 8.7 7.3 12.6 20.3 6.1 14.1 7.6 6.5 9.9 10.1 6.1 10.1 5.4 4.2 11.0 9.8 5.5 7.0 4.6 16.7 11.5 8.5 13.6 8.3 6.7 12.4 4.4 4.7 16.1 22.6 54.4 19.1 17.9 24.1 51.5 18.2 24.1 12.1 12.9 32.6 23.2 15.2 42.3 21.1 19.2 42.7 22.0 32.3 17.8 21.4 14.1 19.7 15.0 23.3 20.9 16.6 20.7 20.2 31.3 17.2 35.5 19.7 26.7 20.2 61.3 24.7 28.8 14.7 15.9 7.6 51.4 20.3 4.9 16.6 19.5 20.2 30.8 32.8 34.6 145.7 25.0 22.0 16.0 37.0 19.5 18.8 22.3 15.9 15.3 22.9 23.1 27.3 27.5 29.9 11.5 16.3 26.4 0.9 4.5 2.1 3.1 8.4 2.7 1.6 2.8 2.8 3.8 2.0 2.6 2.7 4.3 2.8 13.4 1.1 3.2 3.2 6.4 7.8 4.5 8.0 5.3 10.5 5.6 8.7 7.6 5.5 11.5 4.7 22.4 9.6 14.4 100.9 11.2 25.6 19.7 22.6 55.8 16.3 11.0 9.1 47.3 15.7 15.0 5.5 27.1 13.7 5.3 20.2 3.9 22.3 19.4 27.1 13.3 21.3 12.0 18.3 118.2 44.6 6.6 10.7 8.2 48.2 7.6 11.6 15.0 11.9 9.8 13.5 102.5 7.0 20.3 21.4 17.7 9.7 4.7 14.8 10.6 102.1 9.7 8.1 12.3 79.9 47.5 23.5 12.4 14.3 13.4 13.5 25.6 24.3 23.0 10.5 6.6 8.9 10.5 15.5 17.5 22.3 17.0 7.7 13.4 10.0 10.4 14.1 ZBTB18 "C2H2-171, RP58, TAZ-1, ZNF238" ENSG00000179456 "Zinc finger and BTB domain containing 18" Q99592 1 244048939-244057476 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 172.8;skeletal muscle: 85.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 51.8;Muller glia cells: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 217.5" "HPA024656, HPA074019" Enhanced Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Nuclear speckles" "HPA024656: , HPA074019: " "unprognostic (3.48e-3)" "unprognostic (9.17e-3)" "unprognostic (3.69e-3)" "prognostic favorable (1.34e-4)" "unprognostic (6.83e-2)" "unprognostic (4.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.15e-2)" "unprognostic (1.15e-2)" "unprognostic (8.43e-2)" "unprognostic (1.01e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.54e-3)" "prognostic favorable (6.78e-6)" 9.8 6.3 36.2 14.9 45.4 28.2 9.0 172.8 57.5 7.4 20.3 9.2 13.2 7.2 18.5 5.8 8.6 7.4 12.2 66.1 13.5 11.9 19.0 10.0 18.2 18.0 18.1 7.2 24.6 6.2 4.9 9.4 24.7 10.1 10.8 42.2 10.6 11.5 85.5 8.3 14.6 6.1 19.0 20.2 11.4 22.3 18.9 41.9 8.4 37.5 15.7 10.0 5.4 29.8 23.7 8.2 31.2 1.2 4.0 4.1 21.7 13.0 9.6 20.5 12.4 6.3 18.7 17.9 1.2 25.2 6.6 2.4 20.1 6.4 25.5 6.4 17.7 3.0 3.1 3.0 6.3 3.8 9.1 3.5 5.3 12.3 7.7 24.7 22.5 19.3 2.3 7.5 24.5 0.3 31.4 15.2 16.1 7.3 3.6 9.1 21.2 5.1 13.1 8.0 45.8 44.6 5.4 0.2 14.8 13.0 0.4 27.2 33.7 10.5 12.9 6.5 28.0 3.2 0.4 7.0 10.6 11.6 21.6 0.1 0.2 1.3 0.1 0.3 0.1 0.6 0.2 0.2 0.3 0.9 0.5 0.3 2.3 0.1 0.6 0.9 0.2 0.1 36.2 45.4 172.8 57.5 66.1 13.5 18.0 18.1 24.7 19.0 18.9 29.8 18.5 9.6 18.5 37.2 16.2 11.2 3.3 5.0 8.0 6.1 32.6 6.1 22.2 8.6 10.0 18.4 12.5 1.5 8.2 10.5 0.0 4.5 3.8 18.2 3.3 15.3 19.3 0.0 51.8 5.1 2.0 3.8 10.7 11.0 6.3 5.1 12.8 44.3 6.1 6.7 19.8 16.1 18.3 25.4 26.7 5.0 2.1 16.1 3.6 15.0 13.9 52.1 2.1 21.6 20.8 8.5 7.9 4.9 2.2 5.2 6.6 12.0 17.4 27.6 13.1 10.9 6.2 9.8 7.7 8.7 19.7 1.0 7.2 1.7 14.8 4.2 ZC3HAV1L "C7orf39, MGC14289" ENSG00000146858 "Zinc finger CCCH-type containing, antiviral 1 like" Q96H79 7 139025706-139036042 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 5.6;Gastric mucus-secreting cells: 4.6;Microglial cells: 9.4;Oligodendrocyte precursor cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "basophil: 10.2" "Lineage enriched" "Detected in single" 11 "granulocytes: 10.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020386, HPA050741" Uncertain Enhanced Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Cytosol "HPA020386: AB_2257412, HPA050741: AB_2681224" "unprognostic (1.12e-1)" "prognostic unfavorable (7.35e-4)" "unprognostic (3.07e-2)" "unprognostic (1.50e-1)" "unprognostic (6.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.62e-2)" "unprognostic (8.51e-2)" "unprognostic (3.34e-3)" "unprognostic (2.07e-1)" "unprognostic (3.44e-2)" "unprognostic (2.00e-2)" "unprognostic (1.49e-3)" "unprognostic (5.04e-2)" "unprognostic (2.88e-1)" "unprognostic (1.84e-2)" "unprognostic (3.08e-3)" 3.1 3.7 2.2 2.6 2.8 1.3 3.4 0.0 2.1 3.3 9.9 2.3 3.2 6.7 2.2 4.3 4.9 3.2 2.6 3.3 3.8 2.8 0.8 2.5 2.5 1.4 1.2 9.3 1.8 2.3 1.6 9.5 0.9 3.9 3.2 0.5 2.6 4.3 1.7 8.7 2.6 5.2 0.6 4.6 2.8 2.0 4.4 2.9 8.3 1.6 3.0 2.7 2.8 1.0 14.9 11.9 8.6 28.8 7.1 10.8 0.4 7.2 3.2 5.3 7.3 19.9 8.4 0.4 10.1 7.8 0.0 10.5 12.1 3.0 16.0 8.8 0.1 19.0 12.6 6.8 5.7 0.1 6.6 8.3 4.6 7.9 3.7 0.3 9.1 9.3 8.3 0.5 10.9 0.1 20.4 11.4 1.5 2.0 7.4 21.1 29.2 0.2 4.9 7.9 5.8 26.1 17.7 2.5 10.6 1.7 10.9 7.7 12.7 9.5 8.5 3.2 0.1 0.5 0.1 0.3 5.3 0.1 9.0 10.2 0.1 0.9 0.1 0.1 0.2 0.4 0.3 0.2 0.1 0.9 0.2 0.2 0.4 0.2 0.1 0.2 0.2 0.2 2.2 2.8 0.0 2.1 3.3 3.8 1.4 1.2 0.9 0.6 4.4 1.0 2.4 0.0 0.0 1.6 0.1 0.4 0.9 0.2 2.8 0.3 0.8 1.7 0.5 0.0 0.1 0.0 0.0 1.2 0.1 0.2 0.0 0.2 0.0 1.4 4.4 1.6 0.0 3.8 5.6 0.0 1.6 2.0 4.6 0.8 4.5 3.0 1.1 0.0 0.9 0.0 2.3 0.0 0.0 0.3 0.3 0.0 1.8 0.5 0.0 9.4 0.0 0.6 0.0 5.5 0.2 0.2 0.0 1.5 1.5 0.6 0.0 0.3 0.1 0.0 0.0 0.9 2.3 0.0 0.6 2.9 1.0 0.7 0.2 3.8 0.2 0.5 ZCCHC14 "BDG29, MGC14139" ENSG00000140948 "Zinc finger CCHC-type containing 14" Q8WYQ9 16 87406246-87493024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014122 Uncertain "Nuclear membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear membrane" "HPA014122: " "unprognostic (2.04e-2)" "unprognostic (2.84e-1)" "unprognostic (4.62e-2)" "unprognostic (2.67e-1)" "unprognostic (3.99e-1)" "unprognostic (6.74e-2)" "unprognostic (7.44e-2)" "unprognostic (1.69e-1)" "unprognostic (1.46e-1)" "unprognostic (6.41e-2)" "unprognostic (1.20e-1)" "unprognostic (2.88e-2)" "prognostic favorable (1.47e-14)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (7.13e-2)" "unprognostic (2.83e-2)" 12.5 12.9 9.8 6.1 8.3 3.1 10.0 17.1 10.4 12.1 6.3 10.0 13.7 10.5 6.7 9.1 8.7 10.1 10.4 11.4 5.0 10.0 22.0 10.3 5.1 6.1 5.6 15.3 12.3 13.6 10.2 7.5 4.2 7.2 8.0 10.8 8.1 7.2 9.7 11.7 14.0 7.7 3.3 5.3 8.9 35.3 7.0 4.0 12.4 7.9 4.2 10.4 9.6 6.2 12.7 9.1 15.2 19.8 19.5 13.5 9.2 6.2 9.2 7.4 3.7 19.9 11.0 6.8 8.0 12.3 18.5 20.2 14.4 4.8 9.5 2.0 17.6 6.7 13.9 19.9 8.5 1.8 3.2 11.8 9.7 14.1 8.7 11.0 10.4 3.9 15.8 1.9 6.6 13.5 0.3 8.3 11.9 7.7 8.2 17.7 8.1 3.0 13.2 6.9 34.0 42.8 45.7 6.2 26.1 9.3 14.8 14.6 8.4 17.6 13.5 16.3 10.5 3.9 2.5 20.0 8.1 10.7 11.8 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.2 0.3 0.0 0.0 0.4 0.2 0.2 0.2 0.5 0.0 0.4 0.0 9.8 8.3 17.1 10.4 11.4 5.0 6.1 5.6 4.2 3.3 7.0 6.2 21.4 12.8 12.2 30.0 2.3 18.2 2.6 7.4 6.8 19.6 12.8 11.6 11.1 11.5 12.9 5.5 6.2 3.3 6.7 17.7 3.9 7.0 26.0 11.5 23.7 15.2 21.0 3.2 43.6 8.1 1.9 15.0 10.7 18.6 1.3 17.3 11.4 33.2 5.2 23.5 47.6 14.6 8.2 7.2 10.9 40.2 11.1 7.0 7.2 28.1 2.7 7.1 6.2 46.8 29.7 8.7 7.7 10.1 3.0 3.3 24.6 11.1 9.9 15.1 19.7 12.3 21.8 53.9 22.9 12.1 17.5 3.7 6.3 26.0 15.7 2.6 ZFP3 "FLJ30726, ZNF752" ENSG00000180787 "ZFP3 zinc finger protein" Q96NJ6 17 5078467-5096374 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 11.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 5.8;SH-SY5Y: 6.0;SiHa: 5.5" "Low region specificity" "Detected in all" "HPA053085, HPA057290" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "HPA053085: AB_2682039, HPA057290: AB_2683400" "unprognostic (3.71e-2)" "prognostic favorable (5.68e-4)" "unprognostic (1.45e-1)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (3.05e-1)" "prognostic favorable (1.38e-4)" "unprognostic (5.42e-2)" "unprognostic (3.33e-1)" "prognostic favorable (1.07e-4)" "unprognostic (4.89e-2)" "prognostic favorable (7.69e-7)" "unprognostic (8.30e-2)" "unprognostic (1.16e-1)" "unprognostic (6.32e-2)" "unprognostic (3.29e-3)" 2.6 2.6 2.9 3.9 3.7 0.9 4.7 6.4 4.4 3.3 6.7 4.8 7.1 3.4 3.3 2.7 5.8 2.5 6.8 3.2 3.4 5.2 1.2 3.8 5.3 3.9 3.9 4.9 4.6 9.4 2.1 2.7 3.4 3.9 5.7 8.0 6.0 3.7 6.8 3.5 6.1 3.2 3.2 5.1 4.4 3.1 3.9 5.0 5.8 9.7 6.2 2.8 2.3 3.7 0.0 1.0 0.2 0.0 0.9 0.4 0.0 2.2 0.0 1.7 1.9 4.5 2.0 0.0 3.1 2.2 0.8 4.5 0.0 0.0 0.9 0.0 0.1 0.1 1.9 0.0 3.0 0.0 5.8 1.5 0.0 1.2 0.0 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.2 3.2 0.4 0.0 0.6 1.5 2.7 2.7 2.7 6.0 5.5 4.5 2.9 1.0 2.7 4.4 0.0 0.0 0.8 1.5 3.2 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.8 0.6 1.0 0.9 0.6 0.8 0.6 0.9 0.5 2.1 1.5 1.1 0.0 0.7 0.8 0.3 0.6 0.7 2.9 3.7 6.4 4.4 3.2 3.4 3.9 3.9 3.4 3.2 3.9 3.7 1.8 0.0 4.2 1.6 2.1 0.3 0.4 0.9 1.2 4.1 1.6 1.4 7.8 1.5 2.1 1.8 8.4 1.2 2.4 3.1 0.0 1.7 1.8 3.1 2.7 1.8 0.0 0.8 3.0 1.1 0.4 1.8 4.6 0.8 1.3 2.9 4.2 0.1 1.7 3.3 4.5 2.2 0.0 2.5 0.2 0.5 1.5 1.2 0.0 0.0 0.9 2.8 2.1 4.5 3.1 0.6 1.0 1.2 1.8 0.6 2.6 1.4 11.0 6.0 0.0 3.0 1.5 7.1 3.8 2.3 0.1 0.8 1.6 2.9 2.5 0.5 ZKSCAN1 "KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33" ENSG00000106261 "Zinc finger with KRAB and SCAN domains 1" P17029 7 100015572-100041689 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 272.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006672 Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" Yes No "Cluster 18: Basophils - Vesicular transport" "Cluster 15: Liver - Metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nuclear bodies" "Nucleoplasm, Mitochondria" "HPA006672: AB_1080707" "unprognostic (2.58e-1)" "unprognostic (1.59e-2)" "unprognostic (3.57e-2)" "unprognostic (4.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.24e-2)" "unprognostic (1.47e-2)" "unprognostic (4.76e-3)" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.34e-3)" "unprognostic (8.59e-2)" "unprognostic (1.27e-3)" "unprognostic (7.75e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "unprognostic (9.09e-3)" 12.0 18.4 20.2 11.6 29.1 8.7 22.7 17.2 22.1 16.4 7.4 21.5 18.2 15.5 17.1 18.8 21.7 13.9 10.1 14.4 23.8 13.3 52.8 10.9 11.7 21.3 23.2 19.0 26.1 16.5 10.9 11.0 23.4 23.0 23.5 15.8 25.3 10.8 10.4 32.6 16.9 13.7 13.9 13.5 32.6 11.1 24.1 14.2 11.9 8.8 11.9 12.2 17.4 37.5 17.0 12.3 31.8 34.6 32.0 38.7 12.0 18.6 22.5 10.9 11.0 7.4 15.7 19.1 23.0 20.9 19.1 13.7 18.4 16.1 20.6 18.4 11.3 15.5 15.8 19.3 18.0 29.9 17.7 26.1 25.1 14.7 49.0 29.5 24.4 22.2 36.2 16.3 21.7 22.4 28.4 17.6 12.8 31.6 15.2 16.7 16.2 17.3 18.2 26.4 36.8 44.0 28.9 37.4 32.4 17.8 19.1 19.6 36.8 23.7 23.0 27.9 18.9 18.7 35.3 19.5 16.2 20.8 31.7 16.0 4.0 4.1 5.0 3.1 4.9 3.8 3.9 4.9 5.8 4.8 5.3 3.9 4.2 8.8 9.0 3.9 3.5 3.8 20.2 29.1 17.2 22.1 14.4 23.8 21.3 23.2 23.4 13.9 24.1 37.5 45.3 25.6 55.4 57.5 37.0 15.0 45.7 43.4 71.7 93.9 77.6 38.7 42.8 140.2 61.4 46.0 150.1 41.1 40.1 84.8 15.6 55.9 46.5 89.2 90.9 52.2 220.9 24.6 70.1 43.8 15.3 47.9 103.5 68.0 35.4 120.5 44.6 140.8 19.8 89.2 77.7 99.2 77.3 32.7 18.6 18.4 51.3 31.2 40.9 62.8 45.8 61.2 34.0 102.1 272.5 46.6 81.3 53.4 27.1 93.1 70.4 32.4 153.6 70.1 19.7 87.4 43.9 32.8 16.7 62.9 21.5 65.9 32.3 74.0 114.4 62.0 ZKSCAN7 "FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39" ENSG00000196345 "Zinc finger with KRAB and SCAN domains 7" Q9P0L1 3 44555193-44594173 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.4;Late spermatids: 17.1;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;NTERA-2: 3.1;SH-SY5Y: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048312, HPA049906, HPA071850" Uncertain Supported "Nuclear speckles,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Nuclear speckles" "HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458" "unprognostic (3.31e-2)" "unprognostic (4.49e-2)" "unprognostic (7.25e-2)" "unprognostic (5.78e-3)" "unprognostic (3.41e-2)" "unprognostic (1.21e-3)" "unprognostic (2.18e-1)" "unprognostic (2.31e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (4.22e-4)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-1)" "unprognostic (7.17e-3)" 1.5 2.7 0.8 1.0 0.8 0.3 1.6 1.8 1.0 2.8 1.2 1.9 0.4 2.8 2.3 0.8 2.5 0.9 2.1 0.7 0.8 2.7 2.2 1.3 1.3 0.7 0.7 4.2 3.0 0.8 4.2 0.7 0.6 2.4 0.7 3.0 1.6 1.3 1.0 0.6 1.7 1.4 0.4 2.0 1.7 4.1 0.7 2.2 2.6 0.6 1.2 2.4 1.5 0.9 0.0 0.0 2.6 4.0 0.8 0.3 0.0 1.3 1.1 1.4 1.5 0.0 0.0 0.0 0.4 0.9 0.4 0.0 0.0 0.8 1.7 0.0 0.0 0.1 0.9 1.1 2.4 0.0 0.0 1.8 0.9 0.7 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.2 0.0 0.7 0.3 1.9 4.8 0.0 0.1 0.0 2.9 0.0 1.9 0.4 0.8 0.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.5 0.2 0.3 0.8 0.1 0.2 0.3 0.5 0.6 0.2 0.7 0.3 0.7 0.4 0.6 0.3 0.6 0.5 0.3 0.8 0.8 1.8 1.0 0.7 0.8 0.7 0.7 0.6 0.4 0.7 0.9 0.3 0.0 0.5 5.2 1.4 0.1 0.4 0.9 0.6 6.6 0.9 1.1 4.8 0.0 0.4 1.8 0.0 0.0 3.3 0.2 0.0 2.1 15.4 0.6 1.8 0.9 3.0 1.3 4.3 0.5 0.1 2.1 0.0 0.4 0.0 3.1 0.4 1.4 1.1 3.3 4.7 0.3 0.0 0.3 0.4 17.1 0.9 0.7 0.0 1.0 1.4 3.8 6.2 10.6 6.4 0.9 0.0 2.6 0.4 0.5 0.4 1.3 0.3 4.2 0.0 1.0 1.1 10.8 3.6 0.5 0.4 0.1 1.0 2.9 0.6 0.2 ZNF358 "FLJ10390, ZFEND" ENSG00000198816 "Zinc finger protein 358" Q9NW07 19 7515292-7521025 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 126.5;Granulosa cells: 178.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030887, HPA063624" Approved Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 47: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA030887: AB_10602688, HPA063624: AB_2685064" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (1.34e-2)" "unprognostic (1.59e-2)" "unprognostic (9.89e-3)" "unprognostic (7.82e-2)" "unprognostic (7.40e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (6.52e-2)" "prognostic favorable (2.50e-4)" "unprognostic (4.30e-1)" "unprognostic (4.48e-1)" "unprognostic (4.11e-2)" "unprognostic (2.00e-1)" "unprognostic (9.72e-2)" "unprognostic (3.60e-2)" 70.6 57.4 82.5 12.0 73.1 2.2 58.4 64.8 109.9 75.5 47.5 107.9 29.5 69.8 28.0 31.9 62.1 31.9 109.4 79.3 70.9 52.8 67.0 50.6 10.5 77.8 81.7 88.6 50.5 49.6 60.9 18.3 69.7 78.6 18.3 11.8 51.3 43.8 175.5 38.8 47.9 37.4 68.3 39.6 67.9 12.6 88.4 14.1 59.9 147.0 7.9 88.4 54.3 79.7 32.5 21.4 39.7 63.3 83.2 91.8 33.9 12.0 78.2 53.7 47.0 9.4 22.6 0.0 45.7 64.8 8.5 12.4 16.5 30.8 17.2 0.1 35.0 6.2 24.9 13.3 91.0 0.9 0.3 80.3 57.2 25.4 22.0 80.0 57.1 0.0 16.7 0.0 48.2 16.0 0.1 23.5 40.9 13.4 37.4 35.8 21.2 3.5 28.2 13.8 43.8 87.1 15.1 12.5 43.8 25.5 9.5 16.9 27.1 34.4 24.8 51.6 18.4 41.8 24.8 0.1 31.7 0.0 48.6 1.5 0.5 0.4 0.6 0.5 0.4 0.1 0.1 0.3 0.2 0.7 0.4 0.7 0.0 0.2 0.1 0.4 0.0 0.2 82.5 73.1 64.8 109.9 79.3 70.9 77.8 81.7 69.7 68.3 88.4 79.7 29.5 9.6 11.1 11.8 4.6 7.8 11.8 7.1 2.2 20.8 32.8 37.1 126.5 20.0 5.5 16.5 14.6 3.3 6.5 38.8 5.9 13.0 3.8 9.4 28.2 22.1 36.5 0.8 5.8 16.8 5.1 29.2 8.6 14.2 14.7 178.1 32.5 43.0 10.9 50.5 8.5 27.8 8.2 21.1 10.8 7.7 37.9 13.3 5.4 7.5 3.8 48.8 1.0 8.5 14.9 16.0 21.7 37.2 3.4 11.3 48.3 30.7 3.3 20.7 13.1 22.1 27.6 0.7 1.2 3.2 3.7 3.0 3.6 23.9 24.7 12.8 ZNF362 "FLJ25476, lin-29, RN" ENSG00000160094 "Zinc finger protein 362" Q5T0B9 1 33256492-33300719 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059239 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA059239: AB_2683955" "unprognostic (8.31e-3)" "unprognostic (2.61e-1)" "unprognostic (2.23e-2)" "unprognostic (6.90e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (4.02e-3)" "unprognostic (2.02e-2)" "unprognostic (7.74e-2)" "unprognostic (1.82e-1)" "unprognostic (9.25e-2)" "unprognostic (1.52e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (2.67e-1)" "unprognostic (5.83e-2)" "unprognostic (2.66e-1)" 15.7 12.0 18.4 8.5 17.2 6.7 15.5 17.2 23.1 19.5 8.5 18.9 7.3 22.0 10.2 12.6 16.3 9.1 20.2 16.9 15.6 15.4 8.9 12.6 9.4 18.3 15.4 17.0 13.5 11.9 17.7 11.3 14.3 20.1 5.5 6.3 16.4 13.3 19.7 17.7 11.6 11.7 12.7 16.2 13.7 7.6 18.0 12.2 16.3 11.3 6.7 18.6 15.0 15.8 6.3 10.3 43.7 17.4 11.3 7.9 27.8 8.6 10.3 10.7 11.3 10.6 21.2 3.0 17.1 11.2 3.3 20.6 10.2 5.0 4.5 18.0 7.5 16.1 6.1 13.2 10.1 7.3 12.3 16.9 12.2 4.7 4.1 10.8 14.8 21.2 1.6 5.5 8.3 15.7 23.9 12.9 23.9 3.9 8.4 39.4 10.4 1.5 8.6 10.2 15.4 46.4 24.8 7.8 39.9 18.5 7.7 19.9 21.0 6.5 8.2 15.2 5.6 15.8 15.3 3.4 5.1 6.7 19.4 1.9 1.9 2.6 1.8 1.7 1.3 1.1 1.3 1.6 1.4 2.9 1.2 1.2 1.4 1.7 2.0 3.5 1.1 1.3 18.4 17.2 17.2 23.1 16.9 15.6 18.3 15.4 14.3 12.7 18.0 15.8 15.6 9.6 12.4 13.1 9.2 10.1 4.7 6.2 20.5 12.8 11.0 11.2 25.5 5.7 7.9 11.0 0.0 11.7 16.6 2.6 1.9 6.6 2.5 5.2 12.0 13.9 1.8 3.4 14.3 7.3 5.9 11.8 3.6 7.6 10.1 15.3 18.2 6.9 10.2 8.4 17.7 4.4 6.1 13.9 5.0 8.0 13.7 11.2 8.8 19.7 9.9 9.2 10.3 26.7 14.3 4.3 10.7 21.4 7.5 1.9 7.3 11.4 2.4 4.9 6.6 12.4 16.7 1.2 5.0 11.4 9.5 3.6 10.6 7.7 6.1 2.9 ZNF423 "Ebfaz, hOAZ, JBTS19, KIAA0760, NPHP14, OAZ, Zfp104" ENSG00000102935 "Zinc finger protein 423" Q2M1K9 16 49487524-49857919 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.4;skeletal muscle: 27.5" "Cell type enhanced" "Detected in many" "Astrocytes: 75.4;Late spermatids: 115.7;Microglial cells: 53.4;Oligodendrocyte precursor cells: 38.7;Peritubular cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 62.6;NTERA-2: 33.2;REH: 27.5;SCLC-21H: 35.1;SH-SY5Y: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015258, HPA065820" Enhanced Nucleoplasm NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA015258: , HPA065820: AB_2685563" "unprognostic (2.81e-1)" "unprognostic (1.18e-1)" "unprognostic (1.19e-1)" "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.65e-3)" "unprognostic (3.37e-2)" "unprognostic (4.84e-2)" "unprognostic (1.14e-1)" "unprognostic (2.77e-1)" "unprognostic (9.13e-2)" "unprognostic (8.97e-2)" "unprognostic (1.22e-1)" "unprognostic (6.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.92e-2)" "unprognostic (5.84e-2)" 9.1 2.9 13.5 2.3 9.6 0.3 6.7 14.0 10.2 6.3 1.0 4.3 1.3 5.4 3.4 4.7 9.3 5.8 7.8 9.7 11.0 2.0 0.7 2.9 1.9 14.9 30.4 7.6 3.4 3.0 4.0 4.2 11.8 6.0 2.7 3.6 2.8 9.5 27.5 2.0 2.6 6.5 8.6 1.4 2.0 4.5 26.3 1.8 4.3 14.7 1.2 3.9 5.4 7.8 0.0 0.0 62.6 3.3 5.1 0.6 7.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 1.4 0.0 0.0 1.9 0.5 0.0 3.6 0.1 0.2 0.0 0.0 4.4 0.3 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 8.8 0.4 33.2 0.0 0.0 27.5 0.1 0.0 0.0 1.7 35.1 87.7 0.0 0.1 0.0 17.6 0.0 0.0 0.0 0.0 1.0 16.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.5 9.6 14.0 10.2 9.7 11.0 14.9 30.4 11.8 8.6 26.3 7.8 12.7 0.0 0.0 75.4 0.0 2.7 0.3 0.1 1.2 9.8 0.6 0.6 2.6 0.0 0.0 0.0 0.0 0.5 0.1 2.3 1.9 0.2 23.5 2.7 7.6 11.4 0.0 0.0 10.9 0.2 0.7 15.8 0.0 0.6 0.0 1.6 15.4 0.9 0.7 0.0 7.4 1.0 0.0 0.3 5.1 115.7 27.7 0.4 1.8 53.4 0.0 11.7 0.0 38.7 5.1 0.2 0.4 54.5 0.2 0.1 0.2 0.6 0.0 1.1 0.0 4.5 6.4 0.8 1.9 0.1 1.7 0.3 0.3 5.5 0.7 0.1 ZNF513 "FLJ32203, RP58, Zfp513" ENSG00000163795 "Zinc finger protein 513" Q8N8E2 2 27377235-27380790 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" DNA-binding "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 44.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SH-SY5Y: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051493 Uncertain NA NA "Cluster 10: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" "HPA051493: AB_2681505" "unprognostic (1.11e-1)" "unprognostic (1.68e-1)" "unprognostic (4.67e-3)" "unprognostic (1.16e-1)" "unprognostic (2.99e-1)" "unprognostic (2.00e-1)" "prognostic unfavorable (6.21e-5)" "unprognostic (2.86e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-1)" "unprognostic (9.48e-3)" "unprognostic (1.18e-1)" "unprognostic (5.18e-3)" "unprognostic (9.31e-2)" "unprognostic (1.79e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-3)" 16.2 23.7 15.7 12.7 15.0 12.1 16.7 17.5 19.2 16.6 12.6 22.5 18.7 18.2 5.7 23.8 16.7 9.3 14.3 15.2 14.2 27.3 38.5 18.2 11.1 15.5 15.4 13.4 20.5 10.1 30.2 6.6 14.4 25.8 7.8 4.8 18.7 10.6 11.4 19.5 23.6 7.1 14.1 27.2 24.2 36.1 16.6 8.7 23.5 5.4 6.5 19.4 17.2 15.1 10.3 12.4 15.7 16.0 10.3 8.6 20.6 13.1 15.1 9.6 8.3 10.2 7.6 3.5 11.6 9.4 10.1 9.1 6.7 11.8 2.8 13.0 11.0 9.9 8.9 7.7 18.3 3.4 26.6 14.7 13.0 9.5 11.5 6.3 11.4 13.8 6.2 2.1 9.2 3.9 6.4 16.6 23.7 9.9 8.0 8.2 11.7 6.6 13.5 17.8 9.7 50.8 6.4 7.4 12.9 8.5 5.5 9.8 10.9 6.7 4.4 5.5 3.9 30.1 19.9 6.6 9.3 8.0 13.5 1.2 0.5 1.0 0.4 1.0 0.0 0.0 0.4 0.1 0.7 0.1 0.4 0.2 0.8 0.0 0.5 0.7 0.0 0.3 15.7 15.0 17.5 19.2 15.2 14.2 15.5 15.4 14.4 14.1 16.6 15.1 7.2 3.2 7.5 4.9 2.5 9.2 6.0 5.7 10.2 7.9 10.3 6.9 0.4 10.0 4.3 5.5 4.2 5.6 4.0 14.8 0.0 6.2 44.1 9.0 8.9 7.7 8.4 4.4 4.5 10.2 4.7 4.9 22.4 11.5 0.0 6.9 2.5 10.8 6.0 5.0 5.1 10.6 6.1 2.9 4.6 10.5 4.1 5.3 5.4 1.9 5.9 11.7 2.1 3.0 3.7 9.0 13.5 3.4 4.8 11.0 9.2 5.2 4.7 6.5 6.6 5.6 6.2 9.3 10.3 12.2 13.4 16.1 4.5 10.8 9.4 13.6 ZNF536 KIAA0390 ENSG00000198597 "Zinc finger protein 536" O15090 19 30228290-30713538 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 80.7" "Group enriched" "Detected in some" 9 "Inhibitory neurons: 506.0;Oligodendrocytes: 794.4" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 5.0;HAP1: 11.0;SH-SY5Y: 29.5;U-937: 7.5;WM-115: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077341 Approved "Nucleoplasm,Cell Junctions" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Cell Junctions" "HPA077341: AB_2732340" "unprognostic (1.98e-1)" "unprognostic (4.11e-1)" "unprognostic (1.92e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.03e-1)" "unprognostic (4.70e-2)" "unprognostic (4.68e-1)" "unprognostic (5.50e-2)" "unprognostic (1.74e-2)" "unprognostic (1.25e-2)" "unprognostic (4.46e-4)" "unprognostic (1.58e-1)" "unprognostic (2.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.45e-1)" 0.4 2.6 20.7 0.7 43.1 0.0 0.2 28.1 33.2 1.6 17.7 3.6 1.0 0.5 0.3 3.1 0.3 0.3 2.2 18.1 20.2 0.1 0.0 0.2 0.0 36.7 31.2 0.1 0.2 0.3 4.2 0.0 33.9 2.1 1.6 13.7 0.4 0.8 0.4 0.3 1.9 0.3 19.9 0.5 1.1 2.2 36.1 0.0 3.2 0.8 0.0 2.1 1.1 80.7 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 11.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 29.5 0.0 0.0 1.9 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 7.5 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 43.1 28.1 33.2 18.1 20.2 36.7 31.2 33.9 19.9 36.1 80.7 0.0 0.0 0.0 11.1 0.0 0.4 0.2 0.0 0.0 33.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.8 0.0 0.0 2.4 0.0 0.0 4.3 0.0 0.0 0.0 2.3 0.0 0.0 0.7 70.7 506.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 13.1 0.0 48.6 0.0 46.8 794.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 9.7 0.0 9.1 1.6 0.3 0.6 0.1 0.3 0.0 0.1 0.0 0.0 0.3 ZNF662 FLJ45880 ENSG00000182983 "Zinc finger protein 662" Q6ZS27 3 42906142-42919334 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.4;SH-SY5Y: 3.2;THP-1: 3.3;U-2 OS: 4.6" "Low region specificity" "Detected in all" "HPA039116, HPA040377" Uncertain NA NA "Cluster 32: T-cells - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "HPA039116: AB_2676355, HPA040377: AB_2676949" "unprognostic (2.37e-2)" "unprognostic (2.71e-1)" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.14e-1)" "unprognostic (2.55e-4)" "unprognostic (1.80e-3)" "unprognostic (1.09e-2)" "unprognostic (7.99e-2)" "unprognostic (2.96e-2)" "unprognostic (1.37e-1)" "unprognostic (2.69e-1)" "unprognostic (5.39e-3)" "unprognostic (7.18e-4)" "unprognostic (1.19e-1)" "unprognostic (3.60e-1)" "unprognostic (6.62e-2)" 5.9 4.8 3.5 1.4 3.9 0.9 7.3 6.8 6.5 11.3 5.2 7.3 2.0 9.2 4.5 5.8 8.2 2.6 5.1 3.4 3.6 6.9 5.1 4.3 1.6 3.6 3.3 14.2 10.7 1.3 7.2 2.0 3.6 10.4 3.4 11.1 8.3 4.0 3.5 10.9 4.4 4.1 3.0 4.7 6.2 7.4 3.4 1.1 8.2 2.8 1.5 7.9 8.1 5.2 0.1 0.0 0.2 0.0 0.0 0.0 2.4 1.0 0.0 0.7 0.5 2.4 1.4 0.2 1.7 1.1 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.5 0.5 0.0 0.9 0.1 0.4 2.3 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.3 2.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.7 0.1 1.7 3.2 0.0 1.1 0.0 0.6 0.0 3.3 0.1 0.8 4.6 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.1 0.2 0.0 0.1 0.3 0.2 0.1 0.4 0.3 1.3 1.3 0.4 0.5 0.1 0.4 0.2 0.2 3.5 3.9 6.8 6.5 3.4 3.6 3.6 3.3 3.6 3.0 3.4 5.2 4.2 12.8 4.6 7.2 0.2 2.4 2.5 0.2 2.2 6.5 4.4 3.9 2.9 4.3 3.9 1.8 6.2 1.9 0.2 1.4 1.9 1.8 2.0 1.3 5.6 3.4 5.4 1.3 4.3 3.2 2.4 4.6 12.2 2.3 0.0 9.7 3.6 3.4 0.1 6.7 6.5 2.4 2.0 0.8 2.6 4.4 11.5 0.8 5.4 6.5 0.0 4.1 0.0 16.1 8.0 2.9 1.2 4.5 0.1 1.9 0.4 1.7 1.3 10.9 13.1 6.0 3.3 18.5 11.0 0.9 1.8 2.9 0.4 2.2 4.0 2.1 ZNF713 FLJ39963 ENSG00000178665 "Zinc finger protein 713" Q8N859 7 55887456-55942530 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 18.6;Excitatory neurons: 16.2;Late spermatids: 16.2;Oligodendrocytes: 25.6" "Cancer enhanced" "Detected in many" "glioma: 3.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basophil: 2.1;eosinophil: 2.3;neutrophil: 3.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.6" "Cell line enhanced" "Detected in many" "SH-SY5Y: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059425, HPA062887" Uncertain Approved Nucleoli NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoli "HPA059425: AB_2684013, HPA062887: AB_2684894" "unprognostic (5.27e-2)" "unprognostic (2.50e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" "unprognostic (1.36e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-3)" "unprognostic (1.46e-1)" "unprognostic (7.07e-2)" "unprognostic (4.63e-2)" "unprognostic (2.77e-3)" "unprognostic (7.78e-2)" "unprognostic (4.80e-2)" "unprognostic (8.00e-2)" "unprognostic (8.16e-3)" "unprognostic (1.34e-1)" "unprognostic (1.63e-3)" 0.6 0.9 1.2 0.6 1.2 1.6 1.2 1.6 1.6 0.9 0.3 0.7 1.1 1.7 1.0 0.6 1.9 0.8 0.7 1.1 1.1 1.0 0.6 0.8 0.6 1.7 1.3 1.7 1.2 0.6 1.8 0.7 1.7 1.2 0.5 2.4 0.9 0.8 1.7 1.1 0.7 1.0 0.7 0.9 1.4 3.8 1.5 1.5 1.3 0.7 0.6 0.4 0.4 4.2 1.0 0.4 3.5 3.5 0.3 0.7 1.3 0.4 0.3 0.6 0.6 0.3 1.3 1.5 1.4 0.3 1.1 0.3 0.8 0.3 0.4 0.9 1.5 0.4 1.5 1.1 0.7 2.0 1.1 0.8 0.6 0.3 0.5 0.8 0.8 2.1 1.1 0.8 0.5 0.7 2.3 1.4 2.6 1.2 0.7 1.6 1.0 0.2 1.7 1.8 3.8 5.2 1.8 0.6 0.7 1.7 1.6 1.4 0.7 0.6 1.9 0.4 0.6 0.9 1.2 0.7 0.4 1.1 3.2 2.1 0.4 2.3 0.2 0.4 0.1 0.3 0.2 0.1 0.1 0.5 0.2 0.3 3.6 0.4 0.4 0.4 0.1 0.1 1.2 1.2 1.6 1.6 1.1 1.1 1.7 1.3 1.7 0.7 1.5 4.2 1.8 0.0 3.7 11.4 1.2 1.3 3.8 2.6 0.6 3.0 1.6 0.8 1.8 7.2 3.3 0.0 10.4 1.1 0.8 1.3 0.0 1.2 18.6 6.5 2.5 2.2 0.0 3.0 16.2 1.4 1.0 1.6 1.1 2.4 1.3 6.9 1.1 0.3 0.4 8.4 13.3 1.6 4.1 1.3 3.1 16.2 0.6 1.3 0.0 3.7 0.7 6.0 0.0 11.6 25.6 1.6 0.3 2.6 0.1 2.1 0.4 0.5 8.2 2.9 6.6 3.9 2.2 7.0 7.7 0.9 1.8 2.1 1.3 1.2 0.9 2.3 ZNF792 FLJ38451 ENSG00000180884 "Zinc finger protein 792" Q3KQV3 19 34956354-34964229 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 7.0;Endothelial cells: 7.5;Hepatic stellate cells: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 12.8;HMC-1: 16.1;HUVEC TERT2: 11.0;OE19: 9.7;SH-SY5Y: 10.2" "Low region specificity" "Detected in many" "HPA035157, HPA035158" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear bodies" "HPA035157: AB_2674497, HPA035158: AB_10603010" "unprognostic (1.31e-1)" "unprognostic (7.31e-2)" "prognostic favorable (2.72e-4)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (7.91e-2)" "unprognostic (2.41e-5)" "unprognostic (2.49e-2)" "unprognostic (4.30e-2)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "unprognostic (4.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.88e-1)" "unprognostic (2.48e-1)" "unprognostic (6.02e-2)" "unprognostic (2.77e-3)" 3.8 1.3 1.1 2.2 1.6 1.3 3.6 3.6 1.3 2.4 1.1 1.9 2.1 2.2 1.9 1.0 2.6 1.7 2.0 0.9 1.2 1.6 1.3 4.1 3.8 1.2 1.4 2.3 1.8 2.8 1.1 3.4 1.2 1.8 2.3 2.5 2.2 2.2 1.2 1.5 2.4 2.6 0.9 3.6 2.5 0.9 1.3 4.0 1.9 2.1 2.8 2.3 1.4 0.9 1.1 3.8 1.8 2.7 1.8 1.4 0.0 1.1 2.0 1.3 1.6 1.5 1.8 1.6 3.4 1.5 0.6 0.7 2.6 2.0 2.0 4.6 0.6 12.8 1.1 2.9 1.3 1.1 16.1 1.6 0.6 1.1 0.5 2.3 11.0 1.1 3.4 0.0 2.2 0.9 4.5 1.1 1.3 9.7 0.8 2.9 0.0 0.2 1.0 3.5 0.9 10.2 1.0 1.0 1.3 1.6 1.2 3.4 4.5 1.9 2.4 0.8 1.2 0.3 1.0 0.9 2.1 0.2 0.9 5.4 0.5 4.1 1.9 0.4 2.3 1.3 3.0 2.7 0.7 0.9 3.3 2.8 0.1 3.0 0.3 0.1 3.2 1.7 1.1 1.6 3.6 1.3 0.9 1.2 1.2 1.4 1.2 0.9 1.3 0.9 7.0 0.0 1.1 0.7 2.1 0.5 0.1 0.6 0.6 0.8 1.2 0.9 2.0 0.0 0.2 0.0 2.1 0.1 2.9 0.7 0.0 1.8 0.2 0.7 0.7 7.5 1.8 3.4 0.3 2.6 0.4 1.0 2.0 0.8 1.3 1.4 6.4 0.6 1.5 0.0 0.6 1.7 0.0 3.5 1.4 0.4 1.5 1.6 0.0 1.0 1.6 0.5 2.1 2.5 0.3 2.7 1.0 0.0 1.6 0.2 0.5 0.5 0.2 1.8 0.0 0.9 0.6 0.0 1.5 0.4 0.4 0.1 3.0 0.7 1.4 0.1 ZNF853 DKFZp434J1015 ENSG00000236609 "Zinc finger protein 853" P0CG23 7 6615610-6624290 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 13.2;Granulosa cells: 15.1;Muller glia cells: 13.2;Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 20.1;SH-SY5Y: 29.5;U-2 OS: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067690 Approved Approved Nucleoli NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoli "HPA067690: AB_2685888" "unprognostic (1.35e-3)" "unprognostic (2.63e-1)" "unprognostic (7.17e-2)" "unprognostic (8.77e-2)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" "unprognostic (1.17e-1)" "unprognostic (3.54e-1)" "unprognostic (2.26e-2)" "unprognostic (5.06e-2)" "unprognostic (1.87e-3)" "unprognostic (9.28e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.41e-3)" "unprognostic (4.95e-2)" "unprognostic (2.30e-3)" "unprognostic (4.01e-2)" 4.1 2.8 24.8 2.3 24.7 0.6 4.5 20.4 24.0 9.6 11.8 12.9 1.1 11.3 4.4 4.3 9.2 4.5 10.5 23.7 23.7 4.9 0.5 3.7 2.9 27.8 27.9 12.0 7.0 5.5 6.6 2.8 25.1 7.8 1.7 5.1 5.4 8.6 27.1 3.1 4.4 6.6 25.6 3.5 4.9 2.6 24.8 3.3 7.9 20.2 2.0 10.1 4.9 21.0 0.0 1.6 4.7 20.1 0.2 0.0 0.2 0.4 0.0 2.1 0.4 3.6 0.8 0.0 7.8 0.0 0.7 0.0 7.2 0.2 2.0 0.0 2.6 0.6 0.0 3.8 2.8 0.0 0.1 0.7 0.6 0.2 0.1 2.0 0.0 1.6 3.2 0.1 1.3 0.1 0.5 2.7 7.5 0.0 0.0 2.3 7.8 0.1 1.5 7.6 6.3 29.5 0.0 0.3 1.2 3.9 1.1 4.3 0.0 1.5 19.5 0.0 1.9 0.4 0.1 0.1 0.0 0.0 7.8 0.0 0.0 0.8 0.2 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 24.8 24.7 20.4 24.0 23.7 23.7 27.8 27.9 25.1 25.6 24.8 21.0 4.3 0.0 0.0 2.0 1.0 0.5 1.5 0.2 1.2 13.2 3.2 4.4 10.4 0.0 0.6 7.3 6.2 0.0 2.0 0.1 0.0 0.6 1.6 7.5 4.3 3.2 1.8 0.4 1.5 0.7 0.0 4.4 0.5 2.3 0.0 15.1 2.5 0.0 0.1 5.0 2.7 0.0 0.0 0.0 0.9 2.4 5.3 0.2 3.6 1.9 0.1 13.2 1.0 2.0 2.8 0.4 0.1 8.6 1.3 3.3 0.0 0.2 2.3 10.4 13.1 6.4 5.4 0.5 0.5 0.4 0.3 0.3 1.8 6.9 0.1 0.7 ZSCAN16 "dJ265C24.3, FLJ22191, ZNF392, ZNF435" ENSG00000196812 "Zinc finger and SCAN domain containing 16" Q9H4T2 6 28124609-28130082 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 69.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007290 Supported Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 45: Intestine - Brush border" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA007290: AB_1080721" "unprognostic (1.50e-1)" "prognostic favorable (5.73e-4)" "unprognostic (3.29e-2)" "unprognostic (8.93e-2)" "unprognostic (3.05e-3)" "unprognostic (1.00e-2)" "unprognostic (3.07e-2)" "prognostic favorable (3.19e-4)" "unprognostic (1.23e-2)" "prognostic favorable (1.14e-5)" "unprognostic (2.50e-1)" "unprognostic (1.98e-1)" "unprognostic (2.50e-1)" "unprognostic (1.55e-2)" "unprognostic (2.14e-1)" "unprognostic (3.37e-3)" "prognostic favorable (3.41e-5)" 3.2 3.9 5.3 5.5 6.4 3.2 7.0 7.7 7.6 3.9 5.2 7.1 8.6 3.9 7.1 3.6 4.1 4.0 3.0 5.6 6.6 5.4 4.4 4.9 8.3 6.4 5.9 2.5 4.9 6.9 3.2 2.2 6.4 4.7 9.0 7.2 6.6 5.8 3.2 6.9 8.4 4.7 5.5 7.4 7.0 2.2 6.1 8.0 4.6 2.7 9.1 4.2 2.7 9.1 0.1 8.8 11.1 8.2 3.0 0.7 9.1 3.0 6.4 7.8 8.4 6.1 5.7 8.8 8.0 2.8 5.4 6.8 7.8 4.4 7.4 12.8 10.8 9.1 7.4 8.7 4.8 6.8 7.4 1.0 7.3 6.6 3.6 8.3 14.7 0.2 1.3 7.3 2.1 10.0 0.0 10.7 2.3 7.4 5.3 10.9 8.4 12.2 9.3 12.6 15.0 16.5 1.5 9.2 10.9 7.2 12.2 3.2 4.6 2.9 6.7 4.4 7.9 3.7 12.5 2.4 1.3 3.4 1.6 69.0 8.6 10.2 13.8 11.8 17.7 19.3 12.0 10.6 9.0 14.6 14.5 11.8 15.6 17.7 11.6 19.6 14.7 8.6 5.3 6.4 7.7 7.6 5.6 6.6 6.4 5.9 6.4 5.5 6.1 9.1 5.6 6.4 2.6 0.3 5.6 1.8 0.8 4.9 1.2 3.8 5.2 5.6 1.6 10.0 7.5 7.3 4.2 2.2 12.6 4.7 5.9 12.8 3.3 4.2 0.8 4.0 1.8 8.2 1.4 12.6 1.2 1.4 4.6 3.3 2.5 4.8 4.2 2.0 2.1 1.7 1.1 6.0 14.2 3.8 1.3 1.5 0.6 4.3 1.8 1.0 6.1 5.6 11.3 3.5 3.7 9.6 6.1 3.4 4.2 1.3 10.3 8.3 7.7 6.6 0.0 1.7 3.7 1.7 6.3 2.7 1.3 1.8 6.1 2.2 7.0 1.1 ZSWIM4 FLJ12221 ENSG00000132003 "Zinc finger SWIM-type containing 4" Q9H7M6 19 13795460-13832230 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 16.6" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 34.2;Urothelial cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042084 Uncertain NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" "HPA042084: AB_10795392" "unprognostic (3.29e-2)" "unprognostic (4.07e-1)" "unprognostic (4.15e-2)" "unprognostic (1.41e-3)" "unprognostic (4.78e-2)" "unprognostic (1.34e-3)" "unprognostic (4.25e-3)" "unprognostic (6.14e-2)" "unprognostic (5.36e-2)" "unprognostic (1.56e-2)" "unprognostic (1.78e-1)" "unprognostic (6.15e-2)" "prognostic unfavorable (7.85e-5)" "unprognostic (3.47e-1)" "unprognostic (4.95e-1)" "unprognostic (1.86e-1)" "unprognostic (8.63e-2)" 3.3 5.3 0.8 2.0 0.8 1.0 4.9 0.9 1.9 5.6 1.4 2.8 1.1 4.2 0.2 16.6 3.3 1.4 4.1 0.8 1.2 6.2 1.9 7.1 1.2 1.5 1.2 3.6 3.9 1.0 4.7 1.6 1.3 5.0 0.3 1.1 14.8 0.8 2.9 8.5 3.0 0.9 0.8 4.1 3.5 1.4 1.4 1.4 5.8 0.8 1.3 3.2 7.6 0.9 4.3 2.4 4.7 2.4 0.6 0.5 4.5 1.8 3.9 1.6 1.7 0.9 2.3 1.5 2.8 1.5 2.5 1.7 0.8 1.6 1.1 5.4 1.5 0.2 3.0 0.5 3.8 0.4 1.2 2.5 0.4 1.8 0.7 3.9 3.8 3.6 1.4 3.2 0.5 2.3 2.4 3.4 5.5 0.8 2.4 5.3 4.4 2.5 2.2 2.0 1.3 9.1 3.1 7.6 3.3 2.7 1.1 2.8 4.5 4.7 1.7 1.4 6.2 3.9 2.5 1.0 3.0 1.8 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.9 1.9 0.8 1.2 1.5 1.2 1.3 0.8 1.4 0.9 5.5 3.2 2.0 4.9 2.4 5.4 17.1 8.6 2.8 5.4 11.9 6.9 3.3 8.6 7.4 3.7 8.4 4.2 2.0 3.3 0.0 13.1 0.2 11.1 5.0 10.4 10.7 1.7 5.8 23.1 3.4 6.0 4.1 23.0 0.0 3.7 4.6 1.8 4.6 6.7 7.0 3.0 2.0 7.0 11.9 0.4 1.2 5.6 3.6 5.6 3.8 2.4 0.0 6.0 1.8 23.8 2.3 1.2 1.5 14.3 3.9 3.2 12.6 3.7 0.0 34.2 6.4 0.3 0.9 4.9 7.0 6.0 6.8 0.7 3.9 26.8